data_5gjj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5gjj _Structure_validation_residue.Date_analyzed 2017-06-30 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt . . . . . 0 N--CA 1.431 -1.41 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -118.85 41.06 3.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 19.5 m -124.35 177.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.292 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.86 120.84 80.04 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.41 -24.38 10.72 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.219 1.946 . . . . 0.0 112.13 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.02 160.87 21.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.031 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -93.63 112.94 24.92 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -92.16 131.56 37.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.85 179.06 22.26 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.822 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.37 159.92 31.86 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -83.97 117.2 23.22 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 170.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 158' ' ' LEU . 25.8 p -110.82 -97.8 0.41 Allowed 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -173.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.16 163.61 19.67 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.38 92.55 0.08 OUTLIER Glycine 0 CA--C 1.499 -0.962 0 O-C-N 123.76 0.662 . . . . 0.0 112.968 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 65' ' ' MET . . . 104.69 19.17 11.39 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 124.512 0.772 . . . . 0.0 111.735 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -129.36 115.33 34.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 117.016 0.408 . . . . 0.0 110.73 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.33 115.65 27.71 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -100.27 112.64 24.98 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.34 101.67 13.91 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.41 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 5.6 mp -73.32 -49.28 28.35 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.33 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -108.42 105.28 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.02 153.54 21.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.099 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.576 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -57.05 159.33 4.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.047 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 72.56 6.12 5.38 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 124.855 1.262 . . . . 0.0 111.948 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.4 m -91.8 125.73 36.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 10.0 t -68.35 134.71 50.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.517 0.675 . . . . 0.0 112.256 -177.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.428 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 33.1 pt -94.98 154.54 39.65 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.639 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.2 Cg_exo -63.26 133.73 14.9 Favored 'Cis proline' 0 N--CA 1.478 0.566 0 CA-C-N 119.873 0.991 . . . . 0.0 114.012 0.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -110.01 162.18 14.79 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.257 1.023 . . . . 0.0 109.266 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -166.57 148.19 6.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.542 0.527 . . . . 0.0 110.807 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 29' ' ' LEU . 15.3 mm100 -147.75 118.78 7.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 125.821 1.648 . . . . 0.0 107.544 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 84.9 m -111.67 116.33 30.59 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -128.97 141.11 51.36 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.13 124.67 48.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.401 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 97.0 m-85 -111.74 160.12 17.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.75 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 21.3 p -129.89 171.96 12.19 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -113.51 138.49 50.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 119.623 1.101 . . . . 0.0 110.534 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -82.52 -39.22 22.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 p -63.88 98.17 0.19 Allowed 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.759 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.47 160.68 27.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.354 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 m120 62.82 22.42 13.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -94.46 114.11 62.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 3.3 Cg_exo -79.64 -8.04 14.71 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.82 126.75 2.43 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.45 160.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.3 tp -111.86 117.85 33.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.74 118.39 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -132.85 129.85 39.0 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.331 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.38 127.53 50.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -124.21 153.46 41.58 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.566 0.746 . . . . 0.0 110.107 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 37.1 mt-10 -117.09 137.12 52.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.36 -155.45 16.09 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -152.29 130.63 12.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.058 0.543 . . . . 0.0 110.575 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 27.3 mmt180 -147.67 163.91 35.17 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 170.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.54 62.85 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.644 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 58.7 mtt -109.68 135.04 51.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.102 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.43 ' HB ' ' HG2' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -65.25 98.74 0.34 Allowed 'General case' 0 N--CA 1.416 -2.126 0 O-C-N 124.076 0.86 . . . . 0.0 112.573 -175.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 19.3 pttp -176.82 169.81 2.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 66.75 11.26 8.12 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 123.621 0.768 . . . . 0.0 111.874 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.504 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 96.3 m-20 -118.63 179.96 3.98 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.416 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -90.49 151.88 21.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -118.52 121.18 39.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.7 mt -84.65 -48.13 9.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.707 0.289 . . . . 0.0 111.596 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.74 170.89 42.39 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -143.48 162.92 34.57 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -155.06 142.64 19.72 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.68 117.87 35.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.038 0.447 . . . . 0.0 110.299 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.3 tp -92.77 112.65 24.69 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.889 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -107.95 155.36 20.4 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.32 -15.31 6.11 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.948 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.4 mp -60.5 125.41 82.17 Favored Pre-proline 0 C--O 1.247 0.939 0 C-N-CA 122.88 0.472 . . . . 0.0 110.136 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.54 126.8 16.79 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.95 1.767 . . . . 0.0 109.839 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.95 90.45 0.11 Allowed 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.594 2.196 . . . . 0.0 111.167 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.56 167.37 15.18 Favored Pre-proline 0 N--CA 1.42 -1.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.367 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.45 -179.0 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.508 2.805 . . . . 0.0 114.646 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -72.48 129.14 37.65 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.662 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.408 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 85.71 4.02 85.55 Favored Glycine 0 C--N 1.309 -0.949 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.714 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.7 t -90.55 -49.39 0.36 Allowed Pre-proline 0 CA--C 1.557 1.232 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.31 119.93 7.19 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.328 1.352 . . . . 0.0 111.27 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.38 106.61 17.79 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.296 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.36 116.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 39.2 tt0 -90.64 117.48 29.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' THR . 74.1 t -110.41 113.11 43.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.4 m -99.48 111.67 23.99 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -116.67 107.86 15.2 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -174.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -141.02 149.63 41.97 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.061 0.458 . . . . 0.0 111.192 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.8 mt -116.62 140.17 40.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -90.63 -167.25 1.78 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -18.25 59.55 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -82.73 -29.12 30.0 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.49 0.662 . . . . 0.0 109.301 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.16 31.96 3.4 Favored Glycine 0 N--CA 1.416 -2.674 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.9 mt -99.96 121.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.283 0.563 . . . . 0.0 109.751 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 tp -89.07 121.45 31.42 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.493 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -113.41 123.08 49.23 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.02 114.29 45.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -111.49 122.73 48.6 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.297 0.373 . . . . 0.0 110.009 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.65 117.73 34.82 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -118.6 114.56 22.97 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.813 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.72 112.19 13.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 62.5 mttm -67.08 -24.57 65.97 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.669 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -65.52 -54.65 25.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -91.52 -44.61 8.98 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.53 7.08 26.5 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -85.91 137.57 32.65 Favored 'General case' 0 N--CA 1.403 -2.79 0 CA-C-O 121.061 0.457 . . . . 0.0 110.401 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.32 140.81 47.64 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.01 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -135.73 131.79 36.04 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.61 166.16 16.59 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.05 145.05 33.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.8 m -117.45 113.08 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.6 mt -126.84 119.72 53.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 O-C-N 122.324 -0.235 . . . . 0.0 110.864 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.1 t -79.51 132.55 36.35 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 C--N 1.318 -0.799 0 CA-C-O 121.161 0.505 . . . . 0.0 110.331 178.422 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.409 ' O ' HG21 ' A' ' 135' ' ' VAL . 60.3 mt -67.89 -41.95 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.458 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -60.14 -42.33 94.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.819 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -60.42 -43.24 96.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.7 ttm -58.62 -44.91 90.11 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.923 0.889 . . . . 0.0 110.613 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 59.4 t -63.14 -47.1 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -58.94 -43.23 91.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.73 -35.94 82.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.0 110.501 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.95 -30.22 69.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.511 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 7.6 mm-40 -78.79 -44.6 22.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.413 1.101 . . . . 0.0 109.082 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.63 -48.08 83.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.533 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.96 19.01 20.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.85 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 18.8 ttmm -54.32 -47.44 72.47 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.563 0.539 . . . . 0.0 112.139 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.18 70.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.168 0.509 . . . . 0.0 111.589 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.51 -46.84 68.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.447 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.86 -36.97 83.53 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.435 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 45.5 mm-40 -58.1 -50.17 74.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.677 0.217 . . . . 0.0 111.253 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.23 -47.03 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.273 0.358 . . . . 0.0 110.357 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -57.22 -46.23 83.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.73 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -66.06 -47.89 72.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.071 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -75.35 -7.78 54.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.254 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.0 mtp85 -73.99 -20.3 60.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.926 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.61 82.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.0 p -132.66 138.66 47.39 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.234 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -168.61 -54.5 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -169.37 150.1 4.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.401 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 56.6 m-80 -64.57 117.42 7.36 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.302 0.572 . . . . 0.0 110.29 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.02 161.59 38.38 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.648 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' THR . 21.7 mt -120.36 137.11 54.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -112.54 129.93 56.19 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 172.441 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . 0.261 4.0 mm? . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 35' ' ' THR . 2.3 m-20 -94.52 64.42 3.06 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 m -139.52 174.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.998 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.51 120.79 72.24 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.11 -43.33 30.23 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 122.486 2.124 . . . . 0.0 113.116 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.427 ' C ' ' HB3' ' A' ' 32' ' ' ARG . 10.0 mp -123.31 174.18 7.48 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 m -88.3 127.86 35.48 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.4 130.91 37.95 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.2 -170.74 19.76 Favored Glycine 0 N--CA 1.408 -3.169 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.452 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.4 mt -129.27 162.93 26.78 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.169 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.54 144.45 28.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 12.9 p -126.35 -94.29 0.47 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 122.946 0.498 . . . . 0.0 111.575 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.41 106.11 14.53 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.11 -60.64 4.78 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.752 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.91 56.43 0.1 Allowed Glycine 0 C--N 1.291 -1.928 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.9 t -122.11 115.33 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.62 114.02 22.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -106.72 111.39 23.9 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.78 132.04 36.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.031 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -49.8 3.47 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.32 102.68 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 152.99 37.23 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.571 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.527 HH12 ' HA ' ' A' ' 135' ' ' VAL . 36.9 ptt180 -62.58 160.7 13.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 73.82 5.13 4.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.772 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 9.9 t -65.84 135.2 54.53 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.779 0.799 . . . . 0.0 111.548 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 pt -98.89 155.42 36.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.548 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.06 144.59 75.54 Favored 'Cis proline' 0 C--O 1.25 1.089 0 N-CA-C 115.265 1.217 . . . . 0.0 115.265 4.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 p -122.16 161.3 23.4 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.282 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HB2' ' HZ3' ' A' ' 39' ' ' LYS . 4.8 ttmp? -166.08 100.6 0.64 Allowed 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -119.0 131.09 55.98 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.102 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.7 m -114.44 122.44 46.63 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.53 0.732 . . . . 0.0 110.771 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' N ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -129.46 148.7 51.4 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mm -96.23 121.7 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.206 0.527 . . . . 0.0 110.397 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 79.6 m-85 -109.26 143.66 38.43 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.625 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 16.9 p -119.78 171.17 8.59 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -113.89 141.7 47.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.563 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 29.9 m-85 -88.18 -41.09 13.22 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 p -73.87 130.43 39.89 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.557 175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -106.46 166.82 10.27 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.072 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 67.88 23.81 8.27 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.312 0.645 . . . . 0.0 112.091 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.588 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 15.0 mm-40 -81.86 132.77 53.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.07 -39.63 30.79 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.554 1.502 . . . . 0.0 110.674 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.35 166.72 33.79 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -106.48 135.07 46.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.09 0.471 . . . . 0.0 110.947 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.46 107.26 16.62 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.681 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -96.18 114.7 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -122.56 110.79 16.01 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.562 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.83 127.01 44.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 123.594 0.559 . . . . 0.0 111.371 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 53.0 m-85 -133.62 155.26 49.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -110.76 143.27 41.55 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 165.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.38 112.49 0.62 Allowed Glycine 0 C--N 1.263 -3.486 0 C-N-CA 118.285 -1.912 . . . . 0.0 111.105 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.48 86.46 5.16 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -145.18 146.02 31.58 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.25 -50.15 64.75 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.402 1.096 . . . . 0.0 109.846 172.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.2 mtt -112.22 130.3 55.97 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.18 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 101.79 1.03 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 123.912 0.757 . . . . 0.0 109.69 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -76.28 -52.7 9.45 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 122.01 0.91 . . . . 0.0 108.684 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -153.5 -54.0 0.11 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.36 -176.77 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.27 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 65.9 t30 -95.38 112.74 24.4 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.075 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.9 114.08 17.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.27 -34.41 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.669 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.67 176.16 39.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.23 170.4 20.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 117.032 0.416 . . . . 0.0 110.026 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -164.22 155.43 15.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -114.68 118.94 35.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.213 0.53 . . . . 0.0 110.133 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -95.49 108.03 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.3 p -97.03 150.18 21.08 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.81 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 24.01 1.78 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.812 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 50.6 mm -82.51 125.19 76.77 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.84 163.27 35.92 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.544 2.163 . . . . 0.0 112.348 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.35 40.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.217 2.611 . . . . 0.0 111.208 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . . . -84.74 124.91 72.37 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.75 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 16.6 Cg_exo -66.13 99.82 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.148 2.565 . . . . 0.0 115.506 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.4 mtp180 54.91 114.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.617 1.967 . . . . 0.0 115.442 167.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.98 -20.6 31.78 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.661 -0.781 . . . . 0.0 114.764 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.79 -47.03 6.95 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 122.458 -0.436 . . . . 0.0 111.416 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.99 113.26 3.51 Favored 'Trans proline' 0 C--N 1.376 2.005 0 N-CA-C 108.782 -1.276 . . . . 0.0 108.782 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.288 0.0 OUTLIER -129.78 128.01 41.52 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.05 0.929 . . . . 0.0 113.049 -178.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 mm -107.14 126.72 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.713 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.18 107.73 19.4 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.04 120.56 60.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.322 0.582 . . . . 0.0 110.152 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.5 m -113.55 124.76 53.12 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.146 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -105.86 114.34 28.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -123.66 138.58 54.51 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.8 mt -125.71 141.99 43.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -104.78 -170.14 1.72 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.6 -11.81 60.55 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -84.96 -28.76 25.61 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.029 0.442 . . . . 0.0 109.825 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.44 23.34 8.03 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 86.6 mt -90.3 117.57 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-O 121.382 0.611 . . . . 0.0 109.526 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 38.6 tp -95.74 129.27 43.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.646 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.482 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 45.4 m-80 -117.62 108.68 15.74 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.84 113.79 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -111.32 114.44 27.61 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.303 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.19 123.62 47.12 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.471 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.1 m -118.5 119.92 35.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.414 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.84 104.5 6.41 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -68.31 -18.31 64.48 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.582 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -68.43 -61.96 1.6 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.855 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 p -98.98 -37.71 9.27 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 120.8 0.333 . . . . 0.0 111.346 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.24 -0.59 8.21 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.045 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.0 137.31 55.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 117.406 0.603 . . . . 0.0 112.03 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.92 136.85 32.67 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.131 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -139.96 139.52 36.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -137.95 142.01 40.54 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.128 0.49 . . . . 0.0 110.689 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 34.4 pt -119.17 147.66 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.5 m -106.96 113.45 26.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.017 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -128.83 116.4 40.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.7 m -72.54 127.32 32.19 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 168.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 N--CA 1.51 2.548 0 O-C-N 124.339 1.024 . . . . 0.0 111.217 -170.668 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.864 0.364 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 135' ' ' VAL . 48.0 mm -61.15 -45.3 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.66 -25.04 62.82 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -60.21 -45.0 94.68 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.5 mmt -59.48 -45.07 92.72 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.527 ' HA ' HH12 ' A' ' 32' ' ' ARG . 96.2 t -60.29 -57.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.085 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -70.22 -48.47 56.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -172.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.54 -38.62 91.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.02 -39.72 83.07 Favored 'General case' 0 C--O 1.19 -2.079 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.602 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -58.26 -33.31 69.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.493 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.4 -37.81 51.12 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -126.19 15.75 7.82 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -59.3 -27.31 65.74 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.48 95.52 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.772 0.796 . . . . 0.0 108.867 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 24.8 mm-40 -70.61 -44.96 66.17 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.506 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.99 -45.42 83.0 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 123.545 0.528 . . . . 0.0 112.266 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 38.2 mt-10 -61.24 -39.29 89.75 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.79 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.575 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 82.9 t -63.74 -48.73 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.6 mm-40 -56.18 -46.06 79.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.519 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.431 ' C ' ' HD3' ' A' ' 149' ' ' ARG . 2.5 tmt_? -53.29 -50.83 64.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.593 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.1 pt-20 -83.18 -5.14 59.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 11.7 mmp_? -76.29 -34.54 59.07 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.88 -54.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 49.0 m -149.32 129.18 13.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.0 -38.04 9.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.01 0.434 . . . . 0.0 110.779 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.465 ' HE3' ' OG1' ' A' ' 45' ' ' THR . 64.1 tttp -80.65 144.93 31.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 90.0 m-20 -76.68 99.13 4.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.319 0.581 . . . . 0.0 110.675 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -134.6 132.82 39.5 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.907 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.405 HD23 HG23 ' A' ' 21' ' ' THR . 18.5 mt -101.13 114.32 28.15 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.1 119.32 37.64 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.708 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.4 tp . . . . . 0 N--CA 1.419 -1.995 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.8 m-20 -78.76 56.99 1.98 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.538 -172.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.0 m -136.56 168.37 22.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.8 127.2 68.42 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.68 -47.34 9.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.578 2.185 . . . . 0.0 111.972 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.19 169.83 10.86 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.151 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -76.79 129.47 36.32 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.1 131.55 40.97 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.84 178.13 26.6 Favored Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.865 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.7 mt -123.93 164.71 18.75 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.324 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -84.18 109.58 17.85 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 p -99.19 142.47 30.64 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.461 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.64 113.91 0.68 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.355 1.462 . . . . 0.0 113.049 -172.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.08 -11.46 8.2 Favored Glycine 0 N--CA 1.425 -2.06 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.384 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' HA2' ' OE1' ' A' ' 20' ' ' GLU . . . 84.49 50.33 4.29 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.64 134.75 65.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.2 ttt -94.23 101.35 13.32 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.809 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -95.42 119.23 33.56 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 143.79 26.18 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.411 HD23 ' CD2' ' A' ' 94' ' ' PHE . 5.5 mp -102.11 -44.57 5.41 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.235 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.84 129.07 76.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -85.7 167.11 15.58 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ptt85 -69.13 165.37 20.49 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.879 0.371 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 68.78 9.31 7.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.583 1.153 . . . . 0.0 112.659 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -81.61 118.74 23.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 13.2 p -62.76 126.94 29.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.9 pt -91.6 164.68 23.33 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.37 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.3 Cg_exo -68.76 122.77 5.78 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.353 1.162 . . . . 0.0 113.477 1.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -95.17 156.73 16.19 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.495 0.718 . . . . 0.0 110.106 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HG2' ' HB3' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -160.13 104.05 1.48 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.497 HE22 ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -129.52 120.9 26.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.0 m -107.39 141.51 38.65 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.569 0.748 . . . . 0.0 110.492 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' HG3' HE22 ' A' ' 40' ' ' GLN . 88.9 mt-30 -136.62 162.01 34.31 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.703 0.401 . . . . 0.0 109.974 174.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.79 122.94 62.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -107.57 146.57 31.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.86 0.838 . . . . 0.0 111.932 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 3.3 p -114.74 173.08 6.66 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.582 -1.644 . . . . 0.0 108.749 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 p -113.31 151.13 31.55 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 112.243 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -108.0 7.38 27.83 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.725 0.774 . . . . 0.0 110.286 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -89.97 158.15 17.51 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.568 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -118.27 114.42 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 63.3 74.25 0.43 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.245 1.021 . . . . 0.0 111.081 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.73 121.13 50.59 Favored Pre-proline 0 C--N 1.292 -1.904 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.56 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.18 -14.85 6.93 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.091 1.861 . . . . 0.0 110.891 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.87 150.76 20.89 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 29.0 m -118.41 158.64 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 tp -108.23 127.04 53.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.086 0.469 . . . . 0.0 111.426 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.26 105.36 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -113.02 123.51 50.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.82 119.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 123.9 0.75 . . . . 0.0 110.048 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 89.0 m-85 -122.68 156.78 33.66 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.171 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -111.11 149.69 30.49 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.155 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -165.76 12.1 Favored Glycine 0 N--CA 1.422 -2.251 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -148.8 99.36 2.98 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.286 0.565 . . . . 0.0 109.88 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -130.01 153.36 48.5 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.317 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -65.98 -40.66 91.41 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.713 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 69.9 mtm -128.59 135.45 49.36 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.88 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 109.5 2.48 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.438 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 20.3 pttp -155.72 -44.99 0.08 Allowed 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.394 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.438 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 10.9 m-20 -128.67 82.74 2.1 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.453 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 19.6 m120 -145.45 170.43 16.39 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.145 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 71.0 m-20 -90.73 117.78 29.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.99 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -85.88 108.1 17.99 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.54 -42.09 23.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.459 0.647 . . . . 0.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.38 35.52 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 4.4 ppt_? -146.7 147.39 30.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 122.279 0.231 . . . . 0.0 110.874 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.51 157.21 31.67 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.95 135.99 48.41 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 59.4 tp -97.12 104.5 16.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p -103.32 154.5 19.31 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.37 10.53 25.4 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.99 135.54 85.2 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.94 115.82 4.49 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.673 1.582 . . . . 0.0 110.181 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.3 102.72 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.065 2.51 . . . . 0.0 111.727 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.17 173.23 6.12 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.614 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.71 171.51 2.7 Favored 'Trans proline' 0 C--O 1.262 1.708 0 C-N-CA 122.451 2.101 . . . . 0.0 112.836 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -62.6 117.97 6.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.643 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 88.54 19.39 52.26 Favored Glycine 0 CA--C 1.494 -1.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.955 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.7 t -91.25 -54.89 0.27 Allowed Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.398 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.78 138.28 84.81 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 121.748 1.632 . . . . 0.0 112.044 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -102.71 96.11 6.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.642 0.734 . . . . 0.0 111.339 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.9 mm -92.48 133.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -112.63 119.14 37.11 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -120.91 127.97 76.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 95.7 m -118.71 127.41 53.53 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.66 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.411 ' CD2' HD23 ' A' ' 29' ' ' LEU . 9.1 m-85 -105.5 113.26 26.73 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.421 ' HB3' ' HG2' ' A' ' 39' ' ' LYS . 2.6 p30 -132.92 140.97 48.12 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 60.9 mt -127.5 126.42 67.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.457 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.0 p30 -90.84 179.02 5.88 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.07 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.74 63.8 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.06 -16.7 54.51 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.03 29.18 8.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 73.1 mt -94.8 117.68 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.4 tp -94.4 115.09 27.23 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.802 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -103.56 120.75 41.5 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.629 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.94 114.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.1 m -118.01 126.96 53.31 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.81 124.59 52.15 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -126.49 120.77 30.52 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.69 99.29 5.78 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -68.98 -6.19 26.27 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -70.13 -50.23 42.63 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 p -97.82 -43.24 7.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.545 0.688 . . . . 0.0 111.242 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.18 25.66 5.49 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.82 142.15 29.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.21 149.0 48.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.143 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.407 ' OD1' ' HA ' ' A' ' 77' ' ' LEU . 10.6 m120 -144.75 135.0 24.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 125.184 1.394 . . . . 0.0 107.33 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -124.73 166.74 15.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.039 0.447 . . . . 0.0 111.214 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.0 tt -140.36 140.31 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.1 m -116.14 113.77 23.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.821 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.13 101.57 12.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.7 p -92.36 103.36 15.81 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.262 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.3 m120 . . . . . 0 N--CA 1.485 1.279 0 C-N-CA 124.511 1.124 . . . . 0.0 113.531 173.053 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.214 -0.811 0 CA-C-O 120.488 0.185 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 135' ' ' VAL . 62.8 mt -63.34 -52.4 58.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -61.82 -38.51 88.4 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.504 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -63.76 -40.66 97.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 2.1 tpt -63.1 -39.54 94.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.358 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 131' ' ' ILE . 57.4 t -55.98 -50.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 123.227 0.329 . . . . 0.0 110.221 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -58.02 -55.79 30.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.191 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.68 -43.12 99.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.83 88.9 Favored 'General case' 0 C--O 1.204 -1.308 0 O-C-N 123.41 0.444 . . . . 0.0 111.855 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -77.89 -37.64 47.62 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.817 0.341 . . . . 0.0 111.75 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -111.45 19.78 17.87 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -52.73 -56.96 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.661 1.185 . . . . 0.0 110.699 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.88 89.06 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.101 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.55 -50.9 67.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.306 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.24 -39.26 75.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.69 -33.49 75.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.781 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.624 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 70.7 t -64.58 -45.29 95.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 152' ' ' VAL . 78.4 mt-30 -64.25 -37.57 87.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.795 0.331 . . . . 0.0 110.643 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.474 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 52.1 ttp180 -61.62 -32.14 72.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.883 0.873 . . . . 0.0 112.01 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -89.3 -21.12 23.32 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.289 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 23.7 mmm180 -68.5 -42.85 78.02 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 148' ' ' GLN . 60.7 t -70.43 137.11 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.2 p -70.71 86.03 0.66 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.107 0.956 . . . . 0.0 111.126 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.97 166.82 10.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.532 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -170.33 164.23 8.83 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -80.29 74.91 7.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.899 0.857 . . . . 0.0 109.546 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -135.82 127.56 29.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.924 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.5 mt -97.37 152.77 18.59 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.426 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -78.02 172.37 13.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.522 ' H ' ' CD ' ' A' ' 159' ' ' GLU . 34.9 m . . . . . 0 N--CA 1.413 -2.293 0 O-C-N 121.704 -0.622 . . . . 0.0 112.25 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 tp . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 122.925 1.345 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.04 62.69 3.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.911 1.338 . . . . 0.0 110.03 177.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 35' ' ' THR . 32.4 m -144.42 -179.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.95 112.57 52.99 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.68 -13.91 10.45 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 121.586 1.524 . . . . 0.0 111.617 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 131' ' ' ILE . 89.1 mt -135.57 166.15 23.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.623 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 27.3 m -103.65 116.24 31.98 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.58 130.94 38.08 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.05 -177.62 18.18 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.072 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -124.78 166.0 17.0 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.081 0.552 . . . . 0.0 111.584 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.49 109.12 17.1 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.512 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 5.9 p -113.69 156.58 23.5 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.487 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 119.68 6.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.451 1.1 . . . . 0.0 113.286 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.72 4.44 28.15 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.286 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.59 38.31 28.47 Favored Glycine 0 CA--C 1.494 -1.247 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.5 t -99.44 142.21 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.39 -0.905 . . . . 0.0 108.667 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.401 ' HB2' ' N ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -108.92 103.12 12.1 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.217 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -91.95 110.71 22.07 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.75 115.58 28.18 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.717 0.636 . . . . 0.0 110.551 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.484 HD23 ' CD1' ' A' ' 94' ' ' PHE . 6.5 mp -91.21 -49.3 6.45 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 16' ' ' SER . 49.5 mm -97.58 91.04 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -85.76 148.43 25.85 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.874 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -57.38 150.56 18.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 76.64 11.39 2.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.044 1.738 . . . . 0.0 112.408 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 m -94.31 113.4 25.29 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.402 ' HA ' HG11 ' A' ' 12' ' ' VAL . 3.4 m -65.36 143.34 57.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.6 pt -96.15 162.29 24.29 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 23.7 Cg_exo -68.64 132.21 19.95 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.958 1.021 . . . . 0.0 113.614 -0.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.76 154.89 18.25 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.903 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' A' ' 95' ' ' ASP . 50.9 tptt -149.04 101.46 3.16 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -124.03 135.92 53.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 92.1 m -135.51 138.57 43.22 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.37 145.94 50.8 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 122.905 0.482 . . . . 0.0 109.76 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.41 122.09 55.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -114.42 155.94 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.82 171.55 8.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 123.732 0.813 . . . . 0.0 108.879 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -98.9 136.07 39.42 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.098 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -99.18 -14.2 19.42 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.949 0.88 . . . . 0.0 109.021 172.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -95.63 113.65 25.32 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.769 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.26 139.99 41.38 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 62.04 55.95 2.4 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -101.39 136.81 19.57 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.14 -25.92 18.56 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.576 2.184 . . . . 0.0 111.794 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 80' ' ' ILE . . . -171.88 168.0 41.06 Favored Glycine 0 N--CA 1.407 -3.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.569 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.25 138.01 44.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.1 tp -90.51 104.21 16.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.294 0.569 . . . . 0.0 109.822 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.98 117.1 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -135.43 119.37 17.41 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.744 -171.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.09 122.49 47.63 Favored 'Isoleucine or valine' 0 C--O 1.248 0.975 0 O-C-N 124.33 1.018 . . . . 0.0 110.811 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 69' ' ' ASN . 40.3 m-85 -120.7 149.55 42.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.905 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -119.17 157.74 27.33 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' HA2' ' SD ' ' A' ' 134' ' ' MET . . . 104.51 15.95 19.42 Favored Glycine 0 C--N 1.31 -0.909 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 167.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.585 ' OE1' ' HG3' ' A' ' 67' ' ' LYS . 47.4 mm-40 -144.14 179.52 7.16 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 118.309 1.055 . . . . 0.0 112.116 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -120.03 -72.11 0.7 Allowed 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.269 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 145' ' ' ASP . . . -91.97 -50.69 5.57 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.5 mtt -127.93 145.33 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.401 ' N ' ' HB2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -72.26 107.35 4.84 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.672 -174.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.585 ' HG3' ' OE1' ' A' ' 62' ' ' GLU . 10.7 pttp -137.48 -76.45 0.4 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 123.339 0.655 . . . . 0.0 111.587 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.78 75.08 4.94 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 122.77 1.271 . . . . 0.0 110.343 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.479 HD22 ' HB2' ' A' ' 62' ' ' GLU . 22.1 m120 -122.87 152.37 40.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.713 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -111.38 140.15 46.2 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.739 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.1 tp -83.17 119.89 25.1 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.4 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.9 mt -97.2 -65.82 0.94 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.744 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.45 21.61 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.264 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 -153.3 157.49 40.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -161.8 147.72 13.62 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.625 0.578 . . . . 0.0 109.492 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -94.5 113.88 25.79 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -88.78 103.39 15.93 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 p -119.0 166.37 12.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.91 18.32 12.64 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.405 HD13 ' HA2' ' A' ' 53' ' ' GLY . 1.8 mp -77.95 130.05 74.09 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.65 154.17 74.1 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 122.483 2.122 . . . . 0.0 111.895 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.24 92.05 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.18 1.92 . . . . 0.0 110.739 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.14 155.98 80.77 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.184 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.99 176.95 8.44 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.31 2.007 . . . . 0.0 113.356 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 58.0 mtt85 -45.91 131.43 9.57 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.574 1.55 . . . . 0.0 113.124 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.43 -20.25 35.35 Favored Glycine 0 C--N 1.311 -0.807 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -74.73 -53.99 3.01 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 117.671 0.735 . . . . 0.0 112.805 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.79 104.36 1.9 Allowed 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.346 1.364 . . . . 0.0 111.025 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -97.2 131.17 44.2 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.346 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.21 119.21 59.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.82 110.4 22.98 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.35 123.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.594 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.2 m -114.26 127.8 56.05 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.484 ' CD1' HD23 ' A' ' 29' ' ' LEU . 9.9 m-85 -111.3 121.01 44.13 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.498 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 1.7 p30 -138.07 137.7 38.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.942 0.401 . . . . 0.0 111.269 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 33.9 mt -121.78 123.84 70.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -88.48 -170.93 3.14 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 123.415 0.447 . . . . 0.0 111.545 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.8 -16.19 63.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.113 0.565 . . . . 0.0 112.346 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -83.18 -23.63 32.8 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.05 21.8 17.11 Favored Glycine 0 N--CA 1.419 -2.485 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 91.8 mt -90.01 117.61 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.428 0.632 . . . . 0.0 109.87 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.414 ' HB2' HG12 ' A' ' 96' ' ' ILE . 16.7 tp -96.47 122.37 39.3 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.092 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -117.29 120.39 38.06 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.205 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.6 t -99.32 113.14 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.7 m -115.13 126.32 54.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.66 123.71 50.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 m -109.81 128.66 55.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.774 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.427 ' CG ' ' HG1' ' A' ' 111' ' ' THR . 5.6 t0 -85.41 107.21 17.28 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 124.939 1.296 . . . . 0.0 107.647 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -67.5 -18.25 64.98 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.0 m -86.11 -36.66 19.46 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.926 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.427 ' HG1' ' CG ' ' A' ' 108' ' ' ASP . 38.3 p -110.87 -29.14 8.07 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.55 19.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.151 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -92.4 161.9 14.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.97 137.59 16.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.682 0.277 . . . . 0.0 111.065 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -129.99 142.06 50.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 60.7 pttt -129.34 155.5 45.53 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.146 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.1 pt -121.11 157.58 24.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 m -129.85 113.63 14.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.445 0.641 . . . . 0.0 111.551 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.8 mt -115.39 142.66 27.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 m -117.74 166.5 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 40.9 p30 . . . . . 0 N--CA 1.477 0.91 0 CA-C-N 118.343 0.52 . . . . 0.0 111.383 177.65 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 120.99 0.424 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.469 ' HA ' HD23 ' A' ' 15' ' ' LEU . 59.2 mt -60.98 -50.23 81.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.933 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.62 -26.68 60.9 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.774 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -62.97 -36.84 84.84 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.421 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 15.6 ttt -59.24 -50.59 73.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 47.8 t -52.23 -53.8 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 124.084 0.865 . . . . 0.0 110.344 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.5 mt-30 -56.08 -46.84 78.88 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 124.095 0.872 . . . . 0.0 112.004 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.17 -39.49 60.26 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.755 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.03 67.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 9.1 pt-20 -75.16 -41.96 57.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.1 0.476 . . . . 0.0 110.896 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 98.1 mttt -57.62 -48.55 79.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.066 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.08 21.47 6.76 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.333 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 39.3 ttmt -58.7 -44.04 90.19 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.59 0.756 . . . . 0.0 112.021 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.32 -49.43 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -63.62 -46.36 86.07 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.499 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 1.4 m-20 -66.19 -27.97 68.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.969 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 5.4 tp10 -64.47 -39.73 94.36 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.3 t -70.94 -48.23 57.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.911 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 27.7 mt-30 -57.0 -38.3 72.88 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 123.549 0.74 . . . . 0.0 112.921 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -71.43 -31.92 67.77 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.008 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.45 -8.21 56.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.164 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 23.5 mmt85 -82.14 0.84 39.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.64 0.733 . . . . 0.0 109.505 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.4 t -114.36 113.87 45.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -78.56 153.54 31.13 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.63 67.96 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.278 1.037 . . . . 0.0 112.848 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.5 33.49 0.51 Allowed 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -59.83 157.21 12.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.736 -170.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.56 154.55 46.55 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.833 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 52.2 mt -91.73 142.88 27.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -82.97 118.52 23.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 118.106 -1.438 . . . . 0.0 107.456 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.412 -2.351 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.293 -174.027 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.4 mt . . . . . 0 CA--C 1.507 -0.677 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 75.55 16.06 2.62 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 124.91 1.284 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.76 174.94 12.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.799 0.809 . . . . 0.0 112.302 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.28 114.74 64.8 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.794 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.78 -41.72 13.64 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.393 2.062 . . . . 0.0 111.862 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -117.02 144.64 44.36 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.967 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 6.3 m -67.09 137.46 56.39 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.994 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -106.5 131.96 53.07 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.502 0.502 . . . . 0.0 109.651 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -162.67 -158.1 9.45 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.437 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.19 165.88 24.07 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.432 0.693 . . . . 0.0 109.341 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -89.12 120.45 30.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.542 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.6 p -92.22 -105.44 0.11 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.42 146.85 37.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.134 -0.354 . . . . 0.0 110.322 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -57.78 4.99 Favored Glycine 0 C--N 1.317 -0.515 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.369 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.42 41.44 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.95 141.56 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.401 ' HB2' HG23 ' A' ' 66' ' ' THR . 1.1 tmt? -86.1 134.32 33.83 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.032 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -126.46 132.27 51.49 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.461 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -102.04 142.69 32.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.155 0.503 . . . . 0.0 111.657 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 6.4 mp -99.96 -49.12 4.43 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -101.27 112.39 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -85.64 158.72 20.01 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.442 HH22 ' HG3' ' A' ' 142' ' ' LYS . 15.4 ptt-85 -58.23 151.91 18.31 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.848 0.859 . . . . 0.0 110.654 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.7 m120 76.23 11.01 2.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.567 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -87.73 124.07 33.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.147 0.498 . . . . 0.0 110.155 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -68.87 137.33 53.79 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.407 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.68 159.73 28.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.4 140.82 50.49 Favored 'Cis proline' 0 CA--C 1.501 -1.147 0 CA-C-N 120.348 1.16 . . . . 0.0 112.516 -1.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -98.54 -77.98 0.5 Allowed 'General case' 0 N--CA 1.406 -2.668 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.734 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 88.8 tttt 66.81 100.7 0.05 OUTLIER 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.491 1.117 . . . . 0.0 111.022 -171.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.06 130.82 48.85 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -113.01 129.04 56.64 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 123.511 0.507 . . . . 0.0 110.191 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.496 ' NE2' ' HA ' ' A' ' 29' ' ' LEU . 74.4 mt-30 -133.41 141.03 47.67 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 74.8 mt -104.19 120.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.176 0.513 . . . . 0.0 109.972 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -107.33 136.3 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -111.46 162.46 15.06 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.1 p -90.25 135.81 33.44 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.589 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 31.0 m-85 -114.92 -6.36 12.58 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.529 173.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -98.34 119.96 37.92 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.08 163.23 26.83 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.018 0.199 . . . . 0.0 110.996 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.19 23.99 14.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.142 0.977 . . . . 0.0 113.199 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -85.35 120.53 73.33 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.67 -16.08 14.98 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.59 2.193 . . . . 0.0 113.767 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.87 159.05 29.41 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.266 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.69 171.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 tt -129.08 118.6 22.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 111.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -126.53 118.12 24.25 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.12 132.73 30.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.775 -172.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 79.7 m-85 -134.01 152.94 52.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.737 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 16' ' ' SER . 34.7 mt-10 -112.9 151.73 30.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.587 0.554 . . . . 0.0 110.341 175.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.02 152.3 26.71 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.107 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -115.44 121.42 42.7 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.38 0.609 . . . . 0.0 109.795 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -140.29 162.72 34.61 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 145' ' ' ASP . . . -66.65 -37.46 84.85 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 123.865 0.728 . . . . 0.0 111.098 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.77 139.93 46.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.749 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.476 ' HA ' ' OD1' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -70.57 113.95 8.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.266 -175.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.494 ' HZ1' ' HB3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -171.69 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.985 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.83 -14.55 54.13 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.963 0.887 . . . . 0.0 109.17 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.476 ' OD1' ' HA ' ' A' ' 66' ' ' THR . 8.7 m120 -66.96 152.73 45.2 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.311 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 78.4 m-20 -89.06 121.4 31.36 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.73 115.66 21.07 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.04 -36.67 12.01 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.062 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.29 171.97 39.06 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.214 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -149.03 159.29 44.35 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.427 0.291 . . . . 0.0 111.356 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.07 154.52 25.8 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 172.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.89 133.4 53.2 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.515 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 6.1 tt -108.25 104.44 13.84 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.6 p -104.53 159.44 15.74 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.112 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.11 -14.41 5.15 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.5 -0.857 . . . . 0.0 110.971 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.19 119.23 50.75 Favored Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 123.258 0.623 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.99 166.59 11.23 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.595 2.197 . . . . 0.0 110.939 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.09 97.46 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.933 1.755 . . . . 0.0 110.378 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.72 151.41 78.05 Favored Pre-proline 0 N--CA 1.426 -1.659 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.9 133.52 40.2 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.067 2.511 . . . . 0.0 111.466 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -60.98 119.65 8.7 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.397 0.618 . . . . 0.0 111.639 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.22 -27.11 6.2 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.93 -48.82 7.89 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.336 -0.432 . . . . 0.0 111.082 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -70.08 106.67 1.76 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.182 1.255 . . . . 0.0 109.301 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 74.3 mt-30 -113.83 115.33 27.58 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.419 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.21 111.42 25.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -90.1 104.32 16.9 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -104.75 127.11 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.084 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.7 m -122.26 123.01 40.45 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.875 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 5.1 m-85 -99.45 112.35 24.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.728 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -112.95 143.28 44.51 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 11.9 mt -130.99 127.54 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -98.58 -171.68 2.17 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.86 -23.92 64.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.06 -29.82 49.41 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.07 26.2 6.13 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.7 mt -84.59 119.61 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 65.0 tp -96.06 107.84 20.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -103.52 125.83 50.31 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.7 t -111.29 113.02 43.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.8 m -106.24 116.52 32.08 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.63 117.23 33.39 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.7 m -113.45 122.1 46.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 110.65 16.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 54.2 mtpt -67.41 -18.55 65.15 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.541 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.9 p -80.26 -56.75 3.99 Favored 'General case' 0 C--O 1.25 1.102 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.359 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.6 p -76.58 -32.06 57.9 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.168 0.508 . . . . 0.0 110.361 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.93 -8.65 54.4 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.8 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -94.49 160.41 14.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.546 0.673 . . . . 0.0 111.435 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.1 148.43 51.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.283 0.563 . . . . 0.0 111.719 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.515 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.4 m120 -130.86 132.25 45.06 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 157.97 45.56 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.382 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 tt -127.78 146.51 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.2 m -125.18 112.31 16.3 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.235 0.541 . . . . 0.0 109.693 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.59 93.84 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -82.23 107.46 14.93 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--N 1.3 -1.559 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.666 -174.312 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 134' ' ' MET . 7.7 tp10 . . . . . 0 N--CA 1.444 -0.751 0 CA-C-O 120.984 0.421 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.2 -50.58 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.662 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.7 pt-20 -63.91 -32.48 74.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 130' ' ' GLU . 53.9 mtm-85 -60.51 -46.83 88.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 23.9 mmt -60.88 -42.8 98.64 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.657 0.598 . . . . 0.0 109.772 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.61 -51.77 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.042 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 24.1 mt-30 -56.53 -47.55 79.16 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 122.937 0.495 . . . . 0.0 111.434 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.22 -41.27 97.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.95 75.45 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.5 -47.09 18.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.302 0.572 . . . . 0.0 112.505 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.99 -22.82 55.44 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.328 0.585 . . . . 0.0 111.579 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -120.57 26.46 9.13 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.841 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.442 ' HG3' HH22 ' A' ' 32' ' ' ARG . 40.8 tttm -56.31 -42.13 77.1 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.109 0.964 . . . . 0.0 111.241 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.63 -52.84 18.61 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.923 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.39 -39.55 58.95 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -71.06 -49.83 40.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.412 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 37.9 mt-10 -66.26 -35.36 80.21 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.656 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.593 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 38.9 t -62.73 -50.05 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.392 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.18 -37.94 89.21 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.9 0.381 . . . . 0.0 111.726 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -58.11 -52.19 66.58 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.828 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 41.8 mm-40 -72.56 -19.88 61.42 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.826 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 18.4 mmm180 -70.24 -29.45 66.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.178 0.513 . . . . 0.0 109.949 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.91 -59.24 2.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.2 m -89.31 61.46 5.7 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.844 0.83 . . . . 0.0 111.113 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.94 -32.59 30.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.076 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.83 131.31 54.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -73.08 103.34 3.81 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.226 0.536 . . . . 0.0 111.432 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.542 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.41 160.27 41.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.37 140.89 51.88 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -97.7 134.07 41.37 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.483 0.658 . . . . 0.0 111.596 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.412 -2.339 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.441 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 11' ' ' ASP . 5.1 tt . . . . . 0 N--CA 1.427 -1.619 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 35' ' ' THR . 3.5 m-20 -75.97 55.35 0.9 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.66 170.6 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.85 129.71 45.45 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.04 -31.56 6.05 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.069 1.846 . . . . 0.0 112.305 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.4 mp -126.65 157.55 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -86.34 138.16 32.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.07 131.21 48.66 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.03 -171.46 23.12 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.357 -176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.407 HD11 HG11 ' A' ' 92' ' ' VAL . 84.4 mt -126.36 169.88 12.49 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.09 0.556 . . . . 0.0 110.076 -176.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.38 108.44 19.96 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.1 p -92.52 166.37 12.56 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.36 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.68 114.05 0.97 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.411 1.084 . . . . 0.0 112.388 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.94 -2.08 21.21 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.189 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.12 72.28 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.23 145.69 7.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.433 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -92.64 117.37 29.9 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.9 m -115.05 112.19 22.24 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.12 135.08 34.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.199 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.434 HD23 ' CD1' ' A' ' 94' ' ' PHE . 6.3 mp -94.13 -41.0 9.74 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -109.96 113.21 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -90.34 166.64 13.19 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.822 0.82 . . . . 0.0 112.724 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -61.16 141.01 57.78 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.36 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 77.86 2.03 2.89 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.716 1.207 . . . . 0.0 111.873 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -83.47 130.58 35.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 5.5 p -65.47 130.37 43.06 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.46 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 39.5 pt -106.78 148.59 37.17 Favored Pre-proline 0 N--CA 1.435 -1.212 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 52.6 Cg_exo -61.87 132.61 10.61 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.03 1.046 . . . . 0.0 113.639 1.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 m -110.17 143.16 40.69 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.237 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -128.67 108.71 10.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -128.06 141.91 51.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -139.9 135.42 32.84 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -141.61 144.96 34.47 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -92.29 114.82 29.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.43 147.38 25.32 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.811 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 8.9 p -136.6 170.16 16.52 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.882 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -103.7 137.84 41.17 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.817 0.281 . . . . 0.0 110.686 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -112.93 4.54 16.87 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -84.64 175.34 9.29 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.798 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.88 117.49 31.22 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.296 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 37.17 81.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -101.41 139.11 20.15 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.852 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -85.61 0.02 8.64 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.245 1.963 . . . . 0.0 111.964 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.6 176.12 44.23 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.01 152.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.8 tp -101.11 120.39 40.14 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.48 105.45 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -119.22 118.51 31.49 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 t -95.45 134.6 32.31 Favored 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.706 0.629 . . . . 0.0 111.495 -172.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.48 151.48 50.91 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.302 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -116.13 141.08 48.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.91 -117.84 1.83 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 177.26 -99.94 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 126.115 1.766 . . . . 0.0 111.525 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.508 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 20.8 mmm180 55.4 -178.12 0.04 OUTLIER 'General case' 0 C--O 1.244 0.795 0 O-C-N 123.681 0.613 . . . . 0.0 110.524 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -91.28 -49.67 6.23 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.691 0.757 . . . . 0.0 110.663 175.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.2 mtp -97.65 126.15 42.8 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.53 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.328 0.4 OUTLIER -80.33 86.19 5.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.671 1.7 . . . . 0.0 111.418 178.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 69' ' ' ASN . 46.2 mmtm -152.42 -45.83 0.1 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.775 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.35 7.26 1.39 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.209 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 67' ' ' LYS . 89.3 m-20 -109.67 163.74 13.19 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.633 0.373 . . . . 0.0 111.493 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -91.01 136.19 33.24 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 tt -96.78 122.91 40.25 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.64 -45.18 9.53 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.279 0.362 . . . . 0.0 111.494 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.63 175.83 47.17 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.19 156.74 42.61 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.52 139.27 20.77 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -97.4 120.27 37.46 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.64 104.55 14.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 p -110.91 173.87 6.13 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.05 21.76 44.62 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 52.8 mt -90.17 135.26 30.11 Favored Pre-proline 0 N--CA 1.426 -1.673 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.65 117.02 3.9 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.563 2.175 . . . . 0.0 112.479 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.44 91.28 0.97 Allowed 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.191 1.927 . . . . 0.0 109.942 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.55 168.68 13.71 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.304 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.05 100.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.289 2.659 . . . . 0.0 113.237 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 60.85 -160.99 0.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.698 1.199 . . . . 0.0 111.349 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.7 63.33 1.18 Allowed Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 76.5 t -66.4 -48.39 56.66 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 167.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.632 ' HA ' ' OG ' ' A' ' 110' ' ' SER . 15.7 Cg_endo -59.05 129.9 33.99 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.058 1.839 . . . . 0.0 111.347 168.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.67 110.67 22.58 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.04 114.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -90.75 114.33 26.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' THR . 62.1 t -109.32 122.6 64.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.805 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.1 m -109.53 129.63 55.56 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.874 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.434 ' CD1' HD23 ' A' ' 29' ' ' LEU . 5.3 m-85 -109.9 107.74 17.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 17.7 t70 -120.06 113.12 20.01 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.826 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 44.3 mt -111.74 136.07 49.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.99 -168.42 1.56 Allowed 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.32 -8.18 55.95 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.04 -29.82 13.91 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.96 23.85 5.41 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 46.5 mm -81.87 115.44 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD11 HG13 ' A' ' 96' ' ' ILE . 31.5 tp -105.49 113.64 27.33 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.744 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -96.6 102.69 14.52 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.5 t -89.22 113.49 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 20.7 m -119.0 118.81 32.5 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.82 118.91 36.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.6 m -119.6 118.81 31.99 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.665 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 110.5 12.07 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -66.43 -20.33 66.03 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.055 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.632 ' OG ' ' HA ' ' A' ' 88' ' ' PRO . 1.5 m -70.44 -53.34 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.176 0.512 . . . . 0.0 110.823 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.3 p -95.14 -29.46 14.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.096 0.474 . . . . 0.0 112.087 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.97 19.44 24.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.864 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.39 131.36 36.21 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 121.084 0.469 . . . . 0.0 111.894 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.54 134.13 53.08 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.815 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -128.78 128.57 44.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 65.5 pttt -129.15 154.09 47.07 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.854 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.0 pt -126.93 140.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 171.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 m -103.95 112.53 25.54 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.2 mm -111.63 103.49 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.818 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 t -78.29 102.38 7.63 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.1 t30 . . . . . 0 N--CA 1.433 -1.304 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.881 -171.454 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 CA--C 1.516 -0.355 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 135' ' ' VAL . 81.9 mt -58.92 -53.88 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.138 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.6 -33.0 73.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -65.01 -41.54 95.24 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.566 173.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.2 ttt -68.8 -37.06 79.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.378 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 131' ' ' ILE . 81.1 t -60.89 -46.11 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -63.2 -32.33 73.7 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.763 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 22.4 mm-40 -59.23 -52.98 63.33 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.13 -29.53 69.86 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.409 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.77 -48.53 14.68 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.392 0.615 . . . . 0.0 112.439 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -71.24 -36.5 71.81 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.061 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -101.12 10.4 40.96 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 74.9 tttt -47.67 -54.48 11.91 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.974 0.91 . . . . 0.0 112.309 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.35 72.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.48 0.657 . . . . 0.0 111.413 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -72.81 -49.82 28.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.679 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -67.08 -39.41 86.8 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.499 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 48.6 mt-10 -60.37 -45.56 93.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.31 -32.92 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-O 121.405 0.621 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -74.69 -52.99 10.13 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.89 -0.507 . . . . 0.0 111.199 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 63' ' ' ARG . 55.2 ttp180 -69.82 -52.53 24.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.14 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -170.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -91.29 -1.36 57.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.373 0.606 . . . . 0.0 110.762 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.4 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 57.4 t -116.1 -58.3 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 t -90.94 87.39 6.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 122.659 1.219 . . . . 0.0 111.501 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.53 18.62 9.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 171.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 152' ' ' VAL . 49.9 pttt -137.64 137.77 38.79 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.217 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -94.65 97.27 9.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -143.08 127.81 18.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.2 mt -118.72 146.75 44.5 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . 0.273 1.5 pp20? -132.47 173.77 10.95 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.313 -0.998 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.933 -171.806 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.2 tp . . . . . 0 N--CA 1.457 -0.089 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -75.52 53.55 0.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.7 m -138.22 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.48 112.51 53.34 Favored Pre-proline 0 C--N 1.281 -2.404 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.71 -32.59 18.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 121.861 1.707 . . . . 0.0 110.067 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.79 174.95 5.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.928 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 11.8 m -119.63 136.28 54.45 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.2 131.78 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.723 0.639 . . . . 0.0 109.384 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.19 178.13 32.86 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.4 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.2 mp -112.39 156.73 22.02 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.401 0.68 . . . . 0.0 109.233 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -90.9 109.37 20.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -93.66 173.73 7.54 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.727 -0.608 . . . . 0.0 111.383 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 118.61 5.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.959 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.76 6.79 32.4 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.87 39.49 64.77 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -99.14 131.08 47.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.84 118.12 29.19 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -114.07 111.38 21.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.7 122.53 38.56 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.962 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.407 HD11 ' CD2' ' A' ' 94' ' ' PHE . 48.1 mt -87.19 -37.61 17.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.413 0.625 . . . . 0.0 109.548 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.75 102.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.54 161.32 15.53 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.785 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -54.14 134.05 44.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 80.71 11.87 0.91 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.315 1.846 . . . . 0.0 113.552 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -86.22 132.97 33.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.51 140.54 58.62 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.495 1.118 . . . . 0.0 111.519 -176.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 35.3 pt -113.87 146.29 35.27 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.787 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 15.0 Cg_endo -65.31 141.63 49.68 Favored 'Cis proline' 0 CA--C 1.509 -0.731 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.055 -3.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -92.51 -70.76 0.68 Allowed 'General case' 0 N--CA 1.399 -3.008 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.464 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 39' ' ' LYS . 1.1 tmtp? 67.12 101.0 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 124.996 1.318 . . . . 0.0 109.737 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -131.95 140.74 49.1 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 86.9 m -139.58 134.26 31.9 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -130.08 157.52 42.17 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.972 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.2 mm -89.88 114.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.34 148.08 24.03 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 19.6 p -122.8 171.49 9.15 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.857 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 24.4 p -109.08 136.93 47.79 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -90.96 -29.64 17.31 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -89.34 93.09 9.41 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.951 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 85' ' ' ARG . 6.2 p-10 -75.19 161.11 29.65 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.082 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 70.17 6.55 5.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.392 0.677 . . . . 0.0 112.705 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.3 131.43 50.6 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.0 Cg_endo -81.85 8.13 4.64 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.396 2.064 . . . . 0.0 112.322 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.41 175.03 44.32 Favored Glycine 0 N--CA 1.425 -2.035 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.6 171.59 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 123.323 0.649 . . . . 0.0 110.061 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.2 tp -111.16 128.16 55.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.782 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.83 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.5 mt-30 -123.84 127.33 47.89 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.56 114.24 37.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 124.446 1.092 . . . . 0.0 110.325 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -109.52 149.67 29.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.717 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 16' ' ' SER . 45.1 tt0 -111.39 121.44 45.23 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.74 -171.48 22.66 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HG3' ' CB ' ' A' ' 16' ' ' SER . 13.3 mt-10 -139.17 17.7 2.61 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -64.59 131.81 48.06 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.992 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.63 -50.43 63.16 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.929 2.092 . . . . 0.0 113.931 -168.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtt -95.99 128.78 43.19 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.34 86.06 0.28 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -168.04 168.04 12.17 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 76.64 -46.42 0.52 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.608 1.163 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -55.6 147.97 16.96 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.349 1.06 . . . . 0.0 108.629 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 60' ' ' GLU . 2.9 p-10 -90.03 139.09 30.95 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.282 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.08 132.71 35.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.827 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.8 mt -105.1 -41.3 5.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 0.0 111.365 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.34 39.69 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.132 -1.033 . . . . 0.0 111.427 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -150.13 166.0 31.13 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -170.14 144.43 2.63 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 124.595 1.184 . . . . 0.0 108.414 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -93.88 146.83 23.62 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -118.52 105.08 11.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -94.47 169.74 9.98 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.89 -25.96 6.01 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 62.4 mt -54.14 119.91 22.31 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.109 0.963 . . . . 0.0 111.446 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.32 151.27 20.25 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.678 2.252 . . . . 0.0 112.861 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.97 87.71 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.791 2.327 . . . . 0.0 110.821 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.91 166.16 30.42 Favored Pre-proline 0 C--N 1.29 -2.005 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -49.32 141.3 24.81 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.992 2.461 . . . . 0.0 111.409 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 46' ' ' THR . 35.1 ptt180 -64.57 126.15 26.96 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 -175.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.06 -25.96 13.21 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.08 -50.44 51.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.654 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -68.86 121.23 8.1 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.137 1.224 . . . . 0.0 110.327 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -107.08 124.7 50.05 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mm -108.51 109.24 27.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -94.85 109.17 21.19 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 41' ' ' THR . 33.9 t -111.23 126.16 68.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.731 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 87.5 m -106.29 125.38 50.92 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.407 ' CD2' HD11 ' A' ' 29' ' ' LEU . 5.2 m-85 -111.08 107.91 17.44 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -126.15 124.49 40.62 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.34 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 37' ' ' PRO . 13.6 mt -106.75 125.57 62.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.5 -179.04 6.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.574 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.91 66.44 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.627 0.771 . . . . 0.0 112.777 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -77.06 -24.39 51.96 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.5 31.08 8.1 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.7 mt -97.17 128.27 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.44 111.7 21.41 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -100.64 114.54 28.32 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.43 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' THR . 74.9 t -110.48 125.23 67.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 m -122.71 119.6 31.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.58 117.57 33.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.7 m -112.74 120.59 42.02 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.22 106.87 13.53 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -67.43 -19.87 65.43 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.732 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.96 -61.35 1.98 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 43.0 p -80.1 -32.69 39.1 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.665 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.68 12.31 44.41 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.703 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.448 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 20.7 pttp -111.2 161.42 16.0 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.485 -0.421 . . . . 0.0 110.603 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.27 148.89 40.56 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -128.68 146.7 50.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -131.45 164.29 26.06 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.19 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.419 HG22 ' HB ' ' A' ' 104' ' ' VAL . 14.7 tt -136.51 144.39 32.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 m -125.59 113.6 17.62 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.23 103.92 16.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.029 0.442 . . . . 0.0 110.727 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.8 m -75.25 151.7 38.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 122.808 1.289 . . . . 0.0 110.933 176.855 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.7 mt -67.11 -41.0 86.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.622 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.84 -27.58 65.96 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.49 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -63.13 -40.62 98.12 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 mmt -63.38 -38.46 91.24 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.128 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.58 -47.88 89.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.049 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.84 -47.01 85.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.699 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.99 -32.9 74.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.682 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.42 -32.45 74.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -78.67 -36.66 43.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 110.793 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -69.0 -45.98 69.18 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.095 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.55 20.8 15.39 Favored 'General case' 0 C--O 1.198 -1.635 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -49.72 -60.14 3.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.083 1.353 . . . . 0.0 113.008 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.98 -32.74 73.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.887 0.375 . . . . 0.0 110.62 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -61.82 -53.41 56.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.048 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -67.62 -37.45 82.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -59.52 -37.78 79.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.537 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.504 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 96.9 t -72.73 -47.08 51.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.554 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.83 -39.67 74.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -67.37 -32.71 73.82 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.99 -10.0 46.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.9 mmt180 -64.33 -36.1 83.01 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 120.835 0.35 . . . . 0.0 111.094 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.94 102.13 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.0 m -76.93 108.24 9.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.86 41.82 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-O 121.979 0.895 . . . . 0.0 112.561 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -82.17 148.13 28.64 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.64 94.76 0.45 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.182 0.515 . . . . 0.0 110.229 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -142.07 147.91 37.57 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.673 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.58 151.38 26.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -83.65 167.0 17.66 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.464 177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.425 -1.718 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -171.226 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 CA--C 1.493 -1.222 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.4 m-20 -126.46 28.6 5.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.795 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 34' ' ' SER . 20.0 m -135.09 136.51 51.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.003 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.86 116.13 26.82 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.71 -36.06 8.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 111.718 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.97 167.43 11.14 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.468 ' HG ' ' HG3' ' A' ' 62' ' ' GLU . 4.3 p -97.56 150.14 21.45 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.393 1.077 . . . . 0.0 110.496 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.2 mt -127.17 132.67 50.45 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.363 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.64 178.05 28.32 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.88 167.55 11.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.047 0.451 . . . . 0.0 111.021 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.459 ' HG2' ' NE2' ' A' ' 57' ' ' GLN . 5.7 tp10 -84.58 109.0 17.63 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.635 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.415 HG23 HD22 ' A' ' 158' ' ' LEU . 16.8 p -100.82 162.58 12.81 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.509 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 155' ' ' LYS . . . -49.8 117.29 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 113.586 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.35 39.05 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.4 23.67 53.39 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.2 142.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 127.23 38.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.6 m -128.29 115.24 18.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.05 147.11 23.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.418 ' HG ' ' CG ' ' A' ' 42' ' ' GLN . 10.4 mp -116.51 -50.4 2.63 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.954 176.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 116.66 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.96 156.91 19.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.321 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.17 160.34 29.81 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.466 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 m120 70.39 16.65 7.1 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.726 1.21 . . . . 0.0 110.427 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 34.2 p -89.44 136.82 32.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.561 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 14.2 p -73.1 114.9 11.79 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 121.597 0.713 . . . . 0.0 111.184 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.437 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 22.2 pt -95.75 158.09 34.91 Favored Pre-proline 0 C--N 1.287 -2.115 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.794 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.8 Cg_exo -61.42 132.94 10.5 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 N-CA-C 114.848 1.057 . . . . 0.0 114.848 1.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -104.05 166.98 10.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.502 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 50.1 tttp -173.86 107.1 0.13 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.57 144.01 50.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -112.38 133.04 54.69 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.776 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.418 ' CG ' ' HG ' ' A' ' 29' ' ' LEU . 15.5 mm100 -128.59 134.78 48.69 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.64 129.72 49.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.493 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 96.7 m-85 -121.96 167.88 12.56 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 p -135.21 170.79 15.38 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.437 0.16 . . . . 0.0 111.32 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -83.32 176.11 9.37 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -81.97 -46.78 13.54 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.0 p -143.79 -171.77 3.6 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.659 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.62 162.27 18.9 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.904 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 71.28 5.73 5.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.73 112.5 52.29 Favored Pre-proline 0 N--CA 1.402 -2.842 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -100.08 -9.58 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.259 1.973 . . . . 0.0 115.094 -173.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . -148.84 135.13 5.29 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.44 161.15 17.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -111.48 108.5 18.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.196 0.522 . . . . 0.0 109.881 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 mm -83.09 99.86 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.459 ' NE2' ' HG2' ' A' ' 20' ' ' GLU . 43.6 mt-30 -109.06 119.02 38.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.0 t -99.27 124.49 52.59 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 O-C-N 123.655 0.597 . . . . 0.0 110.154 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 80.1 m-85 -122.13 146.84 46.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.389 0.614 . . . . 0.0 111.559 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -111.52 120.11 41.03 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.342 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.55 -166.83 24.42 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.468 ' HG3' ' HG ' ' A' ' 16' ' ' SER . 33.7 mt-10 -153.16 134.46 14.22 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.633 0.773 . . . . 0.0 110.118 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 65' ' ' MET . 40.1 mtp180 -158.13 -176.36 5.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.094 1.358 . . . . 0.0 108.715 171.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.16 73.98 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 122.398 1.094 . . . . 0.0 108.802 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 65.7 mtt -105.0 162.42 13.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.513 -1.676 . . . . 0.0 107.619 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.25 16.06 2.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.646 0.736 . . . . 0.0 109.679 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 65' ' ' MET . 67.5 mttm -85.95 154.77 21.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.557 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 81.58 -32.53 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.581 1.552 . . . . 0.0 110.967 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.614 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 12.7 m120 -64.0 168.01 5.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 35.0 t30 -90.11 117.67 29.07 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.403 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.38 122.05 27.49 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 72' ' ' LEU . 3.5 mp -95.47 -49.85 5.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.36 0.6 . . . . 0.0 109.414 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.29 162.46 34.84 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -152.91 158.05 41.55 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -159.58 163.12 35.33 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.97 143.0 33.78 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.849 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.418 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 2.1 tt -108.49 104.11 13.38 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 103.375 -2.824 . . . . 0.0 103.375 171.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.4 p -120.45 107.95 13.51 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.295 0.569 . . . . 0.0 110.622 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.97 19.25 0.02 OUTLIER Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.352 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.79 127.47 83.96 Favored Pre-proline 0 C--O 1.249 1.072 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.91 153.98 71.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.883 2.389 . . . . 0.0 111.736 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.96 89.56 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.34 2.027 . . . . 0.0 112.284 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.33 144.65 53.3 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.8 148.78 81.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.731 2.287 . . . . 0.0 111.119 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.35 132.28 50.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.243 0.544 . . . . 0.0 111.254 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.68 -34.15 4.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.57 -56.16 1.48 Allowed Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 93.81 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.147 1.231 . . . . 0.0 110.526 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -96.46 124.7 40.54 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.503 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mm -99.72 117.48 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -90.64 106.54 18.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -102.32 115.39 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 m -109.03 126.09 52.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.536 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.414 ' CD2' HD22 ' A' ' 29' ' ' LEU . 2.9 m-85 -115.45 121.23 42.1 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.604 0.762 . . . . 0.0 109.726 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.452 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.1 p30 -140.03 137.08 34.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 71.4 mt -112.3 135.04 52.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -91.19 -168.52 2.08 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -24.39 64.26 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.54 -29.81 33.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.135 0.493 . . . . 0.0 109.902 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.01 24.53 5.44 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 84.6 mt -88.95 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 49.4 tp -94.42 118.38 31.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.663 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -103.35 115.92 31.45 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 121.415 0.626 . . . . 0.0 110.476 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.7 t -100.38 114.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.961 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.2 m -122.94 120.59 33.87 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.19 117.51 33.42 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.9 m -116.53 124.18 49.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.363 0.414 . . . . 0.0 112.019 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.75 114.26 12.98 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 123.607 0.763 . . . . 0.0 111.076 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 109' ' ' LYS . 33.6 mmtp -67.76 -12.22 60.1 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -79.34 -62.66 1.62 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.966 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -94.68 -30.31 14.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.152 0.501 . . . . 0.0 112.303 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.98 4.97 41.61 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.274 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.85 132.02 47.66 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 121.144 0.497 . . . . 0.0 111.073 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.67 43.89 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.102 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -129.51 128.19 42.31 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 165.83 15.15 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.506 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.63 138.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.8 m -100.57 113.68 26.7 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -115.57 96.93 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 26.8 m -66.51 125.41 25.63 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 170.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.632 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.11 -41.49 89.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.815 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.33 -37.67 87.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -63.86 -45.76 88.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.614 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 40.2 ttp -54.77 -48.69 72.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.466 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 78.7 t -61.81 -40.71 87.93 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.842 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -61.94 -38.39 88.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -72.55 -34.42 67.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.576 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.57 -43.27 94.44 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.976 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 12.1 mm-40 -59.98 -38.04 81.42 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.952 0.882 . . . . 0.0 110.479 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.73 -28.56 69.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.839 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -126.91 23.49 6.6 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.342 -0.224 . . . . 0.0 111.153 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.75 -29.48 69.99 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 147' ' ' VAL . . . -66.3 -40.13 89.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -70.61 -50.09 40.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 0.5 OUTLIER -59.21 -43.49 92.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.077 178.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 149' ' ' ARG 0.296 22.2 mt-10 -68.73 -32.52 72.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 118.436 -1.306 . . . . 0.0 113.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 76.6 t -61.8 -40.95 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.246 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 79.5 mt-30 -57.17 -46.21 82.98 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 8.6 ptm180 -71.49 -35.36 70.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 146' ' ' GLU . 43.2 mt-10 -72.9 -21.71 60.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.497 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 22.2 mmt180 -64.82 -28.56 69.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.312 0.577 . . . . 0.0 109.672 173.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.41 -35.58 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 51.6 m 71.04 85.4 0.13 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.906 1.282 . . . . 0.0 112.775 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 43.93 80.37 0.04 OUTLIER 'General case' 0 C--O 1.244 0.811 0 C-N-CA 125.562 1.545 . . . . 0.0 114.269 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 17.4 tppt? -81.28 110.74 17.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 4.3 t30 -111.09 33.0 4.88 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.829 1.3 . . . . 0.0 109.629 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -121.67 142.16 50.43 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.415 HD22 HG23 ' A' ' 21' ' ' THR . 27.6 mt -92.5 150.0 21.03 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.311 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.43 143.79 40.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.777 0.799 . . . . 0.0 111.718 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.845 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--O 1.242 0.677 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.45 67.68 8.59 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.547 1.165 . . . . 0.0 109.883 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 35' ' ' THR . 28.0 m -121.24 -177.17 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-N 113.822 -1.536 . . . . 0.0 107.682 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 110.2 42.94 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.55 -27.77 45.78 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.006 1.804 . . . . 0.0 111.702 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.43 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . 99.7 mt -130.93 156.13 45.6 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.791 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 m -77.35 141.51 39.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 123.665 0.603 . . . . 0.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.7 130.96 45.2 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 28' ' ' ALA . . . -157.17 -176.53 29.34 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 119.092 -1.528 . . . . 0.0 114.304 -175.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 89.0 mt -118.42 150.81 38.93 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 123.933 0.893 . . . . 0.0 109.572 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.408 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 34.8 tt0 -89.56 109.82 20.73 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.0 p -89.69 172.62 8.8 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.694 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.22 110.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.177 0.513 . . . . 0.0 111.57 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -9.16 8.42 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.96 19.41 51.16 Favored Glycine 0 CA--C 1.494 -1.23 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.88 135.64 24.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 62' ' ' GLU . 23.9 ttt -89.54 112.2 23.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.253 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 m -110.26 110.93 21.93 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . . . -97.9 135.44 39.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.101 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.5 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -90.94 -49.44 6.43 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -96.85 114.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 60.6 tptt -80.78 141.5 34.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -58.78 154.09 15.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.673 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 80.25 3.59 1.89 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.749 1.619 . . . . 0.0 111.45 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 t -91.34 136.97 32.73 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.416 ' HA ' HG12 ' A' ' 12' ' ' VAL . 1.5 m -73.03 143.88 47.36 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 123.718 0.807 . . . . 0.0 111.504 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.437 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 42.4 pt -99.51 154.11 37.44 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 42.2 Cg_exo -62.09 144.61 46.07 Favored 'Cis proline' 0 C--O 1.247 0.974 0 CA-C-N 120.2 1.107 . . . . 0.0 113.258 0.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.3 m -129.44 145.53 51.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 55.0 tttp -142.33 112.75 7.18 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 29.8 tp60 -128.56 125.58 38.56 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 m -109.11 134.79 51.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -140.56 156.35 46.33 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.2 mm -101.87 128.65 54.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -117.72 166.16 12.76 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.786 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 2.9 p -148.27 170.81 17.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 122.709 0.404 . . . . 0.0 111.591 -172.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.3 p -103.79 166.04 10.67 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' C ' ' HB3' ' A' ' 85' ' ' ARG . 93.8 m-85 -95.75 -14.97 22.91 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 165.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 p -97.0 178.54 5.24 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.309 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -136.06 134.49 38.49 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 126.471 1.909 . . . . 0.0 106.379 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 70.14 6.28 5.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.417 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 41.6 tt0 -53.52 129.2 53.1 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 123.665 0.786 . . . . 0.0 112.887 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.28 79.3 3.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.231 1.954 . . . . 0.0 112.749 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . 96.63 131.59 6.94 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.966 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 76' ' ' GLU . 29.5 m -105.95 130.14 57.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.0 tp -83.56 112.37 19.94 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.726 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 45.5 mm -98.82 105.38 17.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 48.6 mt-30 -104.44 117.55 34.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -96.67 121.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 O-C-N 124.313 1.008 . . . . 0.0 110.551 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 83.4 m-85 -125.48 156.6 38.69 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.634 0.374 . . . . 0.0 110.571 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' A' ' 70' ' ' ASN . 8.7 pt-20 -122.57 130.77 53.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 15' ' ' LEU . . . 144.09 -155.8 26.41 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.512 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 13.8 mt-10 -161.86 134.05 5.72 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.703 1.601 . . . . 0.0 111.487 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -158.91 170.0 23.07 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 126.554 1.942 . . . . 0.0 106.099 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.81 -47.69 29.32 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.8 mtm -116.98 123.45 46.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.0 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.43 108.71 0.85 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 125.531 1.532 . . . . 0.0 111.037 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -166.81 -36.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.337 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.53 3.89 54.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.745 0.784 . . . . 0.0 109.315 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.473 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 16.6 m120 -100.5 169.51 9.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.726 -173.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.408 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 47.7 t30 -99.4 123.68 43.88 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.442 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.0 tp -83.99 123.22 29.76 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.191 0.596 . . . . 0.0 110.224 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -95.35 -22.55 17.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.97 175.7 33.28 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.987 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 8.5 ptp180 -153.04 151.42 30.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -155.88 157.87 37.08 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 11.6 mp0 -112.03 133.86 53.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.502 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.661 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 54.8 tp -87.1 106.61 17.98 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 172.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 p -67.26 125.42 26.02 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 46.19 96.73 0.01 OUTLIER Glycine 0 C--N 1.344 0.974 0 C-N-CA 125.72 1.629 . . . . 0.0 116.866 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.63 155.27 76.07 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.97 161.95 17.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.921 2.414 . . . . 0.0 113.436 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -67.25 73.19 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.834 2.356 . . . . 0.0 112.19 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.43 142.1 42.86 Favored Pre-proline 0 N--CA 1.417 -2.115 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.87 167.07 28.26 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.39 2.06 . . . . 0.0 112.627 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.403 ' HB3' ' C ' ' A' ' 47' ' ' TYR . 10.6 ptt180 -47.24 124.38 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.196 0.998 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.16 -29.07 9.56 Favored Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.032 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.03 -52.28 1.22 Allowed Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.993 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.22 94.78 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 CA-C-N 120.683 1.28 . . . . 0.0 110.411 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.11 113.2 17.04 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.285 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.8 mm -92.84 108.06 19.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 37.2 tt0 -90.49 106.49 18.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 105' ' ' THR . 47.2 t -104.81 131.98 52.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.0 m -130.64 127.45 38.96 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.267 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 4.5 m-85 -103.46 113.02 26.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.474 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.4 p30 -125.25 125.08 43.01 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.846 175.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 12.1 mt -107.83 145.35 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.25 -160.64 0.82 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.66 51.11 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.43 -29.02 52.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.918 0.39 . . . . 0.0 111.989 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.35 29.22 4.04 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 75.3 mt -87.6 116.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.9 tp -98.88 118.88 36.64 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.288 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -107.6 104.56 14.13 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.274 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 58.0 t -93.45 114.1 29.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.4 m -113.33 124.24 52.01 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.144 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.88 117.81 34.42 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 26.7 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.072 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.18 100.88 10.1 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -67.65 -13.48 62.13 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.4 m -82.56 -47.34 12.24 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.165 0.507 . . . . 0.0 110.537 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -101.38 -27.06 13.36 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.48 45.09 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.264 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 147.82 27.23 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.73 146.24 34.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.46 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.53 131.11 48.25 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 12.3 ptmm? -122.98 135.31 54.43 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.446 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.8 pt -106.94 137.8 35.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 84.9 m -108.53 112.08 24.27 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.055 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.13 97.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.7 p -92.59 101.26 13.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.27 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 N--CA 1.478 0.932 0 O-C-N 124.381 1.051 . . . . 0.0 112.717 177.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 135' ' ' VAL . 78.1 mt -64.63 -52.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.774 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -64.0 -30.45 71.52 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.795 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 44.1 mtp85 -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.588 174.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.473 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 20.8 ptt? -70.73 -21.3 62.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.611 -0.836 . . . . 0.0 113.018 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 131' ' ' ILE . 93.5 t -63.3 -50.01 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.63 -34.94 77.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.792 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 40.7 mm-40 -62.95 -47.02 85.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.45 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.29 -29.91 70.72 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 142' ' ' LYS . 30.6 mm-40 -75.47 -45.91 35.63 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -72.59 -46.61 53.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.022 0.439 . . . . 0.0 111.077 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.65 22.84 7.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 60.0 mttp -42.84 -59.19 2.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.663 0.602 . . . . 0.0 110.524 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.33 -37.51 67.53 Favored 'General case' 0 C--O 1.231 0.086 0 O-C-N 124.312 1.007 . . . . 0.0 112.733 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.94 -53.23 11.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.778 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 13.2 m-20 -70.07 -31.6 69.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 12.4 pt-20 -67.49 -42.9 82.16 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.42 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.7 -42.38 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -61.62 -45.48 93.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 5.1 ptp180 -65.65 -32.13 73.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.817 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -78.95 -24.32 43.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -61.84 -40.58 95.79 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.218 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.63 146.07 7.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m -57.11 140.54 49.05 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.24 103.91 7.44 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -86.44 134.75 33.67 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.036 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.04 22.02 13.29 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 166.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -120.3 140.17 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.706 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 mp -117.53 149.97 39.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.433 ' C ' ' HG ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -96.93 163.4 12.98 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.433 ' HG ' ' C ' ' A' ' 159' ' ' GLU . 16.0 m . . . . . 0 C--N 1.282 -2.349 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.2 tp . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 59.2 68.75 0.78 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.477 1.132 . . . . 0.0 110.032 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 35' ' ' THR . 34.1 m -137.55 -178.55 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.371 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.9 123.27 82.33 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' C ' HD11 ' A' ' 15' ' ' LEU . 19.5 Cg_endo -60.51 -51.48 5.12 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.3 2.0 . . . . 0.0 110.907 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.513 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 7.3 mp -128.1 167.37 16.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.526 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 18.5 m -72.5 142.45 48.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 O-C-N 123.614 0.571 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -114.0 132.12 56.1 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.782 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 28' ' ' ALA . . . -147.79 -177.42 22.18 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.044 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 26' ' ' MET . 83.6 mt -122.83 167.94 12.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.896 0.379 . . . . 0.0 111.63 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.21 109.34 17.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.391 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 p -109.47 158.34 18.07 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.437 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.11 115.93 1.36 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.903 1.281 . . . . 0.0 113.252 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.21 10.74 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.821 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.37 44.17 5.36 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.34 137.17 55.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.468 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 33.1 ttp -96.71 112.05 23.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -94.42 112.3 24.07 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . . . -90.28 133.67 34.8 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.666 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.618 ' HG ' ' OE1' ' A' ' 42' ' ' GLN . 5.9 mp -100.93 -39.67 7.64 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.69 129.85 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -101.31 162.6 12.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HD3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -70.91 142.2 51.14 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.824 178.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.403 ' OD1' ' HD3' ' A' ' 32' ' ' ARG . 16.9 m120 80.64 -6.09 1.69 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.24 1.416 . . . . 0.0 113.252 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.7 m -65.19 115.29 5.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.439 ' HA ' HG13 ' A' ' 12' ' ' VAL . 2.7 m -71.03 129.9 40.18 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.193 -172.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.43 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 28.4 pt -92.97 155.76 41.08 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.029 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.1 Cg_exo -63.48 141.83 42.86 Favored 'Cis proline' 0 N--CA 1.487 1.098 0 C-N-CA 124.604 -0.998 . . . . 0.0 114.24 0.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.6 p -120.89 152.84 37.97 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.762 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 47.6 tttp -153.41 99.81 2.38 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -108.42 135.31 49.93 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -124.02 127.97 48.67 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.618 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 44.8 mt-30 -132.11 150.28 52.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.91 129.42 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.522 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 89.1 m-85 -117.42 155.14 30.15 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 22.9 p -127.37 170.73 12.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 41.5 p -100.51 139.86 35.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.494 ' CD1' ' HB3' ' A' ' 157' ' ' ALA . 31.3 m-85 -117.76 5.13 12.25 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -120.74 127.16 51.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.412 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 84' ' ' PRO . 46.0 t0 -82.05 169.95 16.11 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.34 14.66 9.21 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.822 1.249 . . . . 0.0 113.232 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -90.25 114.62 61.64 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -89.8 -1.82 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.146 1.897 . . . . 0.0 111.839 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.91 145.01 8.89 Favored Glycine 0 N--CA 1.413 -2.874 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.39 147.32 13.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 117.049 0.425 . . . . 0.0 109.93 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.08 118.15 35.19 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.067 0.46 . . . . 0.0 110.705 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.72 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.43 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 90.7 mt-30 -102.2 130.01 48.74 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 t -99.48 129.0 50.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 123.714 0.634 . . . . 0.0 109.354 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.78 156.55 44.79 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.166 0.508 . . . . 0.0 111.524 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.513 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 35.8 tt0 -118.63 136.77 53.71 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.471 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.04 116.55 3.91 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.526 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 40.4 mt-10 -79.47 107.18 12.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -133.57 144.53 49.38 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.9 76.0 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 124.131 0.894 . . . . 0.0 111.552 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.8 mtt -94.76 111.49 23.26 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.271 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -74.71 109.83 8.51 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.066 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -175.25 -41.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.566 1.147 . . . . 0.0 109.016 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -109.21 75.44 0.95 Allowed 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -147.92 164.33 34.07 Favored 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 73.2 m-20 -90.61 129.3 36.75 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.0 tp -83.34 125.09 31.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.05 0.452 . . . . 0.0 111.221 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.423 ' HB3' HD11 ' A' ' 119' ' ' ILE . 7.4 mp -101.99 -9.38 20.69 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.52 178.33 15.37 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.882 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 6.8 ppt_? -153.33 156.91 39.24 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -150.87 152.32 33.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.39 125.01 51.94 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.06 104.22 16.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 p -105.15 163.49 12.54 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.695 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.62 7.09 45.91 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.6 mm -64.56 127.46 92.38 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.59 143.49 68.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.244 1.963 . . . . 0.0 110.613 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.63 90.58 0.6 Allowed 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 121.204 1.27 . . . . 0.0 109.646 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.16 129.53 20.94 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.995 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 17.9 Cg_endo -58.73 -61.04 0.28 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 123.296 2.664 . . . . 0.0 114.643 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 46' ' ' THR . 88.1 mtt180 -139.37 136.1 34.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.01 1.25 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 117.731 1.852 . . . . 0.0 117.731 167.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.411 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.9 t -52.3 -57.53 15.02 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 6.2 Cg_exo -81.73 103.52 1.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.641 1.56 . . . . 0.0 110.821 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -95.11 117.75 30.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.25 121.56 47.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.93 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.41 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 38.4 tt0 -91.35 115.79 28.32 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.7 t -110.49 124.81 67.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 m -121.67 128.85 52.31 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.222 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 7.6 m-85 -110.57 109.55 19.9 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.1 p30 -126.57 128.25 46.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.26 0.552 . . . . 0.0 112.12 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 45.9 mt -123.62 133.92 67.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -88.72 -172.07 3.57 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.11 -5.95 55.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.07 -29.88 21.56 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.46 26.7 4.73 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 72.9 mt -89.07 108.0 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.7 tp -94.63 128.76 41.5 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.388 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER -119.74 108.02 13.91 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 174.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 61.2 t -95.59 113.81 30.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.9 m -112.86 122.03 46.43 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.1 m -122.64 122.22 38.29 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 120.842 0.353 . . . . 0.0 111.429 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -82.52 108.16 15.71 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.063 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.8 -6.88 23.48 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -79.84 -61.97 1.83 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.1 p -82.61 -30.22 29.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.68 13.1 56.01 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.982 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -91.11 144.0 26.1 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 117.626 0.713 . . . . 0.0 109.684 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -123.8 141.71 51.78 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -129.52 134.08 47.58 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 17.5 ptpt -124.25 166.55 15.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.47 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 15.0 tt -131.2 145.53 35.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.8 m -113.51 116.21 29.21 Favored 'General case' 0 C--N 1.276 -2.603 0 O-C-N 124.397 1.061 . . . . 0.0 110.124 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.423 HD11 ' HB3' ' A' ' 72' ' ' LEU . 75.5 mt -120.6 125.24 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.0 m -119.92 140.7 50.48 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 124.401 1.08 . . . . 0.0 111.429 174.51 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.09 -44.42 78.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.664 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.01 -39.32 81.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.541 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -60.41 -43.01 97.15 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.594 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 tpp -58.92 -39.3 81.15 Favored 'General case' 0 C--O 1.212 -0.915 0 O-C-N 123.742 0.652 . . . . 0.0 109.828 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.77 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.084 0.468 . . . . 0.0 109.98 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -61.05 -47.67 85.32 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.708 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.46 -32.55 73.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.513 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.521 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -68.17 -55.53 12.03 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 122.158 -0.339 . . . . 0.0 110.609 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.55 -48.54 77.03 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.74 -17.81 65.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -118.3 16.18 13.95 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -55.1 -43.26 73.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.43 80.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 110.757 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.79 -44.95 65.58 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.045 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -61.32 -42.24 98.33 Favored 'General case' 0 CA--C 1.498 -1.026 0 O-C-N 123.403 0.439 . . . . 0.0 111.537 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 41.3 mt-10 -57.39 -45.51 84.44 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.982 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.647 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 46.0 t -68.76 -42.49 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.398 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -55.88 -48.8 74.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -63.91 -36.93 85.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.0 pt-20 -79.06 -15.51 58.1 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.539 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.647 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 91.6 mtt-85 -71.77 -38.76 70.29 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.9 -57.53 4.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.938 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.455 ' OG ' ' HG2' ' A' ' 155' ' ' LYS . 31.3 t -158.27 -80.78 0.06 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.501 -174.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 65.39 19.21 11.57 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 124.952 1.301 . . . . 0.0 111.771 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.455 ' HG2' ' OG ' ' A' ' 153' ' ' SER . 17.0 ptpt -82.18 144.86 30.42 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 10.4 t30 -84.12 69.34 10.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.283 1.039 . . . . 0.0 111.455 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.774 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.3 151.63 35.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -115.06 175.04 5.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.42 -1.941 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.359 -176.188 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 122.726 1.251 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.523 ' O ' HG12 ' A' ' 36' ' ' ILE . 1.3 m-20 -85.47 74.78 10.28 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.354 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -115.84 175.86 2.62 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.907 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.895 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.08 129.45 67.18 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.45 -23.95 2.61 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 122.131 1.887 . . . . 0.0 112.372 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.43 172.4 10.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 m -94.98 129.25 42.12 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.82 131.7 43.3 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.58 -164.52 14.96 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.332 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.0 mt -131.07 161.85 31.14 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.81 120.81 32.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 117.821 -1.551 . . . . 0.0 109.223 171.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 23.6 p -97.94 -176.33 3.41 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.809 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.71 128.83 39.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.068 0.461 . . . . 0.0 111.922 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.25 59.96 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.43 53.73 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.255 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -92.91 140.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 113.09 25.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.0 m -109.39 110.97 22.27 Favored 'General case' 0 C--N 1.279 -2.468 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.624 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.29 136.26 33.16 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.201 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.441 HD23 ' CD2' ' A' ' 94' ' ' PHE . 5.7 mp -99.45 -49.98 4.25 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.81 103.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -80.71 162.8 23.97 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HD3' ' OE2' ' A' ' 139' ' ' GLU . 9.7 ptm180 -64.43 159.36 21.55 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.316 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m120 77.34 4.8 3.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.499 1.12 . . . . 0.0 112.243 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 m -83.32 115.75 22.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.38 132.84 45.42 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.113 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 11' ' ' ASP . 26.5 pt -91.38 161.39 34.77 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.9 Cg_exo -69.01 147.39 82.98 Favored 'Cis proline' 0 C--O 1.245 0.858 0 CA-C-N 119.834 0.976 . . . . 0.0 113.731 1.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 11.8 p -118.19 136.42 53.65 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.043 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -135.02 101.02 4.74 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 93' ' ' THR . 62.1 tt0 -121.92 131.81 54.22 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -128.67 125.1 37.35 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -135.48 152.3 51.21 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.18 122.47 50.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.088 0.47 . . . . 0.0 110.331 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.5 162.14 14.4 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.848 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 6.1 p -137.76 170.22 16.44 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.041 0.536 . . . . 0.0 109.66 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -95.93 137.01 35.6 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.303 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -108.63 32.11 5.11 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 167.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 p -132.19 159.43 39.01 Favored 'General case' 0 N--CA 1.391 -3.405 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.974 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -136.61 162.17 33.88 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.88 22.08 10.25 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.101 0.876 . . . . 0.0 110.934 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.402 HE22 ' HA ' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -80.48 125.71 80.26 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.959 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.16 -18.51 27.04 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 121.706 1.604 . . . . 0.0 109.657 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.31 175.01 47.2 Favored Glycine 0 N--CA 1.406 -3.365 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.75 129.85 55.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.119 0.485 . . . . 0.0 110.139 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.6 tp -87.17 100.29 12.56 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.595 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mm -84.15 96.98 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -109.3 110.3 21.43 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.1 t -92.98 135.97 26.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.79 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -133.77 163.24 29.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.42 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.85 165.45 25.59 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.46 -103.78 0.9 Allowed Glycine 0 C--N 1.287 -2.146 0 C-N-CA 119.025 -1.56 . . . . 0.0 114.235 170.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.642 ' OE2' ' HG3' ' A' ' 67' ' ' LYS . 39.9 mt-10 -78.46 172.16 14.04 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.594 0.358 . . . . 0.0 110.939 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -112.59 -27.47 8.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.383 -0.372 . . . . 0.0 112.001 -171.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -90.42 -52.43 4.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -172.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.1 mtm -142.1 149.64 40.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -173.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.28 82.55 2.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 O-C-N 124.082 0.863 . . . . 0.0 109.851 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.642 ' HG3' ' OE2' ' A' ' 62' ' ' GLU . 8.3 ptmm? -118.84 -76.53 0.57 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.99 12.4 30.57 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.597 0.713 . . . . 0.0 111.208 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.88 142.22 57.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.694 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -96.09 141.96 28.85 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.566 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.5 tp -76.99 123.37 26.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.458 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.6 mt -89.24 -40.16 13.03 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.521 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 171.27 36.74 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -140.2 135.05 32.0 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -143.22 135.01 26.66 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.76 118.97 37.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.953 0.406 . . . . 0.0 111.421 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.0 tp -90.73 104.29 16.89 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 p -113.55 165.95 12.0 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -168.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 4.33 39.8 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.16 113.15 46.4 Favored Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.37 138.33 50.38 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.475 2.117 . . . . 0.0 112.141 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HA ' HE22 ' A' ' 51' ' ' GLN . 92.2 Cg_exo -47.42 125.88 11.29 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.344 3.362 . . . . 0.0 113.159 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.39 152.85 80.79 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.84 39.64 0.29 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 124.055 3.17 . . . . 0.0 115.07 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 68.34 143.57 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.665 1.586 . . . . 0.0 112.429 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.94 75.88 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.53 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.407 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.8 t -107.13 -55.11 0.07 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.924 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 15.5 Cg_exo -70.38 130.51 18.7 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 121.307 1.338 . . . . 0.0 110.71 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -110.86 123.07 49.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -110.03 125.2 67.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.6 tt0 -90.77 111.59 23.02 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -108.27 129.87 61.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 30.5 m -123.46 118.58 27.74 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.441 ' CD2' HD23 ' A' ' 29' ' ' LEU . 10.5 m-85 -100.54 116.37 32.3 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 173.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' THR . 12.2 t70 -128.91 116.36 19.28 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.764 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 52.5 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.403 ' O ' HD12 ' A' ' 36' ' ' ILE . 2.4 p-10 -87.57 -172.6 3.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -13.96 61.24 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -84.79 -31.46 23.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 117.6 14.11 7.03 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.481 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 80.7 mt -80.54 119.95 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.8 tp -98.44 118.03 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.411 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -112.91 111.24 21.85 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -101.82 116.64 45.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.7 m -111.67 134.34 53.31 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.46 124.12 42.17 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 m -124.22 118.42 26.8 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.521 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.5 123.34 29.63 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.728 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 75.0 mmtt -68.01 -28.82 67.75 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.875 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 m -68.68 -61.91 1.61 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.142 0.496 . . . . 0.0 110.865 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.5 p -84.01 -39.88 19.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.36 0.6 . . . . 0.0 110.799 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.25 39.29 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.16 149.04 43.27 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.496 0.665 . . . . 0.0 112.761 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.22 134.72 42.35 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.349 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 146.22 47.18 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -142.11 162.3 35.82 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.034 0.445 . . . . 0.0 111.731 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 tt -129.44 145.76 35.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.3 m -122.8 117.25 25.23 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.029 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.25 118.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 p -92.26 172.73 8.22 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.854 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 134' ' ' MET . 1.2 mp0 . . . . . 0 C--O 1.223 -0.332 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.1 mt -61.22 -50.84 78.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.783 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.2 pt-20 -72.75 -26.0 61.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -61.88 -44.05 97.59 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 95.0 mmm -60.76 -37.39 81.67 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.103 0.478 . . . . 0.0 109.764 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 88.1 t -58.2 -54.68 29.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.029 176.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 87.4 mt-30 -59.29 -53.78 54.31 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.914 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.78 -53.58 55.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.928 -176.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.61 67.77 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.486 ' OE2' ' HD3' ' A' ' 32' ' ' ARG . 26.1 mm-40 -74.27 -32.93 63.12 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.052 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -71.21 -34.29 70.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.08 11.44 23.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.888 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -53.66 -48.62 69.26 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 118.142 0.428 . . . . 0.0 111.522 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.95 74.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.813 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -74.2 -44.7 52.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.81 -49.39 77.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.67 -32.53 74.04 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.383 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.91 -48.41 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.575 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -55.93 -41.89 75.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.87 0.468 . . . . 0.0 111.066 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.53 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 57.0 ttp180 -61.4 -51.69 67.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.486 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.4 ' HG3' ' HE ' ' A' ' 149' ' ' ARG . 47.6 mt-10 -78.36 -1.37 33.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.9 -14.0 46.16 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 29.9 t -112.18 157.77 12.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -80.56 93.09 6.02 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.323 0.583 . . . . 0.0 110.583 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -90.66 93.11 9.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.533 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -112.71 158.63 19.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.12 68.51 9.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.234 1.016 . . . . 0.0 110.761 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.74 136.18 25.38 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.693 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.93 152.38 25.02 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.903 0.382 . . . . 0.0 110.423 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.24 119.59 36.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.419 -1.979 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.489 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.429 -1.522 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -96.23 25.91 4.61 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -126.88 170.64 16.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-O 121.211 0.529 . . . . 0.0 110.906 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.46 120.87 80.61 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.04 -21.63 23.84 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.094 1.862 . . . . 0.0 111.743 -177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.8 mt -134.49 174.45 10.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 m -101.57 123.01 44.89 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.09 0.244 . . . . 0.0 110.609 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -92.28 131.63 37.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.1 -168.41 21.11 Favored Glycine 0 N--CA 1.425 -2.052 0 C-N-CA 119.375 -1.393 . . . . 0.0 114.63 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.6 mt -133.63 162.79 30.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.735 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -94.81 109.51 21.47 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.9 p -84.16 175.37 9.52 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.083 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.96 116.51 4.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.62 -12.23 11.04 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 51.66 4.53 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.25 127.16 73.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.0 tpt -73.82 102.5 4.06 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -107.78 112.13 24.64 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.29 127.48 38.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.41 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.0 mp -95.57 -50.35 5.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.1 mm -94.18 92.31 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.2 154.92 30.67 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -53.81 140.28 30.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.23 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 79.84 1.7 2.12 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.585 1.554 . . . . 0.0 113.283 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.13 128.15 33.36 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -70.5 134.79 48.05 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.617 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.6 pt -104.09 161.42 22.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.1 Cg_endo -64.44 140.88 42.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 CA-C-N 120.914 1.362 . . . . 0.0 114.115 0.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.3 p -109.59 164.12 12.82 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -159.08 101.64 1.6 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -132.46 128.05 36.61 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.4 m -119.85 124.01 45.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -124.22 146.07 48.95 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.462 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 46.0 mm -97.78 115.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -107.72 133.55 51.97 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 p -107.57 170.25 8.09 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.445 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -96.65 136.96 36.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.742 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -98.06 10.88 39.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.684 1.231 . . . . 0.0 108.623 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.3 p -116.13 145.32 43.15 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.236 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.55 159.62 21.02 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.386 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 6.6 m-20 57.82 27.49 14.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.329 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -77.27 130.16 75.67 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.523 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.34 -15.04 14.4 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.234 1.956 . . . . 0.0 111.784 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 164.19 37.75 Favored Glycine 0 N--CA 1.422 -2.278 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.8 158.51 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 123.006 0.523 . . . . 0.0 109.781 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 75' ' ' PHE . 42.7 tp -117.6 107.88 14.79 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 75' ' ' PHE . 3.8 mp -89.1 105.49 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -92.85 119.69 32.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.25 121.6 54.73 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-O 121.225 0.536 . . . . 0.0 111.035 -173.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.04 164.29 21.86 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.615 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -134.89 132.71 38.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.383 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.03 172.23 13.44 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -135.12 120.87 19.55 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.074 0.937 . . . . 0.0 113.088 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 2.6 mmp_? -154.14 166.51 32.87 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.55 54.87 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.151 0.976 . . . . 0.0 110.042 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.9 mtt -133.52 121.19 21.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.35 96.62 3.43 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.373 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -168.25 -45.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.087 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 17.7 m-20 -95.7 71.3 3.05 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -145.29 160.43 41.52 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 113.186 -1.824 . . . . 0.0 107.768 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -89.87 131.08 35.98 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.33 107.84 19.47 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.25 0.547 . . . . 0.0 109.684 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.25 -23.99 27.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.311 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.11 -162.63 28.81 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.404 ' HG3' ' OE2' ' A' ' 76' ' ' GLU . 23.3 ptt180 -145.87 162.83 36.84 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.506 ' HB3' ' HB ' ' A' ' 56' ' ' ILE . 7.6 t80 -128.92 130.49 46.84 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' OE2' ' HG3' ' A' ' 74' ' ' ARG . 1.7 mp0 -104.0 104.66 14.65 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -112.14 110.19 20.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 p -130.16 166.75 19.6 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.65 19.05 16.62 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.75 129.63 61.36 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.67 137.71 30.62 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.237 1.958 . . . . 0.0 110.97 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 50' ' ' ASN . 50.5 Cg_exo -56.89 107.24 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 122.59 2.193 . . . . 0.0 112.275 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.01 158.12 76.65 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.8 161.36 18.57 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.02 2.48 . . . . 0.0 112.151 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -65.62 142.27 58.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.04 -7.91 79.87 Favored Glycine 0 C--N 1.308 -1.004 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.945 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.39 -54.07 0.29 Allowed Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.8 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.59 112.62 1.83 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 121.41 1.407 . . . . 0.0 111.225 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -99.93 113.46 26.03 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.257 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -100.41 120.7 50.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 40.1 tt0 -90.6 108.98 20.15 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' THR . 46.2 t -109.05 117.33 54.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.208 0.528 . . . . 0.0 109.696 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 84.8 m -108.59 125.43 51.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.562 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.41 ' CD1' HD22 ' A' ' 29' ' ' LEU . 8.8 m-85 -98.91 112.3 24.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.95 112.56 14.2 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.576 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 26.1 mt -119.12 119.79 61.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.422 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.5 p30 -84.11 176.75 8.59 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.781 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.12 -17.25 51.79 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.512 ' HB3' HG12 ' A' ' 101' ' ' ILE . 66.2 t30 -82.46 -15.23 53.3 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.517 0.675 . . . . 0.0 109.573 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.57 7.13 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 43.1 mm -97.28 114.21 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.92 118.49 36.45 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 25.9 m-80 -106.47 108.02 19.33 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.625 173.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.2 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 15.2 m -107.86 117.54 34.4 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.99 123.62 50.15 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -125.94 121.01 31.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.761 0.315 . . . . 0.0 111.634 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.57 106.98 8.54 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.907 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.9 -19.18 64.98 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -63.06 -49.83 72.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.853 0.359 . . . . 0.0 110.771 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.8 p -109.62 -23.13 11.62 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.77 53.62 2.06 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.2 126.27 50.24 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.965 0.412 . . . . 0.0 111.559 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.31 54.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.462 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -135.88 149.9 49.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 146.77 44.34 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 117.742 0.246 . . . . 0.0 111.273 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 23.0 pt -115.49 128.07 72.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 45.5 m -98.04 113.51 25.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.594 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 64.6 mt -121.84 110.47 27.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.603 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 m -77.87 114.74 17.03 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 168.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.313 61.6 t30 . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 117.759 -1.577 . . . . 0.0 113.942 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 CA--C 1.515 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.526 ' O ' HG21 ' A' ' 135' ' ' VAL . 2.0 mp -72.45 -53.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.209 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 136' ' ' GLN 0.267 0.0 OUTLIER -66.35 -30.45 70.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.446 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -67.09 -42.44 84.63 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -73.03 -26.38 61.29 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.829 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 131' ' ' ILE . 97.7 t -67.11 -39.18 82.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 27.9 mm-40 -60.41 -47.05 87.78 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.686 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -66.38 -36.45 82.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.796 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.88 73.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.453 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -79.68 -49.2 12.46 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -73.38 -42.48 62.11 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.85 31.55 5.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.36 -55.66 23.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.553 1.541 . . . . 0.0 110.799 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -67.25 -51.81 48.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.691 -175.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -55.04 -51.83 65.08 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.711 0.804 . . . . 0.0 111.05 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.88 -35.52 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -66.02 -37.23 85.38 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.515 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 64.1 t -70.18 -48.1 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.644 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -56.81 -40.2 75.54 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -56.77 -43.9 81.29 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.936 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.22 -6.68 57.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.626 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 36.3 mmt180 -76.48 -33.09 58.69 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 30.9 t -81.73 -31.22 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 172.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t 77.92 139.92 0.07 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.493 1.517 . . . . 0.0 110.479 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 -43.24 10.9 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.015 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 61.28 -164.47 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.186 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 15.1 m120 -122.93 58.88 1.08 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.605 0.716 . . . . 0.0 109.238 174.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.73 149.18 33.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.92 151.88 37.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.14 131.1 42.94 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.834 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 C--N 1.302 -1.479 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.586 -178.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.44 -0.963 0 CA-C-O 121.053 0.454 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 36' ' ' ILE . 33.7 m-20 -108.45 78.34 1.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 m -127.38 176.56 7.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.069 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.66 121.28 84.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.04 -46.35 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.42 2.08 . . . . 0.0 111.633 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.416 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 89.0 mt -128.86 173.97 9.9 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.5 m -82.84 128.56 34.53 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.46 131.85 37.27 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.65 -177.63 25.6 Favored Glycine 0 N--CA 1.413 -2.851 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.673 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 96.9 mt -126.85 150.96 48.96 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.78 109.01 17.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 25.6 p -93.13 -88.89 0.21 Allowed 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.001 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.37 172.04 12.9 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.23 88.36 0.01 OUTLIER Glycine 0 N--CA 1.469 0.882 0 O-C-N 124.71 1.256 . . . . 0.0 115.906 -173.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.66 29.55 71.23 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.773 -0.714 . . . . 0.0 114.211 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.95 136.04 52.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ttt -100.12 130.04 46.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.0 110.847 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.8 m -114.88 115.02 26.27 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.7 126.44 35.32 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.4 mp -95.58 -50.13 5.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -110.71 107.53 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -74.61 149.52 40.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.869 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.8 ptt85 -52.7 147.24 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.291 1.037 . . . . 0.0 112.322 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 76.88 2.9 3.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.255 1.422 . . . . 0.0 113.593 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -77.88 131.84 37.69 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -72.96 140.17 47.23 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 123.162 0.585 . . . . 0.0 111.506 -174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 11' ' ' ASP . 18.7 pt -109.63 161.15 25.21 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 42.6 Cg_exo -62.19 136.84 20.84 Favored 'Cis proline' 0 C--O 1.241 0.672 0 CA-C-N 120.462 1.201 . . . . 0.0 114.57 0.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -107.44 166.21 10.82 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -167.09 102.11 0.54 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -130.31 130.37 44.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 79.5 m -115.49 126.55 54.44 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.119 0.262 . . . . 0.0 110.534 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -127.64 140.32 52.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -104.34 114.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 87.0 m-85 -106.05 138.78 41.63 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.426 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 4.8 p -106.22 170.81 7.7 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -106.54 146.12 31.02 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.792 -1.192 . . . . 0.0 110.916 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' HA ' ' HG2' ' A' ' 85' ' ' ARG . 28.0 m-85 -87.86 -28.55 21.52 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -71.76 139.0 48.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.26 172.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -104.35 154.88 19.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.797 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 61.27 25.43 15.41 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -65.12 133.96 95.8 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -80.37 -19.82 8.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.332 2.021 . . . . 0.0 110.394 171.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.9 153.05 23.47 Favored Glycine 0 N--CA 1.419 -2.435 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.926 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.06 160.42 15.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 tp -118.4 114.53 23.04 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.2 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.05 110.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 36.5 mt-30 -108.46 113.69 26.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.671 -175.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 t -95.19 120.9 45.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.258 0 O-C-N 123.363 0.414 . . . . 0.0 110.602 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.4 146.71 52.01 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.416 ' OE2' ' HB2' ' A' ' 15' ' ' LEU . 15.4 pt-20 -120.48 150.61 40.55 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.853 0.835 . . . . 0.0 110.771 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.34 -174.01 19.8 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.86 95.52 3.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 118.192 0.996 . . . . 0.0 108.712 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -142.93 153.64 43.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.931 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.43 -49.55 10.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.144 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mmm -98.89 105.44 17.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.404 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 95.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.981 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -151.59 -44.51 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.54 11.14 36.2 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.615 0.721 . . . . 0.0 109.654 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.55 161.95 25.67 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.913 -173.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -90.78 115.13 27.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -82.05 113.73 20.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.98 -33.02 19.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.91 162.7 22.66 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -153.67 138.7 17.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -137.75 151.39 48.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.036 0.446 . . . . 0.0 111.46 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.55 133.16 38.47 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.292 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.04 105.13 13.78 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -96.71 151.29 19.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.402 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.7 -0.62 13.77 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 121.117 -0.564 . . . . 0.0 111.835 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.08 133.96 92.82 Favored Pre-proline 0 C--O 1.254 1.319 0 C-N-CA 122.847 0.459 . . . . 0.0 110.675 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.33 134.88 64.37 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.179 2.586 . . . . 0.0 112.476 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -71.44 67.66 2.79 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.596 2.197 . . . . 0.0 110.593 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.52 158.52 75.4 Favored Pre-proline 0 N--CA 1.417 -2.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.086 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.79 178.68 7.3 Favored 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.192 1.928 . . . . 0.0 114.462 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 47' ' ' TYR . 19.3 mtm180 -30.18 115.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.795 2.438 . . . . 0.0 115.138 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.82 -29.75 8.67 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.666 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.58 -51.01 4.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.41 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.92 124.38 14.38 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.447 1.432 . . . . 0.0 109.421 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -134.93 95.61 3.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.221 1.01 . . . . 0.0 110.388 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.7 mm -93.42 112.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.773 -173.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -90.16 111.9 23.21 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 105' ' ' THR . 62.0 t -111.56 125.68 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -177.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.6 m -112.78 124.27 52.21 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.436 ' CD1' HD22 ' A' ' 29' ' ' LEU . 14.5 m-85 -97.7 109.32 22.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.18 114.22 16.04 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 37' ' ' PRO . 59.4 mt -116.44 140.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' HD13 ' A' ' 36' ' ' ILE . 1.3 p-10 -93.45 -176.5 4.13 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.35 -15.14 62.83 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -82.21 -28.76 31.77 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.63 20.15 7.47 Favored Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 78.6 mt -83.8 113.93 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 tp -95.28 118.8 32.68 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 24.0 t-20 -110.39 113.32 25.88 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 174.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.4 113.78 32.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 21.1 m -103.64 126.76 50.98 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.75 126.04 49.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' LYS . 19.8 m -131.84 118.32 19.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.51 107.62 11.3 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -67.56 -20.53 65.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.555 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.6 t -69.44 -52.53 25.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.044 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.0 p -90.06 -32.2 16.82 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.47 43.98 3.56 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 107' ' ' THR . 54.4 mttm -116.59 133.37 56.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.2 136.64 41.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -138.77 145.96 40.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.267 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -143.26 151.0 40.06 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 123.042 0.214 . . . . 0.0 111.288 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 32.0 pt -121.9 141.21 43.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.962 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.1 m -111.14 113.21 25.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.99 103.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.056 0.455 . . . . 0.0 109.977 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -93.75 127.41 39.46 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 124.453 1.101 . . . . 0.0 111.701 -179.689 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 134' ' ' MET . 46.8 mt-10 . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.4 mt -60.7 -52.02 66.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.793 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.42 -25.1 63.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.509 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 92.2 mmm -59.47 -43.19 93.31 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.3 t -63.24 -47.5 91.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.156 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -57.34 -46.95 82.78 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.82 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.79 -35.61 75.01 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.206 0.316 . . . . 0.0 111.541 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.39 77.97 Favored 'General case' 0 C--O 1.19 -2.064 0 O-C-N 123.472 0.483 . . . . 0.0 110.322 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.08 -48.2 16.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.473 0.654 . . . . 0.0 111.025 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.92 -40.48 96.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.394 -173.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.71 18.11 19.27 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.81 0.338 . . . . 0.0 110.195 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -49.03 -58.93 4.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.458 1.503 . . . . 0.0 112.451 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.55 -34.14 69.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -64.38 -53.42 48.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.044 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 1.4 m-20 -63.6 -36.44 83.81 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.059 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.519 ' OE1' ' HD3' ' A' ' 149' ' ' ARG . 6.9 mm-40 -57.85 -46.43 84.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.021 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 60.2 t -63.32 -40.88 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 32.2 mm-40 -58.78 -54.08 51.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.628 0.771 . . . . 0.0 111.698 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 2.6 ptm180 -68.78 -32.82 72.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.22 -9.91 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.916 0.388 . . . . 0.0 111.752 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 92.2 mtt180 -68.8 -27.67 66.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.24 125.69 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -81.53 75.85 8.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 0.0 111.383 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -101.87 120.47 40.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.577 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -94.67 -163.12 1.01 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 18.1 m120 -76.28 80.16 3.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.847 0.832 . . . . 0.0 109.042 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.618 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.58 153.13 41.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.344 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.2 mt -125.82 136.01 52.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.09 120.2 40.91 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.278 -2.501 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.598 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp . . . . . 0 C--O 1.242 0.707 0 CA-C-O 122.252 1.025 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 36' ' ' ILE . 17.2 t70 -123.13 17.59 9.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 123.083 1.42 . . . . 0.0 108.941 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 m -136.37 171.07 17.44 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.136 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.73 118.66 72.61 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.08 -31.98 13.96 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.983 1.788 . . . . 0.0 112.335 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.04 168.83 17.78 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.1 m -92.67 132.44 36.9 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.08 132.03 50.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.92 179.37 28.55 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.352 -176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 92' ' ' VAL . 97.1 mt -118.75 155.47 31.06 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.809 -0.695 . . . . 0.0 109.867 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -88.59 109.35 20.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.401 HG23 ' HG ' ' A' ' 158' ' ' LEU . 17.2 p -105.3 -166.06 1.18 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.489 -174.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.33 134.69 18.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.615 0.766 . . . . 0.0 112.174 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.81 56.07 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.142 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.51 25.14 31.33 Favored Glycine 0 C--O 1.246 0.898 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.0 t -104.52 146.54 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.507 -1.346 . . . . 0.0 109.208 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.4 ttt -87.89 136.43 32.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.213 0.53 . . . . 0.0 111.983 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.6 m -123.74 112.19 17.04 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.85 116.59 29.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.782 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.492 HD21 ' CD2' ' A' ' 94' ' ' PHE . 5.4 mp -79.41 -47.22 16.1 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.04 112.95 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.19 142.46 28.33 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -56.76 155.74 7.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 77.98 1.29 2.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.528 1.531 . . . . 0.0 111.813 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -86.12 128.99 34.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -60.05 144.91 48.33 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.408 1.083 . . . . 0.0 112.109 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 28.4 pt -106.16 169.75 6.57 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 14.7 Cg_exo -69.08 124.77 7.55 Favored 'Cis proline' 0 C--O 1.244 0.817 0 CA-C-N 121.153 1.447 . . . . 0.0 112.257 0.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -87.96 141.7 28.38 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.405 -178.194 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -148.68 100.02 3.06 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.534 ' O ' ' HA ' ' A' ' 93' ' ' THR . 14.8 mm100 -107.01 117.66 34.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 88.3 m -117.31 116.05 26.47 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.454 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 87.5 mt-30 -120.95 151.39 39.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.77 113.22 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -101.59 165.87 11.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.964 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -145.14 170.89 15.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 p -101.36 139.03 37.59 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.706 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -85.76 -18.8 31.98 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 165.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 p -71.8 110.01 6.05 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.031 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.74 126.65 32.62 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m120 62.05 68.49 0.68 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.426 0.632 . . . . 0.0 111.149 -172.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.5 tp-100 -101.56 117.27 62.23 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.72 -31.75 20.1 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.003 1.802 . . . . 0.0 113.349 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.34 140.09 6.74 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.592 -0.814 . . . . 0.0 111.114 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.85 147.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.135 0.493 . . . . 0.0 110.123 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.506 HD22 ' NH1' ' A' ' 74' ' ' ARG . 42.0 tp -114.7 111.56 21.49 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.141 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.73 105.23 16.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 14.1 mt-30 -103.91 115.11 29.85 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.238 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.02 124.04 55.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 O-C-N 123.643 0.59 . . . . 0.0 110.755 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -129.49 154.4 47.04 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.466 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 34.4 tt0 -122.27 147.74 45.85 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.97 125.73 5.66 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.51 126.36 30.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -152.84 168.41 25.84 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.482 0.713 . . . . 0.0 110.652 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -84.06 -51.1 7.37 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.52 0.676 . . . . 0.0 109.341 174.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.6 mtt -98.63 128.14 44.81 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.989 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -90.0 117.83 29.09 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.877 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -177.59 -52.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.528 1.131 . . . . 0.0 110.058 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.01 79.95 1.81 Allowed 'General case' 0 CA--C 1.464 -2.349 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.93 177.96 7.45 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 112.802 -1.999 . . . . 0.0 106.012 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 30.3 t30 -90.12 109.07 20.15 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.8 107.42 9.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.977 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.18 -41.79 14.38 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.533 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.37 171.52 38.71 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.068 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.506 ' NH1' HD22 ' A' ' 55' ' ' LEU . 7.2 ptp180 -152.58 140.77 20.41 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -147.15 149.02 32.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -97.21 140.14 32.13 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.7 103.39 9.63 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 170.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 p -111.83 161.46 16.33 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 41.71 3.63 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 42.8 mm -86.34 130.49 49.4 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 147.36 94.72 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.74 2.293 . . . . 0.0 112.359 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.88 84.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 122.685 2.256 . . . . 0.0 111.307 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.6 77.92 Favored Pre-proline 0 N--CA 1.42 -1.949 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.841 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.08 168.94 6.69 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.668 2.246 . . . . 0.0 112.712 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -62.94 149.27 45.1 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.657 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.18 -16.0 41.16 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.511 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.25 -55.17 1.39 Allowed Pre-proline 0 C--O 1.247 0.969 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.264 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.71 109.34 1.42 Allowed 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 121.339 1.359 . . . . 0.0 111.283 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -93.64 115.49 27.96 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.004 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.4 mm -102.46 116.77 46.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 17.0 tt0 -90.18 117.18 28.74 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 105' ' ' THR . 39.2 t -117.85 121.16 66.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.657 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 85.6 m -110.95 123.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.664 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.492 ' CD2' HD21 ' A' ' 29' ' ' LEU . 7.1 m-85 -105.2 108.51 20.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 38' ' ' THR . 7.9 t70 -121.19 132.06 54.61 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.414 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 62.8 mt -126.3 135.6 63.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.87 -170.58 2.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.02 -23.6 64.1 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -77.1 -29.31 54.82 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.169 0.509 . . . . 0.0 110.05 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.02 23.35 7.44 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.9 mt -83.35 117.64 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.3 tp -93.58 117.1 29.66 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -109.73 103.38 12.2 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 64.2 t -89.86 118.63 35.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.467 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 35.7 m -113.41 137.17 51.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 91' ' ' GLU . . . -126.79 121.18 31.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 19.7 m -118.81 123.68 45.35 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.497 0.498 . . . . 0.0 110.738 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.57 109.92 16.47 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -66.96 -17.28 64.84 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.918 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -75.6 -62.85 1.44 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.893 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -94.26 -19.47 20.68 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.55 47.96 3.59 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.821 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 107' ' ' THR . 61.3 mttp -106.78 147.24 29.91 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -149.94 131.83 15.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.338 0.589 . . . . 0.0 111.826 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -136.54 139.14 42.0 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.567 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 61.2 pttt -135.85 148.76 48.79 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 120.722 0.296 . . . . 0.0 110.815 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.4 pt -119.16 139.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -104.27 112.77 25.93 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.23 108.5 25.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.8 p -84.59 163.89 19.03 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.455 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 C--O 1.245 0.861 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 174.85 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.051 0.453 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.417 ' O ' HG21 ' A' ' 135' ' ' VAL . 62.3 mt -72.78 -44.23 59.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.12 -39.58 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.257 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 1.2 mmp_? -60.35 -46.35 90.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.915 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.4 ttt -55.71 -47.06 77.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.077 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 131' ' ' ILE . 69.8 t -58.45 -45.97 89.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.362 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.65 -31.8 70.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.433 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 37.1 mt-10 -64.94 -47.7 76.73 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.32 -30.63 68.49 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.231 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.493 ' HA ' ' HG2' ' A' ' 142' ' ' LYS . 31.8 mt-10 -78.15 -31.55 49.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -70.62 -19.16 62.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.118 0.961 . . . . 0.0 109.291 174.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.42 27.4 8.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.33 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' A' ' 139' ' ' GLU . 5.1 mmtt -48.98 -52.47 24.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.788 0.835 . . . . 0.0 112.882 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.433 ' O ' HG21 ' A' ' 147' ' ' VAL . . . -70.54 -51.97 24.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 148' ' ' GLN 0.258 1.4 pm0 -60.28 -45.88 91.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.8 -45.62 88.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.17 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . 0.251 35.8 mt-10 -70.28 -32.53 70.37 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.735 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 143' ' ' ALA . 89.4 t -65.7 -45.77 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 14.4 mm100 -58.08 -43.88 87.28 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 110.752 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.425 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 2.6 tmt_? -61.86 -41.0 97.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.725 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 -11.48 42.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -62.4 -44.41 96.5 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.303 0.573 . . . . 0.0 110.056 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.79 113.68 18.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -77.87 95.54 4.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.93 -21.0 17.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.892 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 63.61 -77.99 0.03 OUTLIER 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.085 1.354 . . . . 0.0 111.398 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -178.26 40.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.44 156.73 34.95 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.533 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.401 ' HG ' HG23 ' A' ' 21' ' ' THR . 1.0 OUTLIER -122.63 153.14 39.73 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.495 0.664 . . . . 0.0 110.622 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.25 158.25 29.88 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 168.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 C--N 1.29 -1.995 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.949 -175.016 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.422 -1.837 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -98.07 37.9 1.38 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 112.983 -1.917 . . . . 0.0 109.955 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.59 146.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.767 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 121.59 46.86 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.455 171.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.405 ' C ' HD11 ' A' ' 15' ' ' LEU . 36.9 Cg_exo -57.58 -58.97 0.65 Allowed 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 5.8 mp -126.77 176.43 7.27 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.2 m -80.93 119.8 23.92 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -92.5 132.07 37.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.853 0.72 . . . . 0.0 109.274 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.72 -169.9 19.19 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.243 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -131.52 163.23 28.46 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.499 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 34.5 tt0 -87.89 109.07 19.51 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 123.0 1.381 . . . . 0.0 109.802 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 11.9 p -85.74 160.21 19.58 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.494 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.54 118.49 1.79 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 125.502 1.521 . . . . 0.0 113.665 -173.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.94 4.25 39.07 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.637 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.98 39.51 27.7 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.8 t -108.44 146.77 13.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -101.87 127.81 48.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.477 0.656 . . . . 0.0 109.285 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.7 m -123.89 116.15 22.44 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.8 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.55 141.35 29.11 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.754 0.659 . . . . 0.0 111.172 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.37 -39.81 6.03 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.58 112.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -79.0 154.42 29.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.342 0.591 . . . . 0.0 110.501 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -64.37 149.81 47.55 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.47 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 66.38 20.79 10.96 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 124.408 1.083 . . . . 0.0 111.881 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.6 t -90.39 126.96 36.05 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.5 119.73 7.54 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.806 0.842 . . . . 0.0 113.263 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.7 pt -101.46 162.25 21.05 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.66 -1.154 . . . . 0.0 107.925 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 137.13 12.24 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 CA-C-N 121.341 1.515 . . . . 0.0 115.152 1.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 p -107.6 154.93 20.71 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -146.83 103.74 3.66 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.97 121.32 20.31 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 m -127.95 115.97 19.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.551 0.215 . . . . 0.0 110.876 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -115.36 153.08 31.65 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.22 114.13 41.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.96 151.13 19.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.6 p -122.1 169.91 10.39 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 33.7 p -95.84 136.94 35.61 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.92 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -107.61 -1.1 21.5 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.245 0.545 . . . . 0.0 111.139 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -101.77 138.91 38.12 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.8 139.5 34.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.44 18.49 11.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.49 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 46.2 tt0 -60.22 114.79 10.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 123.045 0.538 . . . . 0.0 110.226 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.33 -5.78 10.16 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.791 2.327 . . . . 0.0 113.892 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.13 150.34 14.49 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.632 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.2 165.08 24.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.0 tp -117.92 127.82 54.21 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 3.0 mp -98.42 98.34 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.66 110.1 21.04 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.54 114.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.953 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 20' ' ' GLU . 68.6 m-85 -107.69 156.37 19.15 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.529 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 39.8 tt0 -134.99 137.81 43.38 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.74 -107.03 1.14 Allowed Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.261 -0.971 . . . . 0.0 114.785 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.407 ' HA ' HH11 ' A' ' 63' ' ' ARG . 41.8 mt-10 -79.1 158.54 27.77 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.344 1.058 . . . . 0.0 109.414 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.407 HH11 ' HA ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -122.48 -46.31 2.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.705 0.764 . . . . 0.0 112.639 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . . . -71.97 -28.43 63.43 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.538 0.685 . . . . 0.0 110.805 -173.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.5 mmt -134.57 111.47 10.08 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.706 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.1 91.57 4.31 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -144.71 -58.54 0.36 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.45 25.95 10.07 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.489 0.661 . . . . 0.0 109.518 -175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -74.54 160.96 30.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.377 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -93.76 129.99 39.92 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.2 tp -101.69 111.01 23.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.93 -51.13 7.4 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.26 159.02 32.09 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.848 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 78.5 mtm180 -138.15 136.94 37.18 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.84 144.87 30.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.49 133.58 39.32 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.55 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 5.5 tt -113.46 104.05 11.89 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 172.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -120.54 155.39 33.74 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.12 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.12 7.53 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.5 mt -79.16 132.92 61.76 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.36 125.19 13.56 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.504 2.136 . . . . 0.0 111.249 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.25 101.85 0.2 Allowed 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.668 2.246 . . . . 0.0 111.94 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.77 157.61 59.33 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.76 50.73 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.762 2.975 . . . . 0.0 113.312 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 46' ' ' THR . 39.5 ptt180 56.42 164.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.142 2.177 . . . . 0.0 113.89 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.55 -44.2 2.21 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.346 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.6 -50.24 73.37 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 123.976 0.91 . . . . 0.0 113.171 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.75 123.24 11.38 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 121.576 1.517 . . . . 0.0 110.985 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -117.23 115.21 24.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.479 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.33 105.58 18.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -90.62 107.78 19.38 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -107.9 124.48 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.179 0.514 . . . . 0.0 111.118 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.3 m -103.86 121.93 44.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.727 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.56 107.94 19.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.36 125.14 40.2 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.883 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.25 131.75 72.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.9 p30 -89.79 -169.76 2.57 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.376 0.422 . . . . 0.0 110.335 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.85 2.1 47.16 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.122 -0.361 . . . . 0.0 111.958 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -96.01 -13.6 23.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.56 30.18 12.4 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 67.2 mt -102.05 116.46 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.091 0.472 . . . . 0.0 109.889 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.21 111.23 22.81 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.979 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.03 114.42 27.72 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.94 126.58 58.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 122.28 31.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.82 117.83 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.6 m -113.6 117.96 33.07 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.533 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.85 107.87 11.88 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -67.31 -20.21 65.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.613 0.765 . . . . 0.0 110.779 -177.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -69.33 -54.6 13.75 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.785 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.9 p -99.05 -15.44 19.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.058 0.456 . . . . 0.0 112.056 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 30.36 36.22 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.499 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -115.36 158.57 22.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.546 0.673 . . . . 0.0 109.504 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.64 155.88 48.66 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.55 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.1 m120 -129.35 127.61 41.42 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -119.29 145.31 46.23 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.812 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.4 tt -136.64 148.77 26.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 m -113.61 112.93 24.33 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.2 mm -107.58 94.19 2.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t -88.11 122.33 31.56 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.856 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 125.098 1.359 . . . . 0.0 109.624 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.642 ' O ' ' HG3' ' A' ' 134' ' ' MET . 8.9 mm-40 . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.413 ' O ' HG21 ' A' ' 135' ' ' VAL . 61.9 mt -63.7 -41.94 94.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.47 -38.3 90.61 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.206 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 42.4 mtm105 -63.61 -42.12 98.24 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.642 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 53.4 mtt -59.86 -35.88 75.71 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.195 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 131' ' ' ILE . 58.9 t -56.77 -52.84 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -63.8 -42.17 97.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.523 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.0 mm-40 -64.76 -40.37 95.17 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.79 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.653 0.381 . . . . 0.0 111.274 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 25.4 mm-40 -77.85 -38.38 46.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -65.27 -38.76 91.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.348 0.594 . . . . 0.0 109.925 -179.434 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -111.57 28.63 8.56 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.927 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 139' ' ' GLU . 17.9 pttm -62.43 -45.25 93.96 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.47 67.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.397 0.618 . . . . 0.0 109.501 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -71.5 -54.15 11.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.184 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 1.1 m-20 -67.09 -55.2 15.29 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.14 -33.79 76.58 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -172.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.24 -47.82 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.184 175.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 152' ' ' VAL . 16.5 mm-40 -61.32 -41.39 96.94 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -55.29 -47.32 75.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -70.03 -9.51 55.53 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -97.9 0.59 46.85 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 148' ' ' GLN . 61.7 t -96.31 133.11 38.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 t -82.38 21.38 0.95 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.877 0.471 . . . . 0.0 112.014 -173.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.16 -21.76 59.71 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 50.06 -91.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.578 1.551 . . . . 0.0 113.177 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -155.1 67.73 0.68 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.17 140.3 41.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.168 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 76.1 mt -93.13 152.56 19.18 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -93.52 147.22 23.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.249 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.49 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 48.1 t . . . . . 0 C--N 1.311 -1.069 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.423 -1.793 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 36' ' ' ILE . 7.5 m-20 -86.03 75.65 9.92 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.72 179.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.246 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.59 130.79 54.57 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.28 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.24 -60.9 0.27 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.871 2.38 . . . . 0.0 112.359 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.18 174.34 6.39 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -69.51 127.43 32.97 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -95.21 140.62 29.86 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.553 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.58 -171.33 21.31 Favored Glycine 0 N--CA 1.42 -2.393 0 C-N-CA 119.552 -1.309 . . . . 0.0 113.796 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -133.71 156.9 47.11 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.403 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 35.5 tt0 -102.2 109.03 20.61 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 170.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.6 p -98.6 -63.93 1.08 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 122.39 1.091 . . . . 0.0 109.242 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' CB ' ' HG3' ' A' ' 159' ' ' GLU . . . -101.43 155.17 18.22 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.52 28.03 4.01 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.177 -1.011 . . . . 0.0 115.032 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.54 -61.01 0.18 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.99 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.53 145.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 120.729 0.3 . . . . 0.0 111.099 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.76 128.0 33.97 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -107.86 111.42 23.54 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.47 135.81 36.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.742 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.77 -49.24 3.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.255 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.36 128.77 48.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -85.06 158.28 20.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.5 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 12.9 ptm180 -61.89 149.98 38.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.964 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 m120 68.37 11.41 8.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.111 0.964 . . . . 0.0 112.65 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.1 t -75.71 122.38 23.92 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -62.65 126.83 28.68 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.107 0.963 . . . . 0.0 112.945 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 11' ' ' ASP . 21.3 pt -87.52 152.3 51.87 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_exo -67.82 124.23 6.3 Favored 'Cis proline' 0 C--O 1.241 0.668 0 N-CA-C 115.241 1.208 . . . . 0.0 115.241 4.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -96.79 158.13 15.58 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.023 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -165.58 108.56 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 93' ' ' THR . 26.7 mm-40 -121.85 137.59 54.72 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.934 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.4 m -121.8 117.28 26.16 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.185 0.928 . . . . 0.0 109.788 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -125.48 147.87 49.07 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.8 mm -95.9 117.56 40.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.405 0.621 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.14 153.9 20.91 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.312 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 10.8 p -135.11 171.11 14.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 30.7 p -101.87 148.76 24.94 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.829 0.74 . . . . 0.0 109.85 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 37.1 m-85 -81.21 -65.33 1.03 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.16 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -75.69 144.83 41.37 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.78 145.88 44.71 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.551 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 68.62 35.46 3.14 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -73.98 118.17 67.24 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.46 -24.62 10.42 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.032 1.821 . . . . 0.0 111.951 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.01 159.02 29.26 Favored Glycine 0 N--CA 1.411 -2.976 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.92 153.21 33.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 O-C-N 123.945 0.438 . . . . 0.0 109.963 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.0 tp -106.22 115.84 30.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.11 106.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.4 ' HG3' ' HB3' ' A' ' 74' ' ' ARG . 15.1 tt0 -112.47 121.43 44.82 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.0 t -90.32 135.23 26.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.574 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 90.4 m-85 -136.66 167.63 21.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.803 0.811 . . . . 0.0 111.282 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.542 ' CG ' ' HB2' ' A' ' 70' ' ' ASN . 13.4 pt-20 -136.01 151.51 49.96 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 170.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.65 136.49 3.88 Favored Glycine 0 C--N 1.277 -2.703 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.5 ' OE2' ' HD2' ' A' ' 32' ' ' ARG . 30.6 mt-10 -101.44 95.62 6.61 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 -174.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 20.7 mmt180 -146.29 170.45 16.75 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.236 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 145' ' ' ASP . . . -86.44 -49.76 7.37 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.557 175.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.3 mtt -98.9 137.27 37.71 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.587 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.42 85.58 2.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.177 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -146.92 -52.17 0.21 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 7.5 m-20 -94.34 70.03 3.7 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -145.13 150.24 36.43 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.982 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.542 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 85.0 m-20 -90.68 131.57 36.29 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.08 118.41 28.78 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 mp -92.31 -56.91 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.801 0.334 . . . . 0.0 111.186 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.08 163.52 31.01 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -153.2 135.39 14.88 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.9 150.12 41.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -94.97 129.98 41.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 tt -120.0 104.79 10.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 p -121.99 165.4 16.07 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.27 -0.11 14.38 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.51 125.62 88.95 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.458 0.703 . . . . 0.0 109.638 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.78 168.69 22.17 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.07 2.513 . . . . 0.0 111.853 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.08 90.93 0.12 Allowed 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.546 2.164 . . . . 0.0 111.823 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . . . -131.41 147.55 66.59 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.574 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 2.1 Cg_endo -86.6 -171.03 0.72 Allowed 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.425 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 46' ' ' THR . 51.8 ttp180 -59.07 131.93 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.1 0.96 . . . . 0.0 111.54 -177.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 -8.5 64.89 Favored Glycine 0 C--N 1.308 -0.979 0 CA-C-N 115.833 -0.621 . . . . 0.0 114.295 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.6 t -82.88 -54.29 0.57 Allowed Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.25 107.52 2.46 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.336 1.358 . . . . 0.0 110.107 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -94.87 113.39 25.12 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.1 mm -98.24 115.25 37.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.04 113.46 25.72 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -116.64 123.21 71.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 42.1 m -129.45 124.58 34.41 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.3 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -123.6 138.23 54.59 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.927 174.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -134.31 153.2 52.01 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.499 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 64.6 mt -130.91 135.73 59.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.419 ' O ' HD11 ' A' ' 36' ' ' ILE . 1.2 p-10 -84.81 -173.02 4.5 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.88 -13.02 60.26 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.408 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 47.6 m-80 -85.31 -29.51 24.48 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.74 28.81 2.83 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.494 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 68.9 mt -88.35 116.29 29.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 tp -95.66 120.78 36.51 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.95 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -119.99 104.2 9.95 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 44.9 t -94.12 125.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.1 m -123.45 123.44 40.65 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.61 130.62 53.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.1 m -131.58 126.8 35.71 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -83.86 116.6 22.83 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.206 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -67.19 -19.33 65.55 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -74.31 -54.5 7.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.4 p -91.5 -37.01 13.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.14 14.19 36.89 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.03 136.87 35.18 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.475 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.91 137.68 45.06 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.303 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -133.09 138.75 46.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 62.4 pttt -131.4 158.34 41.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.866 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.9 141.0 44.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.1 m -128.5 113.29 15.31 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.1 mt -113.65 111.08 34.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.8 t -92.42 100.98 13.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 . . . . . 0 CA--C 1.562 1.417 0 C-N-CA 123.991 0.916 . . . . 0.0 108.719 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.593 ' O ' HG21 ' A' ' 135' ' ' VAL . 54.1 mt -55.76 -54.11 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.726 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 45.5 mt-10 -66.38 -35.26 79.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.89 -44.13 94.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.265 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.5 mtt -72.55 -30.26 64.28 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.593 HG21 ' O ' ' A' ' 131' ' ' ILE . 60.0 t -62.94 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 53.7 mt-30 -55.66 -47.22 77.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.274 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.737 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.26 74.3 Favored 'General case' 0 C--O 1.196 -1.731 0 C-N-CA 122.568 0.347 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.22 -32.63 74.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.909 0.385 . . . . 0.0 111.404 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.26 -41.97 56.11 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.585 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -108.31 11.67 27.03 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.16 -43.77 64.25 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.146 0.978 . . . . 0.0 111.554 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.37 85.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.7 -38.57 47.09 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.281 -0.568 . . . . 0.0 112.248 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.417 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 1.8 m-20 -64.3 -33.46 75.89 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.976 0.417 . . . . 0.0 109.934 174.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.68 -50.37 74.12 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.456 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 54.7 t -62.06 -46.43 96.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -55.49 -47.45 76.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.476 0.711 . . . . 0.0 111.494 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -68.15 -47.34 68.32 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.88 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -68.76 -10.73 58.3 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.2 mmt180 -72.76 -10.97 60.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.332 0.587 . . . . 0.0 110.022 172.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.15 115.77 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -55.39 -45.35 76.62 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 123.314 0.646 . . . . 0.0 112.648 -172.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.44 158.83 43.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.489 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -136.69 31.51 2.79 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -86.46 33.64 0.63 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.933 -177.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -139.56 134.14 31.77 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.29 151.71 19.27 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 121.307 0.575 . . . . 0.0 111.207 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.441 ' HG3' ' CB ' ' A' ' 22' ' ' ALA . 41.9 mt-10 -116.72 121.61 42.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.294 -1.842 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.832 -177.284 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--O 1.242 0.659 0 CA-C-O 121.368 0.604 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.23 81.05 1.48 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.112 0.958 . . . . 0.0 110.068 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.44 178.14 3.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.126 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.97 116.67 66.89 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.71 -36.45 24.58 Favored 'Trans proline' 0 C--O 1.252 1.186 0 C-N-CA 121.733 1.622 . . . . 0.0 110.729 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 84.8 mt -108.07 174.98 5.64 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.65 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 10.0 t -103.55 -176.38 3.07 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -151.57 129.23 11.52 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 171.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.75 166.23 31.8 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.125 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.78 148.22 34.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.445 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 32.1 tt0 -86.25 112.05 21.0 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.1 p -100.49 172.36 7.17 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.86 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 124.39 20.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.977 0.417 . . . . 0.0 111.915 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.37 28.9 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.903 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.42 35.92 10.17 Favored Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.456 ' HB ' ' OG1' ' A' ' 21' ' ' THR . 27.4 t -99.17 133.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.42 ' HB2' ' OG1' ' A' ' 66' ' ' THR . 26.1 ttt -98.07 108.08 20.71 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.2 m -87.91 111.77 21.81 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.15 24.63 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.431 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.474 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.1 mp -90.7 -45.6 8.76 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.841 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.36 101.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.39 168.3 18.71 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.159 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 35.2 mtp-105 -61.98 150.62 37.39 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.444 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.19 17.03 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 111.604 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -73.15 129.12 37.36 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 p -68.23 114.73 6.96 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 124.272 1.029 . . . . 0.0 111.598 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.431 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 30.3 pt -94.64 164.58 19.39 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.7 Cg_exo -68.92 134.74 28.98 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.773 1.312 . . . . 0.0 113.416 -0.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.4 p -110.69 161.39 15.8 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 123.871 0.868 . . . . 0.0 110.844 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 46.7 tttp -156.96 99.42 1.82 Allowed 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -102.61 135.14 44.8 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -132.64 116.45 16.67 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.404 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 55.0 mt-30 -128.88 158.64 38.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.33 125.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 80.9 m-85 -113.36 160.44 18.37 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.331 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 11.8 p -137.97 171.76 13.94 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 122.859 0.463 . . . . 0.0 110.625 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.584 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 63.4 p -98.77 162.67 12.98 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 26.9 m-85 -103.09 -5.1 23.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.194 0.521 . . . . 0.0 109.602 171.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 p -139.55 164.03 30.99 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.737 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -102.32 158.08 16.45 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.806 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.435 ' ND2' ' HB3' ' A' ' 82' ' ' PRO . 44.1 m-80 71.33 14.33 6.49 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.48 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 75.4 mt-30 -63.5 129.13 93.43 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.25 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.94 -45.14 34.31 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.499 2.133 . . . . 0.0 111.445 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.35 153.81 23.89 Favored Glycine 0 N--CA 1.404 -3.446 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -103.97 137.77 31.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.71 109.95 21.84 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.409 ' HB ' ' CD2' ' A' ' 75' ' ' PHE . 2.3 mp -84.51 94.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . 0.251 6.6 pt20 -99.35 114.22 26.97 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.166 0.984 . . . . 0.0 111.632 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.86 126.65 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.075 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 92.4 m-85 -124.21 155.74 38.01 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' SER . 1.3 pp20? -127.27 165.87 18.85 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.15 124.55 3.53 Favored Glycine 0 C--N 1.263 -3.522 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.83 87.73 4.69 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.976 0.893 . . . . 0.0 109.662 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -128.04 142.11 51.32 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.791 -1.549 . . . . 0.0 107.044 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -66.9 -49.81 64.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.0 mtm -110.82 137.97 47.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.151 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 26' ' ' MET . 2.5 m -89.73 108.21 19.55 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.528 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -141.28 -53.91 0.47 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.134 0.493 . . . . 0.0 111.976 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.75 -61.57 1.35 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.6 m120 40.12 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.442 -1.708 . . . . 0.0 113.899 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -112.04 101.56 9.84 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.52 114.83 4.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.461 0.648 . . . . 0.0 110.395 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.19 -35.92 14.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.085 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.81 154.51 15.34 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.911 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -119.51 139.56 51.91 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 121.559 0.695 . . . . 0.0 109.185 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.409 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 13.8 t80 -143.48 142.09 31.03 Favored 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.41 -174.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.41 131.24 52.96 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.309 0.504 . . . . 0.0 111.249 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.3 tp -124.07 105.22 9.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.5 p -96.9 158.6 15.35 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.844 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.4 31.41 3.26 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.017 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 2.0 mp -77.18 116.17 55.18 Favored Pre-proline 0 C--O 1.242 0.687 0 CA-C-N 117.265 0.533 . . . . 0.0 109.894 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.13 155.15 71.13 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 11.3 Cg_exo -74.05 82.71 1.74 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.544 2.162 . . . . 0.0 111.772 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . . . -132.6 127.63 20.62 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -37.26 -63.74 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 125.07 3.847 . . . . 0.0 115.931 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -175.4 120.26 0.19 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.62 -34.97 3.31 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.631 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.23 -56.97 6.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.863 -0.589 . . . . 0.0 111.198 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 83' ' ' ALA . 21.9 Cg_endo -64.24 104.72 0.53 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.421 1.414 . . . . 0.0 110.448 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -120.06 115.92 24.67 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.5 mm -99.51 116.3 42.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.8 tt0 -90.69 114.3 26.59 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.75 125.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 17.8 m -112.98 131.49 55.74 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.387 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.474 ' CD1' HD22 ' A' ' 29' ' ' LEU . 7.7 m-85 -119.67 108.5 14.53 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.85 1.26 . . . . 0.0 109.057 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.476 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.7 p30 -123.57 136.61 54.62 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.281 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 54.7 mt -121.87 137.75 54.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.9 p-10 -100.66 -169.43 1.71 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.46 -15.34 61.81 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.431 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 43.7 m-80 -90.31 -5.38 56.33 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.983 -0.448 . . . . 0.0 110.859 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.5 25.76 49.51 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.421 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.3 mt -84.3 113.12 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.9 tp -95.87 117.0 29.75 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.095 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -107.7 121.2 44.22 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 93' ' ' THR . 69.9 t -111.61 115.66 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -117.23 127.38 54.04 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.74 118.04 30.98 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.8 m -110.48 125.8 53.68 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.705 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.61 115.63 23.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 68.0 mttm -67.51 -16.55 64.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.6 m -79.4 -50.43 10.84 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.829 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 36.2 p -83.77 -39.22 20.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.135 0.493 . . . . 0.0 111.225 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.15 12.62 48.53 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.428 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 65.4 pttt -103.05 156.43 17.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.331 . . . . 0.0 110.231 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.71 52.08 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.231 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -129.09 152.66 48.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.99 165.94 24.83 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 tt -145.65 143.49 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -122.0 113.11 19.12 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 75.3 mt -108.24 105.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.691 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.8 m -90.77 158.55 16.79 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 122.008 0.908 . . . . 0.0 110.711 -179.459 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 134' ' ' MET . 14.7 mp0 . . . . . 0 C--O 1.217 -0.641 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 75.6 mt -53.15 -51.9 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.568 1.168 . . . . 0.0 110.698 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 60.6 mt-10 -74.01 -33.28 63.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.203 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -67.11 -35.23 79.32 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.678 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.653 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 24.3 mmt -60.14 -52.59 64.7 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.02 -52.65 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 124.027 0.83 . . . . 0.0 112.034 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 70.5 mm-40 -64.37 -45.49 87.52 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.29 -32.81 66.94 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.406 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 142' ' ' LYS . . . -60.5 -48.43 81.81 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.407 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 21.6 mm-40 -61.89 -48.61 79.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -77.37 -24.35 50.63 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.98 13.28 7.29 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 18.5 ptpt -50.04 -43.44 51.0 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.99 78.03 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -71.21 -53.17 15.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.86 -33.87 77.03 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -59.22 -51.08 71.5 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 117.651 0.205 . . . . 0.0 111.189 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.591 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.2 t -62.43 -49.34 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 O-C-N 123.635 0.584 . . . . 0.0 109.998 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -56.79 -45.64 82.03 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.833 0.708 . . . . 0.0 111.916 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 45.3 ttp180 -63.93 -32.68 74.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.163 0.585 . . . . 0.0 111.099 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -85.27 -17.27 37.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.504 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 5.2 mmp_? -80.49 -6.85 58.79 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.79 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.67 71.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.3 m 67.19 167.6 0.24 Allowed 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.497 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.13 25.85 4.9 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.78 155.41 17.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.306 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.476 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 79.0 m-20 -117.3 87.27 2.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.31 145.18 31.84 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 122.162 -0.336 . . . . 0.0 110.305 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.436 ' HG ' HG21 ' A' ' 21' ' ' THR . 0.7 OUTLIER -124.54 152.82 42.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.659 0.742 . . . . 0.0 112.206 -175.201 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -128.73 146.13 50.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 168.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.312 -1.055 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.938 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.425 -1.703 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.7 m-20 -84.27 67.15 9.69 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.944 0.878 . . . . 0.0 110.004 -175.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 m -134.2 179.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.36 133.7 24.52 Favored Pre-proline 0 C--N 1.282 -2.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.524 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 36.3 Cg_endo -68.25 -38.68 11.54 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.461 2.108 . . . . 0.0 110.409 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -134.91 161.31 35.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 m -76.06 149.36 37.5 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 123.289 0.368 . . . . 0.0 110.469 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.09 142.36 44.64 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 120.993 0.425 . . . . 0.0 110.713 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -164.84 -168.76 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 C-N-CA 119.977 -1.106 . . . . 0.0 114.041 -173.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.404 ' N ' HD11 ' A' ' 19' ' ' LEU . 1.7 mp -113.38 156.06 24.11 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.539 0.736 . . . . 0.0 109.118 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.95 109.35 18.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.906 0.86 . . . . 0.0 109.19 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 6.1 p -94.45 171.54 8.75 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.235 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . . . -51.51 124.77 12.83 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.779 1.232 . . . . 0.0 112.145 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.29 -2.73 57.83 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.28 39.8 25.71 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.3 t -96.5 142.03 14.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.261 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.421 ' HE1' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -96.05 107.99 20.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -178.121 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -107.55 111.84 24.3 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -92.27 147.57 22.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 94' ' ' PHE . 51.4 mt -115.34 -24.75 8.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.3 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 94' ' ' PHE . 3.3 mp -117.78 117.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 171.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HZ3' ' CD ' ' A' ' 146' ' ' GLU . 16.7 tptp -85.39 149.86 25.14 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 14' ' ' PRO . 10.6 ptt85 -69.83 152.53 44.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.459 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.96 -0.63 2.97 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.4 1.08 . . . . 0.0 112.147 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -89.24 122.58 32.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 2.9 p -65.18 121.16 14.12 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 123.849 0.86 . . . . 0.0 112.93 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.3 pt -84.94 164.94 39.72 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -60.72 145.7 42.1 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 CA-C-N 120.652 1.269 . . . . 0.0 114.024 1.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 m -142.0 143.76 33.33 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 6.1 ttpm? -147.14 119.56 8.43 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.854 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -121.8 131.81 54.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.087 0.47 . . . . 0.0 111.03 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 35.0 m -115.23 118.3 32.9 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -130.13 155.42 46.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.23 126.41 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.81 146.26 42.99 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.083 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 29.3 p -123.69 171.28 9.7 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 124.916 1.286 . . . . 0.0 107.555 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -113.07 136.85 52.25 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -98.92 -4.2 33.4 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -80.17 106.97 12.58 Favored 'General case' 0 N--CA 1.395 -3.194 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.447 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.75 133.01 44.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.373 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 64.2 29.88 13.78 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.918 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -85.23 120.31 73.24 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.85 -0.41 10.05 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.558 2.172 . . . . 0.0 110.826 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.28 147.85 9.9 Favored Glycine 0 N--CA 1.408 -3.202 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.99 165.24 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 123.955 0.444 . . . . 0.0 110.503 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.9 tp -111.82 115.0 28.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.64 94.78 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -99.64 118.15 35.54 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.752 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.11 134.92 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.813 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -125.63 154.01 42.93 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -114.13 118.72 34.81 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' O ' ' HE1' ' A' ' 26' ' ' MET . . . 154.52 175.03 25.22 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -140.89 104.26 4.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.69 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -154.74 169.45 23.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.06 -31.91 68.45 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.705 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.0 mtt -111.48 135.7 51.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.199 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.94 -13.23 59.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -64.92 -27.15 68.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -171.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -94.53 14.75 19.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.752 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.504 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 14.2 m120 -107.1 175.25 5.56 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.198 -0.314 . . . . 0.0 110.715 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.89 129.24 36.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 tp -76.27 109.17 9.74 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -82.81 -48.31 10.93 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.017 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.47 164.32 33.99 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -142.39 154.52 44.69 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 117.517 0.659 . . . . 0.0 109.84 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -155.33 158.27 38.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -106.63 147.99 28.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.789 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 tp -124.54 104.87 8.96 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.2 p -116.36 153.43 32.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.25 4.46 18.13 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -79.87 130.26 67.67 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 123.664 0.786 . . . . 0.0 109.048 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -56.24 117.97 4.7 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.814 2.343 . . . . 0.0 111.403 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.98 111.84 1.85 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.778 2.318 . . . . 0.0 112.412 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.8 160.54 68.09 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.53 -23.16 37.47 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.808 2.339 . . . . 0.0 112.19 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -140.7 166.25 25.27 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.236 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.405 ' HA3' ' HB ' ' A' ' 45' ' ' THR . . . -73.86 80.54 0.81 Allowed Glycine 0 N--CA 1.432 -1.589 0 O-C-N 123.68 0.613 . . . . 0.0 114.276 -176.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.8 t -69.38 -45.24 27.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -68.07 121.51 8.52 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.394 1.396 . . . . 0.0 110.278 170.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -81.98 115.61 21.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -91.76 119.51 39.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.22 104.19 16.77 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 41' ' ' THR . 40.6 t -110.08 117.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.619 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -103.81 116.36 32.15 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.284 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 3.0 m-85 -96.87 107.21 19.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 171.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD2' ' HD3' ' A' ' 39' ' ' LYS . 18.2 t70 -120.64 113.09 19.72 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 123.656 0.598 . . . . 0.0 110.566 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.76 118.4 56.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.477 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.5 p30 -85.41 -176.79 6.26 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.6 -20.29 63.17 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -80.62 -23.91 39.45 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.855 -0.528 . . . . 0.0 110.671 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.79 15.71 28.22 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.477 ' HB ' ' OD2' ' A' ' 97' ' ' ASP . 83.2 mt -80.4 119.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 114.61 27.0 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.1 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -107.51 101.44 10.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.9 t -93.72 114.27 30.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.0 m -112.1 110.73 21.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.67 117.55 34.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.3 m -119.8 128.69 53.95 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.625 0.726 . . . . 0.0 111.115 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.56 114.48 16.44 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.569 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.72 -21.4 64.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.6 p -80.19 -62.04 1.8 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.3 p -95.69 -31.36 13.27 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.389 0.614 . . . . 0.0 110.411 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.66 34.79 3.21 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.03 175.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -98.68 151.85 20.28 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 117.016 0.408 . . . . 0.0 110.889 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.95 140.59 24.6 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.845 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.82 139.74 43.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 149.2 43.76 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 tt -120.66 148.61 23.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.0 m -114.53 112.92 23.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.45 98.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.123 0.487 . . . . 0.0 110.877 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -91.73 101.78 14.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.5 t30 . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -176.376 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 134' ' ' MET . 1.4 mp0 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 135' ' ' VAL . 51.7 mt -56.87 -50.91 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.09 -45.42 87.19 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 123.575 0.75 . . . . 0.0 110.794 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -60.03 -47.73 84.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.504 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 70.3 mtm -66.55 -36.29 82.3 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 123.48 0.487 . . . . 0.0 111.573 -175.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 70.3 t -61.26 -54.71 31.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 123.621 0.576 . . . . 0.0 109.568 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.0 mt-30 -63.11 -46.77 85.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.08 -40.09 94.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -60.33 -44.5 95.44 Favored 'General case' 0 C--O 1.198 -1.616 0 O-C-N 123.05 0.219 . . . . 0.0 110.416 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 22.2 mm-40 -58.61 -39.63 80.98 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 94.5 mttt -74.21 -48.49 28.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.734 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.53 21.84 10.66 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.331 0.864 . . . . 0.0 113.331 -172.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 138' ' ' ALA . 29.2 mmtt -44.24 -58.68 2.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.06 45.57 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.716 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -58.26 -55.1 39.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.734 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -38.58 44.14 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.447 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 53.6 mt-10 -69.94 -34.16 73.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.128 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.3 -44.05 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.54 ' O ' HG22 ' A' ' 152' ' ' VAL . 67.6 mt-30 -52.75 -50.84 62.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 110.735 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -54.05 -52.66 60.18 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 124.284 0.99 . . . . 0.0 111.341 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.83 -39.15 93.53 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.922 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -63.54 -25.47 68.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 148' ' ' GLN . 22.0 t -88.79 -39.24 12.38 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.6 p -72.14 80.75 0.97 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.518 0.675 . . . . 0.0 111.494 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.42 123.51 44.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 tptm 68.34 10.43 7.85 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 124.016 0.822 . . . . 0.0 110.007 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.47 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.131 1.372 . . . . 0.0 112.66 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -114.39 134.13 55.21 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.335 -175.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 44.7 mt -93.26 152.97 18.85 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.48 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 14.2 tt0 -97.6 173.36 7.18 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 C--N 1.292 -1.895 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.597 -176.038 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 tp . . . . . 0 N--CA 1.435 -1.221 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 73.17 29.5 1.71 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.121 0.968 . . . . 0.0 111.39 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.87 168.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.86 119.05 72.25 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.77 -25.96 16.45 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.245 1.963 . . . . 0.0 112.685 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.1 mp -135.18 172.19 13.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -101.75 129.8 48.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.2 mt -116.79 131.87 56.84 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.39 -176.57 21.94 Favored Glycine 0 N--CA 1.429 -1.816 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.64 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.89 150.53 30.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.27 108.38 17.1 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 34.6 p -107.29 -177.03 3.24 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.645 -172.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.12 119.13 5.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.88 0.872 . . . . 0.0 113.178 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.45 -8.57 22.38 Favored Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.869 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.64 57.27 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 39.4 t -110.65 149.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.1 ttt -92.72 137.81 32.04 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 122.987 0.515 . . . . 0.0 111.052 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -118.84 111.71 18.77 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.3 126.73 45.21 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.658 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -96.54 -33.79 11.69 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.29 125.57 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -120.48 146.02 46.68 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -56.07 151.48 12.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 75.07 14.37 3.13 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.14 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -103.55 133.03 49.27 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 m -68.31 144.86 54.66 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 123.814 0.846 . . . . 0.0 111.715 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.405 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 29.6 pt -111.89 155.4 43.31 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_endo -62.44 152.37 65.26 Favored 'Cis proline' 0 C--N 1.356 0.964 0 CA-C-N 119.922 1.008 . . . . 0.0 113.629 -1.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -107.09 -80.45 0.56 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.014 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 43.5 tttp 65.41 99.43 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 127.424 2.29 . . . . 0.0 111.055 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -121.71 132.06 54.43 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.082 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -118.7 123.81 45.81 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.247 0.342 . . . . 0.0 110.478 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -130.61 146.23 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -93.34 133.93 32.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.92 132.4 50.88 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.8 153.09 36.25 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.7 p -81.7 135.52 35.5 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.353 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 157' ' ' ALA . 23.1 m-85 -114.19 3.96 15.37 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.448 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 24.5 p -97.0 -179.13 4.44 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.076 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -143.18 166.36 24.91 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.263 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 60.19 19.81 9.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.448 ' NE2' ' HB2' ' A' ' 48' ' ' SER . 56.0 mt-30 -101.34 113.56 65.81 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.124 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.2 Cg_endo -85.83 -2.79 8.99 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.028 2.485 . . . . 0.0 111.672 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.16 149.04 16.21 Favored Glycine 0 N--CA 1.401 -3.689 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 m -112.64 149.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.34 101.5 11.42 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 63.1 mt -90.48 117.73 34.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -129.59 119.62 23.93 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.154 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.6 t -92.48 117.61 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.704 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 59.4 m-85 -120.08 144.33 47.65 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.277 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -111.73 154.34 25.15 Favored 'General case' 0 C--O 1.272 2.244 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.219 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.08 118.34 3.5 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -78.08 95.05 4.79 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.632 0.716 . . . . 0.0 110.91 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' A' ' 63' ' ' ARG . 43.3 mtp85 -136.74 157.03 47.71 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.845 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 145' ' ' ASP . . . -91.04 -51.27 5.42 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.7 93.74 9.04 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.6 m -84.61 108.1 17.18 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.905 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -163.49 144.19 9.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 68.19 16.23 9.38 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.476 1.11 . . . . 0.0 111.702 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.18 173.03 10.7 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 85.0 m-20 -90.7 127.45 36.31 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.95 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.7 118.49 29.35 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.713 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.08 -53.98 3.91 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.08 156.01 26.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 10.0 ptm180 -151.19 139.14 19.97 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 123.713 0.805 . . . . 0.0 109.531 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.73 145.66 31.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.806 0.336 . . . . 0.0 111.226 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.64 110.45 22.56 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.4 tp -94.71 104.61 16.53 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 p -96.0 152.27 18.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.35 -35.27 2.09 Favored Glycine 0 CA--C 1.479 -2.188 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.1 mp -51.88 120.16 15.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 O-C-N 125.042 1.084 . . . . 0.0 110.494 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.52 146.72 10.91 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.143 1.895 . . . . 0.0 111.317 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.75 118.17 5.01 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.9 1.734 . . . . 0.0 108.246 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.7 156.75 79.74 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.757 -171.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.34 43.4 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.224 2.616 . . . . 0.0 111.823 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.424 ' HG3' ' HA ' ' A' ' 47' ' ' TYR . 7.9 mpt_? 68.97 148.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.253 1.421 . . . . 0.0 113.109 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.56 -27.86 2.13 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.45 -51.99 77.87 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.12 106.89 2.32 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 121.597 1.531 . . . . 0.0 110.446 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -101.91 103.53 14.2 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mm -91.82 120.51 41.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.453 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . 40.4 tt0 -94.87 112.31 24.04 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.16 128.23 62.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.467 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 m -122.9 120.6 33.93 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.867 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 5.3 m-85 -99.57 107.79 20.03 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 1.5 p-10 -125.61 112.64 16.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.7 mt -99.9 123.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -86.55 -175.35 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 123.722 0.639 . . . . 0.0 109.373 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.36 -13.12 61.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -81.54 -28.66 33.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 112.18 12.79 13.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 92.9 mt -82.13 116.1 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-O 120.996 0.427 . . . . 0.0 110.347 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.1 tp -88.52 108.9 19.64 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -102.91 110.49 22.43 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.757 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.71 114.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.2 m -110.76 124.29 51.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.622 -175.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -132.74 119.37 20.24 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.663 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 m -120.24 127.59 52.55 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.21 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.97 111.04 21.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.082 0.553 . . . . 0.0 111.841 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 91' ' ' GLU . 96.9 mttt -69.01 -11.2 60.57 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.0 p -86.04 -47.98 9.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 118.964 -1.095 . . . . 0.0 112.908 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.0 p -96.88 -33.79 11.5 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.875 -0.515 . . . . 0.0 111.819 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.08 23.67 10.39 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.924 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.37 157.8 16.16 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 122.779 -0.248 . . . . 0.0 110.339 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.77 143.71 22.97 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.113 0.482 . . . . 0.0 111.503 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -129.45 140.69 51.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -136.21 132.76 36.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.42 125.33 72.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.208 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 79.2 m -88.12 112.4 22.65 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.003 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 71.4 mt -101.61 94.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.338 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.5 m -74.51 158.86 33.05 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 124.782 1.233 . . . . 0.0 107.97 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.069 0.461 . . . . 0.0 112.001 -179.242 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.96 -51.11 76.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.902 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.6 -27.04 64.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.078 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.537 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 21.3 ttm180 -63.79 -39.46 94.31 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -68.68 -29.94 68.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.995 0.426 . . . . 0.0 110.602 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.89 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -63.82 -36.17 83.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.741 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 7.6 mm-40 -61.07 -45.44 94.74 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.9 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.203 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.67 -37.51 76.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.942 0.401 . . . . 0.0 110.513 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.66 -42.64 67.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.634 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.53 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . 88.7 m-85 -97.84 15.65 23.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.525 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 7.0 tmtt? -48.09 -66.44 0.4 Allowed 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 124.046 0.938 . . . . 0.0 112.729 -173.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.7 87.3 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 10.0 tp10 -64.75 -54.9 24.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.546 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 1.2 m-20 -77.75 -28.81 50.79 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 66.5 mm-40 -61.75 -42.65 99.25 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.418 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.536 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 60.3 t -72.0 -48.52 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.822 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.5 mm-40 -54.09 -41.6 68.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -64.58 -39.86 94.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.338 0.59 . . . . 0.0 109.993 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.24 0.8 57.04 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 27.4 mmm180 -68.45 -36.42 78.98 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 172.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.83 83.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 m -78.25 142.51 37.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.963 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 45.72 63.37 1.83 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.376 1.47 . . . . 0.0 113.219 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.49 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 2.2 pptp? -106.22 77.25 1.21 Allowed 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 123.011 1.386 . . . . 0.0 110.213 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.09 61.94 6.78 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.296 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . . . -146.39 139.16 25.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.862 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.422 ' CD2' HG21 ' A' ' 21' ' ' THR . 14.0 mt -103.32 151.34 22.84 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.77 144.24 44.71 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.89 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.291 -1.975 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.419 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.246 0.899 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.3 61.7 1.12 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.5 -177.42 2.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.621 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.01 118.87 72.45 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.05 -50.53 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.278 1.985 . . . . 0.0 111.978 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 6.3 mp -114.61 172.25 7.14 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.424 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 15.2 m -92.5 151.04 20.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.124 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.03 132.0 54.58 Favored 'General case' 0 C--O 1.261 1.669 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.923 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.11 158.1 27.57 Favored Glycine 0 N--CA 1.426 -1.982 0 O-C-N 123.91 0.756 . . . . 0.0 112.656 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.9 151.39 22.16 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -86.12 108.45 18.31 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 171.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 18.0 p -107.87 -69.61 0.84 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.286 0.565 . . . . 0.0 111.348 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.26 165.55 11.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.55 -21.05 4.3 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 116.949 1.539 . . . . 0.0 116.949 -171.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.52 33.37 2.15 Favored Glycine 0 CA--C 1.493 -1.341 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.986 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.37 121.5 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.449 0.643 . . . . 0.0 112.12 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.512 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 23.4 ttt -106.31 97.79 7.55 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.9 m -80.35 110.74 16.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.07 119.9 30.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.789 0.328 . . . . 0.0 111.047 -176.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 63.1 mt -104.93 -39.54 6.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.623 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.1 130.4 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.19 162.3 14.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.455 ' HG2' ' HA ' ' A' ' 15' ' ' LEU . 63.6 mtt180 -56.69 140.11 48.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 123.714 0.634 . . . . 0.0 109.515 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 75.26 10.74 3.57 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.231 1.012 . . . . 0.0 112.786 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -81.91 114.73 20.71 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -60.38 131.75 51.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.398 1.079 . . . . 0.0 113.781 -176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.4 pt -95.4 160.83 29.73 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 24.7 Cg_exo -65.66 126.26 6.39 Favored 'Cis proline' 0 C--N 1.358 1.043 0 CA-C-N 120.291 1.14 . . . . 0.0 113.431 0.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.6 p -95.55 149.13 21.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.443 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 37.7 tttp -154.02 99.5 2.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' A' ' 93' ' ' THR . 5.5 tp-100 -107.15 140.12 40.5 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 81.5 m -139.83 116.41 10.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -128.61 144.17 51.1 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.22 118.83 41.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 123.669 0.606 . . . . 0.0 109.535 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.05 169.19 8.64 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.915 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 33.1 p -134.24 171.63 13.98 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.448 ' HB ' ' OG ' ' A' ' 48' ' ' SER . 27.7 p -99.86 139.62 35.25 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.484 176.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.435 ' CE2' ' HB1' ' A' ' 157' ' ' ALA . 27.6 m-85 -85.03 -11.72 54.75 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.448 ' OG ' ' HB ' ' A' ' 46' ' ' THR . 29.5 p -83.75 142.27 30.82 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.905 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.0 124.01 51.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 66.32 61.43 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.693 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.446 ' H ' ' NE2' ' A' ' 51' ' ' GLN . 0.5 OUTLIER -101.3 123.11 45.87 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -85.41 -15.96 5.02 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.821 1.681 . . . . 0.0 111.132 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.59 164.64 36.92 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.43 179.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.1 tp -132.37 132.37 42.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.55 123.26 71.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 120.851 0.358 . . . . 0.0 111.52 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -114.82 129.76 56.75 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.4 123.49 64.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.58 142.97 43.2 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.248 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -111.52 121.23 44.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.57 125.33 5.6 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -172.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 3.8 mp0 -79.0 139.03 38.28 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.576 ' HG2' ' ND2' ' A' ' 69' ' ' ASN . 36.2 mmt180 -139.45 156.86 46.69 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 114.192 -1.367 . . . . 0.0 107.542 172.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.513 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -78.22 -49.87 12.96 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 92.7 mmm -105.55 122.05 45.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.13 102.08 0.1 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -174.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 56.3 pttt 179.41 -177.44 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.174 1.389 . . . . 0.0 107.549 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.98 -45.46 0.6 Allowed 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.44 1.496 . . . . 0.0 114.921 172.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.576 ' ND2' ' HG2' ' A' ' 63' ' ' ARG 0.259 85.8 m-20 -86.17 -166.19 1.47 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -88.69 112.63 23.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.994 0.902 . . . . 0.0 111.724 -167.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.7 108.24 13.1 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.204 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.57 -55.19 6.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.96 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.89 159.07 27.99 Favored Glycine 0 N--CA 1.413 -2.887 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.966 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.29 135.22 21.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.76 168.3 24.81 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.58 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.75 144.21 25.62 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.6 tp -131.07 103.66 6.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -132.96 165.87 23.69 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 120.573 0.225 . . . . 0.0 111.04 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.07 4.95 56.47 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.78 134.39 86.02 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.99 133.87 53.05 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.975 1.784 . . . . 0.0 109.796 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -67.5 63.64 0.8 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.103 2.535 . . . . 0.0 111.974 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.24 153.51 39.01 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.602 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -61.36 177.9 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.459 2.773 . . . . 0.0 114.914 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.61 131.39 50.08 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.469 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.4 20.77 78.49 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.69 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.0 -49.69 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.47 116.13 4.58 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.535 1.49 . . . . 0.0 111.343 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -87.42 112.1 21.81 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.7 mm -98.82 115.94 40.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.73 112.76 24.66 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 41' ' ' THR . 96.0 t -106.07 124.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 32.5 m -124.45 128.32 48.83 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.855 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 34.7 m-85 -112.63 136.62 51.98 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 8.0 t70 -142.31 127.11 18.15 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.1 mt -124.15 126.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -89.13 -170.65 2.96 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.33 63.42 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.422 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 9.1 t30 -84.61 -29.77 25.5 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.274 0.559 . . . . 0.0 110.242 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.3 28.48 4.62 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 77.4 mt -86.89 116.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 49.0 tp -96.12 120.1 35.8 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.08 105.21 15.15 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.8 t -92.12 120.48 41.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -126.99 122.87 35.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.69 117.17 29.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.1 m -115.75 127.73 55.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.145 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -83.04 107.38 15.59 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.23 -12.27 60.71 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 m -70.98 -54.56 10.82 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 35.7 p -86.59 -48.82 8.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.438 0.637 . . . . 0.0 111.14 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.05 5.5 28.76 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.477 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 14.2 ptmm? -92.31 152.5 19.75 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.49 162.68 38.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.337 0.589 . . . . 0.0 112.281 -174.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -129.42 128.06 42.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.09 173.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -132.97 149.53 52.23 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.452 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.4 pt -129.81 151.04 35.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.2 m -117.47 113.11 21.56 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.25 103.13 14.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -84.93 109.4 18.12 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.4 t30 . . . . . 0 C--O 1.246 0.919 0 C-N-CA 124.884 1.274 . . . . 0.0 111.413 -178.468 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 134' ' ' MET . 14.7 mm-40 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.498 0.19 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 135' ' ' VAL . 82.5 mt -60.14 -42.98 91.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 67.4 mt-10 -63.25 -32.38 73.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.702 0.287 . . . . 0.0 110.923 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 44.7 mtp180 -64.03 -43.78 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.036 174.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.519 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 52.7 mtt -65.08 -35.27 80.63 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.006 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 131' ' ' ILE . 86.1 t -55.54 -52.13 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 69.8 mm-40 -65.18 -52.26 55.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.755 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.67 -51.05 71.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -67.78 -30.73 70.24 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -77.6 -34.96 53.32 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.548 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.96 -43.7 74.45 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.7 20.72 7.17 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.468 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 24.4 mmtt -53.3 -58.09 8.27 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.56 -44.81 81.33 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.443 0.464 . . . . 0.0 111.327 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.67 -48.58 71.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.794 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.61 -36.88 68.18 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 56.4 mm-40 -60.43 -42.5 96.18 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.838 0.29 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.665 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.0 t -67.24 -49.72 69.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.409 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -63.75 -43.95 94.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.513 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 40.0 ttp180 -62.84 -48.57 78.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.419 0.628 . . . . 0.0 110.319 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 153' ' ' SER . 7.1 mm-40 -79.3 -0.28 31.75 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.476 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 21.5 mmt180 -84.23 -35.46 23.43 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 -38.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.417 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 26.3 t -66.84 103.23 1.08 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -102.79 -27.48 12.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.215 0.531 . . . . 0.0 110.961 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -161.36 154.56 21.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -74.85 86.54 2.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.384 0.611 . . . . 0.0 109.405 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.57 149.02 35.11 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.275 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 mp -109.15 149.23 29.65 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.56 156.72 19.2 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 121.241 0.544 . . . . 0.0 111.824 -177.493 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.237 0.416 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -37.46 82.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 171.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -95.7 128.4 42.54 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.324 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.6 t -138.41 103.43 2.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -143.91 151.57 39.99 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 120.996 0.427 . . . . 0.0 110.336 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -152.17 -75.37 0.14 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.4 tp 179.33 160.59 0.74 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 60.53 -164.45 0.23 Allowed 'General case' 0 C--O 1.259 1.56 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp 76.16 -54.07 0.61 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.597 1.159 . . . . 0.0 110.87 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.51 67.95 10.12 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -118.85 41.06 3.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 19.5 m -124.35 177.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.292 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.86 120.84 80.04 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.41 -24.38 10.72 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.219 1.946 . . . . 0.0 112.13 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.02 160.87 21.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.031 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -93.63 112.94 24.92 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -92.16 131.56 37.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.85 179.06 22.26 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.822 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.37 159.92 31.86 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -83.97 117.2 23.22 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 170.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 158' ' ' LEU . 25.8 p -110.82 -97.8 0.41 Allowed 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -173.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.16 163.61 19.67 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.38 92.55 0.08 OUTLIER Glycine 0 CA--C 1.499 -0.962 0 O-C-N 123.76 0.662 . . . . 0.0 112.968 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 65' ' ' MET . . . 104.69 19.17 11.39 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 124.512 0.772 . . . . 0.0 111.735 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -129.36 115.33 34.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 117.016 0.408 . . . . 0.0 110.73 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.33 115.65 27.71 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -100.27 112.64 24.98 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.34 101.67 13.91 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.41 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 5.6 mp -73.32 -49.28 28.35 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.33 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -108.42 105.28 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.02 153.54 21.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.099 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.576 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -57.05 159.33 4.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.047 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 72.56 6.12 5.38 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 124.855 1.262 . . . . 0.0 111.948 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.4 m -91.8 125.73 36.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 10.0 t -68.35 134.71 50.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.517 0.675 . . . . 0.0 112.256 -177.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.428 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 33.1 pt -94.98 154.54 39.65 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.639 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.2 Cg_exo -63.26 133.73 14.9 Favored 'Cis proline' 0 N--CA 1.478 0.566 0 CA-C-N 119.873 0.991 . . . . 0.0 114.012 0.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -110.01 162.18 14.79 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.257 1.023 . . . . 0.0 109.266 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -166.57 148.19 6.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.542 0.527 . . . . 0.0 110.807 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 29' ' ' LEU . 15.3 mm100 -147.75 118.78 7.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 125.821 1.648 . . . . 0.0 107.544 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 84.9 m -111.67 116.33 30.59 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -128.97 141.11 51.36 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.13 124.67 48.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.401 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 97.0 m-85 -111.74 160.12 17.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.75 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 21.3 p -129.89 171.96 12.19 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -113.51 138.49 50.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 119.623 1.101 . . . . 0.0 110.534 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -82.52 -39.22 22.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 p -63.88 98.17 0.19 Allowed 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.759 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.47 160.68 27.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.354 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 m120 62.82 22.42 13.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -94.46 114.11 62.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 3.3 Cg_exo -79.64 -8.04 14.71 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.82 126.75 2.43 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.45 160.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.3 tp -111.86 117.85 33.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.74 118.39 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -132.85 129.85 39.0 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.331 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.38 127.53 50.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -124.21 153.46 41.58 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.566 0.746 . . . . 0.0 110.107 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 37.1 mt-10 -117.09 137.12 52.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.36 -155.45 16.09 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -152.29 130.63 12.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.058 0.543 . . . . 0.0 110.575 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 27.3 mmt180 -147.67 163.91 35.17 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 170.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.54 62.85 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.644 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 58.7 mtt -109.68 135.04 51.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.102 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.43 ' HB ' ' HG2' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -65.25 98.74 0.34 Allowed 'General case' 0 N--CA 1.416 -2.126 0 O-C-N 124.076 0.86 . . . . 0.0 112.573 -175.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 19.3 pttp -176.82 169.81 2.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 66.75 11.26 8.12 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 123.621 0.768 . . . . 0.0 111.874 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.504 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 96.3 m-20 -118.63 179.96 3.98 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.416 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -90.49 151.88 21.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -118.52 121.18 39.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.7 mt -84.65 -48.13 9.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.707 0.289 . . . . 0.0 111.596 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.74 170.89 42.39 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -143.48 162.92 34.57 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -155.06 142.64 19.72 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.68 117.87 35.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.038 0.447 . . . . 0.0 110.299 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.3 tp -92.77 112.65 24.69 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.889 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -107.95 155.36 20.4 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.32 -15.31 6.11 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.948 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.4 mp -60.5 125.41 82.17 Favored Pre-proline 0 C--O 1.247 0.939 0 C-N-CA 122.88 0.472 . . . . 0.0 110.136 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.54 126.8 16.79 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.95 1.767 . . . . 0.0 109.839 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.95 90.45 0.11 Allowed 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.594 2.196 . . . . 0.0 111.167 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.56 167.37 15.18 Favored Pre-proline 0 N--CA 1.42 -1.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.367 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.45 -179.0 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.508 2.805 . . . . 0.0 114.646 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -72.48 129.14 37.65 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.662 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.408 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 85.71 4.02 85.55 Favored Glycine 0 C--N 1.309 -0.949 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.714 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.7 t -90.55 -49.39 0.36 Allowed Pre-proline 0 CA--C 1.557 1.232 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.31 119.93 7.19 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.328 1.352 . . . . 0.0 111.27 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.38 106.61 17.79 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.296 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.36 116.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 39.2 tt0 -90.64 117.48 29.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' THR . 74.1 t -110.41 113.11 43.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.4 m -99.48 111.67 23.99 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -116.67 107.86 15.2 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -174.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -141.02 149.63 41.97 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.061 0.458 . . . . 0.0 111.192 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.8 mt -116.62 140.17 40.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -90.63 -167.25 1.78 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -18.25 59.55 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -82.73 -29.12 30.0 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.49 0.662 . . . . 0.0 109.301 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.16 31.96 3.4 Favored Glycine 0 N--CA 1.416 -2.674 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.9 mt -99.96 121.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.283 0.563 . . . . 0.0 109.751 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 tp -89.07 121.45 31.42 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.493 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -113.41 123.08 49.23 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.02 114.29 45.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -111.49 122.73 48.6 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.297 0.373 . . . . 0.0 110.009 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.65 117.73 34.82 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -118.6 114.56 22.97 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.813 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.72 112.19 13.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 62.5 mttm -67.08 -24.57 65.97 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.669 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -65.52 -54.65 25.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -91.52 -44.61 8.98 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.53 7.08 26.5 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -85.91 137.57 32.65 Favored 'General case' 0 N--CA 1.403 -2.79 0 CA-C-O 121.061 0.457 . . . . 0.0 110.401 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.32 140.81 47.64 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.01 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -135.73 131.79 36.04 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.61 166.16 16.59 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.05 145.05 33.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.8 m -117.45 113.08 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.6 mt -126.84 119.72 53.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 O-C-N 122.324 -0.235 . . . . 0.0 110.864 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.1 t -79.51 132.55 36.35 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.71 9.01 38.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.161 0.505 . . . . 0.0 110.331 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.41 -37.84 77.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.917 0.865 . . . . 0.0 108.875 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.77 154.6 21.82 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.63 -172.94 22.96 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 118.932 -1.604 . . . . 0.0 113.065 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -91.94 178.09 5.99 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 57.78 -160.43 0.25 Allowed 'General case' 0 C--O 1.255 1.374 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.4 p -95.03 -58.9 2.03 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.6 tttp 167.74 -36.45 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.952 1.301 . . . . 0.0 107.974 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -58.69 -38.69 78.79 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.671 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.96 -35.52 72.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.313 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.409 ' O ' HG21 ' A' ' 135' ' ' VAL . 60.3 mt -67.89 -41.95 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.458 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -60.14 -42.33 94.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.819 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -60.42 -43.24 96.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.7 ttm -58.62 -44.91 90.11 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.923 0.889 . . . . 0.0 110.613 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 59.4 t -63.14 -47.1 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -58.94 -43.23 91.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.73 -35.94 82.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.0 110.501 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.95 -30.22 69.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.511 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 7.6 mm-40 -78.79 -44.6 22.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.413 1.101 . . . . 0.0 109.082 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.63 -48.08 83.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.533 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.96 19.01 20.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.85 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 18.8 ttmm -54.32 -47.44 72.47 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.563 0.539 . . . . 0.0 112.139 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.18 70.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.168 0.509 . . . . 0.0 111.589 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.51 -46.84 68.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.447 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.86 -36.97 83.53 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.435 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 45.5 mm-40 -58.1 -50.17 74.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.677 0.217 . . . . 0.0 111.253 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.23 -47.03 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.273 0.358 . . . . 0.0 110.357 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -57.22 -46.23 83.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.73 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -66.06 -47.89 72.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.071 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -75.35 -7.78 54.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.254 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.0 mtp85 -73.99 -20.3 60.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.926 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.61 82.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.0 p -132.66 138.66 47.39 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.234 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -168.61 -54.5 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -169.37 150.1 4.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.401 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 56.6 m-80 -64.57 117.42 7.36 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.302 0.572 . . . . 0.0 110.29 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.02 161.59 38.38 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.648 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' THR . 21.7 mt -120.36 137.11 54.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 173.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -112.54 129.93 56.19 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m -97.68 145.47 26.29 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 62.22 34.35 16.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.417 0.687 . . . . 0.0 110.695 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.03 26.79 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.595 1.158 . . . . 0.0 113.05 -174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -146.03 109.89 4.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -96.05 86.74 4.37 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.087 0.47 . . . . 0.0 110.499 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.1 tpt -78.77 -34.0 45.95 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.82 110.61 6.46 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.2 m -75.85 155.2 35.55 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.327 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.19 -65.14 0.76 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.3 m -131.27 140.69 47.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -162.92 40.96 0.11 Allowed 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 122.09 0.947 . . . . 0.0 109.951 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -164.36 85.52 0.44 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -120.66 7.68 10.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.37 160.45 36.07 Favored Glycine 0 C--O 1.249 1.063 0 CA-C-N 115.188 -0.915 . . . . 0.0 113.761 -176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 59.5 mt -81.46 116.78 21.42 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -143.37 -86.53 0.14 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -170.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -93.6 -43.34 3.96 Favored Glycine 0 CA--C 1.482 -2.015 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -77.34 111.41 12.97 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.5 mm 61.52 87.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 122.207 1.003 . . . . 0.0 108.807 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 40.3 m -84.76 0.29 51.17 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.958 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -101.57 96.18 6.95 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 122.098 0.951 . . . . 0.0 110.1 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -112.12 -50.46 2.91 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.825 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.448 ' OD1' ' HG2' ' A' ' 183' ' ' LYS . 34.7 t70 62.99 -73.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.376 1.47 . . . . 0.0 109.467 -173.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.448 ' HG2' ' OD1' ' A' ' 182' ' ' ASP . 22.4 pttm -167.98 113.86 0.69 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.598 1.159 . . . . 0.0 109.097 174.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -114.94 -4.77 12.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.091 0.948 . . . . 0.0 109.388 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.486 ' HZ3' ' CG ' ' A' ' 188' ' ' ASP . 48.2 tttm -120.82 118.11 29.13 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.0 p -109.49 -27.99 2.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 190' ' ' SMC . 3.1 pp -119.21 162.47 18.63 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.486 ' CG ' ' HZ3' ' A' ' 185' ' ' LYS . 18.4 m-20 -146.27 -51.15 0.22 Allowed 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 125.197 1.399 . . . . 0.0 107.624 173.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -88.61 29.07 1.04 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.489 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . 0.415 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 80.35 -50.87 0.34 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.989 1.316 . . . . 0.0 110.987 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -94.06 131.04 39.96 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 12.4 p -58.59 142.37 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 123.87 0.731 . . . . 0.0 111.823 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 45.8 mm -88.67 133.2 31.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.6 p -109.12 147.37 32.56 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -96.48 134.18 39.99 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.77 142.23 37.16 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.72 112.58 13.44 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.069 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -82.06 117.17 22.04 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.162 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -90.86 88.59 7.11 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.354 0.597 . . . . 0.0 109.65 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.9 m -88.56 87.32 7.23 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.625 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.7 mt -142.68 137.07 29.64 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -108.08 165.8 11.2 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -91.83 175.88 6.72 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.671 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -146.7 132.58 19.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.94 166.3 10.53 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -144.63 142.41 30.1 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 125.711 1.604 . . . . 0.0 108.707 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -134.23 161.6 34.49 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.26 140.76 17.83 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -160.93 97.29 1.15 Allowed 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.582 ' O ' ' HG3' ' A' ' 212' ' ' ARG . 4.5 ttmp? -149.96 98.85 2.77 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.002 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 211' ' ' LYS . 83.7 mtt180 179.65 139.71 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.707 2.003 . . . . 0.0 109.322 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -132.25 158.93 40.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 120.668 0.27 . . . . 0.0 111.011 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -117.48 -32.53 4.88 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.332 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.11 102.99 8.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -84.91 -41.31 16.06 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.096 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -120.91 153.2 37.53 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.39 95.36 3.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.641 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -115.25 100.92 54.22 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.96 126.66 15.58 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 122.566 2.177 . . . . 0.0 111.659 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 31.5 pt -109.85 147.5 14.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 8.4 tp -73.47 123.99 29.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.406 0.622 . . . . 0.0 110.743 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 40.5 p -141.47 91.87 2.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.618 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.35 142.06 7.3 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.03 171.52 8.9 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.31 172.5 18.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -140.43 127.75 21.2 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.03 122.98 6.63 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -96.65 148.22 23.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.656 0.265 . . . . 0.0 110.632 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -135.55 161.98 24.82 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -144.9 176.08 24.17 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -96.3 -173.16 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.963 2.442 . . . . 0.0 112.374 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.44 141.38 9.77 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.14 101.54 1.48 Allowed 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.526 2.151 . . . . 0.0 112.246 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -99.92 71.66 0.48 Allowed Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.797 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -116.51 92.38 0.57 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -134.42 141.51 46.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -176.33 122.4 0.85 Allowed Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -98.09 113.64 25.59 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.089 0.445 . . . . 0.0 110.684 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -82.7 150.9 26.47 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.826 0.345 . . . . 0.0 110.743 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -153.9 79.22 0.19 Allowed Glycine 0 C--N 1.301 -1.371 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.17 128.76 14.22 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.924 2.416 . . . . 0.0 111.519 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -151.51 158.81 44.09 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 132.74 79.76 0.16 Allowed Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 121.94 41.25 0.49 Allowed Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.387 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 33.7 t -151.46 144.85 24.8 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 153.26 -153.91 25.16 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 20.2 m -81.19 107.89 14.37 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -119.79 96.2 0.62 Allowed Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.911 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.74 -170.27 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.606 2.204 . . . . 0.0 109.909 174.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.6 p -86.03 17.4 3.56 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp 74.87 -66.07 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.705 1.202 . . . . 0.0 111.323 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -94.48 134.92 36.49 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.835 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.417 ' HG2' HG23 ' A' ' 256' ' ' VAL . 42.5 tt0 -65.04 149.16 50.35 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -171.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.417 HG23 ' HG2' ' A' ' 255' ' ' GLU . 25.5 t 67.54 -83.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 126.429 1.891 . . . . 0.0 112.38 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 CA--C 1.486 -1.488 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.25 -176.599 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 70.46 -80.47 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.846 1.658 . . . . 0.0 110.235 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 46.79 28.2 0.79 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.452 1.901 . . . . 0.0 115.581 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.5 m -81.21 76.4 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.429 1.109 . . . . 0.0 111.221 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -144.23 105.51 4.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.111 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -129.88 120.92 25.69 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.3 mp 69.89 -165.39 0.17 Allowed 'General case' 0 C--O 1.244 0.79 0 O-C-N 124.25 0.969 . . . . 0.0 109.528 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 tt 65.08 71.31 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -175.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 tp -76.33 -68.86 0.55 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.901 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . 0.261 4.0 mm? 63.8 11.21 5.73 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 35' ' ' THR . 2.3 m-20 -94.52 64.42 3.06 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 m -139.52 174.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.998 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.51 120.79 72.24 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.11 -43.33 30.23 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 122.486 2.124 . . . . 0.0 113.116 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.427 ' C ' ' HB3' ' A' ' 32' ' ' ARG . 10.0 mp -123.31 174.18 7.48 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 m -88.3 127.86 35.48 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.4 130.91 37.95 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.2 -170.74 19.76 Favored Glycine 0 N--CA 1.408 -3.169 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.452 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.4 mt -129.27 162.93 26.78 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.169 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.54 144.45 28.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 12.9 p -126.35 -94.29 0.47 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 122.946 0.498 . . . . 0.0 111.575 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.41 106.11 14.53 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.11 -60.64 4.78 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.752 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.91 56.43 0.1 Allowed Glycine 0 C--N 1.291 -1.928 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.9 t -122.11 115.33 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.62 114.02 22.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -106.72 111.39 23.9 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.78 132.04 36.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.031 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -49.8 3.47 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.32 102.68 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 152.99 37.23 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.571 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.527 HH12 ' HA ' ' A' ' 135' ' ' VAL . 36.9 ptt180 -62.58 160.7 13.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 73.82 5.13 4.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.772 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 9.9 t -65.84 135.2 54.53 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.779 0.799 . . . . 0.0 111.548 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 pt -98.89 155.42 36.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.548 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.06 144.59 75.54 Favored 'Cis proline' 0 C--O 1.25 1.089 0 N-CA-C 115.265 1.217 . . . . 0.0 115.265 4.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 p -122.16 161.3 23.4 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.282 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HB2' ' HZ3' ' A' ' 39' ' ' LYS . 4.8 ttmp? -166.08 100.6 0.64 Allowed 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -119.0 131.09 55.98 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.102 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.7 m -114.44 122.44 46.63 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.53 0.732 . . . . 0.0 110.771 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' N ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -129.46 148.7 51.4 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mm -96.23 121.7 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.206 0.527 . . . . 0.0 110.397 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 79.6 m-85 -109.26 143.66 38.43 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.625 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 16.9 p -119.78 171.17 8.59 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -113.89 141.7 47.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.563 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 29.9 m-85 -88.18 -41.09 13.22 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 p -73.87 130.43 39.89 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.557 175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -106.46 166.82 10.27 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.072 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 67.88 23.81 8.27 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.312 0.645 . . . . 0.0 112.091 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.588 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 15.0 mm-40 -81.86 132.77 53.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.07 -39.63 30.79 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.554 1.502 . . . . 0.0 110.674 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.35 166.72 33.79 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 m -106.48 135.07 46.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.09 0.471 . . . . 0.0 110.947 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.46 107.26 16.62 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.681 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -96.18 114.7 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -122.56 110.79 16.01 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.562 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.83 127.01 44.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 123.594 0.559 . . . . 0.0 111.371 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 53.0 m-85 -133.62 155.26 49.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -110.76 143.27 41.55 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 165.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.38 112.49 0.62 Allowed Glycine 0 C--N 1.263 -3.486 0 C-N-CA 118.285 -1.912 . . . . 0.0 111.105 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.48 86.46 5.16 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -145.18 146.02 31.58 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.25 -50.15 64.75 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.402 1.096 . . . . 0.0 109.846 172.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.2 mtt -112.22 130.3 55.97 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.18 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 101.79 1.03 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 123.912 0.757 . . . . 0.0 109.69 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -76.28 -52.7 9.45 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 122.01 0.91 . . . . 0.0 108.684 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -153.5 -54.0 0.11 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.36 -176.77 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.27 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 65.9 t30 -95.38 112.74 24.4 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.075 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.9 114.08 17.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.27 -34.41 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.669 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.67 176.16 39.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.23 170.4 20.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 117.032 0.416 . . . . 0.0 110.026 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -164.22 155.43 15.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -114.68 118.94 35.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.213 0.53 . . . . 0.0 110.133 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -95.49 108.03 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.3 p -97.03 150.18 21.08 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.81 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 24.01 1.78 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.812 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 50.6 mm -82.51 125.19 76.77 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.84 163.27 35.92 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.544 2.163 . . . . 0.0 112.348 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.35 40.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.217 2.611 . . . . 0.0 111.208 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . . . -84.74 124.91 72.37 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.75 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 16.6 Cg_exo -66.13 99.82 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.148 2.565 . . . . 0.0 115.506 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.4 mtp180 54.91 114.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.617 1.967 . . . . 0.0 115.442 167.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.98 -20.6 31.78 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.661 -0.781 . . . . 0.0 114.764 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -73.79 -47.03 6.95 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 122.458 -0.436 . . . . 0.0 111.416 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.99 113.26 3.51 Favored 'Trans proline' 0 C--N 1.376 2.005 0 N-CA-C 108.782 -1.276 . . . . 0.0 108.782 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.288 0.0 OUTLIER -129.78 128.01 41.52 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.05 0.929 . . . . 0.0 113.049 -178.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 mm -107.14 126.72 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.713 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.18 107.73 19.4 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.04 120.56 60.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.322 0.582 . . . . 0.0 110.152 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.5 m -113.55 124.76 53.12 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.146 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -105.86 114.34 28.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -123.66 138.58 54.51 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.8 mt -125.71 141.99 43.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -104.78 -170.14 1.72 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.6 -11.81 60.55 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -84.96 -28.76 25.61 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.029 0.442 . . . . 0.0 109.825 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.44 23.34 8.03 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 86.6 mt -90.3 117.57 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-O 121.382 0.611 . . . . 0.0 109.526 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 38.6 tp -95.74 129.27 43.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.646 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.482 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 45.4 m-80 -117.62 108.68 15.74 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.84 113.79 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -111.32 114.44 27.61 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.303 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.19 123.62 47.12 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.471 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.1 m -118.5 119.92 35.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.414 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.84 104.5 6.41 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -68.31 -18.31 64.48 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.582 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -68.43 -61.96 1.6 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.855 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 p -98.98 -37.71 9.27 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 120.8 0.333 . . . . 0.0 111.346 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.24 -0.59 8.21 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.045 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.0 137.31 55.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 117.406 0.603 . . . . 0.0 112.03 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.92 136.85 32.67 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.131 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -139.96 139.52 36.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -137.95 142.01 40.54 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.128 0.49 . . . . 0.0 110.689 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 34.4 pt -119.17 147.66 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.5 m -106.96 113.45 26.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.017 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -128.83 116.4 40.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.7 m -72.54 127.32 32.19 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 168.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -41.16 -53.68 3.06 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 124.339 1.024 . . . . 0.0 111.217 -170.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.9 t70 62.05 -148.98 0.38 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.635 0.774 . . . . 0.0 110.579 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -55.81 3.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.752 0.311 . . . . 0.0 111.448 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.85 -130.12 10.12 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -116.37 -165.75 1.08 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.3 mt 60.92 -171.98 0.14 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.228 1.011 . . . . 0.0 112.28 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.7 p -106.67 159.48 16.18 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -63.62 -29.81 71.0 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 122.642 0.377 . . . . 0.0 110.463 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.66 -42.71 97.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.957 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.31 -30.18 69.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.706 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 135' ' ' VAL . 48.0 mm -61.15 -45.3 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.66 -25.04 62.82 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -60.21 -45.0 94.68 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.5 mmt -59.48 -45.07 92.72 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.527 ' HA ' HH12 ' A' ' 32' ' ' ARG . 96.2 t -60.29 -57.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.085 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -70.22 -48.47 56.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -172.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.54 -38.62 91.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.02 -39.72 83.07 Favored 'General case' 0 C--O 1.19 -2.079 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.602 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -58.26 -33.31 69.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.493 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.4 -37.81 51.12 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -126.19 15.75 7.82 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -59.3 -27.31 65.74 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.48 95.52 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.772 0.796 . . . . 0.0 108.867 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 24.8 mm-40 -70.61 -44.96 66.17 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.506 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.99 -45.42 83.0 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 123.545 0.528 . . . . 0.0 112.266 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 38.2 mt-10 -61.24 -39.29 89.75 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.79 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.575 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 82.9 t -63.74 -48.73 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.6 mm-40 -56.18 -46.06 79.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.519 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.431 ' C ' ' HD3' ' A' ' 149' ' ' ARG . 2.5 tmt_? -53.29 -50.83 64.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.593 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.1 pt-20 -83.18 -5.14 59.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 11.7 mmp_? -76.29 -34.54 59.07 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.88 -54.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 49.0 m -149.32 129.18 13.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.0 -38.04 9.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.01 0.434 . . . . 0.0 110.779 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.465 ' HE3' ' OG1' ' A' ' 45' ' ' THR . 64.1 tttp -80.65 144.93 31.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 90.0 m-20 -76.68 99.13 4.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.319 0.581 . . . . 0.0 110.675 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -134.6 132.82 39.5 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.907 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.405 HD23 HG23 ' A' ' 21' ' ' THR . 18.5 mt -101.13 114.32 28.15 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.1 119.32 37.64 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.0 m -86.04 131.06 34.35 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 79.9 t80 80.06 -52.84 0.38 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.098 1.359 . . . . 0.0 108.927 -172.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 60.23 92.96 0.04 OUTLIER 'General case' 0 C--O 1.245 0.824 0 C-N-CA 124.913 1.285 . . . . 0.0 112.629 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -90.41 97.01 10.94 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.871 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 47.5 95.22 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 171.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.7 mmt -103.18 108.94 20.33 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -138.38 161.49 36.82 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.339 0.59 . . . . 0.0 111.006 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.3 t -144.66 81.14 1.65 Allowed 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.58 167.46 9.78 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.27 -171.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -102.68 -169.25 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.73 118.25 26.01 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.204 0.526 . . . . 0.0 110.382 176.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.64 -32.3 47.26 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.518 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -80.08 153.0 29.04 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.581 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -88.58 66.66 3.15 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.96 76.84 9.33 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.334 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 47.3 tttm 164.09 -71.15 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 126.521 1.928 . . . . 0.0 107.594 172.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.22 117.02 0.32 Allowed Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.817 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.18 -33.68 38.08 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.2 tp -148.51 82.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.745 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 57.0 m -95.02 130.19 41.79 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.263 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -44.64 105.22 0.05 Allowed 'General case' 0 C--O 1.243 0.762 0 C-N-CA 125.345 1.458 . . . . 0.0 113.626 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.94 103.25 14.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.21 -38.87 92.6 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.098 -171.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -92.26 -38.72 11.92 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.663 -174.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.439 ' HB3' ' HZ1' ' A' ' 184' ' ' LYS . 0.1 OUTLIER 172.15 -33.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.78 0.832 . . . . 0.0 109.816 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.545 ' HG2' ' H ' ' A' ' 186' ' ' VAL . 37.3 ttmt -162.95 -172.16 2.95 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 101.013 -3.699 . . . . 0.0 101.013 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.545 ' H ' ' HG2' ' A' ' 185' ' ' LYS . 7.4 p -55.13 -43.14 68.87 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-N 119.198 0.908 . . . . 0.0 111.082 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 96.1 mt -138.66 -75.72 0.38 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.269 0.557 . . . . 0.0 111.627 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 185' ' ' LYS . 6.5 p-10 -86.45 -173.1 4.36 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.598 -174.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -127.87 -71.02 0.67 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -76.86 -33.19 57.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.701 0.762 . . . . 0.0 109.947 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.94 -9.27 14.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.464 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.79 -44.22 99.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 13.0 tt -109.52 -32.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.257 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.1 m -81.23 53.68 2.09 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -92.4 -23.84 19.07 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.0 mt -104.31 149.9 24.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 172.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.71 -30.35 11.78 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.976 -174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -125.1 -174.67 3.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.95 146.1 32.7 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 7.6 p -80.47 -58.89 2.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.085 0.945 . . . . 0.0 109.99 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 64.5 tp -130.02 -51.69 1.12 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -147.58 -53.27 0.21 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.34 -55.75 0.13 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.023 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -174.57 -64.23 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -167.3 135.16 2.48 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 173.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -112.49 126.72 55.63 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.05 0.452 . . . . 0.0 110.644 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -84.18 -33.92 24.08 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.895 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -140.05 124.28 17.8 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -117.83 -47.46 2.6 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -144.28 124.83 14.0 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.988 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -84.41 93.27 8.25 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.795 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 79.16 9.61 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.853 1.311 . . . . 0.0 110.127 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.31 178.22 7.55 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.302 -1.772 . . . . 0.0 109.996 -174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.7 tp 76.81 149.97 0.11 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.845 1.258 . . . . 0.0 108.489 -172.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -64.18 133.03 52.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.76 95.8 0.37 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.568 0.699 . . . . 0.0 109.93 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.57 117.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.194 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 55.1 t30 175.27 135.2 0.17 Allowed Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.78 101.36 0.56 Allowed 'Trans proline' 0 C--O 1.247 0.951 0 N-CA-C 107.365 -1.821 . . . . 0.0 107.365 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 28.2 pt -54.8 -61.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.2 mm 57.87 97.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.337 0.655 . . . . 0.0 110.185 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 54.5 p -79.79 92.9 5.51 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.476 -0.765 . . . . 0.0 110.368 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -88.87 98.52 2.45 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 43.6 tp 63.9 80.36 0.23 Allowed 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.996 0.903 . . . . 0.0 109.695 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -82.81 -42.94 17.27 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.898 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -141.35 109.84 5.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.705 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -113.11 83.89 0.34 Allowed Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.85 113.42 9.86 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -154.59 48.42 0.51 Allowed Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.28 109.66 3.88 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -60.67 106.15 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.878 2.386 . . . . 0.0 112.609 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -136.93 101.24 0.34 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.35 -0.58 10.85 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.765 2.31 . . . . 0.0 112.584 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -72.99 151.52 45.84 Favored Glycine 0 C--O 1.248 1.028 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 104.53 92.79 2.27 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 80.0 t80 69.4 108.94 0.05 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.667 1.187 . . . . 0.0 110.559 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -115.39 -140.2 7.03 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.3 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -101.3 136.42 41.18 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.44 157.83 15.83 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 123.44 0.462 . . . . 0.0 109.825 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -97.4 126.98 9.06 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -63.91 111.16 1.47 Allowed 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.194 1.929 . . . . 0.0 109.738 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -64.1 108.87 1.65 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.116 -174.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 156.63 -98.62 0.18 Allowed Glycine 0 N--CA 1.424 -2.135 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -84.31 57.53 5.03 Favored Glycine 0 C--O 1.246 0.851 0 C-N-CA 121.725 -0.274 . . . . 0.0 113.762 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.7 p -78.2 132.61 37.66 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.79 -148.47 21.29 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 60.0 m -101.92 23.64 11.15 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.157 0.503 . . . . 0.0 110.923 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -159.5 98.65 0.17 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.558 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.8 76.08 3.44 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.807 2.338 . . . . 0.0 108.153 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 63.3 m 69.88 98.32 0.06 Allowed 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.045 -168.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 26.9 pt -54.43 159.05 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.573 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.63 90.25 2.8 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.519 0.676 . . . . 0.0 109.721 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.73 82.31 8.48 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.894 0.854 . . . . 0.0 110.579 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.78 100.35 3.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 C--N 1.281 -2.373 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.77 -174.627 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -84.14 95.24 8.56 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -87.14 99.8 12.19 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.93 154.18 19.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.072 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -64.31 132.19 49.47 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -53.76 -31.33 48.2 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.58 1.152 . . . . 0.0 113.396 -173.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.77 80.33 6.17 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.5 mp -103.54 72.94 1.16 Allowed 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.2 mt -125.35 104.84 8.68 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.144 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.4 tp -91.65 88.64 6.8 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.8 m-20 -78.76 56.99 1.98 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.538 -172.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.0 m -136.56 168.37 22.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.8 127.2 68.42 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.68 -47.34 9.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.578 2.185 . . . . 0.0 111.972 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.19 169.83 10.86 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.151 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -76.79 129.47 36.32 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.1 131.55 40.97 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.84 178.13 26.6 Favored Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.865 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.7 mt -123.93 164.71 18.75 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.324 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -84.18 109.58 17.85 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 p -99.19 142.47 30.64 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.461 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.64 113.91 0.68 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.355 1.462 . . . . 0.0 113.049 -172.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.08 -11.46 8.2 Favored Glycine 0 N--CA 1.425 -2.06 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.384 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' HA2' ' OE1' ' A' ' 20' ' ' GLU . . . 84.49 50.33 4.29 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.64 134.75 65.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.2 ttt -94.23 101.35 13.32 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.809 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -95.42 119.23 33.56 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 143.79 26.18 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.411 HD23 ' CD2' ' A' ' 94' ' ' PHE . 5.5 mp -102.11 -44.57 5.41 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.235 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.84 129.07 76.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -85.7 167.11 15.58 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ptt85 -69.13 165.37 20.49 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.879 0.371 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 68.78 9.31 7.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.583 1.153 . . . . 0.0 112.659 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -81.61 118.74 23.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 13.2 p -62.76 126.94 29.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.9 pt -91.6 164.68 23.33 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.37 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.3 Cg_exo -68.76 122.77 5.78 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.353 1.162 . . . . 0.0 113.477 1.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -95.17 156.73 16.19 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.495 0.718 . . . . 0.0 110.106 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HG2' ' HB3' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -160.13 104.05 1.48 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.497 HE22 ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -129.52 120.9 26.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.0 m -107.39 141.51 38.65 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.569 0.748 . . . . 0.0 110.492 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' HG3' HE22 ' A' ' 40' ' ' GLN . 88.9 mt-30 -136.62 162.01 34.31 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.703 0.401 . . . . 0.0 109.974 174.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.79 122.94 62.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -107.57 146.57 31.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.86 0.838 . . . . 0.0 111.932 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 3.3 p -114.74 173.08 6.66 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.582 -1.644 . . . . 0.0 108.749 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 p -113.31 151.13 31.55 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 112.243 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -108.0 7.38 27.83 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.725 0.774 . . . . 0.0 110.286 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -89.97 158.15 17.51 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.568 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -118.27 114.42 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 63.3 74.25 0.43 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.245 1.021 . . . . 0.0 111.081 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.73 121.13 50.59 Favored Pre-proline 0 C--N 1.292 -1.904 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.56 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.18 -14.85 6.93 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.091 1.861 . . . . 0.0 110.891 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.87 150.76 20.89 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 29.0 m -118.41 158.64 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 tp -108.23 127.04 53.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.086 0.469 . . . . 0.0 111.426 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.26 105.36 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -113.02 123.51 50.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.82 119.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 123.9 0.75 . . . . 0.0 110.048 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 89.0 m-85 -122.68 156.78 33.66 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.171 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -111.11 149.69 30.49 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.155 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -165.76 12.1 Favored Glycine 0 N--CA 1.422 -2.251 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -148.8 99.36 2.98 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.286 0.565 . . . . 0.0 109.88 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -130.01 153.36 48.5 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.317 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -65.98 -40.66 91.41 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.713 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 69.9 mtm -128.59 135.45 49.36 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.88 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 109.5 2.48 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.438 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 20.3 pttp -155.72 -44.99 0.08 Allowed 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.394 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.438 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 10.9 m-20 -128.67 82.74 2.1 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.453 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 19.6 m120 -145.45 170.43 16.39 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.145 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 71.0 m-20 -90.73 117.78 29.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.99 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -85.88 108.1 17.99 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.54 -42.09 23.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.459 0.647 . . . . 0.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.38 35.52 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 4.4 ppt_? -146.7 147.39 30.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 122.279 0.231 . . . . 0.0 110.874 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.51 157.21 31.67 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.95 135.99 48.41 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 59.4 tp -97.12 104.5 16.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p -103.32 154.5 19.31 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.37 10.53 25.4 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.99 135.54 85.2 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.94 115.82 4.49 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.673 1.582 . . . . 0.0 110.181 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.3 102.72 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.065 2.51 . . . . 0.0 111.727 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.17 173.23 6.12 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.614 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.71 171.51 2.7 Favored 'Trans proline' 0 C--O 1.262 1.708 0 C-N-CA 122.451 2.101 . . . . 0.0 112.836 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -62.6 117.97 6.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.643 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 88.54 19.39 52.26 Favored Glycine 0 CA--C 1.494 -1.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.955 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.7 t -91.25 -54.89 0.27 Allowed Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.398 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.78 138.28 84.81 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 121.748 1.632 . . . . 0.0 112.044 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -102.71 96.11 6.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.642 0.734 . . . . 0.0 111.339 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.9 mm -92.48 133.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -112.63 119.14 37.11 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -120.91 127.97 76.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 95.7 m -118.71 127.41 53.53 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.66 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.411 ' CD2' HD23 ' A' ' 29' ' ' LEU . 9.1 m-85 -105.5 113.26 26.73 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' HB3' ' HG2' ' A' ' 39' ' ' LYS . 2.6 p30 -132.92 140.97 48.12 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 60.9 mt -127.5 126.42 67.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.457 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.0 p30 -90.84 179.02 5.88 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.07 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.74 63.8 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.06 -16.7 54.51 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.03 29.18 8.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 73.1 mt -94.8 117.68 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.4 tp -94.4 115.09 27.23 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.802 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -103.56 120.75 41.5 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.629 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.94 114.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.1 m -118.01 126.96 53.31 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.81 124.59 52.15 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -126.49 120.77 30.52 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.69 99.29 5.78 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -68.98 -6.19 26.27 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -70.13 -50.23 42.63 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 p -97.82 -43.24 7.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.545 0.688 . . . . 0.0 111.242 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.18 25.66 5.49 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.82 142.15 29.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.21 149.0 48.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.143 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.407 ' OD1' ' HA ' ' A' ' 77' ' ' LEU . 10.6 m120 -144.75 135.0 24.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 125.184 1.394 . . . . 0.0 107.33 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -124.73 166.74 15.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.039 0.447 . . . . 0.0 111.214 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.0 tt -140.36 140.31 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.1 m -116.14 113.77 23.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.821 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.13 101.57 12.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.7 p -92.36 103.36 15.81 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.262 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.3 m120 76.81 149.25 0.1 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.511 1.124 . . . . 0.0 113.531 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -67.7 -43.53 79.86 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.109 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -82.64 -0.2 46.05 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.906 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.51 -11.79 65.79 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -123.57 -45.23 2.07 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.804 0.335 . . . . 0.0 111.458 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.0 -175.71 2.9 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.661 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 67.5 p -78.71 -75.98 0.21 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 127' ' ' SER . 5.4 tmtp? 156.7 -27.0 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 128.511 2.725 . . . . 0.0 106.557 174.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.63 -49.24 77.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.663 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.43 -33.36 74.64 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.353 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 135' ' ' VAL . 62.8 mt -63.34 -52.4 58.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -61.82 -38.51 88.4 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.504 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -63.76 -40.66 97.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 2.1 tpt -63.1 -39.54 94.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.358 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 131' ' ' ILE . 57.4 t -55.98 -50.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 123.227 0.329 . . . . 0.0 110.221 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -58.02 -55.79 30.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.191 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.68 -43.12 99.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.83 88.9 Favored 'General case' 0 C--O 1.204 -1.308 0 O-C-N 123.41 0.444 . . . . 0.0 111.855 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -77.89 -37.64 47.62 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.817 0.341 . . . . 0.0 111.75 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -111.45 19.78 17.87 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -52.73 -56.96 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.661 1.185 . . . . 0.0 110.699 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.88 89.06 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.101 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.55 -50.9 67.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.306 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.24 -39.26 75.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.69 -33.49 75.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.781 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.624 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 70.7 t -64.58 -45.29 95.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 152' ' ' VAL . 78.4 mt-30 -64.25 -37.57 87.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.795 0.331 . . . . 0.0 110.643 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.474 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 52.1 ttp180 -61.62 -32.14 72.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.883 0.873 . . . . 0.0 112.01 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -89.3 -21.12 23.32 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.289 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 23.7 mmm180 -68.5 -42.85 78.02 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 148' ' ' GLN . 60.7 t -70.43 137.11 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.2 p -70.71 86.03 0.66 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.107 0.956 . . . . 0.0 111.126 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.97 166.82 10.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.532 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -170.33 164.23 8.83 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -80.29 74.91 7.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.899 0.857 . . . . 0.0 109.546 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -135.82 127.56 29.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.924 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.5 mt -97.37 152.77 18.59 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.426 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -78.02 172.37 13.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.522 ' H ' ' CD ' ' A' ' 159' ' ' GLU . 34.9 m -112.55 -25.66 9.05 Favored 'General case' 0 N--CA 1.413 -2.293 0 O-C-N 121.704 -0.622 . . . . 0.0 112.25 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -157.34 85.8 0.93 Allowed 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.135 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.1 93.47 2.39 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.384 0.612 . . . . 0.0 109.835 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -95.23 76.31 3.43 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.511 0.672 . . . . 0.0 110.455 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -67.83 -37.68 82.23 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.45 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 50.2 ttm -127.69 128.78 46.02 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.424 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -121.54 -63.26 1.33 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.7 m 64.92 -43.75 0.32 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.1 149.51 30.72 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 122.07 -0.394 . . . . 0.0 111.532 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.6 t -84.21 -29.27 7.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 68.46 99.58 0.06 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.447 1.499 . . . . 0.0 112.542 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -98.62 115.04 27.79 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.17 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 105.54 2.22 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 124.104 0.878 . . . . 0.0 110.641 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -122.79 122.82 5.15 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.1 mt -130.28 83.49 2.13 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 122.671 0.388 . . . . 0.0 110.106 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -150.71 103.67 3.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.552 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -130.08 107.61 0.79 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -87.56 -34.77 18.46 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.554 0.177 . . . . 0.0 111.252 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 57.6 mt 59.76 93.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.818 0 CA-C-O 122.053 0.93 . . . . 0.0 110.158 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 19.8 m -68.7 168.6 12.87 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.916 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 81.48 159.95 0.15 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.3 1.44 . . . . 0.0 111.408 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -102.83 3.05 36.25 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.88 134.75 40.21 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.87 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -160.57 25.64 0.15 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.694 -1.139 . . . . 0.0 107.997 174.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.02 -35.98 0.16 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.3 mptt 62.07 69.08 0.64 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.793 0.437 . . . . 0.0 111.138 -167.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 90.8 t 69.5 123.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.134 0.974 . . . . 0.0 112.191 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.0 mp -91.82 89.87 7.24 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.633 -0.667 . . . . 0.0 110.077 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -127.88 112.68 14.97 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.717 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.13 33.64 5.31 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -122.3 125.64 46.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -76.92 113.21 14.36 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.493 0.663 . . . . 0.0 112.185 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.69 133.28 61.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.71 -50.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.696 -174.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 19.9 m -85.27 90.9 8.02 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.811 0.815 . . . . 0.0 112.005 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -91.72 -35.21 14.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.811 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.9 tt -142.31 -73.47 0.3 Allowed 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.3 t70 170.64 -179.58 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -89.47 -30.94 17.93 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -159.22 101.95 1.58 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 13.5 t -63.64 122.37 16.19 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.994 0.902 . . . . 0.0 111.479 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 65.8 tp -143.99 78.0 1.57 Allowed 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.157 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -113.19 -16.86 12.49 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.099 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -93.84 109.34 21.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.053 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -115.76 131.56 56.9 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.31 108.27 19.53 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.185 0.516 . . . . 0.0 111.097 -174.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.62 107.18 19.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -146.97 138.04 23.95 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.37 112.16 21.83 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -132.65 8.19 4.18 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.768 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -117.8 86.28 2.49 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.475 ' HD3' ' N ' ' A' ' 213' ' ' LYS . 2.2 tmt_? -70.94 137.88 49.58 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.185 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.591 ' N ' ' HE2' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -151.8 149.92 29.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.318 0.386 . . . . 0.0 109.974 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -144.53 125.59 14.52 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.0 mt -118.58 105.48 11.67 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 120.914 0.388 . . . . 0.0 111.206 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.539 ' OE2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -138.55 132.26 30.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 175.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -154.87 16.0 0.43 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.041 0.448 . . . . 0.0 110.431 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.539 HG22 ' OE2' ' A' ' 216' ' ' GLU 0.276 34.4 m -87.06 80.08 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 122.832 1.301 . . . . 0.0 112.476 -178.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -69.07 -52.61 15.62 Favored Pre-proline 0 CA--C 1.559 1.311 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.2 105.9 1.28 Allowed 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 121.436 1.424 . . . . 0.0 113.787 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.6 pp -107.04 151.88 8.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.005 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.37 127.77 68.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.229 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t -112.85 140.43 47.65 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -61.58 123.39 31.82 Favored Glycine 0 N--CA 1.444 -0.802 0 O-C-N 123.444 0.465 . . . . 0.0 112.821 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -91.61 91.73 8.16 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -104.3 -5.89 21.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.212 1.006 . . . . 0.0 108.717 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -65.6 115.89 6.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.107 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.85 105.63 0.22 Allowed Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -132.44 -173.01 3.05 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 174.41 -176.3 46.74 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.518 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 119.25 126.81 3.54 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.74 -30.33 41.56 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.027 1.818 . . . . 0.0 111.982 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 101.4 178.43 28.62 Favored Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.3 122.82 8.67 Favored 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 122.519 2.146 . . . . 0.0 111.606 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -135.87 8.89 4.22 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.26 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -114.31 63.05 0.31 Allowed Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.876 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -94.12 -66.86 0.89 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.7 120.55 2.56 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -124.12 157.41 34.7 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -113.08 116.36 29.76 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.16 65.79 0.18 Allowed Glycine 0 C--N 1.297 -1.593 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -87.68 148.0 7.23 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.062 1.842 . . . . 0.0 111.029 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -78.77 85.82 4.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.634 0.73 . . . . 0.0 110.116 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -133.5 42.9 1.32 Allowed Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.3 71.41 0.49 Allowed Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.8 t -86.61 115.6 24.18 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -90.92 178.93 42.52 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 120.804 -0.712 . . . . 0.0 114.49 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 27.2 t -157.49 175.23 14.23 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -82.94 152.19 29.65 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.634 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.24 -42.94 63.05 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.604 2.203 . . . . 0.0 109.636 172.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 91.2 m -100.07 112.33 24.62 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.6 pp -77.14 143.63 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.631 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.1 137.78 42.32 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.546 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -69.15 -42.49 75.89 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.155 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.9 m -87.17 77.14 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 122.627 1.203 . . . . 0.0 111.54 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.298 -1.655 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.688 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.444 -0.775 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -124.94 119.09 27.77 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.16 114.07 15.57 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.2 p -140.69 -53.83 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -127.53 25.74 6.04 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.486 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 8.5 p-10 -131.97 139.59 48.71 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.421 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 6' ' ' ASP . 26.6 mt -161.88 109.81 1.42 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 125.264 1.426 . . . . 0.0 108.718 175.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.8 mt 71.95 143.65 0.06 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.24 1.416 . . . . 0.0 111.663 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -102.05 81.01 2.05 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 tp -107.52 21.0 18.12 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.925 1.345 . . . . 0.0 108.79 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.04 62.69 3.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.911 1.338 . . . . 0.0 110.03 177.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 35' ' ' THR . 32.4 m -144.42 -179.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.95 112.57 52.99 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.68 -13.91 10.45 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 121.586 1.524 . . . . 0.0 111.617 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 131' ' ' ILE . 89.1 mt -135.57 166.15 23.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.623 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 27.3 m -103.65 116.24 31.98 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.58 130.94 38.08 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.05 -177.62 18.18 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.072 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -124.78 166.0 17.0 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.081 0.552 . . . . 0.0 111.584 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.49 109.12 17.1 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.512 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 5.9 p -113.69 156.58 23.5 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.487 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 119.68 6.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.451 1.1 . . . . 0.0 113.286 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.72 4.44 28.15 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.286 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.59 38.31 28.47 Favored Glycine 0 CA--C 1.494 -1.247 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.5 t -99.44 142.21 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.39 -0.905 . . . . 0.0 108.667 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.401 ' HB2' ' N ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -108.92 103.12 12.1 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.217 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -91.95 110.71 22.07 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.75 115.58 28.18 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.717 0.636 . . . . 0.0 110.551 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.484 HD23 ' CD1' ' A' ' 94' ' ' PHE . 6.5 mp -91.21 -49.3 6.45 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 16' ' ' SER . 49.5 mm -97.58 91.04 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -85.76 148.43 25.85 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.874 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -57.38 150.56 18.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 76.64 11.39 2.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.044 1.738 . . . . 0.0 112.408 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 m -94.31 113.4 25.29 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.402 ' HA ' HG11 ' A' ' 12' ' ' VAL . 3.4 m -65.36 143.34 57.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.6 pt -96.15 162.29 24.29 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 23.7 Cg_exo -68.64 132.21 19.95 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.958 1.021 . . . . 0.0 113.614 -0.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.76 154.89 18.25 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.903 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' A' ' 95' ' ' ASP . 50.9 tptt -149.04 101.46 3.16 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -124.03 135.92 53.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 92.1 m -135.51 138.57 43.22 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.37 145.94 50.8 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 122.905 0.482 . . . . 0.0 109.76 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.41 122.09 55.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -114.42 155.94 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.82 171.55 8.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 123.732 0.813 . . . . 0.0 108.879 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -98.9 136.07 39.42 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.098 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -99.18 -14.2 19.42 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.949 0.88 . . . . 0.0 109.021 172.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -95.63 113.65 25.32 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.769 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.26 139.99 41.38 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 62.04 55.95 2.4 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -101.39 136.81 19.57 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.14 -25.92 18.56 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.576 2.184 . . . . 0.0 111.794 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 80' ' ' ILE . . . -171.88 168.0 41.06 Favored Glycine 0 N--CA 1.407 -3.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.569 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.25 138.01 44.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.1 tp -90.51 104.21 16.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.294 0.569 . . . . 0.0 109.822 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.98 117.1 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -135.43 119.37 17.41 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.744 -171.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.09 122.49 47.63 Favored 'Isoleucine or valine' 0 C--O 1.248 0.975 0 O-C-N 124.33 1.018 . . . . 0.0 110.811 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 69' ' ' ASN . 40.3 m-85 -120.7 149.55 42.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.905 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -119.17 157.74 27.33 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' HA2' ' SD ' ' A' ' 134' ' ' MET . . . 104.51 15.95 19.42 Favored Glycine 0 C--N 1.31 -0.909 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 167.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.585 ' OE1' ' HG3' ' A' ' 67' ' ' LYS . 47.4 mm-40 -144.14 179.52 7.16 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 118.309 1.055 . . . . 0.0 112.116 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -120.03 -72.11 0.7 Allowed 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.269 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 145' ' ' ASP . . . -91.97 -50.69 5.57 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.5 mtt -127.93 145.33 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.401 ' N ' ' HB2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -72.26 107.35 4.84 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.672 -174.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.585 ' HG3' ' OE1' ' A' ' 62' ' ' GLU . 10.7 pttp -137.48 -76.45 0.4 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 123.339 0.655 . . . . 0.0 111.587 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.78 75.08 4.94 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 122.77 1.271 . . . . 0.0 110.343 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.479 HD22 ' HB2' ' A' ' 62' ' ' GLU . 22.1 m120 -122.87 152.37 40.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.713 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -111.38 140.15 46.2 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.739 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.1 tp -83.17 119.89 25.1 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.4 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.9 mt -97.2 -65.82 0.94 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.744 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.45 21.61 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.264 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 -153.3 157.49 40.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -161.8 147.72 13.62 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.625 0.578 . . . . 0.0 109.492 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -94.5 113.88 25.79 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -88.78 103.39 15.93 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 p -119.0 166.37 12.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.91 18.32 12.64 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.405 HD13 ' HA2' ' A' ' 53' ' ' GLY . 1.8 mp -77.95 130.05 74.09 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.65 154.17 74.1 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 122.483 2.122 . . . . 0.0 111.895 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.24 92.05 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.18 1.92 . . . . 0.0 110.739 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.14 155.98 80.77 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.184 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.99 176.95 8.44 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.31 2.007 . . . . 0.0 113.356 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 58.0 mtt85 -45.91 131.43 9.57 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.574 1.55 . . . . 0.0 113.124 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.43 -20.25 35.35 Favored Glycine 0 C--N 1.311 -0.807 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -74.73 -53.99 3.01 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 117.671 0.735 . . . . 0.0 112.805 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.79 104.36 1.9 Allowed 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.346 1.364 . . . . 0.0 111.025 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -97.2 131.17 44.2 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.346 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.21 119.21 59.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.82 110.4 22.98 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.35 123.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.594 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.2 m -114.26 127.8 56.05 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.484 ' CD1' HD23 ' A' ' 29' ' ' LEU . 9.9 m-85 -111.3 121.01 44.13 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.498 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 1.7 p30 -138.07 137.7 38.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.942 0.401 . . . . 0.0 111.269 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 33.9 mt -121.78 123.84 70.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -88.48 -170.93 3.14 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 123.415 0.447 . . . . 0.0 111.545 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.8 -16.19 63.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.113 0.565 . . . . 0.0 112.346 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -83.18 -23.63 32.8 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.05 21.8 17.11 Favored Glycine 0 N--CA 1.419 -2.485 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 91.8 mt -90.01 117.61 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.428 0.632 . . . . 0.0 109.87 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.414 ' HB2' HG12 ' A' ' 96' ' ' ILE . 16.7 tp -96.47 122.37 39.3 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.092 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -117.29 120.39 38.06 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.205 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.6 t -99.32 113.14 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.7 m -115.13 126.32 54.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.66 123.71 50.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 m -109.81 128.66 55.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.774 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.427 ' CG ' ' HG1' ' A' ' 111' ' ' THR . 5.6 t0 -85.41 107.21 17.28 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 124.939 1.296 . . . . 0.0 107.647 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -67.5 -18.25 64.98 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.0 m -86.11 -36.66 19.46 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.926 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.427 ' HG1' ' CG ' ' A' ' 108' ' ' ASP . 38.3 p -110.87 -29.14 8.07 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.55 19.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.151 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -92.4 161.9 14.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.97 137.59 16.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.682 0.277 . . . . 0.0 111.065 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -129.99 142.06 50.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 60.7 pttt -129.34 155.5 45.53 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.146 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.1 pt -121.11 157.58 24.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 m -129.85 113.63 14.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.445 0.641 . . . . 0.0 111.551 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.8 mt -115.39 142.66 27.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 m -117.74 166.5 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -80.75 15.06 1.87 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.343 0.52 . . . . 0.0 111.383 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.38 -22.96 66.85 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.825 0.85 . . . . 0.0 109.889 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp 67.39 88.7 0.11 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.472 1.109 . . . . 0.0 110.067 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.64 -10.99 61.16 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.409 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -141.91 156.4 45.5 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.8 mt 68.3 176.98 0.26 Allowed 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.617 1.167 . . . . 0.0 113.091 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -127.8 -175.45 3.48 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -76.77 -15.48 59.74 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.778 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.98 -43.55 98.61 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.29 -34.87 79.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.26 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.469 ' HA ' HD23 ' A' ' 15' ' ' LEU . 59.2 mt -60.98 -50.23 81.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.933 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.62 -26.68 60.9 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.774 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -62.97 -36.84 84.84 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.421 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 15.6 ttt -59.24 -50.59 73.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 47.8 t -52.23 -53.8 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 124.084 0.865 . . . . 0.0 110.344 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.5 mt-30 -56.08 -46.84 78.88 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 124.095 0.872 . . . . 0.0 112.004 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.17 -39.49 60.26 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.755 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.03 67.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 9.1 pt-20 -75.16 -41.96 57.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.1 0.476 . . . . 0.0 110.896 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 98.1 mttt -57.62 -48.55 79.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.066 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.08 21.47 6.76 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.333 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 39.3 ttmt -58.7 -44.04 90.19 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.59 0.756 . . . . 0.0 112.021 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.32 -49.43 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -63.62 -46.36 86.07 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.499 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 1.4 m-20 -66.19 -27.97 68.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.969 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 5.4 tp10 -64.47 -39.73 94.36 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.3 t -70.94 -48.23 57.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.911 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 27.7 mt-30 -57.0 -38.3 72.88 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 123.549 0.74 . . . . 0.0 112.921 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -71.43 -31.92 67.77 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.008 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.45 -8.21 56.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.164 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 23.5 mmt85 -82.14 0.84 39.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.64 0.733 . . . . 0.0 109.505 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 33.4 t -114.36 113.87 45.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -78.56 153.54 31.13 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.63 67.96 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.278 1.037 . . . . 0.0 112.848 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.5 33.49 0.51 Allowed 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -59.83 157.21 12.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.736 -170.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.56 154.55 46.55 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.833 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 52.2 mt -91.73 142.88 27.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -82.97 118.52 23.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 118.106 -1.438 . . . . 0.0 107.456 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.2 m -103.68 86.66 2.66 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.293 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -103.59 95.91 6.37 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.045 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.86 140.02 42.0 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.02 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -84.98 -36.72 21.15 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.218 0.532 . . . . 0.0 110.083 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -133.48 112.25 11.38 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.696 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 60.5 mtm 66.21 -177.41 0.19 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.382 1.073 . . . . 0.0 112.776 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -125.15 89.81 3.12 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 168.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.9 m -72.38 62.01 0.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.716 0.77 . . . . 0.0 113.012 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.32 85.45 2.15 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.074 -0.967 . . . . 0.0 108.638 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.39 7.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 122.067 0.937 . . . . 0.0 108.618 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -77.34 90.13 3.77 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.168 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.9 t70 58.23 86.38 0.08 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.986 1.315 . . . . 0.0 111.769 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.64 177.53 5.89 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.027 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -82.08 69.49 3.31 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.576 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.13 -20.9 47.43 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.709 0.404 . . . . 0.0 110.311 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -60.93 -42.82 98.89 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.158 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.43 159.21 31.26 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.001 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 177' ' ' LYS . 6.6 tmtm? -101.7 -16.12 16.78 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 78.2 mt 84.17 -37.75 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.296 1.438 . . . . 0.0 112.67 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.484 ' O ' ' HD2' ' A' ' 177' ' ' LYS . 32.2 t -148.63 -171.18 3.8 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 59.03 49.44 9.48 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.263 1.025 . . . . 0.0 110.921 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 61.81 78.57 0.28 Allowed 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.469 1.108 . . . . 0.0 110.112 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -95.36 153.83 17.49 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.967 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 183' ' ' LYS . 10.2 mptt -111.17 168.32 9.6 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 -172.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 71.34 13.23 6.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.596 1.159 . . . . 0.0 113.418 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.24 -49.77 6.78 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.0 m -115.44 158.72 15.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.609 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.3 tp -99.75 118.29 35.92 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -80.61 103.67 10.62 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.566 0.698 . . . . 0.0 110.44 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -95.44 -7.26 38.78 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -77.06 78.39 3.59 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 120.479 1.49 . . . . 0.0 111.358 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 194' ' ' ILE . 40.9 tt0 -165.98 140.8 4.64 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.014 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.78 -32.35 57.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.428 ' H ' ' HG2' ' A' ' 192' ' ' GLU 0.297 9.8 tp 54.03 -56.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 C-N-CA 127.21 2.204 . . . . 0.0 114.115 -175.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.1 m -92.65 81.56 4.77 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -77.71 -7.85 57.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.054 0.93 . . . . 0.0 111.18 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.2 147.52 35.02 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -105.06 -67.2 0.92 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 69.01 151.87 0.09 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.044 1.338 . . . . 0.0 112.354 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -155.37 109.0 2.82 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 39.6 p -104.8 12.05 33.12 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.74 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 89.3 mt 76.47 93.05 0.07 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 125.658 1.583 . . . . 0.0 111.756 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.15 142.26 20.34 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -83.39 -32.14 26.32 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.763 0.792 . . . . 0.0 109.149 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -91.48 177.38 6.24 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.836 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.8 103.7 1.5 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.741 0.305 . . . . 0.0 111.19 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -85.82 -29.84 23.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.958 0.885 . . . . 0.0 109.297 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -113.14 136.87 52.24 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.324 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.75 179.76 8.97 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 166.52 69.41 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 126.805 2.042 . . . . 0.0 109.344 169.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.488 ' HZ2' ' HB3' ' A' ' 211' ' ' LYS . 7.6 mtpm? -72.43 -42.91 64.52 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -176.73 90.13 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.177 169.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -116.87 105.97 12.94 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.428 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.78 75.26 1.51 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.9 tp -128.44 -26.24 2.81 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.352 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.46 73.23 6.13 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -84.69 51.3 2.1 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.815 0.817 . . . . 0.0 110.878 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.3 m -82.05 86.47 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 CA-C-O 122.651 1.215 . . . . 0.0 111.051 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -104.43 157.21 34.58 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.445 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.03 50.59 0.63 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 123.345 2.696 . . . . 0.0 112.714 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.1 tt -75.46 -30.93 22.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 123.391 0.676 . . . . 0.0 109.35 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.8 pt -88.58 157.23 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 21.3 t -148.7 -41.91 0.15 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 92.88 -121.92 6.72 Favored Glycine 0 N--CA 1.423 -2.187 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 97.1 mt 67.32 102.95 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.107 0.963 . . . . 0.0 112.448 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -83.15 153.76 24.64 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.811 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -87.06 -38.32 16.63 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.108 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.96 -127.62 1.61 Allowed Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -114.85 101.13 8.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -76.8 -42.42 20.87 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.483 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 115.25 177.12 18.69 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -87.92 17.01 1.78 Allowed 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.761 2.308 . . . . 0.0 112.59 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 79.31 -120.58 5.3 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.23 105.46 1.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.97 1.78 . . . . 0.0 109.373 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.27 178.23 22.59 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.108 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -117.96 -65.17 0.32 Allowed Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.241 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -114.93 113.75 24.56 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.104 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -108.6 -53.55 0.63 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -148.16 -52.3 0.18 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 61.37 91.02 0.06 Allowed 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.114 1.365 . . . . 0.0 112.154 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -124.07 -87.44 0.77 Allowed Glycine 0 C--N 1.299 -1.499 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.46 147.2 46.05 Favored 'Trans proline' 0 C--O 1.254 1.284 0 C-N-CA 122.247 1.964 . . . . 0.0 111.386 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.443 ' HZ3' ' HB2' ' A' ' 244' ' ' LYS . 5.1 ttmp? -129.12 128.18 42.95 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -77.83 81.93 1.24 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 83.34 -128.31 8.47 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 32.7 t -142.19 101.38 3.9 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.52 73.13 2.72 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 17.1 m -69.62 128.55 36.88 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -155.49 178.35 32.16 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.2 -35.84 13.47 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.71 2.273 . . . . 0.0 112.154 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 21.2 m 65.97 76.67 0.31 Allowed 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.171 0.988 . . . . 0.0 109.342 -175.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 27.4 pt -74.73 118.39 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.928 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.55 -43.18 14.75 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.366 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.6 122.84 31.09 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 7.3 p 179.22 -39.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 N--CA 1.433 -1.309 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.93 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.442 -0.86 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -98.63 116.39 30.75 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -84.68 74.5 10.43 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.401 1.096 . . . . 0.0 109.63 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.24 18.03 3.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.471 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -80.44 78.2 7.16 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.556 -0.858 . . . . 0.0 112.276 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -76.5 -39.83 51.96 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.39 86.78 3.05 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.541 174.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tt -85.64 -51.92 6.15 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.3 tp 51.87 77.28 0.15 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.445 1.498 . . . . 0.0 113.802 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.4 mt -153.8 158.46 40.92 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.746 0.818 . . . . 0.0 109.569 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 75.55 16.06 2.62 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 124.91 1.284 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.76 174.94 12.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.799 0.809 . . . . 0.0 112.302 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.28 114.74 64.8 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.794 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.78 -41.72 13.64 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.393 2.062 . . . . 0.0 111.862 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -117.02 144.64 44.36 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.967 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 6.3 m -67.09 137.46 56.39 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.994 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -106.5 131.96 53.07 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.502 0.502 . . . . 0.0 109.651 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -162.67 -158.1 9.45 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.437 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.19 165.88 24.07 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.432 0.693 . . . . 0.0 109.341 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -89.12 120.45 30.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.542 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.6 p -92.22 -105.44 0.11 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.42 146.85 37.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.134 -0.354 . . . . 0.0 110.322 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -57.78 4.99 Favored Glycine 0 C--N 1.317 -0.515 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.369 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.42 41.44 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.95 141.56 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.401 ' HB2' HG23 ' A' ' 66' ' ' THR . 1.1 tmt? -86.1 134.32 33.83 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.032 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -126.46 132.27 51.49 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.461 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -102.04 142.69 32.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.155 0.503 . . . . 0.0 111.657 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 6.4 mp -99.96 -49.12 4.43 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -101.27 112.39 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -85.64 158.72 20.01 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.442 HH22 ' HG3' ' A' ' 142' ' ' LYS . 15.4 ptt-85 -58.23 151.91 18.31 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.848 0.859 . . . . 0.0 110.654 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.7 m120 76.23 11.01 2.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.567 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -87.73 124.07 33.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.147 0.498 . . . . 0.0 110.155 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -68.87 137.33 53.79 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.407 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.68 159.73 28.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.4 140.82 50.49 Favored 'Cis proline' 0 CA--C 1.501 -1.147 0 CA-C-N 120.348 1.16 . . . . 0.0 112.516 -1.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -98.54 -77.98 0.5 Allowed 'General case' 0 N--CA 1.406 -2.668 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.734 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 88.8 tttt 66.81 100.7 0.05 OUTLIER 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.491 1.117 . . . . 0.0 111.022 -171.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.06 130.82 48.85 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -113.01 129.04 56.64 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 123.511 0.507 . . . . 0.0 110.191 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.496 ' NE2' ' HA ' ' A' ' 29' ' ' LEU . 74.4 mt-30 -133.41 141.03 47.67 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 74.8 mt -104.19 120.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.176 0.513 . . . . 0.0 109.972 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -107.33 136.3 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -111.46 162.46 15.06 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.1 p -90.25 135.81 33.44 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.589 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 31.0 m-85 -114.92 -6.36 12.58 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.529 173.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -98.34 119.96 37.92 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.08 163.23 26.83 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.018 0.199 . . . . 0.0 110.996 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.19 23.99 14.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.142 0.977 . . . . 0.0 113.199 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -85.35 120.53 73.33 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.67 -16.08 14.98 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.59 2.193 . . . . 0.0 113.767 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.87 159.05 29.41 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.266 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.69 171.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 tt -129.08 118.6 22.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 111.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -126.53 118.12 24.25 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.12 132.73 30.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.775 -172.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 79.7 m-85 -134.01 152.94 52.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.737 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 16' ' ' SER . 34.7 mt-10 -112.9 151.73 30.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.587 0.554 . . . . 0.0 110.341 175.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.02 152.3 26.71 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.107 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -115.44 121.42 42.7 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.38 0.609 . . . . 0.0 109.795 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -140.29 162.72 34.61 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 145' ' ' ASP . . . -66.65 -37.46 84.85 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 123.865 0.728 . . . . 0.0 111.098 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.77 139.93 46.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.749 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.476 ' HA ' ' OD1' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -70.57 113.95 8.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.266 -175.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.494 ' HZ1' ' HB3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -171.69 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.985 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.83 -14.55 54.13 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.963 0.887 . . . . 0.0 109.17 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.476 ' OD1' ' HA ' ' A' ' 66' ' ' THR . 8.7 m120 -66.96 152.73 45.2 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.311 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 78.4 m-20 -89.06 121.4 31.36 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.73 115.66 21.07 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.04 -36.67 12.01 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.062 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.29 171.97 39.06 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.214 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -149.03 159.29 44.35 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.427 0.291 . . . . 0.0 111.356 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.07 154.52 25.8 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 172.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.89 133.4 53.2 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.515 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 6.1 tt -108.25 104.44 13.84 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.6 p -104.53 159.44 15.74 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.112 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.11 -14.41 5.15 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.5 -0.857 . . . . 0.0 110.971 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.19 119.23 50.75 Favored Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 123.258 0.623 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.99 166.59 11.23 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.595 2.197 . . . . 0.0 110.939 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.09 97.46 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.933 1.755 . . . . 0.0 110.378 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.72 151.41 78.05 Favored Pre-proline 0 N--CA 1.426 -1.659 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.9 133.52 40.2 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.067 2.511 . . . . 0.0 111.466 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -60.98 119.65 8.7 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.397 0.618 . . . . 0.0 111.639 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.22 -27.11 6.2 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.93 -48.82 7.89 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.336 -0.432 . . . . 0.0 111.082 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -70.08 106.67 1.76 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.182 1.255 . . . . 0.0 109.301 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 74.3 mt-30 -113.83 115.33 27.58 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.419 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.21 111.42 25.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -90.1 104.32 16.9 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -104.75 127.11 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.084 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.7 m -122.26 123.01 40.45 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.875 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 5.1 m-85 -99.45 112.35 24.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.728 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -112.95 143.28 44.51 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 11.9 mt -130.99 127.54 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -98.58 -171.68 2.17 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.86 -23.92 64.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.06 -29.82 49.41 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.07 26.2 6.13 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.7 mt -84.59 119.61 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 65.0 tp -96.06 107.84 20.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -103.52 125.83 50.31 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.7 t -111.29 113.02 43.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.8 m -106.24 116.52 32.08 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.63 117.23 33.39 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.7 m -113.45 122.1 46.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 110.65 16.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 54.2 mtpt -67.41 -18.55 65.15 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.541 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.9 p -80.26 -56.75 3.99 Favored 'General case' 0 C--O 1.25 1.102 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.359 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.6 p -76.58 -32.06 57.9 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.168 0.508 . . . . 0.0 110.361 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.93 -8.65 54.4 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.8 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -94.49 160.41 14.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.546 0.673 . . . . 0.0 111.435 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.1 148.43 51.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.283 0.563 . . . . 0.0 111.719 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.515 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.4 m120 -130.86 132.25 45.06 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 157.97 45.56 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.382 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 tt -127.78 146.51 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.2 m -125.18 112.31 16.3 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.235 0.541 . . . . 0.0 109.693 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.59 93.84 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -82.23 107.46 14.93 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.465 ' OD1' ' HD3' ' A' ' 125' ' ' ARG . 4.2 t-20 -102.94 116.28 32.24 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.666 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -127.51 91.11 3.24 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.2 mttp 65.6 -175.02 0.18 Allowed 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.023 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.51 73.34 0.58 Allowed Glycine 0 N--CA 1.469 0.846 0 N-CA-C 112.144 -0.382 . . . . 0.0 112.144 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.465 ' HD3' ' OD1' ' A' ' 121' ' ' ASN . 10.9 mmm180 -113.98 -81.24 0.6 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.533 0.682 . . . . 0.0 110.561 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -136.77 -165.54 1.75 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.1 p -70.92 -75.38 0.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.692 0.758 . . . . 0.0 109.394 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.4 tttp 176.27 -51.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 126.691 1.996 . . . . 0.0 105.741 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 8.2 pt-20 -60.79 -32.46 71.8 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 113.831 -1.532 . . . . 0.0 111.802 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 134' ' ' MET . 7.7 tp10 -63.7 -40.52 96.98 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.984 0.421 . . . . 0.0 110.202 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.2 -50.58 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.662 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.7 pt-20 -63.91 -32.48 74.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 130' ' ' GLU . 53.9 mtm-85 -60.51 -46.83 88.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 23.9 mmt -60.88 -42.8 98.64 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.657 0.598 . . . . 0.0 109.772 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.61 -51.77 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.042 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 24.1 mt-30 -56.53 -47.55 79.16 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 122.937 0.495 . . . . 0.0 111.434 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.22 -41.27 97.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.95 75.45 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.5 -47.09 18.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.302 0.572 . . . . 0.0 112.505 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.99 -22.82 55.44 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.328 0.585 . . . . 0.0 111.579 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -120.57 26.46 9.13 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.841 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.442 ' HG3' HH22 ' A' ' 32' ' ' ARG . 40.8 tttm -56.31 -42.13 77.1 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.109 0.964 . . . . 0.0 111.241 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.63 -52.84 18.61 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.923 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.39 -39.55 58.95 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -71.06 -49.83 40.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.412 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 37.9 mt-10 -66.26 -35.36 80.21 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.656 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.593 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 38.9 t -62.73 -50.05 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.392 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.18 -37.94 89.21 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.9 0.381 . . . . 0.0 111.726 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -58.11 -52.19 66.58 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.828 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 41.8 mm-40 -72.56 -19.88 61.42 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.826 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 18.4 mmm180 -70.24 -29.45 66.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.178 0.513 . . . . 0.0 109.949 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.91 -59.24 2.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.2 m -89.31 61.46 5.7 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.844 0.83 . . . . 0.0 111.113 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.94 -32.59 30.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.076 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.83 131.31 54.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -73.08 103.34 3.81 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.226 0.536 . . . . 0.0 111.432 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.542 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.41 160.27 41.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.37 140.89 51.88 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -97.7 134.07 41.37 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.483 0.658 . . . . 0.0 111.596 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.7 p -87.42 124.59 33.58 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -94.17 10.46 33.79 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.789 0.805 . . . . 0.0 111.062 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -140.08 132.56 28.59 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -127.64 -51.02 1.37 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 72.57 -63.63 0.42 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.277 1.431 . . . . 0.0 111.662 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.08 158.01 0.56 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.51 98.23 0.35 Allowed 'General case' 0 C--O 1.244 0.813 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 171.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.4 m -74.07 139.25 44.52 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.469 -1.241 . . . . 0.0 114.101 -166.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 69.47 118.85 0.03 OUTLIER 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.924 1.69 . . . . 0.0 113.941 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.5 14.5 5.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.913 0.863 . . . . 0.0 108.943 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.6 172.36 8.74 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.631 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -148.6 176.35 10.41 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.44 56.81 0.93 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -120.64 17.29 9.51 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.514 HD21 ' H ' ' A' ' 174' ' ' LEU . 1.8 pt? -78.33 37.54 0.27 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.51 153.21 24.42 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 162.43 -171.18 38.23 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 55.5 tptt 68.19 111.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.557 1.143 . . . . 0.0 112.802 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.0 tp -60.84 128.55 22.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.535 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 18.2 m -84.36 112.32 20.22 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.465 ' HG2' ' HE2' ' A' ' 183' ' ' LYS . 8.2 tp10 -102.84 147.7 26.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -121.41 -45.06 2.34 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -143.13 145.57 32.96 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.648 -173.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HE2' ' HG2' ' A' ' 180' ' ' GLU . 70.8 mmtt -134.02 11.19 3.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 176.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? 58.28 84.09 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.948 0.899 . . . . 0.0 111.84 -170.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -77.65 -24.68 49.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.36 139.36 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.03 135.33 18.07 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 121.373 -0.131 . . . . 0.0 110.702 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 42.5 t0 65.47 177.34 0.2 Allowed 'General case' 0 CA--C 1.553 1.06 0 O-C-N 124.771 1.294 . . . . 0.0 111.209 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -142.15 -177.59 5.31 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -73.94 -24.97 59.72 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.41 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.38 95.46 0.45 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.18 -16.9 8.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 15.6 tt -161.34 141.93 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.808 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.5 t 71.47 179.67 0.24 Allowed 'General case' 0 C--O 1.246 0.881 0 C-N-CA 125.444 1.498 . . . . 0.0 112.157 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 54.5 m95 66.99 80.62 0.21 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.701 1.6 . . . . 0.0 110.448 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -135.5 137.6 42.27 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.291 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.9 t70 74.29 115.02 0.06 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.675 1.59 . . . . 0.0 111.366 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -103.53 -36.17 8.05 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -152.57 127.61 9.71 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.955 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.9 m -82.07 121.12 26.16 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.403 HD12 ' OE2' ' A' ' 204' ' ' GLU . 3.4 tm? -95.83 130.72 42.68 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.27 -175.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -107.24 -70.55 0.79 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.195 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.403 ' OE2' HD12 ' A' ' 202' ' ' LEU . 43.2 mt-10 61.55 97.31 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.934 0.894 . . . . 0.0 112.96 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.619 ' HD3' ' N ' ' A' ' 206' ' ' ASP . 8.4 tmtt? -123.77 133.68 53.79 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.619 ' N ' ' HD3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -74.14 170.19 16.01 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.791 0.805 . . . . 0.0 112.62 -175.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -151.88 33.97 0.54 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 169.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -134.18 -11.14 2.55 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.045 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -84.2 60.37 5.89 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.524 0.678 . . . . 0.0 110.163 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -88.43 -40.7 13.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.209 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 66.74 168.63 0.23 Allowed 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.959 1.304 . . . . 0.0 112.147 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . 0.292 3.6 ppt_? -88.5 76.22 8.25 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.88 0.848 . . . . 0.0 111.844 176.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 213' ' ' LYS . 0.2 OUTLIER -57.38 -58.76 6.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.197 -178.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -168.02 138.99 2.79 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.55 -67.71 0.87 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -97.43 160.81 14.1 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.089 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -154.4 -62.04 0.13 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.806 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 15.6 m -97.71 100.09 10.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.995 0.903 . . . . 0.0 112.785 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -111.51 98.51 40.8 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.56 117.87 0.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.846 2.364 . . . . 0.0 112.744 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 36.9 pt -138.11 142.7 34.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.618 0.247 . . . . 0.0 110.414 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 14.7 tt -110.17 125.54 67.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.2 p -101.13 128.36 47.25 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.993 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -87.79 119.19 5.23 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.71 79.67 3.36 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.436 0.636 . . . . 0.0 110.395 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -85.84 121.73 28.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.619 ' HA ' HE21 ' A' ' 228' ' ' GLN . 0.0 OUTLIER -116.66 158.73 23.29 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.997 0.427 . . . . 0.0 111.057 -173.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 147.84 -174.85 27.44 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.67 18.0 18.67 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.225 0.536 . . . . 0.0 109.991 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -85.73 -4.77 84.87 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.919 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.87 89.16 0.45 Allowed Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -68.29 -40.26 8.7 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 122.165 1.91 . . . . 0.0 112.307 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 95.99 128.48 5.67 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.64 119.39 5.7 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.124 1.883 . . . . 0.0 111.355 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -156.3 -174.62 26.31 Favored Glycine 0 N--CA 1.428 -1.839 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 162.56 -127.68 1.74 Allowed Glycine 0 N--CA 1.425 -2.039 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -146.31 131.21 18.12 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -139.6 52.1 0.72 Allowed Glycine 0 CA--C 1.497 -1.073 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.823 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -138.37 127.32 23.94 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -96.19 170.35 9.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -109.99 99.38 1.19 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.39 179.05 6.89 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.673 2.249 . . . . 0.0 112.497 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 74.47 -53.36 0.68 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.045 1.738 . . . . 0.0 112.445 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -87.39 113.3 3.95 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 88.66 -68.28 2.88 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.6 m -78.5 103.33 8.38 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 110.48 24.28 5.68 Favored Glycine 0 C--N 1.307 -1.08 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.724 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.1 p -80.84 -11.75 59.54 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.494 0.664 . . . . 0.0 111.436 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -153.94 -133.67 1.85 Allowed Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -84.88 80.35 2.18 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 121.577 1.518 . . . . 0.0 110.093 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 43.8 m -90.47 84.14 5.95 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 122.81 1.291 . . . . 0.0 110.257 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 22.4 pt -116.23 165.36 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 113.152 -1.84 . . . . 0.0 107.67 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -116.49 99.27 7.05 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.523 0.678 . . . . 0.0 109.477 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -72.29 152.49 42.11 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.461 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.46 95.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--N 1.296 -1.721 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.91 -32.49 65.35 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.163 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -79.22 130.83 35.87 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.89 96.16 2.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -98.67 72.56 2.0 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -114.29 -59.56 2.0 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.518 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.07 74.35 1.56 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.457 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -130.09 101.93 6.03 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.08 72.3 5.61 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.301 1.048 . . . . 0.0 111.621 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 11' ' ' ASP . 5.1 tt -88.74 149.75 23.3 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 35' ' ' THR . 3.5 m-20 -75.97 55.35 0.9 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.66 170.6 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.85 129.71 45.45 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.04 -31.56 6.05 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.069 1.846 . . . . 0.0 112.305 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.4 mp -126.65 157.55 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -86.34 138.16 32.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.07 131.21 48.66 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.03 -171.46 23.12 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.357 -176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.407 HD11 HG11 ' A' ' 92' ' ' VAL . 84.4 mt -126.36 169.88 12.49 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.09 0.556 . . . . 0.0 110.076 -176.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.38 108.44 19.96 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.1 p -92.52 166.37 12.56 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.36 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.68 114.05 0.97 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.411 1.084 . . . . 0.0 112.388 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.94 -2.08 21.21 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.189 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.12 72.28 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.23 145.69 7.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.433 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -92.64 117.37 29.9 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.9 m -115.05 112.19 22.24 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.12 135.08 34.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.199 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.434 HD23 ' CD1' ' A' ' 94' ' ' PHE . 6.3 mp -94.13 -41.0 9.74 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -109.96 113.21 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -90.34 166.64 13.19 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.822 0.82 . . . . 0.0 112.724 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -61.16 141.01 57.78 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.36 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 77.86 2.03 2.89 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.716 1.207 . . . . 0.0 111.873 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -83.47 130.58 35.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 5.5 p -65.47 130.37 43.06 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.46 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 39.5 pt -106.78 148.59 37.17 Favored Pre-proline 0 N--CA 1.435 -1.212 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 52.6 Cg_exo -61.87 132.61 10.61 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.03 1.046 . . . . 0.0 113.639 1.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 m -110.17 143.16 40.69 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.237 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -128.67 108.71 10.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -128.06 141.91 51.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -139.9 135.42 32.84 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -141.61 144.96 34.47 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -92.29 114.82 29.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.43 147.38 25.32 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.811 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 8.9 p -136.6 170.16 16.52 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.882 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -103.7 137.84 41.17 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.817 0.281 . . . . 0.0 110.686 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -112.93 4.54 16.87 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -84.64 175.34 9.29 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.798 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.88 117.49 31.22 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.296 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 37.17 81.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -101.41 139.11 20.15 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.852 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -85.61 0.02 8.64 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.245 1.963 . . . . 0.0 111.964 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.6 176.12 44.23 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.01 152.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.8 tp -101.11 120.39 40.14 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.48 105.45 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -119.22 118.51 31.49 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 t -95.45 134.6 32.31 Favored 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.706 0.629 . . . . 0.0 111.495 -172.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.48 151.48 50.91 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.302 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -116.13 141.08 48.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.91 -117.84 1.83 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 177.26 -99.94 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 126.115 1.766 . . . . 0.0 111.525 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.508 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 20.8 mmm180 55.4 -178.12 0.04 OUTLIER 'General case' 0 C--O 1.244 0.795 0 O-C-N 123.681 0.613 . . . . 0.0 110.524 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -91.28 -49.67 6.23 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.691 0.757 . . . . 0.0 110.663 175.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.2 mtp -97.65 126.15 42.8 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.53 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.328 0.4 OUTLIER -80.33 86.19 5.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.671 1.7 . . . . 0.0 111.418 178.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 69' ' ' ASN . 46.2 mmtm -152.42 -45.83 0.1 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.775 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.35 7.26 1.39 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.209 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 67' ' ' LYS . 89.3 m-20 -109.67 163.74 13.19 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.633 0.373 . . . . 0.0 111.493 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -91.01 136.19 33.24 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 tt -96.78 122.91 40.25 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.64 -45.18 9.53 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.279 0.362 . . . . 0.0 111.494 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.63 175.83 47.17 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.19 156.74 42.61 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.52 139.27 20.77 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -97.4 120.27 37.46 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.64 104.55 14.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 p -110.91 173.87 6.13 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.05 21.76 44.62 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 52.8 mt -90.17 135.26 30.11 Favored Pre-proline 0 N--CA 1.426 -1.673 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.65 117.02 3.9 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.563 2.175 . . . . 0.0 112.479 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.44 91.28 0.97 Allowed 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.191 1.927 . . . . 0.0 109.942 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.55 168.68 13.71 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.304 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.05 100.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.289 2.659 . . . . 0.0 113.237 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 60.85 -160.99 0.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.698 1.199 . . . . 0.0 111.349 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.7 63.33 1.18 Allowed Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 76.5 t -66.4 -48.39 56.66 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 167.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.632 ' HA ' ' OG ' ' A' ' 110' ' ' SER . 15.7 Cg_endo -59.05 129.9 33.99 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.058 1.839 . . . . 0.0 111.347 168.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.67 110.67 22.58 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.04 114.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -90.75 114.33 26.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' THR . 62.1 t -109.32 122.6 64.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.805 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.1 m -109.53 129.63 55.56 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.874 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.434 ' CD1' HD23 ' A' ' 29' ' ' LEU . 5.3 m-85 -109.9 107.74 17.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 17.7 t70 -120.06 113.12 20.01 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.826 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 44.3 mt -111.74 136.07 49.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.99 -168.42 1.56 Allowed 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.32 -8.18 55.95 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.04 -29.82 13.91 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.96 23.85 5.41 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 46.5 mm -81.87 115.44 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD11 HG13 ' A' ' 96' ' ' ILE . 31.5 tp -105.49 113.64 27.33 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.744 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -96.6 102.69 14.52 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.5 t -89.22 113.49 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 20.7 m -119.0 118.81 32.5 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.82 118.91 36.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.6 m -119.6 118.81 31.99 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.665 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 110.5 12.07 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -66.43 -20.33 66.03 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.055 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.632 ' OG ' ' HA ' ' A' ' 88' ' ' PRO . 1.5 m -70.44 -53.34 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.176 0.512 . . . . 0.0 110.823 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.3 p -95.14 -29.46 14.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.096 0.474 . . . . 0.0 112.087 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.97 19.44 24.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.864 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.39 131.36 36.21 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 121.084 0.469 . . . . 0.0 111.894 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.54 134.13 53.08 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.815 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -128.78 128.57 44.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 65.5 pttt -129.15 154.09 47.07 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.854 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.0 pt -126.93 140.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 171.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 m -103.95 112.53 25.54 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.2 mm -111.63 103.49 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.818 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 t -78.29 102.38 7.63 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -75.52 153.54 37.41 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.881 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . 0.255 27.7 t0 65.14 81.26 0.21 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 125.29 1.436 . . . . 0.0 112.947 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -120.42 27.58 8.5 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.018 -1.901 . . . . 0.0 106.409 172.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.23 35.34 6.69 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -173.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.92 -56.77 12.81 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.68 140.19 40.64 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 p -84.52 169.68 14.22 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -42.98 -56.92 3.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.687 1.195 . . . . 0.0 113.037 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -67.75 -37.15 81.75 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.719 -175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -63.96 -42.89 97.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 135' ' ' VAL . 81.9 mt -58.92 -53.88 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.138 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.6 -33.0 73.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -65.01 -41.54 95.24 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.566 173.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.2 ttt -68.8 -37.06 79.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.378 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 131' ' ' ILE . 81.1 t -60.89 -46.11 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -63.2 -32.33 73.7 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.763 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 22.4 mm-40 -59.23 -52.98 63.33 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.13 -29.53 69.86 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.409 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.77 -48.53 14.68 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.392 0.615 . . . . 0.0 112.439 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -71.24 -36.5 71.81 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.061 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -101.12 10.4 40.96 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 74.9 tttt -47.67 -54.48 11.91 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.974 0.91 . . . . 0.0 112.309 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.35 72.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.48 0.657 . . . . 0.0 111.413 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -72.81 -49.82 28.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.679 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -67.08 -39.41 86.8 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.499 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 48.6 mt-10 -60.37 -45.56 93.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.31 -32.92 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-O 121.405 0.621 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -74.69 -52.99 10.13 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.89 -0.507 . . . . 0.0 111.199 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 63' ' ' ARG . 55.2 ttp180 -69.82 -52.53 24.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.14 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -170.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -91.29 -1.36 57.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.373 0.606 . . . . 0.0 110.762 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.4 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 57.4 t -116.1 -58.3 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 t -90.94 87.39 6.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 122.659 1.219 . . . . 0.0 111.501 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.53 18.62 9.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 171.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 152' ' ' VAL . 49.9 pttt -137.64 137.77 38.79 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.217 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -94.65 97.27 9.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -143.08 127.81 18.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.2 mt -118.72 146.75 44.5 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . 0.273 1.5 pp20? -132.47 173.77 10.95 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.2 t -110.16 14.97 22.7 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.933 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -104.31 -51.64 3.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 65.46 -57.43 0.31 Allowed 'General case' 0 C--O 1.25 1.12 0 C-N-CA 126.104 1.761 . . . . 0.0 114.368 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -168.55 -47.05 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -173.97 93.06 0.09 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.89 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 27.5 ttt -95.87 -42.7 8.18 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -131.5 121.89 25.24 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.4 m -82.1 -26.22 33.8 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.724 0.773 . . . . 0.0 109.026 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -131.82 140.56 49.19 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.96 133.98 42.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.017 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -51.87 120.79 5.68 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 113.024 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -78.42 116.46 18.84 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.984 174.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 150.3 43.53 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 82.18 5.42 89.67 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.2 96.51 10.06 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt 70.56 -33.62 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.389 1.476 . . . . 0.0 113.074 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 177' ' ' LYS . . . -72.61 104.73 1.58 Allowed Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 170.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 176' ' ' GLY . 77.5 tttt 86.63 72.62 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.758 1.623 . . . . 0.0 109.199 -170.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.501 HD12 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -78.78 -38.36 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.435 175.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 46.1 m -161.3 -71.09 0.06 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -142.58 -173.46 3.87 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -83.4 99.36 10.01 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.3 t70 64.9 -156.44 0.29 Allowed 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.148 0.905 . . . . 0.0 108.659 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -145.33 120.91 10.42 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 118.816 0.735 . . . . 0.0 109.757 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -120.32 -68.1 0.93 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.384 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.61 119.99 31.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.877 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 32.5 t -133.39 82.13 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 57.96 66.94 1.02 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.044 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -102.53 -6.7 22.57 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.79 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 65.0 tttp 67.92 102.98 0.05 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.262 1.025 . . . . 0.0 111.87 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 69.84 -66.7 0.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.886 1.675 . . . . 0.0 110.957 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.49 84.33 4.68 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.69 128.39 42.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.62 73.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 122.249 1.024 . . . . 0.0 108.827 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.0 m -157.96 110.32 2.35 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.501 -1.681 . . . . 0.0 106.504 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 44.9 t-105 -89.04 -44.01 10.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.978 -0.101 . . . . 0.0 111.109 -174.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.89 31.05 19.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.112 0.965 . . . . 0.0 112.577 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 71.2 -46.81 0.65 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 124.575 1.15 . . . . 0.0 113.669 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 69.92 -77.51 0.05 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.51 1.524 . . . . 0.0 110.143 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.37 140.83 35.61 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.506 ' O ' ' HB2' ' A' ' 202' ' ' LEU . 27.6 m -83.03 72.83 10.08 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.119 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 201' ' ' THR . 1.4 tm? 160.03 85.68 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -130.35 139.03 50.7 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.552 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -88.07 155.96 19.53 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -86.42 90.95 8.37 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 207' ' ' GLU 0.274 5.1 p-10 -158.18 -100.94 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.529 174.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.421 ' H ' ' CG ' ' A' ' 206' ' ' ASP . 31.6 tt0 66.92 -71.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.475 1.11 . . . . 0.0 108.954 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -151.09 115.35 5.07 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 172.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -41.17 114.99 0.55 Allowed 'General case' 0 C--O 1.247 0.924 0 O-C-N 124.804 1.315 . . . . 0.0 111.956 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -130.11 87.2 2.49 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.69 113.83 24.67 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 168.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -67.83 110.59 3.89 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.588 0.708 . . . . 0.0 110.463 -174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -79.07 117.27 19.97 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.766 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -111.49 -178.99 3.59 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.743 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.7 mt -106.76 104.07 13.67 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.139 -175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.17 108.96 18.57 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -89.92 126.5 35.75 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.65 -3.66 9.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.684 0.754 . . . . 0.0 110.811 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -109.35 109.11 60.35 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.64 137.33 24.85 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.589 2.193 . . . . 0.0 113.192 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 12.8 tt -156.89 126.23 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.875 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 225' ' ' GLY . 15.7 tt -172.87 134.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 19.7 m -75.47 -24.88 57.01 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.045 0.45 . . . . 0.0 110.17 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.416 ' H ' HG12 ' A' ' 223' ' ' ILE . . . 96.93 -45.01 1.85 Allowed Glycine 0 CA--C 1.499 -0.933 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 53.2 tp -170.46 165.0 8.65 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -93.15 17.89 10.28 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.143 0.973 . . . . 0.0 111.037 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -144.26 165.5 27.71 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -70.22 108.82 2.61 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.78 -30.82 32.14 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.431 0.634 . . . . 0.0 109.533 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 105.12 -174.09 21.13 Favored Glycine 0 N--CA 1.422 -2.236 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.262 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 111.14 -96.88 0.92 Allowed Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.56 103.5 0.39 Allowed 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.625 2.217 . . . . 0.0 111.397 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -113.51 -83.42 1.21 Allowed Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.58 -27.37 61.4 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.484 2.123 . . . . 0.0 110.976 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -126.65 96.21 0.46 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -70.06 -42.62 67.43 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -134.45 -42.51 0.78 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 126.12 169.54 12.83 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.733 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -90.92 152.4 20.74 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -83.32 -21.44 33.2 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.82 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 178.25 94.37 0.09 OUTLIER Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -61.08 103.9 0.26 Allowed 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.834 2.356 . . . . 0.0 111.346 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.42 -12.03 41.42 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.79 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.92 -171.99 19.5 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.201 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -138.37 -158.67 7.83 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m 64.09 -65.23 0.13 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.703 1.601 . . . . 0.0 112.282 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.18 52.33 0.76 Allowed Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 16.0 m -82.55 -40.5 20.86 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -130.47 80.22 0.35 Allowed Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.7 149.7 43.73 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 122.904 2.402 . . . . 0.0 112.531 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 90.6 m 69.09 94.98 0.07 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.228 0.955 . . . . 0.0 111.856 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.92 174.74 4.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.358 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.48 131.31 45.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.983 0.802 . . . . 0.0 110.083 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -93.55 134.68 35.58 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.821 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 41.5 t -84.57 91.88 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--N 1.291 -1.964 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.893 -171.777 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -93.82 -61.71 1.49 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.308 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -85.9 103.96 15.11 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.7 p -134.67 96.81 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.104 0.954 . . . . 0.0 108.904 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -83.26 -29.28 28.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.097 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -122.06 130.75 53.54 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.282 0.563 . . . . 0.0 112.083 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.9 mt -119.38 33.29 5.7 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.5 mt 77.12 88.92 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.765 1.626 . . . . 0.0 112.925 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 tt -94.8 111.61 23.38 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.1 134.13 54.32 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.198 0.311 . . . . 0.0 110.225 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -75.52 53.55 0.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.7 m -138.22 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.48 112.51 53.34 Favored Pre-proline 0 C--N 1.281 -2.404 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.71 -32.59 18.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 121.861 1.707 . . . . 0.0 110.067 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.79 174.95 5.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.928 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 11.8 m -119.63 136.28 54.45 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.2 131.78 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.723 0.639 . . . . 0.0 109.384 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.19 178.13 32.86 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.4 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.2 mp -112.39 156.73 22.02 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.401 0.68 . . . . 0.0 109.233 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -90.9 109.37 20.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -93.66 173.73 7.54 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.727 -0.608 . . . . 0.0 111.383 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 118.61 5.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.959 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.76 6.79 32.4 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.87 39.49 64.77 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -99.14 131.08 47.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.84 118.12 29.19 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -114.07 111.38 21.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.7 122.53 38.56 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.962 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.407 HD11 ' CD2' ' A' ' 94' ' ' PHE . 48.1 mt -87.19 -37.61 17.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.413 0.625 . . . . 0.0 109.548 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.75 102.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.54 161.32 15.53 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.785 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -54.14 134.05 44.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 80.71 11.87 0.91 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.315 1.846 . . . . 0.0 113.552 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -86.22 132.97 33.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.51 140.54 58.62 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.495 1.118 . . . . 0.0 111.519 -176.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 35.3 pt -113.87 146.29 35.27 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.787 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 15.0 Cg_endo -65.31 141.63 49.68 Favored 'Cis proline' 0 CA--C 1.509 -0.731 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.055 -3.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -92.51 -70.76 0.68 Allowed 'General case' 0 N--CA 1.399 -3.008 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.464 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 39' ' ' LYS . 1.1 tmtp? 67.12 101.0 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 124.996 1.318 . . . . 0.0 109.737 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -131.95 140.74 49.1 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 86.9 m -139.58 134.26 31.9 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -130.08 157.52 42.17 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.972 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.2 mm -89.88 114.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.34 148.08 24.03 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 19.6 p -122.8 171.49 9.15 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.857 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 24.4 p -109.08 136.93 47.79 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -90.96 -29.64 17.31 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -89.34 93.09 9.41 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.951 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 85' ' ' ARG . 6.2 p-10 -75.19 161.11 29.65 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.082 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 70.17 6.55 5.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.392 0.677 . . . . 0.0 112.705 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.3 131.43 50.6 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.0 Cg_endo -81.85 8.13 4.64 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.396 2.064 . . . . 0.0 112.322 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.41 175.03 44.32 Favored Glycine 0 N--CA 1.425 -2.035 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.6 171.59 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 123.323 0.649 . . . . 0.0 110.061 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 161' ' ' TYR . 44.2 tp -111.16 128.16 55.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.782 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.83 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.5 mt-30 -123.84 127.33 47.89 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.56 114.24 37.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 124.446 1.092 . . . . 0.0 110.325 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -109.52 149.67 29.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.717 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 16' ' ' SER . 45.1 tt0 -111.39 121.44 45.23 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.74 -171.48 22.66 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HG3' ' CB ' ' A' ' 16' ' ' SER . 13.3 mt-10 -139.17 17.7 2.61 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -64.59 131.81 48.06 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.992 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.63 -50.43 63.16 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.929 2.092 . . . . 0.0 113.931 -168.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtt -95.99 128.78 43.19 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.34 86.06 0.28 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -168.04 168.04 12.17 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 76.64 -46.42 0.52 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.608 1.163 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -55.6 147.97 16.96 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.349 1.06 . . . . 0.0 108.629 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 60' ' ' GLU . 2.9 p-10 -90.03 139.09 30.95 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.282 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.08 132.71 35.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.827 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.8 mt -105.1 -41.3 5.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 0.0 111.365 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.34 39.69 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.132 -1.033 . . . . 0.0 111.427 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -150.13 166.0 31.13 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -170.14 144.43 2.63 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 124.595 1.184 . . . . 0.0 108.414 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -93.88 146.83 23.62 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -118.52 105.08 11.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -94.47 169.74 9.98 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.89 -25.96 6.01 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 62.4 mt -54.14 119.91 22.31 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.109 0.963 . . . . 0.0 111.446 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.32 151.27 20.25 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.678 2.252 . . . . 0.0 112.861 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.97 87.71 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.791 2.327 . . . . 0.0 110.821 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.91 166.16 30.42 Favored Pre-proline 0 C--N 1.29 -2.005 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -49.32 141.3 24.81 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.992 2.461 . . . . 0.0 111.409 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 46' ' ' THR . 35.1 ptt180 -64.57 126.15 26.96 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 -175.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.06 -25.96 13.21 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.08 -50.44 51.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.654 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -68.86 121.23 8.1 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.137 1.224 . . . . 0.0 110.327 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -107.08 124.7 50.05 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mm -108.51 109.24 27.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -94.85 109.17 21.19 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 41' ' ' THR . 33.9 t -111.23 126.16 68.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.731 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 87.5 m -106.29 125.38 50.92 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.407 ' CD2' HD11 ' A' ' 29' ' ' LEU . 5.2 m-85 -111.08 107.91 17.44 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -126.15 124.49 40.62 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.34 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 37' ' ' PRO . 13.6 mt -106.75 125.57 62.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.5 -179.04 6.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.574 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.91 66.44 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.627 0.771 . . . . 0.0 112.777 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -77.06 -24.39 51.96 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.5 31.08 8.1 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.7 mt -97.17 128.27 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.44 111.7 21.41 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -100.64 114.54 28.32 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.43 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' THR . 74.9 t -110.48 125.23 67.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 m -122.71 119.6 31.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.58 117.57 33.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.7 m -112.74 120.59 42.02 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.22 106.87 13.53 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -67.43 -19.87 65.43 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.732 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.96 -61.35 1.98 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 43.0 p -80.1 -32.69 39.1 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.665 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.68 12.31 44.41 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.703 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.448 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 20.7 pttp -111.2 161.42 16.0 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.485 -0.421 . . . . 0.0 110.603 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.27 148.89 40.56 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -128.68 146.7 50.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -131.45 164.29 26.06 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.19 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.419 HG22 ' HB ' ' A' ' 104' ' ' VAL . 14.7 tt -136.51 144.39 32.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 m -125.59 113.6 17.62 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.23 103.92 16.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.029 0.442 . . . . 0.0 110.727 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.8 m -75.25 151.7 38.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -72.21 78.5 0.97 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.808 1.289 . . . . 0.0 110.933 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -119.53 131.67 55.6 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.141 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -86.15 84.04 7.59 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.38 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.09 -66.69 1.3 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.383 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -107.0 -5.51 18.08 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.04 0.448 . . . . 0.0 111.649 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.7 mt -123.66 151.7 42.79 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.2 p -96.59 -77.21 0.49 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.928 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.8 tptt 178.15 -32.45 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 11.3 pt-20 -65.26 -32.58 74.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.59 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.8 -40.34 69.24 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.7 mt -67.11 -41.0 86.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.622 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 129' ' ' GLU . 13.1 pt-20 -68.84 -27.58 65.96 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.49 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 78.7 mtp180 -63.13 -40.62 98.12 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 mmt -63.38 -38.46 91.24 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.128 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.58 -47.88 89.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.049 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.84 -47.01 85.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.699 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.99 -32.9 74.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.682 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.42 -32.45 74.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -78.67 -36.66 43.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 110.793 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -69.0 -45.98 69.18 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.095 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.55 20.8 15.39 Favored 'General case' 0 C--O 1.198 -1.635 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -49.72 -60.14 3.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.083 1.353 . . . . 0.0 113.008 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.98 -32.74 73.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.887 0.375 . . . . 0.0 110.62 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -61.82 -53.41 56.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.048 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -67.62 -37.45 82.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -59.52 -37.78 79.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.537 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.504 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 96.9 t -72.73 -47.08 51.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.554 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.83 -39.67 74.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -67.37 -32.71 73.82 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.99 -10.0 46.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.9 mmt180 -64.33 -36.1 83.01 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 120.835 0.35 . . . . 0.0 111.094 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.94 102.13 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.0 m -76.93 108.24 9.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.86 41.82 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-O 121.979 0.895 . . . . 0.0 112.561 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -82.17 148.13 28.64 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.64 94.76 0.45 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.182 0.515 . . . . 0.0 110.229 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -142.07 147.91 37.57 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.673 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.58 151.38 26.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -83.65 167.0 17.66 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.464 177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.2 t -132.14 109.95 10.33 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -171.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.432 ' O ' HD22 ' A' ' 55' ' ' LEU . 43.0 m-85 -151.79 108.55 3.5 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 125.108 1.363 . . . . 0.0 108.655 172.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.74 115.56 25.27 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 161' ' ' TYR . 76.1 m-85 -129.92 160.81 32.45 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -110.77 136.13 50.29 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.671 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.6 mmt -125.82 137.01 53.75 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -92.69 68.5 4.68 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.535 0.683 . . . . 0.0 110.169 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 p -85.52 96.52 9.65 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.404 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.52 163.17 12.97 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.8 m -112.71 -55.47 4.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 69.21 170.3 0.3 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.661 1.184 . . . . 0.0 112.326 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -159.17 166.69 30.91 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.26 -35.21 66.18 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 78.85 -63.69 3.76 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.4 mt -75.63 -68.94 0.52 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? 70.79 -70.69 0.15 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.78 1.632 . . . . 0.0 110.885 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 66.94 -106.83 1.77 Allowed Glycine 0 C--N 1.332 0.343 0 CA-C-N 116.553 -0.294 . . . . 0.0 113.012 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 74.61 138.31 0.06 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.733 1.613 . . . . 0.0 112.465 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -156.68 136.13 3.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 20.8 t -113.3 -60.73 1.84 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.309 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 68.82 155.75 0.13 Allowed 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.842 1.257 . . . . 0.0 110.284 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.02 149.97 29.95 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.586 -0.696 . . . . 0.0 109.96 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -144.5 -153.4 0.47 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 73.76 11.2 4.64 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.257 1.423 . . . . 0.0 111.174 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -168.01 152.43 6.39 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -96.31 -29.23 14.1 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.418 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 59.0 t 73.3 -66.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.546 1.138 . . . . 0.0 110.933 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.9 tp -154.22 135.86 14.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.13 144.56 31.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -108.61 15.68 23.55 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.4 ' HA ' ' OE1' ' A' ' 191' ' ' GLN . 11.3 mm-40 -86.87 117.3 25.51 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.111 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.74 -48.06 70.32 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 124.065 0.853 . . . . 0.0 109.95 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 39.5 t 57.53 88.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.438 0 O-C-N 124.569 1.168 . . . . 0.0 110.491 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.456 HD12 ' H ' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -115.33 133.1 62.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.14 -177.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.8 m -83.47 88.22 7.0 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.79 -1.929 . . . . 0.0 105.79 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -113.25 99.07 7.53 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.961 -172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.34 86.52 2.4 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -73.89 -35.22 64.67 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.749 0.785 . . . . 0.0 108.913 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -123.61 96.3 4.91 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.29 -1.323 . . . . 0.0 107.694 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -75.3 111.48 10.61 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 29.9 p -73.42 98.75 2.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.022 0.439 . . . . 0.0 110.415 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 42.3 tp -163.13 15.64 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.958 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -119.8 17.32 12.68 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.49 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -68.61 116.16 8.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.433 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -125.7 165.14 19.15 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.853 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -75.26 158.72 32.46 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.466 ' OE2' ' HG3' ' A' ' 211' ' ' LYS . 37.3 tt0 -88.89 74.31 8.24 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.459 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 56.59 28.53 14.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.398 -1.728 . . . . 0.0 115.101 171.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 62.32 -40.77 0.16 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -70.32 -19.09 63.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -172.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.466 ' HG3' ' OE2' ' A' ' 207' ' ' GLU . 27.8 mmtp -69.19 153.45 43.67 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.891 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.451 ' HG2' ' H ' ' A' ' 213' ' ' LYS . 10.0 ttm180 68.35 -168.55 0.19 Allowed 'General case' 0 C--O 1.247 0.927 0 O-C-N 124.657 1.223 . . . . 0.0 108.907 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.451 ' H ' ' HG2' ' A' ' 212' ' ' ARG . 99.2 mttt 72.26 -178.16 0.2 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.759 0.824 . . . . 0.0 111.546 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 68.43 117.54 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.647 1.579 . . . . 0.0 114.307 174.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.06 28.57 3.11 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.687 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -103.11 -171.86 2.02 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.82 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -81.51 75.96 8.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.099 0.952 . . . . 0.0 111.852 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.8 111.3 28.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.87 120.76 83.04 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -68.94 96.87 0.54 Allowed 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.853 1.702 . . . . 0.0 111.849 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 57.2 mt -82.28 79.32 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 11.6 tt -159.29 117.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.585 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.8 t -148.65 131.99 16.56 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -88.83 62.59 3.64 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.73 115.29 25.07 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -121.78 104.88 9.89 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -92.02 124.07 35.84 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.194 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.01 167.04 39.39 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.63 144.87 32.01 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -128.51 -59.69 0.11 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 98.46 141.16 11.94 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.44 0.73 9.67 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.389 2.06 . . . . 0.0 111.867 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.42 -158.92 28.04 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.21 119.21 6.23 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.54 2.16 . . . . 0.0 110.763 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -80.89 75.27 2.29 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 128.73 176.95 14.64 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -144.6 137.17 26.53 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -107.4 -147.65 13.83 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.342 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . 68.43 112.15 0.04 OUTLIER 'General case' 0 C--O 1.247 0.963 0 C-N-CA 125.154 1.382 . . . . 0.0 113.147 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 75.74 99.7 0.07 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.636 1.574 . . . . 0.0 112.281 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -131.05 158.5 22.7 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.39 -26.09 14.72 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.136 1.891 . . . . 0.0 111.386 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -157.06 131.12 8.34 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -97.9 -160.21 30.66 Favored Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.944 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 179.17 -170.55 42.28 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.3 m -90.88 144.85 25.26 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 120.967 0.413 . . . . 0.0 110.027 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 130.95 78.36 0.18 Allowed Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.123 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 16.6 t -90.61 -178.8 5.39 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -136.08 73.13 0.45 Allowed Glycine 0 C--N 1.306 -1.114 0 C-N-CA 119.526 -1.321 . . . . 0.0 113.224 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.46 102.96 0.63 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.759 2.306 . . . . 0.0 110.252 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 53.6 m -159.81 133.95 7.46 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 37.2 pt -85.86 148.79 4.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -109.42 104.03 13.05 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.402 0.62 . . . . 0.0 112.254 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.28 139.47 33.2 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.81 18.79 5.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 123.209 1.481 . . . . 0.0 107.52 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--N 1.306 -1.304 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.807 -178.921 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.469 ' HB3' ' OD1' ' A' ' 6' ' ' ASP . 48.8 m . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -99.32 3.2 45.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.154 0.502 . . . . 0.0 110.128 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -96.13 150.25 20.72 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.76 -30.01 40.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 O-C-N 123.017 0.198 . . . . 0.0 111.014 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 12.5 mm-40 -135.04 101.74 4.98 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' OD1' ' HB3' ' A' ' 1' ' ' SER . 5.1 p-10 -160.28 -173.89 4.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 tt -85.18 106.94 16.99 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.171 -1.011 . . . . 0.0 108.539 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.2 tp -85.51 112.26 20.75 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.051 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt 62.17 83.94 0.15 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.859 1.264 . . . . 0.0 114.402 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt 176.14 85.45 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 174.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.4 m-20 -126.46 28.6 5.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.795 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 34' ' ' SER . 20.0 m -135.09 136.51 51.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.003 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.86 116.13 26.82 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.71 -36.06 8.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 111.718 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.97 167.43 11.14 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.468 ' HG ' ' HG3' ' A' ' 62' ' ' GLU . 4.3 p -97.56 150.14 21.45 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.393 1.077 . . . . 0.0 110.496 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.2 mt -127.17 132.67 50.45 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.363 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.64 178.05 28.32 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.88 167.55 11.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.047 0.451 . . . . 0.0 111.021 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.459 ' HG2' ' NE2' ' A' ' 57' ' ' GLN . 5.7 tp10 -84.58 109.0 17.63 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.635 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.415 HG23 HD22 ' A' ' 158' ' ' LEU . 16.8 p -100.82 162.58 12.81 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.509 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 155' ' ' LYS . . . -49.8 117.29 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 113.586 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.35 39.05 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.4 23.67 53.39 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.2 142.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 127.23 38.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.6 m -128.29 115.24 18.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.05 147.11 23.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.418 ' HG ' ' CG ' ' A' ' 42' ' ' GLN . 10.4 mp -116.51 -50.4 2.63 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.954 176.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 116.66 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.96 156.91 19.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.321 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.17 160.34 29.81 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.466 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 m120 70.39 16.65 7.1 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.726 1.21 . . . . 0.0 110.427 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 34.2 p -89.44 136.82 32.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.561 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 14.2 p -73.1 114.9 11.79 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 121.597 0.713 . . . . 0.0 111.184 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.437 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 22.2 pt -95.75 158.09 34.91 Favored Pre-proline 0 C--N 1.287 -2.115 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.794 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.8 Cg_exo -61.42 132.94 10.5 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 N-CA-C 114.848 1.057 . . . . 0.0 114.848 1.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -104.05 166.98 10.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.502 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 50.1 tttp -173.86 107.1 0.13 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.57 144.01 50.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -112.38 133.04 54.69 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.776 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.418 ' CG ' ' HG ' ' A' ' 29' ' ' LEU . 15.5 mm100 -128.59 134.78 48.69 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.64 129.72 49.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.493 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 96.7 m-85 -121.96 167.88 12.56 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 p -135.21 170.79 15.38 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.437 0.16 . . . . 0.0 111.32 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -83.32 176.11 9.37 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -81.97 -46.78 13.54 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.0 p -143.79 -171.77 3.6 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.659 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.62 162.27 18.9 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.904 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 71.28 5.73 5.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.73 112.5 52.29 Favored Pre-proline 0 N--CA 1.402 -2.842 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -100.08 -9.58 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.259 1.973 . . . . 0.0 115.094 -173.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . -148.84 135.13 5.29 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.44 161.15 17.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -111.48 108.5 18.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.196 0.522 . . . . 0.0 109.881 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 mm -83.09 99.86 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.459 ' NE2' ' HG2' ' A' ' 20' ' ' GLU . 43.6 mt-30 -109.06 119.02 38.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.0 t -99.27 124.49 52.59 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 O-C-N 123.655 0.597 . . . . 0.0 110.154 -176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 80.1 m-85 -122.13 146.84 46.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.389 0.614 . . . . 0.0 111.559 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -111.52 120.11 41.03 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.342 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.55 -166.83 24.42 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.468 ' HG3' ' HG ' ' A' ' 16' ' ' SER . 33.7 mt-10 -153.16 134.46 14.22 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.633 0.773 . . . . 0.0 110.118 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 65' ' ' MET . 40.1 mtp180 -158.13 -176.36 5.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.094 1.358 . . . . 0.0 108.715 171.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.16 73.98 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 122.398 1.094 . . . . 0.0 108.802 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 65.7 mtt -105.0 162.42 13.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.513 -1.676 . . . . 0.0 107.619 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.25 16.06 2.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.646 0.736 . . . . 0.0 109.679 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 65' ' ' MET . 67.5 mttm -85.95 154.77 21.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.557 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 81.58 -32.53 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.581 1.552 . . . . 0.0 110.967 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.614 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 12.7 m120 -64.0 168.01 5.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 35.0 t30 -90.11 117.67 29.07 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.403 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.38 122.05 27.49 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 72' ' ' LEU . 3.5 mp -95.47 -49.85 5.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.36 0.6 . . . . 0.0 109.414 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.29 162.46 34.84 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -152.91 158.05 41.55 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -159.58 163.12 35.33 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.97 143.0 33.78 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.849 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.418 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 2.1 tt -108.49 104.11 13.38 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 103.375 -2.824 . . . . 0.0 103.375 171.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.4 p -120.45 107.95 13.51 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.295 0.569 . . . . 0.0 110.622 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.97 19.25 0.02 OUTLIER Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.352 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.79 127.47 83.96 Favored Pre-proline 0 C--O 1.249 1.072 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.91 153.98 71.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.883 2.389 . . . . 0.0 111.736 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.96 89.56 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.34 2.027 . . . . 0.0 112.284 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.33 144.65 53.3 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.8 148.78 81.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.731 2.287 . . . . 0.0 111.119 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.35 132.28 50.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.243 0.544 . . . . 0.0 111.254 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.68 -34.15 4.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.57 -56.16 1.48 Allowed Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 93.81 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.147 1.231 . . . . 0.0 110.526 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -96.46 124.7 40.54 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.503 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mm -99.72 117.48 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -90.64 106.54 18.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -102.32 115.39 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 m -109.03 126.09 52.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.536 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.414 ' CD2' HD22 ' A' ' 29' ' ' LEU . 2.9 m-85 -115.45 121.23 42.1 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.604 0.762 . . . . 0.0 109.726 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.452 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.1 p30 -140.03 137.08 34.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 71.4 mt -112.3 135.04 52.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -91.19 -168.52 2.08 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -24.39 64.26 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.54 -29.81 33.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.135 0.493 . . . . 0.0 109.902 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.01 24.53 5.44 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 84.6 mt -88.95 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 49.4 tp -94.42 118.38 31.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.663 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -103.35 115.92 31.45 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 121.415 0.626 . . . . 0.0 110.476 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.7 t -100.38 114.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.961 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.2 m -122.94 120.59 33.87 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.19 117.51 33.42 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.9 m -116.53 124.18 49.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.363 0.414 . . . . 0.0 112.019 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.75 114.26 12.98 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 123.607 0.763 . . . . 0.0 111.076 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 109' ' ' LYS . 33.6 mmtp -67.76 -12.22 60.1 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -79.34 -62.66 1.62 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.966 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -94.68 -30.31 14.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.152 0.501 . . . . 0.0 112.303 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.98 4.97 41.61 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.274 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.85 132.02 47.66 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 121.144 0.497 . . . . 0.0 111.073 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.67 43.89 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.102 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -129.51 128.19 42.31 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 165.83 15.15 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.506 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.63 138.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.8 m -100.57 113.68 26.7 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -115.57 96.93 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 26.8 m -66.51 125.41 25.63 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 170.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -60.66 96.97 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.9 t70 177.5 -33.91 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -68.87 137.65 54.06 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.021 170.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 160.96 164.99 16.84 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -113.3 9.89 18.36 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.255 0.55 . . . . 0.0 111.069 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.44 HD11 ' HA ' ' A' ' 70' ' ' ASN . 7.5 mp -129.1 155.39 45.53 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.789 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.47 ' O ' HG13 ' A' ' 131' ' ' ILE . 37.4 p -84.27 147.69 27.1 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.646 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -53.94 -46.98 71.71 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.147 0.579 . . . . 0.0 111.906 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -59.19 -42.16 90.23 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.548 1.139 . . . . 0.0 109.907 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 127' ' ' SER . 51.9 tt0 -66.95 -41.51 86.82 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.546 1.138 . . . . 0.0 109.347 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 127' ' ' SER . 96.1 mt -61.11 -41.49 89.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.815 176.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.33 -37.67 87.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -63.86 -45.76 88.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.614 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 40.2 ttp -54.77 -48.69 72.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.466 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 78.7 t -61.81 -40.71 87.93 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.842 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -61.94 -38.39 88.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -72.55 -34.42 67.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.576 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.57 -43.27 94.44 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.976 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 12.1 mm-40 -59.98 -38.04 81.42 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.952 0.882 . . . . 0.0 110.479 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.73 -28.56 69.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.839 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -126.91 23.49 6.6 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.342 -0.224 . . . . 0.0 111.153 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.75 -29.48 69.99 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 147' ' ' VAL . . . -66.3 -40.13 89.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -70.61 -50.09 40.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 0.5 OUTLIER -59.21 -43.49 92.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.077 178.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 149' ' ' ARG 0.296 22.2 mt-10 -68.73 -32.52 72.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 118.436 -1.306 . . . . 0.0 113.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 76.6 t -61.8 -40.95 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.246 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 79.5 mt-30 -57.17 -46.21 82.98 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 8.6 ptm180 -71.49 -35.36 70.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 146' ' ' GLU . 43.2 mt-10 -72.9 -21.71 60.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.497 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 22.2 mmt180 -64.82 -28.56 69.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.312 0.577 . . . . 0.0 109.672 173.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.41 -35.58 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 51.6 m 71.04 85.4 0.13 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.906 1.282 . . . . 0.0 112.775 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 43.93 80.37 0.04 OUTLIER 'General case' 0 C--O 1.244 0.811 0 C-N-CA 125.562 1.545 . . . . 0.0 114.269 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 17.4 tppt? -81.28 110.74 17.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 4.3 t30 -111.09 33.0 4.88 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.829 1.3 . . . . 0.0 109.629 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -121.67 142.16 50.43 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.415 HD22 HG23 ' A' ' 21' ' ' THR . 27.6 mt -92.5 150.0 21.03 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.311 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.43 143.79 40.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.777 0.799 . . . . 0.0 111.718 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.5 m -123.31 92.45 3.7 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -79.35 143.93 34.66 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.502 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.05 82.88 5.18 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.845 0.355 . . . . 0.0 111.909 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 53.73 89.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.41 1.484 . . . . 0.0 113.958 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -74.02 -21.99 59.76 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 84.1 mtp -61.33 -23.27 65.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.132 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -117.22 89.11 3.04 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.1 t -121.45 129.77 53.17 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.21 -177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.6 89.76 1.2 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.21 79.34 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.868 0.842 . . . . 0.0 110.911 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 171' ' ' ASP . 6.6 pt-20 -123.88 -100.41 0.41 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.51 172.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.438 ' H ' ' HG3' ' A' ' 170' ' ' GLU . 24.7 t70 62.69 157.26 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 167.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 73.6 -54.14 0.69 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.72 1.608 . . . . 0.0 113.001 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -71.83 100.7 0.94 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -131.58 100.82 5.26 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -128.05 173.38 10.11 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.698 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -137.0 101.48 0.35 Allowed Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 65.3 178.34 0.2 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.258 1.423 . . . . 0.0 111.476 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.0 147.07 12.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.745 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 17.8 t -79.07 86.85 4.87 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.09 0.471 . . . . 0.0 109.968 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 69.56 -63.21 0.39 Allowed 'General case' 0 C--O 1.246 0.887 0 C-N-CA 125.711 1.604 . . . . 0.0 113.185 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -130.52 144.69 51.57 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 120.99 0.424 . . . . 0.0 110.876 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.44 171.2 9.2 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.494 ' HA ' ' HZ2' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -119.59 18.84 12.71 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 123.111 0.565 . . . . 0.0 110.136 -177.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.94 12.08 14.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -172.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -63.09 139.22 58.75 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.012 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.27 165.6 2.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.683 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.7 130.31 35.1 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -100.64 -51.56 3.56 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 123.525 0.516 . . . . 0.0 111.897 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.479 ' HB2' ' HZ1' ' A' ' 189' ' ' LYS . 4.6 ttmp? -141.07 110.71 6.43 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.182 -169.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -102.65 14.35 32.17 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -82.58 85.27 7.01 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.54 -35.39 50.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.205 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 29.7 pt -55.89 96.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.268 1.033 . . . . 0.0 113.17 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.4 m -102.42 -26.59 13.21 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.409 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -81.4 80.37 7.81 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 122.166 0.984 . . . . 0.0 112.583 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.3 mp -122.21 -46.0 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.297 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.3 141.16 48.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.725 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -136.31 12.77 3.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -87.01 -22.21 25.65 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.641 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 17.3 m -73.31 79.08 1.34 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.628 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 59.3 tp -173.09 101.63 0.13 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.287 1.035 . . . . 0.0 108.61 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -79.96 -63.16 1.48 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -153.82 141.59 20.04 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -93.0 113.95 26.37 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 119.251 -0.979 . . . . 0.0 112.362 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -92.18 80.91 5.02 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.36 -58.1 1.0 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.256 -1.338 . . . . 0.0 107.447 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 54.99 77.38 0.21 Allowed 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.695 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -94.24 132.22 39.03 Favored 'General case' 0 N--CA 1.416 -2.134 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.071 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -61.08 -54.16 48.09 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 123.51 0.506 . . . . 0.0 109.946 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -149.07 69.53 1.07 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . 0.265 75.3 ttt180 42.6 -104.53 0.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 112.307 -2.224 . . . . 0.0 112.552 -170.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -157.06 22.46 0.31 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -150.37 160.13 43.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -175.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 51.6 tp -149.53 152.76 36.09 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 67.29 84.66 0.15 Allowed 'General case' 0 C--N 1.344 0.353 0 O-C-N 124.429 1.08 . . . . 0.0 110.404 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.35 105.28 17.37 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.372 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.1 m -142.05 98.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.536 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -147.08 119.58 4.81 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -48.01 -43.23 30.79 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.296 2.664 . . . . 0.0 112.769 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 50.3 mm -101.59 94.46 3.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.717 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.0 mm -81.55 -34.37 13.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t -169.22 169.87 8.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 178.54 -153.22 12.36 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 94.2 mt 62.26 35.35 15.38 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.621 0.768 . . . . 0.0 110.595 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -89.63 141.65 28.4 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.344 0.592 . . . . 0.0 111.406 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -121.92 94.21 4.24 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 85.28 -73.5 2.6 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -128.67 -68.04 0.77 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.12 44.32 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.595 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -166.53 177.0 41.58 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.72 145.45 98.13 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.019 2.479 . . . . 0.0 111.587 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -92.62 116.32 5.07 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-O 119.626 -0.541 . . . . 0.0 113.061 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.51 145.78 78.31 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 123.702 2.935 . . . . 0.0 113.231 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -149.54 -100.13 0.21 Allowed Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 89.05 21.32 42.61 Favored Glycine 0 C--N 1.312 -0.793 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -103.21 142.85 33.45 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.264 1.026 . . . . 0.0 108.668 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -125.77 -153.35 8.41 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -77.09 108.93 10.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -94.76 -26.86 16.08 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.23 96.52 2.32 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.83 115.65 2.7 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.08 2.52 . . . . 0.0 112.822 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -113.92 -6.85 13.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.224 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -105.71 -1.65 39.95 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -145.54 156.12 26.81 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.7 m -86.84 138.35 31.65 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 117.158 0.479 . . . . 0.0 111.262 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 252' ' ' THR . . . -81.42 -155.5 13.86 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.156 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 77.7 p 63.81 -35.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.999 1.719 . . . . 0.0 114.666 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -144.07 -67.99 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.115 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.964 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.81 -62.16 0.25 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.06 2.507 . . . . 0.0 114.747 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.574 ' O ' ' HA2' ' A' ' 248' ' ' GLY . 14.0 m -120.59 114.6 21.97 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.25 -61.56 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.8 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -147.85 -60.78 0.26 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -147.37 123.07 10.54 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.027 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.513 HG22 ' H ' ' A' ' 257' ' ' ASP . 3.3 m -115.39 -81.1 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.513 ' H ' HG22 ' A' ' 256' ' ' VAL . 38.2 t70 . . . . . 0 CA--C 1.488 -1.429 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -90.94 8.0 37.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.976 0.417 . . . . 0.0 111.928 -175.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -83.42 5.3 24.15 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.897 -0.502 . . . . 0.0 111.345 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.88 -34.84 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -99.44 78.71 2.21 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -91.47 -64.37 1.13 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.668 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.1 tp -147.48 85.29 1.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.324 0.583 . . . . 0.0 110.399 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.82 -24.23 10.56 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.699 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.0 85.04 7.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.726 0.775 . . . . 0.0 110.022 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.85 -179.9 4.31 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.106 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.45 67.68 8.59 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.547 1.165 . . . . 0.0 109.883 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 35' ' ' THR . 28.0 m -121.24 -177.17 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-N 113.822 -1.536 . . . . 0.0 107.682 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 110.2 42.94 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.55 -27.77 45.78 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.006 1.804 . . . . 0.0 111.702 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.43 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . 99.7 mt -130.93 156.13 45.6 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.791 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 m -77.35 141.51 39.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 123.665 0.603 . . . . 0.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.7 130.96 45.2 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 28' ' ' ALA . . . -157.17 -176.53 29.34 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 119.092 -1.528 . . . . 0.0 114.304 -175.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 89.0 mt -118.42 150.81 38.93 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 123.933 0.893 . . . . 0.0 109.572 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.408 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 34.8 tt0 -89.56 109.82 20.73 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.0 p -89.69 172.62 8.8 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.694 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.22 110.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.177 0.513 . . . . 0.0 111.57 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -9.16 8.42 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.96 19.41 51.16 Favored Glycine 0 CA--C 1.494 -1.23 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.88 135.64 24.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 62' ' ' GLU . 23.9 ttt -89.54 112.2 23.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.253 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 m -110.26 110.93 21.93 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . . . -97.9 135.44 39.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.101 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.5 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -90.94 -49.44 6.43 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -96.85 114.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 60.6 tptt -80.78 141.5 34.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -58.78 154.09 15.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.673 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 80.25 3.59 1.89 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.749 1.619 . . . . 0.0 111.45 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 t -91.34 136.97 32.73 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.416 ' HA ' HG12 ' A' ' 12' ' ' VAL . 1.5 m -73.03 143.88 47.36 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 123.718 0.807 . . . . 0.0 111.504 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.437 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 42.4 pt -99.51 154.11 37.44 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 42.2 Cg_exo -62.09 144.61 46.07 Favored 'Cis proline' 0 C--O 1.247 0.974 0 CA-C-N 120.2 1.107 . . . . 0.0 113.258 0.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.3 m -129.44 145.53 51.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 55.0 tttp -142.33 112.75 7.18 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 29.8 tp60 -128.56 125.58 38.56 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 m -109.11 134.79 51.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -140.56 156.35 46.33 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.2 mm -101.87 128.65 54.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -117.72 166.16 12.76 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.786 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 2.9 p -148.27 170.81 17.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 122.709 0.404 . . . . 0.0 111.591 -172.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.3 p -103.79 166.04 10.67 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' C ' ' HB3' ' A' ' 85' ' ' ARG . 93.8 m-85 -95.75 -14.97 22.91 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 165.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 p -97.0 178.54 5.24 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.309 -170.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -136.06 134.49 38.49 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 126.471 1.909 . . . . 0.0 106.379 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 70.14 6.28 5.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.417 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 41.6 tt0 -53.52 129.2 53.1 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 123.665 0.786 . . . . 0.0 112.887 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.28 79.3 3.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.231 1.954 . . . . 0.0 112.749 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . 96.63 131.59 6.94 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.966 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 76' ' ' GLU . 29.5 m -105.95 130.14 57.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.0 tp -83.56 112.37 19.94 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.726 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 45.5 mm -98.82 105.38 17.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 48.6 mt-30 -104.44 117.55 34.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -96.67 121.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 O-C-N 124.313 1.008 . . . . 0.0 110.551 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 83.4 m-85 -125.48 156.6 38.69 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.634 0.374 . . . . 0.0 110.571 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' A' ' 70' ' ' ASN . 8.7 pt-20 -122.57 130.77 53.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 15' ' ' LEU . . . 144.09 -155.8 26.41 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.512 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 13.8 mt-10 -161.86 134.05 5.72 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.703 1.601 . . . . 0.0 111.487 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -158.91 170.0 23.07 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 126.554 1.942 . . . . 0.0 106.099 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.81 -47.69 29.32 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.8 mtm -116.98 123.45 46.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.0 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.43 108.71 0.85 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 125.531 1.532 . . . . 0.0 111.037 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -166.81 -36.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.337 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.53 3.89 54.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.745 0.784 . . . . 0.0 109.315 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.473 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 16.6 m120 -100.5 169.51 9.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.726 -173.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.408 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 47.7 t30 -99.4 123.68 43.88 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.442 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.0 tp -83.99 123.22 29.76 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.191 0.596 . . . . 0.0 110.224 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -95.35 -22.55 17.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.97 175.7 33.28 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.987 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 8.5 ptp180 -153.04 151.42 30.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -155.88 157.87 37.08 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 11.6 mp0 -112.03 133.86 53.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.502 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.661 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 54.8 tp -87.1 106.61 17.98 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 172.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 p -67.26 125.42 26.02 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 46.19 96.73 0.01 OUTLIER Glycine 0 C--N 1.344 0.974 0 C-N-CA 125.72 1.629 . . . . 0.0 116.866 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.63 155.27 76.07 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.97 161.95 17.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.921 2.414 . . . . 0.0 113.436 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -67.25 73.19 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.834 2.356 . . . . 0.0 112.19 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.43 142.1 42.86 Favored Pre-proline 0 N--CA 1.417 -2.115 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.87 167.07 28.26 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.39 2.06 . . . . 0.0 112.627 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.403 ' HB3' ' C ' ' A' ' 47' ' ' TYR . 10.6 ptt180 -47.24 124.38 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.196 0.998 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.16 -29.07 9.56 Favored Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.032 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.03 -52.28 1.22 Allowed Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.993 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.22 94.78 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 CA-C-N 120.683 1.28 . . . . 0.0 110.411 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.11 113.2 17.04 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.285 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.8 mm -92.84 108.06 19.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 37.2 tt0 -90.49 106.49 18.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 105' ' ' THR . 47.2 t -104.81 131.98 52.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.0 m -130.64 127.45 38.96 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.267 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 4.5 m-85 -103.46 113.02 26.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.474 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.4 p30 -125.25 125.08 43.01 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.846 175.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 12.1 mt -107.83 145.35 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.25 -160.64 0.82 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.66 51.11 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.43 -29.02 52.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.918 0.39 . . . . 0.0 111.989 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.35 29.22 4.04 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 75.3 mt -87.6 116.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.9 tp -98.88 118.88 36.64 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.288 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -107.6 104.56 14.13 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.274 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 58.0 t -93.45 114.1 29.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.4 m -113.33 124.24 52.01 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.144 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.88 117.81 34.42 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 26.7 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.072 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.18 100.88 10.1 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -67.65 -13.48 62.13 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.4 m -82.56 -47.34 12.24 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.165 0.507 . . . . 0.0 110.537 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -101.38 -27.06 13.36 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.48 45.09 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.264 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 147.82 27.23 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.73 146.24 34.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.46 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.53 131.11 48.25 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 12.3 ptmm? -122.98 135.31 54.43 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.446 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.8 pt -106.94 137.8 35.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 84.9 m -108.53 112.08 24.27 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.055 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.13 97.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.7 p -92.59 101.26 13.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.27 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 43.97 72.94 0.16 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.381 1.051 . . . . 0.0 112.717 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -128.06 137.44 52.16 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -101.85 14.35 32.2 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.988 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.36 -125.04 6.94 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.549 173.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -117.08 -29.36 5.97 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.629 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.5 mt -97.61 142.89 28.86 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.86 0.362 . . . . 0.0 111.179 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.0 p -82.17 170.94 14.87 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.104 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 9.8 ptpp? -56.01 -33.24 64.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -68.94 -41.11 78.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -68.66 -34.72 76.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 135' ' ' VAL . 78.1 mt -64.63 -52.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.774 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 128' ' ' LYS . 9.5 pt-20 -64.0 -30.45 71.52 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.795 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 44.1 mtp85 -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.588 174.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.473 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 20.8 ptt? -70.73 -21.3 62.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.611 -0.836 . . . . 0.0 113.018 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 131' ' ' ILE . 93.5 t -63.3 -50.01 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.63 -34.94 77.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.792 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 40.7 mm-40 -62.95 -47.02 85.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.45 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.29 -29.91 70.72 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 142' ' ' LYS . 30.6 mm-40 -75.47 -45.91 35.63 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -72.59 -46.61 53.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.022 0.439 . . . . 0.0 111.077 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.65 22.84 7.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 60.0 mttp -42.84 -59.19 2.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.663 0.602 . . . . 0.0 110.524 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.33 -37.51 67.53 Favored 'General case' 0 C--O 1.231 0.086 0 O-C-N 124.312 1.007 . . . . 0.0 112.733 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.94 -53.23 11.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.778 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 13.2 m-20 -70.07 -31.6 69.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 12.4 pt-20 -67.49 -42.9 82.16 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.42 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.7 -42.38 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -61.62 -45.48 93.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 5.1 ptp180 -65.65 -32.13 73.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.817 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -78.95 -24.32 43.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -61.84 -40.58 95.79 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.218 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.63 146.07 7.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m -57.11 140.54 49.05 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.24 103.91 7.44 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -86.44 134.75 33.67 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.036 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.04 22.02 13.29 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 166.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -120.3 140.17 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.706 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 mp -117.53 149.97 39.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.433 ' C ' ' HG ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -96.93 163.4 12.98 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.433 ' HG ' ' C ' ' A' ' 159' ' ' GLU . 16.0 m -153.06 90.19 1.43 Allowed 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 71.9 t80 76.5 89.08 0.08 Allowed 'General case' 0 C--O 1.242 0.69 0 O-C-N 124.836 1.335 . . . . 0.0 109.839 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 85.89 138.73 0.05 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.145 1.778 . . . . 0.0 112.627 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -90.42 83.09 5.87 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.275 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.3 t30 71.89 153.3 0.13 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.49 1.116 . . . . 0.0 111.597 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.0 mmt -119.4 11.5 12.2 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.731 -0.606 . . . . 0.0 110.88 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -122.05 177.89 5.13 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.0 t -92.55 102.64 15.08 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.1 88.11 3.0 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.342 0.591 . . . . 0.0 110.528 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.79 160.04 3.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.016 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -130.97 91.29 3.02 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.913 0.863 . . . . 0.0 111.336 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -80.56 -40.16 26.38 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.918 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 64.19 -81.57 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.831 1.252 . . . . 0.0 111.708 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 66.17 -136.45 34.94 Favored Glycine 0 N--CA 1.436 -1.341 0 O-C-N 123.489 0.493 . . . . 0.0 113.012 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.4 mt 71.83 4.83 5.17 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.449 1.5 . . . . 0.0 111.903 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -126.28 161.63 27.32 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.63 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 91.16 47.47 3.57 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.56 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -158.75 172.09 18.88 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.1 pp -138.5 -174.44 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 123.109 0.564 . . . . 0.0 111.333 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 29.9 m 85.24 7.63 0.42 Allowed 'General case' 0 C--O 1.248 1.008 0 C-N-CA 125.891 1.677 . . . . 0.0 113.04 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.44 -60.11 2.31 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -126.23 99.48 5.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -104.56 161.8 13.8 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -69.22 -50.14 50.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.224 0.535 . . . . 0.0 110.689 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -142.69 97.9 3.19 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -130.1 89.7 2.84 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.68 0.752 . . . . 0.0 109.105 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.95 3.3 7.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.926 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.5 tp -117.46 150.63 38.6 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.91 76.36 3.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.742 1.258 . . . . 0.0 111.676 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -94.06 85.09 4.61 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 69.63 176.46 0.28 Allowed 'General case' 0 C--O 1.245 0.833 0 O-C-N 124.197 0.936 . . . . 0.0 110.887 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 67.73 17.42 9.8 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 122.126 0.965 . . . . 0.0 109.422 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 52.9 t -104.57 113.33 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 16.4 tt -102.04 85.5 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.535 1.159 . . . . 0.0 111.081 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.2 m -86.98 118.49 26.39 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.0 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 25.1 m-90 -84.84 87.3 7.32 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.47 HD21 ' H ' ' A' ' 197' ' ' LEU . 2.2 pt? -83.23 -19.7 35.94 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -81.82 98.98 8.75 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -90.58 161.9 15.24 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -74.44 131.75 41.33 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 17.6 m -53.02 116.92 2.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 124.523 1.139 . . . . 0.0 110.867 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 49.1 tp -87.22 81.69 7.88 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 122.05 0.929 . . . . 0.0 109.843 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.24 97.01 2.25 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' A' ' 205' ' ' LYS . 12.5 tp10 -79.53 -70.49 0.51 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.304 -172.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.487 ' HG3' ' HG3' ' A' ' 204' ' ' GLU . 49.1 mttm -139.99 116.76 10.91 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 121.791 -0.568 . . . . 0.0 110.914 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -108.14 94.13 4.9 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.85 171.82 11.91 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.848 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -149.36 111.99 4.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -53.58 132.96 41.27 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.322 0.649 . . . . 0.0 112.447 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -113.06 85.52 2.19 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.067 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.36 89.57 3.14 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -176.29 102.85 0.06 Allowed 'General case' 0 C--O 1.248 0.984 0 O-C-N 123.895 0.747 . . . . 0.0 110.67 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt 171.57 83.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.374 1.469 . . . . 0.0 107.806 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.58 144.67 27.63 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.06 153.64 30.04 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -108.99 165.25 11.73 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -152.98 96.75 2.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.365 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.97 96.21 4.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -121.63 120.37 28.77 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.16 121.74 9.9 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.168 1.912 . . . . 0.0 111.607 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 63.4 mt -85.07 91.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.47 2.34 6.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.662 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 30.8 t -117.41 121.4 40.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.329 0.585 . . . . 0.0 110.31 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -147.71 112.6 0.6 Allowed Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.7 tt -94.51 96.23 9.34 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.382 0.61 . . . . 0.0 109.786 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -148.69 114.48 5.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -133.7 -52.16 0.86 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.725 -172.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 143.44 113.06 0.89 Allowed Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.638 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -125.78 154.67 42.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -151.24 -157.33 7.81 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.535 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -161.97 87.76 0.11 Allowed Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.973 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.79 128.0 20.99 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.586 2.191 . . . . 0.0 110.531 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -135.18 101.82 0.41 Allowed Glycine 0 N--CA 1.427 -1.9 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.0 154.38 57.83 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 122.079 1.853 . . . . 0.0 110.836 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.96 34.25 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.053 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.35 75.54 2.31 Favored Glycine 0 C--N 1.299 -1.519 0 C-N-CA 121.244 -0.503 . . . . 0.0 111.869 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -76.74 143.25 40.07 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 112.58 81.1 1.07 Allowed Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -175.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.1 85.31 6.93 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.218 0.532 . . . . 0.0 110.815 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -150.0 115.6 5.54 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -105.2 -159.45 23.27 Favored Glycine 0 C--N 1.292 -1.915 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.75 104.45 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.646 2.231 . . . . 0.0 111.097 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -78.2 109.96 12.76 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 162.11 -157.1 28.88 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -171.47 -51.18 0.04 OUTLIER Glycine 0 C--N 1.301 -1.404 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.697 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.3 t 64.12 86.48 0.12 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 124.886 1.274 . . . . 0.0 110.13 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -142.14 47.56 0.82 Allowed Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.625 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 16.0 m -88.7 154.95 19.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -75.55 162.74 53.4 Favored Glycine 0 C--O 1.246 0.903 0 CA-C-O 119.846 -0.419 . . . . 0.0 112.665 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.91 127.47 18.65 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 123.131 2.554 . . . . 0.0 111.83 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 15.7 m -81.2 84.83 6.47 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.458 0.647 . . . . 0.0 110.996 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 253' ' ' ILE . 2.3 pp -95.35 123.7 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.024 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.19 -31.27 34.05 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -170.46 147.79 3.03 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 173.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.26 74.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-O 121.934 0.873 . . . . 0.0 110.602 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.282 178.062 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.241 0.642 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 72.8 -43.66 0.57 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.3 m120 70.55 78.96 0.18 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.509 1.123 . . . . 0.0 109.884 -176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.17 -11.93 11.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.075 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -106.82 9.18 31.04 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.775 0.798 . . . . 0.0 109.677 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.55 157.49 18.6 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.695 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.5 mt -131.46 121.54 24.71 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.773 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp 70.11 141.28 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.864 1.352 . . . . 0.0 112.013 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 tp -97.79 98.5 9.89 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.2 tp -102.74 164.3 11.72 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.388 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 59.2 68.75 0.78 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.477 1.132 . . . . 0.0 110.032 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 35' ' ' THR . 34.1 m -137.55 -178.55 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.371 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.9 123.27 82.33 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' C ' HD11 ' A' ' 15' ' ' LEU . 19.5 Cg_endo -60.51 -51.48 5.12 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.3 2.0 . . . . 0.0 110.907 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 7.3 mp -128.1 167.37 16.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.526 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 18.5 m -72.5 142.45 48.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 O-C-N 123.614 0.571 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -114.0 132.12 56.1 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.782 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 28' ' ' ALA . . . -147.79 -177.42 22.18 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.044 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 26' ' ' MET . 83.6 mt -122.83 167.94 12.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.896 0.379 . . . . 0.0 111.63 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.21 109.34 17.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.391 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 p -109.47 158.34 18.07 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.437 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.11 115.93 1.36 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.903 1.281 . . . . 0.0 113.252 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.21 10.74 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.821 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.37 44.17 5.36 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.34 137.17 55.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.468 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 33.1 ttp -96.71 112.05 23.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -94.42 112.3 24.07 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . . . -90.28 133.67 34.8 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.666 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.618 ' HG ' ' OE1' ' A' ' 42' ' ' GLN . 5.9 mp -100.93 -39.67 7.64 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.69 129.85 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -101.31 162.6 12.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HD3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -70.91 142.2 51.14 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.824 178.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.403 ' OD1' ' HD3' ' A' ' 32' ' ' ARG . 16.9 m120 80.64 -6.09 1.69 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.24 1.416 . . . . 0.0 113.252 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.7 m -65.19 115.29 5.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.439 ' HA ' HG13 ' A' ' 12' ' ' VAL . 2.7 m -71.03 129.9 40.18 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.193 -172.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.43 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 28.4 pt -92.97 155.76 41.08 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.029 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.1 Cg_exo -63.48 141.83 42.86 Favored 'Cis proline' 0 N--CA 1.487 1.098 0 C-N-CA 124.604 -0.998 . . . . 0.0 114.24 0.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.6 p -120.89 152.84 37.97 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.762 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 47.6 tttp -153.41 99.81 2.38 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -108.42 135.31 49.93 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -124.02 127.97 48.67 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.618 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 44.8 mt-30 -132.11 150.28 52.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.91 129.42 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.522 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 89.1 m-85 -117.42 155.14 30.15 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 22.9 p -127.37 170.73 12.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 41.5 p -100.51 139.86 35.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.494 ' CD1' ' HB3' ' A' ' 157' ' ' ALA . 31.3 m-85 -117.76 5.13 12.25 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -120.74 127.16 51.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.412 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 84' ' ' PRO . 46.0 t0 -82.05 169.95 16.11 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.34 14.66 9.21 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.822 1.249 . . . . 0.0 113.232 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -90.25 114.62 61.64 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -89.8 -1.82 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.146 1.897 . . . . 0.0 111.839 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.91 145.01 8.89 Favored Glycine 0 N--CA 1.413 -2.874 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.39 147.32 13.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 117.049 0.425 . . . . 0.0 109.93 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.08 118.15 35.19 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.067 0.46 . . . . 0.0 110.705 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.72 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.43 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 90.7 mt-30 -102.2 130.01 48.74 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 t -99.48 129.0 50.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 123.714 0.634 . . . . 0.0 109.354 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.78 156.55 44.79 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.166 0.508 . . . . 0.0 111.524 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.513 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 35.8 tt0 -118.63 136.77 53.71 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.471 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.04 116.55 3.91 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.526 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 40.4 mt-10 -79.47 107.18 12.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -133.57 144.53 49.38 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.9 76.0 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 124.131 0.894 . . . . 0.0 111.552 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.8 mtt -94.76 111.49 23.26 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.271 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -74.71 109.83 8.51 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.066 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -175.25 -41.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.566 1.147 . . . . 0.0 109.016 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -109.21 75.44 0.95 Allowed 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -147.92 164.33 34.07 Favored 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 73.2 m-20 -90.61 129.3 36.75 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.0 tp -83.34 125.09 31.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.05 0.452 . . . . 0.0 111.221 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.423 ' HB3' HD11 ' A' ' 119' ' ' ILE . 7.4 mp -101.99 -9.38 20.69 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.52 178.33 15.37 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.882 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 6.8 ppt_? -153.33 156.91 39.24 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -150.87 152.32 33.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.39 125.01 51.94 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.06 104.22 16.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 p -105.15 163.49 12.54 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.695 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.62 7.09 45.91 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.6 mm -64.56 127.46 92.38 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.59 143.49 68.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.244 1.963 . . . . 0.0 110.613 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.63 90.58 0.6 Allowed 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 121.204 1.27 . . . . 0.0 109.646 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.16 129.53 20.94 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.995 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 17.9 Cg_endo -58.73 -61.04 0.28 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 123.296 2.664 . . . . 0.0 114.643 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 46' ' ' THR . 88.1 mtt180 -139.37 136.1 34.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.01 1.25 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 117.731 1.852 . . . . 0.0 117.731 167.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.411 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.9 t -52.3 -57.53 15.02 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 6.2 Cg_exo -81.73 103.52 1.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.641 1.56 . . . . 0.0 110.821 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -95.11 117.75 30.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.25 121.56 47.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.93 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.41 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 38.4 tt0 -91.35 115.79 28.32 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.7 t -110.49 124.81 67.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 m -121.67 128.85 52.31 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.222 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 7.6 m-85 -110.57 109.55 19.9 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.1 p30 -126.57 128.25 46.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.26 0.552 . . . . 0.0 112.12 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 45.9 mt -123.62 133.92 67.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -88.72 -172.07 3.57 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.11 -5.95 55.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.07 -29.88 21.56 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.46 26.7 4.73 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 72.9 mt -89.07 108.0 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.7 tp -94.63 128.76 41.5 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.388 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER -119.74 108.02 13.91 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 174.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 61.2 t -95.59 113.81 30.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.9 m -112.86 122.03 46.43 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.1 m -122.64 122.22 38.29 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 120.842 0.353 . . . . 0.0 111.429 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -82.52 108.16 15.71 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.063 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.8 -6.88 23.48 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -79.84 -61.97 1.83 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.1 p -82.61 -30.22 29.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.68 13.1 56.01 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.982 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -91.11 144.0 26.1 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 117.626 0.713 . . . . 0.0 109.684 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -123.8 141.71 51.78 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -129.52 134.08 47.58 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 17.5 ptpt -124.25 166.55 15.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.47 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 15.0 tt -131.2 145.53 35.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.8 m -113.51 116.21 29.21 Favored 'General case' 0 C--N 1.276 -2.603 0 O-C-N 124.397 1.061 . . . . 0.0 110.124 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.423 HD11 ' HB3' ' A' ' 72' ' ' LEU . 75.5 mt -120.6 125.24 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.0 m -119.92 140.7 50.48 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 79.48 -82.94 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.401 1.08 . . . . 0.0 111.429 174.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -156.48 173.11 17.39 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -155.88 164.39 38.57 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.01 -76.42 0.52 Allowed Glycine 0 C--O 1.24 0.521 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.448 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.346 3.2 mpt_? 75.93 89.82 0.08 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -129.96 -170.77 2.37 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.5 p -89.48 158.28 17.76 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.128 -1.429 . . . . 0.0 108.01 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -55.78 -41.24 73.77 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -173.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . 0.281 0.8 OUTLIER -73.95 -23.4 59.5 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.01 -34.52 71.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.09 -44.42 78.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.664 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.01 -39.32 81.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.541 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -60.41 -43.01 97.15 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.594 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 tpp -58.92 -39.3 81.15 Favored 'General case' 0 C--O 1.212 -0.915 0 O-C-N 123.742 0.652 . . . . 0.0 109.828 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.77 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.084 0.468 . . . . 0.0 109.98 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -61.05 -47.67 85.32 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.708 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.46 -32.55 73.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.513 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.521 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -68.17 -55.53 12.03 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 122.158 -0.339 . . . . 0.0 110.609 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.55 -48.54 77.03 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.74 -17.81 65.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -118.3 16.18 13.95 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -55.1 -43.26 73.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.43 80.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 110.757 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.79 -44.95 65.58 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.045 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -61.32 -42.24 98.33 Favored 'General case' 0 CA--C 1.498 -1.026 0 O-C-N 123.403 0.439 . . . . 0.0 111.537 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 41.3 mt-10 -57.39 -45.51 84.44 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.982 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.647 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 46.0 t -68.76 -42.49 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.398 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -55.88 -48.8 74.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -63.91 -36.93 85.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.0 pt-20 -79.06 -15.51 58.1 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.539 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.647 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 91.6 mtt-85 -71.77 -38.76 70.29 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.9 -57.53 4.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.938 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.455 ' OG ' ' HG2' ' A' ' 155' ' ' LYS . 31.3 t -158.27 -80.78 0.06 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.501 -174.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 65.39 19.21 11.57 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 124.952 1.301 . . . . 0.0 111.771 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.455 ' HG2' ' OG ' ' A' ' 153' ' ' SER . 17.0 ptpt -82.18 144.86 30.42 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 10.4 t30 -84.12 69.34 10.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.283 1.039 . . . . 0.0 111.455 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.774 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.3 151.63 35.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -115.06 175.04 5.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t -145.84 -175.79 4.88 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.359 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . 0.34 41.7 m-85 69.5 81.34 0.17 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -127.14 11.57 7.03 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.238 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -99.64 90.72 4.58 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.488 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.408 ' OD1' ' HG3' ' A' ' 165' ' ' MET . 52.0 t-20 -142.79 114.25 7.92 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 176.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.408 ' HG3' ' OD1' ' A' ' 164' ' ' ASN . 90.5 mtp 72.07 22.36 3.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.766 0.827 . . . . 0.0 112.247 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -97.27 81.25 2.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.1 p -152.47 -54.97 0.13 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.266 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.63 28.04 2.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.24 0.543 . . . . 0.0 110.365 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.99 144.45 25.34 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -90.58 76.83 6.5 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -99.02 117.83 34.41 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.523 -175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 173.44 -63.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 126.155 1.782 . . . . 0.0 106.216 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -163.07 154.14 24.96 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.1 mp -119.4 3.31 11.29 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 117.03 0.415 . . . . 0.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt 72.11 140.02 0.05 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.739 1.216 . . . . 0.0 112.306 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -145.06 64.2 0.46 Allowed Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.072 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.18 83.25 6.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.28 -43.51 84.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 19.1 m -157.03 141.67 16.77 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.2 -37.55 45.34 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 48.22 37.86 9.05 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.643 1.177 . . . . 0.0 113.002 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.81 -68.73 0.49 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.875 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt 61.73 -84.58 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.317 1.047 . . . . 0.0 112.806 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -131.83 172.43 12.32 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -107.37 136.15 47.66 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.9 m -86.57 96.5 5.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.999 0.904 . . . . 0.0 108.571 172.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.6 tp -69.03 -31.05 69.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.676 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -99.55 69.95 1.66 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 122.315 1.055 . . . . 0.0 108.473 171.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -62.91 130.91 46.85 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.818 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -121.08 108.16 13.49 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.87 128.64 49.77 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 32.9 m -81.13 -16.57 12.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.394 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . 0.307 8.5 tp 52.0 -70.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 126.963 2.105 . . . . 0.0 114.109 -177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.3 m -145.61 136.1 24.14 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -95.96 108.61 21.01 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 120.284 -0.567 . . . . 0.0 109.507 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.7 mp -95.44 90.35 5.75 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.94 136.13 52.07 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.828 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -98.25 36.69 1.55 Allowed 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.666 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -61.26 -45.9 92.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.157 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 60.2 m -152.24 110.95 3.79 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.909 0.385 . . . . 0.0 110.6 176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.5 HD13 ' N ' ' A' ' 203' ' ' ALA . 3.8 pp -114.86 -38.55 3.9 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.5 ' N ' HD13 ' A' ' 202' ' ' LEU . . . -168.01 89.69 0.28 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.229 0.538 . . . . 0.0 111.161 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -100.9 -6.91 24.0 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.549 0.69 . . . . 0.0 109.429 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.556 ' HD3' ' H ' ' A' ' 206' ' ' ASP . 4.9 tmtt? -103.08 149.53 24.5 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.556 ' H ' ' HD3' ' A' ' 205' ' ' LYS . 3.2 m-20 -56.36 152.93 10.47 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.665 1.186 . . . . 0.0 109.438 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.79 69.14 0.75 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.878 0.847 . . . . 0.0 112.864 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -106.76 -53.92 2.55 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -91.48 -25.78 19.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.735 0.779 . . . . 0.0 109.081 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -96.01 147.18 23.97 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -144.91 153.14 41.24 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -62.31 129.13 39.34 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -116.84 87.63 2.73 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.013 0.911 . . . . 0.0 110.265 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -92.58 106.42 18.41 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 113.689 -1.596 . . . . 0.0 107.645 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.74 -0.78 5.42 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.225 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -98.58 123.2 42.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.172 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 71.55 35.21 1.51 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.471 1.109 . . . . 0.0 111.5 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.03 -10.5 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.814 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 12.4 t30 50.15 80.89 0.28 Allowed Pre-proline 0 N--CA 1.468 0.457 0 C-N-CA 124.978 1.311 . . . . 0.0 111.726 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -84.11 104.61 1.06 Allowed 'Trans proline' 0 N--CA 1.433 -2.081 0 C-N-CA 122.369 2.046 . . . . 0.0 112.025 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.33 151.9 7.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.65 120.08 34.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.356 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.9 m -65.96 139.72 58.26 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.352 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -157.56 123.99 1.35 Allowed Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 118.544 -1.789 . . . . 0.0 113.612 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 70.8 mt -85.22 99.8 11.35 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -91.87 131.05 37.49 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.287 0.565 . . . . 0.0 111.626 -172.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -123.26 137.88 54.76 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -82.6 116.0 4.13 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.36 115.9 5.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.933 0.396 . . . . 0.0 110.91 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 159.02 -155.85 26.92 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 164.29 100.56 0.15 Allowed Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -83.79 107.05 1.31 Allowed 'Trans proline' 0 N--CA 1.44 -1.63 0 C-N-CA 122.008 1.806 . . . . 0.0 112.253 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -161.61 86.36 0.11 Allowed Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.36 108.29 0.68 Allowed 'Trans proline' 0 C--O 1.249 1.055 0 C-N-CA 122.739 2.293 . . . . 0.0 111.948 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -100.61 2.46 55.93 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.762 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -87.05 -174.51 49.03 Favored Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.287 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 64.16 74.72 0.4 Allowed 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.484 1.114 . . . . 0.0 111.091 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -170.08 -38.21 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.186 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.93 85.01 2.45 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.212 0.53 . . . . 0.0 110.03 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -136.94 96.88 3.39 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -91.67 118.93 5.59 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.809 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.28 165.93 28.75 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 122.852 2.368 . . . . 0.0 111.412 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -99.94 107.47 19.46 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.509 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -141.41 162.33 26.9 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -114.85 97.05 0.8 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.2 m -94.47 27.05 3.12 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.084 0.469 . . . . 0.0 111.377 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.85 31.66 5.08 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 18.7 m -94.43 123.68 37.99 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -72.89 156.65 51.92 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.11 -2.59 12.5 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 122.505 2.137 . . . . 0.0 111.955 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.1 t -169.31 153.36 5.29 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 20.1 pt -139.66 178.54 3.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.0 -176.29 3.51 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -79.19 99.1 6.86 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.859 0.837 . . . . 0.0 110.858 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.12 19.46 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 CA--C 1.497 -1.093 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.363 -177.852 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 66.65 68.9 0.42 Allowed 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.837 1.255 . . . . 0.0 114.384 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -132.33 157.36 44.66 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 171.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.2 t 65.89 80.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -170.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -63.88 152.98 38.24 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.816 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -60.84 102.15 0.18 Allowed 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 123.654 0.596 . . . . 0.0 110.83 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.82 121.26 44.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.403 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.4 tp -89.33 -43.51 10.88 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.154 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.4 mt -111.05 123.28 49.89 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.378 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.2 mt -102.15 17.36 23.51 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.726 1.251 . . . . 0.0 108.775 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.523 ' O ' HG12 ' A' ' 36' ' ' ILE . 1.3 m-20 -85.47 74.78 10.28 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.354 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -115.84 175.86 2.62 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.907 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.895 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.08 129.45 67.18 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.45 -23.95 2.61 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 122.131 1.887 . . . . 0.0 112.372 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.43 172.4 10.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 m -94.98 129.25 42.12 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.82 131.7 43.3 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.58 -164.52 14.96 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.332 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.0 mt -131.07 161.85 31.14 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.81 120.81 32.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 117.821 -1.551 . . . . 0.0 109.223 171.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 23.6 p -97.94 -176.33 3.41 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.809 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.71 128.83 39.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.068 0.461 . . . . 0.0 111.922 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.25 59.96 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.43 53.73 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.255 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -92.91 140.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 113.09 25.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.0 m -109.39 110.97 22.27 Favored 'General case' 0 C--N 1.279 -2.468 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.624 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.29 136.26 33.16 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.201 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.441 HD23 ' CD2' ' A' ' 94' ' ' PHE . 5.7 mp -99.45 -49.98 4.25 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.81 103.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -80.71 162.8 23.97 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HD3' ' OE2' ' A' ' 139' ' ' GLU . 9.7 ptm180 -64.43 159.36 21.55 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.316 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m120 77.34 4.8 3.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.499 1.12 . . . . 0.0 112.243 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 m -83.32 115.75 22.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.38 132.84 45.42 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.113 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 11' ' ' ASP . 26.5 pt -91.38 161.39 34.77 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.9 Cg_exo -69.01 147.39 82.98 Favored 'Cis proline' 0 C--O 1.245 0.858 0 CA-C-N 119.834 0.976 . . . . 0.0 113.731 1.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 11.8 p -118.19 136.42 53.65 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.043 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -135.02 101.02 4.74 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 93' ' ' THR . 62.1 tt0 -121.92 131.81 54.22 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -128.67 125.1 37.35 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -135.48 152.3 51.21 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.18 122.47 50.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.088 0.47 . . . . 0.0 110.331 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.5 162.14 14.4 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.848 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 6.1 p -137.76 170.22 16.44 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.041 0.536 . . . . 0.0 109.66 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -95.93 137.01 35.6 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.303 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -108.63 32.11 5.11 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 167.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 33.0 p -132.19 159.43 39.01 Favored 'General case' 0 N--CA 1.391 -3.405 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.974 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -136.61 162.17 33.88 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.88 22.08 10.25 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.101 0.876 . . . . 0.0 110.934 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.402 HE22 ' HA ' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -80.48 125.71 80.26 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.959 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.16 -18.51 27.04 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 121.706 1.604 . . . . 0.0 109.657 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -178.31 175.01 47.2 Favored Glycine 0 N--CA 1.406 -3.365 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.75 129.85 55.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.119 0.485 . . . . 0.0 110.139 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.6 tp -87.17 100.29 12.56 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.595 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mm -84.15 96.98 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -109.3 110.3 21.43 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.1 t -92.98 135.97 26.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.79 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -133.77 163.24 29.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.42 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.85 165.45 25.59 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.46 -103.78 0.9 Allowed Glycine 0 C--N 1.287 -2.146 0 C-N-CA 119.025 -1.56 . . . . 0.0 114.235 170.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.642 ' OE2' ' HG3' ' A' ' 67' ' ' LYS . 39.9 mt-10 -78.46 172.16 14.04 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.594 0.358 . . . . 0.0 110.939 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -112.59 -27.47 8.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.383 -0.372 . . . . 0.0 112.001 -171.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -90.42 -52.43 4.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -172.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.1 mtm -142.1 149.64 40.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -173.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.28 82.55 2.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 O-C-N 124.082 0.863 . . . . 0.0 109.851 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.642 ' HG3' ' OE2' ' A' ' 62' ' ' GLU . 8.3 ptmm? -118.84 -76.53 0.57 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.99 12.4 30.57 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.597 0.713 . . . . 0.0 111.208 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.88 142.22 57.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.694 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -96.09 141.96 28.85 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.566 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.5 tp -76.99 123.37 26.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.458 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.6 mt -89.24 -40.16 13.03 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.521 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 171.27 36.74 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -140.2 135.05 32.0 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -143.22 135.01 26.66 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.76 118.97 37.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.953 0.406 . . . . 0.0 111.421 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.0 tp -90.73 104.29 16.89 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 p -113.55 165.95 12.0 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -168.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 4.33 39.8 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.16 113.15 46.4 Favored Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.37 138.33 50.38 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.475 2.117 . . . . 0.0 112.141 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HA ' HE22 ' A' ' 51' ' ' GLN . 92.2 Cg_exo -47.42 125.88 11.29 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.344 3.362 . . . . 0.0 113.159 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.39 152.85 80.79 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.84 39.64 0.29 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 124.055 3.17 . . . . 0.0 115.07 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 68.34 143.57 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.665 1.586 . . . . 0.0 112.429 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.94 75.88 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.53 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.407 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.8 t -107.13 -55.11 0.07 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.924 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 15.5 Cg_exo -70.38 130.51 18.7 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 121.307 1.338 . . . . 0.0 110.71 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -110.86 123.07 49.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -110.03 125.2 67.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.6 tt0 -90.77 111.59 23.02 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -108.27 129.87 61.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 30.5 m -123.46 118.58 27.74 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.441 ' CD2' HD23 ' A' ' 29' ' ' LEU . 10.5 m-85 -100.54 116.37 32.3 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 173.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' THR . 12.2 t70 -128.91 116.36 19.28 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.764 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 52.5 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.403 ' O ' HD12 ' A' ' 36' ' ' ILE . 2.4 p-10 -87.57 -172.6 3.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -13.96 61.24 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -84.79 -31.46 23.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 117.6 14.11 7.03 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.481 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 80.7 mt -80.54 119.95 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.8 tp -98.44 118.03 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.411 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -112.91 111.24 21.85 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -101.82 116.64 45.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.7 m -111.67 134.34 53.31 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.46 124.12 42.17 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 m -124.22 118.42 26.8 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.521 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.5 123.34 29.63 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.728 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 75.0 mmtt -68.01 -28.82 67.75 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.875 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 m -68.68 -61.91 1.61 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.142 0.496 . . . . 0.0 110.865 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.5 p -84.01 -39.88 19.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.36 0.6 . . . . 0.0 110.799 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.25 39.29 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.16 149.04 43.27 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.496 0.665 . . . . 0.0 112.761 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.22 134.72 42.35 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.349 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 146.22 47.18 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -142.11 162.3 35.82 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.034 0.445 . . . . 0.0 111.731 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 tt -129.44 145.76 35.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.3 m -122.8 117.25 25.23 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.029 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.25 118.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 p -92.26 172.73 8.22 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.67 -24.01 59.92 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -58.65 -50.26 74.5 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.022 -177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -128.38 91.87 3.33 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.91 -116.8 3.41 Favored Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -144.83 143.12 30.46 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.2 mp 66.61 -171.25 0.19 Allowed 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.018 0.824 . . . . 0.0 111.19 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.1 p -96.03 -77.65 0.48 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 56.3 tttp -166.49 -45.1 0.02 OUTLIER 'General case' 0 CA--C 1.484 -1.559 0 CA-C-O 120.638 0.256 . . . . 0.0 110.374 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.36 -49.02 77.21 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.987 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 134' ' ' MET . 1.2 mp0 -57.59 -42.6 83.52 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.103 0.961 . . . . 0.0 109.359 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.1 mt -61.22 -50.84 78.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.783 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.2 pt-20 -72.75 -26.0 61.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -61.88 -44.05 97.59 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 95.0 mmm -60.76 -37.39 81.67 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.103 0.478 . . . . 0.0 109.764 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 88.1 t -58.2 -54.68 29.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.029 176.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 87.4 mt-30 -59.29 -53.78 54.31 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.914 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.78 -53.58 55.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.928 -176.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.61 67.77 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.486 ' OE2' ' HD3' ' A' ' 32' ' ' ARG . 26.1 mm-40 -74.27 -32.93 63.12 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.052 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -71.21 -34.29 70.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.08 11.44 23.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.888 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -53.66 -48.62 69.26 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 118.142 0.428 . . . . 0.0 111.522 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.95 74.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.813 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -74.2 -44.7 52.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.81 -49.39 77.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.67 -32.53 74.04 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.383 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.91 -48.41 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.575 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -55.93 -41.89 75.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.87 0.468 . . . . 0.0 111.066 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.53 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 57.0 ttp180 -61.4 -51.69 67.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.486 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.4 ' HG3' ' HE ' ' A' ' 149' ' ' ARG . 47.6 mt-10 -78.36 -1.37 33.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.9 -14.0 46.16 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 29.9 t -112.18 157.77 12.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -80.56 93.09 6.02 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.323 0.583 . . . . 0.0 110.583 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -90.66 93.11 9.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.533 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -112.71 158.63 19.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.12 68.51 9.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.234 1.016 . . . . 0.0 110.761 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.74 136.18 25.38 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.693 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.93 152.38 25.02 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.903 0.382 . . . . 0.0 110.423 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.24 119.59 36.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.1 t -134.4 100.63 4.72 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 66.5 25.94 10.05 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.441 1.096 . . . . 0.0 112.054 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 48' ' ' SER . . . -69.69 -11.92 61.22 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -73.46 -16.45 61.3 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.893 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 57.74 85.95 0.08 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.07 0.948 . . . . 0.0 112.012 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -165.46 117.01 1.11 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.69 130.82 48.14 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.018 -176.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.9 m -109.22 122.96 48.45 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -166.28 172.57 10.96 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.04 97.99 5.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -115.25 129.2 56.56 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.387 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -136.37 -18.24 1.5 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.204 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -75.27 -44.12 47.61 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.789 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 90.72 -156.52 24.71 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 55.4 tp -87.78 -25.84 23.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.393 0.616 . . . . 0.0 110.859 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -151.83 138.76 19.01 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.651 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -86.33 -22.26 48.6 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.307 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -76.5 100.97 5.44 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.678 0.391 . . . . 0.0 110.124 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.4 pt -108.21 3.0 9.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.6 0.714 . . . . 0.0 110.037 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 12.8 p -90.83 158.82 16.6 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.182 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -69.56 113.82 7.2 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.568 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.46 107.07 7.34 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.37 103.71 11.31 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.62 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 134.15 38.12 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -114.19 172.01 7.27 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.761 -171.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.417 ' HA ' ' OD1' ' A' ' 188' ' ' ASP . 13.2 mptt -74.95 97.65 3.41 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.623 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.78 -62.0 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.938 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 30.3 tp -139.83 24.44 2.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.13 0.966 . . . . 0.0 110.335 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' A' ' 185' ' ' LYS . 5.8 p-10 -92.77 13.14 21.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 174.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -93.9 118.46 31.5 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -137.06 135.21 37.32 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 174.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -88.86 84.82 6.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 55.2 t -72.16 -36.05 55.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.851 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 59.0 mt -104.68 105.05 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.6 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.5 m -93.56 104.6 16.71 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -103.26 -30.81 10.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.485 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 tp -146.61 31.98 0.97 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.33 -35.29 79.9 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.827 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -140.3 -15.18 0.98 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.0 t30 71.94 -71.77 0.13 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.327 1.051 . . . . 0.0 111.466 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 18.5 m 63.71 -76.68 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.907 1.283 . . . . 0.0 112.128 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 71.0 mt 59.05 -81.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.022 1.729 . . . . 0.0 112.29 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.86 138.05 16.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -127.06 -54.71 1.38 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.423 0.63 . . . . 0.0 110.782 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -97.1 146.71 24.77 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 209' ' ' GLU . 4.1 m-20 -73.55 141.92 46.67 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -30.98 69.82 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -114.89 -19.79 10.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.803 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.524 ' OE2' ' HG2' ' A' ' 212' ' ' ARG . 3.6 tp10 -92.15 6.13 47.74 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 122.067 -0.396 . . . . 0.0 110.91 -172.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -86.14 -8.66 57.69 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.249 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -132.31 86.92 2.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.614 0.721 . . . . 0.0 109.794 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.524 ' HG2' ' OE2' ' A' ' 209' ' ' GLU . 4.1 ppt_? -162.73 150.41 13.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.417 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm 59.06 -172.83 0.1 Allowed 'General case' 0 C--O 1.241 0.648 0 O-C-N 124.309 1.006 . . . . 0.0 111.735 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.29 85.42 2.8 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 102.332 -3.21 . . . . 0.0 102.332 169.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 34.2 tp -70.43 141.23 52.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.661 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -61.39 -46.79 88.69 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.358 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -79.25 91.94 5.06 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.55 100.28 4.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.117 0.96 . . . . 0.0 112.561 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -74.48 148.75 85.98 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.244 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.99 104.46 0.71 Allowed 'Trans proline' 0 C--O 1.242 0.687 0 C-N-CA 122.68 2.254 . . . . 0.0 113.962 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.07 133.91 58.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 171.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 80.9 mt 76.06 101.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.931 0 O-C-N 124.17 0.919 . . . . 0.0 108.612 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 50.1 m -147.59 162.43 39.13 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 158.91 -121.7 1.07 Allowed Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.926 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.22 174.0 14.24 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.8 t80 68.02 74.79 0.29 Allowed 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.326 1.05 . . . . 0.0 109.044 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -151.79 -57.57 0.15 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.526 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.5 -151.34 5.85 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.548 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -122.62 149.0 44.58 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 172.01 106.57 0.19 Allowed Glycine 0 C--N 1.299 -1.476 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.477 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 176.97 75.33 0.05 OUTLIER Glycine 0 C--N 1.295 -1.718 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.78 167.8 11.19 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.692 2.262 . . . . 0.0 111.256 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -143.06 121.87 1.8 Allowed Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.5 115.95 4.53 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.118 1.878 . . . . 0.0 111.946 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 88.06 -157.74 28.54 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.31 -97.71 0.24 Allowed Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -134.63 116.94 15.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -73.77 97.82 0.92 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.357 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -138.22 127.66 24.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.71 -33.69 8.85 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 78.64 120.89 0.27 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.698 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.75 129.09 33.14 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.647 2.231 . . . . 0.0 111.915 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -65.75 -47.99 73.38 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.447 0.641 . . . . 0.0 110.236 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.04 -137.86 6.93 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 157.2 53.2 0.01 OUTLIER Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.7 t -66.46 -49.48 66.53 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 78.09 13.92 82.83 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.474 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 38.4 m -137.42 129.06 28.53 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -153.11 144.2 11.12 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.54 104.75 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.236 2.624 . . . . 0.0 112.389 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.2 m -126.9 45.37 2.71 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 26.9 pt -132.49 143.5 39.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.029 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -127.45 112.3 14.81 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.719 0.771 . . . . 0.0 111.577 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.87 100.42 8.84 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 35.2 m -87.87 176.57 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.134 -175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--N 1.313 -1.011 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.0 -178.883 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 C--O 1.246 0.916 0 CA-C-O 121.495 0.664 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -92.08 134.44 34.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.546 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -87.02 -33.94 19.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.336 0.589 . . . . 0.0 110.109 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.5 t 70.32 -84.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 108.812 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 61.7 -76.72 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.698 1.199 . . . . 0.0 112.666 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -132.93 11.71 4.3 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt 70.63 85.03 0.14 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.287 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mp 69.46 87.71 0.12 Allowed 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.913 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 tp -64.19 -43.8 93.97 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -114.49 123.9 50.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.296 176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -96.23 25.91 4.61 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -126.88 170.64 16.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-O 121.211 0.529 . . . . 0.0 110.906 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.46 120.87 80.61 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.04 -21.63 23.84 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.094 1.862 . . . . 0.0 111.743 -177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.8 mt -134.49 174.45 10.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 m -101.57 123.01 44.89 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.09 0.244 . . . . 0.0 110.609 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -92.28 131.63 37.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.1 -168.41 21.11 Favored Glycine 0 N--CA 1.425 -2.052 0 C-N-CA 119.375 -1.393 . . . . 0.0 114.63 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.6 mt -133.63 162.79 30.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.735 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -94.81 109.51 21.47 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.9 p -84.16 175.37 9.52 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.083 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.96 116.51 4.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.62 -12.23 11.04 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 51.66 4.53 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.25 127.16 73.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.0 tpt -73.82 102.5 4.06 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -107.78 112.13 24.64 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.29 127.48 38.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.41 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.0 mp -95.57 -50.35 5.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.1 mm -94.18 92.31 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.2 154.92 30.67 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -53.81 140.28 30.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.23 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 79.84 1.7 2.12 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.585 1.554 . . . . 0.0 113.283 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.13 128.15 33.36 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -70.5 134.79 48.05 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.617 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.6 pt -104.09 161.42 22.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.1 Cg_endo -64.44 140.88 42.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 CA-C-N 120.914 1.362 . . . . 0.0 114.115 0.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.3 p -109.59 164.12 12.82 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -159.08 101.64 1.6 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -132.46 128.05 36.61 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.4 m -119.85 124.01 45.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -124.22 146.07 48.95 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.462 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 46.0 mm -97.78 115.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -107.72 133.55 51.97 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 p -107.57 170.25 8.09 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.445 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -96.65 136.96 36.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.742 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -98.06 10.88 39.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.684 1.231 . . . . 0.0 108.623 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.3 p -116.13 145.32 43.15 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.236 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.55 159.62 21.02 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.386 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 6.6 m-20 57.82 27.49 14.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.329 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -77.27 130.16 75.67 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.523 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.34 -15.04 14.4 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.234 1.956 . . . . 0.0 111.784 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 164.19 37.75 Favored Glycine 0 N--CA 1.422 -2.278 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.8 158.51 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 123.006 0.523 . . . . 0.0 109.781 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 75' ' ' PHE . 42.7 tp -117.6 107.88 14.79 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 75' ' ' PHE . 3.8 mp -89.1 105.49 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -92.85 119.69 32.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.25 121.6 54.73 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-O 121.225 0.536 . . . . 0.0 111.035 -173.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.04 164.29 21.86 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.615 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -134.89 132.71 38.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.383 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.03 172.23 13.44 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -135.12 120.87 19.55 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.074 0.937 . . . . 0.0 113.088 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 2.6 mmp_? -154.14 166.51 32.87 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.55 54.87 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.151 0.976 . . . . 0.0 110.042 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.9 mtt -133.52 121.19 21.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.35 96.62 3.43 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.373 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -168.25 -45.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.087 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 17.7 m-20 -95.7 71.3 3.05 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -145.29 160.43 41.52 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 113.186 -1.824 . . . . 0.0 107.768 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -89.87 131.08 35.98 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.33 107.84 19.47 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.25 0.547 . . . . 0.0 109.684 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.25 -23.99 27.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.311 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.11 -162.63 28.81 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' HG3' ' OE2' ' A' ' 76' ' ' GLU . 23.3 ptt180 -145.87 162.83 36.84 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.506 ' HB3' ' HB ' ' A' ' 56' ' ' ILE . 7.6 t80 -128.92 130.49 46.84 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' OE2' ' HG3' ' A' ' 74' ' ' ARG . 1.7 mp0 -104.0 104.66 14.65 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -112.14 110.19 20.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 p -130.16 166.75 19.6 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.65 19.05 16.62 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.75 129.63 61.36 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.67 137.71 30.62 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.237 1.958 . . . . 0.0 110.97 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 50' ' ' ASN . 50.5 Cg_exo -56.89 107.24 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 122.59 2.193 . . . . 0.0 112.275 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.01 158.12 76.65 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.8 161.36 18.57 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.02 2.48 . . . . 0.0 112.151 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -65.62 142.27 58.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.04 -7.91 79.87 Favored Glycine 0 C--N 1.308 -1.004 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.945 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.39 -54.07 0.29 Allowed Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.8 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.59 112.62 1.83 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 121.41 1.407 . . . . 0.0 111.225 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -99.93 113.46 26.03 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.257 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -100.41 120.7 50.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 40.1 tt0 -90.6 108.98 20.15 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' THR . 46.2 t -109.05 117.33 54.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.208 0.528 . . . . 0.0 109.696 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 84.8 m -108.59 125.43 51.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.562 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.41 ' CD1' HD22 ' A' ' 29' ' ' LEU . 8.8 m-85 -98.91 112.3 24.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.95 112.56 14.2 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.576 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 26.1 mt -119.12 119.79 61.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.422 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.5 p30 -84.11 176.75 8.59 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.781 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.12 -17.25 51.79 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.512 ' HB3' HG12 ' A' ' 101' ' ' ILE . 66.2 t30 -82.46 -15.23 53.3 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.517 0.675 . . . . 0.0 109.573 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.57 7.13 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 43.1 mm -97.28 114.21 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.92 118.49 36.45 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 25.9 m-80 -106.47 108.02 19.33 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.625 173.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.2 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 15.2 m -107.86 117.54 34.4 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.99 123.62 50.15 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -125.94 121.01 31.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.761 0.315 . . . . 0.0 111.634 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.57 106.98 8.54 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.907 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.9 -19.18 64.98 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -63.06 -49.83 72.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.853 0.359 . . . . 0.0 110.771 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.8 p -109.62 -23.13 11.62 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.77 53.62 2.06 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.2 126.27 50.24 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.965 0.412 . . . . 0.0 111.559 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.31 54.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.462 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -135.88 149.9 49.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 146.77 44.34 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 117.742 0.246 . . . . 0.0 111.273 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 23.0 pt -115.49 128.07 72.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 45.5 m -98.04 113.51 25.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.594 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 64.6 mt -121.84 110.47 27.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.603 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 m -77.87 114.74 17.03 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 168.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.313 61.6 t30 -77.6 81.87 4.04 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 117.759 -1.577 . . . . 0.0 113.942 -174.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -176.21 73.58 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -87.71 -13.93 41.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.877 -1.51 . . . . 0.0 112.313 -171.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.31 32.45 31.34 Favored Glycine 0 C--N 1.31 -0.877 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -118.75 140.87 49.25 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp 66.47 176.22 0.23 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.263 0.977 . . . . 0.0 110.437 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.7 p -104.82 -92.34 0.37 Allowed 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.005 0.431 . . . . 0.0 110.026 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -161.54 -32.4 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 36.2 mt-10 -60.81 -33.08 72.47 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 121.03 0.443 . . . . 0.0 111.414 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -67.99 -31.06 70.5 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.124 0.488 . . . . 0.0 109.908 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.526 ' O ' HG21 ' A' ' 135' ' ' VAL . 2.0 mp -72.45 -53.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.209 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 136' ' ' GLN 0.267 0.0 OUTLIER -66.35 -30.45 70.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.446 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -67.09 -42.44 84.63 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -73.03 -26.38 61.29 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.829 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 131' ' ' ILE . 97.7 t -67.11 -39.18 82.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 27.9 mm-40 -60.41 -47.05 87.78 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.686 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -66.38 -36.45 82.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.796 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.88 73.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.453 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -79.68 -49.2 12.46 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -73.38 -42.48 62.11 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.85 31.55 5.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.36 -55.66 23.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.553 1.541 . . . . 0.0 110.799 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -67.25 -51.81 48.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.691 -175.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -55.04 -51.83 65.08 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.711 0.804 . . . . 0.0 111.05 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.88 -35.52 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -66.02 -37.23 85.38 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.515 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 64.1 t -70.18 -48.1 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.644 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -56.81 -40.2 75.54 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -56.77 -43.9 81.29 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.936 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.22 -6.68 57.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.626 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 36.3 mmt180 -76.48 -33.09 58.69 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 30.9 t -81.73 -31.22 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 172.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t 77.92 139.92 0.07 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.493 1.517 . . . . 0.0 110.479 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 -43.24 10.9 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.015 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 61.28 -164.47 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.186 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 15.1 m120 -122.93 58.88 1.08 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.605 0.716 . . . . 0.0 109.238 174.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.73 149.18 33.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.92 151.88 37.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.14 131.1 42.94 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.834 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.9 p -97.52 25.53 5.65 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.586 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -99.4 99.21 10.1 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.473 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -97.38 -18.98 18.78 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 66.2 t80 71.68 -72.29 0.12 Allowed 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 125.526 1.531 . . . . 0.0 110.19 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -90.72 102.92 15.68 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.043 0.925 . . . . 0.0 110.469 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.2 ptm -139.12 16.03 2.62 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.771 -1.559 . . . . 0.0 107.21 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.92 -34.05 11.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.101 -173.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.0 m -80.01 85.66 5.58 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -99.85 83.76 2.79 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.92 134.09 29.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.602 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -106.81 137.68 44.39 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -176.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.52 -23.5 34.56 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 78.21 140.47 0.07 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.609 1.564 . . . . 0.0 111.758 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -112.99 64.24 0.28 Allowed Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.777 -173.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.24 -63.83 1.38 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.45 -67.07 0.12 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.056 1.343 . . . . 0.0 112.594 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 169.13 57.3 0.03 OUTLIER Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 106.432 -2.667 . . . . 0.0 106.432 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -83.09 -35.43 25.66 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.108 -1.046 . . . . 0.0 109.856 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.3 mp -83.0 91.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 35.2 p -102.17 -25.24 13.78 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.409 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -110.02 97.04 6.63 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -101.67 -62.75 1.22 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.141 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -154.46 155.4 34.84 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -161.8 39.11 0.13 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.053 0.93 . . . . 0.0 108.733 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.438 ' C ' ' HD3' ' A' ' 185' ' ' LYS . 33.7 mmtp -85.57 47.66 1.47 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.869 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.438 ' HD3' ' C ' ' A' ' 184' ' ' LYS 0.303 0.0 OUTLIER 42.57 67.02 0.66 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.769 1.228 . . . . 0.0 112.725 -177.238 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.8 m -103.22 152.97 5.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.917 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.76 149.71 50.13 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.654 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -153.38 167.66 28.68 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.472 ' HZ1' ' HB3' ' A' ' 189' ' ' LYS . 8.9 mtpm? -88.01 -26.5 22.57 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -77.31 86.0 3.73 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -77.96 -13.14 59.98 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.326 1.06 . . . . 0.0 109.664 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 14.8 m -106.78 96.29 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.239 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.9 135.3 27.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 74.7 m -153.58 154.94 35.21 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.662 0.744 . . . . 0.0 112.206 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -136.58 150.04 48.38 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.7 tt -139.43 96.58 3.12 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -130.0 -154.44 0.63 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -61.75 137.39 58.24 Favored 'General case' 0 C--O 1.249 1.076 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -80.2 89.77 5.47 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.024 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 9.0 t -174.92 142.15 0.64 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.7 pp -97.88 138.92 34.51 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -88.61 82.11 6.95 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.153 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -127.82 89.32 2.92 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.046 0.927 . . . . 0.0 110.59 174.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -135.97 87.12 2.28 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.43 -36.9 64.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -87.22 -4.29 59.09 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.861 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -148.62 78.58 1.42 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.535 0.683 . . . . 0.0 110.198 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 210' ' ' HIS 0.339 0.0 OUTLIER -128.68 -94.77 0.42 Allowed 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.277 174.931 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.554 ' H ' ' CD ' ' A' ' 209' ' ' GLU . 41.5 m80 56.82 20.88 5.53 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.471 1.108 . . . . 0.0 111.189 -176.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -88.09 147.61 24.86 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.18 107.79 2.46 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -114.26 99.04 7.3 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.314 1.054 . . . . 0.0 113.646 -172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.83 15.74 18.57 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.81 102.09 13.96 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.767 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.27 117.27 12.58 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -85.07 29.69 0.63 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.446 0.698 . . . . 0.0 112.03 -171.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.5 p -84.96 -2.38 7.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.788 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -121.4 91.08 48.16 Favored Pre-proline 0 C--N 1.308 -1.209 0 O-C-N 121.959 -0.463 . . . . 0.0 110.563 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.21 83.55 1.68 Allowed 'Trans proline' 0 N--CA 1.431 -2.191 0 C-N-CA 121.882 1.721 . . . . 0.0 109.233 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.3 tp -82.59 70.57 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-O 123.246 1.498 . . . . 0.0 111.727 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mt -92.09 76.02 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 27.4 p -81.96 114.2 20.39 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.228 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.71 -59.89 2.28 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.498 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 65.29 179.55 0.19 Allowed 'General case' 0 C--O 1.253 1.252 0 C-N-CA 124.058 0.943 . . . . 0.0 111.696 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -131.47 168.35 17.79 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -87.91 100.03 12.58 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.833 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.9 121.65 5.81 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -134.23 129.76 36.18 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -103.04 -146.94 18.04 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -79.58 117.39 4.5 Favored Glycine 0 C--N 1.308 -1.008 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.66 111.84 3.41 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.34 2.026 . . . . 0.0 111.575 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 154.69 171.18 21.24 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.07 -31.23 24.05 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.759 2.306 . . . . 0.0 111.872 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 107.99 -65.4 0.25 Allowed Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 106.25 126.08 5.59 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -110.81 -18.43 13.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 72.07 -88.71 0.48 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.653 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . 64.95 79.02 0.26 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.763 1.225 . . . . 0.0 112.051 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.48 124.32 1.98 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -139.55 84.98 0.22 Allowed Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.067 -1.063 . . . . 0.0 112.261 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -63.59 129.79 26.14 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.382 2.055 . . . . 0.0 111.052 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -95.95 -7.93 35.22 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.661 0.743 . . . . 0.0 109.8 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.07 -128.04 8.3 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.41 161.96 26.91 Favored Glycine 0 N--CA 1.421 -2.321 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.0 m -79.21 -28.63 42.56 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 154.62 -104.35 0.25 Allowed Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.096 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 31.8 p -169.34 140.7 2.36 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -127.08 -156.31 9.12 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.628 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -85.99 106.58 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 122.831 2.354 . . . . 0.0 110.926 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.0 m -70.21 113.78 7.72 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.2 pt -75.35 94.04 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -171.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -85.41 95.5 9.27 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 172.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -162.05 176.54 10.62 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.973 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 65.8 t 68.1 -79.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.525 1.13 . . . . 0.0 109.43 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.26 1.651 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -178.753 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -99.63 128.48 45.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -81.37 76.28 8.31 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.441 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.11 52.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 123.862 1.791 . . . . 0.0 107.446 174.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -143.84 -47.3 0.28 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -96.37 -160.52 0.8 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.0 tp 71.49 128.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.114 0.966 . . . . 0.0 111.983 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.9 tp -74.99 108.84 7.99 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.04 98.36 2.52 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.05 139.47 52.65 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.549 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 36' ' ' ILE . 33.7 m-20 -108.45 78.34 1.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 m -127.38 176.56 7.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.069 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.66 121.28 84.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.04 -46.35 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.42 2.08 . . . . 0.0 111.633 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.416 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 89.0 mt -128.86 173.97 9.9 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.5 m -82.84 128.56 34.53 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.46 131.85 37.27 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.65 -177.63 25.6 Favored Glycine 0 N--CA 1.413 -2.851 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.673 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 96.9 mt -126.85 150.96 48.96 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.78 109.01 17.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 25.6 p -93.13 -88.89 0.21 Allowed 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.001 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.37 172.04 12.9 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.23 88.36 0.01 OUTLIER Glycine 0 N--CA 1.469 0.882 0 O-C-N 124.71 1.256 . . . . 0.0 115.906 -173.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.66 29.55 71.23 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.773 -0.714 . . . . 0.0 114.211 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.95 136.04 52.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ttt -100.12 130.04 46.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.0 110.847 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.8 m -114.88 115.02 26.27 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.7 126.44 35.32 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.4 mp -95.58 -50.13 5.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -110.71 107.53 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -74.61 149.52 40.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.869 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.8 ptt85 -52.7 147.24 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.291 1.037 . . . . 0.0 112.322 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 76.88 2.9 3.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.255 1.422 . . . . 0.0 113.593 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -77.88 131.84 37.69 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -72.96 140.17 47.23 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 123.162 0.585 . . . . 0.0 111.506 -174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 11' ' ' ASP . 18.7 pt -109.63 161.15 25.21 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 42.6 Cg_exo -62.19 136.84 20.84 Favored 'Cis proline' 0 C--O 1.241 0.672 0 CA-C-N 120.462 1.201 . . . . 0.0 114.57 0.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -107.44 166.21 10.82 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -167.09 102.11 0.54 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -130.31 130.37 44.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 79.5 m -115.49 126.55 54.44 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.119 0.262 . . . . 0.0 110.534 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -127.64 140.32 52.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -104.34 114.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 87.0 m-85 -106.05 138.78 41.63 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.426 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 4.8 p -106.22 170.81 7.7 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -106.54 146.12 31.02 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.792 -1.192 . . . . 0.0 110.916 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' HA ' ' HG2' ' A' ' 85' ' ' ARG . 28.0 m-85 -87.86 -28.55 21.52 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -71.76 139.0 48.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.26 172.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -104.35 154.88 19.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.797 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 61.27 25.43 15.41 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -65.12 133.96 95.8 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -80.37 -19.82 8.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.332 2.021 . . . . 0.0 110.394 171.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.9 153.05 23.47 Favored Glycine 0 N--CA 1.419 -2.435 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.926 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.06 160.42 15.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 tp -118.4 114.53 23.04 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.2 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.05 110.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 36.5 mt-30 -108.46 113.69 26.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.671 -175.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 t -95.19 120.9 45.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.258 0 O-C-N 123.363 0.414 . . . . 0.0 110.602 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.4 146.71 52.01 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.416 ' OE2' ' HB2' ' A' ' 15' ' ' LEU . 15.4 pt-20 -120.48 150.61 40.55 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.853 0.835 . . . . 0.0 110.771 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.34 -174.01 19.8 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.86 95.52 3.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 118.192 0.996 . . . . 0.0 108.712 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -142.93 153.64 43.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.931 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.43 -49.55 10.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.144 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mmm -98.89 105.44 17.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.404 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 95.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.981 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -151.59 -44.51 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.54 11.14 36.2 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.615 0.721 . . . . 0.0 109.654 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.55 161.95 25.67 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.913 -173.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -90.78 115.13 27.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -82.05 113.73 20.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.98 -33.02 19.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.91 162.7 22.66 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -153.67 138.7 17.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -137.75 151.39 48.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.036 0.446 . . . . 0.0 111.46 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.55 133.16 38.47 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.292 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.04 105.13 13.78 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -96.71 151.29 19.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.402 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.7 -0.62 13.77 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 121.117 -0.564 . . . . 0.0 111.835 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.08 133.96 92.82 Favored Pre-proline 0 C--O 1.254 1.319 0 C-N-CA 122.847 0.459 . . . . 0.0 110.675 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.33 134.88 64.37 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.179 2.586 . . . . 0.0 112.476 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -71.44 67.66 2.79 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.596 2.197 . . . . 0.0 110.593 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.52 158.52 75.4 Favored Pre-proline 0 N--CA 1.417 -2.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.086 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.79 178.68 7.3 Favored 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.192 1.928 . . . . 0.0 114.462 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 47' ' ' TYR . 19.3 mtm180 -30.18 115.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.795 2.438 . . . . 0.0 115.138 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.82 -29.75 8.67 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.666 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.58 -51.01 4.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.41 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.92 124.38 14.38 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.447 1.432 . . . . 0.0 109.421 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -134.93 95.61 3.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.221 1.01 . . . . 0.0 110.388 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.7 mm -93.42 112.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.773 -173.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -90.16 111.9 23.21 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 105' ' ' THR . 62.0 t -111.56 125.68 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -177.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.6 m -112.78 124.27 52.21 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.436 ' CD1' HD22 ' A' ' 29' ' ' LEU . 14.5 m-85 -97.7 109.32 22.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.18 114.22 16.04 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 37' ' ' PRO . 59.4 mt -116.44 140.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' HD13 ' A' ' 36' ' ' ILE . 1.3 p-10 -93.45 -176.5 4.13 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.35 -15.14 62.83 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -82.21 -28.76 31.77 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.63 20.15 7.47 Favored Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 78.6 mt -83.8 113.93 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 tp -95.28 118.8 32.68 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 24.0 t-20 -110.39 113.32 25.88 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 174.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.4 113.78 32.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 21.1 m -103.64 126.76 50.98 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.75 126.04 49.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' LYS . 19.8 m -131.84 118.32 19.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.51 107.62 11.3 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -67.56 -20.53 65.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.555 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.6 t -69.44 -52.53 25.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.044 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.0 p -90.06 -32.2 16.82 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.47 43.98 3.56 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 107' ' ' THR . 54.4 mttm -116.59 133.37 56.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.2 136.64 41.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -138.77 145.96 40.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.267 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -143.26 151.0 40.06 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 123.042 0.214 . . . . 0.0 111.288 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 32.0 pt -121.9 141.21 43.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.962 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.1 m -111.14 113.21 25.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.99 103.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.056 0.455 . . . . 0.0 109.977 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -93.75 127.41 39.46 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 72.05 114.65 0.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.453 1.101 . . . . 0.0 111.701 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.76 147.2 23.27 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.737 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.9 mttp 67.56 81.54 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.763 1.225 . . . . 0.0 113.717 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -111.45 -21.49 6.5 Favored Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -84.23 -15.73 45.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.507 0.67 . . . . 0.0 110.361 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.33 152.68 36.34 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.148 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.534 ' O ' HG13 ' A' ' 131' ' ' ILE . 45.8 p -106.61 174.01 6.07 Favored 'General case' 0 C--N 1.28 -2.426 0 O-C-N 124.245 0.966 . . . . 0.0 108.988 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -44.56 -53.28 7.24 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.647 1.179 . . . . 0.0 114.087 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.12 -33.93 75.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.807 0.337 . . . . 0.0 111.391 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 134' ' ' MET . 46.8 mt-10 -70.81 -36.11 72.81 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 127' ' ' SER . 84.4 mt -60.7 -52.02 66.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.793 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.42 -25.1 63.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.509 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 92.2 mmm -59.47 -43.19 93.31 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.3 t -63.24 -47.5 91.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.156 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -57.34 -46.95 82.78 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.82 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.79 -35.61 75.01 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.206 0.316 . . . . 0.0 111.541 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.39 77.97 Favored 'General case' 0 C--O 1.19 -2.064 0 O-C-N 123.472 0.483 . . . . 0.0 110.322 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.08 -48.2 16.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.473 0.654 . . . . 0.0 111.025 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.92 -40.48 96.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.394 -173.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.71 18.11 19.27 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.81 0.338 . . . . 0.0 110.195 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -49.03 -58.93 4.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.458 1.503 . . . . 0.0 112.451 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.55 -34.14 69.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -64.38 -53.42 48.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.044 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 1.4 m-20 -63.6 -36.44 83.81 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.059 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.519 ' OE1' ' HD3' ' A' ' 149' ' ' ARG . 6.9 mm-40 -57.85 -46.43 84.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.021 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 60.2 t -63.32 -40.88 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 32.2 mm-40 -58.78 -54.08 51.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.628 0.771 . . . . 0.0 111.698 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 2.6 ptm180 -68.78 -32.82 72.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.22 -9.91 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.916 0.388 . . . . 0.0 111.752 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 92.2 mtt180 -68.8 -27.67 66.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.24 125.69 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -81.53 75.85 8.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 0.0 111.383 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -101.87 120.47 40.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.577 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -94.67 -163.12 1.01 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 18.1 m120 -76.28 80.16 3.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.847 0.832 . . . . 0.0 109.042 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.618 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.58 153.13 41.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.344 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.2 mt -125.82 136.01 52.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.09 120.2 40.91 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.8 p -155.73 164.79 38.12 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -140.59 143.25 35.16 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.1 89.6 4.83 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 73.44 121.27 0.04 OUTLIER 'General case' 0 C--O 1.245 0.843 0 C-N-CA 125.323 1.449 . . . . 0.0 111.436 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.39 170.67 12.72 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.673 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 68.4 mtm 62.54 74.51 0.43 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.25 1.02 . . . . 0.0 112.157 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -142.57 126.61 17.35 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 47.2 m -145.83 79.05 1.55 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.406 0.622 . . . . 0.0 110.34 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -126.54 112.48 15.59 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.4 m -82.67 123.09 38.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.361 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.03 102.51 11.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -117.21 128.86 55.51 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -172.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 63.14 89.75 0.08 Allowed 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.552 1.541 . . . . 0.0 112.315 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.42 104.07 1.46 Allowed Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.708 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 52.7 tp -81.62 142.23 32.96 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -129.0 169.76 14.29 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 93.08 16.12 48.89 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -131.99 100.62 5.12 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 123.388 0.675 . . . . 0.0 109.577 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.7 mm -76.97 126.63 37.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 8.5 m -51.0 122.14 7.08 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.854 0.862 . . . . 0.0 111.246 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.43 57.03 4.21 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.971 0.891 . . . . 0.0 110.983 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -98.95 87.26 3.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -89.69 150.59 22.27 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.945 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -83.01 96.95 8.5 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.414 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -76.69 113.29 14.18 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -102.58 174.51 5.86 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.19 -53.78 7.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.58 102.88 13.67 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.908 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.0 131.88 15.14 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -81.97 83.64 7.19 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.183 -176.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.459 ' C ' ' H ' ' A' ' 193' ' ' VAL . 7.5 pt20 -128.45 14.15 6.57 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.254 1.026 . . . . 0.0 109.094 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -82.0 30.97 0.38 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.043 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.459 ' H ' ' C ' ' A' ' 191' ' ' GLN . 33.5 m -81.9 -10.95 12.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 124.014 0.926 . . . . 0.0 110.823 -176.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 14.6 tt -109.47 0.77 9.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 122.263 1.03 . . . . 0.0 108.344 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.0 m -121.82 154.46 36.99 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.419 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 25.7 m-90 -105.33 132.26 51.75 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -80.87 -5.9 57.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.232 1.015 . . . . 0.0 109.012 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -107.69 109.43 21.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.51 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -149.99 -41.03 0.14 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -84.87 3.67 36.88 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.201 1.0 . . . . 0.0 109.69 -176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.2 p -83.29 -19.62 35.94 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.194 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.53 136.57 32.97 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -75.49 85.28 2.58 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.054 0.93 . . . . 0.0 110.481 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -102.34 95.2 6.13 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -114.47 -52.69 2.7 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.387 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 63.51 73.28 0.45 Allowed 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.895 1.278 . . . . 0.0 113.537 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -99.3 141.13 32.47 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.771 174.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -120.01 126.68 51.43 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -118.38 106.94 13.25 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.088 0.47 . . . . 0.0 111.557 -173.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -144.84 -34.32 0.36 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.518 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -158.15 138.05 12.24 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.183 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -135.45 10.36 3.46 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.62 111.32 12.59 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.12 164.86 19.98 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.676 -174.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.1 pp -126.07 142.98 51.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 171.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -112.92 146.77 38.38 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.401 -174.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.34 -15.23 58.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . 0.305 13.1 p 52.66 107.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.527 1.531 . . . . 0.0 114.207 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -73.52 123.63 89.61 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.52 87.65 1.52 Allowed 'Trans proline' 0 N--CA 1.44 -1.625 0 C-N-CA 122.185 1.923 . . . . 0.0 111.784 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 25.1 pt -123.04 141.0 45.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.003 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 35.2 pt -127.69 153.54 37.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 26.9 m -143.58 156.58 44.63 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -176.48 -163.54 29.05 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.08 108.29 3.51 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -93.59 -52.54 4.43 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.447 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -97.1 112.92 24.48 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.0 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -127.01 75.36 0.41 Allowed Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.07 153.13 27.52 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.818 0.342 . . . . 0.0 111.118 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -129.41 -175.99 14.26 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.81 86.0 0.38 Allowed Glycine 0 C--N 1.302 -1.353 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.14 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -85.18 92.55 0.69 Allowed 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 122.347 2.031 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -141.82 111.67 0.71 Allowed Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.31 145.17 88.75 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.989 2.459 . . . . 0.0 111.568 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -136.03 -166.49 10.96 Favored Glycine 0 C--N 1.307 -1.049 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.04 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 107.41 59.16 0.57 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -105.14 130.0 53.42 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -154.4 174.22 32.81 Favored Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -135.13 -65.18 0.63 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 117.067 0.433 . . . . 0.0 109.844 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 70.12 164.37 0.26 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.705 1.202 . . . . 0.0 112.091 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 106.28 -154.95 16.79 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.763 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.63 139.63 44.94 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 123.151 2.568 . . . . 0.0 112.456 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -112.46 107.61 16.45 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.97 -51.16 4.53 Favored Glycine 0 C--N 1.316 -0.562 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -172.8 -146.3 5.36 Favored Glycine 0 N--CA 1.415 -2.703 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.7 m -102.93 119.34 38.66 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.81 66.58 2.76 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 35.8 t -143.86 95.74 2.78 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -125.53 96.44 0.49 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.58 -73.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.062 2.508 . . . . 0.0 112.878 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.2 m -132.41 97.26 4.05 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.432 HD13 ' H ' ' A' ' 253' ' ' ILE . 0.2 OUTLIER -116.75 166.59 10.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 73.51 78.52 0.13 Allowed 'General case' 0 C--O 1.243 0.749 0 O-C-N 124.621 1.201 . . . . 0.0 111.22 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -163.7 145.54 9.35 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.638 1.175 . . . . 0.0 107.953 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.71 116.48 34.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.526 0.679 . . . . 0.0 111.771 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--N 1.307 -1.276 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.981 -179.867 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -110.12 105.22 14.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.6 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -85.46 88.85 7.56 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.6 m -80.68 127.53 39.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.369 -175.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 62.07 94.46 0.04 OUTLIER 'General case' 0 C--O 1.238 0.487 0 O-C-N 124.412 1.07 . . . . 0.0 112.508 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -84.73 149.89 25.47 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.819 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.5 tp -93.91 44.41 1.12 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.477 0.656 . . . . 0.0 110.514 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.2 tp -81.58 -62.58 1.6 Allowed 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.04 -0.412 . . . . 0.0 111.155 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.62 -57.49 2.65 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.13 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp 62.5 73.92 0.45 Allowed 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.57 1.148 . . . . 0.0 109.862 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 36' ' ' ILE . 17.2 t70 -123.13 17.59 9.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 123.083 1.42 . . . . 0.0 108.941 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 m -136.37 171.07 17.44 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.136 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.73 118.66 72.61 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.08 -31.98 13.96 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.983 1.788 . . . . 0.0 112.335 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.04 168.83 17.78 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.1 m -92.67 132.44 36.9 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.08 132.03 50.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.92 179.37 28.55 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.352 -176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 92' ' ' VAL . 97.1 mt -118.75 155.47 31.06 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.809 -0.695 . . . . 0.0 109.867 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -88.59 109.35 20.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.401 HG23 ' HG ' ' A' ' 158' ' ' LEU . 17.2 p -105.3 -166.06 1.18 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.489 -174.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.33 134.69 18.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.615 0.766 . . . . 0.0 112.174 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.81 56.07 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.142 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.51 25.14 31.33 Favored Glycine 0 C--O 1.246 0.898 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.0 t -104.52 146.54 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.507 -1.346 . . . . 0.0 109.208 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.4 ttt -87.89 136.43 32.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.213 0.53 . . . . 0.0 111.983 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.6 m -123.74 112.19 17.04 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.85 116.59 29.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.782 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.492 HD21 ' CD2' ' A' ' 94' ' ' PHE . 5.4 mp -79.41 -47.22 16.1 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.04 112.95 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.19 142.46 28.33 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -56.76 155.74 7.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 77.98 1.29 2.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.528 1.531 . . . . 0.0 111.813 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -86.12 128.99 34.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -60.05 144.91 48.33 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.408 1.083 . . . . 0.0 112.109 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 28.4 pt -106.16 169.75 6.57 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 14.7 Cg_exo -69.08 124.77 7.55 Favored 'Cis proline' 0 C--O 1.244 0.817 0 CA-C-N 121.153 1.447 . . . . 0.0 112.257 0.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -87.96 141.7 28.38 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.405 -178.194 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -148.68 100.02 3.06 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.534 ' O ' ' HA ' ' A' ' 93' ' ' THR . 14.8 mm100 -107.01 117.66 34.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 88.3 m -117.31 116.05 26.47 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.454 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 87.5 mt-30 -120.95 151.39 39.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.77 113.22 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -101.59 165.87 11.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.964 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -145.14 170.89 15.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 p -101.36 139.03 37.59 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.706 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -85.76 -18.8 31.98 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 165.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 p -71.8 110.01 6.05 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.031 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.74 126.65 32.62 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m120 62.05 68.49 0.68 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.426 0.632 . . . . 0.0 111.149 -172.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.5 tp-100 -101.56 117.27 62.23 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.72 -31.75 20.1 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.003 1.802 . . . . 0.0 113.349 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.34 140.09 6.74 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.592 -0.814 . . . . 0.0 111.114 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.85 147.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.135 0.493 . . . . 0.0 110.123 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.506 HD22 ' NH1' ' A' ' 74' ' ' ARG . 42.0 tp -114.7 111.56 21.49 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.141 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.73 105.23 16.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 14.1 mt-30 -103.91 115.11 29.85 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.238 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.02 124.04 55.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 O-C-N 123.643 0.59 . . . . 0.0 110.755 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -129.49 154.4 47.04 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.466 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 34.4 tt0 -122.27 147.74 45.85 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.97 125.73 5.66 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -79.51 126.36 30.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -152.84 168.41 25.84 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.482 0.713 . . . . 0.0 110.652 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -84.06 -51.1 7.37 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.52 0.676 . . . . 0.0 109.341 174.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.6 mtt -98.63 128.14 44.81 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.989 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -90.0 117.83 29.09 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.877 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -177.59 -52.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.528 1.131 . . . . 0.0 110.058 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.01 79.95 1.81 Allowed 'General case' 0 CA--C 1.464 -2.349 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.93 177.96 7.45 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 112.802 -1.999 . . . . 0.0 106.012 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 30.3 t30 -90.12 109.07 20.15 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.8 107.42 9.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.977 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.18 -41.79 14.38 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.533 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.37 171.52 38.71 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.068 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.506 ' NH1' HD22 ' A' ' 55' ' ' LEU . 7.2 ptp180 -152.58 140.77 20.41 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -147.15 149.02 32.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -97.21 140.14 32.13 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.7 103.39 9.63 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 170.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 p -111.83 161.46 16.33 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 41.71 3.63 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 42.8 mm -86.34 130.49 49.4 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 147.36 94.72 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.74 2.293 . . . . 0.0 112.359 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.88 84.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 122.685 2.256 . . . . 0.0 111.307 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.6 77.92 Favored Pre-proline 0 N--CA 1.42 -1.949 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.841 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.08 168.94 6.69 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.668 2.246 . . . . 0.0 112.712 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -62.94 149.27 45.1 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.657 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.18 -16.0 41.16 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.511 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.25 -55.17 1.39 Allowed Pre-proline 0 C--O 1.247 0.969 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.264 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.71 109.34 1.42 Allowed 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 121.339 1.359 . . . . 0.0 111.283 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -93.64 115.49 27.96 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.004 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.4 mm -102.46 116.77 46.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 17.0 tt0 -90.18 117.18 28.74 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 105' ' ' THR . 39.2 t -117.85 121.16 66.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.657 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 85.6 m -110.95 123.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.664 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.492 ' CD2' HD21 ' A' ' 29' ' ' LEU . 7.1 m-85 -105.2 108.51 20.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 38' ' ' THR . 7.9 t70 -121.19 132.06 54.61 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.414 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 62.8 mt -126.3 135.6 63.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.87 -170.58 2.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.02 -23.6 64.1 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -77.1 -29.31 54.82 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.169 0.509 . . . . 0.0 110.05 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.02 23.35 7.44 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.9 mt -83.35 117.64 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.3 tp -93.58 117.1 29.66 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -109.73 103.38 12.2 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 64.2 t -89.86 118.63 35.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.467 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 35.7 m -113.41 137.17 51.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 91' ' ' GLU . . . -126.79 121.18 31.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 19.7 m -118.81 123.68 45.35 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.497 0.498 . . . . 0.0 110.738 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.57 109.92 16.47 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -66.96 -17.28 64.84 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.918 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -75.6 -62.85 1.44 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.893 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -94.26 -19.47 20.68 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.55 47.96 3.59 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.821 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 107' ' ' THR . 61.3 mttp -106.78 147.24 29.91 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -149.94 131.83 15.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.338 0.589 . . . . 0.0 111.826 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -136.54 139.14 42.0 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.567 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 61.2 pttt -135.85 148.76 48.79 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 120.722 0.296 . . . . 0.0 110.815 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.4 pt -119.16 139.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -104.27 112.77 25.93 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.23 108.5 25.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.8 p -84.59 163.89 19.03 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.455 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -69.22 -40.33 78.02 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 68.41 -65.55 0.26 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 126.178 1.791 . . . . 0.0 113.194 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -174.73 -61.16 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.32 138.67 5.41 Favored Glycine 0 N--CA 1.418 -2.553 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.764 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -100.9 124.75 47.05 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt 61.71 -95.79 0.05 Allowed 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.417 1.087 . . . . 0.0 109.944 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.5 p -140.66 2.32 1.79 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.66 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.5 tttm 68.38 -51.41 0.55 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.31 1.044 . . . . 0.0 112.097 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.04 -43.09 73.44 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.125 1.37 . . . . 0.0 111.831 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.66 -32.82 73.01 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.051 0.453 . . . . 0.0 111.787 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.417 ' O ' HG21 ' A' ' 135' ' ' VAL . 62.3 mt -72.78 -44.23 59.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.12 -39.58 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.257 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 1.2 mmp_? -60.35 -46.35 90.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.915 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.4 ttt -55.71 -47.06 77.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.077 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 131' ' ' ILE . 69.8 t -58.45 -45.97 89.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.362 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.65 -31.8 70.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.433 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 37.1 mt-10 -64.94 -47.7 76.73 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.32 -30.63 68.49 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.231 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.493 ' HA ' ' HG2' ' A' ' 142' ' ' LYS . 31.8 mt-10 -78.15 -31.55 49.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -70.62 -19.16 62.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.118 0.961 . . . . 0.0 109.291 174.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.42 27.4 8.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.33 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' A' ' 139' ' ' GLU . 5.1 mmtt -48.98 -52.47 24.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.788 0.835 . . . . 0.0 112.882 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.433 ' O ' HG21 ' A' ' 147' ' ' VAL . . . -70.54 -51.97 24.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 148' ' ' GLN 0.258 1.4 pm0 -60.28 -45.88 91.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.8 -45.62 88.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.17 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . 0.251 35.8 mt-10 -70.28 -32.53 70.37 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.735 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 143' ' ' ALA . 89.4 t -65.7 -45.77 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 14.4 mm100 -58.08 -43.88 87.28 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 110.752 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.425 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 2.6 tmt_? -61.86 -41.0 97.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.725 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 -11.48 42.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -62.4 -44.41 96.5 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.303 0.573 . . . . 0.0 110.056 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.79 113.68 18.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -77.87 95.54 4.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.93 -21.0 17.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.892 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 63.61 -77.99 0.03 OUTLIER 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.085 1.354 . . . . 0.0 111.398 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -178.26 40.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.44 156.73 34.95 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.533 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.401 ' HG ' HG23 ' A' ' 21' ' ' THR . 1.0 OUTLIER -122.63 153.14 39.73 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.495 0.664 . . . . 0.0 110.622 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.25 158.25 29.88 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 168.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.4 m -135.62 130.11 33.9 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.949 -175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -161.11 173.86 14.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 63.93 79.1 0.27 Allowed 'General case' 0 C--O 1.246 0.878 0 O-C-N 124.581 1.176 . . . . 0.0 111.366 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -79.85 121.61 25.61 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.093 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.4 91.91 6.35 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.748 0.785 . . . . 0.0 110.311 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 66.3 mtt -127.26 35.21 4.59 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -52.97 125.25 16.55 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.163 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m -65.67 108.11 1.97 Allowed 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.417 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.72 89.13 3.0 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.0 m -117.87 -19.28 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.138 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.15 16.24 3.24 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -63.38 144.69 56.74 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.641 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.08 90.86 3.31 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-O 121.842 0.83 . . . . 0.0 112.237 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -121.15 25.68 6.98 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 173.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.6 8.55 11.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.12 -1.04 . . . . 0.0 112.712 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -86.07 92.16 8.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.17 116.95 5.05 Favored Glycine 0 N--CA 1.425 -2.062 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.222 -173.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -93.39 81.05 4.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.8 pt -96.42 -35.96 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.378 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 18.3 m -101.17 -18.23 16.27 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.263 0.554 . . . . 0.0 110.086 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -94.39 88.27 5.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -99.04 108.05 20.61 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -84.39 113.84 21.46 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.01 0.909 . . . . 0.0 111.634 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -179.63 168.6 1.39 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 127.047 2.139 . . . . 0.0 106.32 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -68.94 -38.24 79.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 118.054 0.388 . . . . 0.0 111.795 -175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 72.31 -60.52 0.53 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.564 1.146 . . . . 0.0 112.903 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.85 132.06 64.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.0 mp -95.06 78.03 3.54 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.442 0.639 . . . . 0.0 110.286 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -165.89 158.44 14.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? 74.14 120.26 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.111 0.964 . . . . 0.0 110.967 -173.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -106.38 86.88 2.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.38 -53.61 6.74 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.036 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.62 136.14 23.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.7 mt -120.88 -58.68 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.992 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 33.2 t -84.05 99.43 10.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 120.893 0.377 . . . . 0.0 110.09 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -84.97 84.54 7.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -88.08 97.99 11.29 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -136.31 8.8 3.17 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.193 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -77.77 80.97 4.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.325 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -159.08 113.0 2.36 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 9.0 m -106.81 -56.54 2.18 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -74.78 117.95 17.2 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -134.27 -46.25 0.77 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 66.35 115.13 0.03 OUTLIER 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.411 1.484 . . . . 0.0 113.708 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -140.23 101.81 4.22 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 172.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -128.73 137.84 51.8 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -92.57 172.31 8.45 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.059 0.457 . . . . 0.0 111.969 -175.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -76.36 153.43 35.79 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.195 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -148.81 -51.59 0.16 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -60.82 -22.97 64.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.795 -174.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -62.55 -43.0 99.89 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.112 0.482 . . . . 0.0 110.077 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 212' ' ' ARG . 37.1 mmt180 -83.47 135.21 34.75 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.424 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -149.63 -67.27 0.21 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 57.68 101.13 0.02 OUTLIER 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.891 1.276 . . . . 0.0 112.754 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.43 167.22 21.63 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -100.82 -10.52 20.65 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.152 -171.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 60.26 31.13 20.36 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.551 0.741 . . . . 0.0 109.15 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.74 77.37 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 123.163 1.459 . . . . 0.0 112.794 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -92.63 118.65 68.07 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.577 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.43 151.56 33.4 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.561 2.174 . . . . 0.0 111.213 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.459 ' H ' HD11 ' A' ' 222' ' ' ILE . 0.2 OUTLIER -80.33 105.81 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.775 0.798 . . . . 0.0 110.924 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.0 pt -92.54 -2.51 10.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.356 0.598 . . . . 0.0 110.334 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 13.6 p -149.09 178.86 8.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.043 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -149.29 150.49 22.61 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.07 95.2 6.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -137.05 -81.44 0.37 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.692 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 64.0 171.88 0.18 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.906 1.283 . . . . 0.0 111.298 -174.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -132.84 -153.84 7.36 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -120.56 -27.48 5.13 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 117.093 0.446 . . . . 0.0 110.498 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 66.58 43.55 91.93 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 107.9 82.89 1.49 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 -174.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.02 -25.93 78.08 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.174 2.583 . . . . 0.0 113.181 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 142.94 94.91 0.21 Allowed Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.274 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.79 -24.89 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.319 2.013 . . . . 0.0 112.347 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.41 -177.82 17.07 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -101.39 -45.4 1.84 Allowed Glycine 0 C--O 1.246 0.904 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.101 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 73.41 149.17 0.1 Allowed 'General case' 0 C--O 1.252 1.196 0 C-N-CA 124.749 1.22 . . . . 0.0 113.72 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 112.31 -60.09 0.35 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.518 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -154.38 167.54 29.64 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.38 16.95 12.18 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 158.87 -75.77 0.2 Allowed Glycine 0 C--N 1.311 -0.824 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -80.65 116.31 3.2 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.128 1.886 . . . . 0.0 110.098 174.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.75 -41.43 90.97 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 123.118 0.567 . . . . 0.0 110.167 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.73 127.66 2.08 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -71.73 173.46 44.33 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.6 m -82.3 -24.12 34.82 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.231 0.539 . . . . 0.0 109.972 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 179.61 79.53 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.849 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 43.1 m -135.09 130.46 35.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -92.66 -146.22 18.51 Favored Glycine 0 C--O 1.248 0.986 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.37 96.04 0.4 Allowed 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.236 1.957 . . . . 0.0 109.486 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 26.5 m -88.91 73.93 8.29 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 122.584 1.183 . . . . 0.0 110.657 -174.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.88 134.64 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 CA-C-N 113.085 -1.871 . . . . 0.0 106.917 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.45 114.09 24.71 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -134.75 82.58 1.97 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 122.022 0.915 . . . . 0.0 110.728 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 13.6 p -130.67 -2.39 2.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.525 -1.216 . . . . 0.0 107.885 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 C--O 1.255 1.387 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.216 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.438 -1.031 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.43 133.2 33.77 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -84.69 100.61 11.58 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.005 0.907 . . . . 0.0 110.199 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.41 13.03 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.689 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -112.42 102.07 10.22 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.28 111.69 19.2 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.197 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.4 tp -90.43 93.32 9.26 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -116.49 75.86 0.99 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.279 1.038 . . . . 0.0 111.618 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.06 -57.75 2.01 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.0 mt -108.03 76.03 1.03 Allowed 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -98.07 37.9 1.38 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 112.983 -1.917 . . . . 0.0 109.955 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.59 146.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.767 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 121.59 46.86 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.455 171.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.405 ' C ' HD11 ' A' ' 15' ' ' LEU . 36.9 Cg_exo -57.58 -58.97 0.65 Allowed 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 5.8 mp -126.77 176.43 7.27 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.2 m -80.93 119.8 23.92 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -92.5 132.07 37.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.853 0.72 . . . . 0.0 109.274 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.72 -169.9 19.19 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.243 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -131.52 163.23 28.46 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.499 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 34.5 tt0 -87.89 109.07 19.51 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 123.0 1.381 . . . . 0.0 109.802 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 11.9 p -85.74 160.21 19.58 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.494 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.54 118.49 1.79 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 125.502 1.521 . . . . 0.0 113.665 -173.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.94 4.25 39.07 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.637 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.98 39.51 27.7 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.8 t -108.44 146.77 13.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -101.87 127.81 48.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.477 0.656 . . . . 0.0 109.285 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.7 m -123.89 116.15 22.44 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.8 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.55 141.35 29.11 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.754 0.659 . . . . 0.0 111.172 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.37 -39.81 6.03 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.58 112.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -79.0 154.42 29.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.342 0.591 . . . . 0.0 110.501 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -64.37 149.81 47.55 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.47 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 66.38 20.79 10.96 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 124.408 1.083 . . . . 0.0 111.881 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.6 t -90.39 126.96 36.05 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.5 119.73 7.54 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.806 0.842 . . . . 0.0 113.263 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.7 pt -101.46 162.25 21.05 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.66 -1.154 . . . . 0.0 107.925 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 137.13 12.24 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 CA-C-N 121.341 1.515 . . . . 0.0 115.152 1.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 p -107.6 154.93 20.71 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -146.83 103.74 3.66 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.97 121.32 20.31 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 m -127.95 115.97 19.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.551 0.215 . . . . 0.0 110.876 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -115.36 153.08 31.65 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.22 114.13 41.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.96 151.13 19.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.6 p -122.1 169.91 10.39 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 33.7 p -95.84 136.94 35.61 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.92 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -107.61 -1.1 21.5 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.245 0.545 . . . . 0.0 111.139 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -101.77 138.91 38.12 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.8 139.5 34.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.44 18.49 11.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.49 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 46.2 tt0 -60.22 114.79 10.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 123.045 0.538 . . . . 0.0 110.226 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.33 -5.78 10.16 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.791 2.327 . . . . 0.0 113.892 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.13 150.34 14.49 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.632 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.2 165.08 24.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.0 tp -117.92 127.82 54.21 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 3.0 mp -98.42 98.34 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.66 110.1 21.04 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.54 114.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.953 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 20' ' ' GLU . 68.6 m-85 -107.69 156.37 19.15 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.529 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 39.8 tt0 -134.99 137.81 43.38 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.74 -107.03 1.14 Allowed Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.261 -0.971 . . . . 0.0 114.785 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.407 ' HA ' HH11 ' A' ' 63' ' ' ARG . 41.8 mt-10 -79.1 158.54 27.77 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.344 1.058 . . . . 0.0 109.414 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.407 HH11 ' HA ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -122.48 -46.31 2.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.705 0.764 . . . . 0.0 112.639 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . . . -71.97 -28.43 63.43 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.538 0.685 . . . . 0.0 110.805 -173.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.5 mmt -134.57 111.47 10.08 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.706 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.1 91.57 4.31 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -144.71 -58.54 0.36 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -105.45 25.95 10.07 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.489 0.661 . . . . 0.0 109.518 -175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -74.54 160.96 30.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.377 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -93.76 129.99 39.92 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.441 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 62.2 tp -101.69 111.01 23.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.93 -51.13 7.4 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.26 159.02 32.09 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.848 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 78.5 mtm180 -138.15 136.94 37.18 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.84 144.87 30.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.49 133.58 39.32 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.55 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 5.5 tt -113.46 104.05 11.89 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 172.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -120.54 155.39 33.74 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.12 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.12 7.53 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.5 mt -79.16 132.92 61.76 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.36 125.19 13.56 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.504 2.136 . . . . 0.0 111.249 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.25 101.85 0.2 Allowed 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.668 2.246 . . . . 0.0 111.94 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.77 157.61 59.33 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.76 50.73 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.762 2.975 . . . . 0.0 113.312 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 46' ' ' THR . 39.5 ptt180 56.42 164.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.142 2.177 . . . . 0.0 113.89 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.55 -44.2 2.21 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.346 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.6 -50.24 73.37 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 123.976 0.91 . . . . 0.0 113.171 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.75 123.24 11.38 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 121.576 1.517 . . . . 0.0 110.985 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -117.23 115.21 24.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.479 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.33 105.58 18.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -90.62 107.78 19.38 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -107.9 124.48 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.179 0.514 . . . . 0.0 111.118 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.3 m -103.86 121.93 44.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.727 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.56 107.94 19.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.36 125.14 40.2 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.883 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.25 131.75 72.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.9 p30 -89.79 -169.76 2.57 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.376 0.422 . . . . 0.0 110.335 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.85 2.1 47.16 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.122 -0.361 . . . . 0.0 111.958 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -96.01 -13.6 23.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.56 30.18 12.4 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 67.2 mt -102.05 116.46 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.091 0.472 . . . . 0.0 109.889 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.21 111.23 22.81 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.979 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.03 114.42 27.72 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.94 126.58 58.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 122.28 31.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.82 117.83 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.6 m -113.6 117.96 33.07 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.533 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.85 107.87 11.88 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -67.31 -20.21 65.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.613 0.765 . . . . 0.0 110.779 -177.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -69.33 -54.6 13.75 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.785 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.9 p -99.05 -15.44 19.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.058 0.456 . . . . 0.0 112.056 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 30.36 36.22 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.499 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -115.36 158.57 22.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.546 0.673 . . . . 0.0 109.504 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.64 155.88 48.66 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.55 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.1 m120 -129.35 127.61 41.42 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -119.29 145.31 46.23 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.812 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.4 tt -136.64 148.77 26.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 m -113.61 112.93 24.33 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.2 mm -107.58 94.19 2.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t -88.11 122.33 31.56 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.856 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 71.72 -85.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.098 1.359 . . . . 0.0 109.624 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.14 161.6 33.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -142.13 23.71 2.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -81.88 -26.11 50.59 Favored Glycine 0 CA--C 1.497 -1.081 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.128 -174.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 69.1 3.3 4.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.057 0.943 . . . . 0.0 113.245 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.31 147.2 26.66 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.9 p -63.26 145.58 55.23 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 123.732 0.645 . . . . 0.0 110.236 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -55.62 -36.77 67.34 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 122.811 0.444 . . . . 0.0 111.42 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 41.4 mt-10 -57.44 -40.3 78.14 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.642 ' O ' ' HG3' ' A' ' 134' ' ' MET . 8.9 mm-40 -67.07 -42.35 84.84 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.413 ' O ' HG21 ' A' ' 135' ' ' VAL . 61.9 mt -63.7 -41.94 94.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.47 -38.3 90.61 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.206 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 42.4 mtm105 -63.61 -42.12 98.24 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.642 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 53.4 mtt -59.86 -35.88 75.71 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.195 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 131' ' ' ILE . 58.9 t -56.77 -52.84 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -63.8 -42.17 97.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.523 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.0 mm-40 -64.76 -40.37 95.17 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.79 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.653 0.381 . . . . 0.0 111.274 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 25.4 mm-40 -77.85 -38.38 46.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.459 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -65.27 -38.76 91.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.348 0.594 . . . . 0.0 109.925 -179.434 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -111.57 28.63 8.56 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.927 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 139' ' ' GLU . 17.9 pttm -62.43 -45.25 93.96 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.47 67.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.397 0.618 . . . . 0.0 109.501 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -71.5 -54.15 11.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.184 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 1.1 m-20 -67.09 -55.2 15.29 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.14 -33.79 76.58 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -172.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.24 -47.82 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.184 175.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 152' ' ' VAL . 16.5 mm-40 -61.32 -41.39 96.94 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -55.29 -47.32 75.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -70.03 -9.51 55.53 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -97.9 0.59 46.85 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 148' ' ' GLN . 61.7 t -96.31 133.11 38.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 t -82.38 21.38 0.95 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.877 0.471 . . . . 0.0 112.014 -173.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.16 -21.76 59.71 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 50.06 -91.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.578 1.551 . . . . 0.0 113.177 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -155.1 67.73 0.68 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.17 140.3 41.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.168 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 76.1 mt -93.13 152.56 19.18 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -93.52 147.22 23.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.249 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.49 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 48.1 t -88.78 -26.57 21.65 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 80.7 t80 69.06 112.65 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.926 1.29 . . . . 0.0 112.16 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.09 135.27 33.35 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.466 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -164.41 -57.95 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -93.18 113.48 25.71 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.819 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.9 mmm -75.47 -17.61 60.08 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.273 0.559 . . . . 0.0 110.69 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -81.06 137.73 36.0 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.1 p -73.5 158.24 35.28 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.615 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.82 116.71 4.28 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.9 t -80.67 -60.3 2.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.146 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -145.61 152.25 39.38 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.609 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.77 117.24 24.52 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -89.0 -27.38 20.92 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.047 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.09 61.26 4.6 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.986 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.48 -56.03 3.53 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -75.99 109.36 9.57 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.94 -16.79 7.73 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -60.36 -43.73 96.26 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.523 0.678 . . . . 0.0 110.209 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 55.0 mt -69.9 -30.77 45.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.91 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 65.3 m 71.1 -61.03 0.49 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.944 1.298 . . . . 0.0 111.79 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 67.36 -69.58 0.13 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.806 1.242 . . . . 0.0 110.506 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -146.15 80.81 1.58 Allowed 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -85.46 111.09 19.65 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -129.14 135.69 49.2 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 53.31 -158.12 0.16 Allowed 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.003 0.814 . . . . 0.0 109.597 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -143.8 -30.32 0.49 Allowed 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 123.448 0.699 . . . . 0.0 110.652 169.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.76 82.95 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.424 ' HB3' ' SG ' ' A' ' 190' ' ' SMC . 7.2 mp -75.34 -48.76 21.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.5 t70 62.6 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.965 -1.47 . . . . 0.0 113.236 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -114.85 105.39 12.96 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.661 0.743 . . . . 0.0 111.454 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . 0.424 ' SG ' ' HB3' ' A' ' 187' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.35 -174.11 2.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.844 -172.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -52.33 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.141 1.777 . . . . 0.0 114.549 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.85 141.65 39.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 171.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.5 -37.03 6.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.9 m 78.53 130.64 0.05 Allowed 'General case' 0 C--O 1.249 1.055 0 C-N-CA 125.603 1.561 . . . . 0.0 110.723 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 73.88 -55.59 0.66 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.352 1.461 . . . . 0.0 111.138 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.8 mp -71.37 -15.35 62.37 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 122.749 0.42 . . . . 0.0 110.744 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.26 -55.04 13.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.364 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 64.36 100.94 0.04 OUTLIER 'General case' 0 C--O 1.238 0.47 0 O-C-N 124.643 1.214 . . . . 0.0 108.124 -173.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -39.05 -68.89 0.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.443 1.089 . . . . 0.0 112.476 -171.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 5.8 m 57.85 34.25 24.15 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.593 1.187 . . . . 0.0 109.981 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 94.1 mt -143.15 -172.07 3.61 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -76.62 0.45 20.15 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.308 0.575 . . . . 0.0 111.328 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.33 23.05 1.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.392 0.677 . . . . 0.0 109.88 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -85.76 -170.97 3.35 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 74.71 107.06 0.07 Allowed 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 124.698 1.199 . . . . 0.0 111.205 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -75.33 124.75 27.64 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -108.09 147.14 31.63 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -70.86 115.84 10.47 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.422 0.451 . . . . 0.0 110.141 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -110.76 151.84 27.3 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -84.67 106.1 15.96 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.539 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.4 90.12 3.07 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -104.34 128.17 52.11 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.339 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -122.41 112.65 18.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.163 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp -100.07 109.35 21.66 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.912 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -101.8 139.52 37.33 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -149.73 156.04 41.18 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 122.142 0.177 . . . . 0.0 110.6 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.1 m -129.02 161.03 39.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 O-C-N 123.326 0.391 . . . . 0.0 110.734 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -123.82 100.57 37.13 Favored Pre-proline 0 C--N 1.309 -1.162 0 C-N-CA 121.386 -0.126 . . . . 0.0 111.331 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.21 125.98 14.35 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.034 1.822 . . . . 0.0 108.514 173.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 6.1 tp -111.05 114.83 48.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.502 0.668 . . . . 0.0 111.675 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 36.8 pt -101.42 140.18 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.269 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 41.9 m -143.88 105.68 4.33 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -149.94 73.12 0.29 Allowed Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.42 HD21 ' H ' ' A' ' 226' ' ' LEU . 1.9 pt? -117.83 -6.98 11.01 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -97.64 109.72 22.42 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.46 158.6 32.44 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.763 -1.562 . . . . 0.0 107.467 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.89 85.45 0.78 Allowed Glycine 0 C--N 1.315 -0.636 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -94.23 116.13 28.49 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 122.94 0.496 . . . . 0.0 110.159 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -119.08 154.5 16.44 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.47 114.53 1.55 Allowed Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -88.17 123.08 1.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.692 2.261 . . . . 0.0 112.156 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -129.56 111.06 1.13 Allowed Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.576 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.3 148.9 85.14 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.706 2.271 . . . . 0.0 111.428 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -75.17 -43.48 25.91 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 141.62 157.54 7.2 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -144.26 113.21 6.78 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -144.9 168.8 26.84 Favored Glycine 0 C--N 1.301 -1.371 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -157.15 108.87 2.39 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 117.353 0.577 . . . . 0.0 109.52 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -140.5 163.55 32.52 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.794 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 156.37 -161.18 30.7 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.37 143.67 97.28 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.463 2.775 . . . . 0.0 112.681 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -78.21 172.86 12.94 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.86 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -86.55 54.75 4.67 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -146.53 39.56 1.09 Allowed Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.7 m -69.05 112.28 5.57 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -91.93 -138.99 8.45 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.879 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 9.3 m 72.05 141.88 0.06 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.787 1.235 . . . . 0.0 110.458 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 113.02 -92.81 0.64 Allowed Glycine 0 C--N 1.302 -1.311 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -80.08 60.61 7.9 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.597 2.198 . . . . 0.0 110.833 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.3 t -125.5 4.88 7.6 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.138 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 38.0 pt -128.33 141.15 47.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.729 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -168.34 133.84 1.8 Allowed 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 122.978 0.511 . . . . 0.0 110.618 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.55 122.21 47.23 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 34.3 m -77.37 164.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 C--N 1.3 -1.545 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.039 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -82.79 102.09 11.35 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -110.67 160.99 16.2 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.003 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.47 120.5 45.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -83.99 119.56 25.07 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.937 0.398 . . . . 0.0 111.961 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -102.91 96.87 7.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.9 mt -68.07 130.8 44.04 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.111 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.6 tp -97.9 3.23 49.74 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.98 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 tp 71.29 -69.15 0.19 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.975 1.31 . . . . 0.0 109.727 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.66 123.44 46.37 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 36' ' ' ILE . 7.5 m-20 -86.03 75.65 9.92 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.72 179.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.246 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.59 130.79 54.57 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.28 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.24 -60.9 0.27 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.871 2.38 . . . . 0.0 112.359 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.18 174.34 6.39 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -69.51 127.43 32.97 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -95.21 140.62 29.86 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.553 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.58 -171.33 21.31 Favored Glycine 0 N--CA 1.42 -2.393 0 C-N-CA 119.552 -1.309 . . . . 0.0 113.796 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -133.71 156.9 47.11 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.403 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 35.5 tt0 -102.2 109.03 20.61 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 170.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.6 p -98.6 -63.93 1.08 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 122.39 1.091 . . . . 0.0 109.242 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' CB ' ' HG3' ' A' ' 159' ' ' GLU . . . -101.43 155.17 18.22 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.52 28.03 4.01 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.177 -1.011 . . . . 0.0 115.032 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.54 -61.01 0.18 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.99 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.53 145.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 120.729 0.3 . . . . 0.0 111.099 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.76 128.0 33.97 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -107.86 111.42 23.54 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.47 135.81 36.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.742 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.77 -49.24 3.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.255 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.36 128.77 48.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -85.06 158.28 20.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.5 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 12.9 ptm180 -61.89 149.98 38.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.964 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 m120 68.37 11.41 8.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.111 0.964 . . . . 0.0 112.65 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.1 t -75.71 122.38 23.92 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -62.65 126.83 28.68 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.107 0.963 . . . . 0.0 112.945 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 11' ' ' ASP . 21.3 pt -87.52 152.3 51.87 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_exo -67.82 124.23 6.3 Favored 'Cis proline' 0 C--O 1.241 0.668 0 N-CA-C 115.241 1.208 . . . . 0.0 115.241 4.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -96.79 158.13 15.58 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.023 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -165.58 108.56 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 93' ' ' THR . 26.7 mm-40 -121.85 137.59 54.72 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.934 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.4 m -121.8 117.28 26.16 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.185 0.928 . . . . 0.0 109.788 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -125.48 147.87 49.07 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.8 mm -95.9 117.56 40.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.405 0.621 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.14 153.9 20.91 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.312 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 10.8 p -135.11 171.11 14.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 30.7 p -101.87 148.76 24.94 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.829 0.74 . . . . 0.0 109.85 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 37.1 m-85 -81.21 -65.33 1.03 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.16 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -75.69 144.83 41.37 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.78 145.88 44.71 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.551 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 68.62 35.46 3.14 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -73.98 118.17 67.24 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.46 -24.62 10.42 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.032 1.821 . . . . 0.0 111.951 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.01 159.02 29.26 Favored Glycine 0 N--CA 1.411 -2.976 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.92 153.21 33.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 O-C-N 123.945 0.438 . . . . 0.0 109.963 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.0 tp -106.22 115.84 30.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.11 106.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.4 ' HG3' ' HB3' ' A' ' 74' ' ' ARG . 15.1 tt0 -112.47 121.43 44.82 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.0 t -90.32 135.23 26.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.574 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 90.4 m-85 -136.66 167.63 21.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.803 0.811 . . . . 0.0 111.282 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' CG ' ' HB2' ' A' ' 70' ' ' ASN . 13.4 pt-20 -136.01 151.51 49.96 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 170.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.65 136.49 3.88 Favored Glycine 0 C--N 1.277 -2.703 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.5 ' OE2' ' HD2' ' A' ' 32' ' ' ARG . 30.6 mt-10 -101.44 95.62 6.61 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 -174.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 20.7 mmt180 -146.29 170.45 16.75 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.236 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 145' ' ' ASP . . . -86.44 -49.76 7.37 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.557 175.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.3 mtt -98.9 137.27 37.71 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.587 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.42 85.58 2.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.177 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -146.92 -52.17 0.21 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 7.5 m-20 -94.34 70.03 3.7 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -145.13 150.24 36.43 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.982 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.542 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 85.0 m-20 -90.68 131.57 36.29 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.08 118.41 28.78 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 mp -92.31 -56.91 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.801 0.334 . . . . 0.0 111.186 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.08 163.52 31.01 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' O ' ' HD3' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -153.2 135.39 14.88 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.9 150.12 41.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -94.97 129.98 41.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 tt -120.0 104.79 10.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 p -121.99 165.4 16.07 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.27 -0.11 14.38 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.51 125.62 88.95 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.458 0.703 . . . . 0.0 109.638 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.78 168.69 22.17 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.07 2.513 . . . . 0.0 111.853 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.08 90.93 0.12 Allowed 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.546 2.164 . . . . 0.0 111.823 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . . . -131.41 147.55 66.59 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.574 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 2.1 Cg_endo -86.6 -171.03 0.72 Allowed 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.425 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 46' ' ' THR . 51.8 ttp180 -59.07 131.93 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.1 0.96 . . . . 0.0 111.54 -177.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 -8.5 64.89 Favored Glycine 0 C--N 1.308 -0.979 0 CA-C-N 115.833 -0.621 . . . . 0.0 114.295 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.6 t -82.88 -54.29 0.57 Allowed Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.25 107.52 2.46 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.336 1.358 . . . . 0.0 110.107 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -94.87 113.39 25.12 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.1 mm -98.24 115.25 37.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.04 113.46 25.72 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -116.64 123.21 71.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 42.1 m -129.45 124.58 34.41 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.3 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -123.6 138.23 54.59 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.927 174.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -134.31 153.2 52.01 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.499 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 64.6 mt -130.91 135.73 59.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.419 ' O ' HD11 ' A' ' 36' ' ' ILE . 1.2 p-10 -84.81 -173.02 4.5 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.88 -13.02 60.26 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.408 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 47.6 m-80 -85.31 -29.51 24.48 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.74 28.81 2.83 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.494 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 68.9 mt -88.35 116.29 29.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 tp -95.66 120.78 36.51 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.95 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -119.99 104.2 9.95 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 44.9 t -94.12 125.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.1 m -123.45 123.44 40.65 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.61 130.62 53.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.1 m -131.58 126.8 35.71 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -83.86 116.6 22.83 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.206 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -67.19 -19.33 65.55 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -74.31 -54.5 7.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.4 p -91.5 -37.01 13.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.14 14.19 36.89 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.03 136.87 35.18 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.475 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.91 137.68 45.06 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.303 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -133.09 138.75 46.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 62.4 pttt -131.4 158.34 41.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.866 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.9 141.0 44.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.1 m -128.5 113.29 15.31 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.1 mt -113.65 111.08 34.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.8 t -92.42 100.98 13.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 59.65 -164.25 0.22 Allowed 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.991 0.916 . . . . 0.0 108.719 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 t70 64.96 -160.33 0.28 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -168.59 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.17 -122.17 3.58 Favored Glycine 0 N--CA 1.415 -2.755 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -99.04 20.46 13.29 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.5 mt -124.29 141.26 52.22 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.614 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.2 p -120.55 -178.7 3.77 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.975 0.416 . . . . 0.0 111.869 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 131' ' ' ILE . 53.3 tttm -58.74 -28.7 66.11 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.867 1.267 . . . . 0.0 111.296 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.89 -40.04 95.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -68.77 -38.13 79.83 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.593 ' O ' HG21 ' A' ' 135' ' ' VAL . 54.1 mt -55.76 -54.11 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.726 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 45.5 mt-10 -66.38 -35.26 79.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.89 -44.13 94.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.265 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.5 mtt -72.55 -30.26 64.28 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.593 HG21 ' O ' ' A' ' 131' ' ' ILE . 60.0 t -62.94 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 53.7 mt-30 -55.66 -47.22 77.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.274 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.737 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.26 74.3 Favored 'General case' 0 C--O 1.196 -1.731 0 C-N-CA 122.568 0.347 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.22 -32.63 74.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.909 0.385 . . . . 0.0 111.404 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.26 -41.97 56.11 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.585 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -108.31 11.67 27.03 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.16 -43.77 64.25 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.146 0.978 . . . . 0.0 111.554 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.37 85.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.7 -38.57 47.09 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.281 -0.568 . . . . 0.0 112.248 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.417 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 1.8 m-20 -64.3 -33.46 75.89 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.976 0.417 . . . . 0.0 109.934 174.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.68 -50.37 74.12 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.456 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 54.7 t -62.06 -46.43 96.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -55.49 -47.45 76.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.476 0.711 . . . . 0.0 111.494 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -68.15 -47.34 68.32 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.88 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -68.76 -10.73 58.3 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.2 mmt180 -72.76 -10.97 60.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.332 0.587 . . . . 0.0 110.022 172.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.15 115.77 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -55.39 -45.35 76.62 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 123.314 0.646 . . . . 0.0 112.648 -172.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.44 158.83 43.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.489 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -136.69 31.51 2.79 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -86.46 33.64 0.63 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.933 -177.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -139.56 134.14 31.77 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.29 151.71 19.27 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 121.307 0.575 . . . . 0.0 111.207 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.441 ' HG3' ' CB ' ' A' ' 22' ' ' ALA . 41.9 mt-10 -116.72 121.61 42.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 41.9 t -75.94 111.67 11.55 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.832 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -102.32 164.34 11.73 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.884 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.38 95.59 1.36 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.076 0.465 . . . . 0.0 110.704 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -83.11 158.13 22.53 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.223 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -77.09 136.99 38.67 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.239 0.542 . . . . 0.0 110.811 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 69.0 mtm -92.58 176.05 6.6 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.191 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -81.05 132.18 35.35 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.064 0.459 . . . . 0.0 112.009 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.2 m -138.53 101.35 4.33 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -164.35 105.14 0.86 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.9 t -135.67 107.51 7.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 173.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.47 -69.45 0.6 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.546 0.689 . . . . 0.0 110.064 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -165.0 132.39 3.06 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -96.45 -19.69 18.97 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -93.15 49.2 2.44 Favored Glycine 0 CA--C 1.495 -1.212 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.641 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.14 156.32 25.79 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 66.03 -172.87 0.18 Allowed 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.046 0.939 . . . . 0.0 112.689 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -154.64 172.78 33.1 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -99.92 8.24 44.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 118.092 0.946 . . . . 0.0 111.021 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.89 175.73 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.344 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 50.2 m -146.65 94.83 2.49 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -105.67 112.36 25.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.574 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -133.2 153.52 51.47 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -105.95 93.2 4.5 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.395 0.617 . . . . 0.0 110.344 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -112.34 106.51 15.06 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -134.49 163.21 30.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -79.58 128.51 33.47 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.92 74.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 122.709 1.242 . . . . 0.0 111.08 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.8 tt -150.25 77.87 1.32 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -169.5 117.4 0.61 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.518 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -93.39 -18.4 22.42 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -127.58 95.98 4.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.376 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -94.98 -50.06 5.27 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 57.0 t -121.09 128.71 76.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 36.0 pt -113.46 -9.86 12.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.113 0.482 . . . . 0.0 110.544 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.2 t -163.21 136.38 5.64 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.454 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -102.78 109.65 21.3 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.025 0.441 . . . . 0.0 109.939 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 51.8 tp -105.06 89.84 3.26 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.78 127.44 55.37 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.452 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -112.8 -29.76 7.29 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.81 20.74 12.35 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.759 1.224 . . . . 0.0 110.572 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 10.3 p -82.8 -20.35 35.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.663 0.744 . . . . 0.0 110.529 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 202' ' ' LEU . 1.9 pt? -101.02 135.26 42.75 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -132.6 90.5 2.79 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.486 0.66 . . . . 0.0 110.571 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -91.46 169.38 10.82 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.672 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt 71.78 93.55 0.08 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.4 1.063 . . . . 0.0 110.424 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -95.33 25.12 4.55 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.422 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 73.87 -72.85 0.11 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.706 1.603 . . . . 0.0 108.221 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -127.02 103.59 7.54 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -175.56 175.0 2.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -80.94 80.11 7.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.386 1.089 . . . . 0.0 112.211 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -134.52 96.5 3.59 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.93 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 -73.89 0.36 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -126.42 -29.67 2.93 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.886 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 216' ' ' GLU 0.275 1.1 mp0 74.91 -34.05 0.26 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 177.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -72.96 2.45 6.89 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.008 0.908 . . . . 0.0 109.599 175.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 214' ' ' GLU . 28.8 mt-10 -60.15 -25.86 65.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.215 1.806 . . . . 0.0 108.552 173.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -121.36 81.94 1.86 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 172.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.0 p -83.42 -25.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.332 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.662 ' OD1' HG12 ' A' ' 222' ' ' ILE . 25.8 t-20 -143.42 129.86 10.37 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.94 -9.49 25.79 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.933 2.422 . . . . 0.0 115.938 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.662 HG12 ' OD1' ' A' ' 220' ' ' ASN . 10.8 pt -92.85 -18.43 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 118.358 -1.337 . . . . 0.0 111.101 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.09 140.88 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 120.946 0.403 . . . . 0.0 111.28 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 18.0 m -152.56 -40.5 0.1 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.362 0.601 . . . . 0.0 109.733 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.18 -41.37 2.01 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 54.98 -99.15 0.09 Allowed 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.979 1.312 . . . . 0.0 112.399 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -99.91 88.36 3.75 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -101.17 141.54 33.9 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.605 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 141.57 150.06 5.31 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.01 -17.15 41.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.364 0.602 . . . . 0.0 110.757 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 104.31 -6.77 46.48 Favored Glycine 0 C--N 1.311 -0.807 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.799 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.52 115.83 1.54 Allowed Glycine 0 C--N 1.311 -0.843 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.788 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.29 126.02 19.0 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 123.094 2.529 . . . . 0.0 111.643 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 72.31 82.52 0.29 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.183 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.16 -48.09 8.86 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.481 2.121 . . . . 0.0 111.573 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -172.79 160.88 32.04 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -116.98 90.56 0.51 Allowed Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -85.46 -14.91 44.66 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.327 0.584 . . . . 0.0 110.579 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.96 28.64 9.09 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.61 107.86 19.14 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 64.7 82.13 0.19 Allowed 'General case' 0 C--O 1.239 0.545 0 O-C-N 124.579 1.174 . . . . 0.0 112.485 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 117.46 84.5 1.03 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.158 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -84.65 -6.9 9.75 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.153 1.902 . . . . 0.0 112.291 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp 60.84 92.88 0.05 OUTLIER 'General case' 0 C--O 1.252 1.185 0 C-N-CA 124.547 1.139 . . . . 0.0 112.762 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -76.31 -58.59 3.59 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 171.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 53.92 39.38 62.41 Favored Glycine 0 CA--C 1.498 -0.977 0 CA-C-N 114.461 -0.869 . . . . 0.0 112.421 175.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 43.8 m -145.15 157.53 44.07 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 170.88 122.66 0.65 Allowed Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.047 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 40.5 m -155.39 80.01 1.04 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 54.68 -152.15 13.15 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.487 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.16 -9.99 25.22 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.891 2.394 . . . . 0.0 112.382 177.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.6 m -64.96 -58.2 6.75 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.301 0.572 . . . . 0.0 110.096 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 45.1 mm -83.3 -35.69 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.708 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.259 13.6 pt-20 47.26 76.67 0.1 Allowed 'General case' 0 C--O 1.247 0.951 0 C-N-CA 125.168 1.387 . . . . 0.0 114.612 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -129.56 17.01 5.9 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.406 1.098 . . . . 0.0 108.969 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 40.0 t -87.54 81.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.646 -175.273 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.384 0.135 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 60.49 13.76 4.36 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 59.77 85.71 0.1 Allowed 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.464 0.705 . . . . 0.0 112.077 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.82 -16.46 10.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.756 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -80.11 156.32 27.09 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.416 175.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.34 114.71 26.52 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.23 143.38 34.44 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.657 0.741 . . . . 0.0 111.776 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.3 tp -126.25 113.53 17.09 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.44 157.07 38.33 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 123.585 0.553 . . . . 0.0 111.447 -174.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp 76.76 173.62 0.22 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.146 1.378 . . . . 0.0 111.081 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.23 81.05 1.48 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.112 0.958 . . . . 0.0 110.068 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.44 178.14 3.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.126 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.97 116.67 66.89 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.71 -36.45 24.58 Favored 'Trans proline' 0 C--O 1.252 1.186 0 C-N-CA 121.733 1.622 . . . . 0.0 110.729 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 84.8 mt -108.07 174.98 5.64 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.65 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 10.0 t -103.55 -176.38 3.07 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -151.57 129.23 11.52 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 171.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.75 166.23 31.8 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.125 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.78 148.22 34.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.445 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 32.1 tt0 -86.25 112.05 21.0 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.1 p -100.49 172.36 7.17 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.86 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 124.39 20.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.977 0.417 . . . . 0.0 111.915 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.37 28.9 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.903 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.42 35.92 10.17 Favored Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.456 ' HB ' ' OG1' ' A' ' 21' ' ' THR . 27.4 t -99.17 133.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.42 ' HB2' ' OG1' ' A' ' 66' ' ' THR . 26.1 ttt -98.07 108.08 20.71 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.2 m -87.91 111.77 21.81 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.15 24.63 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.431 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.474 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.1 mp -90.7 -45.6 8.76 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.841 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.36 101.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.39 168.3 18.71 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.159 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 35.2 mtp-105 -61.98 150.62 37.39 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.444 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.19 17.03 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 111.604 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -73.15 129.12 37.36 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 p -68.23 114.73 6.96 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 124.272 1.029 . . . . 0.0 111.598 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.431 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 30.3 pt -94.64 164.58 19.39 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.7 Cg_exo -68.92 134.74 28.98 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.773 1.312 . . . . 0.0 113.416 -0.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.4 p -110.69 161.39 15.8 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 123.871 0.868 . . . . 0.0 110.844 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 46.7 tttp -156.96 99.42 1.82 Allowed 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -102.61 135.14 44.8 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -132.64 116.45 16.67 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.404 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 55.0 mt-30 -128.88 158.64 38.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.33 125.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 80.9 m-85 -113.36 160.44 18.37 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.331 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 11.8 p -137.97 171.76 13.94 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 122.859 0.463 . . . . 0.0 110.625 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.584 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 63.4 p -98.77 162.67 12.98 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 26.9 m-85 -103.09 -5.1 23.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.194 0.521 . . . . 0.0 109.602 171.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 p -139.55 164.03 30.99 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.737 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -102.32 158.08 16.45 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.806 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.435 ' ND2' ' HB3' ' A' ' 82' ' ' PRO . 44.1 m-80 71.33 14.33 6.49 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.48 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 75.4 mt-30 -63.5 129.13 93.43 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.25 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.94 -45.14 34.31 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.499 2.133 . . . . 0.0 111.445 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.35 153.81 23.89 Favored Glycine 0 N--CA 1.404 -3.446 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -103.97 137.77 31.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 161' ' ' TYR . 1.2 tt -101.71 109.95 21.84 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.409 ' HB ' ' CD2' ' A' ' 75' ' ' PHE . 2.3 mp -84.51 94.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . 0.251 6.6 pt20 -99.35 114.22 26.97 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.166 0.984 . . . . 0.0 111.632 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.86 126.65 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.075 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 92.4 m-85 -124.21 155.74 38.01 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' SER . 1.3 pp20? -127.27 165.87 18.85 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.15 124.55 3.53 Favored Glycine 0 C--N 1.263 -3.522 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.83 87.73 4.69 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.976 0.893 . . . . 0.0 109.662 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -128.04 142.11 51.32 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.791 -1.549 . . . . 0.0 107.044 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -66.9 -49.81 64.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.0 mtm -110.82 137.97 47.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.151 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 26' ' ' MET . 2.5 m -89.73 108.21 19.55 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.528 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -141.28 -53.91 0.47 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.134 0.493 . . . . 0.0 111.976 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.75 -61.57 1.35 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.6 m120 40.12 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.442 -1.708 . . . . 0.0 113.899 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -112.04 101.56 9.84 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.52 114.83 4.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.461 0.648 . . . . 0.0 110.395 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.19 -35.92 14.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.085 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.81 154.51 15.34 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.911 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -119.51 139.56 51.91 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 121.559 0.695 . . . . 0.0 109.185 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.409 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 13.8 t80 -143.48 142.09 31.03 Favored 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.41 -174.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.41 131.24 52.96 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.309 0.504 . . . . 0.0 111.249 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.3 tp -124.07 105.22 9.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.5 p -96.9 158.6 15.35 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.844 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.4 31.41 3.26 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.017 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 2.0 mp -77.18 116.17 55.18 Favored Pre-proline 0 C--O 1.242 0.687 0 CA-C-N 117.265 0.533 . . . . 0.0 109.894 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.13 155.15 71.13 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 11.3 Cg_exo -74.05 82.71 1.74 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.544 2.162 . . . . 0.0 111.772 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . . . -132.6 127.63 20.62 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -37.26 -63.74 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 125.07 3.847 . . . . 0.0 115.931 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -175.4 120.26 0.19 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.62 -34.97 3.31 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.631 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.23 -56.97 6.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.863 -0.589 . . . . 0.0 111.198 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 83' ' ' ALA . 21.9 Cg_endo -64.24 104.72 0.53 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.421 1.414 . . . . 0.0 110.448 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -120.06 115.92 24.67 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.5 mm -99.51 116.3 42.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.8 tt0 -90.69 114.3 26.59 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.75 125.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 17.8 m -112.98 131.49 55.74 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.387 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.474 ' CD1' HD22 ' A' ' 29' ' ' LEU . 7.7 m-85 -119.67 108.5 14.53 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.85 1.26 . . . . 0.0 109.057 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.476 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.7 p30 -123.57 136.61 54.62 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.281 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 54.7 mt -121.87 137.75 54.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.9 p-10 -100.66 -169.43 1.71 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.46 -15.34 61.81 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.431 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 43.7 m-80 -90.31 -5.38 56.33 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.983 -0.448 . . . . 0.0 110.859 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.5 25.76 49.51 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.421 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.3 mt -84.3 113.12 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.9 tp -95.87 117.0 29.75 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.095 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -107.7 121.2 44.22 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 93' ' ' THR . 69.9 t -111.61 115.66 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -117.23 127.38 54.04 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.74 118.04 30.98 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.8 m -110.48 125.8 53.68 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.705 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.61 115.63 23.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 68.0 mttm -67.51 -16.55 64.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.6 m -79.4 -50.43 10.84 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.829 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 36.2 p -83.77 -39.22 20.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.135 0.493 . . . . 0.0 111.225 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.15 12.62 48.53 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.428 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 65.4 pttt -103.05 156.43 17.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.331 . . . . 0.0 110.231 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.71 52.08 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.231 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -129.09 152.66 48.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.99 165.94 24.83 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 tt -145.65 143.49 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -122.0 113.11 19.12 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 75.3 mt -108.24 105.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.691 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.8 m -90.77 158.55 16.79 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -63.96 104.12 0.67 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.008 0.908 . . . . 0.0 110.711 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -156.6 147.04 21.46 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -104.76 88.17 2.85 Favored 'General case' 0 N--CA 1.423 -1.809 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.78 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -124.18 30.48 4.76 Favored Glycine 0 C--N 1.286 -2.246 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 170.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.481 ' HD2' ' C ' ' A' ' 124' ' ' GLY . 1.8 mpt_? -129.54 95.66 4.06 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.486 HD21 ' HG2' ' A' ' 130' ' ' GLU . 6.6 mp 67.08 -161.24 0.23 Allowed 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.08 0.862 . . . . 0.0 111.941 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 79.9 p -100.41 -72.59 0.67 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -170.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.9 -45.37 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -172.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 60.4 mm-40 -56.45 -49.2 75.27 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.136 -177.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 134' ' ' MET . 14.7 mp0 -57.88 -47.14 83.63 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.063 0.852 . . . . 0.0 109.76 -177.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 75.6 mt -53.15 -51.9 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.568 1.168 . . . . 0.0 110.698 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 60.6 mt-10 -74.01 -33.28 63.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.203 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 95.4 mtt180 -67.11 -35.23 79.32 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.678 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.653 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 24.3 mmt -60.14 -52.59 64.7 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.02 -52.65 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 124.027 0.83 . . . . 0.0 112.034 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 70.5 mm-40 -64.37 -45.49 87.52 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.29 -32.81 66.94 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.406 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 142' ' ' LYS . . . -60.5 -48.43 81.81 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.407 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 21.6 mm-40 -61.89 -48.61 79.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -77.37 -24.35 50.63 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.98 13.28 7.29 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 18.5 ptpt -50.04 -43.44 51.0 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.99 78.03 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -71.21 -53.17 15.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.86 -33.87 77.03 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -59.22 -51.08 71.5 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 117.651 0.205 . . . . 0.0 111.189 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.591 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.2 t -62.43 -49.34 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 O-C-N 123.635 0.584 . . . . 0.0 109.998 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -56.79 -45.64 82.03 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.833 0.708 . . . . 0.0 111.916 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 45.3 ttp180 -63.93 -32.68 74.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.163 0.585 . . . . 0.0 111.099 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -85.27 -17.27 37.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.504 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 5.2 mmp_? -80.49 -6.85 58.79 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.79 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.67 71.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.3 m 67.19 167.6 0.24 Allowed 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.497 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.13 25.85 4.9 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.78 155.41 17.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.306 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.476 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 79.0 m-20 -117.3 87.27 2.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.31 145.18 31.84 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 122.162 -0.336 . . . . 0.0 110.305 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.436 ' HG ' HG21 ' A' ' 21' ' ' THR . 0.7 OUTLIER -124.54 152.82 42.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.659 0.742 . . . . 0.0 112.206 -175.201 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -128.73 146.13 50.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 168.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.8 p -158.67 177.04 11.63 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.446 ' O ' HD13 ' A' ' 55' ' ' LEU . 62.5 t80 -108.9 106.01 15.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.954 1.302 . . . . 0.0 108.135 -177.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -103.99 143.65 32.59 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.8 t80 59.89 92.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.809 1.644 . . . . 0.0 112.859 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -78.77 129.38 34.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.4 mmt -75.81 106.12 7.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -135.02 123.11 22.78 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.437 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.6 m -156.13 101.64 2.09 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.967 0.507 . . . . 0.0 109.919 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -137.8 -164.84 1.68 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.63 121.22 25.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 O-C-N 121.88 -0.512 . . . . 0.0 110.865 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.9 103.36 16.03 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.1 t70 77.2 133.41 0.06 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.472 1.509 . . . . 0.0 112.401 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -146.59 97.76 2.97 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -104.34 89.37 0.66 Allowed Glycine 0 C--N 1.306 -1.135 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.179 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 67.5 tp -94.37 -50.77 5.08 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.184 0.516 . . . . 0.0 110.814 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -105.51 136.19 45.54 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.252 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 161.1 -39.12 0.42 Allowed Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 119.698 -1.239 . . . . 0.0 114.442 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -79.9 96.87 6.49 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -174.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.2 pt -137.5 94.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.256 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.3 t -166.62 136.63 3.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -129.88 148.81 51.79 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.08 86.75 5.5 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.394 0.616 . . . . 0.0 109.415 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -79.6 -23.5 42.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.875 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -87.68 129.91 34.98 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.628 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? 77.42 81.95 0.08 Allowed 'General case' 0 C--N 1.316 -0.853 0 O-C-N 124.779 1.3 . . . . 0.0 113.005 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.532 ' O ' HG11 ' A' ' 186' ' ' VAL . 99.7 mttt -125.81 155.36 41.23 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 185' ' ' LYS . 0.8 OUTLIER 78.72 -14.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 127.022 2.129 . . . . 0.0 109.731 -173.329 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 185' ' ' LYS . 3.4 mm? 70.01 -82.28 0.03 OUTLIER 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.678 1.591 . . . . 0.0 114.025 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 189' ' ' LYS . 8.3 t70 -157.06 -163.81 1.48 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -173.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.403 ' H ' ' CG ' ' A' ' 188' ' ' ASP . 33.8 mtmm -79.1 29.56 0.22 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.344 1.457 . . . . 0.0 113.386 -173.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -123.73 140.91 52.52 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 73.15 -174.5 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.278 1.031 . . . . 0.0 111.358 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 46.0 t 65.32 -80.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 125.665 1.586 . . . . 0.0 112.471 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . 0.29 8.5 tt 42.52 92.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.852 1.661 . . . . 0.0 114.146 -175.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.8 p -77.17 134.79 38.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.944 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -139.3 120.29 14.53 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.333 0.587 . . . . 0.0 109.654 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 65.0 tp -115.99 150.69 36.8 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.36 109.91 8.23 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -102.4 91.14 4.13 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -98.46 132.87 43.56 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.8 p -90.72 125.55 35.72 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.306 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.38 117.4 26.12 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -113.41 122.58 47.77 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.836 0.351 . . . . 0.0 110.577 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -88.5 -84.89 0.2 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.776 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -174.59 131.9 0.35 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 -176.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.408 ' HB3' ' CE1' ' A' ' 208' ' ' PHE . 11.3 t70 -85.5 166.23 16.48 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -95.26 88.02 5.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.961 0.886 . . . . 0.0 112.7 -174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 206' ' ' ASP . 89.1 m-85 -100.83 -22.19 14.92 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.834 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.96 -81.15 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 124.972 1.309 . . . . 0.0 111.683 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -156.37 -49.36 0.08 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -144.95 5.11 1.13 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.541 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 67.74 -56.76 0.47 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.742 1.617 . . . . 0.0 112.186 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -144.15 150.69 38.46 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -130.93 163.77 26.77 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.19 83.71 7.66 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.425 1.107 . . . . 0.0 108.107 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -90.46 -37.5 13.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.532 -175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -98.2 119.86 37.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.327 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.08 175.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.2 t30 55.79 95.32 0.05 OUTLIER Pre-proline 0 N--CA 1.486 1.364 0 C-N-CA 124.153 0.981 . . . . 0.0 112.203 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.41 108.87 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.36 2.04 . . . . 0.0 113.208 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 222' ' ' ILE . 2.9 pp -119.56 122.64 69.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 29.9 pt -132.37 169.26 22.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.234 0.54 . . . . 0.0 111.828 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.8 m -136.09 -171.57 2.91 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.17 -2.67 14.34 Favored Glycine 0 C--N 1.312 -0.801 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.789 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -144.2 116.33 8.41 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.036 0.446 . . . . 0.0 109.978 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -150.0 -68.38 0.2 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.42 -48.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 120.46 -149.59 17.57 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.66 157.09 17.15 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -147.86 53.45 0.53 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -152.79 85.59 0.14 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.56 -52.3 4.85 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.695 2.263 . . . . 0.0 111.918 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -153.54 167.53 32.0 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.4 -51.19 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 122.671 2.247 . . . . 0.0 112.972 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 145.9 -165.05 28.14 Favored Glycine 0 CA--C 1.497 -1.083 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.45 26.58 73.0 Favored Glycine 0 C--N 1.318 -0.421 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.394 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -101.5 160.26 14.58 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.0 36.17 42.06 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.321 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.81 116.88 21.69 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -126.47 101.42 6.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -172.09 98.11 0.13 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.94 -24.97 28.25 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.438 2.092 . . . . 0.0 111.227 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt 67.41 87.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.158 1.383 . . . . 0.0 112.461 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -129.13 149.9 18.68 Favored Glycine 0 N--CA 1.423 -2.185 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.025 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 152.07 -35.44 0.84 Allowed Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.522 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 24.4 p -82.89 132.68 35.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.74 0.27 . . . . 0.0 111.259 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.89 175.79 51.16 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.42 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 -172.6 2.04 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -117.03 94.16 0.62 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -81.85 95.73 0.91 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.418 2.079 . . . . 0.0 111.096 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.9 p -85.43 82.13 8.44 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 121.651 0.739 . . . . 0.0 110.228 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.1 pt -80.85 158.81 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -70.58 136.36 49.17 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -175.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -108.82 91.57 3.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.81 145.24 7.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.082 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.5 177.332 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -80.03 125.54 29.91 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -162.33 120.56 2.18 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.93 84.29 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-O 122.894 1.33 . . . . 0.0 108.607 172.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.61 138.93 34.05 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.857 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . 0.285 5.7 m-20 69.89 76.08 0.21 Allowed 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 124.961 1.304 . . . . 0.0 113.479 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.5 mt -83.08 63.91 7.37 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.402 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.61 92.61 5.99 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -87.18 102.95 14.95 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.526 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.84 140.08 49.2 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.7 m-20 -84.27 67.15 9.69 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.944 0.878 . . . . 0.0 110.004 -175.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 m -134.2 179.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.36 133.7 24.52 Favored Pre-proline 0 C--N 1.282 -2.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 36.3 Cg_endo -68.25 -38.68 11.54 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.461 2.108 . . . . 0.0 110.409 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -134.91 161.31 35.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 m -76.06 149.36 37.5 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 123.289 0.368 . . . . 0.0 110.469 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.09 142.36 44.64 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 120.993 0.425 . . . . 0.0 110.713 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -164.84 -168.76 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 C-N-CA 119.977 -1.106 . . . . 0.0 114.041 -173.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.404 ' N ' HD11 ' A' ' 19' ' ' LEU . 1.7 mp -113.38 156.06 24.11 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.539 0.736 . . . . 0.0 109.118 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.95 109.35 18.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.906 0.86 . . . . 0.0 109.19 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 6.1 p -94.45 171.54 8.75 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.235 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . . . -51.51 124.77 12.83 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.779 1.232 . . . . 0.0 112.145 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.29 -2.73 57.83 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.28 39.8 25.71 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.3 t -96.5 142.03 14.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.261 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.421 ' HE1' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -96.05 107.99 20.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -178.121 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -107.55 111.84 24.3 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -92.27 147.57 22.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 94' ' ' PHE . 51.4 mt -115.34 -24.75 8.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.3 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 94' ' ' PHE . 3.3 mp -117.78 117.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 171.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HZ3' ' CD ' ' A' ' 146' ' ' GLU . 16.7 tptp -85.39 149.86 25.14 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 14' ' ' PRO . 10.6 ptt85 -69.83 152.53 44.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.459 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.96 -0.63 2.97 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.4 1.08 . . . . 0.0 112.147 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -89.24 122.58 32.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 2.9 p -65.18 121.16 14.12 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 123.849 0.86 . . . . 0.0 112.93 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.3 pt -84.94 164.94 39.72 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -60.72 145.7 42.1 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 CA-C-N 120.652 1.269 . . . . 0.0 114.024 1.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 m -142.0 143.76 33.33 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 6.1 ttpm? -147.14 119.56 8.43 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.854 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -121.8 131.81 54.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.087 0.47 . . . . 0.0 111.03 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 35.0 m -115.23 118.3 32.9 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -130.13 155.42 46.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.23 126.41 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.81 146.26 42.99 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.083 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 29.3 p -123.69 171.28 9.7 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 124.916 1.286 . . . . 0.0 107.555 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -113.07 136.85 52.25 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -98.92 -4.2 33.4 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -80.17 106.97 12.58 Favored 'General case' 0 N--CA 1.395 -3.194 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.447 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.75 133.01 44.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.373 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 64.2 29.88 13.78 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.918 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -85.23 120.31 73.24 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.85 -0.41 10.05 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.558 2.172 . . . . 0.0 110.826 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.28 147.85 9.9 Favored Glycine 0 N--CA 1.408 -3.202 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.99 165.24 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 123.955 0.444 . . . . 0.0 110.503 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.9 tp -111.82 115.0 28.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.64 94.78 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -99.64 118.15 35.54 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.752 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.11 134.92 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.813 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -125.63 154.01 42.93 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -114.13 118.72 34.81 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' O ' ' HE1' ' A' ' 26' ' ' MET . . . 154.52 175.03 25.22 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -140.89 104.26 4.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.69 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -154.74 169.45 23.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.06 -31.91 68.45 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.705 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.0 mtt -111.48 135.7 51.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.199 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.94 -13.23 59.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -64.92 -27.15 68.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -171.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -94.53 14.75 19.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.752 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.504 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 14.2 m120 -107.1 175.25 5.56 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.198 -0.314 . . . . 0.0 110.715 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.89 129.24 36.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 tp -76.27 109.17 9.74 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -82.81 -48.31 10.93 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.017 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.47 164.32 33.99 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -142.39 154.52 44.69 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 117.517 0.659 . . . . 0.0 109.84 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -155.33 158.27 38.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -106.63 147.99 28.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.789 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 tp -124.54 104.87 8.96 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.2 p -116.36 153.43 32.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.25 4.46 18.13 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -79.87 130.26 67.67 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 123.664 0.786 . . . . 0.0 109.048 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -56.24 117.97 4.7 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.814 2.343 . . . . 0.0 111.403 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.98 111.84 1.85 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.778 2.318 . . . . 0.0 112.412 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.8 160.54 68.09 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.53 -23.16 37.47 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.808 2.339 . . . . 0.0 112.19 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -140.7 166.25 25.27 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.236 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.405 ' HA3' ' HB ' ' A' ' 45' ' ' THR . . . -73.86 80.54 0.81 Allowed Glycine 0 N--CA 1.432 -1.589 0 O-C-N 123.68 0.613 . . . . 0.0 114.276 -176.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.8 t -69.38 -45.24 27.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -68.07 121.51 8.52 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.394 1.396 . . . . 0.0 110.278 170.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -81.98 115.61 21.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -91.76 119.51 39.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.22 104.19 16.77 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 41' ' ' THR . 40.6 t -110.08 117.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.619 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -103.81 116.36 32.15 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.284 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 3.0 m-85 -96.87 107.21 19.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 171.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD2' ' HD3' ' A' ' 39' ' ' LYS . 18.2 t70 -120.64 113.09 19.72 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 123.656 0.598 . . . . 0.0 110.566 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.76 118.4 56.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.477 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.5 p30 -85.41 -176.79 6.26 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.6 -20.29 63.17 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -80.62 -23.91 39.45 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.855 -0.528 . . . . 0.0 110.671 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.79 15.71 28.22 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.477 ' HB ' ' OD2' ' A' ' 97' ' ' ASP . 83.2 mt -80.4 119.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 114.61 27.0 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.1 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -107.51 101.44 10.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.9 t -93.72 114.27 30.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.0 m -112.1 110.73 21.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.67 117.55 34.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.3 m -119.8 128.69 53.95 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.625 0.726 . . . . 0.0 111.115 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.56 114.48 16.44 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.569 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.72 -21.4 64.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.6 p -80.19 -62.04 1.8 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.3 p -95.69 -31.36 13.27 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.389 0.614 . . . . 0.0 110.411 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.66 34.79 3.21 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.03 175.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -98.68 151.85 20.28 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 117.016 0.408 . . . . 0.0 110.889 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.95 140.59 24.6 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.845 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.82 139.74 43.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 149.2 43.76 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 tt -120.66 148.61 23.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.0 m -114.53 112.92 23.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.45 98.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.123 0.487 . . . . 0.0 110.877 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -91.73 101.78 14.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -160.13 127.65 4.57 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.55 89.4 7.7 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.463 0.649 . . . . 0.0 111.692 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm 70.64 160.71 0.22 Allowed 'General case' 0 C--O 1.25 1.115 0 C-N-CA 126.397 1.879 . . . . 0.0 111.386 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.73 -43.83 83.04 Favored Glycine 0 CA--C 1.502 -0.723 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 68.33 -78.82 0.04 OUTLIER 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.474 1.11 . . . . 0.0 112.802 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.7 mt 57.3 -87.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.421 1.488 . . . . 0.0 113.319 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 129' ' ' GLU . 69.2 p -115.41 -12.89 11.67 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.65 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 74.01 -22.56 0.24 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.12 1.368 . . . . 0.0 110.614 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 127' ' ' SER . 32.2 tt0 -74.7 -39.71 61.77 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.089 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 134' ' ' MET . 1.4 mp0 -62.54 -38.95 91.98 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.337 175.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 135' ' ' VAL . 51.7 mt -56.87 -50.91 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.09 -45.42 87.19 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 123.575 0.75 . . . . 0.0 110.794 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -60.03 -47.73 84.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.504 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 70.3 mtm -66.55 -36.29 82.3 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 123.48 0.487 . . . . 0.0 111.573 -175.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 70.3 t -61.26 -54.71 31.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 123.621 0.576 . . . . 0.0 109.568 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.0 mt-30 -63.11 -46.77 85.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.08 -40.09 94.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -60.33 -44.5 95.44 Favored 'General case' 0 C--O 1.198 -1.616 0 O-C-N 123.05 0.219 . . . . 0.0 110.416 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 22.2 mm-40 -58.61 -39.63 80.98 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 94.5 mttt -74.21 -48.49 28.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.734 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.53 21.84 10.66 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.331 0.864 . . . . 0.0 113.331 -172.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 138' ' ' ALA . 29.2 mmtt -44.24 -58.68 2.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.06 45.57 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.716 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -58.26 -55.1 39.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.734 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -38.58 44.14 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.447 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 53.6 mt-10 -69.94 -34.16 73.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.128 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.3 -44.05 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.54 ' O ' HG22 ' A' ' 152' ' ' VAL . 67.6 mt-30 -52.75 -50.84 62.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 110.735 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -54.05 -52.66 60.18 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 124.284 0.99 . . . . 0.0 111.341 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.83 -39.15 93.53 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.922 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -63.54 -25.47 68.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 148' ' ' GLN . 22.0 t -88.79 -39.24 12.38 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.6 p -72.14 80.75 0.97 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.518 0.675 . . . . 0.0 111.494 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.42 123.51 44.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 tptm 68.34 10.43 7.85 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 124.016 0.822 . . . . 0.0 110.007 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.47 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.131 1.372 . . . . 0.0 112.66 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -114.39 134.13 55.21 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.335 -175.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 44.7 mt -93.26 152.97 18.85 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.48 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 14.2 tt0 -97.6 173.36 7.18 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.2 t -122.54 -170.37 2.07 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.597 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -68.07 87.81 0.27 Allowed 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.902 1.281 . . . . 0.0 113.076 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.75 96.57 10.49 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.878 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -90.71 -50.25 6.02 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 66.05 -72.55 0.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.573 1.549 . . . . 0.0 110.945 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 89.0 mtp 59.81 31.62 20.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.064 1.346 . . . . 0.0 113.664 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -100.26 91.18 4.62 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.2 m -73.22 -60.52 2.2 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.41 -80.13 0.02 OUTLIER 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.966 1.307 . . . . 0.0 111.969 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.264 10.2 p 41.31 77.88 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.994 1.717 . . . . 0.0 113.301 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.91 -55.39 9.82 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.616 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -110.7 146.42 36.29 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.702 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -133.48 -44.88 0.82 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.58 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -168.39 -175.06 37.69 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.165 -1.016 . . . . 0.0 111.703 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.1 mp 60.69 23.58 13.43 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.316 1.046 . . . . 0.0 111.49 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -103.76 90.06 3.52 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -174.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.78 -58.33 2.15 Favored Glycine 0 N--CA 1.465 0.571 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -65.0 142.37 58.46 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 124.277 1.031 . . . . 0.0 111.412 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.84 -59.04 3.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 15.7 m 48.0 78.58 0.08 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.703 1.201 . . . . 0.0 111.365 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -152.51 125.25 8.39 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.938 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 69.59 -81.1 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 125.519 1.527 . . . . 0.0 112.604 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 24.3 t70 62.75 107.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.172 0.989 . . . . 0.0 112.088 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.493 ' HZ3' ' HB2' ' A' ' 183' ' ' LYS . 5.1 ttmp? -60.66 121.59 12.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.939 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -123.4 136.0 54.41 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt 65.89 175.24 0.22 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.979 1.312 . . . . 0.0 113.436 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.2 156.13 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 91.8 mt -117.66 -4.71 11.18 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.217 -173.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.458 ' HB2' ' SG ' ' A' ' 190' ' ' SMC . 6.1 p-10 -148.41 -58.43 0.23 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp 60.0 26.35 15.65 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.402 0.62 . . . . 0.0 110.215 -172.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . 0.458 ' SG ' ' HB2' ' A' ' 188' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.565 ' HA ' HE21 ' A' ' 191' ' ' GLN . 0.0 OUTLIER -86.89 81.31 8.18 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 69.19 153.13 0.1 Allowed 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.76 1.224 . . . . 0.0 111.343 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.29 76.76 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 123.238 1.494 . . . . 0.0 108.121 172.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 45.4 pt -74.0 139.8 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.472 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.8 m -93.17 135.19 34.6 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -80.19 118.32 21.77 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.159 -174.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.99 -163.73 0.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.766 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.3 t70 71.61 -65.61 0.34 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.298 1.839 . . . . 0.0 113.656 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -69.22 -39.04 78.82 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.898 0.38 . . . . 0.0 110.711 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -88.92 103.64 16.21 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.603 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.9 m -137.78 76.22 1.57 Allowed 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.93 129.76 40.26 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.342 -175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . 178.84 39.28 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 102.914 -2.995 . . . . 0.0 102.914 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -133.1 153.5 51.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.633 -1.622 . . . . 0.0 111.324 -166.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -167.42 175.69 7.07 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 101.441 -3.54 . . . . 0.0 101.441 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.51 96.81 1.21 Allowed 'General case' 0 C--O 1.249 1.058 0 CA-C-N 120.399 1.454 . . . . 0.0 109.835 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.407 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 8.3 tp10 -165.73 107.07 0.75 Allowed 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.54 -47.6 72.35 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.792 0.33 . . . . 0.0 110.782 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -92.69 96.01 9.92 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.407 ' CE1' ' HB3' ' A' ' 207' ' ' GLU . 26.6 m80 -106.45 -55.18 2.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 168.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -98.76 69.9 1.85 Allowed 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.956 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -88.87 91.09 8.69 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -118.33 79.21 1.34 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.204 1.002 . . . . 0.0 113.082 -175.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.33 -73.86 0.63 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.316 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.33 80.1 3.17 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.012 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -129.27 -64.49 0.9 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -82.86 114.93 21.51 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.244 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.0 89.1 2.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -81.14 150.31 67.97 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.803 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.18 -6.39 12.05 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.203 1.935 . . . . 0.0 111.939 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 61.8 mt 71.81 -65.52 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.755 1.222 . . . . 0.0 109.782 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 83.0 mt -140.77 115.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.3 m -68.67 109.72 3.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.114 0.483 . . . . 0.0 111.309 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 100.5 -25.28 28.91 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.4 mp 62.79 -80.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.18 1.392 . . . . 0.0 113.388 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 29.4 t80 60.77 91.86 0.05 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.629 1.171 . . . . 0.0 108.542 -170.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -61.34 -34.14 74.77 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.672 -1.604 . . . . 0.0 112.909 -170.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 169.51 -168.9 41.65 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.14 -13.28 57.44 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 117.21 0.505 . . . . 0.0 110.999 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 167.89 175.55 37.75 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -136.91 64.66 0.57 Allowed Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.53 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -102.52 16.78 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.209 2.606 . . . . 0.0 111.674 176.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 238' ' ' PHE . . . -82.1 164.41 44.23 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.859 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.78 -11.35 26.27 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.329 2.686 . . . . 0.0 114.367 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -68.0 95.82 0.36 Allowed Glycine 0 C--N 1.315 -0.599 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 93.39 -40.71 2.76 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.491 ' HB3' ' O ' ' A' ' 234' ' ' GLY . 56.5 t80 -79.71 -17.22 54.1 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.635 0.731 . . . . 0.0 110.086 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -121.42 111.38 1.86 Allowed Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.41 118.19 18.03 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -118.28 105.65 11.98 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.742 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -73.22 136.33 22.31 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.12 129.33 33.77 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.973 2.449 . . . . 0.0 112.425 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -103.51 150.75 23.6 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 128.87 -159.45 22.19 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 121.15 101.97 1.79 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.7 p -82.49 -24.38 34.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.744 0.783 . . . . 0.0 109.629 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 142.12 162.99 9.45 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.248 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 46.8 m -148.33 25.48 0.99 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -153.93 89.91 0.13 Allowed Glycine 0 N--CA 1.422 -2.237 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.085 -176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.25 8.81 3.37 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.634 2.223 . . . . 0.0 111.059 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 1.8 p -77.97 -25.34 48.1 Favored 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 125.046 1.338 . . . . 0.0 110.463 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 41.2 pt -84.06 122.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.32 0.581 . . . . 0.0 109.577 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -132.19 91.54 2.97 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.12 80.08 7.65 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.431 1.11 . . . . 0.0 108.883 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.38 93.65 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--N 1.294 -1.827 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -174.624 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.241 0.63 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -108.62 173.03 6.5 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.783 -173.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -64.84 -58.74 5.41 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.92 124.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.991 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -103.92 84.53 2.27 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 62.68 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.891 1.276 . . . . 0.0 109.885 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 mt -156.06 136.77 13.37 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 173.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.45 78.28 7.17 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.305 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.4 tp -104.6 -12.2 16.55 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 tp -160.79 178.78 9.1 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 73.17 29.5 1.71 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.121 0.968 . . . . 0.0 111.39 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.87 168.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.86 119.05 72.25 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.77 -25.96 16.45 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.245 1.963 . . . . 0.0 112.685 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.1 mp -135.18 172.19 13.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -101.75 129.8 48.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.2 mt -116.79 131.87 56.84 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.39 -176.57 21.94 Favored Glycine 0 N--CA 1.429 -1.816 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.64 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.89 150.53 30.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.27 108.38 17.1 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 34.6 p -107.29 -177.03 3.24 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.645 -172.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.12 119.13 5.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.88 0.872 . . . . 0.0 113.178 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.45 -8.57 22.38 Favored Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.869 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.64 57.27 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 39.4 t -110.65 149.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.1 ttt -92.72 137.81 32.04 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 122.987 0.515 . . . . 0.0 111.052 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -118.84 111.71 18.77 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.3 126.73 45.21 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.658 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -96.54 -33.79 11.69 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.29 125.57 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -120.48 146.02 46.68 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -56.07 151.48 12.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 75.07 14.37 3.13 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.14 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -103.55 133.03 49.27 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 m -68.31 144.86 54.66 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 123.814 0.846 . . . . 0.0 111.715 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.405 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 29.6 pt -111.89 155.4 43.31 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_endo -62.44 152.37 65.26 Favored 'Cis proline' 0 C--N 1.356 0.964 0 CA-C-N 119.922 1.008 . . . . 0.0 113.629 -1.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -107.09 -80.45 0.56 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.014 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 43.5 tttp 65.41 99.43 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 127.424 2.29 . . . . 0.0 111.055 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -121.71 132.06 54.43 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.082 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -118.7 123.81 45.81 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.247 0.342 . . . . 0.0 110.478 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -130.61 146.23 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -93.34 133.93 32.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.92 132.4 50.88 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.8 153.09 36.25 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.7 p -81.7 135.52 35.5 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.353 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 157' ' ' ALA . 23.1 m-85 -114.19 3.96 15.37 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.448 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 24.5 p -97.0 -179.13 4.44 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.076 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -143.18 166.36 24.91 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.263 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 60.19 19.81 9.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.448 ' NE2' ' HB2' ' A' ' 48' ' ' SER . 56.0 mt-30 -101.34 113.56 65.81 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.124 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.2 Cg_endo -85.83 -2.79 8.99 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.028 2.485 . . . . 0.0 111.672 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.16 149.04 16.21 Favored Glycine 0 N--CA 1.401 -3.689 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 m -112.64 149.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.34 101.5 11.42 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 63.1 mt -90.48 117.73 34.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -129.59 119.62 23.93 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.154 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.6 t -92.48 117.61 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.704 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 59.4 m-85 -120.08 144.33 47.65 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.277 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -111.73 154.34 25.15 Favored 'General case' 0 C--O 1.272 2.244 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.219 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.08 118.34 3.5 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -78.08 95.05 4.79 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.632 0.716 . . . . 0.0 110.91 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' A' ' 63' ' ' ARG . 43.3 mtp85 -136.74 157.03 47.71 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.845 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 145' ' ' ASP . . . -91.04 -51.27 5.42 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.7 93.74 9.04 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.6 m -84.61 108.1 17.18 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.905 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -163.49 144.19 9.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 68.19 16.23 9.38 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.476 1.11 . . . . 0.0 111.702 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.18 173.03 10.7 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 85.0 m-20 -90.7 127.45 36.31 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.95 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.7 118.49 29.35 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.713 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.08 -53.98 3.91 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.08 156.01 26.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 10.0 ptm180 -151.19 139.14 19.97 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 123.713 0.805 . . . . 0.0 109.531 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.73 145.66 31.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.806 0.336 . . . . 0.0 111.226 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.64 110.45 22.56 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.4 tp -94.71 104.61 16.53 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 p -96.0 152.27 18.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.35 -35.27 2.09 Favored Glycine 0 CA--C 1.479 -2.188 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.1 mp -51.88 120.16 15.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 O-C-N 125.042 1.084 . . . . 0.0 110.494 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.52 146.72 10.91 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.143 1.895 . . . . 0.0 111.317 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.75 118.17 5.01 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.9 1.734 . . . . 0.0 108.246 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.7 156.75 79.74 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.757 -171.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.34 43.4 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.224 2.616 . . . . 0.0 111.823 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.424 ' HG3' ' HA ' ' A' ' 47' ' ' TYR . 7.9 mpt_? 68.97 148.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.253 1.421 . . . . 0.0 113.109 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.56 -27.86 2.13 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.45 -51.99 77.87 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.12 106.89 2.32 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 121.597 1.531 . . . . 0.0 110.446 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -101.91 103.53 14.2 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mm -91.82 120.51 41.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.453 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . 40.4 tt0 -94.87 112.31 24.04 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.16 128.23 62.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.467 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 m -122.9 120.6 33.93 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.867 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 5.3 m-85 -99.57 107.79 20.03 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 1.5 p-10 -125.61 112.64 16.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.7 mt -99.9 123.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -86.55 -175.35 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 123.722 0.639 . . . . 0.0 109.373 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.36 -13.12 61.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -81.54 -28.66 33.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 112.18 12.79 13.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 92.9 mt -82.13 116.1 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-O 120.996 0.427 . . . . 0.0 110.347 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.1 tp -88.52 108.9 19.64 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -102.91 110.49 22.43 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.757 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.71 114.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.2 m -110.76 124.29 51.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.622 -175.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -132.74 119.37 20.24 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.663 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 m -120.24 127.59 52.55 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.21 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.97 111.04 21.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.082 0.553 . . . . 0.0 111.841 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 91' ' ' GLU . 96.9 mttt -69.01 -11.2 60.57 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.0 p -86.04 -47.98 9.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 118.964 -1.095 . . . . 0.0 112.908 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.0 p -96.88 -33.79 11.5 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.875 -0.515 . . . . 0.0 111.819 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.08 23.67 10.39 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.924 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.37 157.8 16.16 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 122.779 -0.248 . . . . 0.0 110.339 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.77 143.71 22.97 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.113 0.482 . . . . 0.0 111.503 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -129.45 140.69 51.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -136.21 132.76 36.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.42 125.33 72.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.208 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 79.2 m -88.12 112.4 22.65 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.003 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 71.4 mt -101.61 94.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.338 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.5 m -74.51 158.86 33.05 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 124.782 1.233 . . . . 0.0 107.97 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -58.9 -27.63 65.43 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.069 0.461 . . . . 0.0 112.001 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.68 12.21 9.33 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -105.52 113.52 27.14 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.86 131.81 1.43 Allowed Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.834 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -103.43 19.23 20.12 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.881 0.848 . . . . 0.0 110.131 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 71.7 mt -115.19 177.76 4.54 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.1 p -112.87 -60.62 1.85 Allowed 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.102 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.8 tptm 173.41 -38.58 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.881 0.873 . . . . 0.0 108.709 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.04 -44.09 97.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.374 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -63.89 -41.11 97.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.96 -51.11 76.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.902 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.6 -27.04 64.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.078 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.537 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 21.3 ttm180 -63.79 -39.46 94.31 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -68.68 -29.94 68.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.995 0.426 . . . . 0.0 110.602 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.89 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -63.82 -36.17 83.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.741 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 7.6 mm-40 -61.07 -45.44 94.74 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.9 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.203 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.67 -37.51 76.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.942 0.401 . . . . 0.0 110.513 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.66 -42.64 67.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.634 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.53 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . 88.7 m-85 -97.84 15.65 23.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.525 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 7.0 tmtt? -48.09 -66.44 0.4 Allowed 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 124.046 0.938 . . . . 0.0 112.729 -173.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.7 87.3 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 10.0 tp10 -64.75 -54.9 24.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.546 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 1.2 m-20 -77.75 -28.81 50.79 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 66.5 mm-40 -61.75 -42.65 99.25 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.418 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.536 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 60.3 t -72.0 -48.52 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.822 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.5 mm-40 -54.09 -41.6 68.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -64.58 -39.86 94.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.338 0.59 . . . . 0.0 109.993 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.24 0.8 57.04 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 27.4 mmm180 -68.45 -36.42 78.98 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 172.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.83 83.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 m -78.25 142.51 37.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.963 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 45.72 63.37 1.83 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.376 1.47 . . . . 0.0 113.219 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.49 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 2.2 pptp? -106.22 77.25 1.21 Allowed 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 123.011 1.386 . . . . 0.0 110.213 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.09 61.94 6.78 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.296 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . . . -146.39 139.16 25.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.862 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.422 ' CD2' HG21 ' A' ' 21' ' ' THR . 14.0 mt -103.32 151.34 22.84 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.77 144.24 44.71 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.89 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 39.9 m -156.26 -174.64 5.03 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -162.08 156.45 22.06 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 172.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -141.53 162.88 34.41 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -79.03 102.32 8.3 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -122.41 116.6 24.27 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.651 0.739 . . . . 0.0 110.583 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 61.5 mtt -139.13 92.9 2.63 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 65.32 13.79 9.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.433 1.093 . . . . 0.0 110.228 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.5 m -74.05 -24.87 59.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.361 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -149.71 -176.97 5.62 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.9 t 66.99 89.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 124.194 0.934 . . . . 0.0 111.055 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -123.94 134.14 53.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.32 106.14 12.11 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.36 0.6 . . . . 0.0 112.334 -172.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.02 -3.36 10.14 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.434 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.41 -175.91 42.35 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 106.153 -2.779 . . . . 0.0 106.153 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 49.8 tp -79.87 115.94 19.74 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 118.688 1.244 . . . . 0.0 109.426 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 77.26 -58.91 0.48 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.562 1.545 . . . . 0.0 111.431 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 178.46 -173.25 45.67 Favored Glycine 0 CA--C 1.486 -1.761 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -83.6 83.12 8.02 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.405 0.602 . . . . 0.0 109.404 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.6 tt -161.21 102.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 122.087 0.946 . . . . 0.0 110.248 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 21.3 t -130.58 83.08 2.09 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -115.07 -13.78 11.84 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.836 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 69.15 170.67 0.3 Allowed 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.763 1.225 . . . . 0.0 111.967 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -111.27 115.92 30.14 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.429 0.633 . . . . 0.0 110.542 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -106.37 86.06 2.29 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 57.28 30.29 18.2 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.754 0.659 . . . . 0.0 109.465 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.83 83.31 4.97 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.901 0.857 . . . . 0.0 110.855 -173.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 6.4 p -177.02 -49.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 113.034 -1.894 . . . . 0.0 107.108 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.6 pp -178.57 157.45 0.98 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.229 1.011 . . . . 0.0 110.859 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -140.35 100.1 3.81 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -121.7 149.76 42.76 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -173.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 61.08 20.57 11.03 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -84.99 69.08 10.77 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.258 1.028 . . . . 0.0 109.074 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 57.0 t -133.38 126.85 52.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 9.6 tp -83.54 84.23 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.455 1.121 . . . . 0.0 109.352 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.9 p -101.78 -78.48 0.53 Allowed 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -70.15 -32.59 70.64 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 122.745 0.418 . . . . 0.0 111.594 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 31.8 tp -92.63 145.33 24.51 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -108.39 -11.12 15.23 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.201 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 72.18 -61.64 0.49 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.657 1.583 . . . . 0.0 113.09 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -125.59 124.17 40.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.2 m -83.58 -54.69 4.76 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.909 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 95.1 mt 66.95 -175.9 0.2 Allowed 'General case' 0 C--O 1.252 1.214 0 C-N-CA 124.416 1.086 . . . . 0.0 113.087 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . 67.1 38.98 3.27 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.532 1.533 . . . . 0.0 112.409 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 205' ' ' LYS . 43.1 tt0 -74.2 98.59 3.2 Favored 'General case' 0 C--O 1.248 0.995 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.01 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.449 ' HG2' ' H ' ' A' ' 206' ' ' ASP . 36.5 ttpt 167.18 -177.23 0.02 OUTLIER 'General case' 0 C--O 1.249 1.051 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.449 ' H ' ' HG2' ' A' ' 205' ' ' LYS . 2.7 p-10 -150.43 169.34 21.7 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -139.73 39.21 2.01 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -128.46 -50.32 1.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.445 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -83.59 -38.07 22.12 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.526 -2.028 . . . . 0.0 105.526 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -78.44 99.93 6.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 168.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -75.02 107.6 7.19 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.783 -171.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -126.25 -28.14 3.14 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.927 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -70.9 -20.83 62.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.269 0.557 . . . . 0.0 110.921 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -111.76 121.91 46.36 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.0 tp -88.54 119.33 28.89 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.805 -174.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.78 136.72 45.51 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -93.01 -41.4 10.01 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -168.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 18.9 m -106.62 157.16 7.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.008 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.01 145.86 98.98 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.133 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.65 97.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.694 2.262 . . . . 0.0 112.092 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 8.8 tp -114.93 -29.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.099 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 59.3 mt -84.2 133.4 29.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.5 t -84.7 84.7 7.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.25 -146.05 17.22 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.3 tt -179.8 -58.88 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -131.05 109.99 10.89 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.229 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -129.79 107.59 9.52 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.933 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -162.71 -97.21 0.12 Allowed Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.061 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -153.8 -33.89 0.11 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.07 0.462 . . . . 0.0 111.658 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 106.02 179.19 23.48 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -142.76 163.4 27.29 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.881 -1.152 . . . . 0.0 112.053 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.79 144.06 57.96 Favored 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.753 2.302 . . . . 0.0 110.5 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 140.65 -63.37 0.53 Allowed Glycine 0 C--N 1.304 -1.238 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.607 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.8 -22.36 29.27 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.906 3.071 . . . . 0.0 115.285 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -78.18 93.16 1.19 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 147.96 -6.53 1.0 Allowed Glycine 0 C--N 1.302 -1.346 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -96.26 -167.02 1.51 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.33 -81.78 1.73 Allowed Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -92.15 78.04 5.23 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 171.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -86.37 131.18 34.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.971 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 85.75 104.52 0.71 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.47 -33.95 59.57 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 123.37 2.713 . . . . 0.0 113.866 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.78 13.93 4.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.536 0.684 . . . . 0.0 109.997 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -84.44 155.76 31.29 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.1 -88.84 0.49 Allowed Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 4.8 p -96.69 96.03 8.34 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.138 0.494 . . . . 0.0 110.84 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -150.9 34.24 0.94 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 13.0 p -86.08 -22.1 27.33 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.108 0.48 . . . . 0.0 111.356 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.72 -142.89 29.45 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.731 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.14 -27.93 13.29 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.484 2.123 . . . . 0.0 112.612 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.8 m 62.03 99.36 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.215 1.006 . . . . 0.0 111.413 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 31.0 pt -78.19 0.37 2.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -72.93 99.89 2.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -86.1 -94.32 0.08 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.282 -170.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.59 -3.19 10.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.997 0.903 . . . . 0.0 109.664 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.365 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.435 -1.221 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 60.94 25.09 15.1 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -78.88 122.31 25.94 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.17 131.76 34.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.114 0.483 . . . . 0.0 110.673 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -83.97 -38.51 20.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.72 147.69 51.37 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.7 tp -115.96 102.24 9.48 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -96.44 -13.33 23.22 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -171.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.5 tp -136.33 17.26 3.17 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.762 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.6 mt 57.3 -164.42 0.17 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.087 -174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.3 61.7 1.12 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.5 -177.42 2.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.621 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.01 118.87 72.45 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.05 -50.53 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.278 1.985 . . . . 0.0 111.978 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 6.3 mp -114.61 172.25 7.14 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.424 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 15.2 m -92.5 151.04 20.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.124 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.03 132.0 54.58 Favored 'General case' 0 C--O 1.261 1.669 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.923 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.11 158.1 27.57 Favored Glycine 0 N--CA 1.426 -1.982 0 O-C-N 123.91 0.756 . . . . 0.0 112.656 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.9 151.39 22.16 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.422 ' HG2' ' HH ' ' A' ' 161' ' ' TYR . 41.7 tt0 -86.12 108.45 18.31 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 171.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 18.0 p -107.87 -69.61 0.84 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.286 0.565 . . . . 0.0 111.348 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.26 165.55 11.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.55 -21.05 4.3 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 116.949 1.539 . . . . 0.0 116.949 -171.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.52 33.37 2.15 Favored Glycine 0 CA--C 1.493 -1.341 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.986 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.37 121.5 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.449 0.643 . . . . 0.0 112.12 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.512 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 23.4 ttt -106.31 97.79 7.55 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.9 m -80.35 110.74 16.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.07 119.9 30.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.789 0.328 . . . . 0.0 111.047 -176.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 63.1 mt -104.93 -39.54 6.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.623 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.1 130.4 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.19 162.3 14.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.455 ' HG2' ' HA ' ' A' ' 15' ' ' LEU . 63.6 mtt180 -56.69 140.11 48.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 123.714 0.634 . . . . 0.0 109.515 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 75.26 10.74 3.57 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.231 1.012 . . . . 0.0 112.786 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -81.91 114.73 20.71 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -60.38 131.75 51.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.398 1.079 . . . . 0.0 113.781 -176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.4 pt -95.4 160.83 29.73 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 24.7 Cg_exo -65.66 126.26 6.39 Favored 'Cis proline' 0 C--N 1.358 1.043 0 CA-C-N 120.291 1.14 . . . . 0.0 113.431 0.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.6 p -95.55 149.13 21.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.443 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 37.7 tttp -154.02 99.5 2.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' A' ' 93' ' ' THR . 5.5 tp-100 -107.15 140.12 40.5 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 81.5 m -139.83 116.41 10.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -128.61 144.17 51.1 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.22 118.83 41.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 123.669 0.606 . . . . 0.0 109.535 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.05 169.19 8.64 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.915 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 33.1 p -134.24 171.63 13.98 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.448 ' HB ' ' OG ' ' A' ' 48' ' ' SER . 27.7 p -99.86 139.62 35.25 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.484 176.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.435 ' CE2' ' HB1' ' A' ' 157' ' ' ALA . 27.6 m-85 -85.03 -11.72 54.75 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.448 ' OG ' ' HB ' ' A' ' 46' ' ' THR . 29.5 p -83.75 142.27 30.82 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.905 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.0 124.01 51.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 66.32 61.43 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.693 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.446 ' H ' ' NE2' ' A' ' 51' ' ' GLN . 0.5 OUTLIER -101.3 123.11 45.87 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -85.41 -15.96 5.02 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.821 1.681 . . . . 0.0 111.132 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.59 164.64 36.92 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.43 179.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.1 tp -132.37 132.37 42.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.55 123.26 71.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 120.851 0.358 . . . . 0.0 111.52 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -114.82 129.76 56.75 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.4 123.49 64.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.58 142.97 43.2 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.248 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -111.52 121.23 44.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.57 125.33 5.6 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -172.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 3.8 mp0 -79.0 139.03 38.28 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.576 ' HG2' ' ND2' ' A' ' 69' ' ' ASN . 36.2 mmt180 -139.45 156.86 46.69 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 114.192 -1.367 . . . . 0.0 107.542 172.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.513 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -78.22 -49.87 12.96 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 92.7 mmm -105.55 122.05 45.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.13 102.08 0.1 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -174.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 56.3 pttt 179.41 -177.44 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.174 1.389 . . . . 0.0 107.549 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.98 -45.46 0.6 Allowed 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.44 1.496 . . . . 0.0 114.921 172.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.576 ' ND2' ' HG2' ' A' ' 63' ' ' ARG 0.259 85.8 m-20 -86.17 -166.19 1.47 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -88.69 112.63 23.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.994 0.902 . . . . 0.0 111.724 -167.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.7 108.24 13.1 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.204 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.57 -55.19 6.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.96 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.89 159.07 27.99 Favored Glycine 0 N--CA 1.413 -2.887 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.966 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.29 135.22 21.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.76 168.3 24.81 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.58 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.75 144.21 25.62 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.6 tp -131.07 103.66 6.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -132.96 165.87 23.69 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 120.573 0.225 . . . . 0.0 111.04 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.07 4.95 56.47 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.78 134.39 86.02 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.99 133.87 53.05 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.975 1.784 . . . . 0.0 109.796 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -67.5 63.64 0.8 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.103 2.535 . . . . 0.0 111.974 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.24 153.51 39.01 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.602 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -61.36 177.9 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.459 2.773 . . . . 0.0 114.914 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.61 131.39 50.08 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.469 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.4 20.77 78.49 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.69 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.0 -49.69 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.47 116.13 4.58 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.535 1.49 . . . . 0.0 111.343 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -87.42 112.1 21.81 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.7 mm -98.82 115.94 40.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.73 112.76 24.66 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 41' ' ' THR . 96.0 t -106.07 124.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 32.5 m -124.45 128.32 48.83 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.855 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 34.7 m-85 -112.63 136.62 51.98 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 8.0 t70 -142.31 127.11 18.15 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.1 mt -124.15 126.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -89.13 -170.65 2.96 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.33 63.42 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.422 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 9.1 t30 -84.61 -29.77 25.5 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.274 0.559 . . . . 0.0 110.242 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.3 28.48 4.62 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 77.4 mt -86.89 116.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 49.0 tp -96.12 120.1 35.8 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.08 105.21 15.15 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.8 t -92.12 120.48 41.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -126.99 122.87 35.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.69 117.17 29.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.1 m -115.75 127.73 55.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.145 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -83.04 107.38 15.59 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.23 -12.27 60.71 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 m -70.98 -54.56 10.82 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 35.7 p -86.59 -48.82 8.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.438 0.637 . . . . 0.0 111.14 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.05 5.5 28.76 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.477 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 14.2 ptmm? -92.31 152.5 19.75 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.49 162.68 38.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.337 0.589 . . . . 0.0 112.281 -174.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -129.42 128.06 42.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.09 173.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -132.97 149.53 52.23 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.452 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.4 pt -129.81 151.04 35.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.2 m -117.47 113.11 21.56 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.25 103.13 14.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -84.93 109.4 18.12 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.4 t30 79.48 119.57 0.05 Allowed 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.884 1.274 . . . . 0.0 111.413 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.87 -27.66 68.38 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.303 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -87.9 22.83 2.22 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.529 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.8 9.85 74.74 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -128.72 147.35 50.76 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 124.69 1.196 . . . . 0.0 108.008 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 78.7 mt 53.29 -125.17 2.35 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.099 0.96 . . . . 0.0 112.431 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.0 p -150.71 158.46 44.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 63.1 tttm -66.74 -30.24 70.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.53 -45.8 92.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.448 0.699 . . . . 0.0 109.409 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 134' ' ' MET . 14.7 mm-40 -61.2 -46.49 90.24 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.694 175.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 135' ' ' VAL . 82.5 mt -60.14 -42.98 91.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 128' ' ' LYS . 67.4 mt-10 -63.25 -32.38 73.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.702 0.287 . . . . 0.0 110.923 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 44.7 mtp180 -64.03 -43.78 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.036 174.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.519 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 52.7 mtt -65.08 -35.27 80.63 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.006 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 131' ' ' ILE . 86.1 t -55.54 -52.13 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 69.8 mm-40 -65.18 -52.26 55.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.755 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.67 -51.05 71.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -67.78 -30.73 70.24 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -77.6 -34.96 53.32 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.548 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.96 -43.7 74.45 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.7 20.72 7.17 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.468 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 24.4 mmtt -53.3 -58.09 8.27 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.56 -44.81 81.33 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.443 0.464 . . . . 0.0 111.327 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.67 -48.58 71.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.794 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.61 -36.88 68.18 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 56.4 mm-40 -60.43 -42.5 96.18 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.838 0.29 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.665 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.0 t -67.24 -49.72 69.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.409 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -63.75 -43.95 94.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.513 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 40.0 ttp180 -62.84 -48.57 78.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.419 0.628 . . . . 0.0 110.319 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 153' ' ' SER . 7.1 mm-40 -79.3 -0.28 31.75 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.476 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 21.5 mmt180 -84.23 -35.46 23.43 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 -38.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.417 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 26.3 t -66.84 103.23 1.08 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -102.79 -27.48 12.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.215 0.531 . . . . 0.0 110.961 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -161.36 154.56 21.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -74.85 86.54 2.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.384 0.611 . . . . 0.0 109.405 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.57 149.02 35.11 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.275 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 mp -109.15 149.23 29.65 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.56 156.72 19.2 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.2 p -79.42 113.74 17.8 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.241 0.544 . . . . 0.0 111.824 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.422 ' HH ' ' HG2' ' A' ' 20' ' ' GLU . 96.8 m-85 -93.57 149.48 21.19 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.039 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -86.41 154.94 20.8 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -94.27 133.51 37.72 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -81.09 159.68 24.67 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.278 0.561 . . . . 0.0 110.567 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.2 ptp -133.93 176.51 8.51 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 166' ' ' LYS . 9.0 mmpt? -116.75 -179.76 3.78 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.5 m -53.65 125.2 17.42 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.46 0.475 . . . . 0.0 110.083 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.03 -5.45 59.11 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -172.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 64.6 t 76.33 110.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.072 0.949 . . . . 0.0 109.054 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -97.72 -35.64 10.5 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.337 -170.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -120.85 121.16 37.52 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -137.67 95.4 3.05 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.36 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.79 139.45 10.62 Favored Glycine 0 C--N 1.311 -0.843 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.141 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -123.86 101.21 7.14 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.42 0.628 . . . . 0.0 109.315 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.2 -64.51 1.03 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.54 -174.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.53 152.57 22.11 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -96.92 79.75 2.94 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 117.921 0.861 . . . . 0.0 111.804 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.4 mp -81.37 93.69 2.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 15.9 m -118.63 -37.21 3.32 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 52.24 46.87 25.88 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.152 1.781 . . . . 0.0 111.71 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.79 80.16 8.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.782 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.412 ' OD1' ' HG3' ' A' ' 183' ' ' LYS . 4.0 p30 -76.74 -52.84 8.84 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -173.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 182' ' ' ASP . 97.2 mttt -100.96 15.38 28.82 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 121.771 -0.581 . . . . 0.0 112.345 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.519 ' HE2' ' HA ' ' A' ' 184' ' ' LYS . 8.6 mmpt? -79.52 0.45 29.68 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.411 0.624 . . . . 0.0 111.612 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -84.26 68.45 10.18 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.35 101.5 2.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -170.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.1 73.9 0.89 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.57 118.89 31.94 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt 56.98 74.94 0.39 Allowed 'General case' 0 C--O 1.245 0.86 0 O-C-N 124.427 1.08 . . . . 0.0 109.572 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -76.09 96.78 3.91 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -65.39 -66.09 0.59 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.635 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.9 p 51.91 26.76 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 125.876 1.671 . . . . 0.0 111.056 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 75.8 mt -83.64 86.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 44.8 m -142.0 91.38 2.34 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.226 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -127.73 89.47 2.95 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -158.0 89.12 0.99 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -98.62 94.18 6.52 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.817 0.818 . . . . 0.0 111.165 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -99.57 -24.61 14.69 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 171.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 65.86 -75.72 0.05 OUTLIER 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 125.863 1.665 . . . . 0.0 112.009 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 20.8 p -144.07 94.83 2.63 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 62.4 mt -126.55 85.96 2.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.495 0.664 . . . . 0.0 112.77 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -82.76 109.33 16.82 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -139.95 116.81 10.97 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.009 -171.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -117.47 96.92 5.62 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.05 -23.79 67.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.427 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.66 77.96 0.29 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.823 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -84.62 103.12 13.46 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 169.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -51.36 118.5 3.33 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 124.328 1.017 . . . . 0.0 111.929 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -94.46 104.92 16.88 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.079 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -71.6 135.6 47.03 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -156.56 132.2 9.5 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.131 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.31 113.64 23.25 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 171.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -94.38 113.4 25.28 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.14 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.28 112.85 25.47 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -83.69 -57.96 3.01 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 63.96 161.25 0.11 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.179 1.392 . . . . 0.0 112.161 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.3 m -106.45 161.86 5.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.197 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' SMC . . . . . 0.483 ' O ' ' HD3' ' A' ' 221' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -108.78 95.31 16.49 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 219' ' ' SMC . 3.3 Cg_exo -78.64 121.28 5.05 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.37 2.046 . . . . 0.0 110.933 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.6 tp -84.36 -33.32 8.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 32.2 pt 51.84 176.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 127.235 2.214 . . . . 0.0 115.441 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 13.2 t 66.78 84.82 0.15 Allowed 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.335 1.454 . . . . 0.0 111.232 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -111.06 5.52 28.84 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.023 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.405 HD22 ' H ' ' A' ' 226' ' ' LEU . 2.4 pt? -89.19 116.63 27.58 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -111.67 -9.1 14.16 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 70.93 -62.97 0.43 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.721 1.608 . . . . 0.0 112.87 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 112.81 164.54 16.3 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.93 155.97 23.81 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 160.35 -172.28 36.74 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -151.64 159.13 28.12 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.09 162.01 23.32 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.719 2.279 . . . . 0.0 112.436 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -91.41 124.31 7.54 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -87.02 -3.68 7.99 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.528 2.152 . . . . 0.0 113.432 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 129.35 -178.01 17.63 Favored Glycine 0 C--N 1.306 -1.125 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -95.55 -146.36 20.69 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.103 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.94 -39.2 43.47 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.381 0.61 . . . . 0.0 109.736 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 110.96 109.12 3.12 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.022 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.5 93.37 9.14 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -149.43 111.54 4.63 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.806 -173.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.15 111.49 0.49 Allowed Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -50.58 138.07 40.31 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 123.492 2.795 . . . . 0.0 113.36 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -104.59 110.26 22.49 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -88.17 -25.17 32.1 Favored Glycine 0 C--N 1.307 -1.042 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 99.71 170.48 30.15 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.8 t -78.61 95.29 5.2 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.93 108.03 2.46 Favored Glycine 0 CA--C 1.498 -1.026 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 23.1 t -151.87 143.29 23.44 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -137.9 86.63 0.22 Allowed Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.14 97.97 0.52 Allowed 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 122.67 2.247 . . . . 0.0 111.848 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 5.3 m -87.31 -32.93 19.41 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 65.3 mt 68.54 99.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.505 1.122 . . . . 0.0 111.299 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -114.99 -4.33 12.56 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.087 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.02 139.92 49.78 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.88 88.06 2.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.943 0.878 . . . . 0.0 110.443 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--N 1.301 -1.504 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.206 -177.221 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt . . . . . 0 N--CA 1.431 -1.41 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -118.85 41.06 3.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 19.5 m -124.35 177.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.292 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.86 120.84 80.04 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.41 -24.38 10.72 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.219 1.946 . . . . 0.0 112.13 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.02 160.87 21.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.031 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -93.63 112.94 24.92 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -92.16 131.56 37.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.85 179.06 22.26 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.822 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.37 159.92 31.86 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -83.97 117.2 23.22 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 170.352 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 p -110.82 -97.8 0.41 Allowed 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.16 163.61 19.67 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.38 92.55 0.08 OUTLIER Glycine 0 CA--C 1.499 -0.962 0 O-C-N 123.76 0.662 . . . . 0.0 112.968 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' A' ' 65' ' ' MET . . . 104.69 19.17 11.39 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 124.512 0.772 . . . . 0.0 111.735 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -129.36 115.33 34.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 117.016 0.408 . . . . 0.0 110.73 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.33 115.65 27.71 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -100.27 112.64 24.98 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.34 101.67 13.91 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 5.6 mp -73.32 -49.28 28.35 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.33 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -108.42 105.28 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.02 153.54 21.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.099 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.689 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -57.05 159.33 4.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.047 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 72.56 6.12 5.38 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 124.855 1.262 . . . . 0.0 111.948 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.4 m -91.8 125.73 36.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 10.0 t -68.35 134.71 50.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.517 0.675 . . . . 0.0 112.256 -177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.43 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 33.1 pt -94.98 154.54 39.65 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.639 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.2 Cg_exo -63.26 133.73 14.9 Favored 'Cis proline' 0 N--CA 1.478 0.566 0 CA-C-N 119.873 0.991 . . . . 0.0 114.012 0.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -110.01 162.18 14.79 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.257 1.023 . . . . 0.0 109.266 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 15.4 ptpt -166.57 148.19 6.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.542 0.527 . . . . 0.0 110.807 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 29' ' ' LEU . 22.6 mm-40 -147.75 118.78 7.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 125.821 1.648 . . . . 0.0 107.544 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 84.9 m -111.67 116.33 30.59 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -128.97 141.11 51.36 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.13 124.67 48.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 97.0 m-85 -111.74 160.12 17.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.75 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 21.3 p -129.89 171.96 12.19 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -113.51 138.49 50.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 119.623 1.101 . . . . 0.0 110.534 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -82.52 -39.22 22.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 p -63.88 98.17 0.19 Allowed 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.759 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.47 160.68 27.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.354 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 m120 62.82 22.42 13.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -94.46 114.11 62.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 3.3 Cg_exo -79.64 -8.04 14.71 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.82 126.75 2.43 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.45 160.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.451 HD13 ' HG2' ' A' ' 76' ' ' GLU . 53.3 tp -111.86 117.85 33.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.74 118.39 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' ' 20' ' ' GLU . 16.6 pt20 -132.85 129.85 39.0 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.331 -176.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.38 127.53 50.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -124.21 153.46 41.58 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.566 0.746 . . . . 0.0 110.107 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 37.1 mt-10 -117.09 137.12 52.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.36 -155.45 16.09 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.486 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 22.3 mt-10 -152.29 130.63 12.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.058 0.543 . . . . 0.0 110.575 174.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 27.3 mmt180 -147.67 163.91 35.17 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 170.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.54 62.85 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.644 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 58.7 mtt -109.68 135.04 51.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.102 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -65.25 98.74 0.34 Allowed 'General case' 0 N--CA 1.416 -2.126 0 O-C-N 124.076 0.86 . . . . 0.0 112.573 -175.385 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 19.3 pttp -176.82 169.81 2.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 66.75 11.26 8.12 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 123.621 0.768 . . . . 0.0 111.874 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 96.3 m-20 -118.63 179.96 3.98 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.416 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -90.49 151.88 21.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -118.52 121.18 39.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.7 mt -84.65 -48.13 9.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.707 0.289 . . . . 0.0 111.596 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.74 170.89 42.39 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -143.48 162.92 34.57 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -155.06 142.64 19.72 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HG2' HD13 ' A' ' 55' ' ' LEU . 43.5 mt-10 -102.68 117.87 35.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.038 0.447 . . . . 0.0 110.299 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.3 tp -92.77 112.65 24.69 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.889 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -107.95 155.36 20.4 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.32 -15.31 6.11 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.948 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.4 mp -60.5 125.41 82.17 Favored Pre-proline 0 C--O 1.247 0.939 0 C-N-CA 122.88 0.472 . . . . 0.0 110.136 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 80' ' ' ILE . 23.5 Cg_exo -65.54 126.8 16.79 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.95 1.767 . . . . 0.0 109.839 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.95 90.45 0.11 Allowed 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.594 2.196 . . . . 0.0 111.167 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.56 167.37 15.18 Favored Pre-proline 0 N--CA 1.42 -1.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.367 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.45 -179.0 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.508 2.805 . . . . 0.0 114.646 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -72.48 129.14 37.65 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.662 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 85.71 4.02 85.55 Favored Glycine 0 C--N 1.309 -0.949 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.714 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.7 t -90.55 -49.39 0.36 Allowed Pre-proline 0 CA--C 1.557 1.232 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' THR . 31.8 Cg_exo -63.31 119.93 7.19 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.328 1.352 . . . . 0.0 111.27 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.38 106.61 17.79 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.296 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.36 116.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.527 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 39.2 tt0 -90.64 117.48 29.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 41' ' ' THR . 74.1 t -110.41 113.11 43.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.4 m -99.48 111.67 23.99 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -116.67 107.86 15.2 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -174.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 39' ' ' LYS . 3.9 p30 -141.02 149.63 41.97 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.061 0.458 . . . . 0.0 111.192 -175.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.8 mt -116.62 140.17 40.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -90.63 -167.25 1.78 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -18.25 59.55 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -82.73 -29.12 30.0 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.49 0.662 . . . . 0.0 109.301 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.16 31.96 3.4 Favored Glycine 0 N--CA 1.416 -2.674 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.9 mt -99.96 121.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.283 0.563 . . . . 0.0 109.751 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 tp -89.07 121.45 31.42 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.493 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -113.41 123.08 49.23 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.02 114.29 45.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -111.49 122.73 48.6 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.297 0.373 . . . . 0.0 110.009 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.65 117.73 34.82 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -118.6 114.56 22.97 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.813 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.72 112.19 13.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.527 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 62.5 mttm -67.08 -24.57 65.97 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.669 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -65.52 -54.65 25.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -91.52 -44.61 8.98 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.53 7.08 26.5 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -85.91 137.57 32.65 Favored 'General case' 0 N--CA 1.403 -2.79 0 CA-C-O 121.061 0.457 . . . . 0.0 110.401 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.32 140.81 47.64 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.01 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -135.73 131.79 36.04 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.61 166.16 16.59 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.05 145.05 33.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.8 m -117.45 113.08 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.6 mt -126.84 119.72 53.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 O-C-N 122.324 -0.235 . . . . 0.0 110.864 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.1 t -79.51 132.55 36.35 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 C--N 1.318 -0.799 0 CA-C-O 121.161 0.505 . . . . 0.0 110.331 178.422 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 135' ' ' VAL . 60.3 mt -67.89 -41.95 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.458 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -60.14 -42.33 94.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.819 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -60.42 -43.24 96.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.7 ttm -58.62 -44.91 90.11 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.923 0.889 . . . . 0.0 110.613 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.448 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 59.4 t -63.14 -47.1 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -58.94 -43.23 91.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.73 -35.94 82.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.0 110.501 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -67.95 -30.22 69.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.511 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 7.6 mm-40 -78.79 -44.6 22.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.413 1.101 . . . . 0.0 109.082 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.63 -48.08 83.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.533 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.96 19.01 20.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.85 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 18.8 ttmm -54.32 -47.44 72.47 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.563 0.539 . . . . 0.0 112.139 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.18 70.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.168 0.509 . . . . 0.0 111.589 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.51 -46.84 68.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.447 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.86 -36.97 83.53 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.435 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 45.5 mm-40 -58.1 -50.17 74.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.677 0.217 . . . . 0.0 111.253 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.23 -47.03 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.273 0.358 . . . . 0.0 110.357 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -57.22 -46.23 83.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.73 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -66.06 -47.89 72.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.071 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -75.35 -7.78 54.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.254 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.0 mtp85 -73.99 -20.3 60.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.926 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.61 82.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.0 p -132.66 138.66 47.39 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.234 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -168.61 -54.5 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -169.37 150.1 4.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 56.6 m-80 -64.57 117.42 7.36 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.302 0.572 . . . . 0.0 110.29 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.02 161.59 38.38 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.648 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.7 mt -120.36 137.11 54.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -112.54 129.93 56.19 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 172.441 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 10' ' ' LEU 0.261 4.0 mm? . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 35' ' ' THR . 2.3 m-20 -94.52 64.42 3.06 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 m -139.52 174.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.998 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.51 120.79 72.24 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.11 -43.33 30.23 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 122.486 2.124 . . . . 0.0 113.116 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.438 ' C ' ' HB3' ' A' ' 32' ' ' ARG . 10.0 mp -123.31 174.18 7.48 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 m -88.3 127.86 35.48 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.4 130.91 37.95 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.2 -170.74 19.76 Favored Glycine 0 N--CA 1.408 -3.169 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.452 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.4 mt -129.27 162.93 26.78 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.169 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.54 144.45 28.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 HD23 ' A' ' 158' ' ' LEU . 12.9 p -126.35 -94.29 0.47 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 122.946 0.498 . . . . 0.0 111.575 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.41 106.11 14.53 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.11 -60.64 4.78 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.752 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.91 56.43 0.1 Allowed Glycine 0 C--N 1.291 -1.928 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.41 HG13 ' HG2' ' A' ' 149' ' ' ARG . 89.9 t -122.11 115.33 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -175.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.62 114.02 22.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -106.72 111.39 23.9 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.78 132.04 36.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.031 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -49.8 3.47 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.32 102.68 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 152.99 37.23 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.571 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.563 HH12 ' HA ' ' A' ' 135' ' ' VAL . 36.9 ptt180 -62.58 160.7 13.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 73.82 5.13 4.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.772 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 9.9 t -65.84 135.2 54.53 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.779 0.799 . . . . 0.0 111.548 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 pt -98.89 155.42 36.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.548 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.06 144.59 75.54 Favored 'Cis proline' 0 C--O 1.25 1.089 0 N-CA-C 115.265 1.217 . . . . 0.0 115.265 4.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 p -122.16 161.3 23.4 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.282 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 4.8 ttmp? -166.08 100.6 0.64 Allowed 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 93' ' ' THR . 54.3 mt-30 -119.0 131.09 55.98 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.102 -175.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.7 m -114.44 122.44 46.63 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.53 0.732 . . . . 0.0 110.771 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -129.46 148.7 51.4 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mm -96.23 121.7 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.206 0.527 . . . . 0.0 110.397 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 79.6 m-85 -109.26 143.66 38.43 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.625 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 16.9 p -119.78 171.17 8.59 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -113.89 141.7 47.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 29.9 m-85 -88.18 -41.09 13.22 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 p -73.87 130.43 39.89 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.557 175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -106.46 166.82 10.27 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.072 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 67.88 23.81 8.27 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.312 0.645 . . . . 0.0 112.091 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.601 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 15.0 mm-40 -81.86 132.77 53.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.07 -39.63 30.79 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.554 1.502 . . . . 0.0 110.674 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.35 166.72 33.79 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG13 HG13 ' A' ' 80' ' ' ILE . 16.1 m -106.48 135.07 46.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.09 0.471 . . . . 0.0 110.947 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.46 107.26 16.62 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.681 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -96.18 114.7 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -122.56 110.79 16.01 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.562 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.83 127.01 44.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 123.594 0.559 . . . . 0.0 111.371 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 53.0 m-85 -133.62 155.26 49.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 40.1 mt-10 -110.76 143.27 41.55 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 165.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.38 112.49 0.62 Allowed Glycine 0 C--N 1.263 -3.486 0 C-N-CA 118.285 -1.912 . . . . 0.0 111.105 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.48 86.46 5.16 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -145.18 146.02 31.58 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -66.25 -50.15 64.75 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.402 1.096 . . . . 0.0 109.846 172.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.2 mtt -112.22 130.3 55.97 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.18 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 101.79 1.03 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 123.912 0.757 . . . . 0.0 109.69 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -76.28 -52.7 9.45 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 122.01 0.91 . . . . 0.0 108.684 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -153.5 -54.0 0.11 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.36 -176.77 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.27 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 65.9 t30 -95.38 112.74 24.4 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.075 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.9 114.08 17.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.27 -34.41 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.669 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.67 176.16 39.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.23 170.4 20.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 117.032 0.416 . . . . 0.0 110.026 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -164.22 155.43 15.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -114.68 118.94 35.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.213 0.53 . . . . 0.0 110.133 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -95.49 108.03 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.3 p -97.03 150.18 21.08 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.81 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 24.01 1.78 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.812 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 50.6 mm -82.51 125.19 76.77 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.84 163.27 35.92 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.544 2.163 . . . . 0.0 112.348 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.35 40.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.217 2.611 . . . . 0.0 111.208 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 87' ' ' VAL . . . -84.74 124.91 72.37 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.75 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 16.6 Cg_exo -66.13 99.82 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.148 2.565 . . . . 0.0 115.506 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.4 mtp180 54.91 114.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.617 1.967 . . . . 0.0 115.442 167.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.98 -20.6 31.78 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.661 -0.781 . . . . 0.0 114.764 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 83' ' ' ALA . 21.7 t -73.79 -47.03 6.95 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 122.458 -0.436 . . . . 0.0 111.416 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.99 113.26 3.51 Favored 'Trans proline' 0 C--N 1.376 2.005 0 N-CA-C 108.782 -1.276 . . . . 0.0 108.782 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.288 0.0 OUTLIER -129.78 128.01 41.52 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.05 0.929 . . . . 0.0 113.049 -178.14 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 mm -107.14 126.72 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.713 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.18 107.73 19.4 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.04 120.56 60.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.322 0.582 . . . . 0.0 110.152 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 62.5 m -113.55 124.76 53.12 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.146 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -105.86 114.34 28.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -123.66 138.58 54.51 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.332 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.8 mt -125.71 141.99 43.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -104.78 -170.14 1.72 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.6 -11.81 60.55 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -84.96 -28.76 25.61 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.029 0.442 . . . . 0.0 109.825 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.44 23.34 8.03 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 86.6 mt -90.3 117.57 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-O 121.382 0.611 . . . . 0.0 109.526 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 38.6 tp -95.74 129.27 43.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.646 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 45.4 m-80 -117.62 108.68 15.74 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 47.1 t -88.84 113.79 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -111.32 114.44 27.61 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.303 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.19 123.62 47.12 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.471 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.1 m -118.5 119.92 35.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.414 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.84 104.5 6.41 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -68.31 -18.31 64.48 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.582 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -68.43 -61.96 1.6 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.855 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 p -98.98 -37.71 9.27 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 120.8 0.333 . . . . 0.0 111.346 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.24 -0.59 8.21 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.045 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.0 137.31 55.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 117.406 0.603 . . . . 0.0 112.03 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.92 136.85 32.67 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.131 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -139.96 139.52 36.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 21.4 ptmt -137.95 142.01 40.54 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.128 0.49 . . . . 0.0 110.689 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 34.4 pt -119.17 147.66 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.5 m -106.96 113.45 26.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.017 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.417 HD11 HD12 ' A' ' 117' ' ' ILE . 50.7 mt -128.83 116.4 40.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.7 m -72.54 127.32 32.19 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 168.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 N--CA 1.51 2.548 0 O-C-N 124.339 1.024 . . . . 0.0 111.217 -170.668 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.864 0.364 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 135' ' ' VAL . 48.0 mm -61.15 -45.3 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.66 -25.04 62.82 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -60.21 -45.0 94.68 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.5 mmt -59.48 -45.07 92.72 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.563 ' HA ' HH12 ' A' ' 32' ' ' ARG . 96.2 t -60.29 -57.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.085 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -70.22 -48.47 56.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -172.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.54 -38.62 91.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.02 -39.72 83.07 Favored 'General case' 0 C--O 1.19 -2.079 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.602 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -58.26 -33.31 69.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.493 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.4 -37.81 51.12 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -126.19 15.75 7.82 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -59.3 -27.31 65.74 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.48 95.52 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.772 0.796 . . . . 0.0 108.867 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 24.8 mm-40 -70.61 -44.96 66.17 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.506 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 3.0 m-20 -56.99 -45.42 83.0 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 123.545 0.528 . . . . 0.0 112.266 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 38.2 mt-10 -61.24 -39.29 89.75 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.79 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 82.9 t -63.74 -48.73 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.6 mm-40 -56.18 -46.06 79.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.519 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.436 ' C ' ' HD3' ' A' ' 149' ' ' ARG . 2.5 tmt_? -53.29 -50.83 64.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.593 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.1 pt-20 -83.18 -5.14 59.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 11.7 mmp_? -76.29 -34.54 59.07 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.88 -54.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 49.0 m -149.32 129.18 13.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.0 -38.04 9.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.01 0.434 . . . . 0.0 110.779 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HE3' ' OG1' ' A' ' 45' ' ' THR . 64.1 tttp -80.65 144.93 31.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 90.0 m-20 -76.68 99.13 4.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.319 0.581 . . . . 0.0 110.675 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -134.6 132.82 39.5 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.907 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 21' ' ' THR . 18.5 mt -101.13 114.32 28.15 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.1 119.32 37.64 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.708 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 12' ' ' VAL . 49.4 tp . . . . . 0 N--CA 1.419 -1.995 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.8 m-20 -78.76 56.99 1.98 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.538 -172.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG22 ' HG ' ' A' ' 10' ' ' LEU . 10.0 m -136.56 168.37 22.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.8 127.2 68.42 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.68 -47.34 9.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.578 2.185 . . . . 0.0 111.972 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CB ' ' HB3' ' A' ' 60' ' ' GLU . 3.9 mm? -123.19 169.83 10.86 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.151 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 19.7 m -76.79 129.47 36.32 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.1 131.55 40.97 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.84 178.13 26.6 Favored Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.865 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.7 mt -123.93 164.71 18.75 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.324 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -84.18 109.58 17.85 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 HD23 ' A' ' 158' ' ' LEU . 12.2 p -99.19 142.47 30.64 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.461 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.64 113.91 0.68 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.355 1.462 . . . . 0.0 113.049 -172.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.08 -11.46 8.2 Favored Glycine 0 N--CA 1.425 -2.06 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.384 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' A' ' 20' ' ' GLU . . . 84.49 50.33 4.29 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.64 134.75 65.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.2 ttt -94.23 101.35 13.32 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.809 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -95.42 119.23 33.56 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 143.79 26.18 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.5 mp -102.11 -44.57 5.41 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.235 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.84 129.07 76.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -85.7 167.11 15.58 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ptt85 -69.13 165.37 20.49 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.879 0.371 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 68.78 9.31 7.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.583 1.153 . . . . 0.0 112.659 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -81.61 118.74 23.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 13.2 p -62.76 126.94 29.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.9 pt -91.6 164.68 23.33 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.37 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.3 Cg_exo -68.76 122.77 5.78 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.353 1.162 . . . . 0.0 113.477 1.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -95.17 156.73 16.19 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.495 0.718 . . . . 0.0 110.106 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -160.13 104.05 1.48 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -129.52 120.9 26.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.0 m -107.39 141.51 38.65 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.569 0.748 . . . . 0.0 110.492 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -136.62 162.01 34.31 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.703 0.401 . . . . 0.0 109.974 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.79 122.94 62.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -107.57 146.57 31.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.86 0.838 . . . . 0.0 111.932 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 3.3 p -114.74 173.08 6.66 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.582 -1.644 . . . . 0.0 108.749 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 p -113.31 151.13 31.55 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 112.243 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -108.0 7.38 27.83 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.725 0.774 . . . . 0.0 110.286 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -89.97 158.15 17.51 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.568 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -118.27 114.42 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 63.3 74.25 0.43 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.245 1.021 . . . . 0.0 111.081 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.45 ' CD ' ' H ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -102.73 121.13 50.59 Favored Pre-proline 0 C--N 1.292 -1.904 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.56 -178.001 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.18 -14.85 6.93 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.091 1.861 . . . . 0.0 110.891 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.87 150.76 20.89 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 29.0 m -118.41 158.64 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 tp -108.23 127.04 53.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.086 0.469 . . . . 0.0 111.426 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.26 105.36 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -113.02 123.51 50.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.82 119.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 123.9 0.75 . . . . 0.0 110.048 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 89.0 m-85 -122.68 156.78 33.66 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.171 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HB3' ' CB ' ' A' ' 15' ' ' LEU . 49.0 mt-10 -111.11 149.69 30.49 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.155 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -165.76 12.1 Favored Glycine 0 N--CA 1.422 -2.251 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 30.7 mt-10 -148.8 99.36 2.98 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.286 0.565 . . . . 0.0 109.88 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -130.01 153.36 48.5 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.317 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -65.98 -40.66 91.41 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.713 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 69.9 mtm -128.59 135.45 49.36 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.88 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 109.5 2.48 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 20.3 pttp -155.72 -44.99 0.08 Allowed 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.394 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.444 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 10.9 m-20 -128.67 82.74 2.1 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.464 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 19.6 m120 -145.45 170.43 16.39 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.145 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 71.0 m-20 -90.73 117.78 29.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.99 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -85.88 108.1 17.99 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.54 -42.09 23.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.459 0.647 . . . . 0.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.38 35.52 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.515 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 4.4 ppt_? -146.7 147.39 30.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 122.279 0.231 . . . . 0.0 110.874 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.51 157.21 31.67 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.95 135.99 48.41 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 59.4 tp -97.12 104.5 16.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p -103.32 154.5 19.31 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.37 10.53 25.4 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.99 135.54 85.2 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.94 115.82 4.49 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.673 1.582 . . . . 0.0 110.181 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.3 102.72 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.065 2.51 . . . . 0.0 111.727 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.17 173.23 6.12 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.614 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.71 171.51 2.7 Favored 'Trans proline' 0 C--O 1.262 1.708 0 C-N-CA 122.451 2.101 . . . . 0.0 112.836 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -62.6 117.97 6.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.643 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.465 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 88.54 19.39 52.26 Favored Glycine 0 CA--C 1.494 -1.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.955 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.412 ' H ' ' HD2' ' A' ' 88' ' ' PRO . 62.7 t -91.25 -54.89 0.27 Allowed Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.398 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' A' ' 87' ' ' VAL . 18.1 Cg_endo -58.78 138.28 84.81 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 121.748 1.632 . . . . 0.0 112.044 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -102.71 96.11 6.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.642 0.734 . . . . 0.0 111.339 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.9 mm -92.48 133.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -112.63 119.14 37.11 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -120.91 127.97 76.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 95.7 m -118.71 127.41 53.53 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.66 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 29' ' ' LEU . 9.1 m-85 -105.5 113.26 26.73 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.485 ' HB3' ' HG2' ' A' ' 39' ' ' LYS . 2.6 p30 -132.92 140.97 48.12 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 60.9 mt -127.5 126.42 67.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.468 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.0 p30 -90.84 179.02 5.88 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.07 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.74 63.8 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.06 -16.7 54.51 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.03 29.18 8.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 73.1 mt -94.8 117.68 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.4 tp -94.4 115.09 27.23 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.802 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -103.56 120.75 41.5 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.629 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.94 114.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.1 m -118.01 126.96 53.31 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.81 124.59 52.15 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -126.49 120.77 30.52 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.69 99.29 5.78 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -68.98 -6.19 26.27 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -70.13 -50.23 42.63 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 p -97.82 -43.24 7.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.545 0.688 . . . . 0.0 111.242 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.18 25.66 5.49 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.82 142.15 29.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.21 149.0 48.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.143 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.407 ' OD1' ' HA ' ' A' ' 77' ' ' LEU . 10.6 m120 -144.75 135.0 24.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 125.184 1.394 . . . . 0.0 107.33 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -124.73 166.74 15.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.039 0.447 . . . . 0.0 111.214 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.0 tt -140.36 140.31 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.1 m -116.14 113.77 23.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.821 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.13 101.57 12.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.7 p -92.36 103.36 15.81 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.262 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.3 m120 . . . . . 0 N--CA 1.485 1.279 0 C-N-CA 124.511 1.124 . . . . 0.0 113.531 173.053 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.214 -0.811 0 CA-C-O 120.488 0.185 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 135' ' ' VAL . 62.8 mt -63.34 -52.4 58.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -61.82 -38.51 88.4 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.504 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -63.76 -40.66 97.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.464 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 2.1 tpt -63.1 -39.54 94.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.358 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 131' ' ' ILE . 57.4 t -55.98 -50.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 123.227 0.329 . . . . 0.0 110.221 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -58.02 -55.79 30.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.191 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.68 -43.12 99.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.83 88.9 Favored 'General case' 0 C--O 1.204 -1.308 0 O-C-N 123.41 0.444 . . . . 0.0 111.855 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -77.89 -37.64 47.62 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.817 0.341 . . . . 0.0 111.75 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -111.45 19.78 17.87 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -52.73 -56.96 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.661 1.185 . . . . 0.0 110.699 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.88 89.06 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.101 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.55 -50.9 67.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.306 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.24 -39.26 75.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.69 -33.49 75.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.781 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 70.7 t -64.58 -45.29 95.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.41 ' O ' HG23 ' A' ' 152' ' ' VAL . 78.4 mt-30 -64.25 -37.57 87.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.795 0.331 . . . . 0.0 110.643 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 52.1 ttp180 -61.62 -32.14 72.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.883 0.873 . . . . 0.0 112.01 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -89.3 -21.12 23.32 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.289 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 23.7 mmm180 -68.5 -42.85 78.02 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 148' ' ' GLN . 60.7 t -70.43 137.11 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.2 p -70.71 86.03 0.66 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.107 0.956 . . . . 0.0 111.126 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.97 166.82 10.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.532 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -170.33 164.23 8.83 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -80.29 74.91 7.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.899 0.857 . . . . 0.0 109.546 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -135.82 127.56 29.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.924 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 21' ' ' THR . 28.5 mt -97.37 152.77 18.59 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.426 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -78.02 172.37 13.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.516 ' H ' ' CD ' ' A' ' 159' ' ' GLU . 34.9 m . . . . . 0 N--CA 1.413 -2.293 0 O-C-N 121.704 -0.622 . . . . 0.0 112.25 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 tp . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 122.925 1.345 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.04 62.69 3.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.911 1.338 . . . . 0.0 110.03 177.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 35' ' ' THR . 32.4 m -144.42 -179.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.95 112.57 52.99 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.68 -13.91 10.45 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 121.586 1.524 . . . . 0.0 111.617 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 131' ' ' ILE . 89.1 mt -135.57 166.15 23.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.623 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 27.3 m -103.65 116.24 31.98 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.58 130.94 38.08 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.05 -177.62 18.18 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.072 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -124.78 166.0 17.0 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.081 0.552 . . . . 0.0 111.584 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.49 109.12 17.1 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.512 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 5.9 p -113.69 156.58 23.5 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.487 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 119.68 6.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.451 1.1 . . . . 0.0 113.286 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.72 4.44 28.15 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.286 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.59 38.31 28.47 Favored Glycine 0 CA--C 1.494 -1.247 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 152' ' ' VAL . 63.5 t -99.44 142.21 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.39 -0.905 . . . . 0.0 108.667 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.415 ' HB2' ' N ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -108.92 103.12 12.1 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.217 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -91.95 110.71 22.07 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.75 115.58 28.18 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.717 0.636 . . . . 0.0 110.551 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.493 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.5 mp -91.21 -49.3 6.45 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 16' ' ' SER . 49.5 mm -97.58 91.04 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -85.76 148.43 25.85 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.874 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -57.38 150.56 18.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 76.64 11.39 2.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.044 1.738 . . . . 0.0 112.408 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 m -94.31 113.4 25.29 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 12' ' ' VAL . 3.4 m -65.36 143.34 57.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.6 pt -96.15 162.29 24.29 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 23.7 Cg_exo -68.64 132.21 19.95 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.958 1.021 . . . . 0.0 113.614 -0.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.76 154.89 18.25 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.903 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 95' ' ' ASP . 50.9 tptt -149.04 101.46 3.16 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -124.03 135.92 53.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 92.1 m -135.51 138.57 43.22 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.37 145.94 50.8 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 122.905 0.482 . . . . 0.0 109.76 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.41 122.09 55.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -114.42 155.94 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.82 171.55 8.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 123.732 0.813 . . . . 0.0 108.879 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -98.9 136.07 39.42 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.098 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -99.18 -14.2 19.42 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.949 0.88 . . . . 0.0 109.021 172.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -95.63 113.65 25.32 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.769 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.26 139.99 41.38 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 62.04 55.95 2.4 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 52' ' ' PRO . 70.9 mm-40 -101.39 136.81 19.57 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 175.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.403 ' HD2' ' OE1' ' A' ' 51' ' ' GLN . 54.5 Cg_endo -72.14 -25.92 18.56 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.576 2.184 . . . . 0.0 111.794 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' A' ' 80' ' ' ILE . . . -171.88 168.0 41.06 Favored Glycine 0 N--CA 1.407 -3.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.569 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.25 138.01 44.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.1 tp -90.51 104.21 16.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.294 0.569 . . . . 0.0 109.822 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.98 117.1 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -135.43 119.37 17.41 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.744 -171.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.09 122.49 47.63 Favored 'Isoleucine or valine' 0 C--O 1.248 0.975 0 O-C-N 124.33 1.018 . . . . 0.0 110.811 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 69' ' ' ASN . 40.3 m-85 -120.7 149.55 42.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.905 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.427 ' OE2' HD13 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -119.17 157.74 27.33 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' SD ' ' A' ' 134' ' ' MET . . . 104.51 15.95 19.42 Favored Glycine 0 C--N 1.31 -0.909 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 167.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.595 ' OE1' ' HG3' ' A' ' 67' ' ' LYS . 47.4 mm-40 -144.14 179.52 7.16 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 118.309 1.055 . . . . 0.0 112.116 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -120.03 -72.11 0.7 Allowed 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.269 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -91.97 -50.69 5.57 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.5 mtt -127.93 145.33 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.415 ' N ' ' HB2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -72.26 107.35 4.84 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.672 -174.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.595 ' HG3' ' OE1' ' A' ' 62' ' ' GLU . 10.7 pttp -137.48 -76.45 0.4 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 123.339 0.655 . . . . 0.0 111.587 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.78 75.08 4.94 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 122.77 1.271 . . . . 0.0 110.343 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.515 HD21 ' HB2' ' A' ' 62' ' ' GLU . 22.1 m120 -122.87 152.37 40.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.713 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -111.38 140.15 46.2 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.739 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.1 tp -83.17 119.89 25.1 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.4 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.9 mt -97.2 -65.82 0.94 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.744 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.45 21.61 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.264 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 -153.3 157.49 40.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -161.8 147.72 13.62 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.625 0.578 . . . . 0.0 109.492 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -94.5 113.88 25.79 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -88.78 103.39 15.93 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 p -119.0 166.37 12.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.91 18.32 12.64 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.449 HD13 ' HA2' ' A' ' 53' ' ' GLY . 1.8 mp -77.95 130.05 74.09 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.65 154.17 74.1 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 122.483 2.122 . . . . 0.0 111.895 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.24 92.05 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.18 1.92 . . . . 0.0 110.739 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.14 155.98 80.77 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.184 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.99 176.95 8.44 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.31 2.007 . . . . 0.0 113.356 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 58.0 mtt85 -45.91 131.43 9.57 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.574 1.55 . . . . 0.0 113.124 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.43 -20.25 35.35 Favored Glycine 0 C--N 1.311 -0.807 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.427 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 54.9 t -74.73 -53.99 3.01 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 117.671 0.735 . . . . 0.0 112.805 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 5.5 Cg_exo -76.79 104.36 1.9 Allowed 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.346 1.364 . . . . 0.0 111.025 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -97.2 131.17 44.2 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.346 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.21 119.21 59.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.82 110.4 22.98 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.35 123.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.594 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.2 m -114.26 127.8 56.05 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.493 ' CD1' HD22 ' A' ' 29' ' ' LEU . 9.9 m-85 -111.3 121.01 44.13 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.621 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 1.7 p30 -138.07 137.7 38.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.942 0.401 . . . . 0.0 111.269 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 33.9 mt -121.78 123.84 70.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -88.48 -170.93 3.14 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 123.415 0.447 . . . . 0.0 111.545 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.8 -16.19 63.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.113 0.565 . . . . 0.0 112.346 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -83.18 -23.63 32.8 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.05 21.8 17.11 Favored Glycine 0 N--CA 1.419 -2.485 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 91.8 mt -90.01 117.61 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.428 0.632 . . . . 0.0 109.87 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 96' ' ' ILE . 16.7 tp -96.47 122.37 39.3 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.092 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -117.29 120.39 38.06 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.205 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.6 t -99.32 113.14 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.7 m -115.13 126.32 54.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.66 123.71 50.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 m -109.81 128.66 55.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.774 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 5.6 t0 -85.41 107.21 17.28 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 124.939 1.296 . . . . 0.0 107.647 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -67.5 -18.25 64.98 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.0 m -86.11 -36.66 19.46 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.926 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -110.87 -29.14 8.07 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.55 19.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.151 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 108' ' ' ASP . 9.9 ptpp? -92.4 161.9 14.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.97 137.59 16.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.682 0.277 . . . . 0.0 111.065 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -129.99 142.06 50.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 60.7 pttt -129.34 155.5 45.53 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.146 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.1 pt -121.11 157.58 24.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 m -129.85 113.63 14.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.445 0.641 . . . . 0.0 111.551 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.8 mt -115.39 142.66 27.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 m -117.74 166.5 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 40.9 p30 . . . . . 0 N--CA 1.477 0.91 0 CA-C-N 118.343 0.52 . . . . 0.0 111.383 177.65 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 120.99 0.424 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.547 ' HA ' HD21 ' A' ' 15' ' ' LEU . 59.2 mt -60.98 -50.23 81.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.933 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.62 -26.68 60.9 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.774 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 136' ' ' GLN . 17.3 mmm180 -62.97 -36.84 84.84 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 173.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.419 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 15.6 ttt -59.24 -50.59 73.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 47.8 t -52.23 -53.8 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 124.084 0.865 . . . . 0.0 110.344 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.55 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.5 mt-30 -56.08 -46.84 78.88 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 124.095 0.872 . . . . 0.0 112.004 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.17 -39.49 60.26 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.755 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.03 67.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 9.1 pt-20 -75.16 -41.96 57.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.1 0.476 . . . . 0.0 110.896 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 98.1 mttt -57.62 -48.55 79.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.066 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.08 21.47 6.76 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.333 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 39.3 ttmt -58.7 -44.04 90.19 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.59 0.756 . . . . 0.0 112.021 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.32 -49.43 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -63.62 -46.36 86.07 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 m-20 -66.19 -27.97 68.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.969 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 5.4 tp10 -64.47 -39.73 94.36 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.3 t -70.94 -48.23 57.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.911 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 96.6 mt-30 -57.0 -38.3 72.88 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 123.549 0.74 . . . . 0.0 112.921 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -71.43 -31.92 67.77 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.008 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.45 -8.21 56.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.164 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 23.5 mmt85 -82.14 0.84 39.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.64 0.733 . . . . 0.0 109.505 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 25' ' ' VAL . 33.4 t -114.36 113.87 45.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -78.56 153.54 31.13 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.63 67.96 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.278 1.037 . . . . 0.0 112.848 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.5 33.49 0.51 Allowed 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -59.83 157.21 12.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.736 -170.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.56 154.55 46.55 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.833 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 52.2 mt -91.73 142.88 27.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -82.97 118.52 23.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 118.106 -1.438 . . . . 0.0 107.456 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.412 -2.351 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.293 -174.027 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.4 mt . . . . . 0 CA--C 1.507 -0.677 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 75.55 16.06 2.62 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 124.91 1.284 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.76 174.94 12.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.799 0.809 . . . . 0.0 112.302 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.28 114.74 64.8 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.794 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.78 -41.72 13.64 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.393 2.062 . . . . 0.0 111.862 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -117.02 144.64 44.36 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.967 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 m -67.09 137.46 56.39 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.994 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -106.5 131.96 53.07 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.502 0.502 . . . . 0.0 109.651 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -162.67 -158.1 9.45 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.437 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.19 165.88 24.07 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.432 0.693 . . . . 0.0 109.341 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -89.12 120.45 30.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.6 p -92.22 -105.44 0.11 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' A' ' 159' ' ' GLU . . . -112.42 146.85 37.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.134 -0.354 . . . . 0.0 110.322 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -57.78 4.99 Favored Glycine 0 C--N 1.317 -0.515 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.369 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.42 41.44 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.95 141.56 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.511 ' HB2' HG23 ' A' ' 66' ' ' THR . 1.1 tmt? -86.1 134.32 33.83 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.032 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -126.46 132.27 51.49 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -102.04 142.69 32.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.155 0.503 . . . . 0.0 111.657 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 6.4 mp -99.96 -49.12 4.43 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -101.27 112.39 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -85.64 158.72 20.01 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.459 HH22 ' HG3' ' A' ' 142' ' ' LYS . 15.4 ptt-85 -58.23 151.91 18.31 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.848 0.859 . . . . 0.0 110.654 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.7 m120 76.23 11.01 2.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.567 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -87.73 124.07 33.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.147 0.498 . . . . 0.0 110.155 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -68.87 137.33 53.79 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.407 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.68 159.73 28.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.4 140.82 50.49 Favored 'Cis proline' 0 CA--C 1.501 -1.147 0 CA-C-N 120.348 1.16 . . . . 0.0 112.516 -1.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -98.54 -77.98 0.5 Allowed 'General case' 0 N--CA 1.406 -2.668 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.734 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 88.8 tttt 66.81 100.7 0.05 OUTLIER 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.491 1.117 . . . . 0.0 111.022 -171.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -128.06 130.82 48.85 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -113.01 129.04 56.64 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 123.511 0.507 . . . . 0.0 110.191 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 29' ' ' LEU . 74.4 mt-30 -133.41 141.03 47.67 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 74.8 mt -104.19 120.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.176 0.513 . . . . 0.0 109.972 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -107.33 136.3 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -111.46 162.46 15.06 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.1 p -90.25 135.81 33.44 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.589 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 31.0 m-85 -114.92 -6.36 12.58 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.529 173.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -98.34 119.96 37.92 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.08 163.23 26.83 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.018 0.199 . . . . 0.0 110.996 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.19 23.99 14.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.142 0.977 . . . . 0.0 113.199 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -85.35 120.53 73.33 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.67 -16.08 14.98 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.59 2.193 . . . . 0.0 113.767 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.87 159.05 29.41 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.266 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.69 171.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 tt -129.08 118.6 22.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 111.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -126.53 118.12 24.25 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.12 132.73 30.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.775 -172.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 79.7 m-85 -134.01 152.94 52.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.737 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -112.9 151.73 30.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.587 0.554 . . . . 0.0 110.341 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.02 152.3 26.71 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.107 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -115.44 121.42 42.7 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.38 0.609 . . . . 0.0 109.795 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -140.29 162.72 34.61 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -66.65 -37.46 84.85 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 123.865 0.728 . . . . 0.0 111.098 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.77 139.93 46.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.749 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.511 HG23 ' HB2' ' A' ' 26' ' ' MET . 0.2 OUTLIER -70.57 113.95 8.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.266 -175.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.452 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -171.69 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.985 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.83 -14.55 54.13 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.963 0.887 . . . . 0.0 109.17 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.499 ' OD1' ' HA ' ' A' ' 66' ' ' THR . 8.7 m120 -66.96 152.73 45.2 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.311 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 78.4 m-20 -89.06 121.4 31.36 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.73 115.66 21.07 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.04 -36.67 12.01 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.062 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.29 171.97 39.06 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.214 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -149.03 159.29 44.35 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.427 0.291 . . . . 0.0 111.356 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.07 154.52 25.8 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 172.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.89 133.4 53.2 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 6.1 tt -108.25 104.44 13.84 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.6 p -104.53 159.44 15.74 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.112 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.11 -14.41 5.15 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.5 -0.857 . . . . 0.0 110.971 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.19 119.23 50.75 Favored Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 123.258 0.623 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.99 166.59 11.23 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.595 2.197 . . . . 0.0 110.939 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.09 97.46 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.933 1.755 . . . . 0.0 110.378 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.72 151.41 78.05 Favored Pre-proline 0 N--CA 1.426 -1.659 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.9 133.52 40.2 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.067 2.511 . . . . 0.0 111.466 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -60.98 119.65 8.7 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.397 0.618 . . . . 0.0 111.639 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.22 -27.11 6.2 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.406 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 87.6 t -72.93 -48.82 7.89 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.336 -0.432 . . . . 0.0 111.082 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 21.9 Cg_exo -70.08 106.67 1.76 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.182 1.255 . . . . 0.0 109.301 172.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 74.3 mt-30 -113.83 115.33 27.58 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.419 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.21 111.42 25.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -90.1 104.32 16.9 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -104.75 127.11 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.084 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.7 m -122.26 123.01 40.45 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.875 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 5.1 m-85 -99.45 112.35 24.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.728 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -112.95 143.28 44.51 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 11.9 mt -130.99 127.54 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -98.58 -171.68 2.17 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.86 -23.92 64.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.06 -29.82 49.41 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.07 26.2 6.13 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.7 mt -84.59 119.61 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 65.0 tp -96.06 107.84 20.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -103.52 125.83 50.31 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.7 t -111.29 113.02 43.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.8 m -106.24 116.52 32.08 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.63 117.23 33.39 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.7 m -113.45 122.1 46.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 110.65 16.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 54.2 mtpt -67.41 -18.55 65.15 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.541 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.9 p -80.26 -56.75 3.99 Favored 'General case' 0 C--O 1.25 1.102 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.359 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.6 p -76.58 -32.06 57.9 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.168 0.508 . . . . 0.0 110.361 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.93 -8.65 54.4 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.8 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -94.49 160.41 14.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.546 0.673 . . . . 0.0 111.435 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.1 148.43 51.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.283 0.563 . . . . 0.0 111.719 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.509 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.4 m120 -130.86 132.25 45.06 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 157.97 45.56 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.382 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 tt -127.78 146.51 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.2 m -125.18 112.31 16.3 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.235 0.541 . . . . 0.0 109.693 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.59 93.84 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -82.23 107.46 14.93 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--N 1.3 -1.559 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.666 -174.312 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 134' ' ' MET . 7.7 tp10 . . . . . 0 N--CA 1.444 -0.751 0 CA-C-O 120.984 0.421 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 135' ' ' VAL . 66.0 mt -65.2 -50.58 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.662 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.7 pt-20 -63.91 -32.48 74.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 130' ' ' GLU . 53.9 mtm-85 -60.51 -46.83 88.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 23.9 mmt -60.88 -42.8 98.64 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.657 0.598 . . . . 0.0 109.772 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 131' ' ' ILE . 88.2 t -59.61 -51.77 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.042 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 98.1 mt-30 -56.53 -47.55 79.16 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 122.937 0.495 . . . . 0.0 111.434 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.22 -41.27 97.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.95 75.45 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.5 -47.09 18.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.302 0.572 . . . . 0.0 112.505 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.99 -22.82 55.44 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.328 0.585 . . . . 0.0 111.579 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -120.57 26.46 9.13 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.841 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.459 ' HG3' HH22 ' A' ' 32' ' ' ARG . 40.8 tttm -56.31 -42.13 77.1 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.109 0.964 . . . . 0.0 111.241 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.63 -52.84 18.61 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.923 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.39 -39.55 58.95 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.605 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -71.06 -49.83 40.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.412 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 37.9 mt-10 -66.26 -35.36 80.21 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.656 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 38.9 t -62.73 -50.05 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.392 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.18 -37.94 89.21 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.9 0.381 . . . . 0.0 111.726 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 58.9 ttt180 -58.11 -52.19 66.58 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.828 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 41.8 mm-40 -72.56 -19.88 61.42 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.826 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 18.4 mmm180 -70.24 -29.45 66.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.178 0.513 . . . . 0.0 109.949 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.91 -59.24 2.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.2 m -89.31 61.46 5.7 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.844 0.83 . . . . 0.0 111.113 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.94 -32.59 30.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.076 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.83 131.31 54.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -73.08 103.34 3.81 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.226 0.536 . . . . 0.0 111.432 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.549 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.41 160.27 41.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.37 140.89 51.88 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 22' ' ' ALA . 45.9 mm-40 -97.7 134.07 41.37 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.483 0.658 . . . . 0.0 111.596 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.412 -2.339 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.441 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 12' ' ' VAL . 5.1 tt . . . . . 0 N--CA 1.427 -1.619 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' THR . 3.5 m-20 -75.97 55.35 0.9 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.478 HG13 HD22 ' A' ' 10' ' ' LEU . 30.9 m -136.66 170.6 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.85 129.71 45.45 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.04 -31.56 6.05 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.069 1.846 . . . . 0.0 112.305 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.4 mp -126.65 157.55 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.436 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 20.0 m -86.34 138.16 32.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.07 131.21 48.66 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -157.03 -171.46 23.12 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.357 -176.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 92' ' ' VAL . 84.4 mt -126.36 169.88 12.49 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.09 0.556 . . . . 0.0 110.076 -176.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.38 108.44 19.96 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.441 HG22 HD23 ' A' ' 158' ' ' LEU . 6.1 p -92.52 166.37 12.56 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.36 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.68 114.05 0.97 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.411 1.084 . . . . 0.0 112.388 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.94 -2.08 21.21 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.189 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.12 72.28 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.23 145.69 7.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.438 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -92.64 117.37 29.9 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.9 m -115.05 112.19 22.24 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -93.12 135.08 34.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.199 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.3 mp -94.13 -41.0 9.74 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -109.96 113.21 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -90.34 166.64 13.19 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.822 0.82 . . . . 0.0 112.724 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -61.16 141.01 57.78 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.36 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 77.86 2.03 2.89 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.716 1.207 . . . . 0.0 111.873 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -83.47 130.58 35.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 5.5 p -65.47 130.37 43.06 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 39.5 pt -106.78 148.59 37.17 Favored Pre-proline 0 N--CA 1.435 -1.212 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 52.6 Cg_exo -61.87 132.61 10.61 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.03 1.046 . . . . 0.0 113.639 1.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 m -110.17 143.16 40.69 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.237 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -128.67 108.71 10.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -128.06 141.91 51.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -139.9 135.42 32.84 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -141.61 144.96 34.47 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 91' ' ' GLU . 42.3 mm -92.29 114.82 29.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.43 147.38 25.32 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.811 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 8.9 p -136.6 170.16 16.52 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.882 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -103.7 137.84 41.17 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.817 0.281 . . . . 0.0 110.686 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 43.8 m-85 -112.93 4.54 16.87 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -84.64 175.34 9.29 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.798 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.88 117.49 31.22 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.296 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 37.17 81.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' A' ' 159' ' ' GLU . 25.5 mt-30 -101.41 139.11 20.15 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.852 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -85.61 0.02 8.64 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.245 1.963 . . . . 0.0 111.964 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.6 176.12 44.23 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.01 152.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.8 tp -101.11 120.39 40.14 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.48 105.45 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -119.22 118.51 31.49 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 t -95.45 134.6 32.31 Favored 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.706 0.629 . . . . 0.0 111.495 -172.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.48 151.48 50.91 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.302 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -116.13 141.08 48.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.91 -117.84 1.83 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 9.4 mt-10 177.26 -99.94 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 126.115 1.766 . . . . 0.0 111.525 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.526 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 20.8 mmm180 55.4 -178.12 0.04 OUTLIER 'General case' 0 C--O 1.244 0.795 0 O-C-N 123.681 0.613 . . . . 0.0 110.524 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -91.28 -49.67 6.23 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.691 0.757 . . . . 0.0 110.663 175.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.2 mtp -97.65 126.15 42.8 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.53 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.328 0.4 OUTLIER -80.33 86.19 5.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.671 1.7 . . . . 0.0 111.418 178.331 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -152.42 -45.83 0.1 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.775 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.35 7.26 1.39 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.209 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' ND2' ' HG3' ' A' ' 26' ' ' MET . 89.3 m-20 -109.67 163.74 13.19 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.633 0.373 . . . . 0.0 111.493 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -91.01 136.19 33.24 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 tt -96.78 122.91 40.25 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.64 -45.18 9.53 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.279 0.362 . . . . 0.0 111.494 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.63 175.83 47.17 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.19 156.74 42.61 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.52 139.27 20.77 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -97.4 120.27 37.46 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.64 104.55 14.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 p -110.91 173.87 6.13 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.05 21.76 44.62 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 52.8 mt -90.17 135.26 30.11 Favored Pre-proline 0 N--CA 1.426 -1.673 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.65 117.02 3.9 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.563 2.175 . . . . 0.0 112.479 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.44 91.28 0.97 Allowed 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.191 1.927 . . . . 0.0 109.942 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.55 168.68 13.71 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.304 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.05 100.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.289 2.659 . . . . 0.0 113.237 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 60.85 -160.99 0.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.698 1.199 . . . . 0.0 111.349 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.7 63.33 1.18 Allowed Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 76.5 t -66.4 -48.39 56.66 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 167.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.601 ' HA ' ' OG ' ' A' ' 110' ' ' SER . 15.7 Cg_endo -59.05 129.9 33.99 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.058 1.839 . . . . 0.0 111.347 168.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.67 110.67 22.58 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.04 114.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 43' ' ' ILE . 35.1 tt0 -90.75 114.33 26.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.434 HG11 HD11 ' A' ' 19' ' ' LEU . 62.1 t -109.32 122.6 64.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.805 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.1 m -109.53 129.63 55.56 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.874 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.447 ' CD1' HD22 ' A' ' 29' ' ' LEU . 5.3 m-85 -109.9 107.74 17.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 17.7 t70 -120.06 113.12 20.01 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.826 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 44.3 mt -111.74 136.07 49.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.0 OUTLIER -100.99 -168.42 1.56 Allowed 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.32 -8.18 55.95 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.424 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -96.04 -29.82 13.91 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.96 23.85 5.41 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 46.5 mm -81.87 115.44 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.455 HD13 HG13 ' A' ' 96' ' ' ILE . 31.5 tp -105.49 113.64 27.33 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.744 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -96.6 102.69 14.52 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.5 t -89.22 113.49 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 20.7 m -119.0 118.81 32.5 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.82 118.91 36.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.6 m -119.6 118.81 31.99 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.665 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 110.5 12.07 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -66.43 -20.33 66.03 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.055 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 88' ' ' PRO . 1.5 m -70.44 -53.34 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.176 0.512 . . . . 0.0 110.823 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.3 p -95.14 -29.46 14.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.096 0.474 . . . . 0.0 112.087 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.97 19.44 24.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.864 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.39 131.36 36.21 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 121.084 0.469 . . . . 0.0 111.894 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.54 134.13 53.08 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.815 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -128.78 128.57 44.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 65.5 pttt -129.15 154.09 47.07 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.854 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 HD11 ' A' ' 119' ' ' ILE . 25.0 pt -126.93 140.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 171.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 m -103.95 112.53 25.54 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.41 HD11 HD12 ' A' ' 117' ' ' ILE . 46.2 mm -111.63 103.49 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.818 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 t -78.29 102.38 7.63 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.1 t30 . . . . . 0 N--CA 1.433 -1.304 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.881 -171.454 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 CA--C 1.516 -0.355 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 135' ' ' VAL . 81.9 mt -58.92 -53.88 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.138 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.6 -33.0 73.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -65.01 -41.54 95.24 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.566 173.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.2 ttt -68.8 -37.06 79.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.378 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 131' ' ' ILE . 81.1 t -60.89 -46.11 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -63.2 -32.33 73.7 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.763 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 22.4 mm-40 -59.23 -52.98 63.33 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.13 -29.53 69.86 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.409 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.77 -48.53 14.68 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.392 0.615 . . . . 0.0 112.439 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -71.24 -36.5 71.81 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.061 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -101.12 10.4 40.96 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 74.9 tttt -47.67 -54.48 11.91 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.974 0.91 . . . . 0.0 112.309 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.35 72.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.48 0.657 . . . . 0.0 111.413 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -72.81 -49.82 28.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.679 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -67.08 -39.41 86.8 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.499 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 48.6 mt-10 -60.37 -45.56 93.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.31 -32.92 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-O 121.405 0.621 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -74.69 -52.99 10.13 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.89 -0.507 . . . . 0.0 111.199 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 63' ' ' ARG . 55.2 ttp180 -69.82 -52.53 24.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.14 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -170.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 151' ' ' ARG . 22.6 mmt180 -91.29 -1.36 57.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.373 0.606 . . . . 0.0 110.762 176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.408 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 57.4 t -116.1 -58.3 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 t -90.94 87.39 6.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 122.659 1.219 . . . . 0.0 111.501 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.53 18.62 9.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 171.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 152' ' ' VAL . 49.9 pttt -137.64 137.77 38.79 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.217 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -94.65 97.27 9.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -143.08 127.81 18.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.441 HD23 HG22 ' A' ' 21' ' ' THR . 13.2 mt -118.72 146.75 44.5 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.4 ' HA ' HE22 ' A' ' 51' ' ' GLN 0.273 1.5 pp20? -132.47 173.77 10.95 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.313 -0.998 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.933 -171.806 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.2 tp . . . . . 0 N--CA 1.457 -0.089 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -75.52 53.55 0.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 35' ' ' THR . 24.7 m -138.22 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.48 112.51 53.34 Favored Pre-proline 0 C--N 1.281 -2.404 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.71 -32.59 18.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 121.861 1.707 . . . . 0.0 110.067 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.79 174.95 5.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.928 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 11.8 m -119.63 136.28 54.45 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.2 131.78 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.723 0.639 . . . . 0.0 109.384 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.19 178.13 32.86 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.4 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.2 mp -112.39 156.73 22.02 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.401 0.68 . . . . 0.0 109.233 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -90.9 109.37 20.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -93.66 173.73 7.54 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.727 -0.608 . . . . 0.0 111.383 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 118.61 5.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.959 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.76 6.79 32.4 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.87 39.49 64.77 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -99.14 131.08 47.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.84 118.12 29.19 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -114.07 111.38 21.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.7 122.53 38.56 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.962 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.412 HD12 ' CD2' ' A' ' 94' ' ' PHE . 48.1 mt -87.19 -37.61 17.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.413 0.625 . . . . 0.0 109.548 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 94' ' ' PHE . 3.4 mp -115.75 102.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.54 161.32 15.53 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.785 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -54.14 134.05 44.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 80.71 11.87 0.91 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.315 1.846 . . . . 0.0 113.552 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -86.22 132.97 33.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.43 ' HA ' HG12 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -62.51 140.54 58.62 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.495 1.118 . . . . 0.0 111.519 -176.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.454 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 35.3 pt -113.87 146.29 35.27 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.787 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 15.0 Cg_endo -65.31 141.63 49.68 Favored 'Cis proline' 0 CA--C 1.509 -0.731 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.055 -3.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -92.51 -70.76 0.68 Allowed 'General case' 0 N--CA 1.399 -3.008 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.464 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 1.1 tmtp? 67.12 101.0 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 124.996 1.318 . . . . 0.0 109.737 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -131.95 140.74 49.1 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 86.9 m -139.58 134.26 31.9 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -130.08 157.52 42.17 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.972 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.2 mm -89.88 114.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.34 148.08 24.03 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 19.6 p -122.8 171.49 9.15 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.857 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 24.4 p -109.08 136.93 47.79 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -90.96 -29.64 17.31 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -89.34 93.09 9.41 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.951 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 85' ' ' ARG . 6.2 p-10 -75.19 161.11 29.65 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.082 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 70.17 6.55 5.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.392 0.677 . . . . 0.0 112.705 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.3 131.43 50.6 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.0 Cg_endo -81.85 8.13 4.64 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.396 2.064 . . . . 0.0 112.322 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.41 175.03 44.32 Favored Glycine 0 N--CA 1.425 -2.035 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.6 171.59 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 123.323 0.649 . . . . 0.0 110.061 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.2 tp -111.16 128.16 55.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.782 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.83 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.5 mt-30 -123.84 127.33 47.89 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.56 114.24 37.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 124.446 1.092 . . . . 0.0 110.325 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -109.52 149.67 29.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.717 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 16' ' ' SER . 45.1 tt0 -111.39 121.44 45.23 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.74 -171.48 22.66 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.449 ' HG3' ' CB ' ' A' ' 16' ' ' SER . 13.3 mt-10 -139.17 17.7 2.61 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -64.59 131.81 48.06 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.992 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -52.63 -50.43 63.16 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.929 2.092 . . . . 0.0 113.931 -168.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtt -95.99 128.78 43.19 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.34 86.06 0.28 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -168.04 168.04 12.17 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 76.64 -46.42 0.52 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.608 1.163 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -55.6 147.97 16.96 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.349 1.06 . . . . 0.0 108.629 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 60' ' ' GLU . 2.9 p-10 -90.03 139.09 30.95 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.282 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.08 132.71 35.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.827 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.8 mt -105.1 -41.3 5.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 0.0 111.365 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.34 39.69 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.132 -1.033 . . . . 0.0 111.427 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -150.13 166.0 31.13 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -170.14 144.43 2.63 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 124.595 1.184 . . . . 0.0 108.414 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -93.88 146.83 23.62 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -118.52 105.08 11.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -94.47 169.74 9.98 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.89 -25.96 6.01 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 62.4 mt -54.14 119.91 22.31 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.109 0.963 . . . . 0.0 111.446 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 93.2 Cg_endo -80.32 151.27 20.25 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.678 2.252 . . . . 0.0 112.861 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 13.4 Cg_exo -70.97 87.71 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.791 2.327 . . . . 0.0 110.821 175.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.91 166.16 30.42 Favored Pre-proline 0 C--N 1.29 -2.005 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -49.32 141.3 24.81 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.992 2.461 . . . . 0.0 111.409 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 46' ' ' THR . 35.1 ptt180 -64.57 126.15 26.96 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 -175.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.06 -25.96 13.21 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 70.1 t -66.08 -50.44 51.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.654 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 21.3 Cg_exo -68.86 121.23 8.1 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.137 1.224 . . . . 0.0 110.327 174.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -107.08 124.7 50.05 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mm -108.51 109.24 27.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.409 ' CB ' ' HD3' ' A' ' 109' ' ' LYS . 43.9 tt0 -94.85 109.17 21.19 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 41' ' ' THR . 33.9 t -111.23 126.16 68.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.731 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 87.5 m -106.29 125.38 50.92 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.413 ' HB3' ' CD1' ' A' ' 30' ' ' ILE . 5.2 m-85 -111.08 107.91 17.44 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 39' ' ' LYS . 22.6 t70 -126.15 124.49 40.62 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.34 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' PRO . 13.6 mt -106.75 125.57 62.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.5 -179.04 6.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.574 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.91 66.44 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.627 0.771 . . . . 0.0 112.777 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -77.06 -24.39 51.96 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.5 31.08 8.1 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.7 mt -97.17 128.27 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.44 111.7 21.41 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -100.64 114.54 28.32 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.43 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.52 ' HB ' HG22 ' A' ' 117' ' ' ILE . 74.9 t -110.48 125.23 67.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 m -122.71 119.6 31.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.58 117.57 33.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.7 m -112.74 120.59 42.02 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.22 106.87 13.53 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.409 ' HD3' ' CB ' ' A' ' 91' ' ' GLU . 30.3 mmmt -67.43 -19.87 65.43 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.732 -176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.96 -61.35 1.98 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 43.0 p -80.1 -32.69 39.1 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.665 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.68 12.31 44.41 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.703 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.461 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 20.7 pttp -111.2 161.42 16.0 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.485 -0.421 . . . . 0.0 110.603 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.27 148.89 40.56 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -128.68 146.7 50.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.414 ' HD2' ' C ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -131.45 164.29 26.06 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.19 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.52 HG22 ' HB ' ' A' ' 104' ' ' VAL . 14.7 tt -136.51 144.39 32.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 m -125.59 113.6 17.62 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.23 103.92 16.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.029 0.442 . . . . 0.0 110.727 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.8 m -75.25 151.7 38.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 122.808 1.289 . . . . 0.0 110.933 176.855 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.7 mt -67.11 -41.0 86.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.622 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.84 -27.58 65.96 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.49 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -63.13 -40.62 98.12 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 mmt -63.38 -38.46 91.24 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.128 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.58 -47.88 89.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.049 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.84 -47.01 85.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.699 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.99 -32.9 74.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.682 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.42 -32.45 74.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 60.5 mm-40 -78.67 -36.66 43.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 110.793 174.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -69.0 -45.98 69.18 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.095 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.55 20.8 15.39 Favored 'General case' 0 C--O 1.198 -1.635 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 71.6 tttt -49.72 -60.14 3.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.083 1.353 . . . . 0.0 113.008 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.98 -32.74 73.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.887 0.375 . . . . 0.0 110.62 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -61.82 -53.41 56.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.048 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 10.6 m-20 -67.62 -37.45 82.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -59.52 -37.78 79.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.537 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 96.9 t -72.73 -47.08 51.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.554 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.83 -39.67 74.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -67.37 -32.71 73.82 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.99 -10.0 46.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.9 mmt180 -64.33 -36.1 83.01 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 120.835 0.35 . . . . 0.0 111.094 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.94 102.13 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.0 m -76.93 108.24 9.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.86 41.82 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-O 121.979 0.895 . . . . 0.0 112.561 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -82.17 148.13 28.64 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.64 94.76 0.45 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.182 0.515 . . . . 0.0 110.229 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -142.07 147.91 37.57 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.673 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.58 151.38 26.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -83.65 167.0 17.66 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.464 177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.425 -1.718 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -171.226 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 CA--C 1.493 -1.222 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.4 m-20 -126.46 28.6 5.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.795 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 34' ' ' SER . 20.0 m -135.09 136.51 51.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.003 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -64.86 116.13 26.82 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 12.1 Cg_exo -70.71 -36.06 8.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 111.718 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.97 167.43 11.14 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 p -97.56 150.14 21.45 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.393 1.077 . . . . 0.0 110.496 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.456 HD13 HD22 ' A' ' 102' ' ' LEU . 60.2 mt -127.17 132.67 50.45 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.363 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.64 178.05 28.32 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.88 167.55 11.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.047 0.451 . . . . 0.0 111.021 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.58 109.0 17.63 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.635 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 HD23 ' A' ' 158' ' ' LEU . 16.8 p -100.82 162.58 12.81 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.509 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 155' ' ' LYS . . . -49.8 117.29 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 113.586 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.35 39.05 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.4 23.67 53.39 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.2 142.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 127.23 38.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.6 m -128.29 115.24 18.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.05 147.11 23.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.457 ' HG ' ' HG3' ' A' ' 42' ' ' GLN . 10.4 mp -116.51 -50.4 2.63 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.954 176.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 116.66 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.96 156.91 19.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.321 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.17 160.34 29.81 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.466 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 m120 70.39 16.65 7.1 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.726 1.21 . . . . 0.0 110.427 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 34.2 p -89.44 136.82 32.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.561 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 14.2 p -73.1 114.9 11.79 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 121.597 0.713 . . . . 0.0 111.184 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.463 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 22.2 pt -95.75 158.09 34.91 Favored Pre-proline 0 C--N 1.287 -2.115 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.794 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.8 Cg_exo -61.42 132.94 10.5 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 N-CA-C 114.848 1.057 . . . . 0.0 114.848 1.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -104.05 166.98 10.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.502 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.515 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 50.1 tttp -173.86 107.1 0.13 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.57 144.01 50.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -112.38 133.04 54.69 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.776 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.457 ' HG3' ' HG ' ' A' ' 29' ' ' LEU . 24.9 mm-40 -128.59 134.78 48.69 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.64 129.72 49.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.501 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 96.7 m-85 -121.96 167.88 12.56 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 17.0 p -135.21 170.79 15.38 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.437 0.16 . . . . 0.0 111.32 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -83.32 176.11 9.37 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.508 ' CE2' ' HB2' ' A' ' 22' ' ' ALA . 1.5 m-85 -81.97 -46.78 13.54 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.0 p -143.79 -171.77 3.6 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.659 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.62 162.27 18.9 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.904 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 82' ' ' PRO . 32.9 m-20 71.28 5.73 5.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.73 112.5 52.29 Favored Pre-proline 0 N--CA 1.402 -2.842 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -100.08 -9.58 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.259 1.973 . . . . 0.0 115.094 -173.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . -148.84 135.13 5.29 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.44 161.15 17.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.45 ' HG ' ' HG3' ' A' ' 57' ' ' GLN . 53.9 tp -111.48 108.5 18.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.196 0.522 . . . . 0.0 109.881 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 mm -83.09 99.86 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.45 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 45.4 mt-30 -109.06 119.02 38.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 104' ' ' VAL . 45.0 t -99.27 124.49 52.59 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 O-C-N 123.655 0.597 . . . . 0.0 110.154 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 80.1 m-85 -122.13 146.84 46.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.389 0.614 . . . . 0.0 111.559 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' A' ' 72' ' ' LEU . 39.8 tt0 -111.52 120.11 41.03 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.342 177.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.55 -166.83 24.42 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -153.16 134.46 14.22 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.633 0.773 . . . . 0.0 110.118 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 65' ' ' MET . 40.1 mtp180 -158.13 -176.36 5.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.094 1.358 . . . . 0.0 108.715 171.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.16 73.98 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 122.398 1.094 . . . . 0.0 108.802 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 65.7 mtt -105.0 162.42 13.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.513 -1.676 . . . . 0.0 107.619 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.25 16.06 2.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.646 0.736 . . . . 0.0 109.679 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -85.95 154.77 21.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.557 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 81.58 -32.53 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.581 1.552 . . . . 0.0 110.967 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.614 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 12.7 m120 -64.0 168.01 5.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 35.0 t30 -90.11 117.67 29.07 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.403 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.38 122.05 27.49 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 60' ' ' GLU . 3.5 mp -95.47 -49.85 5.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.36 0.6 . . . . 0.0 109.414 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.29 162.46 34.84 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -152.91 158.05 41.55 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -159.58 163.12 35.33 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.97 143.0 33.78 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.849 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.433 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 2.1 tt -108.49 104.11 13.38 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 103.375 -2.824 . . . . 0.0 103.375 171.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.4 p -120.45 107.95 13.51 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.295 0.569 . . . . 0.0 110.622 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.97 19.25 0.02 OUTLIER Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.352 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.79 127.47 83.96 Favored Pre-proline 0 C--O 1.249 1.072 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.91 153.98 71.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.883 2.389 . . . . 0.0 111.736 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 31.3 Cg_endo -65.96 89.56 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.34 2.027 . . . . 0.0 112.284 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.33 144.65 53.3 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.8 148.78 81.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.731 2.287 . . . . 0.0 111.119 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.35 132.28 50.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.243 0.544 . . . . 0.0 111.254 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.68 -34.15 4.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.57 -56.16 1.48 Allowed Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 93.81 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.147 1.231 . . . . 0.0 110.526 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -96.46 124.7 40.54 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.503 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mm -99.72 117.48 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -90.64 106.54 18.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -102.32 115.39 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 m -109.03 126.09 52.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.536 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.411 ' CD2' HD22 ' A' ' 29' ' ' LEU . 2.9 m-85 -115.45 121.23 42.1 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.604 0.762 . . . . 0.0 109.726 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.515 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.1 p30 -140.03 137.08 34.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 71.4 mt -112.3 135.04 52.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.8 p-10 -91.19 -168.52 2.08 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -24.39 64.26 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.407 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 6.0 t30 -81.54 -29.81 33.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.135 0.493 . . . . 0.0 109.902 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.01 24.53 5.44 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 84.6 mt -88.95 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 17' ' ' LEU . 49.4 tp -94.42 118.38 31.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.663 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -103.35 115.92 31.45 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 121.415 0.626 . . . . 0.0 110.476 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 58' ' ' VAL . 96.7 t -100.38 114.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.961 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.2 m -122.94 120.59 33.87 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.19 117.51 33.42 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.9 m -116.53 124.18 49.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.363 0.414 . . . . 0.0 112.019 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.75 114.26 12.98 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 123.607 0.763 . . . . 0.0 111.076 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 109' ' ' LYS . 33.6 mmtp -67.76 -12.22 60.1 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -79.34 -62.66 1.62 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.966 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -94.68 -30.31 14.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.152 0.501 . . . . 0.0 112.303 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.98 4.97 41.61 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.274 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.85 132.02 47.66 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 121.144 0.497 . . . . 0.0 111.073 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.67 43.89 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.102 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -129.51 128.19 42.31 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 165.83 15.15 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.506 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.63 138.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.8 m -100.57 113.68 26.7 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -115.57 96.93 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 26.8 m -66.51 125.41 25.63 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 170.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.632 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.11 -41.49 89.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.815 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.33 -37.67 87.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -63.86 -45.76 88.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.614 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 40.2 ttp -54.77 -48.69 72.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.466 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.422 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 78.7 t -61.81 -40.71 87.93 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.842 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -61.94 -38.39 88.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 36.6 mt-10 -72.55 -34.42 67.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.576 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.57 -43.27 94.44 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.976 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 12.1 mm-40 -59.98 -38.04 81.42 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.952 0.882 . . . . 0.0 110.479 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 87.4 tttt -61.73 -28.56 69.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.839 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -126.91 23.49 6.6 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.342 -0.224 . . . . 0.0 111.153 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.75 -29.48 69.99 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -66.3 -40.13 89.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -70.61 -50.09 40.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 0.5 OUTLIER -59.21 -43.49 92.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.077 178.447 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 149' ' ' ARG 0.296 22.2 mt-10 -68.73 -32.52 72.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 118.436 -1.306 . . . . 0.0 113.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 76.6 t -61.8 -40.95 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.246 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 79.5 mt-30 -57.17 -46.21 82.98 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 8.6 ptm180 -71.49 -35.36 70.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 146' ' ' GLU . 43.2 mt-10 -72.9 -21.71 60.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.497 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 22.2 mmt180 -64.82 -28.56 69.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.312 0.577 . . . . 0.0 109.672 173.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.41 -35.58 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 51.6 m 71.04 85.4 0.13 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.906 1.282 . . . . 0.0 112.775 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 43.93 80.37 0.04 OUTLIER 'General case' 0 C--O 1.244 0.811 0 C-N-CA 125.562 1.545 . . . . 0.0 114.269 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 17.4 tppt? -81.28 110.74 17.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 4.3 t30 -111.09 33.0 4.88 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.829 1.3 . . . . 0.0 109.629 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -121.67 142.16 50.43 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 21' ' ' THR . 27.6 mt -92.5 150.0 21.03 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.311 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.43 143.79 40.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.777 0.799 . . . . 0.0 111.718 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.845 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--O 1.242 0.677 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.45 67.68 8.59 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.547 1.165 . . . . 0.0 109.883 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 28.0 m -121.24 -177.17 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-N 113.822 -1.536 . . . . 0.0 107.682 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 110.2 42.94 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.55 -27.77 45.78 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.006 1.804 . . . . 0.0 111.702 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.474 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . 99.7 mt -130.93 156.13 45.6 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.791 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 m -77.35 141.51 39.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 123.665 0.603 . . . . 0.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.7 130.96 45.2 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -157.17 -176.53 29.34 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 119.092 -1.528 . . . . 0.0 114.304 -175.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 89.0 mt -118.42 150.81 38.93 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 123.933 0.893 . . . . 0.0 109.572 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 34.8 tt0 -89.56 109.82 20.73 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.421 HG22 ' HG ' ' A' ' 158' ' ' LEU . 16.0 p -89.69 172.62 8.8 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.694 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.22 110.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.177 0.513 . . . . 0.0 111.57 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -9.16 8.42 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.96 19.41 51.16 Favored Glycine 0 CA--C 1.494 -1.23 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.88 135.64 24.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 62' ' ' GLU . 23.9 ttt -89.54 112.2 23.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.253 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 m -110.26 110.93 21.93 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -97.9 135.44 39.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.101 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -90.94 -49.44 6.43 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -96.85 114.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -80.78 141.5 34.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -58.78 154.09 15.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.673 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 80.25 3.59 1.89 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.749 1.619 . . . . 0.0 111.45 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 t -91.34 136.97 32.73 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 1.5 m -73.03 143.88 47.36 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 123.718 0.807 . . . . 0.0 111.504 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.422 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 42.4 pt -99.51 154.11 37.44 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 42.2 Cg_exo -62.09 144.61 46.07 Favored 'Cis proline' 0 C--O 1.247 0.974 0 CA-C-N 120.2 1.107 . . . . 0.0 113.258 0.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.3 m -129.44 145.53 51.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 55.0 tttp -142.33 112.75 7.18 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 29.8 tp60 -128.56 125.58 38.56 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 m -109.11 134.79 51.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -140.56 156.35 46.33 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.2 mm -101.87 128.65 54.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -117.72 166.16 12.76 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.786 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 2.9 p -148.27 170.81 17.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 122.709 0.404 . . . . 0.0 111.591 -172.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.411 ' HB ' ' OG ' ' A' ' 48' ' ' SER . 41.3 p -103.79 166.04 10.67 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.417 ' C ' ' HB3' ' A' ' 85' ' ' ARG . 93.8 m-85 -95.75 -14.97 22.91 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 165.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.411 ' OG ' ' HB ' ' A' ' 46' ' ' THR . 27.3 p -97.0 178.54 5.24 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.309 -170.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -136.06 134.49 38.49 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 126.471 1.909 . . . . 0.0 106.379 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.412 HD21 ' HB3' ' A' ' 82' ' ' PRO . 33.5 m-80 70.14 6.28 5.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 41.6 tt0 -53.52 129.2 53.1 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 123.665 0.786 . . . . 0.0 112.887 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.28 79.3 3.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.231 1.954 . . . . 0.0 112.749 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.667 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . 96.63 131.59 6.94 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.966 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -105.95 130.14 57.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HG ' ' HG3' ' A' ' 57' ' ' GLN . 55.0 tp -83.56 112.37 19.94 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.726 -176.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 45.5 mm -98.82 105.38 17.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.605 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 48.6 mt-30 -104.44 117.55 34.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -96.67 121.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 O-C-N 124.313 1.008 . . . . 0.0 110.551 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 83.4 m-85 -125.48 156.6 38.69 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.634 0.374 . . . . 0.0 110.571 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 70' ' ' ASN . 8.7 pt-20 -122.57 130.77 53.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 15' ' ' LEU . . . 144.09 -155.8 26.41 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.512 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 13.8 mt-10 -161.86 134.05 5.72 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.703 1.601 . . . . 0.0 111.487 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -158.91 170.0 23.07 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 126.554 1.942 . . . . 0.0 106.099 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.81 -47.69 29.32 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.8 mtm -116.98 123.45 46.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.0 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.43 108.71 0.85 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 125.531 1.532 . . . . 0.0 111.037 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -166.81 -36.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.337 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.53 3.89 54.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.745 0.784 . . . . 0.0 109.315 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.489 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 16.6 m120 -100.5 169.51 9.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.726 -173.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.484 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 47.7 t30 -99.4 123.68 43.88 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.442 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.0 tp -83.99 123.22 29.76 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.191 0.596 . . . . 0.0 110.224 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -95.35 -22.55 17.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.97 175.7 33.28 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.987 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 8.5 ptp180 -153.04 151.42 30.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -155.88 157.87 37.08 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -112.03 133.86 53.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.502 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.667 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 54.8 tp -87.1 106.61 17.98 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 172.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 p -67.26 125.42 26.02 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' H ' ' N ' ' A' ' 53' ' ' GLY . . . 46.19 96.73 0.01 OUTLIER Glycine 0 C--N 1.344 0.974 0 C-N-CA 125.72 1.629 . . . . 0.0 116.866 173.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.437 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -79.63 155.27 76.07 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 28.5 Cg_endo -59.97 161.95 17.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.921 2.414 . . . . 0.0 113.436 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HB3' HD21 ' A' ' 50' ' ' ASN . 21.9 Cg_endo -67.25 73.19 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.834 2.356 . . . . 0.0 112.19 175.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.43 142.1 42.86 Favored Pre-proline 0 N--CA 1.417 -2.115 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.87 167.07 28.26 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.39 2.06 . . . . 0.0 112.627 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HB3' ' C ' ' A' ' 47' ' ' TYR . 10.6 ptt180 -47.24 124.38 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.196 0.998 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.16 -29.07 9.56 Favored Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.032 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.03 -52.28 1.22 Allowed Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.993 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.22 94.78 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 CA-C-N 120.683 1.28 . . . . 0.0 110.411 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.11 113.2 17.04 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.285 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.8 mm -92.84 108.06 19.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.425 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 37.2 tt0 -90.49 106.49 18.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' THR . 47.2 t -104.81 131.98 52.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.0 m -130.64 127.45 38.96 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.267 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 4.5 m-85 -103.46 113.02 26.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.4 p30 -125.25 125.08 43.01 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.846 175.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 12.1 mt -107.83 145.35 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.25 -160.64 0.82 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.66 51.11 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.43 -29.02 52.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.918 0.39 . . . . 0.0 111.989 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.35 29.22 4.04 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 75.3 mt -87.6 116.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.9 tp -98.88 118.88 36.64 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.288 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -107.6 104.56 14.13 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.274 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 58.0 t -93.45 114.1 29.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.4 m -113.33 124.24 52.01 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.144 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.88 117.81 34.42 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 26.7 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.072 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.18 100.88 10.1 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 53.3 mtpt -67.65 -13.48 62.13 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.4 m -82.56 -47.34 12.24 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.165 0.507 . . . . 0.0 110.537 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -101.38 -27.06 13.36 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.48 45.09 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.264 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 147.82 27.23 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.73 146.24 34.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.46 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.53 131.11 48.25 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 12.3 ptmm? -122.98 135.31 54.43 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.446 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.8 pt -106.94 137.8 35.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.406 HG22 HG23 ' A' ' 120' ' ' THR . 84.9 m -108.53 112.08 24.27 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.055 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.13 97.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.406 HG23 HG22 ' A' ' 118' ' ' THR . 15.7 p -92.59 101.26 13.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.27 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 N--CA 1.478 0.932 0 O-C-N 124.381 1.051 . . . . 0.0 112.717 177.916 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 135' ' ' VAL . 78.1 mt -64.63 -52.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.774 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -64.0 -30.45 71.52 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.795 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 44.1 mtp85 -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.588 174.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 20.8 ptt? -70.73 -21.3 62.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.611 -0.836 . . . . 0.0 113.018 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 131' ' ' ILE . 93.5 t -63.3 -50.01 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.63 -34.94 77.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.792 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 40.7 mm-40 -62.95 -47.02 85.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.45 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.29 -29.91 70.72 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 142' ' ' LYS . 30.6 mm-40 -75.47 -45.91 35.63 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -72.59 -46.61 53.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.022 0.439 . . . . 0.0 111.077 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.65 22.84 7.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 60.0 mttp -42.84 -59.19 2.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.663 0.602 . . . . 0.0 110.524 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.33 -37.51 67.53 Favored 'General case' 0 C--O 1.231 0.086 0 O-C-N 124.312 1.007 . . . . 0.0 112.733 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.94 -53.23 11.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.778 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 13.2 m-20 -70.07 -31.6 69.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 12.4 pt-20 -67.49 -42.9 82.16 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.42 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 79.5 t -67.7 -42.38 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -61.62 -45.48 93.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 5.1 ptp180 -65.65 -32.13 73.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.817 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -78.95 -24.32 43.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 22.4 mmm180 -61.84 -40.58 95.79 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.218 176.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.63 146.07 7.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m -57.11 140.54 49.05 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.24 103.91 7.44 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -86.44 134.75 33.67 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.036 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.04 22.02 13.29 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 166.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.603 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -120.3 140.17 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.706 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 21' ' ' THR . 1.6 mp -117.53 149.97 39.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.93 163.4 12.98 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.407 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 16.0 m . . . . . 0 C--N 1.282 -2.349 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.2 tp . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 59.2 68.75 0.78 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.477 1.132 . . . . 0.0 110.032 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 35' ' ' THR . 34.1 m -137.55 -178.55 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.371 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.9 123.27 82.33 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.426 ' C ' HD12 ' A' ' 15' ' ' LEU . 19.5 Cg_endo -60.51 -51.48 5.12 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.3 2.0 . . . . 0.0 110.907 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.546 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 7.3 mp -128.1 167.37 16.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.626 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 18.5 m -72.5 142.45 48.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 O-C-N 123.614 0.571 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -114.0 132.12 56.1 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.782 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 28' ' ' ALA . . . -147.79 -177.42 22.18 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.044 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.496 HD11 HG11 ' A' ' 92' ' ' VAL . 83.6 mt -122.83 167.94 12.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.896 0.379 . . . . 0.0 111.63 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.21 109.34 17.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.391 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 p -109.47 158.34 18.07 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.437 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.11 115.93 1.36 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.903 1.281 . . . . 0.0 113.252 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.21 10.74 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.821 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.37 44.17 5.36 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.34 137.17 55.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 33.1 ttp -96.71 112.05 23.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -94.42 112.3 24.07 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . . . -90.28 133.67 34.8 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.666 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.629 ' HG ' ' OE1' ' A' ' 42' ' ' GLN . 5.9 mp -100.93 -39.67 7.64 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.69 129.85 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -101.31 162.6 12.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.42 ' HD3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -70.91 142.2 51.14 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.824 178.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' OD1' ' HD3' ' A' ' 32' ' ' ARG . 16.9 m120 80.64 -6.09 1.69 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.24 1.416 . . . . 0.0 113.252 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.7 m -65.19 115.29 5.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 12' ' ' VAL . 2.7 m -71.03 129.9 40.18 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.193 -172.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.425 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 28.4 pt -92.97 155.76 41.08 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.029 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.1 Cg_exo -63.48 141.83 42.86 Favored 'Cis proline' 0 N--CA 1.487 1.098 0 C-N-CA 124.604 -0.998 . . . . 0.0 114.24 0.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.6 p -120.89 152.84 37.97 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.762 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 47.6 tttp -153.41 99.81 2.38 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -108.42 135.31 49.93 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -124.02 127.97 48.67 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.629 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 44.8 mt-30 -132.11 150.28 52.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.91 129.42 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.533 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 89.1 m-85 -117.42 155.14 30.15 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 22.9 p -127.37 170.73 12.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 41.5 p -100.51 139.86 35.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 31.3 m-85 -117.76 5.13 12.25 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -120.74 127.16 51.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.412 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 84' ' ' PRO . 46.0 t0 -82.05 169.95 16.11 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 68.34 14.66 9.21 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.822 1.249 . . . . 0.0 113.232 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -90.25 114.62 61.64 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -89.8 -1.82 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.146 1.897 . . . . 0.0 111.839 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.91 145.01 8.89 Favored Glycine 0 N--CA 1.413 -2.874 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.39 147.32 13.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 117.049 0.425 . . . . 0.0 109.93 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.08 118.15 35.19 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.067 0.46 . . . . 0.0 110.705 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.72 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 90.7 mt-30 -102.2 130.01 48.74 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 t -99.48 129.0 50.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 123.714 0.634 . . . . 0.0 109.354 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.78 156.55 44.79 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.166 0.508 . . . . 0.0 111.524 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.546 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 35.8 tt0 -118.63 136.77 53.71 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.471 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.04 116.55 3.91 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.626 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 40.4 mt-10 -79.47 107.18 12.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -133.57 144.53 49.38 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.9 76.0 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 124.131 0.894 . . . . 0.0 111.552 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.8 mtt -94.76 111.49 23.26 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.271 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.411 ' HA ' ' OD1' ' A' ' 69' ' ' ASN . 1.9 m -74.71 109.83 8.51 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.066 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -175.25 -41.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.566 1.147 . . . . 0.0 109.016 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -109.21 75.44 0.95 Allowed 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 66' ' ' THR . 9.2 m120 -147.92 164.33 34.07 Favored 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 73.2 m-20 -90.61 129.3 36.75 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.0 tp -83.34 125.09 31.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.05 0.452 . . . . 0.0 111.221 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' A' ' 119' ' ' ILE . 7.4 mp -101.99 -9.38 20.69 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.52 178.33 15.37 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.882 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.507 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 6.8 ppt_? -153.33 156.91 39.24 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -150.87 152.32 33.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.39 125.01 51.94 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.06 104.22 16.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 p -105.15 163.49 12.54 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.695 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.62 7.09 45.91 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.6 mm -64.56 127.46 92.38 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.59 143.49 68.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.244 1.963 . . . . 0.0 110.613 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.63 90.58 0.6 Allowed 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 121.204 1.27 . . . . 0.0 109.646 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.16 129.53 20.94 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.995 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.429 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 17.9 Cg_endo -58.73 -61.04 0.28 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 123.296 2.664 . . . . 0.0 114.643 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 46' ' ' THR . 88.1 mtt180 -139.37 136.1 34.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.01 1.25 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 117.731 1.852 . . . . 0.0 117.731 167.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.9 t -52.3 -57.53 15.02 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 6.2 Cg_exo -81.73 103.52 1.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.641 1.56 . . . . 0.0 110.821 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -95.11 117.75 30.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.25 121.56 47.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.93 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 38.4 tt0 -91.35 115.79 28.32 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 19' ' ' LEU . 84.7 t -110.49 124.81 67.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 m -121.67 128.85 52.31 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.222 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -110.57 109.55 19.9 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.559 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.1 p30 -126.57 128.25 46.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.26 0.552 . . . . 0.0 112.12 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 45.9 mt -123.62 133.92 67.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.0 p-10 -88.72 -172.07 3.57 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.11 -5.95 55.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.41 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -87.07 -29.88 21.56 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.46 26.7 4.73 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 72.9 mt -89.07 108.0 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.408 HD23 HD12 ' A' ' 119' ' ' ILE . 32.7 tp -94.63 128.76 41.5 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.388 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER -119.74 108.02 13.91 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 174.543 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 61.2 t -95.59 113.81 30.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.9 m -112.86 122.03 46.43 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.1 m -122.64 122.22 38.29 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 120.842 0.353 . . . . 0.0 111.429 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -82.52 108.16 15.71 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.063 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.8 -6.88 23.48 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -79.84 -61.97 1.83 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.1 p -82.61 -30.22 29.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.68 13.1 56.01 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.982 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -91.11 144.0 26.1 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 117.626 0.713 . . . . 0.0 109.684 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -123.8 141.71 51.78 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -129.52 134.08 47.58 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 17.5 ptpt -124.25 166.55 15.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.47 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.431 HG22 ' HB ' ' A' ' 104' ' ' VAL . 15.0 tt -131.2 145.53 35.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.8 m -113.51 116.21 29.21 Favored 'General case' 0 C--N 1.276 -2.603 0 O-C-N 124.397 1.061 . . . . 0.0 110.124 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 72' ' ' LEU . 75.5 mt -120.6 125.24 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.0 m -119.92 140.7 50.48 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 124.401 1.08 . . . . 0.0 111.429 174.51 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.09 -44.42 78.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.664 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.01 -39.32 81.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.541 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -60.41 -43.01 97.15 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.594 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 tpp -58.92 -39.3 81.15 Favored 'General case' 0 C--O 1.212 -0.915 0 O-C-N 123.742 0.652 . . . . 0.0 109.828 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.77 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.084 0.468 . . . . 0.0 109.98 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -61.05 -47.67 85.32 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.708 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.46 -32.55 73.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.513 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -68.17 -55.53 12.03 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 122.158 -0.339 . . . . 0.0 110.609 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.55 -48.54 77.03 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.74 -17.81 65.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -118.3 16.18 13.95 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -55.1 -43.26 73.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.43 80.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 110.757 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.79 -44.95 65.58 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.045 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -61.32 -42.24 98.33 Favored 'General case' 0 CA--C 1.498 -1.026 0 O-C-N 123.403 0.439 . . . . 0.0 111.537 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 41.3 mt-10 -57.39 -45.51 84.44 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.982 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.65 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 46.0 t -68.76 -42.49 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.398 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -55.88 -48.8 74.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -63.91 -36.93 85.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.0 pt-20 -79.06 -15.51 58.1 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.539 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.65 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 91.6 mtt-85 -71.77 -38.76 70.29 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.9 -57.53 4.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.938 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.45 ' OG ' ' HG2' ' A' ' 155' ' ' LYS . 31.3 t -158.27 -80.78 0.06 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.501 -174.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 65.39 19.21 11.57 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 124.952 1.301 . . . . 0.0 111.771 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HG2' ' OG ' ' A' ' 153' ' ' SER . 17.0 ptpt -82.18 144.86 30.42 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 10.4 t30 -84.12 69.34 10.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.283 1.039 . . . . 0.0 111.455 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.774 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.3 151.63 35.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -115.06 175.04 5.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.42 -1.941 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.359 -176.188 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 122.726 1.251 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 36' ' ' ILE . 1.3 m-20 -85.47 74.78 10.28 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.354 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -115.84 175.86 2.62 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.907 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.895 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.08 129.45 67.18 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.45 -23.95 2.61 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 122.131 1.887 . . . . 0.0 112.372 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.43 172.4 10.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 m -94.98 129.25 42.12 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.82 131.7 43.3 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.58 -164.52 14.96 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.332 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.0 mt -131.07 161.85 31.14 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.81 120.81 32.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 117.821 -1.551 . . . . 0.0 109.223 171.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 23.6 p -97.94 -176.33 3.41 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.809 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . . . -57.71 128.83 39.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.068 0.461 . . . . 0.0 111.922 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.25 59.96 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.43 53.73 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.255 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -92.91 140.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 113.09 25.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.0 m -109.39 110.97 22.27 Favored 'General case' 0 C--N 1.279 -2.468 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.624 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.29 136.26 33.16 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.201 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.7 mp -99.45 -49.98 4.25 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.81 103.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -80.71 162.8 23.97 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.499 ' HD3' ' OE2' ' A' ' 139' ' ' GLU . 9.7 ptm180 -64.43 159.36 21.55 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.316 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m120 77.34 4.8 3.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.499 1.12 . . . . 0.0 112.243 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 m -83.32 115.75 22.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.38 132.84 45.42 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.113 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 11' ' ' ASP . 26.5 pt -91.38 161.39 34.77 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.494 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.9 Cg_exo -69.01 147.39 82.98 Favored 'Cis proline' 0 C--O 1.245 0.858 0 CA-C-N 119.834 0.976 . . . . 0.0 113.731 1.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 11.8 p -118.19 136.42 53.65 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.043 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -135.02 101.02 4.74 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 93' ' ' THR . 62.1 tt0 -121.92 131.81 54.22 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -128.67 125.1 37.35 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -135.48 152.3 51.21 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.18 122.47 50.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.088 0.47 . . . . 0.0 110.331 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.5 162.14 14.4 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.848 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 6.1 p -137.76 170.22 16.44 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.041 0.536 . . . . 0.0 109.66 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -95.93 137.01 35.6 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.303 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -108.63 32.11 5.11 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 167.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 p -132.19 159.43 39.01 Favored 'General case' 0 N--CA 1.391 -3.405 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.974 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -136.61 162.17 33.88 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 66.88 22.08 10.25 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.101 0.876 . . . . 0.0 110.934 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.48 125.71 80.26 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.959 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.16 -18.51 27.04 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 121.706 1.604 . . . . 0.0 109.657 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 78' ' ' SER . . . -178.31 175.01 47.2 Favored Glycine 0 N--CA 1.406 -3.365 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.75 129.85 55.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.119 0.485 . . . . 0.0 110.139 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.6 tp -87.17 100.29 12.56 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.595 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mm -84.15 96.98 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -109.3 110.3 21.43 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.1 t -92.98 135.97 26.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.79 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -133.77 163.24 29.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.42 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.85 165.45 25.59 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.46 -103.78 0.9 Allowed Glycine 0 C--N 1.287 -2.146 0 C-N-CA 119.025 -1.56 . . . . 0.0 114.235 170.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.652 ' OE2' ' HG3' ' A' ' 67' ' ' LYS . 39.9 mt-10 -78.46 172.16 14.04 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.594 0.358 . . . . 0.0 110.939 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -112.59 -27.47 8.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.383 -0.372 . . . . 0.0 112.001 -171.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -90.42 -52.43 4.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -172.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.1 mtm -142.1 149.64 40.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -173.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.28 82.55 2.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 O-C-N 124.082 0.863 . . . . 0.0 109.851 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.652 ' HG3' ' OE2' ' A' ' 62' ' ' GLU . 8.3 ptmm? -118.84 -76.53 0.57 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.99 12.4 30.57 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.597 0.713 . . . . 0.0 111.208 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.88 142.22 57.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.694 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -96.09 141.96 28.85 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.566 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.5 tp -76.99 123.37 26.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.458 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.6 mt -89.24 -40.16 13.03 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.521 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 171.27 36.74 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -140.2 135.05 32.0 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -143.22 135.01 26.66 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.76 118.97 37.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.953 0.406 . . . . 0.0 111.421 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.0 tp -90.73 104.29 16.89 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.415 ' HA ' ' HA3' ' A' ' 53' ' ' GLY . 15.9 p -113.55 165.95 12.0 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -168.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 4.33 39.8 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.16 113.15 46.4 Favored Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.37 138.33 50.38 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.475 2.117 . . . . 0.0 112.141 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -47.42 125.88 11.29 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.344 3.362 . . . . 0.0 113.159 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.39 152.85 80.79 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.84 39.64 0.29 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 124.055 3.17 . . . . 0.0 115.07 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 68.34 143.57 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.665 1.586 . . . . 0.0 112.429 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.94 75.88 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.53 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.458 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.8 t -107.13 -55.11 0.07 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.924 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 15.5 Cg_exo -70.38 130.51 18.7 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 121.307 1.338 . . . . 0.0 110.71 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -110.86 123.07 49.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -110.03 125.2 67.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.6 tt0 -90.77 111.59 23.02 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -108.27 129.87 61.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 30.5 m -123.46 118.58 27.74 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.455 ' CD2' HD22 ' A' ' 29' ' ' LEU . 10.5 m-85 -100.54 116.37 32.3 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 173.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 38' ' ' THR . 12.2 t70 -128.91 116.36 19.28 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.764 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 52.5 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.4 p-10 -87.57 -172.6 3.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -13.96 61.24 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.408 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 4.6 t30 -84.79 -31.46 23.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 117.6 14.11 7.03 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.481 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 80.7 mt -80.54 119.95 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.8 tp -98.44 118.03 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.411 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.46 HD21 ' HD3' ' A' ' 116' ' ' LYS . 16.0 t-20 -112.91 111.24 21.85 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -101.82 116.64 45.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.7 m -111.67 134.34 53.31 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.46 124.12 42.17 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 m -124.22 118.42 26.8 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.521 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.5 123.34 29.63 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.728 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.486 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 75.0 mmtt -68.01 -28.82 67.75 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.875 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 m -68.68 -61.91 1.61 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.142 0.496 . . . . 0.0 110.865 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.5 p -84.01 -39.88 19.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.36 0.6 . . . . 0.0 110.799 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.25 39.29 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.16 149.04 43.27 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.496 0.665 . . . . 0.0 112.761 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.22 134.72 42.35 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.349 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 146.22 47.18 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 103' ' ' ASN . 17.7 ptpt -142.11 162.3 35.82 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.034 0.445 . . . . 0.0 111.731 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 tt -129.44 145.76 35.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.3 m -122.8 117.25 25.23 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.029 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.25 118.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 p -92.26 172.73 8.22 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.854 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 134' ' ' MET . 1.2 mp0 . . . . . 0 C--O 1.223 -0.332 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.1 mt -61.22 -50.84 78.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.783 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.2 pt-20 -72.75 -26.0 61.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -61.88 -44.05 97.59 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 95.0 mmm -60.76 -37.39 81.67 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.103 0.478 . . . . 0.0 109.764 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 88.1 t -58.2 -54.68 29.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.029 176.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 87.4 mt-30 -59.29 -53.78 54.31 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.914 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.78 -53.58 55.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.928 -176.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.61 67.77 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.499 ' OE2' ' HD3' ' A' ' 32' ' ' ARG . 26.1 mm-40 -74.27 -32.93 63.12 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.052 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -71.21 -34.29 70.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.08 11.44 23.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.888 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -53.66 -48.62 69.26 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 118.142 0.428 . . . . 0.0 111.522 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.95 74.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.813 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -74.2 -44.7 52.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 0.6 OUTLIER -60.81 -49.39 77.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 177.081 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.67 -32.53 74.04 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.383 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.91 -48.41 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.575 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -55.93 -41.89 75.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.87 0.468 . . . . 0.0 111.066 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.5 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 57.0 ttp180 -61.4 -51.69 67.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.486 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.462 ' HG3' ' HE ' ' A' ' 149' ' ' ARG . 47.6 mt-10 -78.36 -1.37 33.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.9 -14.0 46.16 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 29.9 t -112.18 157.77 12.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -80.56 93.09 6.02 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.323 0.583 . . . . 0.0 110.583 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -90.66 93.11 9.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.533 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -112.71 158.63 19.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.12 68.51 9.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.234 1.016 . . . . 0.0 110.761 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.74 136.18 25.38 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.693 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.93 152.38 25.02 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.903 0.382 . . . . 0.0 110.423 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 0.4 OUTLIER -97.24 119.59 36.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.236 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.419 -1.979 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.489 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.429 -1.522 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 36' ' ' ILE . 9.4 m-20 -96.23 25.91 4.61 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -126.88 170.64 16.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-O 121.211 0.529 . . . . 0.0 110.906 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.46 120.87 80.61 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.04 -21.63 23.84 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.094 1.862 . . . . 0.0 111.743 -177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.8 mt -134.49 174.45 10.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 23.5 m -101.57 123.01 44.89 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.09 0.244 . . . . 0.0 110.609 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 2.4 mm? -92.28 131.63 37.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.1 -168.41 21.11 Favored Glycine 0 N--CA 1.425 -2.052 0 C-N-CA 119.375 -1.393 . . . . 0.0 114.63 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.437 HD11 HG11 ' A' ' 92' ' ' VAL . 83.6 mt -133.63 162.79 30.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.735 -176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -94.81 109.51 21.47 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.9 p -84.16 175.37 9.52 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.083 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.96 116.51 4.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.62 -12.23 11.04 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 51.66 4.53 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.25 127.16 73.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.0 tpt -73.82 102.5 4.06 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -107.78 112.13 24.64 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.29 127.48 38.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.418 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.0 mp -95.57 -50.35 5.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.454 HG21 HD12 ' A' ' 96' ' ' ILE . 34.1 mm -94.18 92.31 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.2 154.92 30.67 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -53.81 140.28 30.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.23 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 79.84 1.7 2.12 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.585 1.554 . . . . 0.0 113.283 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.13 128.15 33.36 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -70.5 134.79 48.05 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.617 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 11' ' ' ASP . 27.6 pt -104.09 161.42 22.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.1 Cg_endo -64.44 140.88 42.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 CA-C-N 120.914 1.362 . . . . 0.0 114.115 0.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.3 p -109.59 164.12 12.82 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -159.08 101.64 1.6 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -132.46 128.05 36.61 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.4 m -119.85 124.01 45.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -124.22 146.07 48.95 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 46.0 mm -97.78 115.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -107.72 133.55 51.97 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 p -107.57 170.25 8.09 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.445 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -96.65 136.96 36.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.742 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -98.06 10.88 39.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.684 1.231 . . . . 0.0 108.623 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.3 p -116.13 145.32 43.15 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.236 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.55 159.62 21.02 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.386 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 6.6 m-20 57.82 27.49 14.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.329 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -77.27 130.16 75.67 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.523 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.34 -15.04 14.4 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.234 1.956 . . . . 0.0 111.784 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 164.19 37.75 Favored Glycine 0 N--CA 1.422 -2.278 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.8 158.51 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 123.006 0.523 . . . . 0.0 109.781 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 75' ' ' PHE . 42.7 tp -117.6 107.88 14.79 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 75' ' ' PHE . 3.8 mp -89.1 105.49 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -92.85 119.69 32.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.25 121.6 54.73 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-O 121.225 0.536 . . . . 0.0 111.035 -173.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.04 164.29 21.86 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.615 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 38.6 tt0 -134.89 132.71 38.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.383 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.03 172.23 13.44 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 27.8 mt-10 -135.12 120.87 19.55 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.074 0.937 . . . . 0.0 113.088 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 2.6 mmp_? -154.14 166.51 32.87 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.55 54.87 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.151 0.976 . . . . 0.0 110.042 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.9 mtt -133.52 121.19 21.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.35 96.62 3.43 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.373 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -168.25 -45.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.087 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 17.7 m-20 -95.7 71.3 3.05 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -145.29 160.43 41.52 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 113.186 -1.824 . . . . 0.0 107.768 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 28.0 t30 -89.87 131.08 35.98 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.33 107.84 19.47 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.25 0.547 . . . . 0.0 109.684 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.25 -23.99 27.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.311 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.11 -162.63 28.81 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.412 ' HG3' ' OE2' ' A' ' 76' ' ' GLU . 23.3 ptt180 -145.87 162.83 36.84 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.671 ' HB3' ' HB ' ' A' ' 56' ' ' ILE . 7.6 t80 -128.92 130.49 46.84 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.412 ' OE2' ' HG3' ' A' ' 74' ' ' ARG . 1.7 mp0 -104.0 104.66 14.65 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -112.14 110.19 20.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 p -130.16 166.75 19.6 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.65 19.05 16.62 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.75 129.63 61.36 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 48.4 Cg_endo -71.67 137.71 30.62 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.237 1.958 . . . . 0.0 110.97 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' ASN . 50.5 Cg_exo -56.89 107.24 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 122.59 2.193 . . . . 0.0 112.275 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.01 158.12 76.65 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.8 161.36 18.57 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.02 2.48 . . . . 0.0 112.151 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -65.62 142.27 58.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.04 -7.91 79.87 Favored Glycine 0 C--N 1.308 -1.004 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.945 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.39 -54.07 0.29 Allowed Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.8 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.59 112.62 1.83 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 121.41 1.407 . . . . 0.0 111.225 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -99.93 113.46 26.03 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.257 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -100.41 120.7 50.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 40.1 tt0 -90.6 108.98 20.15 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 19' ' ' LEU . 46.2 t -109.05 117.33 54.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.208 0.528 . . . . 0.0 109.696 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 84.8 m -108.59 125.43 51.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.562 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.418 ' CD1' HD22 ' A' ' 29' ' ' LEU . 8.8 m-85 -98.91 112.3 24.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.95 112.56 14.2 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.576 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 26.1 mt -119.12 119.79 61.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 2.5 p30 -84.11 176.75 8.59 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.781 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.12 -17.25 51.79 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.565 ' HB3' HG12 ' A' ' 101' ' ' ILE . 66.2 t30 -82.46 -15.23 53.3 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.517 0.675 . . . . 0.0 109.573 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.57 7.13 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 43.1 mm -97.28 114.21 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.92 118.49 36.45 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 25.9 m-80 -106.47 108.02 19.33 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.625 173.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.2 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.2 m -107.86 117.54 34.4 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.99 123.62 50.15 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -125.94 121.01 31.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.761 0.315 . . . . 0.0 111.634 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.57 106.98 8.54 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.907 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.9 -19.18 64.98 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -63.06 -49.83 72.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.853 0.359 . . . . 0.0 110.771 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.8 p -109.62 -23.13 11.62 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.77 53.62 2.06 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.2 126.27 50.24 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.965 0.412 . . . . 0.0 111.559 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.31 54.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.462 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -135.88 149.9 49.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 146.77 44.34 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 117.742 0.246 . . . . 0.0 111.273 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 23.0 pt -115.49 128.07 72.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 45.5 m -98.04 113.51 25.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.594 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 64.6 mt -121.84 110.47 27.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.603 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.405 ' HA ' HD13 ' A' ' 101' ' ' ILE . 11.1 m -77.87 114.74 17.03 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 168.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.313 61.6 t30 . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 117.759 -1.577 . . . . 0.0 113.942 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 CA--C 1.515 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 135' ' ' VAL . 2.0 mp -72.45 -53.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.209 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 136' ' ' GLN 0.267 0.0 OUTLIER -66.35 -30.45 70.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.446 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -67.09 -42.44 84.63 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -73.03 -26.38 61.29 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.829 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 131' ' ' ILE . 97.7 t -67.11 -39.18 82.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.582 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 27.9 mm-40 -60.41 -47.05 87.78 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.686 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -66.38 -36.45 82.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.796 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.88 73.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.453 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -79.68 -49.2 12.46 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -73.38 -42.48 62.11 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.85 31.55 5.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.36 -55.66 23.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.553 1.541 . . . . 0.0 110.799 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -67.25 -51.81 48.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.691 -175.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -55.04 -51.83 65.08 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.711 0.804 . . . . 0.0 111.05 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.88 -35.52 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -66.02 -37.23 85.38 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.515 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 64.1 t -70.18 -48.1 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.644 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -56.81 -40.2 75.54 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -56.77 -43.9 81.29 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.936 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.22 -6.68 57.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.626 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 36.3 mmt180 -76.48 -33.09 58.69 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 30.9 t -81.73 -31.22 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 172.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t 77.92 139.92 0.07 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.493 1.517 . . . . 0.0 110.479 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 -43.24 10.9 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.015 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 61.28 -164.47 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.186 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 15.1 m120 -122.93 58.88 1.08 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.605 0.716 . . . . 0.0 109.238 174.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.73 149.18 33.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.92 151.88 37.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.14 131.1 42.94 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.834 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 C--N 1.302 -1.479 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.586 -178.945 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.44 -0.963 0 CA-C-O 121.053 0.454 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 36' ' ' ILE . 33.7 m-20 -108.45 78.34 1.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 35' ' ' THR . 29.2 m -127.38 176.56 7.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.069 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.66 121.28 84.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.04 -46.35 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.42 2.08 . . . . 0.0 111.633 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.424 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 89.0 mt -128.86 173.97 9.9 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.5 m -82.84 128.56 34.53 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.46 131.85 37.27 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.65 -177.63 25.6 Favored Glycine 0 N--CA 1.413 -2.851 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.673 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 96.9 mt -126.85 150.96 48.96 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.78 109.01 17.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 25.6 p -93.13 -88.89 0.21 Allowed 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.001 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.37 172.04 12.9 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.23 88.36 0.01 OUTLIER Glycine 0 N--CA 1.469 0.882 0 O-C-N 124.71 1.256 . . . . 0.0 115.906 -173.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.66 29.55 71.23 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.773 -0.714 . . . . 0.0 114.211 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.95 136.04 52.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ttt -100.12 130.04 46.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.0 110.847 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.8 m -114.88 115.02 26.27 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.7 126.44 35.32 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.4 mp -95.58 -50.13 5.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -110.71 107.53 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -74.61 149.52 40.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.869 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.8 ptt85 -52.7 147.24 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.291 1.037 . . . . 0.0 112.322 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 76.88 2.9 3.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.255 1.422 . . . . 0.0 113.593 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -77.88 131.84 37.69 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.439 ' HA ' HG12 ' A' ' 12' ' ' VAL . 2.5 m -72.96 140.17 47.23 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 123.162 0.585 . . . . 0.0 111.506 -174.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 11' ' ' ASP . 18.7 pt -109.63 161.15 25.21 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 42.6 Cg_exo -62.19 136.84 20.84 Favored 'Cis proline' 0 C--O 1.241 0.672 0 CA-C-N 120.462 1.201 . . . . 0.0 114.57 0.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -107.44 166.21 10.82 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -167.09 102.11 0.54 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -130.31 130.37 44.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 79.5 m -115.49 126.55 54.44 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.119 0.262 . . . . 0.0 110.534 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -127.64 140.32 52.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -104.34 114.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 87.0 m-85 -106.05 138.78 41.63 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.426 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 4.8 p -106.22 170.81 7.7 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -106.54 146.12 31.02 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.792 -1.192 . . . . 0.0 110.916 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.436 ' HA ' ' HG2' ' A' ' 85' ' ' ARG . 28.0 m-85 -87.86 -28.55 21.52 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -71.76 139.0 48.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.26 172.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -104.35 154.88 19.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.797 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 61.27 25.43 15.41 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 47.9 mt-30 -65.12 133.96 95.8 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 51' ' ' GLN . 2.7 Cg_exo -80.37 -19.82 8.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.332 2.021 . . . . 0.0 110.394 171.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.9 153.05 23.47 Favored Glycine 0 N--CA 1.419 -2.435 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.926 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.06 160.42 15.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 tp -118.4 114.53 23.04 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.2 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.05 110.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 36.5 mt-30 -108.46 113.69 26.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.671 -175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 104' ' ' VAL . 34.8 t -95.19 120.9 45.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.258 0 O-C-N 123.363 0.414 . . . . 0.0 110.602 -177.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.4 146.71 52.01 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.424 ' OE2' ' HB2' ' A' ' 15' ' ' LEU . 15.4 pt-20 -120.48 150.61 40.55 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.853 0.835 . . . . 0.0 110.771 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.34 -174.01 19.8 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.86 95.52 3.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 118.192 0.996 . . . . 0.0 108.712 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -142.93 153.64 43.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.931 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -81.43 -49.55 10.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.144 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mmm -98.89 105.44 17.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.404 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 95.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.981 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -151.59 -44.51 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.54 11.14 36.2 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.615 0.721 . . . . 0.0 109.654 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.55 161.95 25.67 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.913 -173.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -90.78 115.13 27.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -82.05 113.73 20.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.98 -33.02 19.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.91 162.7 22.66 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -153.67 138.7 17.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -137.75 151.39 48.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.036 0.446 . . . . 0.0 111.46 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.55 133.16 38.47 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.292 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.04 105.13 13.78 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -96.71 151.29 19.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.402 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.7 -0.62 13.77 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 121.117 -0.564 . . . . 0.0 111.835 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.08 133.96 92.82 Favored Pre-proline 0 C--O 1.254 1.319 0 C-N-CA 122.847 0.459 . . . . 0.0 110.675 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 111' ' ' THR . 19.2 Cg_endo -58.33 134.88 64.37 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.179 2.586 . . . . 0.0 112.476 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -71.44 67.66 2.79 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.596 2.197 . . . . 0.0 110.593 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.52 158.52 75.4 Favored Pre-proline 0 N--CA 1.417 -2.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.086 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.79 178.68 7.3 Favored 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.192 1.928 . . . . 0.0 114.462 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 47' ' ' TYR . 19.3 mtm180 -30.18 115.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.795 2.438 . . . . 0.0 115.138 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.82 -29.75 8.67 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.666 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.58 -51.01 4.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.41 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.92 124.38 14.38 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.447 1.432 . . . . 0.0 109.421 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -134.93 95.61 3.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.221 1.01 . . . . 0.0 110.388 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.7 mm -93.42 112.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.773 -173.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -90.16 111.9 23.21 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 105' ' ' THR . 62.0 t -111.56 125.68 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -177.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.6 m -112.78 124.27 52.21 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.446 ' CD1' HD22 ' A' ' 29' ' ' LEU . 14.5 m-85 -97.7 109.32 22.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.18 114.22 16.04 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 59.4 mt -116.44 140.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' HD12 ' A' ' 36' ' ' ILE . 1.3 p-10 -93.45 -176.5 4.13 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.35 -15.14 62.83 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -82.21 -28.76 31.77 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.63 20.15 7.47 Favored Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 78.6 mt -83.8 113.93 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 tp -95.28 118.8 32.68 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 24.0 t-20 -110.39 113.32 25.88 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 174.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 58' ' ' VAL . 59.7 t -97.4 113.78 32.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 21.1 m -103.64 126.76 50.98 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.75 126.04 49.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 113' ' ' LYS . 19.8 m -131.84 118.32 19.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.51 107.62 11.3 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -67.56 -20.53 65.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.555 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.6 t -69.44 -52.53 25.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.044 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.411 HG23 ' HD3' ' A' ' 81' ' ' PRO . 38.0 p -90.06 -32.2 16.82 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.47 43.98 3.56 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 107' ' ' THR . 54.4 mttm -116.59 133.37 56.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.2 136.64 41.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -138.77 145.96 40.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.267 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -143.26 151.0 40.06 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 123.042 0.214 . . . . 0.0 111.288 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 32.0 pt -121.9 141.21 43.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.962 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.1 m -111.14 113.21 25.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.99 103.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.056 0.455 . . . . 0.0 109.977 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -93.75 127.41 39.46 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 124.453 1.101 . . . . 0.0 111.701 -179.689 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 134' ' ' MET . 46.8 mt-10 . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.4 mt -60.7 -52.02 66.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.793 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 9.5 pt-20 -70.42 -25.1 63.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.509 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 92.2 mmm -59.47 -43.19 93.31 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.3 t -63.24 -47.5 91.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.156 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 15.8 mm-40 -57.34 -46.95 82.78 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.82 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.79 -35.61 75.01 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.206 0.316 . . . . 0.0 111.541 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.39 77.97 Favored 'General case' 0 C--O 1.19 -2.064 0 O-C-N 123.472 0.483 . . . . 0.0 110.322 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.08 -48.2 16.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.473 0.654 . . . . 0.0 111.025 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.92 -40.48 96.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.394 -173.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.71 18.11 19.27 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.81 0.338 . . . . 0.0 110.195 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -49.03 -58.93 4.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.458 1.503 . . . . 0.0 112.451 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -71.55 -34.14 69.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 33.8 mm-40 -64.38 -53.42 48.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.044 -176.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 1.4 m-20 -63.6 -36.44 83.81 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.059 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.528 ' OE1' ' HD3' ' A' ' 149' ' ' ARG . 6.9 mm-40 -57.85 -46.43 84.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.021 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 60.2 t -63.32 -40.88 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 17.7 mm100 -58.78 -54.08 51.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.628 0.771 . . . . 0.0 111.698 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 2.6 ptm180 -68.78 -32.82 72.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.22 -9.91 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.916 0.388 . . . . 0.0 111.752 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 92.2 mtt180 -68.8 -27.67 66.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.24 125.69 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -81.53 75.85 8.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 0.0 111.383 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -101.87 120.47 40.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.577 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -94.67 -163.12 1.01 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 18.1 m120 -76.28 80.16 3.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.847 0.832 . . . . 0.0 109.042 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.631 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.58 153.13 41.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.344 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.2 mt -125.82 136.01 52.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.09 120.2 40.91 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.278 -2.501 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.598 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp . . . . . 0 C--O 1.242 0.707 0 CA-C-O 122.252 1.025 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 36' ' ' ILE . 17.2 t70 -123.13 17.59 9.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 123.083 1.42 . . . . 0.0 108.941 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 m -136.37 171.07 17.44 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.136 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.73 118.66 72.61 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.08 -31.98 13.96 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.983 1.788 . . . . 0.0 112.335 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.04 168.83 17.78 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.428 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 24.1 m -92.67 132.44 36.9 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.08 132.03 50.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.92 179.37 28.55 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.352 -176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.47 HD11 HG11 ' A' ' 92' ' ' VAL . 97.1 mt -118.75 155.47 31.06 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.809 -0.695 . . . . 0.0 109.867 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -88.59 109.35 20.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.444 HG22 ' HG ' ' A' ' 158' ' ' LEU . 17.2 p -105.3 -166.06 1.18 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.489 -174.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.33 134.69 18.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.615 0.766 . . . . 0.0 112.174 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.81 56.07 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.142 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.51 25.14 31.33 Favored Glycine 0 C--O 1.246 0.898 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 152' ' ' VAL . 64.0 t -104.52 146.54 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.507 -1.346 . . . . 0.0 109.208 -175.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.4 ttt -87.89 136.43 32.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.213 0.53 . . . . 0.0 111.983 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.6 m -123.74 112.19 17.04 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.85 116.59 29.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.782 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.515 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.4 mp -79.41 -47.22 16.1 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.04 112.95 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.19 142.46 28.33 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 32' ' ' ARG . 16.8 ptt180 -56.76 155.74 7.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 77.98 1.29 2.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.528 1.531 . . . . 0.0 111.813 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -86.12 128.99 34.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -60.05 144.91 48.33 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.408 1.083 . . . . 0.0 112.109 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.611 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 28.4 pt -106.16 169.75 6.57 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.611 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 14.7 Cg_exo -69.08 124.77 7.55 Favored 'Cis proline' 0 C--O 1.244 0.817 0 CA-C-N 121.153 1.447 . . . . 0.0 112.257 0.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -87.96 141.7 28.38 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.405 -178.194 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -148.68 100.02 3.06 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 93' ' ' THR . 14.8 mm100 -107.01 117.66 34.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 88.3 m -117.31 116.05 26.47 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.457 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 87.5 mt-30 -120.95 151.39 39.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.77 113.22 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -101.59 165.87 11.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.964 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -145.14 170.89 15.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 p -101.36 139.03 37.59 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.706 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -85.76 -18.8 31.98 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 165.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 p -71.8 110.01 6.05 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.031 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.74 126.65 32.62 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m120 62.05 68.49 0.68 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.426 0.632 . . . . 0.0 111.149 -172.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.5 tp-100 -101.56 117.27 62.23 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.72 -31.75 20.1 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.003 1.802 . . . . 0.0 113.349 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.34 140.09 6.74 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.592 -0.814 . . . . 0.0 111.114 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.85 147.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.135 0.493 . . . . 0.0 110.123 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.517 HD21 ' NH1' ' A' ' 74' ' ' ARG . 42.0 tp -114.7 111.56 21.49 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.141 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.73 105.23 16.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.498 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 83.9 mt-30 -103.91 115.11 29.85 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.238 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.02 124.04 55.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 O-C-N 123.643 0.59 . . . . 0.0 110.755 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -129.49 154.4 47.04 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.466 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 34.4 tt0 -122.27 147.74 45.85 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.97 125.73 5.66 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 16' ' ' SER . 37.5 mt-10 -79.51 126.36 30.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -152.84 168.41 25.84 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.482 0.713 . . . . 0.0 110.652 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -84.06 -51.1 7.37 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.52 0.676 . . . . 0.0 109.341 174.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.6 mtt -98.63 128.14 44.81 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.989 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -90.0 117.83 29.09 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.877 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -177.59 -52.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.528 1.131 . . . . 0.0 110.058 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.01 79.95 1.81 Allowed 'General case' 0 CA--C 1.464 -2.349 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.93 177.96 7.45 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 112.802 -1.999 . . . . 0.0 106.012 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 30.3 t30 -90.12 109.07 20.15 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.8 107.42 9.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.977 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.18 -41.79 14.38 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.533 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.37 171.52 38.71 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.068 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.517 ' NH1' HD21 ' A' ' 55' ' ' LEU . 7.2 ptp180 -152.58 140.77 20.41 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -147.15 149.02 32.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -97.21 140.14 32.13 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.7 103.39 9.63 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 170.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 p -111.83 161.46 16.33 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 41.71 3.63 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 42.8 mm -86.34 130.49 49.4 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 147.36 94.72 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.74 2.293 . . . . 0.0 112.359 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.88 84.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 122.685 2.256 . . . . 0.0 111.307 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.6 77.92 Favored Pre-proline 0 N--CA 1.42 -1.949 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.841 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.08 168.94 6.69 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.668 2.246 . . . . 0.0 112.712 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -62.94 149.27 45.1 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.657 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.18 -16.0 41.16 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.511 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.25 -55.17 1.39 Allowed Pre-proline 0 C--O 1.247 0.969 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.264 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.71 109.34 1.42 Allowed 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 121.339 1.359 . . . . 0.0 111.283 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -93.64 115.49 27.96 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.004 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.4 mm -102.46 116.77 46.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 17.0 tt0 -90.18 117.18 28.74 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 105' ' ' THR . 39.2 t -117.85 121.16 66.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.657 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 85.6 m -110.95 123.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.664 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 29' ' ' LEU . 7.1 m-85 -105.2 108.51 20.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 38' ' ' THR . 7.9 t70 -121.19 132.06 54.61 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.414 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 62.8 mt -126.3 135.6 63.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.87 -170.58 2.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.02 -23.6 64.1 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -77.1 -29.31 54.82 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.169 0.509 . . . . 0.0 110.05 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.02 23.35 7.44 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.9 mt -83.35 117.64 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.3 tp -93.58 117.1 29.66 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -109.73 103.38 12.2 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 64.2 t -89.86 118.63 35.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.467 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 35.7 m -113.41 137.17 51.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 91' ' ' GLU . . . -126.79 121.18 31.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 19.7 m -118.81 123.68 45.35 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.497 0.498 . . . . 0.0 110.738 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.57 109.92 16.47 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -66.96 -17.28 64.84 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.918 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -75.6 -62.85 1.44 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.893 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -94.26 -19.47 20.68 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.55 47.96 3.59 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.821 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 107' ' ' THR . 61.3 mttp -106.78 147.24 29.91 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -149.94 131.83 15.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.338 0.589 . . . . 0.0 111.826 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -136.54 139.14 42.0 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.567 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 61.2 pttt -135.85 148.76 48.79 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 120.722 0.296 . . . . 0.0 110.815 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.4 pt -119.16 139.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -104.27 112.77 25.93 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.23 108.5 25.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.8 p -84.59 163.89 19.03 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.455 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 C--O 1.245 0.861 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 174.85 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.051 0.453 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 135' ' ' VAL . 62.3 mt -72.78 -44.23 59.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.12 -39.58 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.257 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 1.2 mmp_? -60.35 -46.35 90.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.915 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.4 ttt -55.71 -47.06 77.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.077 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 131' ' ' ILE . 69.8 t -58.45 -45.97 89.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.362 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.65 -31.8 70.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.433 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 37.1 mt-10 -64.94 -47.7 76.73 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.32 -30.63 68.49 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.231 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HA ' ' HG2' ' A' ' 142' ' ' LYS . 31.8 mt-10 -78.15 -31.55 49.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -70.62 -19.16 62.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.118 0.961 . . . . 0.0 109.291 174.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.42 27.4 8.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.33 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 139' ' ' GLU . 5.1 mmtt -48.98 -52.47 24.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.788 0.835 . . . . 0.0 112.882 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -70.54 -51.97 24.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 148' ' ' GLN 0.258 1.4 pm0 -60.28 -45.88 91.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.251 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.8 -45.62 88.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.17 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . 0.251 35.8 mt-10 -70.28 -32.53 70.37 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.735 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 143' ' ' ALA . 89.4 t -65.7 -45.77 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 14.4 mm100 -58.08 -43.88 87.28 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 110.752 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.426 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 2.6 tmt_? -61.86 -41.0 97.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.725 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 -11.48 42.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -62.4 -44.41 96.5 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.303 0.573 . . . . 0.0 110.056 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 25' ' ' VAL . 48.7 t -78.79 113.68 18.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -77.87 95.54 4.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.93 -21.0 17.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.892 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 63.61 -77.99 0.03 OUTLIER 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.085 1.354 . . . . 0.0 111.398 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -178.26 40.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.44 156.73 34.95 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.533 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -122.63 153.14 39.73 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.495 0.664 . . . . 0.0 110.622 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.25 158.25 29.88 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 168.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 C--N 1.29 -1.995 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.949 -175.016 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.422 -1.837 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -98.07 37.9 1.38 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 112.983 -1.917 . . . . 0.0 109.955 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.59 146.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.767 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 121.59 46.86 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.455 171.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' C ' HD12 ' A' ' 15' ' ' LEU . 36.9 Cg_exo -57.58 -58.97 0.65 Allowed 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 5.8 mp -126.77 176.43 7.27 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.2 m -80.93 119.8 23.92 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -92.5 132.07 37.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.853 0.72 . . . . 0.0 109.274 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -153.72 -169.9 19.19 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.243 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.46 HD23 HG23 ' A' ' 56' ' ' ILE . 2.3 mp -131.52 163.23 28.46 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.538 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 34.5 tt0 -87.89 109.07 19.51 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 123.0 1.381 . . . . 0.0 109.802 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 11.9 p -85.74 160.21 19.58 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.494 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.54 118.49 1.79 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 125.502 1.521 . . . . 0.0 113.665 -173.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.94 4.25 39.07 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.637 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.98 39.51 27.7 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.8 t -108.44 146.77 13.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.403 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -101.87 127.81 48.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.477 0.656 . . . . 0.0 109.285 -178.178 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.7 m -123.89 116.15 22.44 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.8 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -86.55 141.35 29.11 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.754 0.659 . . . . 0.0 111.172 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.37 -39.81 6.03 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.58 112.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -79.0 154.42 29.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.342 0.591 . . . . 0.0 110.501 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -64.37 149.81 47.55 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.47 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 66.38 20.79 10.96 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 124.408 1.083 . . . . 0.0 111.881 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.6 t -90.39 126.96 36.05 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.5 119.73 7.54 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.806 0.842 . . . . 0.0 113.263 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.43 HG22 HG23 ' A' ' 38' ' ' THR . 23.7 pt -101.46 162.25 21.05 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.66 -1.154 . . . . 0.0 107.925 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 137.13 12.24 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 CA-C-N 121.341 1.515 . . . . 0.0 115.152 1.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 36' ' ' ILE . 1.1 p -107.6 154.93 20.71 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -146.83 103.74 3.66 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.97 121.32 20.31 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 m -127.95 115.97 19.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.551 0.215 . . . . 0.0 110.876 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -115.36 153.08 31.65 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.22 114.13 41.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.96 151.13 19.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.6 p -122.1 169.91 10.39 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 33.7 p -95.84 136.94 35.61 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.92 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -107.61 -1.1 21.5 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.245 0.545 . . . . 0.0 111.139 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -101.77 138.91 38.12 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.8 139.5 34.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.44 18.49 11.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.516 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 46.2 tt0 -60.22 114.79 10.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 123.045 0.538 . . . . 0.0 110.226 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.33 -5.78 10.16 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.791 2.327 . . . . 0.0 113.892 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.13 150.34 14.49 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.632 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.2 165.08 24.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.0 tp -117.92 127.82 54.21 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.46 HG23 HD23 ' A' ' 19' ' ' LEU . 3.0 mp -98.42 98.34 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.66 110.1 21.04 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.54 114.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.953 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.538 ' CE2' ' HB2' ' A' ' 20' ' ' GLU . 68.6 m-85 -107.69 156.37 19.15 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.529 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.541 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 39.8 tt0 -134.99 137.81 43.38 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.74 -107.03 1.14 Allowed Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.261 -0.971 . . . . 0.0 114.785 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' CD ' ' HZ2' ' A' ' 67' ' ' LYS . 41.8 mt-10 -79.1 158.54 27.77 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.344 1.058 . . . . 0.0 109.414 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.428 HH11 ' HA ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -122.48 -46.31 2.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.705 0.764 . . . . 0.0 112.639 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -71.97 -28.43 63.43 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.538 0.685 . . . . 0.0 110.805 -173.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.5 mmt -134.57 111.47 10.08 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.706 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.1 91.57 4.31 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.448 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 19.8 pttp -144.71 -58.54 0.36 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.403 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 5.5 m-20 -105.45 25.95 10.07 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.489 0.661 . . . . 0.0 109.518 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -74.54 160.96 30.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.377 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -93.76 129.99 39.92 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.2 tp -101.69 111.01 23.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.93 -51.13 7.4 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.26 159.02 32.09 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.848 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 78.5 mtm180 -138.15 136.94 37.18 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.84 144.87 30.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.49 133.58 39.32 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.563 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 5.5 tt -113.46 104.05 11.89 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 172.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -120.54 155.39 33.74 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.12 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.12 7.53 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.5 mt -79.16 132.92 61.76 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 38.0 Cg_endo -66.36 125.19 13.56 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.504 2.136 . . . . 0.0 111.249 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 32.5 Cg_exo -61.25 101.85 0.2 Allowed 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.668 2.246 . . . . 0.0 111.94 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.77 157.61 59.33 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 68.0 Cg_endo -70.76 50.73 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.762 2.975 . . . . 0.0 113.312 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' THR . 39.5 ptt180 56.42 164.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.142 2.177 . . . . 0.0 113.89 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.55 -44.2 2.21 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.346 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.6 -50.24 73.37 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 123.976 0.91 . . . . 0.0 113.171 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.75 123.24 11.38 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 121.576 1.517 . . . . 0.0 110.985 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 76.4 mt-30 -117.23 115.21 24.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.479 -175.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.33 105.58 18.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -90.62 107.78 19.38 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -107.9 124.48 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.179 0.514 . . . . 0.0 111.118 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.3 m -103.86 121.93 44.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.727 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.56 107.94 19.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.36 125.14 40.2 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.883 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.25 131.75 72.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.9 p30 -89.79 -169.76 2.57 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.376 0.422 . . . . 0.0 110.335 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.85 2.1 47.16 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.122 -0.361 . . . . 0.0 111.958 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -96.01 -13.6 23.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.56 30.18 12.4 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 67.2 mt -102.05 116.46 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.091 0.472 . . . . 0.0 109.889 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.21 111.23 22.81 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.979 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.03 114.42 27.72 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.94 126.58 58.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 122.28 31.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.82 117.83 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.6 m -113.6 117.96 33.07 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.533 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.85 107.87 11.88 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 28.2 mmmt -67.31 -20.21 65.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.613 0.765 . . . . 0.0 110.779 -177.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -69.33 -54.6 13.75 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.785 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.9 p -99.05 -15.44 19.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.058 0.456 . . . . 0.0 112.056 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 30.36 36.22 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.499 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -115.36 158.57 22.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.546 0.673 . . . . 0.0 109.504 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.64 155.88 48.66 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.563 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.1 m120 -129.35 127.61 41.42 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -119.29 145.31 46.23 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.812 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.4 tt -136.64 148.77 26.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 m -113.61 112.93 24.33 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.2 mm -107.58 94.19 2.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t -88.11 122.33 31.56 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.856 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 125.098 1.359 . . . . 0.0 109.624 -178.271 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 134' ' ' MET . 8.9 mm-40 . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 135' ' ' VAL . 61.9 mt -63.7 -41.94 94.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.47 -38.3 90.61 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.206 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 42.4 mtm105 -63.61 -42.12 98.24 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 53.4 mtt -59.86 -35.88 75.71 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.195 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 131' ' ' ILE . 58.9 t -56.77 -52.84 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -63.8 -42.17 97.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.523 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.0 mm-40 -64.76 -40.37 95.17 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.79 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.653 0.381 . . . . 0.0 111.274 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 25.4 mm-40 -77.85 -38.38 46.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.518 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -65.27 -38.76 91.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.348 0.594 . . . . 0.0 109.925 -179.434 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -111.57 28.63 8.56 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.927 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 139' ' ' GLU . 17.9 pttm -62.43 -45.25 93.96 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.47 67.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.397 0.618 . . . . 0.0 109.501 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -71.5 -54.15 11.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.184 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.1 m-20 -67.09 -55.2 15.29 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.14 -33.79 76.58 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -172.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.24 -47.82 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.184 175.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 152' ' ' VAL . 16.5 mm-40 -61.32 -41.39 96.94 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -55.29 -47.32 75.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -70.03 -9.51 55.53 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -97.9 0.59 46.85 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 148' ' ' GLN . 61.7 t -96.31 133.11 38.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 t -82.38 21.38 0.95 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.877 0.471 . . . . 0.0 112.014 -173.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.16 -21.76 59.71 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 50.06 -91.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.578 1.551 . . . . 0.0 113.177 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -155.1 67.73 0.68 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.17 140.3 41.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.168 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 76.1 mt -93.13 152.56 19.18 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -93.52 147.22 23.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.249 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.516 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 48.1 t . . . . . 0 C--N 1.311 -1.069 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.423 -1.793 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 36' ' ' ILE . 7.5 m-20 -86.03 75.65 9.92 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 35' ' ' THR . 27.8 m -130.72 179.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.246 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.59 130.79 54.57 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.28 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.24 -60.9 0.27 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.871 2.38 . . . . 0.0 112.359 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD2' HG23 ' A' ' 131' ' ' ILE . 3.4 mm? -119.18 174.34 6.39 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -69.51 127.43 32.97 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -95.21 140.62 29.86 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.553 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.58 -171.33 21.31 Favored Glycine 0 N--CA 1.42 -2.393 0 C-N-CA 119.552 -1.309 . . . . 0.0 113.796 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -133.71 156.9 47.11 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 35.5 tt0 -102.2 109.03 20.61 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 170.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.6 p -98.6 -63.93 1.08 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 122.39 1.091 . . . . 0.0 109.242 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.434 ' CB ' ' HG3' ' A' ' 159' ' ' GLU . . . -101.43 155.17 18.22 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.52 28.03 4.01 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.177 -1.011 . . . . 0.0 115.032 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.54 -61.01 0.18 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.99 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 155' ' ' LYS . 58.7 t -109.53 145.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 120.729 0.3 . . . . 0.0 111.099 -173.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.76 128.0 33.97 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -107.86 111.42 23.54 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.47 135.81 36.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.742 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' CE1' ' A' ' 94' ' ' PHE . 5.6 mp -109.77 -49.24 3.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.255 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.36 128.77 48.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -85.06 158.28 20.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 12.9 ptm180 -61.89 149.98 38.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.964 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 m120 68.37 11.41 8.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.111 0.964 . . . . 0.0 112.65 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.1 t -75.71 122.38 23.92 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.404 ' HA ' HG12 ' A' ' 12' ' ' VAL . 1.4 p -62.65 126.83 28.68 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.107 0.963 . . . . 0.0 112.945 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 11' ' ' ASP . 21.3 pt -87.52 152.3 51.87 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_exo -67.82 124.23 6.3 Favored 'Cis proline' 0 C--O 1.241 0.668 0 N-CA-C 115.241 1.208 . . . . 0.0 115.241 4.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -96.79 158.13 15.58 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.023 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -165.58 108.56 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 93' ' ' THR . 26.7 mm-40 -121.85 137.59 54.72 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.934 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.4 m -121.8 117.28 26.16 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.185 0.928 . . . . 0.0 109.788 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -125.48 147.87 49.07 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.8 mm -95.9 117.56 40.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.405 0.621 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.14 153.9 20.91 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.312 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 10.8 p -135.11 171.11 14.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 30.7 p -101.87 148.76 24.94 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.829 0.74 . . . . 0.0 109.85 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 37.1 m-85 -81.21 -65.33 1.03 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.16 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -75.69 144.83 41.37 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.78 145.88 44.71 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.551 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 68.62 35.46 3.14 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -73.98 118.17 67.24 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.46 -24.62 10.42 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.032 1.821 . . . . 0.0 111.951 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.01 159.02 29.26 Favored Glycine 0 N--CA 1.411 -2.976 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.92 153.21 33.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 O-C-N 123.945 0.438 . . . . 0.0 109.963 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.0 tp -106.22 115.84 30.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.11 106.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 74' ' ' ARG . 15.1 tt0 -112.47 121.43 44.82 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.0 t -90.32 135.23 26.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.574 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 90.4 m-85 -136.66 167.63 21.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.803 0.811 . . . . 0.0 111.282 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.563 ' CG ' ' HB2' ' A' ' 70' ' ' ASN . 13.4 pt-20 -136.01 151.51 49.96 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 170.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.65 136.49 3.88 Favored Glycine 0 C--N 1.277 -2.703 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' OE2' ' HD2' ' A' ' 32' ' ' ARG . 30.6 mt-10 -101.44 95.62 6.61 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 -174.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 20.7 mmt180 -146.29 170.45 16.75 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.236 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -86.44 -49.76 7.37 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.557 175.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.3 mtt -98.9 137.27 37.71 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.587 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.42 85.58 2.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.177 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -146.92 -52.17 0.21 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.472 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 7.5 m-20 -94.34 70.03 3.7 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -145.13 150.24 36.43 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.982 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.563 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 85.0 m-20 -90.68 131.57 36.29 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.08 118.41 28.78 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 mp -92.31 -56.91 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.801 0.334 . . . . 0.0 111.186 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.08 163.52 31.01 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.436 ' HB3' ' HG3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -153.2 135.39 14.88 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.9 150.12 41.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -94.97 129.98 41.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 tt -120.0 104.79 10.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 p -121.99 165.4 16.07 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.27 -0.11 14.38 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.51 125.62 88.95 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.458 0.703 . . . . 0.0 109.638 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 111' ' ' THR . 60.9 Cg_endo -70.78 168.69 22.17 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.07 2.513 . . . . 0.0 111.853 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.08 90.93 0.12 Allowed 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.546 2.164 . . . . 0.0 111.823 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.41 147.55 66.59 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.574 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.6 -171.03 0.72 Allowed 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.425 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 46' ' ' THR . 51.8 ttp180 -59.07 131.93 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.1 0.96 . . . . 0.0 111.54 -177.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 -8.5 64.89 Favored Glycine 0 C--N 1.308 -0.979 0 CA-C-N 115.833 -0.621 . . . . 0.0 114.295 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.6 t -82.88 -54.29 0.57 Allowed Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.25 107.52 2.46 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.336 1.358 . . . . 0.0 110.107 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.45 ' HB2' ' HD2' ' A' ' 109' ' ' LYS . 92.9 mt-30 -94.87 113.39 25.12 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.1 mm -98.24 115.25 37.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.04 113.46 25.72 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -116.64 123.21 71.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 42.1 m -129.45 124.58 34.41 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.3 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.402 ' CE1' HD22 ' A' ' 29' ' ' LEU . 45.9 p90 -123.6 138.23 54.59 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.927 174.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -134.31 153.2 52.01 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.499 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 64.6 mt -130.91 135.73 59.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.2 p-10 -84.81 -173.02 4.5 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.88 -13.02 60.26 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.447 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 47.6 m-80 -85.31 -29.51 24.48 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.74 28.81 2.83 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.494 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 68.9 mt -88.35 116.29 29.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 tp -95.66 120.78 36.51 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.95 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -119.99 104.2 9.95 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.12 125.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.1 m -123.45 123.44 40.65 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.61 130.62 53.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.1 m -131.58 126.8 35.71 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -83.86 116.6 22.83 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.206 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 89' ' ' GLN . 67.9 mttm -67.19 -19.33 65.55 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -74.31 -54.5 7.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.416 HG23 ' HD3' ' A' ' 81' ' ' PRO . 38.4 p -91.5 -37.01 13.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.14 14.19 36.89 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.03 136.87 35.18 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.475 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.91 137.68 45.06 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.303 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -133.09 138.75 46.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -131.4 158.34 41.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.866 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.9 141.0 44.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.1 m -128.5 113.29 15.31 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.1 mt -113.65 111.08 34.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.8 t -92.42 100.98 13.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 . . . . . 0 CA--C 1.562 1.417 0 C-N-CA 123.991 0.916 . . . . 0.0 108.719 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 135' ' ' VAL . 54.1 mt -55.76 -54.11 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.726 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 45.5 mt-10 -66.38 -35.26 79.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.89 -44.13 94.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.265 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.5 mtt -72.55 -30.26 64.28 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 131' ' ' ILE . 60.0 t -62.94 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 53.7 mt-30 -55.66 -47.22 77.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.274 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.737 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.26 74.3 Favored 'General case' 0 C--O 1.196 -1.731 0 C-N-CA 122.568 0.347 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.22 -32.63 74.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.909 0.385 . . . . 0.0 111.404 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.26 -41.97 56.11 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.585 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -108.31 11.67 27.03 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.16 -43.77 64.25 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.146 0.978 . . . . 0.0 111.554 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -66.5 -43.37 85.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -177.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.7 -38.57 47.09 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.281 -0.568 . . . . 0.0 112.248 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.8 m-20 -64.3 -33.46 75.89 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.976 0.417 . . . . 0.0 109.934 174.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.68 -50.37 74.12 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 54.7 t -62.06 -46.43 96.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -55.49 -47.45 76.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.476 0.711 . . . . 0.0 111.494 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -68.15 -47.34 68.32 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.88 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -68.76 -10.73 58.3 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.2 mmt180 -72.76 -10.97 60.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.332 0.587 . . . . 0.0 110.022 172.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.15 115.77 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -55.39 -45.35 76.62 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 123.314 0.646 . . . . 0.0 112.648 -172.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.44 158.83 43.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -136.69 31.51 2.79 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.323 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -86.46 33.64 0.63 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.933 -177.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -139.56 134.14 31.77 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.29 151.71 19.27 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 121.307 0.575 . . . . 0.0 111.207 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.434 ' HG3' ' CB ' ' A' ' 22' ' ' ALA . 41.9 mt-10 -116.72 121.61 42.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.294 -1.842 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.832 -177.284 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--O 1.242 0.659 0 CA-C-O 121.368 0.604 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.23 81.05 1.48 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.112 0.958 . . . . 0.0 110.068 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.44 178.14 3.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.126 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.97 116.67 66.89 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.71 -36.45 24.58 Favored 'Trans proline' 0 C--O 1.252 1.186 0 C-N-CA 121.733 1.622 . . . . 0.0 110.729 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 84.8 mt -108.07 174.98 5.64 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.65 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.528 ' HB2' ' HG3' ' A' ' 32' ' ' ARG . 10.0 t -103.55 -176.38 3.07 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -151.57 129.23 11.52 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 171.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.75 166.23 31.8 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.125 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.78 148.22 34.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 32.1 tt0 -86.25 112.05 21.0 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.1 p -100.49 172.36 7.17 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.86 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 124.39 20.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.977 0.417 . . . . 0.0 111.915 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.37 28.9 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.903 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.42 35.92 10.17 Favored Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.461 ' HB ' ' OG1' ' A' ' 21' ' ' THR . 27.4 t -99.17 133.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.425 ' HB2' ' OG1' ' A' ' 66' ' ' THR . 26.1 ttt -98.07 108.08 20.71 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.2 m -87.91 111.77 21.81 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.15 24.63 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.431 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.482 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.1 mp -90.7 -45.6 8.76 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.841 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.36 101.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.498 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -72.39 168.3 18.71 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.159 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.528 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 35.2 mtp-105 -61.98 150.62 37.39 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.444 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.19 17.03 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 111.604 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -73.15 129.12 37.36 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 p -68.23 114.73 6.96 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 124.272 1.029 . . . . 0.0 111.598 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 30.3 pt -94.64 164.58 19.39 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.7 Cg_exo -68.92 134.74 28.98 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.773 1.312 . . . . 0.0 113.416 -0.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.4 p -110.69 161.39 15.8 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 123.871 0.868 . . . . 0.0 110.844 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.531 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 46.7 tttp -156.96 99.42 1.82 Allowed 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -102.61 135.14 44.8 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -132.64 116.45 16.67 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.416 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 55.0 mt-30 -128.88 158.64 38.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.33 125.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 80.9 m-85 -113.36 160.44 18.37 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.331 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 11.8 p -137.97 171.76 13.94 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 122.859 0.463 . . . . 0.0 110.625 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 63.4 p -98.77 162.67 12.98 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 157' ' ' ALA . 26.9 m-85 -103.09 -5.1 23.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.194 0.521 . . . . 0.0 109.602 171.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 p -139.55 164.03 30.99 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.737 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -102.32 158.08 16.45 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.806 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 82' ' ' PRO . 44.1 m-80 71.33 14.33 6.49 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.491 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 75.4 mt-30 -63.5 129.13 93.43 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.25 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.94 -45.14 34.31 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.499 2.133 . . . . 0.0 111.445 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 78' ' ' SER . . . -166.35 153.81 23.89 Favored Glycine 0 N--CA 1.404 -3.446 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 HD11 ' A' ' 80' ' ' ILE . 19.1 m -103.97 137.77 31.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.71 109.95 21.84 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.419 ' HB ' ' CD2' ' A' ' 75' ' ' PHE . 2.3 mp -84.51 94.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . 0.251 6.6 pt20 -99.35 114.22 26.97 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.166 0.984 . . . . 0.0 111.632 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.86 126.65 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.075 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 92.4 m-85 -124.21 155.74 38.01 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 16' ' ' SER . 1.3 pp20? -127.27 165.87 18.85 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.15 124.55 3.53 Favored Glycine 0 C--N 1.263 -3.522 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 7.4 mm-40 -78.83 87.73 4.69 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.976 0.893 . . . . 0.0 109.662 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -128.04 142.11 51.32 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.791 -1.549 . . . . 0.0 107.044 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -66.9 -49.81 64.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.0 mtm -110.82 137.97 47.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.151 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 26' ' ' MET . 2.5 m -89.73 108.21 19.55 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.528 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -141.28 -53.91 0.47 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.134 0.493 . . . . 0.0 111.976 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.75 -61.57 1.35 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.6 m120 40.12 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.442 -1.708 . . . . 0.0 113.899 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -112.04 101.56 9.84 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.52 114.83 4.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.461 0.648 . . . . 0.0 110.395 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.19 -35.92 14.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.085 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.81 154.51 15.34 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.911 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -119.51 139.56 51.91 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 121.559 0.695 . . . . 0.0 109.185 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.419 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 13.8 t80 -143.48 142.09 31.03 Favored 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.41 -174.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.41 131.24 52.96 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.309 0.504 . . . . 0.0 111.249 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.3 tp -124.07 105.22 9.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.448 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 22.5 p -96.9 158.6 15.35 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.844 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.4 31.41 3.26 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.017 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 2.0 mp -77.18 116.17 55.18 Favored Pre-proline 0 C--O 1.242 0.687 0 CA-C-N 117.265 0.533 . . . . 0.0 109.894 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 25.6 Cg_exo -66.13 155.15 71.13 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 11.3 Cg_exo -74.05 82.71 1.74 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.544 2.162 . . . . 0.0 111.772 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . . . -132.6 127.63 20.62 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -37.26 -63.74 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 125.07 3.847 . . . . 0.0 115.931 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -175.4 120.26 0.19 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.62 -34.97 3.31 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.631 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.23 -56.97 6.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.863 -0.589 . . . . 0.0 111.198 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 83' ' ' ALA . 21.9 Cg_endo -64.24 104.72 0.53 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.421 1.414 . . . . 0.0 110.448 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -120.06 115.92 24.67 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.5 mm -99.51 116.3 42.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.8 tt0 -90.69 114.3 26.59 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.75 125.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 17.8 m -112.98 131.49 55.74 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.387 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CD1' HD22 ' A' ' 29' ' ' LEU . 7.7 m-85 -119.67 108.5 14.53 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.85 1.26 . . . . 0.0 109.057 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.531 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.7 p30 -123.57 136.61 54.62 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.281 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 54.7 mt -121.87 137.75 54.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.9 p-10 -100.66 -169.43 1.71 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.46 -15.34 61.81 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 43.7 m-80 -90.31 -5.38 56.33 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.983 -0.448 . . . . 0.0 110.859 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.5 25.76 49.51 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.421 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.3 mt -84.3 113.12 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.9 tp -95.87 117.0 29.75 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.095 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -107.7 121.2 44.22 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 93' ' ' THR . 69.9 t -111.61 115.66 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -117.23 127.38 54.04 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.74 118.04 30.98 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.8 m -110.48 125.8 53.68 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.705 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.61 115.63 23.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 68.0 mttm -67.51 -16.55 64.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.6 m -79.4 -50.43 10.84 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.829 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 36.2 p -83.77 -39.22 20.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.135 0.493 . . . . 0.0 111.225 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.15 12.62 48.53 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.439 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 65.4 pttt -103.05 156.43 17.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.331 . . . . 0.0 110.231 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.71 52.08 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.231 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -129.09 152.66 48.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.99 165.94 24.83 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 tt -145.65 143.49 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -122.0 113.11 19.12 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 75.3 mt -108.24 105.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.691 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.8 m -90.77 158.55 16.79 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 122.008 0.908 . . . . 0.0 110.711 -179.459 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HG2' ' A' ' 134' ' ' MET . 14.7 mp0 . . . . . 0 C--O 1.217 -0.641 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 75.6 mt -53.15 -51.9 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.568 1.168 . . . . 0.0 110.698 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 60.6 mt-10 -74.01 -33.28 63.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.203 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -67.11 -35.23 79.32 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.678 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 24.3 mmt -60.14 -52.59 64.7 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.02 -52.65 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 124.027 0.83 . . . . 0.0 112.034 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 70.5 mm-40 -64.37 -45.49 87.52 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.29 -32.81 66.94 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.406 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' A' ' 142' ' ' LYS . . . -60.5 -48.43 81.81 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.466 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 21.6 mm-40 -61.89 -48.61 79.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -77.37 -24.35 50.63 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.98 13.28 7.29 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 18.5 ptpt -50.04 -43.44 51.0 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.99 78.03 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -71.21 -53.17 15.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 m-20 -64.86 -33.87 77.03 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -59.22 -51.08 71.5 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 117.651 0.205 . . . . 0.0 111.189 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.2 t -62.43 -49.34 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 O-C-N 123.635 0.584 . . . . 0.0 109.998 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -56.79 -45.64 82.03 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.833 0.708 . . . . 0.0 111.916 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 45.3 ttp180 -63.93 -32.68 74.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.163 0.585 . . . . 0.0 111.099 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -85.27 -17.27 37.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.504 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 5.2 mmp_? -80.49 -6.85 58.79 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.79 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.67 71.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.3 m 67.19 167.6 0.24 Allowed 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.497 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.13 25.85 4.9 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.78 155.41 17.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.306 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 79.0 m-20 -117.3 87.27 2.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.31 145.18 31.84 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 122.162 -0.336 . . . . 0.0 110.305 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.477 ' HG ' HG22 ' A' ' 21' ' ' THR . 0.7 OUTLIER -124.54 152.82 42.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.659 0.742 . . . . 0.0 112.206 -175.201 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -128.73 146.13 50.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 168.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.312 -1.055 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.938 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.425 -1.703 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.7 m-20 -84.27 67.15 9.69 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.944 0.878 . . . . 0.0 110.004 -175.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 m -134.2 179.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . . . -96.36 133.7 24.52 Favored Pre-proline 0 C--N 1.282 -2.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 36.3 Cg_endo -68.25 -38.68 11.54 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.461 2.108 . . . . 0.0 110.409 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -134.91 161.31 35.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 m -76.06 149.36 37.5 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 123.289 0.368 . . . . 0.0 110.469 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.09 142.36 44.64 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 120.993 0.425 . . . . 0.0 110.713 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -164.84 -168.76 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 C-N-CA 119.977 -1.106 . . . . 0.0 114.041 -173.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.432 HD21 HG11 ' A' ' 92' ' ' VAL . 1.7 mp -113.38 156.06 24.11 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.539 0.736 . . . . 0.0 109.118 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.95 109.35 18.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.906 0.86 . . . . 0.0 109.19 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 6.1 p -94.45 171.54 8.75 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.235 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . . . -51.51 124.77 12.83 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.779 1.232 . . . . 0.0 112.145 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.29 -2.73 57.83 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.28 39.8 25.71 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.3 t -96.5 142.03 14.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.261 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.05 107.99 20.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -107.55 111.84 24.3 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.501 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -92.27 147.57 22.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 94' ' ' PHE . 51.4 mt -115.34 -24.75 8.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.3 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 94' ' ' PHE . 3.3 mp -117.78 117.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 171.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -85.39 149.86 25.14 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 14' ' ' PRO . 10.6 ptt85 -69.83 152.53 44.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.459 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.96 -0.63 2.97 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.4 1.08 . . . . 0.0 112.147 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -89.24 122.58 32.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 2.9 p -65.18 121.16 14.12 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 123.849 0.86 . . . . 0.0 112.93 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 36.3 pt -84.94 164.94 39.72 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 47.0 Cg_exo -60.72 145.7 42.1 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 CA-C-N 120.652 1.269 . . . . 0.0 114.024 1.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 m -142.0 143.76 33.33 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 6.1 ttpm? -147.14 119.56 8.43 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.854 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 29' ' ' LEU . 30.7 mt-30 -121.8 131.81 54.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.087 0.47 . . . . 0.0 111.03 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 35.0 m -115.23 118.3 32.9 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -130.13 155.42 46.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.23 126.41 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.81 146.26 42.99 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.083 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 29.3 p -123.69 171.28 9.7 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 124.916 1.286 . . . . 0.0 107.555 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -113.07 136.85 52.25 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -98.92 -4.2 33.4 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -80.17 106.97 12.58 Favored 'General case' 0 N--CA 1.395 -3.194 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.447 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.75 133.01 44.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.373 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 64.2 29.88 13.78 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.918 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -85.23 120.31 73.24 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 88.2 Cg_endo -82.85 -0.41 10.05 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.558 2.172 . . . . 0.0 110.826 177.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.28 147.85 9.9 Favored Glycine 0 N--CA 1.408 -3.202 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.99 165.24 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 123.955 0.444 . . . . 0.0 110.503 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.9 tp -111.82 115.0 28.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.64 94.78 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -99.64 118.15 35.54 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.752 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.11 134.92 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.813 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -125.63 154.01 42.93 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -114.13 118.72 34.81 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' HA3' ' SD ' ' A' ' 134' ' ' MET . . . 154.52 175.03 25.22 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -140.89 104.26 4.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.69 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -154.74 169.45 23.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.06 -31.91 68.45 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.705 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.0 mtt -111.48 135.7 51.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.199 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.94 -13.23 59.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -64.92 -27.15 68.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -171.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -94.53 14.75 19.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.752 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.523 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 14.2 m120 -107.1 175.25 5.56 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.198 -0.314 . . . . 0.0 110.715 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.89 129.24 36.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 tp -76.27 109.17 9.74 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -82.81 -48.31 10.93 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.017 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.47 164.32 33.99 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -142.39 154.52 44.69 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 117.517 0.659 . . . . 0.0 109.84 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -155.33 158.27 38.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -106.63 147.99 28.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.789 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 tp -124.54 104.87 8.96 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.2 p -116.36 153.43 32.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.25 4.46 18.13 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 75.0 mt -79.87 130.26 67.67 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 123.664 0.786 . . . . 0.0 109.048 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -56.24 117.97 4.7 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.814 2.343 . . . . 0.0 111.403 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.98 111.84 1.85 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.778 2.318 . . . . 0.0 112.412 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.8 160.54 68.09 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.53 -23.16 37.47 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.808 2.339 . . . . 0.0 112.19 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -140.7 166.25 25.27 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.236 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.46 ' HA3' ' HB ' ' A' ' 45' ' ' THR . . . -73.86 80.54 0.81 Allowed Glycine 0 N--CA 1.432 -1.589 0 O-C-N 123.68 0.613 . . . . 0.0 114.276 -176.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.429 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 52.8 t -69.38 -45.24 27.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 32.6 Cg_exo -68.07 121.51 8.52 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.394 1.396 . . . . 0.0 110.278 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -81.98 115.61 21.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -91.76 119.51 39.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.22 104.19 16.77 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' THR . 40.6 t -110.08 117.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.619 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -103.81 116.36 32.15 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.284 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 3.0 m-85 -96.87 107.21 19.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 171.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' OD2' ' HD3' ' A' ' 39' ' ' LYS . 18.2 t70 -120.64 113.09 19.72 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 123.656 0.598 . . . . 0.0 110.566 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.76 118.4 56.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.486 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.5 p30 -85.41 -176.79 6.26 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.6 -20.29 63.17 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -80.62 -23.91 39.45 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.855 -0.528 . . . . 0.0 110.671 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.79 15.71 28.22 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.486 ' HB ' ' OD2' ' A' ' 97' ' ' ASP . 83.2 mt -80.4 119.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 114.61 27.0 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.1 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -107.51 101.44 10.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.9 t -93.72 114.27 30.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.0 m -112.1 110.73 21.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.67 117.55 34.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.3 m -119.8 128.69 53.95 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.625 0.726 . . . . 0.0 111.115 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.56 114.48 16.44 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.569 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.72 -21.4 64.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.6 p -80.19 -62.04 1.8 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.3 p -95.69 -31.36 13.27 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.389 0.614 . . . . 0.0 110.411 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.66 34.79 3.21 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.03 175.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -98.68 151.85 20.28 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 117.016 0.408 . . . . 0.0 110.889 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.95 140.59 24.6 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.845 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.82 139.74 43.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 149.2 43.76 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 tt -120.66 148.61 23.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.0 m -114.53 112.92 23.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.45 98.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.123 0.487 . . . . 0.0 110.877 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -91.73 101.78 14.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.5 t30 . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -176.376 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 134' ' ' MET . 1.4 mp0 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 135' ' ' VAL . 51.7 mt -56.87 -50.91 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.09 -45.42 87.19 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 123.575 0.75 . . . . 0.0 110.794 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -60.03 -47.73 84.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.523 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 70.3 mtm -66.55 -36.29 82.3 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 123.48 0.487 . . . . 0.0 111.573 -175.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 70.3 t -61.26 -54.71 31.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 123.621 0.576 . . . . 0.0 109.568 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.0 mt-30 -63.11 -46.77 85.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.08 -40.09 94.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -60.33 -44.5 95.44 Favored 'General case' 0 C--O 1.198 -1.616 0 O-C-N 123.05 0.219 . . . . 0.0 110.416 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 22.2 mm-40 -58.61 -39.63 80.98 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 94.5 mttt -74.21 -48.49 28.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.734 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.53 21.84 10.66 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.331 0.864 . . . . 0.0 113.331 -172.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 138' ' ' ALA . 29.2 mmtt -44.24 -58.68 2.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.06 45.57 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.716 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -58.26 -55.1 39.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.734 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -38.58 44.14 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.94 -34.16 73.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.128 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.3 -44.05 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.552 ' O ' HG23 ' A' ' 152' ' ' VAL . 67.6 mt-30 -52.75 -50.84 62.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 110.735 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -54.05 -52.66 60.18 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 124.284 0.99 . . . . 0.0 111.341 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.83 -39.15 93.53 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.922 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -63.54 -25.47 68.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 148' ' ' GLN . 22.0 t -88.79 -39.24 12.38 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.6 p -72.14 80.75 0.97 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.518 0.675 . . . . 0.0 111.494 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.42 123.51 44.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 tptm 68.34 10.43 7.85 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 124.016 0.822 . . . . 0.0 110.007 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.47 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.131 1.372 . . . . 0.0 112.66 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -114.39 134.13 55.21 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.335 -175.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 44.7 mt -93.26 152.97 18.85 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.48 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 14.2 tt0 -97.6 173.36 7.18 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 C--N 1.292 -1.895 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.597 -176.038 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 tp . . . . . 0 N--CA 1.435 -1.221 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 73.17 29.5 1.71 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.121 0.968 . . . . 0.0 111.39 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 17.5 m -126.87 168.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.86 119.05 72.25 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.77 -25.96 16.45 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.245 1.963 . . . . 0.0 112.685 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.1 mp -135.18 172.19 13.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -101.75 129.8 48.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.445 HD13 HD22 ' A' ' 102' ' ' LEU . 62.2 mt -116.79 131.87 56.84 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.39 -176.57 21.94 Favored Glycine 0 N--CA 1.429 -1.816 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.64 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.89 150.53 30.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.27 108.38 17.1 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.644 HG22 HD23 ' A' ' 158' ' ' LEU . 34.6 p -107.29 -177.03 3.24 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.645 -172.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.12 119.13 5.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.88 0.872 . . . . 0.0 113.178 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.45 -8.57 22.38 Favored Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.869 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.64 57.27 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 39.4 t -110.65 149.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.1 ttt -92.72 137.81 32.04 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 122.987 0.515 . . . . 0.0 111.052 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -118.84 111.71 18.77 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.3 126.73 45.21 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.658 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -96.54 -33.79 11.69 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.29 125.57 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -120.48 146.02 46.68 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -56.07 151.48 12.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 75.07 14.37 3.13 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.14 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -103.55 133.03 49.27 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 1.6 m -68.31 144.86 54.66 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 123.814 0.846 . . . . 0.0 111.715 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.89 155.4 43.31 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_endo -62.44 152.37 65.26 Favored 'Cis proline' 0 C--N 1.356 0.964 0 CA-C-N 119.922 1.008 . . . . 0.0 113.629 -1.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -107.09 -80.45 0.56 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.014 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 43.5 tttp 65.41 99.43 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 127.424 2.29 . . . . 0.0 111.055 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -121.71 132.06 54.43 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.082 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -118.7 123.81 45.81 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.247 0.342 . . . . 0.0 110.478 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -130.61 146.23 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -93.34 133.93 32.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.92 132.4 50.88 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.8 153.09 36.25 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.7 p -81.7 135.52 35.5 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.353 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 23.1 m-85 -114.19 3.96 15.37 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 24.5 p -97.0 -179.13 4.44 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.076 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -143.18 166.36 24.91 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.263 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 60.19 19.81 9.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 48' ' ' SER . 56.0 mt-30 -101.34 113.56 65.81 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.124 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.2 Cg_endo -85.83 -2.79 8.99 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.028 2.485 . . . . 0.0 111.672 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.16 149.04 16.21 Favored Glycine 0 N--CA 1.401 -3.689 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 m -112.64 149.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.34 101.5 11.42 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 63.1 mt -90.48 117.73 34.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -129.59 119.62 23.93 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.154 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 104' ' ' VAL . 36.6 t -92.48 117.61 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.704 -178.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 59.4 m-85 -120.08 144.33 47.65 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.277 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -111.73 154.34 25.15 Favored 'General case' 0 C--O 1.272 2.244 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.219 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.08 118.34 3.5 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -78.08 95.05 4.79 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.632 0.716 . . . . 0.0 110.91 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 63' ' ' ARG . 43.3 mtp85 -136.74 157.03 47.71 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.845 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -91.04 -51.27 5.42 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.7 93.74 9.04 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.6 m -84.61 108.1 17.18 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.905 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -163.49 144.19 9.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 68.19 16.23 9.38 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.476 1.11 . . . . 0.0 111.702 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.18 173.03 10.7 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 85.0 m-20 -90.7 127.45 36.31 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.95 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.7 118.49 29.35 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.713 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.08 -53.98 3.91 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.08 156.01 26.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 10.0 ptm180 -151.19 139.14 19.97 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 123.713 0.805 . . . . 0.0 109.531 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.73 145.66 31.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.806 0.336 . . . . 0.0 111.226 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.64 110.45 22.56 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.4 tp -94.71 104.61 16.53 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 p -96.0 152.27 18.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.35 -35.27 2.09 Favored Glycine 0 CA--C 1.479 -2.188 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.1 mp -51.88 120.16 15.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 O-C-N 125.042 1.084 . . . . 0.0 110.494 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.52 146.72 10.91 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.143 1.895 . . . . 0.0 111.317 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.75 118.17 5.01 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.9 1.734 . . . . 0.0 108.246 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.7 156.75 79.74 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.757 -171.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.34 43.4 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.224 2.616 . . . . 0.0 111.823 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HG3' ' HA ' ' A' ' 47' ' ' TYR . 7.9 mpt_? 68.97 148.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.253 1.421 . . . . 0.0 113.109 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.56 -27.86 2.13 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.436 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 48.6 t -58.45 -51.99 77.87 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 7.7 Cg_exo -77.12 106.89 2.32 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 121.597 1.531 . . . . 0.0 110.446 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -101.91 103.53 14.2 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mm -91.82 120.51 41.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.519 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . 40.4 tt0 -94.87 112.31 24.04 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.16 128.23 62.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.467 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 m -122.9 120.6 33.93 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.867 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -99.57 107.79 20.03 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.48 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 1.5 p-10 -125.61 112.64 16.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.7 mt -99.9 123.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.2 p-10 -86.55 -175.35 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 123.722 0.639 . . . . 0.0 109.373 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.36 -13.12 61.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.402 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 64.3 t30 -81.54 -28.66 33.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 112.18 12.79 13.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 92.9 mt -82.13 116.1 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-O 120.996 0.427 . . . . 0.0 110.347 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.445 HD22 HD13 ' A' ' 17' ' ' LEU . 22.1 tp -88.52 108.9 19.64 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 116' ' ' LYS . 1.2 t30 -102.91 110.49 22.43 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.757 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 58' ' ' VAL . 45.4 t -88.71 114.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 116' ' ' LYS . 7.2 m -110.76 124.29 51.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.622 -175.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -132.74 119.37 20.24 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.663 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 m -120.24 127.59 52.55 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.21 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.97 111.04 21.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.082 0.553 . . . . 0.0 111.841 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 91' ' ' GLU . 96.9 mttt -69.01 -11.2 60.57 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.0 p -86.04 -47.98 9.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 118.964 -1.095 . . . . 0.0 112.908 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.0 p -96.88 -33.79 11.5 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.875 -0.515 . . . . 0.0 111.819 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.08 23.67 10.39 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.924 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.37 157.8 16.16 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 122.779 -0.248 . . . . 0.0 110.339 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.77 143.71 22.97 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.113 0.482 . . . . 0.0 111.503 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -129.45 140.69 51.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.529 ' HG2' HG23 ' A' ' 105' ' ' THR . 83.6 mttt -136.21 132.76 36.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.42 125.33 72.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.208 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 79.2 m -88.12 112.4 22.65 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.003 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 71.4 mt -101.61 94.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.338 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.5 m -74.51 158.86 33.05 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 124.782 1.233 . . . . 0.0 107.97 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.069 0.461 . . . . 0.0 112.001 -179.242 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.96 -51.11 76.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.902 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.6 -27.04 64.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.078 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 21.3 ttm180 -63.79 -39.46 94.31 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -68.68 -29.94 68.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.995 0.426 . . . . 0.0 110.602 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.89 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -63.82 -36.17 83.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.741 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 7.6 mm-40 -61.07 -45.44 94.74 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.9 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.203 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.67 -37.51 76.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.942 0.401 . . . . 0.0 110.513 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.66 -42.64 67.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.634 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.537 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . 88.7 m-85 -97.84 15.65 23.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.525 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 7.0 tmtt? -48.09 -66.44 0.4 Allowed 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 124.046 0.938 . . . . 0.0 112.729 -173.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.7 87.3 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 10.0 tp10 -64.75 -54.9 24.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.2 m-20 -77.75 -28.81 50.79 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 66.5 mm-40 -61.75 -42.65 99.25 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.418 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 60.3 t -72.0 -48.52 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.822 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.5 mm-40 -54.09 -41.6 68.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -64.58 -39.86 94.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.338 0.59 . . . . 0.0 109.993 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.24 0.8 57.04 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 27.4 mmm180 -68.45 -36.42 78.98 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 172.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.407 HG12 ' HG2' ' A' ' 155' ' ' LYS . 21.6 t -93.83 83.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 m -78.25 142.51 37.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.963 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 45.72 63.37 1.83 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.376 1.47 . . . . 0.0 113.219 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 2.2 pptp? -106.22 77.25 1.21 Allowed 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 123.011 1.386 . . . . 0.0 110.213 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.09 61.94 6.78 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.296 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . . . -146.39 139.16 25.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.862 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.644 HD23 HG22 ' A' ' 21' ' ' THR . 14.0 mt -103.32 151.34 22.84 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.77 144.24 44.71 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.89 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.291 -1.975 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.419 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.246 0.899 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.3 61.7 1.12 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.5 -177.42 2.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.621 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.01 118.87 72.45 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.05 -50.53 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.278 1.985 . . . . 0.0 111.978 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.441 HD11 HG22 ' A' ' 135' ' ' VAL . 6.3 mp -114.61 172.25 7.14 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.488 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 15.2 m -92.5 151.04 20.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.124 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.03 132.0 54.58 Favored 'General case' 0 C--O 1.261 1.669 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.923 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.11 158.1 27.57 Favored Glycine 0 N--CA 1.426 -1.982 0 O-C-N 123.91 0.756 . . . . 0.0 112.656 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.9 151.39 22.16 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -86.12 108.45 18.31 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 171.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 18.0 p -107.87 -69.61 0.84 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.286 0.565 . . . . 0.0 111.348 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.26 165.55 11.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.55 -21.05 4.3 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 116.949 1.539 . . . . 0.0 116.949 -171.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.52 33.37 2.15 Favored Glycine 0 CA--C 1.493 -1.341 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.986 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.37 121.5 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.449 0.643 . . . . 0.0 112.12 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.518 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 23.4 ttt -106.31 97.79 7.55 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.9 m -80.35 110.74 16.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.07 119.9 30.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.789 0.328 . . . . 0.0 111.047 -176.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 63.1 mt -104.93 -39.54 6.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.623 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.1 130.4 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.19 162.3 14.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 15' ' ' LEU . 63.6 mtt180 -56.69 140.11 48.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 123.714 0.634 . . . . 0.0 109.515 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 75.26 10.74 3.57 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.231 1.012 . . . . 0.0 112.786 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -81.91 114.73 20.71 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -60.38 131.75 51.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.398 1.079 . . . . 0.0 113.781 -176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 36.4 pt -95.4 160.83 29.73 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 24.7 Cg_exo -65.66 126.26 6.39 Favored 'Cis proline' 0 C--N 1.358 1.043 0 CA-C-N 120.291 1.14 . . . . 0.0 113.431 0.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.6 p -95.55 149.13 21.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.443 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 37.7 tttp -154.02 99.5 2.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' THR . 5.5 tp-100 -107.15 140.12 40.5 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 81.5 m -139.83 116.41 10.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HG3' HD22 ' A' ' 29' ' ' LEU . 86.5 mm-40 -128.61 144.17 51.1 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.22 118.83 41.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 123.669 0.606 . . . . 0.0 109.535 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.05 169.19 8.64 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.915 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 33.1 p -134.24 171.63 13.98 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.469 ' HB ' ' OG ' ' A' ' 48' ' ' SER . 27.7 p -99.86 139.62 35.25 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.484 176.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 27.6 m-85 -85.03 -11.72 54.75 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 46' ' ' THR . 29.5 p -83.75 142.27 30.82 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.905 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.0 124.01 51.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 66.32 61.43 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.693 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.517 ' H ' ' NE2' ' A' ' 51' ' ' GLN . 0.5 OUTLIER -101.3 123.11 45.87 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -85.41 -15.96 5.02 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.821 1.681 . . . . 0.0 111.132 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.59 164.64 36.92 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.43 179.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.1 tp -132.37 132.37 42.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.55 123.26 71.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 120.851 0.358 . . . . 0.0 111.52 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -114.82 129.76 56.75 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.4 123.49 64.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.58 142.97 43.2 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.248 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -111.52 121.23 44.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.57 125.33 5.6 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -172.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 3.8 mp0 -79.0 139.03 38.28 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 36.2 mmt180 -139.45 156.86 46.69 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 114.192 -1.367 . . . . 0.0 107.542 172.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.599 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -78.22 -49.87 12.96 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 92.7 mmm -105.55 122.05 45.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.13 102.08 0.1 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -174.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 56.3 pttt 179.41 -177.44 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.174 1.389 . . . . 0.0 107.549 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.98 -45.46 0.6 Allowed 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.44 1.496 . . . . 0.0 114.921 172.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.582 ' ND2' ' HG2' ' A' ' 63' ' ' ARG 0.259 85.8 m-20 -86.17 -166.19 1.47 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -88.69 112.63 23.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.994 0.902 . . . . 0.0 111.724 -167.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.7 108.24 13.1 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.204 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.57 -55.19 6.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.96 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.89 159.07 27.99 Favored Glycine 0 N--CA 1.413 -2.887 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.966 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.29 135.22 21.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.76 168.3 24.81 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.58 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.75 144.21 25.62 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.6 tp -131.07 103.66 6.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -132.96 165.87 23.69 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 120.573 0.225 . . . . 0.0 111.04 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.07 4.95 56.47 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.78 134.39 86.02 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 37.5 Cg_exo -59.99 133.87 53.05 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.975 1.784 . . . . 0.0 109.796 177.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 22.5 Cg_exo -67.5 63.64 0.8 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.103 2.535 . . . . 0.0 111.974 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.24 153.51 39.01 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.602 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -61.36 177.9 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.459 2.773 . . . . 0.0 114.914 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.61 131.39 50.08 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.469 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 75.4 20.77 78.49 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.69 176.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.0 -49.69 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.47 116.13 4.58 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.535 1.49 . . . . 0.0 111.343 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -87.42 112.1 21.81 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.7 mm -98.82 115.94 40.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.73 112.76 24.66 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 41' ' ' THR . 96.0 t -106.07 124.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 32.5 m -124.45 128.32 48.83 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.855 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 34.7 m-85 -112.63 136.62 51.98 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 8.0 t70 -142.31 127.11 18.15 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.1 mt -124.15 126.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -89.13 -170.65 2.96 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.279 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.33 63.42 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.452 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 9.1 t30 -84.61 -29.77 25.5 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.274 0.559 . . . . 0.0 110.242 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.3 28.48 4.62 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 77.4 mt -86.89 116.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 49.0 tp -96.12 120.1 35.8 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 3.1 t-20 -105.08 105.21 15.15 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 38.8 t -92.12 120.48 41.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 174.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -126.99 122.87 35.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.69 117.17 29.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.1 m -115.75 127.73 55.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.145 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -83.04 107.38 15.59 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.23 -12.27 60.71 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 m -70.98 -54.56 10.82 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 35.7 p -86.59 -48.82 8.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.438 0.637 . . . . 0.0 111.14 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.05 5.5 28.76 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.475 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 14.2 ptmm? -92.31 152.5 19.75 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.49 162.68 38.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.337 0.589 . . . . 0.0 112.281 -174.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -129.42 128.06 42.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.09 173.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 19.6 ptpt -132.97 149.53 52.23 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.452 -178.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.4 pt -129.81 151.04 35.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.2 m -117.47 113.11 21.56 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.25 103.13 14.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -84.93 109.4 18.12 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.4 t30 . . . . . 0 C--O 1.246 0.919 0 C-N-CA 124.884 1.274 . . . . 0.0 111.413 -178.468 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 134' ' ' MET . 14.7 mm-40 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.498 0.19 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 135' ' ' VAL . 82.5 mt -60.14 -42.98 91.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 67.4 mt-10 -63.25 -32.38 73.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.702 0.287 . . . . 0.0 110.923 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 44.7 mtp180 -64.03 -43.78 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.036 174.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 52.7 mtt -65.08 -35.27 80.63 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.006 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 131' ' ' ILE . 86.1 t -55.54 -52.13 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 69.8 mm-40 -65.18 -52.26 55.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.755 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.67 -51.05 71.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -67.78 -30.73 70.24 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.425 ' HA ' ' HG2' ' A' ' 142' ' ' LYS . 39.3 mt-10 -77.6 -34.96 53.32 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.548 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.96 -43.7 74.45 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.7 20.72 7.17 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.468 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 24.4 mmtt -53.3 -58.09 8.27 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -56.56 -44.81 81.33 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.443 0.464 . . . . 0.0 111.327 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.67 -48.58 71.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.794 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.43 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.2 m-20 -72.61 -36.88 68.18 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 56.4 mm-40 -60.43 -42.5 96.18 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.838 0.29 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.676 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.0 t -67.24 -49.72 69.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.409 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -63.75 -43.95 94.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.599 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 40.0 ttp180 -62.84 -48.57 78.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.419 0.628 . . . . 0.0 110.319 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 153' ' ' SER . 7.1 mm-40 -79.3 -0.28 31.75 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.476 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 21.5 mmt180 -84.23 -35.46 23.43 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 -38.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 26.3 t -66.84 103.23 1.08 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -102.79 -27.48 12.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.215 0.531 . . . . 0.0 110.961 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -161.36 154.56 21.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -74.85 86.54 2.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.384 0.611 . . . . 0.0 109.405 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.57 149.02 35.11 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.275 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 mp -109.15 149.23 29.65 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.56 156.72 19.2 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 121.241 0.544 . . . . 0.0 111.824 -177.493 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.237 0.416 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -37.46 82.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 171.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -95.7 128.4 42.54 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.324 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.6 t -138.41 103.43 2.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -143.91 151.57 39.99 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 120.996 0.427 . . . . 0.0 110.336 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -152.17 -75.37 0.14 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.4 tp 179.33 160.59 0.74 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 60.53 -164.45 0.23 Allowed 'General case' 0 C--O 1.259 1.56 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp 76.16 -54.07 0.61 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.597 1.159 . . . . 0.0 110.87 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.51 67.95 10.12 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -118.85 41.06 3.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 19.5 m -124.35 177.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.292 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.86 120.84 80.04 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.41 -24.38 10.72 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.219 1.946 . . . . 0.0 112.13 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.02 160.87 21.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.031 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -93.63 112.94 24.92 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -92.16 131.56 37.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.85 179.06 22.26 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.822 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.37 159.92 31.86 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -83.97 117.2 23.22 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 170.352 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 p -110.82 -97.8 0.41 Allowed 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.16 163.61 19.67 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.38 92.55 0.08 OUTLIER Glycine 0 CA--C 1.499 -0.962 0 O-C-N 123.76 0.662 . . . . 0.0 112.968 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' A' ' 65' ' ' MET . . . 104.69 19.17 11.39 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 124.512 0.772 . . . . 0.0 111.735 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -129.36 115.33 34.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 117.016 0.408 . . . . 0.0 110.73 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.33 115.65 27.71 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -100.27 112.64 24.98 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.34 101.67 13.91 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 5.6 mp -73.32 -49.28 28.35 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.33 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -108.42 105.28 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.02 153.54 21.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.099 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.689 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -57.05 159.33 4.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.047 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 72.56 6.12 5.38 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 124.855 1.262 . . . . 0.0 111.948 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.4 m -91.8 125.73 36.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 10.0 t -68.35 134.71 50.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.517 0.675 . . . . 0.0 112.256 -177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.43 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 33.1 pt -94.98 154.54 39.65 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.639 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.2 Cg_exo -63.26 133.73 14.9 Favored 'Cis proline' 0 N--CA 1.478 0.566 0 CA-C-N 119.873 0.991 . . . . 0.0 114.012 0.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -110.01 162.18 14.79 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.257 1.023 . . . . 0.0 109.266 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 15.4 ptpt -166.57 148.19 6.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.542 0.527 . . . . 0.0 110.807 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 29' ' ' LEU . 22.6 mm-40 -147.75 118.78 7.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 125.821 1.648 . . . . 0.0 107.544 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 84.9 m -111.67 116.33 30.59 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -128.97 141.11 51.36 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.13 124.67 48.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 97.0 m-85 -111.74 160.12 17.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.75 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 21.3 p -129.89 171.96 12.19 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -113.51 138.49 50.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 119.623 1.101 . . . . 0.0 110.534 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -82.52 -39.22 22.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 p -63.88 98.17 0.19 Allowed 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.759 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.47 160.68 27.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.354 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 m120 62.82 22.42 13.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -94.46 114.11 62.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 3.3 Cg_exo -79.64 -8.04 14.71 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.82 126.75 2.43 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.45 160.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.451 HD13 ' HG2' ' A' ' 76' ' ' GLU . 53.3 tp -111.86 117.85 33.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.74 118.39 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' ' 20' ' ' GLU . 16.6 pt20 -132.85 129.85 39.0 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.331 -176.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.38 127.53 50.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -124.21 153.46 41.58 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.566 0.746 . . . . 0.0 110.107 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 37.1 mt-10 -117.09 137.12 52.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.36 -155.45 16.09 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.486 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 22.3 mt-10 -152.29 130.63 12.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.058 0.543 . . . . 0.0 110.575 174.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 27.3 mmt180 -147.67 163.91 35.17 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 170.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.54 62.85 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.644 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 58.7 mtt -109.68 135.04 51.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.102 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -65.25 98.74 0.34 Allowed 'General case' 0 N--CA 1.416 -2.126 0 O-C-N 124.076 0.86 . . . . 0.0 112.573 -175.385 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 19.3 pttp -176.82 169.81 2.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 66.75 11.26 8.12 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 123.621 0.768 . . . . 0.0 111.874 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 96.3 m-20 -118.63 179.96 3.98 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.416 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -90.49 151.88 21.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -118.52 121.18 39.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.7 mt -84.65 -48.13 9.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.707 0.289 . . . . 0.0 111.596 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.74 170.89 42.39 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -143.48 162.92 34.57 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -155.06 142.64 19.72 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HG2' HD13 ' A' ' 55' ' ' LEU . 43.5 mt-10 -102.68 117.87 35.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.038 0.447 . . . . 0.0 110.299 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.3 tp -92.77 112.65 24.69 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.889 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -107.95 155.36 20.4 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.32 -15.31 6.11 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.948 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.4 mp -60.5 125.41 82.17 Favored Pre-proline 0 C--O 1.247 0.939 0 C-N-CA 122.88 0.472 . . . . 0.0 110.136 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 80' ' ' ILE . 23.5 Cg_exo -65.54 126.8 16.79 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.95 1.767 . . . . 0.0 109.839 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.95 90.45 0.11 Allowed 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.594 2.196 . . . . 0.0 111.167 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.56 167.37 15.18 Favored Pre-proline 0 N--CA 1.42 -1.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.367 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.45 -179.0 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.508 2.805 . . . . 0.0 114.646 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -72.48 129.14 37.65 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.662 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 85.71 4.02 85.55 Favored Glycine 0 C--N 1.309 -0.949 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.714 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.7 t -90.55 -49.39 0.36 Allowed Pre-proline 0 CA--C 1.557 1.232 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' THR . 31.8 Cg_exo -63.31 119.93 7.19 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.328 1.352 . . . . 0.0 111.27 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.38 106.61 17.79 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.296 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.36 116.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.527 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 39.2 tt0 -90.64 117.48 29.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 41' ' ' THR . 74.1 t -110.41 113.11 43.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.4 m -99.48 111.67 23.99 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -116.67 107.86 15.2 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -174.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 39' ' ' LYS . 3.9 p30 -141.02 149.63 41.97 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.061 0.458 . . . . 0.0 111.192 -175.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.8 mt -116.62 140.17 40.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -90.63 -167.25 1.78 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -18.25 59.55 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -82.73 -29.12 30.0 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.49 0.662 . . . . 0.0 109.301 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.16 31.96 3.4 Favored Glycine 0 N--CA 1.416 -2.674 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.9 mt -99.96 121.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.283 0.563 . . . . 0.0 109.751 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 tp -89.07 121.45 31.42 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.493 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -113.41 123.08 49.23 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.02 114.29 45.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -111.49 122.73 48.6 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.297 0.373 . . . . 0.0 110.009 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.65 117.73 34.82 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -118.6 114.56 22.97 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.813 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.72 112.19 13.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.527 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 62.5 mttm -67.08 -24.57 65.97 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.669 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -65.52 -54.65 25.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -91.52 -44.61 8.98 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.53 7.08 26.5 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -85.91 137.57 32.65 Favored 'General case' 0 N--CA 1.403 -2.79 0 CA-C-O 121.061 0.457 . . . . 0.0 110.401 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.32 140.81 47.64 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.01 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -135.73 131.79 36.04 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.61 166.16 16.59 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.05 145.05 33.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.8 m -117.45 113.08 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.6 mt -126.84 119.72 53.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 O-C-N 122.324 -0.235 . . . . 0.0 110.864 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.1 t -79.51 132.55 36.35 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.71 9.01 38.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.161 0.505 . . . . 0.0 110.331 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.41 -37.84 77.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.917 0.865 . . . . 0.0 108.875 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.77 154.6 21.82 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.63 -172.94 22.96 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 118.932 -1.604 . . . . 0.0 113.065 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -91.94 178.09 5.99 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 57.78 -160.43 0.25 Allowed 'General case' 0 C--O 1.255 1.374 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.4 p -95.03 -58.9 2.03 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.6 tttp 167.74 -36.45 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.952 1.301 . . . . 0.0 107.974 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -58.69 -38.69 78.79 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.671 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.96 -35.52 72.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.313 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 135' ' ' VAL . 60.3 mt -67.89 -41.95 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.458 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -60.14 -42.33 94.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.819 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -60.42 -43.24 96.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.7 ttm -58.62 -44.91 90.11 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.923 0.889 . . . . 0.0 110.613 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.448 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 59.4 t -63.14 -47.1 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -58.94 -43.23 91.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.73 -35.94 82.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.0 110.501 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -67.95 -30.22 69.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.511 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 7.6 mm-40 -78.79 -44.6 22.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.413 1.101 . . . . 0.0 109.082 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.63 -48.08 83.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.533 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.96 19.01 20.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.85 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 18.8 ttmm -54.32 -47.44 72.47 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.563 0.539 . . . . 0.0 112.139 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.18 70.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.168 0.509 . . . . 0.0 111.589 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.51 -46.84 68.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.447 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.86 -36.97 83.53 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.435 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 45.5 mm-40 -58.1 -50.17 74.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.677 0.217 . . . . 0.0 111.253 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.23 -47.03 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.273 0.358 . . . . 0.0 110.357 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -57.22 -46.23 83.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.73 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -66.06 -47.89 72.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.071 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -75.35 -7.78 54.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.254 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.0 mtp85 -73.99 -20.3 60.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.926 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.61 82.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.0 p -132.66 138.66 47.39 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.234 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -168.61 -54.5 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -169.37 150.1 4.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 56.6 m-80 -64.57 117.42 7.36 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.302 0.572 . . . . 0.0 110.29 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.02 161.59 38.38 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.648 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.7 mt -120.36 137.11 54.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -112.54 129.93 56.19 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m -97.68 145.47 26.29 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 62.22 34.35 16.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.417 0.687 . . . . 0.0 110.695 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.03 26.79 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.595 1.158 . . . . 0.0 113.05 -174.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -146.03 109.89 4.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -96.05 86.74 4.37 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.087 0.47 . . . . 0.0 110.499 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.1 tpt -78.77 -34.0 45.95 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.82 110.61 6.46 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.2 m -75.85 155.2 35.55 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.327 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.19 -65.14 0.76 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.3 m -131.27 140.69 47.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -162.92 40.96 0.11 Allowed 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 122.09 0.947 . . . . 0.0 109.951 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -164.36 85.52 0.44 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -120.66 7.68 10.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.37 160.45 36.07 Favored Glycine 0 C--O 1.249 1.063 0 CA-C-N 115.188 -0.915 . . . . 0.0 113.761 -176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.418 HD22 ' HB ' ' A' ' 178' ' ' ILE . 59.5 mt -81.46 116.78 21.42 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -143.37 -86.53 0.14 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -170.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -93.6 -43.34 3.96 Favored Glycine 0 CA--C 1.482 -2.015 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -77.34 111.41 12.97 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.418 ' HB ' HD22 ' A' ' 174' ' ' LEU . 47.5 mm 61.52 87.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 122.207 1.003 . . . . 0.0 108.807 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 40.3 m -84.76 0.29 51.17 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.958 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -101.57 96.18 6.95 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 122.098 0.951 . . . . 0.0 110.1 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 174' ' ' LEU . . . -112.12 -50.46 2.91 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.825 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 183' ' ' LYS . 34.7 t70 62.99 -73.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.376 1.47 . . . . 0.0 109.467 -173.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 182' ' ' ASP . 22.4 pttm -167.98 113.86 0.69 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.598 1.159 . . . . 0.0 109.097 174.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -114.94 -4.77 12.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.091 0.948 . . . . 0.0 109.388 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -120.82 118.11 29.13 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.0 p -109.49 -27.99 2.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 190' ' ' SMC . 3.1 pp -119.21 162.47 18.63 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.27 -51.15 0.22 Allowed 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 125.197 1.399 . . . . 0.0 107.624 173.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -88.61 29.07 1.04 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.489 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SMC . . . . . 0.479 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 80.35 -50.87 0.34 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.989 1.316 . . . . 0.0 110.987 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -94.06 131.04 39.96 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 12.4 p -58.59 142.37 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 123.87 0.731 . . . . 0.0 111.823 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 45.8 mm -88.67 133.2 31.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.6 p -109.12 147.37 32.56 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -96.48 134.18 39.99 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.77 142.23 37.16 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.72 112.58 13.44 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.069 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -82.06 117.17 22.04 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.162 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -90.86 88.59 7.11 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.354 0.597 . . . . 0.0 109.65 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.9 m -88.56 87.32 7.23 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.625 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.7 mt -142.68 137.07 29.64 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -108.08 165.8 11.2 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -91.83 175.88 6.72 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.671 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -146.7 132.58 19.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.94 166.3 10.53 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -144.63 142.41 30.1 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 125.711 1.604 . . . . 0.0 108.707 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -134.23 161.6 34.49 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.26 140.76 17.83 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -160.93 97.29 1.15 Allowed 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.582 ' O ' ' HG3' ' A' ' 212' ' ' ARG . 4.5 ttmp? -149.96 98.85 2.77 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.002 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 211' ' ' LYS . 83.7 mtt180 179.65 139.71 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.707 2.003 . . . . 0.0 109.322 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -132.25 158.93 40.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 120.668 0.27 . . . . 0.0 111.011 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -117.48 -32.53 4.88 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.332 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.11 102.99 8.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -84.91 -41.31 16.06 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.096 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -120.91 153.2 37.53 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.39 95.36 3.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.641 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -115.25 100.92 54.22 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.96 126.66 15.58 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 122.566 2.177 . . . . 0.0 111.659 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 31.5 pt -109.85 147.5 14.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 8.4 tp -73.47 123.99 29.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.406 0.622 . . . . 0.0 110.743 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 40.5 p -141.47 91.87 2.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.618 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.35 142.06 7.3 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.03 171.52 8.9 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.31 172.5 18.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -140.43 127.75 21.2 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.03 122.98 6.63 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -96.65 148.22 23.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.656 0.265 . . . . 0.0 110.632 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -135.55 161.98 24.82 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -144.9 176.08 24.17 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -96.3 -173.16 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.963 2.442 . . . . 0.0 112.374 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 235' ' ' PRO . . . -145.44 141.38 9.77 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 176.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 234' ' ' GLY . 6.0 Cg_exo -75.14 101.54 1.48 Allowed 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.526 2.151 . . . . 0.0 112.246 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -99.92 71.66 0.48 Allowed Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.797 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -116.51 92.38 0.57 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -134.42 141.51 46.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -176.33 122.4 0.85 Allowed Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -98.09 113.64 25.59 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.089 0.445 . . . . 0.0 110.684 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -82.7 150.9 26.47 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.826 0.345 . . . . 0.0 110.743 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -153.9 79.22 0.19 Allowed Glycine 0 C--N 1.301 -1.371 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.17 128.76 14.22 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.924 2.416 . . . . 0.0 111.519 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -151.51 158.81 44.09 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 132.74 79.76 0.16 Allowed Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 121.94 41.25 0.49 Allowed Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.387 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 33.7 t -151.46 144.85 24.8 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 153.26 -153.91 25.16 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 20.2 m -81.19 107.89 14.37 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -119.79 96.2 0.62 Allowed Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.911 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.74 -170.27 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.606 2.204 . . . . 0.0 109.909 174.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.6 p -86.03 17.4 3.56 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp 74.87 -66.07 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.705 1.202 . . . . 0.0 111.323 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -94.48 134.92 36.49 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.835 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.542 ' HG2' HG23 ' A' ' 256' ' ' VAL . 42.5 tt0 -65.04 149.16 50.35 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -171.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.542 HG23 ' HG2' ' A' ' 255' ' ' GLU . 25.5 t 67.54 -83.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 126.429 1.891 . . . . 0.0 112.38 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 CA--C 1.486 -1.488 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.25 -176.599 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 70.46 -80.47 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.846 1.658 . . . . 0.0 110.235 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 46.79 28.2 0.79 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.452 1.901 . . . . 0.0 115.581 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.5 m -81.21 76.4 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.429 1.109 . . . . 0.0 111.221 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -144.23 105.51 4.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.111 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -129.88 120.92 25.69 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.3 mp 69.89 -165.39 0.17 Allowed 'General case' 0 C--O 1.244 0.79 0 O-C-N 124.25 0.969 . . . . 0.0 109.528 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 tt 65.08 71.31 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -175.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.476 ' HG ' ' H ' ' A' ' 11' ' ' ASP . 54.9 tp -76.33 -68.86 0.55 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.901 -176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 10' ' ' LEU 0.261 4.0 mm? 63.8 11.21 5.73 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.476 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 2.3 m-20 -94.52 64.42 3.06 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 m -139.52 174.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.998 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.51 120.79 72.24 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.11 -43.33 30.23 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 122.486 2.124 . . . . 0.0 113.116 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.438 ' C ' ' HB3' ' A' ' 32' ' ' ARG . 10.0 mp -123.31 174.18 7.48 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 m -88.3 127.86 35.48 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.4 130.91 37.95 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.2 -170.74 19.76 Favored Glycine 0 N--CA 1.408 -3.169 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.452 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.4 mt -129.27 162.93 26.78 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.169 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.54 144.45 28.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 HD23 ' A' ' 158' ' ' LEU . 12.9 p -126.35 -94.29 0.47 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 122.946 0.498 . . . . 0.0 111.575 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.41 106.11 14.53 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.11 -60.64 4.78 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.752 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.91 56.43 0.1 Allowed Glycine 0 C--N 1.291 -1.928 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG13 ' HG2' ' A' ' 149' ' ' ARG . 89.9 t -122.11 115.33 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -175.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.62 114.02 22.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -106.72 111.39 23.9 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.78 132.04 36.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.031 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -49.8 3.47 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.32 102.68 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 152.99 37.23 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.571 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.563 HH12 ' HA ' ' A' ' 135' ' ' VAL . 36.9 ptt180 -62.58 160.7 13.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 73.82 5.13 4.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.772 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 9.9 t -65.84 135.2 54.53 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.779 0.799 . . . . 0.0 111.548 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 pt -98.89 155.42 36.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.548 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.06 144.59 75.54 Favored 'Cis proline' 0 C--O 1.25 1.089 0 N-CA-C 115.265 1.217 . . . . 0.0 115.265 4.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 p -122.16 161.3 23.4 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.282 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 4.8 ttmp? -166.08 100.6 0.64 Allowed 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 93' ' ' THR . 54.3 mt-30 -119.0 131.09 55.98 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.102 -175.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.7 m -114.44 122.44 46.63 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.53 0.732 . . . . 0.0 110.771 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -129.46 148.7 51.4 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mm -96.23 121.7 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.206 0.527 . . . . 0.0 110.397 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 79.6 m-85 -109.26 143.66 38.43 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.625 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 16.9 p -119.78 171.17 8.59 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -113.89 141.7 47.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 29.9 m-85 -88.18 -41.09 13.22 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 p -73.87 130.43 39.89 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.557 175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -106.46 166.82 10.27 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.072 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 67.88 23.81 8.27 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.312 0.645 . . . . 0.0 112.091 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.601 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 15.0 mm-40 -81.86 132.77 53.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.07 -39.63 30.79 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.554 1.502 . . . . 0.0 110.674 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.35 166.72 33.79 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG13 HG13 ' A' ' 80' ' ' ILE . 16.1 m -106.48 135.07 46.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.09 0.471 . . . . 0.0 110.947 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.46 107.26 16.62 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.681 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -96.18 114.7 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -122.56 110.79 16.01 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.562 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.83 127.01 44.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 123.594 0.559 . . . . 0.0 111.371 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 53.0 m-85 -133.62 155.26 49.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 40.1 mt-10 -110.76 143.27 41.55 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 165.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.38 112.49 0.62 Allowed Glycine 0 C--N 1.263 -3.486 0 C-N-CA 118.285 -1.912 . . . . 0.0 111.105 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.48 86.46 5.16 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -145.18 146.02 31.58 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -66.25 -50.15 64.75 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.402 1.096 . . . . 0.0 109.846 172.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.2 mtt -112.22 130.3 55.97 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.18 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 101.79 1.03 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 123.912 0.757 . . . . 0.0 109.69 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -76.28 -52.7 9.45 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 122.01 0.91 . . . . 0.0 108.684 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -153.5 -54.0 0.11 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.36 -176.77 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.27 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 65.9 t30 -95.38 112.74 24.4 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.075 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.9 114.08 17.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.27 -34.41 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.669 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.67 176.16 39.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.23 170.4 20.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 117.032 0.416 . . . . 0.0 110.026 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -164.22 155.43 15.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -114.68 118.94 35.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.213 0.53 . . . . 0.0 110.133 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -95.49 108.03 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.3 p -97.03 150.18 21.08 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.81 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 24.01 1.78 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.812 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 50.6 mm -82.51 125.19 76.77 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.84 163.27 35.92 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.544 2.163 . . . . 0.0 112.348 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.35 40.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.217 2.611 . . . . 0.0 111.208 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 87' ' ' VAL . . . -84.74 124.91 72.37 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.75 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 16.6 Cg_exo -66.13 99.82 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.148 2.565 . . . . 0.0 115.506 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.4 mtp180 54.91 114.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.617 1.967 . . . . 0.0 115.442 167.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.98 -20.6 31.78 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.661 -0.781 . . . . 0.0 114.764 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 83' ' ' ALA . 21.7 t -73.79 -47.03 6.95 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 122.458 -0.436 . . . . 0.0 111.416 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.99 113.26 3.51 Favored 'Trans proline' 0 C--N 1.376 2.005 0 N-CA-C 108.782 -1.276 . . . . 0.0 108.782 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.288 0.0 OUTLIER -129.78 128.01 41.52 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.05 0.929 . . . . 0.0 113.049 -178.14 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 mm -107.14 126.72 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.713 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.18 107.73 19.4 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.04 120.56 60.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.322 0.582 . . . . 0.0 110.152 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 62.5 m -113.55 124.76 53.12 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.146 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -105.86 114.34 28.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -123.66 138.58 54.51 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.332 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.8 mt -125.71 141.99 43.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -104.78 -170.14 1.72 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.6 -11.81 60.55 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -84.96 -28.76 25.61 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.029 0.442 . . . . 0.0 109.825 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.44 23.34 8.03 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 86.6 mt -90.3 117.57 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-O 121.382 0.611 . . . . 0.0 109.526 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 38.6 tp -95.74 129.27 43.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.646 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 45.4 m-80 -117.62 108.68 15.74 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 47.1 t -88.84 113.79 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -111.32 114.44 27.61 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.303 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.19 123.62 47.12 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.471 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.1 m -118.5 119.92 35.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.414 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.84 104.5 6.41 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -68.31 -18.31 64.48 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.582 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -68.43 -61.96 1.6 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.855 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 p -98.98 -37.71 9.27 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 120.8 0.333 . . . . 0.0 111.346 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.24 -0.59 8.21 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.045 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.0 137.31 55.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 117.406 0.603 . . . . 0.0 112.03 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.92 136.85 32.67 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.131 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -139.96 139.52 36.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 21.4 ptmt -137.95 142.01 40.54 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.128 0.49 . . . . 0.0 110.689 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 34.4 pt -119.17 147.66 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.5 m -106.96 113.45 26.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.017 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.417 HD11 HD12 ' A' ' 117' ' ' ILE . 50.7 mt -128.83 116.4 40.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.7 m -72.54 127.32 32.19 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 168.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -41.16 -53.68 3.06 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 124.339 1.024 . . . . 0.0 111.217 -170.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.9 t70 62.05 -148.98 0.38 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.635 0.774 . . . . 0.0 110.579 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -55.81 3.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.752 0.311 . . . . 0.0 111.448 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.85 -130.12 10.12 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -116.37 -165.75 1.08 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.3 mt 60.92 -171.98 0.14 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.228 1.011 . . . . 0.0 112.28 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.7 p -106.67 159.48 16.18 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -63.62 -29.81 71.0 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 122.642 0.377 . . . . 0.0 110.463 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.66 -42.71 97.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.957 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.31 -30.18 69.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.706 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 135' ' ' VAL . 48.0 mm -61.15 -45.3 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.66 -25.04 62.82 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -60.21 -45.0 94.68 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.5 mmt -59.48 -45.07 92.72 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.563 ' HA ' HH12 ' A' ' 32' ' ' ARG . 96.2 t -60.29 -57.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.085 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -70.22 -48.47 56.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -172.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.54 -38.62 91.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.02 -39.72 83.07 Favored 'General case' 0 C--O 1.19 -2.079 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.602 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -58.26 -33.31 69.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.493 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.4 -37.81 51.12 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -126.19 15.75 7.82 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -59.3 -27.31 65.74 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.48 95.52 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.772 0.796 . . . . 0.0 108.867 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 24.8 mm-40 -70.61 -44.96 66.17 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.506 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 3.0 m-20 -56.99 -45.42 83.0 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 123.545 0.528 . . . . 0.0 112.266 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 38.2 mt-10 -61.24 -39.29 89.75 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.79 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 82.9 t -63.74 -48.73 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.6 mm-40 -56.18 -46.06 79.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.519 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.436 ' C ' ' HD3' ' A' ' 149' ' ' ARG . 2.5 tmt_? -53.29 -50.83 64.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.593 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.1 pt-20 -83.18 -5.14 59.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 11.7 mmp_? -76.29 -34.54 59.07 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.88 -54.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 49.0 m -149.32 129.18 13.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.0 -38.04 9.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.01 0.434 . . . . 0.0 110.779 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HE3' ' OG1' ' A' ' 45' ' ' THR . 64.1 tttp -80.65 144.93 31.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 90.0 m-20 -76.68 99.13 4.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.319 0.581 . . . . 0.0 110.675 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -134.6 132.82 39.5 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.907 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 21' ' ' THR . 18.5 mt -101.13 114.32 28.15 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.1 119.32 37.64 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.0 m -86.04 131.06 34.35 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 79.9 t80 80.06 -52.84 0.38 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.098 1.359 . . . . 0.0 108.927 -172.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 60.23 92.96 0.04 OUTLIER 'General case' 0 C--O 1.245 0.824 0 C-N-CA 124.913 1.285 . . . . 0.0 112.629 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -90.41 97.01 10.94 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.871 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 47.5 95.22 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 171.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.7 mmt -103.18 108.94 20.33 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -138.38 161.49 36.82 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.339 0.59 . . . . 0.0 111.006 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.3 t -144.66 81.14 1.65 Allowed 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.58 167.46 9.78 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.27 -171.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -102.68 -169.25 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 170' ' ' GLU . 0.6 OUTLIER -86.73 118.25 26.01 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.204 0.526 . . . . 0.0 110.382 176.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.64 -32.3 47.26 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.518 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -80.08 153.0 29.04 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.581 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -88.58 66.66 3.15 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.96 76.84 9.33 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.334 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 47.3 tttm 164.09 -71.15 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 126.521 1.928 . . . . 0.0 107.594 172.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.22 117.02 0.32 Allowed Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.817 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.18 -33.68 38.08 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.2 tp -148.51 82.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.745 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 57.0 m -95.02 130.19 41.79 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.263 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -44.64 105.22 0.05 Allowed 'General case' 0 C--O 1.243 0.762 0 C-N-CA 125.345 1.458 . . . . 0.0 113.626 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.94 103.25 14.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.21 -38.87 92.6 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.098 -171.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -92.26 -38.72 11.92 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.663 -174.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 184' ' ' LYS . 0.1 OUTLIER 172.15 -33.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.78 0.832 . . . . 0.0 109.816 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.588 ' HG2' ' H ' ' A' ' 186' ' ' VAL . 37.3 ttmt -162.95 -172.16 2.95 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 101.013 -3.699 . . . . 0.0 101.013 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.588 ' H ' ' HG2' ' A' ' 185' ' ' LYS . 7.4 p -55.13 -43.14 68.87 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-N 119.198 0.908 . . . . 0.0 111.082 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 96.1 mt -138.66 -75.72 0.38 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.269 0.557 . . . . 0.0 111.627 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 185' ' ' LYS . 6.5 p-10 -86.45 -173.1 4.36 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.598 -174.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -127.87 -71.02 0.67 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -76.86 -33.19 57.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.701 0.762 . . . . 0.0 109.947 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.94 -9.27 14.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.464 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.79 -44.22 99.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 13.0 tt -109.52 -32.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.257 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.1 m -81.23 53.68 2.09 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -92.4 -23.84 19.07 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.0 mt -104.31 149.9 24.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 172.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.71 -30.35 11.78 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.976 -174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -125.1 -174.67 3.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.95 146.1 32.7 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 7.6 p -80.47 -58.89 2.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.085 0.945 . . . . 0.0 109.99 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 64.5 tp -130.02 -51.69 1.12 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -147.58 -53.27 0.21 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.34 -55.75 0.13 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.023 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -174.57 -64.23 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -167.3 135.16 2.48 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 173.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -112.49 126.72 55.63 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.05 0.452 . . . . 0.0 110.644 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -84.18 -33.92 24.08 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.895 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -140.05 124.28 17.8 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -117.83 -47.46 2.6 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -144.28 124.83 14.0 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.988 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.412 ' HB3' ' HG3' ' A' ' 214' ' ' GLU . 92.9 mtt180 -84.41 93.27 8.25 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.795 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 79.16 9.61 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.853 1.311 . . . . 0.0 110.127 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 212' ' ' ARG . 37.7 mt-10 -85.31 178.22 7.55 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.302 -1.772 . . . . 0.0 109.996 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.7 tp 76.81 149.97 0.11 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.845 1.258 . . . . 0.0 108.489 -172.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -64.18 133.03 52.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -66.76 95.8 0.37 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.568 0.699 . . . . 0.0 109.93 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.57 117.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.194 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 55.1 t30 175.27 135.2 0.17 Allowed Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.78 101.36 0.56 Allowed 'Trans proline' 0 C--O 1.247 0.951 0 N-CA-C 107.365 -1.821 . . . . 0.0 107.365 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 28.2 pt -54.8 -61.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.2 mm 57.87 97.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.337 0.655 . . . . 0.0 110.185 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 54.5 p -79.79 92.9 5.51 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.476 -0.765 . . . . 0.0 110.368 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -88.87 98.52 2.45 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 43.6 tp 63.9 80.36 0.23 Allowed 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.996 0.903 . . . . 0.0 109.695 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -82.81 -42.94 17.27 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.898 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -141.35 109.84 5.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.705 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -113.11 83.89 0.34 Allowed Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.85 113.42 9.86 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -154.59 48.42 0.51 Allowed Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.28 109.66 3.88 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -60.67 106.15 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.878 2.386 . . . . 0.0 112.609 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -136.93 101.24 0.34 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.35 -0.58 10.85 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.765 2.31 . . . . 0.0 112.584 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -72.99 151.52 45.84 Favored Glycine 0 C--O 1.248 1.028 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 104.53 92.79 2.27 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 80.0 t80 69.4 108.94 0.05 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.667 1.187 . . . . 0.0 110.559 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -115.39 -140.2 7.03 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.3 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -101.3 136.42 41.18 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.44 157.83 15.83 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 123.44 0.462 . . . . 0.0 109.825 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -97.4 126.98 9.06 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -63.91 111.16 1.47 Allowed 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.194 1.929 . . . . 0.0 109.738 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -64.1 108.87 1.65 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.116 -174.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 156.63 -98.62 0.18 Allowed Glycine 0 N--CA 1.424 -2.135 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -84.31 57.53 5.03 Favored Glycine 0 C--O 1.246 0.851 0 C-N-CA 121.725 -0.274 . . . . 0.0 113.762 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.7 p -78.2 132.61 37.66 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.79 -148.47 21.29 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 60.0 m -101.92 23.64 11.15 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.157 0.503 . . . . 0.0 110.923 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -159.5 98.65 0.17 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.558 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.8 76.08 3.44 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.807 2.338 . . . . 0.0 108.153 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 63.3 m 69.88 98.32 0.06 Allowed 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.045 -168.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 26.9 pt -54.43 159.05 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.573 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.63 90.25 2.8 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.519 0.676 . . . . 0.0 109.721 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.73 82.31 8.48 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.894 0.854 . . . . 0.0 110.579 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.78 100.35 3.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 C--N 1.281 -2.373 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.77 -174.627 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -84.14 95.24 8.56 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -87.14 99.8 12.19 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.93 154.18 19.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.072 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -64.31 132.19 49.47 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -53.76 -31.33 48.2 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.58 1.152 . . . . 0.0 113.396 -173.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.77 80.33 6.17 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.5 mp -103.54 72.94 1.16 Allowed 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.2 mt -125.35 104.84 8.68 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.144 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 12' ' ' VAL . 49.4 tp -91.65 88.64 6.8 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 174.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.8 m-20 -78.76 56.99 1.98 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.538 -172.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG22 ' HG ' ' A' ' 10' ' ' LEU . 10.0 m -136.56 168.37 22.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.8 127.2 68.42 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.68 -47.34 9.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.578 2.185 . . . . 0.0 111.972 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CB ' ' HB3' ' A' ' 60' ' ' GLU . 3.9 mm? -123.19 169.83 10.86 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.151 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 19.7 m -76.79 129.47 36.32 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.1 131.55 40.97 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.84 178.13 26.6 Favored Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.865 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.7 mt -123.93 164.71 18.75 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.324 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -84.18 109.58 17.85 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 HD23 ' A' ' 158' ' ' LEU . 12.2 p -99.19 142.47 30.64 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.461 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.64 113.91 0.68 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.355 1.462 . . . . 0.0 113.049 -172.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.08 -11.46 8.2 Favored Glycine 0 N--CA 1.425 -2.06 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.384 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' A' ' 20' ' ' GLU . . . 84.49 50.33 4.29 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.64 134.75 65.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.2 ttt -94.23 101.35 13.32 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.809 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -95.42 119.23 33.56 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 143.79 26.18 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.5 mp -102.11 -44.57 5.41 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.235 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.84 129.07 76.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -85.7 167.11 15.58 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ptt85 -69.13 165.37 20.49 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.879 0.371 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 68.78 9.31 7.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.583 1.153 . . . . 0.0 112.659 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -81.61 118.74 23.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 13.2 p -62.76 126.94 29.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.9 pt -91.6 164.68 23.33 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.37 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.3 Cg_exo -68.76 122.77 5.78 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.353 1.162 . . . . 0.0 113.477 1.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -95.17 156.73 16.19 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.495 0.718 . . . . 0.0 110.106 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -160.13 104.05 1.48 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -129.52 120.9 26.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.0 m -107.39 141.51 38.65 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.569 0.748 . . . . 0.0 110.492 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -136.62 162.01 34.31 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.703 0.401 . . . . 0.0 109.974 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.79 122.94 62.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -107.57 146.57 31.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.86 0.838 . . . . 0.0 111.932 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 3.3 p -114.74 173.08 6.66 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.582 -1.644 . . . . 0.0 108.749 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 p -113.31 151.13 31.55 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 112.243 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -108.0 7.38 27.83 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.725 0.774 . . . . 0.0 110.286 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -89.97 158.15 17.51 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.568 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -118.27 114.42 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 63.3 74.25 0.43 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.245 1.021 . . . . 0.0 111.081 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.45 ' CD ' ' H ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -102.73 121.13 50.59 Favored Pre-proline 0 C--N 1.292 -1.904 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.56 -178.001 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.18 -14.85 6.93 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.091 1.861 . . . . 0.0 110.891 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.87 150.76 20.89 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 29.0 m -118.41 158.64 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 tp -108.23 127.04 53.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.086 0.469 . . . . 0.0 111.426 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.26 105.36 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -113.02 123.51 50.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.82 119.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 123.9 0.75 . . . . 0.0 110.048 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 89.0 m-85 -122.68 156.78 33.66 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.171 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HB3' ' CB ' ' A' ' 15' ' ' LEU . 49.0 mt-10 -111.11 149.69 30.49 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.155 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -165.76 12.1 Favored Glycine 0 N--CA 1.422 -2.251 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 30.7 mt-10 -148.8 99.36 2.98 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.286 0.565 . . . . 0.0 109.88 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -130.01 153.36 48.5 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.317 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -65.98 -40.66 91.41 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.713 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 69.9 mtm -128.59 135.45 49.36 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.88 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 109.5 2.48 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 20.3 pttp -155.72 -44.99 0.08 Allowed 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.394 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.444 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 10.9 m-20 -128.67 82.74 2.1 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.464 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 19.6 m120 -145.45 170.43 16.39 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.145 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 71.0 m-20 -90.73 117.78 29.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.99 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -85.88 108.1 17.99 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.54 -42.09 23.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.459 0.647 . . . . 0.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.38 35.52 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.515 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 4.4 ppt_? -146.7 147.39 30.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 122.279 0.231 . . . . 0.0 110.874 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.51 157.21 31.67 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.95 135.99 48.41 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 59.4 tp -97.12 104.5 16.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p -103.32 154.5 19.31 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.37 10.53 25.4 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.99 135.54 85.2 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.94 115.82 4.49 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.673 1.582 . . . . 0.0 110.181 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.3 102.72 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.065 2.51 . . . . 0.0 111.727 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.17 173.23 6.12 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.614 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.71 171.51 2.7 Favored 'Trans proline' 0 C--O 1.262 1.708 0 C-N-CA 122.451 2.101 . . . . 0.0 112.836 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -62.6 117.97 6.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.643 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.465 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 88.54 19.39 52.26 Favored Glycine 0 CA--C 1.494 -1.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.955 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.412 ' H ' ' HD2' ' A' ' 88' ' ' PRO . 62.7 t -91.25 -54.89 0.27 Allowed Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.398 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' A' ' 87' ' ' VAL . 18.1 Cg_endo -58.78 138.28 84.81 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 121.748 1.632 . . . . 0.0 112.044 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -102.71 96.11 6.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.642 0.734 . . . . 0.0 111.339 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.9 mm -92.48 133.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -112.63 119.14 37.11 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -120.91 127.97 76.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 95.7 m -118.71 127.41 53.53 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.66 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 29' ' ' LEU . 9.1 m-85 -105.5 113.26 26.73 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' HB3' ' HG2' ' A' ' 39' ' ' LYS . 2.6 p30 -132.92 140.97 48.12 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 60.9 mt -127.5 126.42 67.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.468 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.0 p30 -90.84 179.02 5.88 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.07 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.74 63.8 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.06 -16.7 54.51 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.03 29.18 8.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 73.1 mt -94.8 117.68 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.4 tp -94.4 115.09 27.23 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.802 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -103.56 120.75 41.5 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.629 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.94 114.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.1 m -118.01 126.96 53.31 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.81 124.59 52.15 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -126.49 120.77 30.52 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.69 99.29 5.78 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -68.98 -6.19 26.27 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -70.13 -50.23 42.63 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 p -97.82 -43.24 7.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.545 0.688 . . . . 0.0 111.242 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.18 25.66 5.49 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.82 142.15 29.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.21 149.0 48.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.143 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.407 ' OD1' ' HA ' ' A' ' 77' ' ' LEU . 10.6 m120 -144.75 135.0 24.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 125.184 1.394 . . . . 0.0 107.33 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -124.73 166.74 15.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.039 0.447 . . . . 0.0 111.214 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.0 tt -140.36 140.31 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.1 m -116.14 113.77 23.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.821 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.13 101.57 12.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.7 p -92.36 103.36 15.81 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.262 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.3 m120 76.81 149.25 0.1 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.511 1.124 . . . . 0.0 113.531 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -67.7 -43.53 79.86 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.109 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -82.64 -0.2 46.05 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.906 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.51 -11.79 65.79 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -123.57 -45.23 2.07 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.804 0.335 . . . . 0.0 111.458 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 70' ' ' ASN . 86.7 mt -118.0 -175.71 2.9 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.661 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 67.5 p -78.71 -75.98 0.21 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 127' ' ' SER . 5.4 tmtp? 156.7 -27.0 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 128.511 2.725 . . . . 0.0 106.557 174.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.63 -49.24 77.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.663 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.43 -33.36 74.64 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.353 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 135' ' ' VAL . 62.8 mt -63.34 -52.4 58.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -61.82 -38.51 88.4 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.504 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -63.76 -40.66 97.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.464 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 2.1 tpt -63.1 -39.54 94.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.358 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 131' ' ' ILE . 57.4 t -55.98 -50.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 123.227 0.329 . . . . 0.0 110.221 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -58.02 -55.79 30.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.191 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.68 -43.12 99.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.83 88.9 Favored 'General case' 0 C--O 1.204 -1.308 0 O-C-N 123.41 0.444 . . . . 0.0 111.855 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -77.89 -37.64 47.62 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.817 0.341 . . . . 0.0 111.75 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -111.45 19.78 17.87 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -52.73 -56.96 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.661 1.185 . . . . 0.0 110.699 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.88 89.06 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.101 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.55 -50.9 67.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.306 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.24 -39.26 75.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.69 -33.49 75.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.781 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 70.7 t -64.58 -45.29 95.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.41 ' O ' HG23 ' A' ' 152' ' ' VAL . 78.4 mt-30 -64.25 -37.57 87.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.795 0.331 . . . . 0.0 110.643 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 52.1 ttp180 -61.62 -32.14 72.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.883 0.873 . . . . 0.0 112.01 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -89.3 -21.12 23.32 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.289 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 23.7 mmm180 -68.5 -42.85 78.02 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 148' ' ' GLN . 60.7 t -70.43 137.11 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.2 p -70.71 86.03 0.66 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.107 0.956 . . . . 0.0 111.126 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.97 166.82 10.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.532 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -170.33 164.23 8.83 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -80.29 74.91 7.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.899 0.857 . . . . 0.0 109.546 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -135.82 127.56 29.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.924 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 21' ' ' THR . 28.5 mt -97.37 152.77 18.59 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.426 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -78.02 172.37 13.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.516 ' H ' ' CD ' ' A' ' 159' ' ' GLU . 34.9 m -112.55 -25.66 9.05 Favored 'General case' 0 N--CA 1.413 -2.293 0 O-C-N 121.704 -0.622 . . . . 0.0 112.25 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -157.34 85.8 0.93 Allowed 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.135 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.1 93.47 2.39 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.384 0.612 . . . . 0.0 109.835 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -95.23 76.31 3.43 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.511 0.672 . . . . 0.0 110.455 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -67.83 -37.68 82.23 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.45 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 50.2 ttm -127.69 128.78 46.02 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.424 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -121.54 -63.26 1.33 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.7 m 64.92 -43.75 0.32 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.1 149.51 30.72 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 122.07 -0.394 . . . . 0.0 111.532 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.6 t -84.21 -29.27 7.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 68.46 99.58 0.06 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.447 1.499 . . . . 0.0 112.542 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -98.62 115.04 27.79 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.17 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 105.54 2.22 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 124.104 0.878 . . . . 0.0 110.641 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -122.79 122.82 5.15 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.1 mt -130.28 83.49 2.13 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 122.671 0.388 . . . . 0.0 110.106 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -150.71 103.67 3.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.552 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -130.08 107.61 0.79 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -87.56 -34.77 18.46 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.554 0.177 . . . . 0.0 111.252 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 57.6 mt 59.76 93.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.818 0 CA-C-O 122.053 0.93 . . . . 0.0 110.158 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 19.8 m -68.7 168.6 12.87 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.916 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 81.48 159.95 0.15 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.3 1.44 . . . . 0.0 111.408 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -102.83 3.05 36.25 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -173.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.88 134.75 40.21 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.87 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -160.57 25.64 0.15 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.694 -1.139 . . . . 0.0 107.997 174.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.02 -35.98 0.16 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.3 mptt 62.07 69.08 0.64 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.793 0.437 . . . . 0.0 111.138 -167.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 90.8 t 69.5 123.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.134 0.974 . . . . 0.0 112.191 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.0 mp -91.82 89.87 7.24 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.633 -0.667 . . . . 0.0 110.077 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -127.88 112.68 14.97 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.717 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.13 33.64 5.31 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -122.3 125.64 46.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -76.92 113.21 14.36 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.493 0.663 . . . . 0.0 112.185 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.69 133.28 61.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.71 -50.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.696 -174.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 19.9 m -85.27 90.9 8.02 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.811 0.815 . . . . 0.0 112.005 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -91.72 -35.21 14.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.811 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.9 tt -142.31 -73.47 0.3 Allowed 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.3 t70 170.64 -179.58 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -89.47 -30.94 17.93 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -159.22 101.95 1.58 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 13.5 t -63.64 122.37 16.19 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.994 0.902 . . . . 0.0 111.479 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 65.8 tp -143.99 78.0 1.57 Allowed 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.157 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -113.19 -16.86 12.49 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.099 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -93.84 109.34 21.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.053 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -115.76 131.56 56.9 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.31 108.27 19.53 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.185 0.516 . . . . 0.0 111.097 -174.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.62 107.18 19.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -146.97 138.04 23.95 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.37 112.16 21.83 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -132.65 8.19 4.18 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.768 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -117.8 86.28 2.49 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.473 ' HD3' ' N ' ' A' ' 213' ' ' LYS . 2.2 tmt_? -70.94 137.88 49.58 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.185 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.593 ' N ' ' HE2' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -151.8 149.92 29.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.318 0.386 . . . . 0.0 109.974 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -144.53 125.59 14.52 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.0 mt -118.58 105.48 11.67 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 120.914 0.388 . . . . 0.0 111.206 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.551 ' OE2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -138.55 132.26 30.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 175.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -154.87 16.0 0.43 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.041 0.448 . . . . 0.0 110.431 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.551 HG22 ' OE2' ' A' ' 216' ' ' GLU 0.276 34.4 m -87.06 80.08 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 122.832 1.301 . . . . 0.0 112.476 -178.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -69.07 -52.61 15.62 Favored Pre-proline 0 CA--C 1.559 1.311 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.2 105.9 1.28 Allowed 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 121.436 1.424 . . . . 0.0 113.787 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.6 pp -107.04 151.88 8.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.005 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.37 127.77 68.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.229 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t -112.85 140.43 47.65 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -61.58 123.39 31.82 Favored Glycine 0 N--CA 1.444 -0.802 0 O-C-N 123.444 0.465 . . . . 0.0 112.821 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -91.61 91.73 8.16 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -104.3 -5.89 21.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.212 1.006 . . . . 0.0 108.717 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -65.6 115.89 6.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.107 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.85 105.63 0.22 Allowed Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -132.44 -173.01 3.05 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 174.41 -176.3 46.74 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.518 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 119.25 126.81 3.54 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.74 -30.33 41.56 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.027 1.818 . . . . 0.0 111.982 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 101.4 178.43 28.62 Favored Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.3 122.82 8.67 Favored 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 122.519 2.146 . . . . 0.0 111.606 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -135.87 8.89 4.22 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.26 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -114.31 63.05 0.31 Allowed Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.876 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -94.12 -66.86 0.89 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.7 120.55 2.56 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -124.12 157.41 34.7 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -113.08 116.36 29.76 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.16 65.79 0.18 Allowed Glycine 0 C--N 1.297 -1.593 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -87.68 148.0 7.23 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.062 1.842 . . . . 0.0 111.029 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -78.77 85.82 4.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.634 0.73 . . . . 0.0 110.116 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -133.5 42.9 1.32 Allowed Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.3 71.41 0.49 Allowed Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.8 t -86.61 115.6 24.18 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -90.92 178.93 42.52 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 120.804 -0.712 . . . . 0.0 114.49 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 27.2 t -157.49 175.23 14.23 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -82.94 152.19 29.65 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.634 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.24 -42.94 63.05 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.604 2.203 . . . . 0.0 109.636 172.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 91.2 m -100.07 112.33 24.62 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.6 pp -77.14 143.63 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.631 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.1 137.78 42.32 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.546 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -69.15 -42.49 75.89 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.155 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.9 m -87.17 77.14 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 122.627 1.203 . . . . 0.0 111.54 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.298 -1.655 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.688 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.444 -0.775 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -124.94 119.09 27.77 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -77.16 114.07 15.57 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.2 p -140.69 -53.83 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -127.53 25.74 6.04 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 8.5 p-10 -131.97 139.59 48.71 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.421 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 6' ' ' ASP . 26.6 mt -161.88 109.81 1.42 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 125.264 1.426 . . . . 0.0 108.718 175.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.8 mt 71.95 143.65 0.06 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.24 1.416 . . . . 0.0 111.663 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -102.05 81.01 2.05 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 tp -107.52 21.0 18.12 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.925 1.345 . . . . 0.0 108.79 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.04 62.69 3.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.911 1.338 . . . . 0.0 110.03 177.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 35' ' ' THR . 32.4 m -144.42 -179.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.95 112.57 52.99 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.68 -13.91 10.45 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 121.586 1.524 . . . . 0.0 111.617 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 131' ' ' ILE . 89.1 mt -135.57 166.15 23.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.623 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 27.3 m -103.65 116.24 31.98 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.58 130.94 38.08 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.05 -177.62 18.18 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.072 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -124.78 166.0 17.0 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.081 0.552 . . . . 0.0 111.584 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.49 109.12 17.1 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.512 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 5.9 p -113.69 156.58 23.5 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.487 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 119.68 6.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.451 1.1 . . . . 0.0 113.286 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.72 4.44 28.15 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.286 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.59 38.31 28.47 Favored Glycine 0 CA--C 1.494 -1.247 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 152' ' ' VAL . 63.5 t -99.44 142.21 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.39 -0.905 . . . . 0.0 108.667 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.415 ' HB2' ' N ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -108.92 103.12 12.1 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.217 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -91.95 110.71 22.07 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.75 115.58 28.18 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.717 0.636 . . . . 0.0 110.551 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.493 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.5 mp -91.21 -49.3 6.45 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 16' ' ' SER . 49.5 mm -97.58 91.04 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -85.76 148.43 25.85 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.874 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -57.38 150.56 18.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 76.64 11.39 2.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.044 1.738 . . . . 0.0 112.408 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 m -94.31 113.4 25.29 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 12' ' ' VAL . 3.4 m -65.36 143.34 57.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.6 pt -96.15 162.29 24.29 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 23.7 Cg_exo -68.64 132.21 19.95 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.958 1.021 . . . . 0.0 113.614 -0.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.76 154.89 18.25 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.903 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 95' ' ' ASP . 50.9 tptt -149.04 101.46 3.16 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -124.03 135.92 53.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 92.1 m -135.51 138.57 43.22 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.37 145.94 50.8 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 122.905 0.482 . . . . 0.0 109.76 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.41 122.09 55.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -114.42 155.94 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.82 171.55 8.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 123.732 0.813 . . . . 0.0 108.879 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -98.9 136.07 39.42 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.098 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -99.18 -14.2 19.42 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.949 0.88 . . . . 0.0 109.021 172.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -95.63 113.65 25.32 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.769 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.26 139.99 41.38 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 62.04 55.95 2.4 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 52' ' ' PRO . 70.9 mm-40 -101.39 136.81 19.57 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 175.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.403 ' HD2' ' OE1' ' A' ' 51' ' ' GLN . 54.5 Cg_endo -72.14 -25.92 18.56 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.576 2.184 . . . . 0.0 111.794 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' A' ' 80' ' ' ILE . . . -171.88 168.0 41.06 Favored Glycine 0 N--CA 1.407 -3.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.569 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.25 138.01 44.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.1 tp -90.51 104.21 16.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.294 0.569 . . . . 0.0 109.822 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.98 117.1 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -135.43 119.37 17.41 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.744 -171.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.09 122.49 47.63 Favored 'Isoleucine or valine' 0 C--O 1.248 0.975 0 O-C-N 124.33 1.018 . . . . 0.0 110.811 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 69' ' ' ASN . 40.3 m-85 -120.7 149.55 42.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.905 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' OE2' HD13 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -119.17 157.74 27.33 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' SD ' ' A' ' 134' ' ' MET . . . 104.51 15.95 19.42 Favored Glycine 0 C--N 1.31 -0.909 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 167.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.595 ' OE1' ' HG3' ' A' ' 67' ' ' LYS . 47.4 mm-40 -144.14 179.52 7.16 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 118.309 1.055 . . . . 0.0 112.116 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -120.03 -72.11 0.7 Allowed 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.269 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -91.97 -50.69 5.57 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.5 mtt -127.93 145.33 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.415 ' N ' ' HB2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -72.26 107.35 4.84 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.672 -174.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.595 ' HG3' ' OE1' ' A' ' 62' ' ' GLU . 10.7 pttp -137.48 -76.45 0.4 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 123.339 0.655 . . . . 0.0 111.587 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.78 75.08 4.94 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 122.77 1.271 . . . . 0.0 110.343 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.515 HD21 ' HB2' ' A' ' 62' ' ' GLU . 22.1 m120 -122.87 152.37 40.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.713 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -111.38 140.15 46.2 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.739 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.1 tp -83.17 119.89 25.1 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.4 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.9 mt -97.2 -65.82 0.94 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.744 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.45 21.61 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.264 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 -153.3 157.49 40.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -161.8 147.72 13.62 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.625 0.578 . . . . 0.0 109.492 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -94.5 113.88 25.79 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -88.78 103.39 15.93 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 p -119.0 166.37 12.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.91 18.32 12.64 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.449 HD13 ' HA2' ' A' ' 53' ' ' GLY . 1.8 mp -77.95 130.05 74.09 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.65 154.17 74.1 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 122.483 2.122 . . . . 0.0 111.895 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.24 92.05 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.18 1.92 . . . . 0.0 110.739 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.14 155.98 80.77 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.184 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.99 176.95 8.44 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.31 2.007 . . . . 0.0 113.356 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 58.0 mtt85 -45.91 131.43 9.57 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.574 1.55 . . . . 0.0 113.124 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.43 -20.25 35.35 Favored Glycine 0 C--N 1.311 -0.807 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.427 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 54.9 t -74.73 -53.99 3.01 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 117.671 0.735 . . . . 0.0 112.805 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 5.5 Cg_exo -76.79 104.36 1.9 Allowed 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.346 1.364 . . . . 0.0 111.025 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -97.2 131.17 44.2 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.346 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.21 119.21 59.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.82 110.4 22.98 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.35 123.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.594 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.2 m -114.26 127.8 56.05 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.493 ' CD1' HD22 ' A' ' 29' ' ' LEU . 9.9 m-85 -111.3 121.01 44.13 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.621 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 1.7 p30 -138.07 137.7 38.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.942 0.401 . . . . 0.0 111.269 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 33.9 mt -121.78 123.84 70.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -88.48 -170.93 3.14 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 123.415 0.447 . . . . 0.0 111.545 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.8 -16.19 63.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.113 0.565 . . . . 0.0 112.346 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -83.18 -23.63 32.8 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.05 21.8 17.11 Favored Glycine 0 N--CA 1.419 -2.485 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 91.8 mt -90.01 117.61 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.428 0.632 . . . . 0.0 109.87 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 96' ' ' ILE . 16.7 tp -96.47 122.37 39.3 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.092 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -117.29 120.39 38.06 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.205 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.6 t -99.32 113.14 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.7 m -115.13 126.32 54.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.66 123.71 50.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 m -109.81 128.66 55.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.774 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 5.6 t0 -85.41 107.21 17.28 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 124.939 1.296 . . . . 0.0 107.647 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -67.5 -18.25 64.98 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.0 m -86.11 -36.66 19.46 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.926 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -110.87 -29.14 8.07 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.55 19.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.151 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 108' ' ' ASP . 9.9 ptpp? -92.4 161.9 14.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.97 137.59 16.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.682 0.277 . . . . 0.0 111.065 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -129.99 142.06 50.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 60.7 pttt -129.34 155.5 45.53 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.146 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.1 pt -121.11 157.58 24.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 m -129.85 113.63 14.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.445 0.641 . . . . 0.0 111.551 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.8 mt -115.39 142.66 27.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 m -117.74 166.5 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -80.75 15.06 1.87 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.343 0.52 . . . . 0.0 111.383 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.38 -22.96 66.85 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.825 0.85 . . . . 0.0 109.889 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp 67.39 88.7 0.11 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.472 1.109 . . . . 0.0 110.067 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.64 -10.99 61.16 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.409 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -141.91 156.4 45.5 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.413 HD22 ' HG2' ' A' ' 130' ' ' GLU . 34.8 mt 68.3 176.98 0.26 Allowed 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.617 1.167 . . . . 0.0 113.091 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -127.8 -175.45 3.48 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -76.77 -15.48 59.74 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.778 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.98 -43.55 98.61 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.413 ' HG2' HD22 ' A' ' 126' ' ' LEU . 3.0 mp0 -64.29 -34.87 79.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.26 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.547 ' HA ' HD21 ' A' ' 15' ' ' LEU . 59.2 mt -60.98 -50.23 81.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.933 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.62 -26.68 60.9 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.774 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 136' ' ' GLN . 17.3 mmm180 -62.97 -36.84 84.84 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 173.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.419 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 15.6 ttt -59.24 -50.59 73.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 47.8 t -52.23 -53.8 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 124.084 0.865 . . . . 0.0 110.344 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.55 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.5 mt-30 -56.08 -46.84 78.88 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 124.095 0.872 . . . . 0.0 112.004 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.17 -39.49 60.26 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.755 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.03 67.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 9.1 pt-20 -75.16 -41.96 57.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.1 0.476 . . . . 0.0 110.896 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 98.1 mttt -57.62 -48.55 79.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.066 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.08 21.47 6.76 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.333 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 39.3 ttmt -58.7 -44.04 90.19 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.59 0.756 . . . . 0.0 112.021 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.32 -49.43 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -63.62 -46.36 86.07 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 m-20 -66.19 -27.97 68.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.969 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 5.4 tp10 -64.47 -39.73 94.36 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.3 t -70.94 -48.23 57.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.911 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 96.6 mt-30 -57.0 -38.3 72.88 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 123.549 0.74 . . . . 0.0 112.921 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -71.43 -31.92 67.77 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.008 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.45 -8.21 56.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.164 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 23.5 mmt85 -82.14 0.84 39.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.64 0.733 . . . . 0.0 109.505 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 25' ' ' VAL . 33.4 t -114.36 113.87 45.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -78.56 153.54 31.13 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.63 67.96 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.278 1.037 . . . . 0.0 112.848 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.5 33.49 0.51 Allowed 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -59.83 157.21 12.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.736 -170.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.56 154.55 46.55 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.833 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 52.2 mt -91.73 142.88 27.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -82.97 118.52 23.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 118.106 -1.438 . . . . 0.0 107.456 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.2 m -103.68 86.66 2.66 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.293 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -103.59 95.91 6.37 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.045 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.86 140.02 42.0 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.02 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -84.98 -36.72 21.15 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.218 0.532 . . . . 0.0 110.083 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -133.48 112.25 11.38 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.696 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 60.5 mtm 66.21 -177.41 0.19 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.382 1.073 . . . . 0.0 112.776 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -125.15 89.81 3.12 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 168.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.9 m -72.38 62.01 0.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.716 0.77 . . . . 0.0 113.012 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.32 85.45 2.15 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.074 -0.967 . . . . 0.0 108.638 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.39 7.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 122.067 0.937 . . . . 0.0 108.618 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -77.34 90.13 3.77 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.168 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.9 t70 58.23 86.38 0.08 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.986 1.315 . . . . 0.0 111.769 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.64 177.53 5.89 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.027 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -82.08 69.49 3.31 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.576 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.13 -20.9 47.43 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.709 0.404 . . . . 0.0 110.311 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -60.93 -42.82 98.89 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.158 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.43 159.21 31.26 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.001 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 177' ' ' LYS . 6.6 tmtm? -101.7 -16.12 16.78 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 78.2 mt 84.17 -37.75 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.296 1.438 . . . . 0.0 112.67 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.497 ' O ' ' HD2' ' A' ' 177' ' ' LYS . 32.2 t -148.63 -171.18 3.8 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 59.03 49.44 9.48 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.263 1.025 . . . . 0.0 110.921 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 61.81 78.57 0.28 Allowed 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.469 1.108 . . . . 0.0 110.112 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.432 ' CG ' ' H ' ' A' ' 177' ' ' LYS . 45.6 t0 -95.36 153.83 17.49 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.967 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 183' ' ' LYS . 10.2 mptt -111.17 168.32 9.6 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 -172.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 71.34 13.23 6.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.596 1.159 . . . . 0.0 113.418 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.24 -49.77 6.78 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.0 m -115.44 158.72 15.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.609 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.3 tp -99.75 118.29 35.92 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -80.61 103.67 10.62 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.566 0.698 . . . . 0.0 110.44 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -95.44 -7.26 38.78 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -77.06 78.39 3.59 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 120.479 1.49 . . . . 0.0 111.358 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 194' ' ' ILE . 40.9 tt0 -165.98 140.8 4.64 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.014 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.78 -32.35 57.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.491 ' H ' ' HG2' ' A' ' 192' ' ' GLU 0.297 9.8 tp 54.03 -56.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 C-N-CA 127.21 2.204 . . . . 0.0 114.115 -175.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.1 m -92.65 81.56 4.77 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -77.71 -7.85 57.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.054 0.93 . . . . 0.0 111.18 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.2 147.52 35.02 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -105.06 -67.2 0.92 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 69.01 151.87 0.09 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.044 1.338 . . . . 0.0 112.354 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -155.37 109.0 2.82 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.409 ' H ' ' CD ' ' A' ' 207' ' ' GLU . 39.6 p -104.8 12.05 33.12 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.74 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 89.3 mt 76.47 93.05 0.07 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 125.658 1.583 . . . . 0.0 111.756 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.15 142.26 20.34 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -83.39 -32.14 26.32 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.763 0.792 . . . . 0.0 109.149 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -91.48 177.38 6.24 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.836 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.8 103.7 1.5 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.741 0.305 . . . . 0.0 111.19 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 201' ' ' THR . 8.9 pt-20 -85.82 -29.84 23.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.958 0.885 . . . . 0.0 109.297 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -113.14 136.87 52.24 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.324 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.75 179.76 8.97 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 166.52 69.41 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 126.805 2.042 . . . . 0.0 109.344 169.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -72.43 -42.91 64.52 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -176.73 90.13 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.177 169.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -116.87 105.97 12.94 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.428 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.78 75.26 1.51 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.9 tp -128.44 -26.24 2.81 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.352 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.46 73.23 6.13 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -84.69 51.3 2.1 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.815 0.817 . . . . 0.0 110.878 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.3 m -82.05 86.47 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 CA-C-O 122.651 1.215 . . . . 0.0 111.051 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -104.43 157.21 34.58 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.445 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.03 50.59 0.63 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 123.345 2.696 . . . . 0.0 112.714 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.1 tt -75.46 -30.93 22.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 123.391 0.676 . . . . 0.0 109.35 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.8 pt -88.58 157.23 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 21.3 t -148.7 -41.91 0.15 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 92.88 -121.92 6.72 Favored Glycine 0 N--CA 1.423 -2.187 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 97.1 mt 67.32 102.95 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.107 0.963 . . . . 0.0 112.448 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -83.15 153.76 24.64 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.811 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -87.06 -38.32 16.63 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.108 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.96 -127.62 1.61 Allowed Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -114.85 101.13 8.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -76.8 -42.42 20.87 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.483 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 115.25 177.12 18.69 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -87.92 17.01 1.78 Allowed 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.761 2.308 . . . . 0.0 112.59 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 79.31 -120.58 5.3 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.23 105.46 1.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.97 1.78 . . . . 0.0 109.373 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.27 178.23 22.59 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.108 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -117.96 -65.17 0.32 Allowed Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.241 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -114.93 113.75 24.56 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.104 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -108.6 -53.55 0.63 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -148.16 -52.3 0.18 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 61.37 91.02 0.06 Allowed 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.114 1.365 . . . . 0.0 112.154 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -124.07 -87.44 0.77 Allowed Glycine 0 C--N 1.299 -1.499 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.46 147.2 46.05 Favored 'Trans proline' 0 C--O 1.254 1.284 0 C-N-CA 122.247 1.964 . . . . 0.0 111.386 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -129.12 128.18 42.95 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -77.83 81.93 1.24 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 83.34 -128.31 8.47 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 32.7 t -142.19 101.38 3.9 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.52 73.13 2.72 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 17.1 m -69.62 128.55 36.88 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -155.49 178.35 32.16 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.2 -35.84 13.47 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.71 2.273 . . . . 0.0 112.154 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 21.2 m 65.97 76.67 0.31 Allowed 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.171 0.988 . . . . 0.0 109.342 -175.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 27.4 pt -74.73 118.39 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.928 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.55 -43.18 14.75 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.366 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.6 122.84 31.09 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 7.3 p 179.22 -39.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 N--CA 1.433 -1.309 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.93 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.442 -0.86 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -98.63 116.39 30.75 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -84.68 74.5 10.43 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.401 1.096 . . . . 0.0 109.63 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.24 18.03 3.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.471 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -80.44 78.2 7.16 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.556 -0.858 . . . . 0.0 112.276 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -76.5 -39.83 51.96 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.39 86.78 3.05 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.541 174.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tt -85.64 -51.92 6.15 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.3 tp 51.87 77.28 0.15 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.445 1.498 . . . . 0.0 113.802 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.4 mt -153.8 158.46 40.92 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.746 0.818 . . . . 0.0 109.569 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 75.55 16.06 2.62 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 124.91 1.284 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.76 174.94 12.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.799 0.809 . . . . 0.0 112.302 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.28 114.74 64.8 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.794 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.78 -41.72 13.64 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.393 2.062 . . . . 0.0 111.862 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -117.02 144.64 44.36 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.967 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 m -67.09 137.46 56.39 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.994 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -106.5 131.96 53.07 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.502 0.502 . . . . 0.0 109.651 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -162.67 -158.1 9.45 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.437 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.19 165.88 24.07 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.432 0.693 . . . . 0.0 109.341 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -89.12 120.45 30.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.6 p -92.22 -105.44 0.11 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' A' ' 159' ' ' GLU . . . -112.42 146.85 37.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.134 -0.354 . . . . 0.0 110.322 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -57.78 4.99 Favored Glycine 0 C--N 1.317 -0.515 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.369 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.42 41.44 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.95 141.56 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.511 ' HB2' HG23 ' A' ' 66' ' ' THR . 1.1 tmt? -86.1 134.32 33.83 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.032 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -126.46 132.27 51.49 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -102.04 142.69 32.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.155 0.503 . . . . 0.0 111.657 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 6.4 mp -99.96 -49.12 4.43 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -101.27 112.39 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -85.64 158.72 20.01 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.459 HH22 ' HG3' ' A' ' 142' ' ' LYS . 15.4 ptt-85 -58.23 151.91 18.31 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.848 0.859 . . . . 0.0 110.654 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.7 m120 76.23 11.01 2.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.567 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -87.73 124.07 33.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.147 0.498 . . . . 0.0 110.155 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -68.87 137.33 53.79 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.407 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.68 159.73 28.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.4 140.82 50.49 Favored 'Cis proline' 0 CA--C 1.501 -1.147 0 CA-C-N 120.348 1.16 . . . . 0.0 112.516 -1.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -98.54 -77.98 0.5 Allowed 'General case' 0 N--CA 1.406 -2.668 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.734 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 88.8 tttt 66.81 100.7 0.05 OUTLIER 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.491 1.117 . . . . 0.0 111.022 -171.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -128.06 130.82 48.85 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -113.01 129.04 56.64 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 123.511 0.507 . . . . 0.0 110.191 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 29' ' ' LEU . 74.4 mt-30 -133.41 141.03 47.67 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 74.8 mt -104.19 120.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.176 0.513 . . . . 0.0 109.972 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -107.33 136.3 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -111.46 162.46 15.06 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.1 p -90.25 135.81 33.44 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.589 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 31.0 m-85 -114.92 -6.36 12.58 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.529 173.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -98.34 119.96 37.92 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.08 163.23 26.83 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.018 0.199 . . . . 0.0 110.996 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.19 23.99 14.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.142 0.977 . . . . 0.0 113.199 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -85.35 120.53 73.33 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.67 -16.08 14.98 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.59 2.193 . . . . 0.0 113.767 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.87 159.05 29.41 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.266 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.69 171.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 tt -129.08 118.6 22.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 111.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -126.53 118.12 24.25 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.12 132.73 30.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.775 -172.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 79.7 m-85 -134.01 152.94 52.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.737 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -112.9 151.73 30.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.587 0.554 . . . . 0.0 110.341 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.02 152.3 26.71 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.107 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -115.44 121.42 42.7 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.38 0.609 . . . . 0.0 109.795 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -140.29 162.72 34.61 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -66.65 -37.46 84.85 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 123.865 0.728 . . . . 0.0 111.098 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.77 139.93 46.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.749 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.511 HG23 ' HB2' ' A' ' 26' ' ' MET . 0.2 OUTLIER -70.57 113.95 8.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.266 -175.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.452 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -171.69 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.985 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.83 -14.55 54.13 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.963 0.887 . . . . 0.0 109.17 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.499 ' OD1' ' HA ' ' A' ' 66' ' ' THR . 8.7 m120 -66.96 152.73 45.2 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.311 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 78.4 m-20 -89.06 121.4 31.36 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.73 115.66 21.07 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.04 -36.67 12.01 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.062 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.29 171.97 39.06 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.214 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -149.03 159.29 44.35 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.427 0.291 . . . . 0.0 111.356 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.07 154.52 25.8 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 172.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.89 133.4 53.2 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 6.1 tt -108.25 104.44 13.84 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.6 p -104.53 159.44 15.74 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.112 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.11 -14.41 5.15 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.5 -0.857 . . . . 0.0 110.971 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.19 119.23 50.75 Favored Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 123.258 0.623 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.99 166.59 11.23 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.595 2.197 . . . . 0.0 110.939 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.09 97.46 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.933 1.755 . . . . 0.0 110.378 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.72 151.41 78.05 Favored Pre-proline 0 N--CA 1.426 -1.659 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.9 133.52 40.2 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.067 2.511 . . . . 0.0 111.466 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -60.98 119.65 8.7 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.397 0.618 . . . . 0.0 111.639 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.22 -27.11 6.2 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.406 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 87.6 t -72.93 -48.82 7.89 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.336 -0.432 . . . . 0.0 111.082 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 21.9 Cg_exo -70.08 106.67 1.76 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.182 1.255 . . . . 0.0 109.301 172.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 74.3 mt-30 -113.83 115.33 27.58 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.419 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.21 111.42 25.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -90.1 104.32 16.9 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -104.75 127.11 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.084 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.7 m -122.26 123.01 40.45 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.875 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 5.1 m-85 -99.45 112.35 24.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.728 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -112.95 143.28 44.51 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 11.9 mt -130.99 127.54 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -98.58 -171.68 2.17 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.86 -23.92 64.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.06 -29.82 49.41 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.07 26.2 6.13 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.7 mt -84.59 119.61 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 65.0 tp -96.06 107.84 20.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -103.52 125.83 50.31 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.7 t -111.29 113.02 43.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.8 m -106.24 116.52 32.08 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.63 117.23 33.39 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.7 m -113.45 122.1 46.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 110.65 16.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 54.2 mtpt -67.41 -18.55 65.15 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.541 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.9 p -80.26 -56.75 3.99 Favored 'General case' 0 C--O 1.25 1.102 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.359 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.6 p -76.58 -32.06 57.9 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.168 0.508 . . . . 0.0 110.361 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.93 -8.65 54.4 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.8 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -94.49 160.41 14.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.546 0.673 . . . . 0.0 111.435 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.1 148.43 51.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.283 0.563 . . . . 0.0 111.719 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.509 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.4 m120 -130.86 132.25 45.06 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 157.97 45.56 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.382 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 tt -127.78 146.51 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.2 m -125.18 112.31 16.3 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.235 0.541 . . . . 0.0 109.693 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.59 93.84 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -82.23 107.46 14.93 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.463 ' OD1' ' HD3' ' A' ' 125' ' ' ARG . 4.2 t-20 -102.94 116.28 32.24 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.666 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -127.51 91.11 3.24 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.2 mttp 65.6 -175.02 0.18 Allowed 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.023 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.51 73.34 0.58 Allowed Glycine 0 N--CA 1.469 0.846 0 N-CA-C 112.144 -0.382 . . . . 0.0 112.144 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.463 ' HD3' ' OD1' ' A' ' 121' ' ' ASN . 10.9 mmm180 -113.98 -81.24 0.6 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.533 0.682 . . . . 0.0 110.561 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -136.77 -165.54 1.75 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.1 p -70.92 -75.38 0.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.692 0.758 . . . . 0.0 109.394 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.4 tttp 176.27 -51.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 126.691 1.996 . . . . 0.0 105.741 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 132' ' ' GLU . 8.2 pt-20 -60.79 -32.46 71.8 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 113.831 -1.532 . . . . 0.0 111.802 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 134' ' ' MET . 7.7 tp10 -63.7 -40.52 96.98 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.984 0.421 . . . . 0.0 110.202 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 135' ' ' VAL . 66.0 mt -65.2 -50.58 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.662 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.7 pt-20 -63.91 -32.48 74.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 130' ' ' GLU . 53.9 mtm-85 -60.51 -46.83 88.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 23.9 mmt -60.88 -42.8 98.64 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.657 0.598 . . . . 0.0 109.772 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 131' ' ' ILE . 88.2 t -59.61 -51.77 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.042 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 98.1 mt-30 -56.53 -47.55 79.16 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 122.937 0.495 . . . . 0.0 111.434 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.22 -41.27 97.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.95 75.45 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.5 -47.09 18.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.302 0.572 . . . . 0.0 112.505 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.99 -22.82 55.44 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.328 0.585 . . . . 0.0 111.579 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -120.57 26.46 9.13 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.841 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.459 ' HG3' HH22 ' A' ' 32' ' ' ARG . 40.8 tttm -56.31 -42.13 77.1 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.109 0.964 . . . . 0.0 111.241 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.63 -52.84 18.61 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.923 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.39 -39.55 58.95 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.605 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -71.06 -49.83 40.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.412 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 37.9 mt-10 -66.26 -35.36 80.21 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.656 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 38.9 t -62.73 -50.05 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.392 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.18 -37.94 89.21 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.9 0.381 . . . . 0.0 111.726 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 58.9 ttt180 -58.11 -52.19 66.58 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.828 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 41.8 mm-40 -72.56 -19.88 61.42 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.826 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 18.4 mmm180 -70.24 -29.45 66.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.178 0.513 . . . . 0.0 109.949 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.91 -59.24 2.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.2 m -89.31 61.46 5.7 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.844 0.83 . . . . 0.0 111.113 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.94 -32.59 30.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.076 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.83 131.31 54.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -73.08 103.34 3.81 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.226 0.536 . . . . 0.0 111.432 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.549 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.41 160.27 41.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.37 140.89 51.88 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 22' ' ' ALA . 45.9 mm-40 -97.7 134.07 41.37 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.483 0.658 . . . . 0.0 111.596 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.7 p -87.42 124.59 33.58 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -94.17 10.46 33.79 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.789 0.805 . . . . 0.0 111.062 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -140.08 132.56 28.59 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -127.64 -51.02 1.37 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 72.57 -63.63 0.42 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.277 1.431 . . . . 0.0 111.662 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.08 158.01 0.56 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.51 98.23 0.35 Allowed 'General case' 0 C--O 1.244 0.813 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 171.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.4 m -74.07 139.25 44.52 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.469 -1.241 . . . . 0.0 114.101 -166.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 69.47 118.85 0.03 OUTLIER 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.924 1.69 . . . . 0.0 113.941 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.5 14.5 5.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.913 0.863 . . . . 0.0 108.943 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.6 172.36 8.74 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.631 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -148.6 176.35 10.41 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.44 56.81 0.93 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -120.64 17.29 9.51 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.698 ' H ' HD23 ' A' ' 174' ' ' LEU . 1.8 pt? -78.33 37.54 0.27 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.51 153.21 24.42 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 162.43 -171.18 38.23 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 55.5 tptt 68.19 111.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.557 1.143 . . . . 0.0 112.802 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.0 tp -60.84 128.55 22.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.535 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 18.2 m -84.36 112.32 20.22 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.538 ' HG2' ' HE2' ' A' ' 183' ' ' LYS . 8.2 tp10 -102.84 147.7 26.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -121.41 -45.06 2.34 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -143.13 145.57 32.96 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.648 -173.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.538 ' HE2' ' HG2' ' A' ' 180' ' ' GLU . 70.8 mmtt -134.02 11.19 3.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 176.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? 58.28 84.09 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.948 0.899 . . . . 0.0 111.84 -170.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -77.65 -24.68 49.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.36 139.36 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.03 135.33 18.07 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 121.373 -0.131 . . . . 0.0 110.702 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 42.5 t0 65.47 177.34 0.2 Allowed 'General case' 0 CA--C 1.553 1.06 0 O-C-N 124.771 1.294 . . . . 0.0 111.209 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -142.15 -177.59 5.31 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -73.94 -24.97 59.72 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.41 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.38 95.46 0.45 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.18 -16.9 8.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 15.6 tt -161.34 141.93 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.808 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.5 t 71.47 179.67 0.24 Allowed 'General case' 0 C--O 1.246 0.881 0 C-N-CA 125.444 1.498 . . . . 0.0 112.157 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 54.5 m95 66.99 80.62 0.21 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.701 1.6 . . . . 0.0 110.448 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -135.5 137.6 42.27 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.291 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.9 t70 74.29 115.02 0.06 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.675 1.59 . . . . 0.0 111.366 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -103.53 -36.17 8.05 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -152.57 127.61 9.71 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.955 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.9 m -82.07 121.12 26.16 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.408 HD11 ' OE2' ' A' ' 204' ' ' GLU . 3.4 tm? -95.83 130.72 42.68 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.27 -175.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -107.24 -70.55 0.79 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.195 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.408 ' OE2' HD11 ' A' ' 202' ' ' LEU . 43.2 mt-10 61.55 97.31 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.934 0.894 . . . . 0.0 112.96 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.629 ' HD3' ' N ' ' A' ' 206' ' ' ASP . 8.4 tmtt? -123.77 133.68 53.79 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.629 ' N ' ' HD3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -74.14 170.19 16.01 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.791 0.805 . . . . 0.0 112.62 -175.289 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -151.88 33.97 0.54 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 169.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -134.18 -11.14 2.55 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.045 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -84.2 60.37 5.89 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.524 0.678 . . . . 0.0 110.163 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -88.43 -40.7 13.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.209 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 66.74 168.63 0.23 Allowed 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.959 1.304 . . . . 0.0 112.147 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . 0.292 3.6 ppt_? -88.5 76.22 8.25 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.88 0.848 . . . . 0.0 111.844 176.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 213' ' ' LYS . 0.2 OUTLIER -57.38 -58.76 6.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.197 -178.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -168.02 138.99 2.79 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.55 -67.71 0.87 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -97.43 160.81 14.1 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.089 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -154.4 -62.04 0.13 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.806 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 15.6 m -97.71 100.09 10.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.995 0.903 . . . . 0.0 112.785 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -111.51 98.51 40.8 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.56 117.87 0.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.846 2.364 . . . . 0.0 112.744 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 36.9 pt -138.11 142.7 34.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.618 0.247 . . . . 0.0 110.414 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 14.7 tt -110.17 125.54 67.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.2 p -101.13 128.36 47.25 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.993 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -87.79 119.19 5.23 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.71 79.67 3.36 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.436 0.636 . . . . 0.0 110.395 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -85.84 121.73 28.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -116.66 158.73 23.29 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.997 0.427 . . . . 0.0 111.057 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 147.84 -174.85 27.44 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.67 18.0 18.67 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.225 0.536 . . . . 0.0 109.991 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -85.73 -4.77 84.87 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.919 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.87 89.16 0.45 Allowed Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -68.29 -40.26 8.7 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 122.165 1.91 . . . . 0.0 112.307 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 95.99 128.48 5.67 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.64 119.39 5.7 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.124 1.883 . . . . 0.0 111.355 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -156.3 -174.62 26.31 Favored Glycine 0 N--CA 1.428 -1.839 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 162.56 -127.68 1.74 Allowed Glycine 0 N--CA 1.425 -2.039 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -146.31 131.21 18.12 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -139.6 52.1 0.72 Allowed Glycine 0 CA--C 1.497 -1.073 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.823 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -138.37 127.32 23.94 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -96.19 170.35 9.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -109.99 99.38 1.19 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.39 179.05 6.89 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.673 2.249 . . . . 0.0 112.497 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 74.47 -53.36 0.68 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.045 1.738 . . . . 0.0 112.445 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -87.39 113.3 3.95 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 88.66 -68.28 2.88 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.6 m -78.5 103.33 8.38 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 110.48 24.28 5.68 Favored Glycine 0 C--N 1.307 -1.08 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.724 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.1 p -80.84 -11.75 59.54 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.494 0.664 . . . . 0.0 111.436 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -153.94 -133.67 1.85 Allowed Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -84.88 80.35 2.18 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 121.577 1.518 . . . . 0.0 110.093 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 43.8 m -90.47 84.14 5.95 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 122.81 1.291 . . . . 0.0 110.257 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 22.4 pt -116.23 165.36 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 113.152 -1.84 . . . . 0.0 107.67 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -116.49 99.27 7.05 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.523 0.678 . . . . 0.0 109.477 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -72.29 152.49 42.11 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.461 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.46 95.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--N 1.296 -1.721 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.961 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.91 -32.49 65.35 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.163 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -79.22 130.83 35.87 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.89 96.16 2.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -98.67 72.56 2.0 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -114.29 -59.56 2.0 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.518 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.07 74.35 1.56 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.457 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -130.09 101.93 6.03 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.08 72.3 5.61 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.301 1.048 . . . . 0.0 111.621 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 12' ' ' VAL . 5.1 tt -88.74 149.75 23.3 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' THR . 3.5 m-20 -75.97 55.35 0.9 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.478 HG13 HD22 ' A' ' 10' ' ' LEU . 30.9 m -136.66 170.6 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.85 129.71 45.45 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.04 -31.56 6.05 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.069 1.846 . . . . 0.0 112.305 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.4 mp -126.65 157.55 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.436 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 20.0 m -86.34 138.16 32.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.07 131.21 48.66 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -157.03 -171.46 23.12 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.357 -176.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 92' ' ' VAL . 84.4 mt -126.36 169.88 12.49 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.09 0.556 . . . . 0.0 110.076 -176.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.38 108.44 19.96 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.441 HG22 HD23 ' A' ' 158' ' ' LEU . 6.1 p -92.52 166.37 12.56 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.36 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.68 114.05 0.97 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.411 1.084 . . . . 0.0 112.388 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.94 -2.08 21.21 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.189 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.12 72.28 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.23 145.69 7.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.438 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -92.64 117.37 29.9 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.9 m -115.05 112.19 22.24 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -93.12 135.08 34.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.199 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.3 mp -94.13 -41.0 9.74 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -109.96 113.21 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -90.34 166.64 13.19 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.822 0.82 . . . . 0.0 112.724 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -61.16 141.01 57.78 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.36 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 77.86 2.03 2.89 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.716 1.207 . . . . 0.0 111.873 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -83.47 130.58 35.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 5.5 p -65.47 130.37 43.06 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 39.5 pt -106.78 148.59 37.17 Favored Pre-proline 0 N--CA 1.435 -1.212 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 52.6 Cg_exo -61.87 132.61 10.61 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.03 1.046 . . . . 0.0 113.639 1.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 m -110.17 143.16 40.69 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.237 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -128.67 108.71 10.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -128.06 141.91 51.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -139.9 135.42 32.84 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -141.61 144.96 34.47 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 91' ' ' GLU . 42.3 mm -92.29 114.82 29.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.43 147.38 25.32 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.811 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 8.9 p -136.6 170.16 16.52 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.882 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -103.7 137.84 41.17 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.817 0.281 . . . . 0.0 110.686 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 43.8 m-85 -112.93 4.54 16.87 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -84.64 175.34 9.29 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.798 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.88 117.49 31.22 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.296 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 37.17 81.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' A' ' 159' ' ' GLU . 25.5 mt-30 -101.41 139.11 20.15 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.852 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -85.61 0.02 8.64 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.245 1.963 . . . . 0.0 111.964 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.6 176.12 44.23 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.01 152.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.8 tp -101.11 120.39 40.14 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.48 105.45 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -119.22 118.51 31.49 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 t -95.45 134.6 32.31 Favored 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.706 0.629 . . . . 0.0 111.495 -172.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.48 151.48 50.91 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.302 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -116.13 141.08 48.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.91 -117.84 1.83 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 9.4 mt-10 177.26 -99.94 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 126.115 1.766 . . . . 0.0 111.525 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.526 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 20.8 mmm180 55.4 -178.12 0.04 OUTLIER 'General case' 0 C--O 1.244 0.795 0 O-C-N 123.681 0.613 . . . . 0.0 110.524 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -91.28 -49.67 6.23 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.691 0.757 . . . . 0.0 110.663 175.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.2 mtp -97.65 126.15 42.8 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.53 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.328 0.4 OUTLIER -80.33 86.19 5.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.671 1.7 . . . . 0.0 111.418 178.331 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -152.42 -45.83 0.1 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.775 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.35 7.26 1.39 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.209 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' ND2' ' HG3' ' A' ' 26' ' ' MET . 89.3 m-20 -109.67 163.74 13.19 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.633 0.373 . . . . 0.0 111.493 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -91.01 136.19 33.24 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 tt -96.78 122.91 40.25 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.64 -45.18 9.53 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.279 0.362 . . . . 0.0 111.494 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.63 175.83 47.17 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.19 156.74 42.61 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.52 139.27 20.77 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -97.4 120.27 37.46 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.64 104.55 14.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 p -110.91 173.87 6.13 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.05 21.76 44.62 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 52.8 mt -90.17 135.26 30.11 Favored Pre-proline 0 N--CA 1.426 -1.673 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.65 117.02 3.9 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.563 2.175 . . . . 0.0 112.479 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.44 91.28 0.97 Allowed 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.191 1.927 . . . . 0.0 109.942 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.55 168.68 13.71 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.304 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.05 100.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.289 2.659 . . . . 0.0 113.237 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 60.85 -160.99 0.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.698 1.199 . . . . 0.0 111.349 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.7 63.33 1.18 Allowed Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 76.5 t -66.4 -48.39 56.66 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 167.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.601 ' HA ' ' OG ' ' A' ' 110' ' ' SER . 15.7 Cg_endo -59.05 129.9 33.99 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.058 1.839 . . . . 0.0 111.347 168.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.67 110.67 22.58 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.04 114.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 43' ' ' ILE . 35.1 tt0 -90.75 114.33 26.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.434 HG11 HD11 ' A' ' 19' ' ' LEU . 62.1 t -109.32 122.6 64.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.805 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.1 m -109.53 129.63 55.56 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.874 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.447 ' CD1' HD22 ' A' ' 29' ' ' LEU . 5.3 m-85 -109.9 107.74 17.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 17.7 t70 -120.06 113.12 20.01 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.826 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 44.3 mt -111.74 136.07 49.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.0 OUTLIER -100.99 -168.42 1.56 Allowed 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.32 -8.18 55.95 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.424 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -96.04 -29.82 13.91 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.96 23.85 5.41 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 46.5 mm -81.87 115.44 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.455 HD13 HG13 ' A' ' 96' ' ' ILE . 31.5 tp -105.49 113.64 27.33 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.744 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -96.6 102.69 14.52 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.5 t -89.22 113.49 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 20.7 m -119.0 118.81 32.5 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.82 118.91 36.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.6 m -119.6 118.81 31.99 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.665 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 110.5 12.07 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -66.43 -20.33 66.03 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.055 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 88' ' ' PRO . 1.5 m -70.44 -53.34 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.176 0.512 . . . . 0.0 110.823 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.3 p -95.14 -29.46 14.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.096 0.474 . . . . 0.0 112.087 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.97 19.44 24.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.864 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.39 131.36 36.21 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 121.084 0.469 . . . . 0.0 111.894 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.54 134.13 53.08 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.815 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -128.78 128.57 44.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 65.5 pttt -129.15 154.09 47.07 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.854 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 HD11 ' A' ' 119' ' ' ILE . 25.0 pt -126.93 140.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 171.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 m -103.95 112.53 25.54 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.41 HD11 HD12 ' A' ' 117' ' ' ILE . 46.2 mm -111.63 103.49 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.818 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 t -78.29 102.38 7.63 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -75.52 153.54 37.41 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.881 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . 0.255 27.7 t0 65.14 81.26 0.21 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 125.29 1.436 . . . . 0.0 112.947 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -120.42 27.58 8.5 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.018 -1.901 . . . . 0.0 106.409 172.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.23 35.34 6.69 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -173.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.92 -56.77 12.81 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.68 140.19 40.64 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 p -84.52 169.68 14.22 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -42.98 -56.92 3.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.687 1.195 . . . . 0.0 113.037 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.447 ' HA ' ' HG2' ' A' ' 132' ' ' GLU . 29.8 mt-10 -67.75 -37.15 81.75 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.719 -175.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -63.96 -42.89 97.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 135' ' ' VAL . 81.9 mt -58.92 -53.88 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.138 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 129' ' ' GLU . 8.4 pt-20 -68.6 -33.0 73.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -65.01 -41.54 95.24 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.566 173.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.2 ttt -68.8 -37.06 79.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.378 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 131' ' ' ILE . 81.1 t -60.89 -46.11 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -63.2 -32.33 73.7 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.763 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 22.4 mm-40 -59.23 -52.98 63.33 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.13 -29.53 69.86 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.409 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.77 -48.53 14.68 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.392 0.615 . . . . 0.0 112.439 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -71.24 -36.5 71.81 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.061 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -101.12 10.4 40.96 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 74.9 tttt -47.67 -54.48 11.91 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.974 0.91 . . . . 0.0 112.309 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.35 72.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.48 0.657 . . . . 0.0 111.413 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -72.81 -49.82 28.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.679 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -67.08 -39.41 86.8 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.499 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 48.6 mt-10 -60.37 -45.56 93.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.31 -32.92 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-O 121.405 0.621 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -74.69 -52.99 10.13 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.89 -0.507 . . . . 0.0 111.199 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 63' ' ' ARG . 55.2 ttp180 -69.82 -52.53 24.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.14 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -170.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 151' ' ' ARG . 22.6 mmt180 -91.29 -1.36 57.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.373 0.606 . . . . 0.0 110.762 176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.408 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 57.4 t -116.1 -58.3 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 t -90.94 87.39 6.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 122.659 1.219 . . . . 0.0 111.501 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.53 18.62 9.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 171.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 152' ' ' VAL . 49.9 pttt -137.64 137.77 38.79 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.217 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -94.65 97.27 9.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -143.08 127.81 18.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.441 HD23 HG22 ' A' ' 21' ' ' THR . 13.2 mt -118.72 146.75 44.5 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.4 ' HA ' HE22 ' A' ' 51' ' ' GLN 0.273 1.5 pp20? -132.47 173.77 10.95 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.2 t -110.16 14.97 22.7 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.933 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -104.31 -51.64 3.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 65.46 -57.43 0.31 Allowed 'General case' 0 C--O 1.25 1.12 0 C-N-CA 126.104 1.761 . . . . 0.0 114.368 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -168.55 -47.05 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -173.97 93.06 0.09 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.89 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 27.5 ttt -95.87 -42.7 8.18 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -131.5 121.89 25.24 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.4 m -82.1 -26.22 33.8 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.724 0.773 . . . . 0.0 109.026 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -131.82 140.56 49.19 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.96 133.98 42.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.017 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -51.87 120.79 5.68 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 113.024 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -78.42 116.46 18.84 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.984 174.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 150.3 43.53 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 82.18 5.42 89.67 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.2 96.51 10.06 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt 70.56 -33.62 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.389 1.476 . . . . 0.0 113.074 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 177' ' ' LYS . . . -72.61 104.73 1.58 Allowed Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 170.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 176' ' ' GLY . 77.5 tttt 86.63 72.62 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.758 1.623 . . . . 0.0 109.199 -170.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.689 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -78.78 -38.36 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.435 175.107 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 46.1 m -161.3 -71.09 0.06 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -142.58 -173.46 3.87 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -83.4 99.36 10.01 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.3 t70 64.9 -156.44 0.29 Allowed 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.148 0.905 . . . . 0.0 108.659 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -145.33 120.91 10.42 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 118.816 0.735 . . . . 0.0 109.757 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -120.32 -68.1 0.93 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.384 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.61 119.99 31.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.877 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 32.5 t -133.39 82.13 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 57.96 66.94 1.02 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.044 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -102.53 -6.7 22.57 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.79 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 192' ' ' GLU . 65.0 tttp 67.92 102.98 0.05 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.262 1.025 . . . . 0.0 111.87 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 69.84 -66.7 0.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.886 1.675 . . . . 0.0 110.957 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.463 ' HB2' ' HE3' ' A' ' 189' ' ' LYS . 46.6 mt-10 -93.49 84.33 4.68 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.69 128.39 42.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.62 73.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 122.249 1.024 . . . . 0.0 108.827 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.0 m -157.96 110.32 2.35 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.501 -1.681 . . . . 0.0 106.504 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 44.9 t-105 -89.04 -44.01 10.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.978 -0.101 . . . . 0.0 111.109 -174.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.89 31.05 19.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.112 0.965 . . . . 0.0 112.577 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 71.2 -46.81 0.65 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 124.575 1.15 . . . . 0.0 113.669 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 69.92 -77.51 0.05 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.51 1.524 . . . . 0.0 110.143 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.37 140.83 35.61 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 202' ' ' LEU . 27.6 m -83.03 72.83 10.08 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.119 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 201' ' ' THR . 1.4 tm? 160.03 85.68 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -130.35 139.03 50.7 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.552 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -88.07 155.96 19.53 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -86.42 90.95 8.37 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . 0.274 5.1 p-10 -158.18 -100.94 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.529 174.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 66.92 -71.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.475 1.11 . . . . 0.0 108.954 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -151.09 115.35 5.07 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 172.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -41.17 114.99 0.55 Allowed 'General case' 0 C--O 1.247 0.924 0 O-C-N 124.804 1.315 . . . . 0.0 111.956 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -130.11 87.2 2.49 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.69 113.83 24.67 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 168.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -67.83 110.59 3.89 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.588 0.708 . . . . 0.0 110.463 -174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -79.07 117.27 19.97 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.766 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -111.49 -178.99 3.59 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.743 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.7 mt -106.76 104.07 13.67 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.139 -175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.17 108.96 18.57 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -89.92 126.5 35.75 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.65 -3.66 9.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.684 0.754 . . . . 0.0 110.811 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -109.35 109.11 60.35 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.64 137.33 24.85 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.589 2.193 . . . . 0.0 113.192 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 12.8 tt -156.89 126.23 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.875 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.547 HG12 ' H ' ' A' ' 225' ' ' GLY . 15.7 tt -172.87 134.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 19.7 m -75.47 -24.88 57.01 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.045 0.45 . . . . 0.0 110.17 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.547 ' H ' HG12 ' A' ' 223' ' ' ILE . . . 96.93 -45.01 1.85 Allowed Glycine 0 CA--C 1.499 -0.933 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 53.2 tp -170.46 165.0 8.65 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -93.15 17.89 10.28 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.143 0.973 . . . . 0.0 111.037 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -144.26 165.5 27.71 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -70.22 108.82 2.61 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.78 -30.82 32.14 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.431 0.634 . . . . 0.0 109.533 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 105.12 -174.09 21.13 Favored Glycine 0 N--CA 1.422 -2.236 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.262 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 111.14 -96.88 0.92 Allowed Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.56 103.5 0.39 Allowed 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.625 2.217 . . . . 0.0 111.397 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -113.51 -83.42 1.21 Allowed Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.58 -27.37 61.4 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.484 2.123 . . . . 0.0 110.976 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -126.65 96.21 0.46 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -70.06 -42.62 67.43 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -134.45 -42.51 0.78 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 126.12 169.54 12.83 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.733 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -90.92 152.4 20.74 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -83.32 -21.44 33.2 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.82 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 178.25 94.37 0.09 OUTLIER Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -61.08 103.9 0.26 Allowed 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.834 2.356 . . . . 0.0 111.346 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.42 -12.03 41.42 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.79 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.92 -171.99 19.5 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.201 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -138.37 -158.67 7.83 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m 64.09 -65.23 0.13 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.703 1.601 . . . . 0.0 112.282 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.18 52.33 0.76 Allowed Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 16.0 m -82.55 -40.5 20.86 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -130.47 80.22 0.35 Allowed Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.7 149.7 43.73 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 122.904 2.402 . . . . 0.0 112.531 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 90.6 m 69.09 94.98 0.07 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.228 0.955 . . . . 0.0 111.856 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.468 HD13 ' H ' ' A' ' 253' ' ' ILE . 0.2 OUTLIER -119.92 174.74 4.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.358 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 254' ' ' GLU . 1.4 mp0 -66.48 131.31 45.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.983 0.802 . . . . 0.0 110.083 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -93.55 134.68 35.58 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.821 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 41.5 t -84.57 91.88 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--N 1.291 -1.964 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.893 -171.777 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -93.82 -61.71 1.49 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.308 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -85.9 103.96 15.11 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.7 p -134.67 96.81 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.104 0.954 . . . . 0.0 108.904 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -83.26 -29.28 28.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.097 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -122.06 130.75 53.54 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.282 0.563 . . . . 0.0 112.083 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.9 mt -119.38 33.29 5.7 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.5 mt 77.12 88.92 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.765 1.626 . . . . 0.0 112.925 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 tt -94.8 111.61 23.38 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.1 134.13 54.32 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.198 0.311 . . . . 0.0 110.225 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -75.52 53.55 0.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 35' ' ' THR . 24.7 m -138.22 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.48 112.51 53.34 Favored Pre-proline 0 C--N 1.281 -2.404 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.71 -32.59 18.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 121.861 1.707 . . . . 0.0 110.067 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.79 174.95 5.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.928 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 11.8 m -119.63 136.28 54.45 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.2 131.78 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.723 0.639 . . . . 0.0 109.384 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.19 178.13 32.86 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.4 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.2 mp -112.39 156.73 22.02 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.401 0.68 . . . . 0.0 109.233 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -90.9 109.37 20.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -93.66 173.73 7.54 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.727 -0.608 . . . . 0.0 111.383 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 118.61 5.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.959 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.76 6.79 32.4 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.87 39.49 64.77 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -99.14 131.08 47.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.84 118.12 29.19 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -114.07 111.38 21.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.7 122.53 38.56 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.962 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.412 HD12 ' CD2' ' A' ' 94' ' ' PHE . 48.1 mt -87.19 -37.61 17.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.413 0.625 . . . . 0.0 109.548 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 94' ' ' PHE . 3.4 mp -115.75 102.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.54 161.32 15.53 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.785 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -54.14 134.05 44.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 80.71 11.87 0.91 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.315 1.846 . . . . 0.0 113.552 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -86.22 132.97 33.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.43 ' HA ' HG12 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -62.51 140.54 58.62 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.495 1.118 . . . . 0.0 111.519 -176.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.454 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 35.3 pt -113.87 146.29 35.27 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.787 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 15.0 Cg_endo -65.31 141.63 49.68 Favored 'Cis proline' 0 CA--C 1.509 -0.731 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.055 -3.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -92.51 -70.76 0.68 Allowed 'General case' 0 N--CA 1.399 -3.008 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.464 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 1.1 tmtp? 67.12 101.0 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 124.996 1.318 . . . . 0.0 109.737 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -131.95 140.74 49.1 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 86.9 m -139.58 134.26 31.9 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -130.08 157.52 42.17 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.972 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.2 mm -89.88 114.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.34 148.08 24.03 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 19.6 p -122.8 171.49 9.15 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.857 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 24.4 p -109.08 136.93 47.79 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -90.96 -29.64 17.31 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -89.34 93.09 9.41 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.951 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 85' ' ' ARG . 6.2 p-10 -75.19 161.11 29.65 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.082 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 70.17 6.55 5.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.392 0.677 . . . . 0.0 112.705 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.3 131.43 50.6 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.0 Cg_endo -81.85 8.13 4.64 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.396 2.064 . . . . 0.0 112.322 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.41 175.03 44.32 Favored Glycine 0 N--CA 1.425 -2.035 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.6 171.59 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 123.323 0.649 . . . . 0.0 110.061 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.444 HD22 ' O ' ' A' ' 161' ' ' TYR . 44.2 tp -111.16 128.16 55.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.782 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.83 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.5 mt-30 -123.84 127.33 47.89 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.56 114.24 37.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 124.446 1.092 . . . . 0.0 110.325 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -109.52 149.67 29.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.717 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 16' ' ' SER . 45.1 tt0 -111.39 121.44 45.23 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.74 -171.48 22.66 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.449 ' HG3' ' CB ' ' A' ' 16' ' ' SER . 13.3 mt-10 -139.17 17.7 2.61 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -64.59 131.81 48.06 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.992 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -52.63 -50.43 63.16 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.929 2.092 . . . . 0.0 113.931 -168.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtt -95.99 128.78 43.19 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.34 86.06 0.28 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -168.04 168.04 12.17 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 76.64 -46.42 0.52 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.608 1.163 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -55.6 147.97 16.96 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.349 1.06 . . . . 0.0 108.629 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 60' ' ' GLU . 2.9 p-10 -90.03 139.09 30.95 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.282 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.08 132.71 35.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.827 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.8 mt -105.1 -41.3 5.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 0.0 111.365 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.34 39.69 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.132 -1.033 . . . . 0.0 111.427 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -150.13 166.0 31.13 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -170.14 144.43 2.63 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 124.595 1.184 . . . . 0.0 108.414 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -93.88 146.83 23.62 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -118.52 105.08 11.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -94.47 169.74 9.98 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.89 -25.96 6.01 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 62.4 mt -54.14 119.91 22.31 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.109 0.963 . . . . 0.0 111.446 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 93.2 Cg_endo -80.32 151.27 20.25 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.678 2.252 . . . . 0.0 112.861 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 13.4 Cg_exo -70.97 87.71 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.791 2.327 . . . . 0.0 110.821 175.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.91 166.16 30.42 Favored Pre-proline 0 C--N 1.29 -2.005 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -49.32 141.3 24.81 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.992 2.461 . . . . 0.0 111.409 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 46' ' ' THR . 35.1 ptt180 -64.57 126.15 26.96 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 -175.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.06 -25.96 13.21 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 70.1 t -66.08 -50.44 51.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.654 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 21.3 Cg_exo -68.86 121.23 8.1 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.137 1.224 . . . . 0.0 110.327 174.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -107.08 124.7 50.05 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mm -108.51 109.24 27.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.409 ' CB ' ' HD3' ' A' ' 109' ' ' LYS . 43.9 tt0 -94.85 109.17 21.19 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 41' ' ' THR . 33.9 t -111.23 126.16 68.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.731 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 87.5 m -106.29 125.38 50.92 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.413 ' HB3' ' CD1' ' A' ' 30' ' ' ILE . 5.2 m-85 -111.08 107.91 17.44 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 39' ' ' LYS . 22.6 t70 -126.15 124.49 40.62 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.34 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' PRO . 13.6 mt -106.75 125.57 62.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.5 -179.04 6.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.574 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.91 66.44 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.627 0.771 . . . . 0.0 112.777 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -77.06 -24.39 51.96 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.5 31.08 8.1 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.7 mt -97.17 128.27 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.44 111.7 21.41 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -100.64 114.54 28.32 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.43 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.52 ' HB ' HG22 ' A' ' 117' ' ' ILE . 74.9 t -110.48 125.23 67.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 m -122.71 119.6 31.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.58 117.57 33.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.7 m -112.74 120.59 42.02 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.22 106.87 13.53 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.409 ' HD3' ' CB ' ' A' ' 91' ' ' GLU . 30.3 mmmt -67.43 -19.87 65.43 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.732 -176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.96 -61.35 1.98 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 43.0 p -80.1 -32.69 39.1 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.665 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.68 12.31 44.41 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.703 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.461 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 20.7 pttp -111.2 161.42 16.0 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.485 -0.421 . . . . 0.0 110.603 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.27 148.89 40.56 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -128.68 146.7 50.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.414 ' HD2' ' C ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -131.45 164.29 26.06 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.19 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.52 HG22 ' HB ' ' A' ' 104' ' ' VAL . 14.7 tt -136.51 144.39 32.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 m -125.59 113.6 17.62 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.23 103.92 16.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.029 0.442 . . . . 0.0 110.727 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.8 m -75.25 151.7 38.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -72.21 78.5 0.97 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.808 1.289 . . . . 0.0 110.933 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -119.53 131.67 55.6 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.141 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -86.15 84.04 7.59 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.38 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.09 -66.69 1.3 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.383 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -107.0 -5.51 18.08 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.04 0.448 . . . . 0.0 111.649 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.7 mt -123.66 151.7 42.79 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.2 p -96.59 -77.21 0.49 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.928 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.8 tptt 178.15 -32.45 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.459 ' HA ' ' HG2' ' A' ' 132' ' ' GLU . 11.3 pt-20 -65.26 -32.58 74.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.59 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.8 -40.34 69.24 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.7 mt -67.11 -41.0 86.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.622 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 129' ' ' GLU . 13.1 pt-20 -68.84 -27.58 65.96 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.49 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 78.7 mtp180 -63.13 -40.62 98.12 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 mmt -63.38 -38.46 91.24 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.128 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.58 -47.88 89.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.049 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.84 -47.01 85.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.699 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.99 -32.9 74.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.682 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.42 -32.45 74.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 60.5 mm-40 -78.67 -36.66 43.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 110.793 174.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -69.0 -45.98 69.18 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.095 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.55 20.8 15.39 Favored 'General case' 0 C--O 1.198 -1.635 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 71.6 tttt -49.72 -60.14 3.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.083 1.353 . . . . 0.0 113.008 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.98 -32.74 73.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.887 0.375 . . . . 0.0 110.62 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -61.82 -53.41 56.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.048 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 10.6 m-20 -67.62 -37.45 82.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -59.52 -37.78 79.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.537 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 96.9 t -72.73 -47.08 51.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.554 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.83 -39.67 74.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -67.37 -32.71 73.82 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.99 -10.0 46.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.9 mmt180 -64.33 -36.1 83.01 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 120.835 0.35 . . . . 0.0 111.094 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.94 102.13 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.0 m -76.93 108.24 9.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.86 41.82 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-O 121.979 0.895 . . . . 0.0 112.561 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -82.17 148.13 28.64 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.64 94.76 0.45 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.182 0.515 . . . . 0.0 110.229 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -142.07 147.91 37.57 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.673 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.58 151.38 26.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -83.65 167.0 17.66 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.464 177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.2 t -132.14 109.95 10.33 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -171.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.445 ' HB3' ' CE2' ' A' ' 163' ' ' PHE . 43.0 m-85 -151.79 108.55 3.5 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 125.108 1.363 . . . . 0.0 108.655 172.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.74 115.56 25.27 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 161' ' ' TYR . 76.1 m-85 -129.92 160.81 32.45 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -110.77 136.13 50.29 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.671 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.6 mmt -125.82 137.01 53.75 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -92.69 68.5 4.68 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.535 0.683 . . . . 0.0 110.169 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 p -85.52 96.52 9.65 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.404 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.52 163.17 12.97 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.8 m -112.71 -55.47 4.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 69.21 170.3 0.3 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.661 1.184 . . . . 0.0 112.326 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -159.17 166.69 30.91 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.26 -35.21 66.18 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 78.85 -63.69 3.76 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.4 mt -75.63 -68.94 0.52 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? 70.79 -70.69 0.15 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.78 1.632 . . . . 0.0 110.885 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 66.94 -106.83 1.77 Allowed Glycine 0 C--N 1.332 0.343 0 CA-C-N 116.553 -0.294 . . . . 0.0 113.012 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 74.61 138.31 0.06 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.733 1.613 . . . . 0.0 112.465 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -156.68 136.13 3.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 20.8 t -113.3 -60.73 1.84 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.309 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 68.82 155.75 0.13 Allowed 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.842 1.257 . . . . 0.0 110.284 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.02 149.97 29.95 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.586 -0.696 . . . . 0.0 109.96 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -144.5 -153.4 0.47 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 73.76 11.2 4.64 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.257 1.423 . . . . 0.0 111.174 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -168.01 152.43 6.39 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -96.31 -29.23 14.1 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.418 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 59.0 t 73.3 -66.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.546 1.138 . . . . 0.0 110.933 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.9 tp -154.22 135.86 14.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.13 144.56 31.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -108.61 15.68 23.55 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.434 ' HA ' ' OE1' ' A' ' 191' ' ' GLN . 11.3 mm-40 -86.87 117.3 25.51 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.111 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.74 -48.06 70.32 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 124.065 0.853 . . . . 0.0 109.95 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 39.5 t 57.53 88.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.438 0 O-C-N 124.569 1.168 . . . . 0.0 110.491 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.552 HD13 ' H ' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -115.33 133.1 62.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.14 -177.261 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.8 m -83.47 88.22 7.0 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.79 -1.929 . . . . 0.0 105.79 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -113.25 99.07 7.53 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.961 -172.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.34 86.52 2.4 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -73.89 -35.22 64.67 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.749 0.785 . . . . 0.0 108.913 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -123.61 96.3 4.91 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.29 -1.323 . . . . 0.0 107.694 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -75.3 111.48 10.61 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 29.9 p -73.42 98.75 2.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.022 0.439 . . . . 0.0 110.415 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 42.3 tp -163.13 15.64 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.958 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -119.8 17.32 12.68 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.49 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -68.61 116.16 8.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.433 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -125.7 165.14 19.15 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.853 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -75.26 158.72 32.46 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.472 ' OE2' ' HG3' ' A' ' 211' ' ' LYS . 37.3 tt0 -88.89 74.31 8.24 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.459 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 56.59 28.53 14.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.398 -1.728 . . . . 0.0 115.101 171.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 62.32 -40.77 0.16 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -70.32 -19.09 63.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -172.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.472 ' HG3' ' OE2' ' A' ' 207' ' ' GLU . 27.8 mmtp -69.19 153.45 43.67 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.891 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.501 ' HG2' ' H ' ' A' ' 213' ' ' LYS . 10.0 ttm180 68.35 -168.55 0.19 Allowed 'General case' 0 C--O 1.247 0.927 0 O-C-N 124.657 1.223 . . . . 0.0 108.907 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.501 ' H ' ' HG2' ' A' ' 212' ' ' ARG . 99.2 mttt 72.26 -178.16 0.2 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.759 0.824 . . . . 0.0 111.546 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 68.43 117.54 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.647 1.579 . . . . 0.0 114.307 174.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.06 28.57 3.11 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.687 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -103.11 -171.86 2.02 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.82 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -81.51 75.96 8.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.099 0.952 . . . . 0.0 111.852 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.8 111.3 28.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.87 120.76 83.04 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -68.94 96.87 0.54 Allowed 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.853 1.702 . . . . 0.0 111.849 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 57.2 mt -82.28 79.32 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 11.6 tt -159.29 117.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.585 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.8 t -148.65 131.99 16.56 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -88.83 62.59 3.64 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.73 115.29 25.07 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -121.78 104.88 9.89 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -92.02 124.07 35.84 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.194 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.01 167.04 39.39 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.63 144.87 32.01 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -128.51 -59.69 0.11 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.425 ' HA2' ' HD3' ' A' ' 233' ' ' PRO . . . 98.46 141.16 11.94 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.425 ' HD3' ' HA2' ' A' ' 232' ' ' GLY . 3.5 Cg_exo -78.44 0.73 9.67 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.389 2.06 . . . . 0.0 111.867 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.42 -158.92 28.04 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.21 119.21 6.23 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.54 2.16 . . . . 0.0 110.763 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -80.89 75.27 2.29 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 128.73 176.95 14.64 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -144.6 137.17 26.53 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -107.4 -147.65 13.83 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.342 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . 68.43 112.15 0.04 OUTLIER 'General case' 0 C--O 1.247 0.963 0 C-N-CA 125.154 1.382 . . . . 0.0 113.147 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 75.74 99.7 0.07 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.636 1.574 . . . . 0.0 112.281 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -131.05 158.5 22.7 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.39 -26.09 14.72 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.136 1.891 . . . . 0.0 111.386 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -157.06 131.12 8.34 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -97.9 -160.21 30.66 Favored Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.944 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 179.17 -170.55 42.28 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.3 m -90.88 144.85 25.26 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 120.967 0.413 . . . . 0.0 110.027 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 130.95 78.36 0.18 Allowed Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.123 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 16.6 t -90.61 -178.8 5.39 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -136.08 73.13 0.45 Allowed Glycine 0 C--N 1.306 -1.114 0 C-N-CA 119.526 -1.321 . . . . 0.0 113.224 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.46 102.96 0.63 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.759 2.306 . . . . 0.0 110.252 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 53.6 m -159.81 133.95 7.46 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 37.2 pt -85.86 148.79 4.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -109.42 104.03 13.05 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.402 0.62 . . . . 0.0 112.254 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.28 139.47 33.2 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.81 18.79 5.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 123.209 1.481 . . . . 0.0 107.52 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--N 1.306 -1.304 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.807 -178.921 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' A' ' 6' ' ' ASP . 48.8 m . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -99.32 3.2 45.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.154 0.502 . . . . 0.0 110.128 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -96.13 150.25 20.72 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.76 -30.01 40.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 O-C-N 123.017 0.198 . . . . 0.0 111.014 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.462 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 12.5 mm-40 -135.04 101.74 4.98 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 1' ' ' SER . 5.1 p-10 -160.28 -173.89 4.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 tt -85.18 106.94 16.99 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.171 -1.011 . . . . 0.0 108.539 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.415 HD13 ' HB2' ' A' ' 1' ' ' SER . 66.2 tp -85.51 112.26 20.75 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.051 -175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt 62.17 83.94 0.15 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.859 1.264 . . . . 0.0 114.402 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt 176.14 85.45 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 174.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.4 m-20 -126.46 28.6 5.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.795 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 34' ' ' SER . 20.0 m -135.09 136.51 51.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.003 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -64.86 116.13 26.82 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 12.1 Cg_exo -70.71 -36.06 8.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 111.718 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.97 167.43 11.14 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 p -97.56 150.14 21.45 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.393 1.077 . . . . 0.0 110.496 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.456 HD13 HD22 ' A' ' 102' ' ' LEU . 60.2 mt -127.17 132.67 50.45 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.363 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.64 178.05 28.32 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.88 167.55 11.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.047 0.451 . . . . 0.0 111.021 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.58 109.0 17.63 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.635 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 HD23 ' A' ' 158' ' ' LEU . 16.8 p -100.82 162.58 12.81 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.509 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 155' ' ' LYS . . . -49.8 117.29 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 113.586 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.35 39.05 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.4 23.67 53.39 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.2 142.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 127.23 38.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.6 m -128.29 115.24 18.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.05 147.11 23.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.457 ' HG ' ' HG3' ' A' ' 42' ' ' GLN . 10.4 mp -116.51 -50.4 2.63 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.954 176.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 116.66 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.96 156.91 19.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.321 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.17 160.34 29.81 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.466 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 m120 70.39 16.65 7.1 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.726 1.21 . . . . 0.0 110.427 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 34.2 p -89.44 136.82 32.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.561 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 14.2 p -73.1 114.9 11.79 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 121.597 0.713 . . . . 0.0 111.184 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.463 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 22.2 pt -95.75 158.09 34.91 Favored Pre-proline 0 C--N 1.287 -2.115 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.794 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.8 Cg_exo -61.42 132.94 10.5 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 N-CA-C 114.848 1.057 . . . . 0.0 114.848 1.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -104.05 166.98 10.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.502 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.515 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 50.1 tttp -173.86 107.1 0.13 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.57 144.01 50.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -112.38 133.04 54.69 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.776 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.457 ' HG3' ' HG ' ' A' ' 29' ' ' LEU . 24.9 mm-40 -128.59 134.78 48.69 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.64 129.72 49.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.501 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 96.7 m-85 -121.96 167.88 12.56 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 17.0 p -135.21 170.79 15.38 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.437 0.16 . . . . 0.0 111.32 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -83.32 176.11 9.37 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.508 ' CE2' ' HB2' ' A' ' 22' ' ' ALA . 1.5 m-85 -81.97 -46.78 13.54 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.0 p -143.79 -171.77 3.6 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.659 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.62 162.27 18.9 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.904 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 82' ' ' PRO . 32.9 m-20 71.28 5.73 5.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.73 112.5 52.29 Favored Pre-proline 0 N--CA 1.402 -2.842 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -100.08 -9.58 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.259 1.973 . . . . 0.0 115.094 -173.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . -148.84 135.13 5.29 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.44 161.15 17.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.45 ' HG ' ' HG3' ' A' ' 57' ' ' GLN . 53.9 tp -111.48 108.5 18.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.196 0.522 . . . . 0.0 109.881 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 mm -83.09 99.86 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.45 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 45.4 mt-30 -109.06 119.02 38.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 104' ' ' VAL . 45.0 t -99.27 124.49 52.59 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 O-C-N 123.655 0.597 . . . . 0.0 110.154 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 80.1 m-85 -122.13 146.84 46.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.389 0.614 . . . . 0.0 111.559 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' A' ' 72' ' ' LEU . 39.8 tt0 -111.52 120.11 41.03 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.342 177.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.55 -166.83 24.42 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -153.16 134.46 14.22 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.633 0.773 . . . . 0.0 110.118 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 65' ' ' MET . 40.1 mtp180 -158.13 -176.36 5.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.094 1.358 . . . . 0.0 108.715 171.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.16 73.98 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 122.398 1.094 . . . . 0.0 108.802 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 65.7 mtt -105.0 162.42 13.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.513 -1.676 . . . . 0.0 107.619 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.25 16.06 2.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.646 0.736 . . . . 0.0 109.679 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -85.95 154.77 21.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.557 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 81.58 -32.53 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.581 1.552 . . . . 0.0 110.967 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.614 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 12.7 m120 -64.0 168.01 5.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.468 ' HA ' HD13 ' A' ' 126' ' ' LEU . 35.0 t30 -90.11 117.67 29.07 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.403 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.38 122.05 27.49 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 60' ' ' GLU . 3.5 mp -95.47 -49.85 5.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.36 0.6 . . . . 0.0 109.414 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.29 162.46 34.84 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -152.91 158.05 41.55 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -159.58 163.12 35.33 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.97 143.0 33.78 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.849 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.433 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 2.1 tt -108.49 104.11 13.38 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 103.375 -2.824 . . . . 0.0 103.375 171.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.4 p -120.45 107.95 13.51 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.295 0.569 . . . . 0.0 110.622 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.97 19.25 0.02 OUTLIER Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.352 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.79 127.47 83.96 Favored Pre-proline 0 C--O 1.249 1.072 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.91 153.98 71.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.883 2.389 . . . . 0.0 111.736 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 31.3 Cg_endo -65.96 89.56 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.34 2.027 . . . . 0.0 112.284 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.33 144.65 53.3 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.8 148.78 81.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.731 2.287 . . . . 0.0 111.119 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.35 132.28 50.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.243 0.544 . . . . 0.0 111.254 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.68 -34.15 4.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.57 -56.16 1.48 Allowed Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 93.81 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.147 1.231 . . . . 0.0 110.526 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -96.46 124.7 40.54 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.503 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mm -99.72 117.48 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -90.64 106.54 18.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -102.32 115.39 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 m -109.03 126.09 52.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.536 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.411 ' CD2' HD22 ' A' ' 29' ' ' LEU . 2.9 m-85 -115.45 121.23 42.1 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.604 0.762 . . . . 0.0 109.726 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.515 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.1 p30 -140.03 137.08 34.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 71.4 mt -112.3 135.04 52.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.8 p-10 -91.19 -168.52 2.08 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -24.39 64.26 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.407 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 6.0 t30 -81.54 -29.81 33.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.135 0.493 . . . . 0.0 109.902 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.01 24.53 5.44 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 84.6 mt -88.95 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 17' ' ' LEU . 49.4 tp -94.42 118.38 31.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.663 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -103.35 115.92 31.45 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 121.415 0.626 . . . . 0.0 110.476 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 58' ' ' VAL . 96.7 t -100.38 114.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.961 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.2 m -122.94 120.59 33.87 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.19 117.51 33.42 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.9 m -116.53 124.18 49.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.363 0.414 . . . . 0.0 112.019 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.75 114.26 12.98 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 123.607 0.763 . . . . 0.0 111.076 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 109' ' ' LYS . 33.6 mmtp -67.76 -12.22 60.1 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -79.34 -62.66 1.62 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.966 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -94.68 -30.31 14.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.152 0.501 . . . . 0.0 112.303 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.98 4.97 41.61 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.274 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.85 132.02 47.66 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 121.144 0.497 . . . . 0.0 111.073 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.67 43.89 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.102 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -129.51 128.19 42.31 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 165.83 15.15 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.506 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.63 138.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.8 m -100.57 113.68 26.7 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -115.57 96.93 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 26.8 m -66.51 125.41 25.63 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 170.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -60.66 96.97 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.9 t70 177.5 -33.91 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -68.87 137.65 54.06 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.021 170.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 160.96 164.99 16.84 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -113.3 9.89 18.36 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.255 0.55 . . . . 0.0 111.069 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 70' ' ' ASN . 7.5 mp -129.1 155.39 45.53 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.789 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.469 ' O ' HG13 ' A' ' 131' ' ' ILE . 37.4 p -84.27 147.69 27.1 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.646 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 128' ' ' LYS . 1.8 tpmt? -53.94 -46.98 71.71 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.147 0.579 . . . . 0.0 111.906 -174.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -59.19 -42.16 90.23 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.548 1.139 . . . . 0.0 109.907 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 127' ' ' SER . 51.9 tt0 -66.95 -41.51 86.82 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.546 1.138 . . . . 0.0 109.347 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 127' ' ' SER . 96.1 mt -61.11 -41.49 89.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.815 176.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.33 -37.67 87.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -63.86 -45.76 88.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.614 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 40.2 ttp -54.77 -48.69 72.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.466 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.422 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 78.7 t -61.81 -40.71 87.93 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.842 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -61.94 -38.39 88.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 36.6 mt-10 -72.55 -34.42 67.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.576 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.57 -43.27 94.44 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.976 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 12.1 mm-40 -59.98 -38.04 81.42 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.952 0.882 . . . . 0.0 110.479 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 87.4 tttt -61.73 -28.56 69.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.839 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -126.91 23.49 6.6 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.342 -0.224 . . . . 0.0 111.153 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.75 -29.48 69.99 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -66.3 -40.13 89.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -70.61 -50.09 40.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 0.5 OUTLIER -59.21 -43.49 92.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.077 178.447 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 149' ' ' ARG 0.296 22.2 mt-10 -68.73 -32.52 72.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 118.436 -1.306 . . . . 0.0 113.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 76.6 t -61.8 -40.95 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.246 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 79.5 mt-30 -57.17 -46.21 82.98 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 8.6 ptm180 -71.49 -35.36 70.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 146' ' ' GLU . 43.2 mt-10 -72.9 -21.71 60.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.497 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 22.2 mmt180 -64.82 -28.56 69.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.312 0.577 . . . . 0.0 109.672 173.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.41 -35.58 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 51.6 m 71.04 85.4 0.13 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.906 1.282 . . . . 0.0 112.775 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 43.93 80.37 0.04 OUTLIER 'General case' 0 C--O 1.244 0.811 0 C-N-CA 125.562 1.545 . . . . 0.0 114.269 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 17.4 tppt? -81.28 110.74 17.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 4.3 t30 -111.09 33.0 4.88 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.829 1.3 . . . . 0.0 109.629 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -121.67 142.16 50.43 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 21' ' ' THR . 27.6 mt -92.5 150.0 21.03 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.311 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.43 143.79 40.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.777 0.799 . . . . 0.0 111.718 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.5 m -123.31 92.45 3.7 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -79.35 143.93 34.66 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.502 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.05 82.88 5.18 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.845 0.355 . . . . 0.0 111.909 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 53.73 89.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.41 1.484 . . . . 0.0 113.958 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -74.02 -21.99 59.76 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 84.1 mtp -61.33 -23.27 65.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.132 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -117.22 89.11 3.04 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.1 t -121.45 129.77 53.17 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.21 -177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.6 89.76 1.2 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.21 79.34 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.868 0.842 . . . . 0.0 110.911 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 171' ' ' ASP . 6.6 pt-20 -123.88 -100.41 0.41 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.51 172.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.465 ' H ' ' HG3' ' A' ' 170' ' ' GLU . 24.7 t70 62.69 157.26 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 167.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 73.6 -54.14 0.69 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.72 1.608 . . . . 0.0 113.001 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -71.83 100.7 0.94 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -131.58 100.82 5.26 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -128.05 173.38 10.11 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.698 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -137.0 101.48 0.35 Allowed Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 65.3 178.34 0.2 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.258 1.423 . . . . 0.0 111.476 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.0 147.07 12.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.745 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 17.8 t -79.07 86.85 4.87 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.09 0.471 . . . . 0.0 109.968 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 69.56 -63.21 0.39 Allowed 'General case' 0 C--O 1.246 0.887 0 C-N-CA 125.711 1.604 . . . . 0.0 113.185 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -130.52 144.69 51.57 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 120.99 0.424 . . . . 0.0 110.876 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.44 171.2 9.2 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.462 ' NZ ' ' HA ' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -119.59 18.84 12.71 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 123.111 0.565 . . . . 0.0 110.136 -177.119 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.94 12.08 14.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -172.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -63.09 139.22 58.75 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.012 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.27 165.6 2.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.683 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.7 130.31 35.1 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -100.64 -51.56 3.56 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 123.525 0.516 . . . . 0.0 111.897 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -141.07 110.71 6.43 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.182 -169.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -102.65 14.35 32.17 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -82.58 85.27 7.01 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.54 -35.39 50.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.205 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 29.7 pt -55.89 96.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.268 1.033 . . . . 0.0 113.17 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.4 m -102.42 -26.59 13.21 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.409 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -81.4 80.37 7.81 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 122.166 0.984 . . . . 0.0 112.583 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.3 mp -122.21 -46.0 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.297 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.3 141.16 48.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.725 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -136.31 12.77 3.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -87.01 -22.21 25.65 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.641 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 17.3 m -73.31 79.08 1.34 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.628 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 59.3 tp -173.09 101.63 0.13 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.287 1.035 . . . . 0.0 108.61 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -79.96 -63.16 1.48 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -153.82 141.59 20.04 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -93.0 113.95 26.37 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 119.251 -0.979 . . . . 0.0 112.362 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -92.18 80.91 5.02 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.36 -58.1 1.0 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.256 -1.338 . . . . 0.0 107.447 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 54.99 77.38 0.21 Allowed 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.695 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -94.24 132.22 39.03 Favored 'General case' 0 N--CA 1.416 -2.134 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.071 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -61.08 -54.16 48.09 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 123.51 0.506 . . . . 0.0 109.946 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -149.07 69.53 1.07 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . 0.265 75.3 ttt180 42.6 -104.53 0.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 112.307 -2.224 . . . . 0.0 112.552 -170.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -157.06 22.46 0.31 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -150.37 160.13 43.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -175.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 51.6 tp -149.53 152.76 36.09 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 67.29 84.66 0.15 Allowed 'General case' 0 C--N 1.344 0.353 0 O-C-N 124.429 1.08 . . . . 0.0 110.404 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.35 105.28 17.37 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.372 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.1 m -142.05 98.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.536 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -147.08 119.58 4.81 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -48.01 -43.23 30.79 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.296 2.664 . . . . 0.0 112.769 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 50.3 mm -101.59 94.46 3.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.717 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.0 mm -81.55 -34.37 13.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t -169.22 169.87 8.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 178.54 -153.22 12.36 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 94.2 mt 62.26 35.35 15.38 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.621 0.768 . . . . 0.0 110.595 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -89.63 141.65 28.4 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.344 0.592 . . . . 0.0 111.406 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -121.92 94.21 4.24 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 85.28 -73.5 2.6 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -128.67 -68.04 0.77 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.12 44.32 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.595 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -166.53 177.0 41.58 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.72 145.45 98.13 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.019 2.479 . . . . 0.0 111.587 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -92.62 116.32 5.07 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-O 119.626 -0.541 . . . . 0.0 113.061 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.51 145.78 78.31 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 123.702 2.935 . . . . 0.0 113.231 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -149.54 -100.13 0.21 Allowed Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 89.05 21.32 42.61 Favored Glycine 0 C--N 1.312 -0.793 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -103.21 142.85 33.45 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.264 1.026 . . . . 0.0 108.668 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -125.77 -153.35 8.41 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -77.09 108.93 10.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -94.76 -26.86 16.08 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.23 96.52 2.32 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.83 115.65 2.7 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.08 2.52 . . . . 0.0 112.822 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -113.92 -6.85 13.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.224 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -105.71 -1.65 39.95 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -145.54 156.12 26.81 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.7 m -86.84 138.35 31.65 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 117.158 0.479 . . . . 0.0 111.262 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 252' ' ' THR . . . -81.42 -155.5 13.86 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.156 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 77.7 p 63.81 -35.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.999 1.719 . . . . 0.0 114.666 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -144.07 -67.99 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.115 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.964 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.81 -62.16 0.25 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.06 2.507 . . . . 0.0 114.747 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.588 ' O ' ' HA2' ' A' ' 248' ' ' GLY . 14.0 m -120.59 114.6 21.97 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 253' ' ' ILE . 0.2 OUTLIER -127.25 -61.56 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.8 -178.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -147.85 -60.78 0.26 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -147.37 123.07 10.54 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.027 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.577 HG23 ' H ' ' A' ' 257' ' ' ASP . 3.3 m -115.39 -81.1 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.577 ' H ' HG23 ' A' ' 256' ' ' VAL . 38.2 t70 . . . . . 0 CA--C 1.488 -1.429 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -90.94 8.0 37.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.976 0.417 . . . . 0.0 111.928 -175.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -83.42 5.3 24.15 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.897 -0.502 . . . . 0.0 111.345 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.88 -34.84 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.405 ' HA ' HD23 ' A' ' 8' ' ' LEU . 46.3 mt-30 -99.44 78.71 2.21 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -91.47 -64.37 1.13 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.668 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.1 tp -147.48 85.29 1.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.324 0.583 . . . . 0.0 110.399 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 5' ' ' GLN . 3.3 mm? -110.82 -24.23 10.56 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.699 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.0 85.04 7.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.726 0.775 . . . . 0.0 110.022 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.85 -179.9 4.31 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.106 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.45 67.68 8.59 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.547 1.165 . . . . 0.0 109.883 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 28.0 m -121.24 -177.17 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-N 113.822 -1.536 . . . . 0.0 107.682 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 110.2 42.94 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.55 -27.77 45.78 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.006 1.804 . . . . 0.0 111.702 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.474 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . 99.7 mt -130.93 156.13 45.6 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.791 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 m -77.35 141.51 39.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 123.665 0.603 . . . . 0.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.7 130.96 45.2 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -157.17 -176.53 29.34 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 119.092 -1.528 . . . . 0.0 114.304 -175.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 89.0 mt -118.42 150.81 38.93 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 123.933 0.893 . . . . 0.0 109.572 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 34.8 tt0 -89.56 109.82 20.73 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.421 HG22 ' HG ' ' A' ' 158' ' ' LEU . 16.0 p -89.69 172.62 8.8 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.694 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.22 110.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.177 0.513 . . . . 0.0 111.57 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -9.16 8.42 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.96 19.41 51.16 Favored Glycine 0 CA--C 1.494 -1.23 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.88 135.64 24.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 62' ' ' GLU . 23.9 ttt -89.54 112.2 23.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.253 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 m -110.26 110.93 21.93 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -97.9 135.44 39.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.101 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -90.94 -49.44 6.43 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -96.85 114.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -80.78 141.5 34.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -58.78 154.09 15.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.673 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 80.25 3.59 1.89 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.749 1.619 . . . . 0.0 111.45 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 t -91.34 136.97 32.73 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 1.5 m -73.03 143.88 47.36 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 123.718 0.807 . . . . 0.0 111.504 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.422 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 42.4 pt -99.51 154.11 37.44 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 42.2 Cg_exo -62.09 144.61 46.07 Favored 'Cis proline' 0 C--O 1.247 0.974 0 CA-C-N 120.2 1.107 . . . . 0.0 113.258 0.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.3 m -129.44 145.53 51.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 55.0 tttp -142.33 112.75 7.18 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 29.8 tp60 -128.56 125.58 38.56 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 m -109.11 134.79 51.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -140.56 156.35 46.33 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.2 mm -101.87 128.65 54.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -117.72 166.16 12.76 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.786 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 2.9 p -148.27 170.81 17.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 122.709 0.404 . . . . 0.0 111.591 -172.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.411 ' HB ' ' OG ' ' A' ' 48' ' ' SER . 41.3 p -103.79 166.04 10.67 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.417 ' C ' ' HB3' ' A' ' 85' ' ' ARG . 93.8 m-85 -95.75 -14.97 22.91 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 165.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.411 ' OG ' ' HB ' ' A' ' 46' ' ' THR . 27.3 p -97.0 178.54 5.24 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.309 -170.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -136.06 134.49 38.49 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 126.471 1.909 . . . . 0.0 106.379 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.412 HD21 ' HB3' ' A' ' 82' ' ' PRO . 33.5 m-80 70.14 6.28 5.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 41.6 tt0 -53.52 129.2 53.1 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 123.665 0.786 . . . . 0.0 112.887 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.28 79.3 3.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.231 1.954 . . . . 0.0 112.749 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.667 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . 96.63 131.59 6.94 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.966 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -105.95 130.14 57.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HG ' ' HG3' ' A' ' 57' ' ' GLN . 55.0 tp -83.56 112.37 19.94 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.726 -176.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 45.5 mm -98.82 105.38 17.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.605 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 48.6 mt-30 -104.44 117.55 34.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -96.67 121.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 O-C-N 124.313 1.008 . . . . 0.0 110.551 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 83.4 m-85 -125.48 156.6 38.69 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.634 0.374 . . . . 0.0 110.571 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 70' ' ' ASN . 8.7 pt-20 -122.57 130.77 53.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 15' ' ' LEU . . . 144.09 -155.8 26.41 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.512 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 13.8 mt-10 -161.86 134.05 5.72 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.703 1.601 . . . . 0.0 111.487 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -158.91 170.0 23.07 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 126.554 1.942 . . . . 0.0 106.099 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.81 -47.69 29.32 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.8 mtm -116.98 123.45 46.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.0 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.43 108.71 0.85 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 125.531 1.532 . . . . 0.0 111.037 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -166.81 -36.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.337 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.53 3.89 54.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.745 0.784 . . . . 0.0 109.315 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.489 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 16.6 m120 -100.5 169.51 9.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.726 -173.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.484 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 47.7 t30 -99.4 123.68 43.88 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.442 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.0 tp -83.99 123.22 29.76 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.191 0.596 . . . . 0.0 110.224 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -95.35 -22.55 17.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.97 175.7 33.28 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.987 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 8.5 ptp180 -153.04 151.42 30.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -155.88 157.87 37.08 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -112.03 133.86 53.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.502 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.667 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 54.8 tp -87.1 106.61 17.98 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 172.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 p -67.26 125.42 26.02 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' H ' ' N ' ' A' ' 53' ' ' GLY . . . 46.19 96.73 0.01 OUTLIER Glycine 0 C--N 1.344 0.974 0 C-N-CA 125.72 1.629 . . . . 0.0 116.866 173.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.437 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -79.63 155.27 76.07 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 28.5 Cg_endo -59.97 161.95 17.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.921 2.414 . . . . 0.0 113.436 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HB3' HD21 ' A' ' 50' ' ' ASN . 21.9 Cg_endo -67.25 73.19 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.834 2.356 . . . . 0.0 112.19 175.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.43 142.1 42.86 Favored Pre-proline 0 N--CA 1.417 -2.115 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.87 167.07 28.26 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.39 2.06 . . . . 0.0 112.627 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HB3' ' C ' ' A' ' 47' ' ' TYR . 10.6 ptt180 -47.24 124.38 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.196 0.998 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.16 -29.07 9.56 Favored Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.032 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.03 -52.28 1.22 Allowed Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.993 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.22 94.78 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 CA-C-N 120.683 1.28 . . . . 0.0 110.411 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.11 113.2 17.04 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.285 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.8 mm -92.84 108.06 19.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.425 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 37.2 tt0 -90.49 106.49 18.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' THR . 47.2 t -104.81 131.98 52.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.0 m -130.64 127.45 38.96 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.267 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 4.5 m-85 -103.46 113.02 26.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.4 p30 -125.25 125.08 43.01 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.846 175.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 12.1 mt -107.83 145.35 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.25 -160.64 0.82 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.66 51.11 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.43 -29.02 52.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.918 0.39 . . . . 0.0 111.989 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.35 29.22 4.04 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 75.3 mt -87.6 116.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.9 tp -98.88 118.88 36.64 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.288 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -107.6 104.56 14.13 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.274 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 58.0 t -93.45 114.1 29.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.4 m -113.33 124.24 52.01 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.144 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.88 117.81 34.42 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 26.7 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.072 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.18 100.88 10.1 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 53.3 mtpt -67.65 -13.48 62.13 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.4 m -82.56 -47.34 12.24 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.165 0.507 . . . . 0.0 110.537 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -101.38 -27.06 13.36 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.48 45.09 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.264 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 147.82 27.23 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.73 146.24 34.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.46 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.53 131.11 48.25 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 12.3 ptmm? -122.98 135.31 54.43 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.446 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.8 pt -106.94 137.8 35.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.406 HG22 HG23 ' A' ' 120' ' ' THR . 84.9 m -108.53 112.08 24.27 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.055 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.13 97.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.406 HG23 HG22 ' A' ' 118' ' ' THR . 15.7 p -92.59 101.26 13.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.27 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 43.97 72.94 0.16 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.381 1.051 . . . . 0.0 112.717 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -128.06 137.44 52.16 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -101.85 14.35 32.2 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.988 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.36 -125.04 6.94 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.549 173.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -117.08 -29.36 5.97 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.629 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . 88.5 mt -97.61 142.89 28.86 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.86 0.362 . . . . 0.0 111.179 -177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.0 p -82.17 170.94 14.87 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.104 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 9.8 ptpp? -56.01 -33.24 64.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' HG2' ' A' ' 132' ' ' GLU . 45.2 tt0 -68.94 -41.11 78.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 66.4 mm-40 -68.66 -34.72 76.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 135' ' ' VAL . 78.1 mt -64.63 -52.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.774 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 129' ' ' GLU . 9.5 pt-20 -64.0 -30.45 71.52 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.795 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 44.1 mtp85 -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.588 174.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 20.8 ptt? -70.73 -21.3 62.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.611 -0.836 . . . . 0.0 113.018 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 131' ' ' ILE . 93.5 t -63.3 -50.01 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.63 -34.94 77.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.792 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 40.7 mm-40 -62.95 -47.02 85.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.45 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.29 -29.91 70.72 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 142' ' ' LYS . 30.6 mm-40 -75.47 -45.91 35.63 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -72.59 -46.61 53.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.022 0.439 . . . . 0.0 111.077 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.65 22.84 7.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 60.0 mttp -42.84 -59.19 2.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.663 0.602 . . . . 0.0 110.524 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.33 -37.51 67.53 Favored 'General case' 0 C--O 1.231 0.086 0 O-C-N 124.312 1.007 . . . . 0.0 112.733 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.94 -53.23 11.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.778 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 13.2 m-20 -70.07 -31.6 69.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 12.4 pt-20 -67.49 -42.9 82.16 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.42 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 79.5 t -67.7 -42.38 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -61.62 -45.48 93.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 5.1 ptp180 -65.65 -32.13 73.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.817 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -78.95 -24.32 43.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 22.4 mmm180 -61.84 -40.58 95.79 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.218 176.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.63 146.07 7.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m -57.11 140.54 49.05 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.24 103.91 7.44 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -86.44 134.75 33.67 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.036 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.04 22.02 13.29 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 166.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.603 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -120.3 140.17 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.706 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 21' ' ' THR . 1.6 mp -117.53 149.97 39.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.93 163.4 12.98 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.407 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 16.0 m -153.06 90.19 1.43 Allowed 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 71.9 t80 76.5 89.08 0.08 Allowed 'General case' 0 C--O 1.242 0.69 0 O-C-N 124.836 1.335 . . . . 0.0 109.839 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 85.89 138.73 0.05 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.145 1.778 . . . . 0.0 112.627 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -90.42 83.09 5.87 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.275 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.3 t30 71.89 153.3 0.13 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.49 1.116 . . . . 0.0 111.597 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.0 mmt -119.4 11.5 12.2 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.731 -0.606 . . . . 0.0 110.88 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -122.05 177.89 5.13 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.0 t -92.55 102.64 15.08 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.1 88.11 3.0 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.342 0.591 . . . . 0.0 110.528 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.79 160.04 3.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.016 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -130.97 91.29 3.02 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.913 0.863 . . . . 0.0 111.336 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -80.56 -40.16 26.38 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.918 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 64.19 -81.57 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.831 1.252 . . . . 0.0 111.708 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 66.17 -136.45 34.94 Favored Glycine 0 N--CA 1.436 -1.341 0 O-C-N 123.489 0.493 . . . . 0.0 113.012 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.4 mt 71.83 4.83 5.17 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.449 1.5 . . . . 0.0 111.903 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -126.28 161.63 27.32 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.63 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 91.16 47.47 3.57 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.56 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -158.75 172.09 18.88 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.1 pp -138.5 -174.44 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 123.109 0.564 . . . . 0.0 111.333 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 29.9 m 85.24 7.63 0.42 Allowed 'General case' 0 C--O 1.248 1.008 0 C-N-CA 125.891 1.677 . . . . 0.0 113.04 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.44 -60.11 2.31 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -126.23 99.48 5.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -104.56 161.8 13.8 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -69.22 -50.14 50.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.224 0.535 . . . . 0.0 110.689 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -142.69 97.9 3.19 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -130.1 89.7 2.84 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.68 0.752 . . . . 0.0 109.105 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.95 3.3 7.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.926 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.5 tp -117.46 150.63 38.6 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.91 76.36 3.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.742 1.258 . . . . 0.0 111.676 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -94.06 85.09 4.61 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 69.63 176.46 0.28 Allowed 'General case' 0 C--O 1.245 0.833 0 O-C-N 124.197 0.936 . . . . 0.0 110.887 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 67.73 17.42 9.8 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 122.126 0.965 . . . . 0.0 109.422 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 52.9 t -104.57 113.33 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 16.4 tt -102.04 85.5 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.535 1.159 . . . . 0.0 111.081 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.2 m -86.98 118.49 26.39 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.0 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 25.1 m-90 -84.84 87.3 7.32 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 197' ' ' LEU . 2.2 pt? -83.23 -19.7 35.94 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -81.82 98.98 8.75 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -90.58 161.9 15.24 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -74.44 131.75 41.33 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 17.6 m -53.02 116.92 2.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 124.523 1.139 . . . . 0.0 110.867 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 49.1 tp -87.22 81.69 7.88 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 122.05 0.929 . . . . 0.0 109.843 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.24 97.01 2.25 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.541 ' HG3' ' HG3' ' A' ' 205' ' ' LYS . 12.5 tp10 -79.53 -70.49 0.51 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.304 -172.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.541 ' HG3' ' HG3' ' A' ' 204' ' ' GLU . 49.1 mttm -139.99 116.76 10.91 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 121.791 -0.568 . . . . 0.0 110.914 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -108.14 94.13 4.9 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.85 171.82 11.91 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.848 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -149.36 111.99 4.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -53.58 132.96 41.27 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.322 0.649 . . . . 0.0 112.447 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -113.06 85.52 2.19 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.067 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.36 89.57 3.14 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -176.29 102.85 0.06 Allowed 'General case' 0 C--O 1.248 0.984 0 O-C-N 123.895 0.747 . . . . 0.0 110.67 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt 171.57 83.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.374 1.469 . . . . 0.0 107.806 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.58 144.67 27.63 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.06 153.64 30.04 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -108.99 165.25 11.73 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -152.98 96.75 2.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.365 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.97 96.21 4.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -121.63 120.37 28.77 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.16 121.74 9.9 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.168 1.912 . . . . 0.0 111.607 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 63.4 mt -85.07 91.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.47 2.34 6.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.662 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 30.8 t -117.41 121.4 40.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.329 0.585 . . . . 0.0 110.31 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -147.71 112.6 0.6 Allowed Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.7 tt -94.51 96.23 9.34 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.382 0.61 . . . . 0.0 109.786 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -148.69 114.48 5.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -133.7 -52.16 0.86 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.725 -172.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 143.44 113.06 0.89 Allowed Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.638 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -125.78 154.67 42.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -151.24 -157.33 7.81 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.535 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -161.97 87.76 0.11 Allowed Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.973 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.79 128.0 20.99 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.586 2.191 . . . . 0.0 110.531 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -135.18 101.82 0.41 Allowed Glycine 0 N--CA 1.427 -1.9 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.0 154.38 57.83 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 122.079 1.853 . . . . 0.0 110.836 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.96 34.25 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.053 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.35 75.54 2.31 Favored Glycine 0 C--N 1.299 -1.519 0 C-N-CA 121.244 -0.503 . . . . 0.0 111.869 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -76.74 143.25 40.07 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 112.58 81.1 1.07 Allowed Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -175.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.1 85.31 6.93 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.218 0.532 . . . . 0.0 110.815 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -150.0 115.6 5.54 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -105.2 -159.45 23.27 Favored Glycine 0 C--N 1.292 -1.915 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.75 104.45 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.646 2.231 . . . . 0.0 111.097 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -78.2 109.96 12.76 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 162.11 -157.1 28.88 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -171.47 -51.18 0.04 OUTLIER Glycine 0 C--N 1.301 -1.404 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.697 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.3 t 64.12 86.48 0.12 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 124.886 1.274 . . . . 0.0 110.13 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -142.14 47.56 0.82 Allowed Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.625 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 16.0 m -88.7 154.95 19.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -75.55 162.74 53.4 Favored Glycine 0 C--O 1.246 0.903 0 CA-C-O 119.846 -0.419 . . . . 0.0 112.665 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.91 127.47 18.65 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 123.131 2.554 . . . . 0.0 111.83 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 15.7 m -81.2 84.83 6.47 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.458 0.647 . . . . 0.0 110.996 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 253' ' ' ILE . 2.3 pp -95.35 123.7 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.024 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.19 -31.27 34.05 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -170.46 147.79 3.03 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 173.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.26 74.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-O 121.934 0.873 . . . . 0.0 110.602 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.282 178.062 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.241 0.642 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 72.8 -43.66 0.57 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.3 m120 70.55 78.96 0.18 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.509 1.123 . . . . 0.0 109.884 -176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.17 -11.93 11.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.075 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -106.82 9.18 31.04 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.775 0.798 . . . . 0.0 109.677 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.55 157.49 18.6 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.695 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.5 mt -131.46 121.54 24.71 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.773 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp 70.11 141.28 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.864 1.352 . . . . 0.0 112.013 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 tp -97.79 98.5 9.89 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.2 tp -102.74 164.3 11.72 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.388 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 59.2 68.75 0.78 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.477 1.132 . . . . 0.0 110.032 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 35' ' ' THR . 34.1 m -137.55 -178.55 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.371 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.9 123.27 82.33 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.426 ' C ' HD12 ' A' ' 15' ' ' LEU . 19.5 Cg_endo -60.51 -51.48 5.12 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.3 2.0 . . . . 0.0 110.907 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.546 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 7.3 mp -128.1 167.37 16.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.626 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 18.5 m -72.5 142.45 48.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 O-C-N 123.614 0.571 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -114.0 132.12 56.1 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.782 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 28' ' ' ALA . . . -147.79 -177.42 22.18 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.044 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.496 HD11 HG11 ' A' ' 92' ' ' VAL . 83.6 mt -122.83 167.94 12.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.896 0.379 . . . . 0.0 111.63 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.21 109.34 17.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.391 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 p -109.47 158.34 18.07 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.437 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.11 115.93 1.36 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.903 1.281 . . . . 0.0 113.252 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.21 10.74 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.821 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.37 44.17 5.36 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.34 137.17 55.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 33.1 ttp -96.71 112.05 23.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -94.42 112.3 24.07 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . . . -90.28 133.67 34.8 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.666 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.629 ' HG ' ' OE1' ' A' ' 42' ' ' GLN . 5.9 mp -100.93 -39.67 7.64 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.69 129.85 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -101.31 162.6 12.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.42 ' HD3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -70.91 142.2 51.14 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.824 178.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' OD1' ' HD3' ' A' ' 32' ' ' ARG . 16.9 m120 80.64 -6.09 1.69 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.24 1.416 . . . . 0.0 113.252 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.7 m -65.19 115.29 5.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 12' ' ' VAL . 2.7 m -71.03 129.9 40.18 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.193 -172.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.425 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 28.4 pt -92.97 155.76 41.08 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.029 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.1 Cg_exo -63.48 141.83 42.86 Favored 'Cis proline' 0 N--CA 1.487 1.098 0 C-N-CA 124.604 -0.998 . . . . 0.0 114.24 0.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.6 p -120.89 152.84 37.97 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.762 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 47.6 tttp -153.41 99.81 2.38 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -108.42 135.31 49.93 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -124.02 127.97 48.67 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 44.8 mt-30 -132.11 150.28 52.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.91 129.42 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.533 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 89.1 m-85 -117.42 155.14 30.15 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 22.9 p -127.37 170.73 12.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 41.5 p -100.51 139.86 35.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 31.3 m-85 -117.76 5.13 12.25 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -120.74 127.16 51.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.412 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 84' ' ' PRO . 46.0 t0 -82.05 169.95 16.11 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 68.34 14.66 9.21 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.822 1.249 . . . . 0.0 113.232 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -90.25 114.62 61.64 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -89.8 -1.82 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.146 1.897 . . . . 0.0 111.839 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.91 145.01 8.89 Favored Glycine 0 N--CA 1.413 -2.874 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.39 147.32 13.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 117.049 0.425 . . . . 0.0 109.93 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.08 118.15 35.19 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.067 0.46 . . . . 0.0 110.705 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.72 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 90.7 mt-30 -102.2 130.01 48.74 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 t -99.48 129.0 50.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 123.714 0.634 . . . . 0.0 109.354 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.78 156.55 44.79 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.166 0.508 . . . . 0.0 111.524 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.546 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 35.8 tt0 -118.63 136.77 53.71 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.471 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.04 116.55 3.91 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.626 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 40.4 mt-10 -79.47 107.18 12.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -133.57 144.53 49.38 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.9 76.0 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 124.131 0.894 . . . . 0.0 111.552 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.8 mtt -94.76 111.49 23.26 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.271 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.411 ' HA ' ' OD1' ' A' ' 69' ' ' ASN . 1.9 m -74.71 109.83 8.51 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.066 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -175.25 -41.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.566 1.147 . . . . 0.0 109.016 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -109.21 75.44 0.95 Allowed 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 66' ' ' THR . 9.2 m120 -147.92 164.33 34.07 Favored 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 73.2 m-20 -90.61 129.3 36.75 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.0 tp -83.34 125.09 31.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.05 0.452 . . . . 0.0 111.221 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' A' ' 119' ' ' ILE . 7.4 mp -101.99 -9.38 20.69 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.52 178.33 15.37 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.882 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.507 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 6.8 ppt_? -153.33 156.91 39.24 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -150.87 152.32 33.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.39 125.01 51.94 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.06 104.22 16.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 p -105.15 163.49 12.54 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.695 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.62 7.09 45.91 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.6 mm -64.56 127.46 92.38 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.59 143.49 68.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.244 1.963 . . . . 0.0 110.613 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.63 90.58 0.6 Allowed 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 121.204 1.27 . . . . 0.0 109.646 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.16 129.53 20.94 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.995 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.429 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 17.9 Cg_endo -58.73 -61.04 0.28 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 123.296 2.664 . . . . 0.0 114.643 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 46' ' ' THR . 88.1 mtt180 -139.37 136.1 34.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.01 1.25 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 117.731 1.852 . . . . 0.0 117.731 167.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.9 t -52.3 -57.53 15.02 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 6.2 Cg_exo -81.73 103.52 1.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.641 1.56 . . . . 0.0 110.821 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -95.11 117.75 30.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.25 121.56 47.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.93 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 38.4 tt0 -91.35 115.79 28.32 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 19' ' ' LEU . 84.7 t -110.49 124.81 67.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 m -121.67 128.85 52.31 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.222 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -110.57 109.55 19.9 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.559 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.1 p30 -126.57 128.25 46.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.26 0.552 . . . . 0.0 112.12 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 45.9 mt -123.62 133.92 67.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.0 p-10 -88.72 -172.07 3.57 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.11 -5.95 55.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.41 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -87.07 -29.88 21.56 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.46 26.7 4.73 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 72.9 mt -89.07 108.0 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.408 HD23 HD12 ' A' ' 119' ' ' ILE . 32.7 tp -94.63 128.76 41.5 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.388 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER -119.74 108.02 13.91 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 174.543 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 61.2 t -95.59 113.81 30.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.9 m -112.86 122.03 46.43 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.1 m -122.64 122.22 38.29 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 120.842 0.353 . . . . 0.0 111.429 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -82.52 108.16 15.71 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.063 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.8 -6.88 23.48 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -79.84 -61.97 1.83 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.1 p -82.61 -30.22 29.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.68 13.1 56.01 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.982 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -91.11 144.0 26.1 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 117.626 0.713 . . . . 0.0 109.684 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -123.8 141.71 51.78 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -129.52 134.08 47.58 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 17.5 ptpt -124.25 166.55 15.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.47 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.431 HG22 ' HB ' ' A' ' 104' ' ' VAL . 15.0 tt -131.2 145.53 35.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.8 m -113.51 116.21 29.21 Favored 'General case' 0 C--N 1.276 -2.603 0 O-C-N 124.397 1.061 . . . . 0.0 110.124 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 72' ' ' LEU . 75.5 mt -120.6 125.24 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.0 m -119.92 140.7 50.48 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 79.48 -82.94 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.401 1.08 . . . . 0.0 111.429 174.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -156.48 173.11 17.39 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -155.88 164.39 38.57 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.01 -76.42 0.52 Allowed Glycine 0 C--O 1.24 0.521 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.448 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.346 3.2 mpt_? 75.93 89.82 0.08 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -129.96 -170.77 2.37 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.5 p -89.48 158.28 17.76 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.128 -1.429 . . . . 0.0 108.01 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -55.78 -41.24 73.77 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -173.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 129' ' ' GLU 0.281 0.8 OUTLIER -73.95 -23.4 59.5 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.755 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.01 -34.52 71.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.09 -44.42 78.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.664 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.01 -39.32 81.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.541 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -60.41 -43.01 97.15 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.594 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 tpp -58.92 -39.3 81.15 Favored 'General case' 0 C--O 1.212 -0.915 0 O-C-N 123.742 0.652 . . . . 0.0 109.828 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.77 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.084 0.468 . . . . 0.0 109.98 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -61.05 -47.67 85.32 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.708 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.46 -32.55 73.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.513 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -68.17 -55.53 12.03 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 122.158 -0.339 . . . . 0.0 110.609 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.55 -48.54 77.03 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.74 -17.81 65.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -118.3 16.18 13.95 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -55.1 -43.26 73.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.43 80.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 110.757 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.79 -44.95 65.58 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.045 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -61.32 -42.24 98.33 Favored 'General case' 0 CA--C 1.498 -1.026 0 O-C-N 123.403 0.439 . . . . 0.0 111.537 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 41.3 mt-10 -57.39 -45.51 84.44 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.982 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.65 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 46.0 t -68.76 -42.49 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.398 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -55.88 -48.8 74.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -63.91 -36.93 85.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.0 pt-20 -79.06 -15.51 58.1 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.539 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.65 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 91.6 mtt-85 -71.77 -38.76 70.29 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.9 -57.53 4.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.938 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.45 ' OG ' ' HG2' ' A' ' 155' ' ' LYS . 31.3 t -158.27 -80.78 0.06 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.501 -174.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 65.39 19.21 11.57 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 124.952 1.301 . . . . 0.0 111.771 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HG2' ' OG ' ' A' ' 153' ' ' SER . 17.0 ptpt -82.18 144.86 30.42 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 10.4 t30 -84.12 69.34 10.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.283 1.039 . . . . 0.0 111.455 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.774 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.3 151.63 35.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -115.06 175.04 5.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t -145.84 -175.79 4.88 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.359 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . 0.34 41.7 m-85 69.5 81.34 0.17 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -127.14 11.57 7.03 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.238 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -99.64 90.72 4.58 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.488 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.418 ' OD1' ' HG3' ' A' ' 165' ' ' MET . 52.0 t-20 -142.79 114.25 7.92 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 176.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.418 ' HG3' ' OD1' ' A' ' 164' ' ' ASN . 90.5 mtp 72.07 22.36 3.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.766 0.827 . . . . 0.0 112.247 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -97.27 81.25 2.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.1 p -152.47 -54.97 0.13 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.266 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.63 28.04 2.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.24 0.543 . . . . 0.0 110.365 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.99 144.45 25.34 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -90.58 76.83 6.5 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -99.02 117.83 34.41 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.523 -175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 173.44 -63.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 126.155 1.782 . . . . 0.0 106.216 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -163.07 154.14 24.96 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.1 mp -119.4 3.31 11.29 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 117.03 0.415 . . . . 0.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt 72.11 140.02 0.05 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.739 1.216 . . . . 0.0 112.306 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -145.06 64.2 0.46 Allowed Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.072 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.18 83.25 6.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.28 -43.51 84.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 19.1 m -157.03 141.67 16.77 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.2 -37.55 45.34 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 48.22 37.86 9.05 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.643 1.177 . . . . 0.0 113.002 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.81 -68.73 0.49 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.875 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt 61.73 -84.58 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.317 1.047 . . . . 0.0 112.806 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -131.83 172.43 12.32 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -107.37 136.15 47.66 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.9 m -86.57 96.5 5.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.999 0.904 . . . . 0.0 108.571 172.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.6 tp -69.03 -31.05 69.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.676 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -99.55 69.95 1.66 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 122.315 1.055 . . . . 0.0 108.473 171.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -62.91 130.91 46.85 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.818 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -121.08 108.16 13.49 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.87 128.64 49.77 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 32.9 m -81.13 -16.57 12.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.394 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . 0.307 8.5 tp 52.0 -70.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 126.963 2.105 . . . . 0.0 114.109 -177.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.3 m -145.61 136.1 24.14 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -95.96 108.61 21.01 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 120.284 -0.567 . . . . 0.0 109.507 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.7 mp -95.44 90.35 5.75 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.94 136.13 52.07 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.828 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -98.25 36.69 1.55 Allowed 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.666 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -61.26 -45.9 92.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.157 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 60.2 m -152.24 110.95 3.79 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.909 0.385 . . . . 0.0 110.6 176.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 203' ' ' ALA . 3.8 pp -114.86 -38.55 3.9 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.508 ' N ' HD12 ' A' ' 202' ' ' LEU . . . -168.01 89.69 0.28 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.229 0.538 . . . . 0.0 111.161 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -100.9 -6.91 24.0 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.549 0.69 . . . . 0.0 109.429 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.609 ' HD3' ' H ' ' A' ' 206' ' ' ASP . 4.9 tmtt? -103.08 149.53 24.5 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.609 ' H ' ' HD3' ' A' ' 205' ' ' LYS . 3.2 m-20 -56.36 152.93 10.47 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.665 1.186 . . . . 0.0 109.438 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.79 69.14 0.75 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.878 0.847 . . . . 0.0 112.864 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -106.76 -53.92 2.55 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -91.48 -25.78 19.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.735 0.779 . . . . 0.0 109.081 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -96.01 147.18 23.97 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -144.91 153.14 41.24 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -62.31 129.13 39.34 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 213' ' ' LYS . 34.2 mmtp -116.84 87.63 2.73 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.013 0.911 . . . . 0.0 110.265 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -92.58 106.42 18.41 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 113.689 -1.596 . . . . 0.0 107.645 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.74 -0.78 5.42 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.225 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -98.58 123.2 42.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.172 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 71.55 35.21 1.51 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.471 1.109 . . . . 0.0 111.5 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.03 -10.5 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.814 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 12.4 t30 50.15 80.89 0.28 Allowed Pre-proline 0 N--CA 1.468 0.457 0 C-N-CA 124.978 1.311 . . . . 0.0 111.726 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -84.11 104.61 1.06 Allowed 'Trans proline' 0 N--CA 1.433 -2.081 0 C-N-CA 122.369 2.046 . . . . 0.0 112.025 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.52 HD13 ' H ' ' A' ' 222' ' ' ILE . 0.2 OUTLIER -74.33 151.9 7.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.155 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.65 120.08 34.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.356 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.9 m -65.96 139.72 58.26 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.352 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -157.56 123.99 1.35 Allowed Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 118.544 -1.789 . . . . 0.0 113.612 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 70.8 mt -85.22 99.8 11.35 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -91.87 131.05 37.49 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.287 0.565 . . . . 0.0 111.626 -172.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -123.26 137.88 54.76 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -82.6 116.0 4.13 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.36 115.9 5.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.933 0.396 . . . . 0.0 110.91 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 159.02 -155.85 26.92 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 164.29 100.56 0.15 Allowed Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -83.79 107.05 1.31 Allowed 'Trans proline' 0 N--CA 1.44 -1.63 0 C-N-CA 122.008 1.806 . . . . 0.0 112.253 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -161.61 86.36 0.11 Allowed Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.36 108.29 0.68 Allowed 'Trans proline' 0 C--O 1.249 1.055 0 C-N-CA 122.739 2.293 . . . . 0.0 111.948 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -100.61 2.46 55.93 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.762 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -87.05 -174.51 49.03 Favored Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.287 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 64.16 74.72 0.4 Allowed 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.484 1.114 . . . . 0.0 111.091 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -170.08 -38.21 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.186 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.93 85.01 2.45 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.212 0.53 . . . . 0.0 110.03 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -136.94 96.88 3.39 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 243' ' ' PRO . . . -91.67 118.93 5.59 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.809 -175.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 242' ' ' GLY . 16.8 Cg_exo -69.28 165.93 28.75 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 122.852 2.368 . . . . 0.0 111.412 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -99.94 107.47 19.46 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.509 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -141.41 162.33 26.9 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -114.85 97.05 0.8 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.2 m -94.47 27.05 3.12 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.084 0.469 . . . . 0.0 111.377 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.85 31.66 5.08 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 18.7 m -94.43 123.68 37.99 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -72.89 156.65 51.92 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.11 -2.59 12.5 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 122.505 2.137 . . . . 0.0 111.955 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.1 t -169.31 153.36 5.29 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 20.1 pt -139.66 178.54 3.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.0 -176.29 3.51 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -79.19 99.1 6.86 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.859 0.837 . . . . 0.0 110.858 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.12 19.46 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 CA--C 1.497 -1.093 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.363 -177.852 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 66.65 68.9 0.42 Allowed 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.837 1.255 . . . . 0.0 114.384 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -132.33 157.36 44.66 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 171.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.2 t 65.89 80.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -170.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -63.88 152.98 38.24 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.816 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -60.84 102.15 0.18 Allowed 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 123.654 0.596 . . . . 0.0 110.83 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.82 121.26 44.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.403 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.4 tp -89.33 -43.51 10.88 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.154 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.4 mt -111.05 123.28 49.89 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.378 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.2 mt -102.15 17.36 23.51 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.726 1.251 . . . . 0.0 108.775 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 36' ' ' ILE . 1.3 m-20 -85.47 74.78 10.28 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.354 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -115.84 175.86 2.62 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.907 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.895 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.08 129.45 67.18 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.45 -23.95 2.61 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 122.131 1.887 . . . . 0.0 112.372 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.43 172.4 10.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 m -94.98 129.25 42.12 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.82 131.7 43.3 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.58 -164.52 14.96 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.332 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.0 mt -131.07 161.85 31.14 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.81 120.81 32.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 117.821 -1.551 . . . . 0.0 109.223 171.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 23.6 p -97.94 -176.33 3.41 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.809 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . . . -57.71 128.83 39.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.068 0.461 . . . . 0.0 111.922 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.25 59.96 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.43 53.73 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.255 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -92.91 140.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 113.09 25.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.0 m -109.39 110.97 22.27 Favored 'General case' 0 C--N 1.279 -2.468 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.624 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.29 136.26 33.16 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.201 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.7 mp -99.45 -49.98 4.25 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.81 103.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -80.71 162.8 23.97 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.499 ' HD3' ' OE2' ' A' ' 139' ' ' GLU . 9.7 ptm180 -64.43 159.36 21.55 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.316 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m120 77.34 4.8 3.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.499 1.12 . . . . 0.0 112.243 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 m -83.32 115.75 22.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.38 132.84 45.42 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.113 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 11' ' ' ASP . 26.5 pt -91.38 161.39 34.77 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.494 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.9 Cg_exo -69.01 147.39 82.98 Favored 'Cis proline' 0 C--O 1.245 0.858 0 CA-C-N 119.834 0.976 . . . . 0.0 113.731 1.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 11.8 p -118.19 136.42 53.65 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.043 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -135.02 101.02 4.74 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 93' ' ' THR . 62.1 tt0 -121.92 131.81 54.22 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -128.67 125.1 37.35 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -135.48 152.3 51.21 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.18 122.47 50.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.088 0.47 . . . . 0.0 110.331 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.5 162.14 14.4 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.848 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 6.1 p -137.76 170.22 16.44 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.041 0.536 . . . . 0.0 109.66 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -95.93 137.01 35.6 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.303 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -108.63 32.11 5.11 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 167.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 162' ' ' ALA . 33.0 p -132.19 159.43 39.01 Favored 'General case' 0 N--CA 1.391 -3.405 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.974 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -136.61 162.17 33.88 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.88 22.08 10.25 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.101 0.876 . . . . 0.0 110.934 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.48 125.71 80.26 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.959 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.16 -18.51 27.04 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 121.706 1.604 . . . . 0.0 109.657 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 78' ' ' SER . . . -178.31 175.01 47.2 Favored Glycine 0 N--CA 1.406 -3.365 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.75 129.85 55.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.119 0.485 . . . . 0.0 110.139 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.6 tp -87.17 100.29 12.56 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.595 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mm -84.15 96.98 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -109.3 110.3 21.43 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.1 t -92.98 135.97 26.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.79 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -133.77 163.24 29.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.42 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.85 165.45 25.59 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.46 -103.78 0.9 Allowed Glycine 0 C--N 1.287 -2.146 0 C-N-CA 119.025 -1.56 . . . . 0.0 114.235 170.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.652 ' OE2' ' HG3' ' A' ' 67' ' ' LYS . 39.9 mt-10 -78.46 172.16 14.04 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.594 0.358 . . . . 0.0 110.939 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -112.59 -27.47 8.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.383 -0.372 . . . . 0.0 112.001 -171.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -90.42 -52.43 4.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -172.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.1 mtm -142.1 149.64 40.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -173.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.28 82.55 2.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 O-C-N 124.082 0.863 . . . . 0.0 109.851 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.652 ' HG3' ' OE2' ' A' ' 62' ' ' GLU . 8.3 ptmm? -118.84 -76.53 0.57 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.99 12.4 30.57 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.597 0.713 . . . . 0.0 111.208 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.88 142.22 57.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.694 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -96.09 141.96 28.85 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.566 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.5 tp -76.99 123.37 26.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.458 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.6 mt -89.24 -40.16 13.03 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.521 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 171.27 36.74 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -140.2 135.05 32.0 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -143.22 135.01 26.66 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.76 118.97 37.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.953 0.406 . . . . 0.0 111.421 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.0 tp -90.73 104.29 16.89 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.415 ' HA ' ' HA3' ' A' ' 53' ' ' GLY . 15.9 p -113.55 165.95 12.0 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -168.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 4.33 39.8 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.16 113.15 46.4 Favored Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.37 138.33 50.38 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.475 2.117 . . . . 0.0 112.141 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -47.42 125.88 11.29 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.344 3.362 . . . . 0.0 113.159 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.39 152.85 80.79 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.84 39.64 0.29 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 124.055 3.17 . . . . 0.0 115.07 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 68.34 143.57 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.665 1.586 . . . . 0.0 112.429 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.94 75.88 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.53 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.458 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.8 t -107.13 -55.11 0.07 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.924 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 15.5 Cg_exo -70.38 130.51 18.7 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 121.307 1.338 . . . . 0.0 110.71 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -110.86 123.07 49.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -110.03 125.2 67.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.6 tt0 -90.77 111.59 23.02 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -108.27 129.87 61.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 30.5 m -123.46 118.58 27.74 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.455 ' CD2' HD22 ' A' ' 29' ' ' LEU . 10.5 m-85 -100.54 116.37 32.3 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 173.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 38' ' ' THR . 12.2 t70 -128.91 116.36 19.28 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.764 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 52.5 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.4 p-10 -87.57 -172.6 3.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -13.96 61.24 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.408 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 4.6 t30 -84.79 -31.46 23.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 117.6 14.11 7.03 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.481 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 80.7 mt -80.54 119.95 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.8 tp -98.44 118.03 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.411 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.46 HD21 ' HD3' ' A' ' 116' ' ' LYS . 16.0 t-20 -112.91 111.24 21.85 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -101.82 116.64 45.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.7 m -111.67 134.34 53.31 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.46 124.12 42.17 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 m -124.22 118.42 26.8 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.521 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.5 123.34 29.63 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.728 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.486 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 75.0 mmtt -68.01 -28.82 67.75 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.875 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 m -68.68 -61.91 1.61 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.142 0.496 . . . . 0.0 110.865 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.5 p -84.01 -39.88 19.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.36 0.6 . . . . 0.0 110.799 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.25 39.29 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.16 149.04 43.27 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.496 0.665 . . . . 0.0 112.761 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.22 134.72 42.35 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.349 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 146.22 47.18 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 103' ' ' ASN . 17.7 ptpt -142.11 162.3 35.82 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.034 0.445 . . . . 0.0 111.731 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 tt -129.44 145.76 35.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.3 m -122.8 117.25 25.23 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.029 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.25 118.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 p -92.26 172.73 8.22 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.67 -24.01 59.92 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -58.65 -50.26 74.5 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.022 -177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -128.38 91.87 3.33 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.91 -116.8 3.41 Favored Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -144.83 143.12 30.46 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.2 mp 66.61 -171.25 0.19 Allowed 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.018 0.824 . . . . 0.0 111.19 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.1 p -96.03 -77.65 0.48 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 56.3 tttp -166.49 -45.1 0.02 OUTLIER 'General case' 0 CA--C 1.484 -1.559 0 CA-C-O 120.638 0.256 . . . . 0.0 110.374 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.36 -49.02 77.21 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.987 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 134' ' ' MET . 1.2 mp0 -57.59 -42.6 83.52 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.103 0.961 . . . . 0.0 109.359 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.1 mt -61.22 -50.84 78.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.783 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.2 pt-20 -72.75 -26.0 61.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -61.88 -44.05 97.59 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 95.0 mmm -60.76 -37.39 81.67 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.103 0.478 . . . . 0.0 109.764 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 88.1 t -58.2 -54.68 29.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.029 176.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 87.4 mt-30 -59.29 -53.78 54.31 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.914 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.78 -53.58 55.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.928 -176.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.61 67.77 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.499 ' OE2' ' HD3' ' A' ' 32' ' ' ARG . 26.1 mm-40 -74.27 -32.93 63.12 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.052 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -71.21 -34.29 70.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.08 11.44 23.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.888 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -53.66 -48.62 69.26 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 118.142 0.428 . . . . 0.0 111.522 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.95 74.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.813 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -74.2 -44.7 52.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 0.6 OUTLIER -60.81 -49.39 77.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 177.081 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.67 -32.53 74.04 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.383 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.91 -48.41 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.575 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -55.93 -41.89 75.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.87 0.468 . . . . 0.0 111.066 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.5 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 57.0 ttp180 -61.4 -51.69 67.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.486 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.462 ' HG3' ' HE ' ' A' ' 149' ' ' ARG . 47.6 mt-10 -78.36 -1.37 33.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.9 -14.0 46.16 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 29.9 t -112.18 157.77 12.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -80.56 93.09 6.02 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.323 0.583 . . . . 0.0 110.583 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -90.66 93.11 9.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.533 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -112.71 158.63 19.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.12 68.51 9.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.234 1.016 . . . . 0.0 110.761 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.74 136.18 25.38 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.693 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.93 152.38 25.02 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.903 0.382 . . . . 0.0 110.423 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 0.4 OUTLIER -97.24 119.59 36.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.1 t -134.4 100.63 4.72 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 66.5 25.94 10.05 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.441 1.096 . . . . 0.0 112.054 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 48' ' ' SER . . . -69.69 -11.92 61.22 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -73.46 -16.45 61.3 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.893 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 57.74 85.95 0.08 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.07 0.948 . . . . 0.0 112.012 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -165.46 117.01 1.11 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.69 130.82 48.14 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.018 -176.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.9 m -109.22 122.96 48.45 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -166.28 172.57 10.96 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.04 97.99 5.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -115.25 129.2 56.56 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.387 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -136.37 -18.24 1.5 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.204 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -75.27 -44.12 47.61 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.789 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 90.72 -156.52 24.71 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 55.4 tp -87.78 -25.84 23.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.393 0.616 . . . . 0.0 110.859 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -151.83 138.76 19.01 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.651 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -86.33 -22.26 48.6 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.307 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 177' ' ' LYS . 3.4 mptp? -76.5 100.97 5.44 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.678 0.391 . . . . 0.0 110.124 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.4 pt -108.21 3.0 9.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.6 0.714 . . . . 0.0 110.037 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 12.8 p -90.83 158.82 16.6 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.182 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -69.56 113.82 7.2 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.568 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.46 107.07 7.34 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.37 103.71 11.31 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.62 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 134.15 38.12 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -114.19 172.01 7.27 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.761 -171.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.43 ' HA ' ' OD1' ' A' ' 188' ' ' ASP . 13.2 mptt -74.95 97.65 3.41 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.623 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.78 -62.0 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.938 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 30.3 tp -139.83 24.44 2.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.13 0.966 . . . . 0.0 110.335 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 185' ' ' LYS . 5.8 p-10 -92.77 13.14 21.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 174.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -93.9 118.46 31.5 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -137.06 135.21 37.32 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 174.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -88.86 84.82 6.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 55.2 t -72.16 -36.05 55.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.851 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 59.0 mt -104.68 105.05 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.6 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.5 m -93.56 104.6 16.71 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -103.26 -30.81 10.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.485 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 tp -146.61 31.98 0.97 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.33 -35.29 79.9 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.827 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -140.3 -15.18 0.98 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.0 t30 71.94 -71.77 0.13 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.327 1.051 . . . . 0.0 111.466 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 18.5 m 63.71 -76.68 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.907 1.283 . . . . 0.0 112.128 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 71.0 mt 59.05 -81.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.022 1.729 . . . . 0.0 112.29 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.86 138.05 16.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -127.06 -54.71 1.38 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.423 0.63 . . . . 0.0 110.782 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -97.1 146.71 24.77 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.521 ' HB2' ' HB3' ' A' ' 209' ' ' GLU . 4.1 m-20 -73.55 141.92 46.67 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -60.28 -30.98 69.82 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.581 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -114.89 -19.79 10.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.803 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.531 ' OE2' ' HG2' ' A' ' 212' ' ' ARG . 3.6 tp10 -92.15 6.13 47.74 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 122.067 -0.396 . . . . 0.0 110.91 -172.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -86.14 -8.66 57.69 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.249 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -132.31 86.92 2.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.614 0.721 . . . . 0.0 109.794 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.531 ' HG2' ' OE2' ' A' ' 209' ' ' GLU . 4.1 ppt_? -162.73 150.41 13.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.417 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm 59.06 -172.83 0.1 Allowed 'General case' 0 C--O 1.241 0.648 0 O-C-N 124.309 1.006 . . . . 0.0 111.735 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.29 85.42 2.8 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 102.332 -3.21 . . . . 0.0 102.332 169.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 34.2 tp -70.43 141.23 52.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.661 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -61.39 -46.79 88.69 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.358 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -79.25 91.94 5.06 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.55 100.28 4.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.117 0.96 . . . . 0.0 112.561 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -74.48 148.75 85.98 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.244 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.99 104.46 0.71 Allowed 'Trans proline' 0 C--O 1.242 0.687 0 C-N-CA 122.68 2.254 . . . . 0.0 113.962 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.4 HG22 HG13 ' A' ' 223' ' ' ILE . 1.8 mp -114.07 133.91 58.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 171.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.4 HG13 HG22 ' A' ' 222' ' ' ILE . 80.9 mt 76.06 101.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.931 0 O-C-N 124.17 0.919 . . . . 0.0 108.612 -172.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 50.1 m -147.59 162.43 39.13 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 158.91 -121.7 1.07 Allowed Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.926 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.22 174.0 14.24 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.8 t80 68.02 74.79 0.29 Allowed 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.326 1.05 . . . . 0.0 109.044 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -151.79 -57.57 0.15 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.526 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.5 -151.34 5.85 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.548 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -122.62 149.0 44.58 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 172.01 106.57 0.19 Allowed Glycine 0 C--N 1.299 -1.476 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.477 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 176.97 75.33 0.05 OUTLIER Glycine 0 C--N 1.295 -1.718 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.78 167.8 11.19 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.692 2.262 . . . . 0.0 111.256 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -143.06 121.87 1.8 Allowed Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.5 115.95 4.53 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.118 1.878 . . . . 0.0 111.946 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 88.06 -157.74 28.54 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.31 -97.71 0.24 Allowed Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -134.63 116.94 15.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -73.77 97.82 0.92 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.357 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -138.22 127.66 24.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.71 -33.69 8.85 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 78.64 120.89 0.27 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.698 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.75 129.09 33.14 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.647 2.231 . . . . 0.0 111.915 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -65.75 -47.99 73.38 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.447 0.641 . . . . 0.0 110.236 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.04 -137.86 6.93 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 157.2 53.2 0.01 OUTLIER Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.7 t -66.46 -49.48 66.53 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 78.09 13.92 82.83 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.474 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 38.4 m -137.42 129.06 28.53 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -153.11 144.2 11.12 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.54 104.75 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.236 2.624 . . . . 0.0 112.389 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.2 m -126.9 45.37 2.71 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 26.9 pt -132.49 143.5 39.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.029 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -127.45 112.3 14.81 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.719 0.771 . . . . 0.0 111.577 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.87 100.42 8.84 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 35.2 m -87.87 176.57 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.134 -175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--N 1.313 -1.011 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.0 -178.883 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 C--O 1.246 0.916 0 CA-C-O 121.495 0.664 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -92.08 134.44 34.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.546 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -87.02 -33.94 19.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.336 0.589 . . . . 0.0 110.109 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.5 t 70.32 -84.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 108.812 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 61.7 -76.72 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.698 1.199 . . . . 0.0 112.666 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -132.93 11.71 4.3 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt 70.63 85.03 0.14 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.287 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mp 69.46 87.71 0.12 Allowed 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.913 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 tp -64.19 -43.8 93.97 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -114.49 123.9 50.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.296 176.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 36' ' ' ILE . 9.4 m-20 -96.23 25.91 4.61 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -126.88 170.64 16.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-O 121.211 0.529 . . . . 0.0 110.906 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.46 120.87 80.61 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.04 -21.63 23.84 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.094 1.862 . . . . 0.0 111.743 -177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.8 mt -134.49 174.45 10.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 23.5 m -101.57 123.01 44.89 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.09 0.244 . . . . 0.0 110.609 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 2.4 mm? -92.28 131.63 37.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.1 -168.41 21.11 Favored Glycine 0 N--CA 1.425 -2.052 0 C-N-CA 119.375 -1.393 . . . . 0.0 114.63 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.437 HD11 HG11 ' A' ' 92' ' ' VAL . 83.6 mt -133.63 162.79 30.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.735 -176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -94.81 109.51 21.47 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.9 p -84.16 175.37 9.52 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.083 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.96 116.51 4.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.62 -12.23 11.04 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 51.66 4.53 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.25 127.16 73.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.0 tpt -73.82 102.5 4.06 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -107.78 112.13 24.64 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.29 127.48 38.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.418 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.0 mp -95.57 -50.35 5.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.454 HG21 HD12 ' A' ' 96' ' ' ILE . 34.1 mm -94.18 92.31 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.2 154.92 30.67 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -53.81 140.28 30.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.23 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 79.84 1.7 2.12 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.585 1.554 . . . . 0.0 113.283 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.13 128.15 33.36 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -70.5 134.79 48.05 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.617 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 11' ' ' ASP . 27.6 pt -104.09 161.42 22.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.1 Cg_endo -64.44 140.88 42.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 CA-C-N 120.914 1.362 . . . . 0.0 114.115 0.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.3 p -109.59 164.12 12.82 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -159.08 101.64 1.6 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -132.46 128.05 36.61 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.4 m -119.85 124.01 45.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -124.22 146.07 48.95 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 46.0 mm -97.78 115.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -107.72 133.55 51.97 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 p -107.57 170.25 8.09 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.445 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -96.65 136.96 36.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.742 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -98.06 10.88 39.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.684 1.231 . . . . 0.0 108.623 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.3 p -116.13 145.32 43.15 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.236 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.55 159.62 21.02 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.386 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 6.6 m-20 57.82 27.49 14.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.329 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -77.27 130.16 75.67 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.523 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.34 -15.04 14.4 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.234 1.956 . . . . 0.0 111.784 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 164.19 37.75 Favored Glycine 0 N--CA 1.422 -2.278 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.8 158.51 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 123.006 0.523 . . . . 0.0 109.781 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 75' ' ' PHE . 42.7 tp -117.6 107.88 14.79 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 75' ' ' PHE . 3.8 mp -89.1 105.49 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -92.85 119.69 32.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.25 121.6 54.73 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-O 121.225 0.536 . . . . 0.0 111.035 -173.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.04 164.29 21.86 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.615 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 38.6 tt0 -134.89 132.71 38.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.383 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.03 172.23 13.44 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 27.8 mt-10 -135.12 120.87 19.55 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.074 0.937 . . . . 0.0 113.088 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 2.6 mmp_? -154.14 166.51 32.87 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.55 54.87 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.151 0.976 . . . . 0.0 110.042 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.9 mtt -133.52 121.19 21.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.35 96.62 3.43 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.373 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -168.25 -45.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.087 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 17.7 m-20 -95.7 71.3 3.05 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -145.29 160.43 41.52 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 113.186 -1.824 . . . . 0.0 107.768 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 28.0 t30 -89.87 131.08 35.98 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.33 107.84 19.47 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.25 0.547 . . . . 0.0 109.684 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.25 -23.99 27.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.311 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.11 -162.63 28.81 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.412 ' HG3' ' OE2' ' A' ' 76' ' ' GLU . 23.3 ptt180 -145.87 162.83 36.84 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.671 ' HB3' ' HB ' ' A' ' 56' ' ' ILE . 7.6 t80 -128.92 130.49 46.84 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.412 ' OE2' ' HG3' ' A' ' 74' ' ' ARG . 1.7 mp0 -104.0 104.66 14.65 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -112.14 110.19 20.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 p -130.16 166.75 19.6 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.65 19.05 16.62 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.75 129.63 61.36 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 48.4 Cg_endo -71.67 137.71 30.62 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.237 1.958 . . . . 0.0 110.97 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' ASN . 50.5 Cg_exo -56.89 107.24 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 122.59 2.193 . . . . 0.0 112.275 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.01 158.12 76.65 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.8 161.36 18.57 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.02 2.48 . . . . 0.0 112.151 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -65.62 142.27 58.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.04 -7.91 79.87 Favored Glycine 0 C--N 1.308 -1.004 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.945 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.39 -54.07 0.29 Allowed Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.8 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.59 112.62 1.83 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 121.41 1.407 . . . . 0.0 111.225 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -99.93 113.46 26.03 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.257 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -100.41 120.7 50.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 40.1 tt0 -90.6 108.98 20.15 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 19' ' ' LEU . 46.2 t -109.05 117.33 54.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.208 0.528 . . . . 0.0 109.696 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 84.8 m -108.59 125.43 51.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.562 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' CD1' HD22 ' A' ' 29' ' ' LEU . 8.8 m-85 -98.91 112.3 24.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.95 112.56 14.2 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.576 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 26.1 mt -119.12 119.79 61.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 2.5 p30 -84.11 176.75 8.59 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.781 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.12 -17.25 51.79 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.565 ' HB3' HG12 ' A' ' 101' ' ' ILE . 66.2 t30 -82.46 -15.23 53.3 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.517 0.675 . . . . 0.0 109.573 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.57 7.13 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 43.1 mm -97.28 114.21 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.92 118.49 36.45 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 25.9 m-80 -106.47 108.02 19.33 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.625 173.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.2 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.2 m -107.86 117.54 34.4 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.99 123.62 50.15 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -125.94 121.01 31.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.761 0.315 . . . . 0.0 111.634 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.57 106.98 8.54 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.907 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.9 -19.18 64.98 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -63.06 -49.83 72.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.853 0.359 . . . . 0.0 110.771 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.8 p -109.62 -23.13 11.62 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.77 53.62 2.06 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.2 126.27 50.24 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.965 0.412 . . . . 0.0 111.559 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.31 54.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.462 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -135.88 149.9 49.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 146.77 44.34 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 117.742 0.246 . . . . 0.0 111.273 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 23.0 pt -115.49 128.07 72.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 45.5 m -98.04 113.51 25.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.594 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 64.6 mt -121.84 110.47 27.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.603 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.405 ' HA ' HD13 ' A' ' 101' ' ' ILE . 11.1 m -77.87 114.74 17.03 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 168.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.313 61.6 t30 -77.6 81.87 4.04 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 117.759 -1.577 . . . . 0.0 113.942 -174.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -176.21 73.58 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -87.71 -13.93 41.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.877 -1.51 . . . . 0.0 112.313 -171.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.31 32.45 31.34 Favored Glycine 0 C--N 1.31 -0.877 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -118.75 140.87 49.25 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp 66.47 176.22 0.23 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.263 0.977 . . . . 0.0 110.437 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.7 p -104.82 -92.34 0.37 Allowed 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.005 0.431 . . . . 0.0 110.026 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -161.54 -32.4 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.491 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 36.2 mt-10 -60.81 -33.08 72.47 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 121.03 0.443 . . . . 0.0 111.414 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -67.99 -31.06 70.5 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.124 0.488 . . . . 0.0 109.908 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 135' ' ' VAL . 2.0 mp -72.45 -53.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.209 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 136' ' ' GLN 0.267 0.0 OUTLIER -66.35 -30.45 70.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.446 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -67.09 -42.44 84.63 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -73.03 -26.38 61.29 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.829 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 131' ' ' ILE . 97.7 t -67.11 -39.18 82.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.582 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 27.9 mm-40 -60.41 -47.05 87.78 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.686 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -66.38 -36.45 82.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.796 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.88 73.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.453 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -79.68 -49.2 12.46 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -73.38 -42.48 62.11 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.85 31.55 5.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.36 -55.66 23.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.553 1.541 . . . . 0.0 110.799 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -67.25 -51.81 48.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.691 -175.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -55.04 -51.83 65.08 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.711 0.804 . . . . 0.0 111.05 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.88 -35.52 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -66.02 -37.23 85.38 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.515 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 64.1 t -70.18 -48.1 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.644 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -56.81 -40.2 75.54 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -56.77 -43.9 81.29 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.936 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.22 -6.68 57.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.626 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 36.3 mmt180 -76.48 -33.09 58.69 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 30.9 t -81.73 -31.22 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 172.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t 77.92 139.92 0.07 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.493 1.517 . . . . 0.0 110.479 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 -43.24 10.9 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.015 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 61.28 -164.47 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.186 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 15.1 m120 -122.93 58.88 1.08 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.605 0.716 . . . . 0.0 109.238 174.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.73 149.18 33.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.92 151.88 37.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.14 131.1 42.94 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.834 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.9 p -97.52 25.53 5.65 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.586 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -99.4 99.21 10.1 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.473 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -97.38 -18.98 18.78 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 66.2 t80 71.68 -72.29 0.12 Allowed 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 125.526 1.531 . . . . 0.0 110.19 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -90.72 102.92 15.68 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.043 0.925 . . . . 0.0 110.469 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.2 ptm -139.12 16.03 2.62 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.771 -1.559 . . . . 0.0 107.21 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.92 -34.05 11.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.101 -173.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.0 m -80.01 85.66 5.58 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -99.85 83.76 2.79 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.92 134.09 29.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.602 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -106.81 137.68 44.39 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -176.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.52 -23.5 34.56 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 78.21 140.47 0.07 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.609 1.564 . . . . 0.0 111.758 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -112.99 64.24 0.28 Allowed Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.777 -173.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.24 -63.83 1.38 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.45 -67.07 0.12 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.056 1.343 . . . . 0.0 112.594 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 169.13 57.3 0.03 OUTLIER Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 106.432 -2.667 . . . . 0.0 106.432 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -83.09 -35.43 25.66 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.108 -1.046 . . . . 0.0 109.856 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.3 mp -83.0 91.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 35.2 p -102.17 -25.24 13.78 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.409 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -110.02 97.04 6.63 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -101.67 -62.75 1.22 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.141 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -154.46 155.4 34.84 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -161.8 39.11 0.13 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.053 0.93 . . . . 0.0 108.733 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.437 ' C ' ' HD3' ' A' ' 185' ' ' LYS . 33.7 mmtp -85.57 47.66 1.47 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.869 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.437 ' HD3' ' C ' ' A' ' 184' ' ' LYS 0.303 0.0 OUTLIER 42.57 67.02 0.66 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.769 1.228 . . . . 0.0 112.725 -177.238 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.8 m -103.22 152.97 5.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.917 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.76 149.71 50.13 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.654 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -153.38 167.66 28.68 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -88.01 -26.5 22.57 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -77.31 86.0 3.73 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -77.96 -13.14 59.98 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.326 1.06 . . . . 0.0 109.664 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 14.8 m -106.78 96.29 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.239 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -73.9 135.3 27.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 74.7 m -153.58 154.94 35.21 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.662 0.744 . . . . 0.0 112.206 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -136.58 150.04 48.38 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.7 tt -139.43 96.58 3.12 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -130.0 -154.44 0.63 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -61.75 137.39 58.24 Favored 'General case' 0 C--O 1.249 1.076 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -80.2 89.77 5.47 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.024 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 9.0 t -174.92 142.15 0.64 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.7 pp -97.88 138.92 34.51 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -88.61 82.11 6.95 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.153 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -127.82 89.32 2.92 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.046 0.927 . . . . 0.0 110.59 174.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -135.97 87.12 2.28 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.43 -36.9 64.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -87.22 -4.29 59.09 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.861 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -148.62 78.58 1.42 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.535 0.683 . . . . 0.0 110.198 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 210' ' ' HIS 0.339 0.0 OUTLIER -128.68 -94.77 0.42 Allowed 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.277 174.931 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.582 ' H ' ' CD ' ' A' ' 209' ' ' GLU . 41.5 m80 56.82 20.88 5.53 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.471 1.108 . . . . 0.0 111.189 -176.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -88.09 147.61 24.86 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.18 107.79 2.46 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -114.26 99.04 7.3 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.314 1.054 . . . . 0.0 113.646 -172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.83 15.74 18.57 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.81 102.09 13.96 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.767 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.27 117.27 12.58 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -85.07 29.69 0.63 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.446 0.698 . . . . 0.0 112.03 -171.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.5 p -84.96 -2.38 7.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.788 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -121.4 91.08 48.16 Favored Pre-proline 0 C--N 1.308 -1.209 0 O-C-N 121.959 -0.463 . . . . 0.0 110.563 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.21 83.55 1.68 Allowed 'Trans proline' 0 N--CA 1.431 -2.191 0 C-N-CA 121.882 1.721 . . . . 0.0 109.233 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.3 tp -82.59 70.57 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-O 123.246 1.498 . . . . 0.0 111.727 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mt -92.09 76.02 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 27.4 p -81.96 114.2 20.39 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.228 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.71 -59.89 2.28 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.498 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 65.29 179.55 0.19 Allowed 'General case' 0 C--O 1.253 1.252 0 C-N-CA 124.058 0.943 . . . . 0.0 111.696 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -131.47 168.35 17.79 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -87.91 100.03 12.58 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.833 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.9 121.65 5.81 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -134.23 129.76 36.18 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -103.04 -146.94 18.04 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 233' ' ' PRO . . . -79.58 117.39 4.5 Favored Glycine 0 C--N 1.308 -1.008 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 232' ' ' GLY . 2.8 Cg_exo -74.66 111.84 3.41 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.34 2.026 . . . . 0.0 111.575 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 154.69 171.18 21.24 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.07 -31.23 24.05 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.759 2.306 . . . . 0.0 111.872 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 107.99 -65.4 0.25 Allowed Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 106.25 126.08 5.59 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -110.81 -18.43 13.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 72.07 -88.71 0.48 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.653 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . 64.95 79.02 0.26 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.763 1.225 . . . . 0.0 112.051 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -164.48 124.32 1.98 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -139.55 84.98 0.22 Allowed Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.067 -1.063 . . . . 0.0 112.261 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -63.59 129.79 26.14 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.382 2.055 . . . . 0.0 111.052 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -95.95 -7.93 35.22 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.661 0.743 . . . . 0.0 109.8 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.07 -128.04 8.3 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.41 161.96 26.91 Favored Glycine 0 N--CA 1.421 -2.321 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.0 m -79.21 -28.63 42.56 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 154.62 -104.35 0.25 Allowed Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.096 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 31.8 p -169.34 140.7 2.36 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -127.08 -156.31 9.12 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.628 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -85.99 106.58 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 122.831 2.354 . . . . 0.0 110.926 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.0 m -70.21 113.78 7.72 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.2 pt -75.35 94.04 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -171.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -85.41 95.5 9.27 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 172.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -162.05 176.54 10.62 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.973 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 65.8 t 68.1 -79.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.525 1.13 . . . . 0.0 109.43 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.26 1.651 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -178.753 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -99.63 128.48 45.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -81.37 76.28 8.31 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.441 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.11 52.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 123.862 1.791 . . . . 0.0 107.446 174.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -143.84 -47.3 0.28 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -96.37 -160.52 0.8 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.0 tp 71.49 128.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.114 0.966 . . . . 0.0 111.983 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.9 tp -74.99 108.84 7.99 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.04 98.36 2.52 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.05 139.47 52.65 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.549 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 36' ' ' ILE . 33.7 m-20 -108.45 78.34 1.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 35' ' ' THR . 29.2 m -127.38 176.56 7.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.069 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.66 121.28 84.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.04 -46.35 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.42 2.08 . . . . 0.0 111.633 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.424 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 89.0 mt -128.86 173.97 9.9 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.5 m -82.84 128.56 34.53 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.46 131.85 37.27 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.65 -177.63 25.6 Favored Glycine 0 N--CA 1.413 -2.851 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.673 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 96.9 mt -126.85 150.96 48.96 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.78 109.01 17.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 25.6 p -93.13 -88.89 0.21 Allowed 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.001 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.37 172.04 12.9 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.23 88.36 0.01 OUTLIER Glycine 0 N--CA 1.469 0.882 0 O-C-N 124.71 1.256 . . . . 0.0 115.906 -173.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.66 29.55 71.23 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.773 -0.714 . . . . 0.0 114.211 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.95 136.04 52.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ttt -100.12 130.04 46.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.0 110.847 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.8 m -114.88 115.02 26.27 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.7 126.44 35.32 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.4 mp -95.58 -50.13 5.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -110.71 107.53 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -74.61 149.52 40.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.869 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.8 ptt85 -52.7 147.24 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.291 1.037 . . . . 0.0 112.322 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 76.88 2.9 3.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.255 1.422 . . . . 0.0 113.593 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -77.88 131.84 37.69 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.439 ' HA ' HG12 ' A' ' 12' ' ' VAL . 2.5 m -72.96 140.17 47.23 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 123.162 0.585 . . . . 0.0 111.506 -174.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 11' ' ' ASP . 18.7 pt -109.63 161.15 25.21 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 42.6 Cg_exo -62.19 136.84 20.84 Favored 'Cis proline' 0 C--O 1.241 0.672 0 CA-C-N 120.462 1.201 . . . . 0.0 114.57 0.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -107.44 166.21 10.82 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -167.09 102.11 0.54 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -130.31 130.37 44.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 79.5 m -115.49 126.55 54.44 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.119 0.262 . . . . 0.0 110.534 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -127.64 140.32 52.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -104.34 114.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 87.0 m-85 -106.05 138.78 41.63 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.426 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 4.8 p -106.22 170.81 7.7 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -106.54 146.12 31.02 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.792 -1.192 . . . . 0.0 110.916 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.436 ' HA ' ' HG2' ' A' ' 85' ' ' ARG . 28.0 m-85 -87.86 -28.55 21.52 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -71.76 139.0 48.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.26 172.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -104.35 154.88 19.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.797 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 61.27 25.43 15.41 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 47.9 mt-30 -65.12 133.96 95.8 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 51' ' ' GLN . 2.7 Cg_exo -80.37 -19.82 8.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.332 2.021 . . . . 0.0 110.394 171.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.9 153.05 23.47 Favored Glycine 0 N--CA 1.419 -2.435 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.926 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.06 160.42 15.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 tp -118.4 114.53 23.04 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.2 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.05 110.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 36.5 mt-30 -108.46 113.69 26.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.671 -175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 104' ' ' VAL . 34.8 t -95.19 120.9 45.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.258 0 O-C-N 123.363 0.414 . . . . 0.0 110.602 -177.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.4 146.71 52.01 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' OE2' ' HB2' ' A' ' 15' ' ' LEU . 15.4 pt-20 -120.48 150.61 40.55 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.853 0.835 . . . . 0.0 110.771 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.34 -174.01 19.8 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.86 95.52 3.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 118.192 0.996 . . . . 0.0 108.712 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -142.93 153.64 43.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.931 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -81.43 -49.55 10.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.144 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mmm -98.89 105.44 17.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.404 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 95.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.981 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -151.59 -44.51 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.54 11.14 36.2 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.615 0.721 . . . . 0.0 109.654 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.55 161.95 25.67 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.913 -173.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -90.78 115.13 27.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -82.05 113.73 20.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.98 -33.02 19.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.91 162.7 22.66 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -153.67 138.7 17.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -137.75 151.39 48.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.036 0.446 . . . . 0.0 111.46 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.55 133.16 38.47 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.292 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -111.04 105.13 13.78 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -96.71 151.29 19.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.402 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.7 -0.62 13.77 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 121.117 -0.564 . . . . 0.0 111.835 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.08 133.96 92.82 Favored Pre-proline 0 C--O 1.254 1.319 0 C-N-CA 122.847 0.459 . . . . 0.0 110.675 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 111' ' ' THR . 19.2 Cg_endo -58.33 134.88 64.37 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.179 2.586 . . . . 0.0 112.476 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -71.44 67.66 2.79 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.596 2.197 . . . . 0.0 110.593 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.52 158.52 75.4 Favored Pre-proline 0 N--CA 1.417 -2.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.086 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.79 178.68 7.3 Favored 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.192 1.928 . . . . 0.0 114.462 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 47' ' ' TYR . 19.3 mtm180 -30.18 115.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.795 2.438 . . . . 0.0 115.138 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.82 -29.75 8.67 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.666 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.58 -51.01 4.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.41 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.92 124.38 14.38 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.447 1.432 . . . . 0.0 109.421 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -134.93 95.61 3.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.221 1.01 . . . . 0.0 110.388 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.7 mm -93.42 112.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.773 -173.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -90.16 111.9 23.21 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 105' ' ' THR . 62.0 t -111.56 125.68 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -177.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.6 m -112.78 124.27 52.21 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.446 ' CD1' HD22 ' A' ' 29' ' ' LEU . 14.5 m-85 -97.7 109.32 22.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.18 114.22 16.04 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 59.4 mt -116.44 140.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' HD12 ' A' ' 36' ' ' ILE . 1.3 p-10 -93.45 -176.5 4.13 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.35 -15.14 62.83 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -82.21 -28.76 31.77 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.63 20.15 7.47 Favored Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 78.6 mt -83.8 113.93 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 tp -95.28 118.8 32.68 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 24.0 t-20 -110.39 113.32 25.88 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 174.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 58' ' ' VAL . 59.7 t -97.4 113.78 32.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 21.1 m -103.64 126.76 50.98 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.75 126.04 49.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 113' ' ' LYS . 19.8 m -131.84 118.32 19.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.51 107.62 11.3 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -67.56 -20.53 65.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.555 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.6 t -69.44 -52.53 25.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.044 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.411 HG23 ' HD3' ' A' ' 81' ' ' PRO . 38.0 p -90.06 -32.2 16.82 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.47 43.98 3.56 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 107' ' ' THR . 54.4 mttm -116.59 133.37 56.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.2 136.64 41.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -138.77 145.96 40.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.267 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -143.26 151.0 40.06 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 123.042 0.214 . . . . 0.0 111.288 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 32.0 pt -121.9 141.21 43.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.962 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.1 m -111.14 113.21 25.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.99 103.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.056 0.455 . . . . 0.0 109.977 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -93.75 127.41 39.46 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 72.05 114.65 0.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.453 1.101 . . . . 0.0 111.701 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.76 147.2 23.27 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.737 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.9 mttp 67.56 81.54 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.763 1.225 . . . . 0.0 113.717 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -111.45 -21.49 6.5 Favored Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -84.23 -15.73 45.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.507 0.67 . . . . 0.0 110.361 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.33 152.68 36.34 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.148 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.528 ' O ' HG13 ' A' ' 131' ' ' ILE . 45.8 p -106.61 174.01 6.07 Favored 'General case' 0 C--N 1.28 -2.426 0 O-C-N 124.245 0.966 . . . . 0.0 108.988 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -44.56 -53.28 7.24 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.647 1.179 . . . . 0.0 114.087 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.12 -33.93 75.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.807 0.337 . . . . 0.0 111.391 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 134' ' ' MET . 46.8 mt-10 -70.81 -36.11 72.81 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 127' ' ' SER . 84.4 mt -60.7 -52.02 66.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.793 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 9.5 pt-20 -70.42 -25.1 63.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.509 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 92.2 mmm -59.47 -43.19 93.31 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.3 t -63.24 -47.5 91.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.156 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 15.8 mm-40 -57.34 -46.95 82.78 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.82 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.79 -35.61 75.01 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.206 0.316 . . . . 0.0 111.541 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.39 77.97 Favored 'General case' 0 C--O 1.19 -2.064 0 O-C-N 123.472 0.483 . . . . 0.0 110.322 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.08 -48.2 16.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.473 0.654 . . . . 0.0 111.025 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.92 -40.48 96.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.394 -173.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.71 18.11 19.27 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.81 0.338 . . . . 0.0 110.195 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -49.03 -58.93 4.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.458 1.503 . . . . 0.0 112.451 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -71.55 -34.14 69.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 33.8 mm-40 -64.38 -53.42 48.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.044 -176.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 1.4 m-20 -63.6 -36.44 83.81 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.059 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.528 ' OE1' ' HD3' ' A' ' 149' ' ' ARG . 6.9 mm-40 -57.85 -46.43 84.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.021 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 60.2 t -63.32 -40.88 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 17.7 mm100 -58.78 -54.08 51.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.628 0.771 . . . . 0.0 111.698 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 2.6 ptm180 -68.78 -32.82 72.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.22 -9.91 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.916 0.388 . . . . 0.0 111.752 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 92.2 mtt180 -68.8 -27.67 66.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.24 125.69 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -81.53 75.85 8.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 0.0 111.383 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -101.87 120.47 40.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.577 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -94.67 -163.12 1.01 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 18.1 m120 -76.28 80.16 3.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.847 0.832 . . . . 0.0 109.042 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.631 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.58 153.13 41.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.344 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.2 mt -125.82 136.01 52.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.09 120.2 40.91 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.8 p -155.73 164.79 38.12 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -140.59 143.25 35.16 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.1 89.6 4.83 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 73.44 121.27 0.04 OUTLIER 'General case' 0 C--O 1.245 0.843 0 C-N-CA 125.323 1.449 . . . . 0.0 111.436 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.39 170.67 12.72 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.673 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 68.4 mtm 62.54 74.51 0.43 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.25 1.02 . . . . 0.0 112.157 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -142.57 126.61 17.35 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 47.2 m -145.83 79.05 1.55 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.406 0.622 . . . . 0.0 110.34 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -126.54 112.48 15.59 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.4 m -82.67 123.09 38.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.361 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.03 102.51 11.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -117.21 128.86 55.51 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -172.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 63.14 89.75 0.08 Allowed 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.552 1.541 . . . . 0.0 112.315 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.42 104.07 1.46 Allowed Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.708 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 52.7 tp -81.62 142.23 32.96 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -129.0 169.76 14.29 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 93.08 16.12 48.89 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -131.99 100.62 5.12 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 123.388 0.675 . . . . 0.0 109.577 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.7 mm -76.97 126.63 37.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 8.5 m -51.0 122.14 7.08 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.854 0.862 . . . . 0.0 111.246 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.43 57.03 4.21 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.971 0.891 . . . . 0.0 110.983 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -98.95 87.26 3.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -89.69 150.59 22.27 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.945 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -83.01 96.95 8.5 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.414 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -76.69 113.29 14.18 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.42 ' HD2' ' HB2' ' A' ' 188' ' ' ASP . 74.5 mttt -102.58 174.51 5.86 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.19 -53.78 7.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.58 102.88 13.67 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.908 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 185' ' ' LYS . 15.9 t70 -150.0 131.88 15.14 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -81.97 83.64 7.19 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.183 -176.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.407 ' C ' ' H ' ' A' ' 193' ' ' VAL . 7.5 pt20 -128.45 14.15 6.57 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.254 1.026 . . . . 0.0 109.094 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -82.0 30.97 0.38 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.043 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 191' ' ' GLN . 33.5 m -81.9 -10.95 12.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 124.014 0.926 . . . . 0.0 110.823 -176.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 14.6 tt -109.47 0.77 9.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 122.263 1.03 . . . . 0.0 108.344 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.0 m -121.82 154.46 36.99 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.419 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 25.7 m-90 -105.33 132.26 51.75 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -80.87 -5.9 57.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.232 1.015 . . . . 0.0 109.012 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -107.69 109.43 21.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.51 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -149.99 -41.03 0.14 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -84.87 3.67 36.88 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.201 1.0 . . . . 0.0 109.69 -176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.2 p -83.29 -19.62 35.94 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.194 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.53 136.57 32.97 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -75.49 85.28 2.58 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.054 0.93 . . . . 0.0 110.481 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -102.34 95.2 6.13 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -114.47 -52.69 2.7 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.387 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 63.51 73.28 0.45 Allowed 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.895 1.278 . . . . 0.0 113.537 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -99.3 141.13 32.47 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.771 174.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -120.01 126.68 51.43 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -118.38 106.94 13.25 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.088 0.47 . . . . 0.0 111.557 -173.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -144.84 -34.32 0.36 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.518 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -158.15 138.05 12.24 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.183 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -135.45 10.36 3.46 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.62 111.32 12.59 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.12 164.86 19.98 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.676 -174.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.1 pp -126.07 142.98 51.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 171.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -112.92 146.77 38.38 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.401 -174.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.34 -15.23 58.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . 0.305 13.1 p 52.66 107.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.527 1.531 . . . . 0.0 114.207 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 222' ' ' ILE . 47.9 t-20 -73.52 123.63 89.61 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.52 87.65 1.52 Allowed 'Trans proline' 0 N--CA 1.44 -1.625 0 C-N-CA 122.185 1.923 . . . . 0.0 111.784 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.4 HG23 ' OD1' ' A' ' 220' ' ' ASN . 25.1 pt -123.04 141.0 45.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.003 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 35.2 pt -127.69 153.54 37.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 26.9 m -143.58 156.58 44.63 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -176.48 -163.54 29.05 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.08 108.29 3.51 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -93.59 -52.54 4.43 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.447 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -97.1 112.92 24.48 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.0 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -127.01 75.36 0.41 Allowed Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.07 153.13 27.52 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.818 0.342 . . . . 0.0 111.118 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -129.41 -175.99 14.26 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.81 86.0 0.38 Allowed Glycine 0 C--N 1.302 -1.353 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.14 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -85.18 92.55 0.69 Allowed 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 122.347 2.031 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -141.82 111.67 0.71 Allowed Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.31 145.17 88.75 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.989 2.459 . . . . 0.0 111.568 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -136.03 -166.49 10.96 Favored Glycine 0 C--N 1.307 -1.049 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.04 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 107.41 59.16 0.57 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -105.14 130.0 53.42 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -154.4 174.22 32.81 Favored Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -135.13 -65.18 0.63 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 117.067 0.433 . . . . 0.0 109.844 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 70.12 164.37 0.26 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.705 1.202 . . . . 0.0 112.091 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 106.28 -154.95 16.79 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.763 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.63 139.63 44.94 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 123.151 2.568 . . . . 0.0 112.456 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -112.46 107.61 16.45 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.97 -51.16 4.53 Favored Glycine 0 C--N 1.316 -0.562 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -172.8 -146.3 5.36 Favored Glycine 0 N--CA 1.415 -2.703 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.7 m -102.93 119.34 38.66 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.81 66.58 2.76 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 35.8 t -143.86 95.74 2.78 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -125.53 96.44 0.49 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.58 -73.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.062 2.508 . . . . 0.0 112.878 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.2 m -132.41 97.26 4.05 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.533 HD13 ' H ' ' A' ' 253' ' ' ILE . 0.2 OUTLIER -116.75 166.59 10.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 73.51 78.52 0.13 Allowed 'General case' 0 C--O 1.243 0.749 0 O-C-N 124.621 1.201 . . . . 0.0 111.22 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -163.7 145.54 9.35 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.638 1.175 . . . . 0.0 107.953 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.71 116.48 34.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.526 0.679 . . . . 0.0 111.771 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--N 1.307 -1.276 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.981 -179.867 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -110.12 105.22 14.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.6 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -85.46 88.85 7.56 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.6 m -80.68 127.53 39.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.369 -175.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 62.07 94.46 0.04 OUTLIER 'General case' 0 C--O 1.238 0.487 0 O-C-N 124.412 1.07 . . . . 0.0 112.508 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -84.73 149.89 25.47 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.819 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.5 tp -93.91 44.41 1.12 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.477 0.656 . . . . 0.0 110.514 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.2 tp -81.58 -62.58 1.6 Allowed 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.04 -0.412 . . . . 0.0 111.155 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.62 -57.49 2.65 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.13 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp 62.5 73.92 0.45 Allowed 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.57 1.148 . . . . 0.0 109.862 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 36' ' ' ILE . 17.2 t70 -123.13 17.59 9.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 123.083 1.42 . . . . 0.0 108.941 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 m -136.37 171.07 17.44 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.136 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.73 118.66 72.61 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.08 -31.98 13.96 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.983 1.788 . . . . 0.0 112.335 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.04 168.83 17.78 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.428 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 24.1 m -92.67 132.44 36.9 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.08 132.03 50.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.92 179.37 28.55 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.352 -176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.47 HD11 HG11 ' A' ' 92' ' ' VAL . 97.1 mt -118.75 155.47 31.06 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.809 -0.695 . . . . 0.0 109.867 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -88.59 109.35 20.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.444 HG22 ' HG ' ' A' ' 158' ' ' LEU . 17.2 p -105.3 -166.06 1.18 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.489 -174.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.33 134.69 18.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.615 0.766 . . . . 0.0 112.174 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.81 56.07 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.142 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.51 25.14 31.33 Favored Glycine 0 C--O 1.246 0.898 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 152' ' ' VAL . 64.0 t -104.52 146.54 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.507 -1.346 . . . . 0.0 109.208 -175.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.4 ttt -87.89 136.43 32.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.213 0.53 . . . . 0.0 111.983 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.6 m -123.74 112.19 17.04 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.85 116.59 29.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.782 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.515 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.4 mp -79.41 -47.22 16.1 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.04 112.95 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.19 142.46 28.33 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 32' ' ' ARG . 16.8 ptt180 -56.76 155.74 7.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 77.98 1.29 2.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.528 1.531 . . . . 0.0 111.813 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -86.12 128.99 34.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -60.05 144.91 48.33 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.408 1.083 . . . . 0.0 112.109 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.611 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 28.4 pt -106.16 169.75 6.57 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.611 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 14.7 Cg_exo -69.08 124.77 7.55 Favored 'Cis proline' 0 C--O 1.244 0.817 0 CA-C-N 121.153 1.447 . . . . 0.0 112.257 0.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -87.96 141.7 28.38 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.405 -178.194 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -148.68 100.02 3.06 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 93' ' ' THR . 14.8 mm100 -107.01 117.66 34.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 88.3 m -117.31 116.05 26.47 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.457 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 87.5 mt-30 -120.95 151.39 39.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.77 113.22 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -101.59 165.87 11.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.964 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -145.14 170.89 15.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 p -101.36 139.03 37.59 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.706 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -85.76 -18.8 31.98 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 165.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 p -71.8 110.01 6.05 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.031 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.74 126.65 32.62 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m120 62.05 68.49 0.68 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.426 0.632 . . . . 0.0 111.149 -172.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.5 tp-100 -101.56 117.27 62.23 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.72 -31.75 20.1 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.003 1.802 . . . . 0.0 113.349 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.34 140.09 6.74 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.592 -0.814 . . . . 0.0 111.114 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.85 147.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.135 0.493 . . . . 0.0 110.123 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.517 HD21 ' NH1' ' A' ' 74' ' ' ARG . 42.0 tp -114.7 111.56 21.49 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.141 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.73 105.23 16.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.498 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 83.9 mt-30 -103.91 115.11 29.85 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.238 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.02 124.04 55.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 O-C-N 123.643 0.59 . . . . 0.0 110.755 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -129.49 154.4 47.04 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.466 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 34.4 tt0 -122.27 147.74 45.85 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.97 125.73 5.66 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 16' ' ' SER . 37.5 mt-10 -79.51 126.36 30.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -152.84 168.41 25.84 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.482 0.713 . . . . 0.0 110.652 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -84.06 -51.1 7.37 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.52 0.676 . . . . 0.0 109.341 174.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.6 mtt -98.63 128.14 44.81 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.989 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -90.0 117.83 29.09 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.877 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -177.59 -52.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.528 1.131 . . . . 0.0 110.058 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.01 79.95 1.81 Allowed 'General case' 0 CA--C 1.464 -2.349 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.93 177.96 7.45 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 112.802 -1.999 . . . . 0.0 106.012 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 30.3 t30 -90.12 109.07 20.15 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.8 107.42 9.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.977 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.18 -41.79 14.38 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.533 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.37 171.52 38.71 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.068 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.517 ' NH1' HD21 ' A' ' 55' ' ' LEU . 7.2 ptp180 -152.58 140.77 20.41 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -147.15 149.02 32.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -97.21 140.14 32.13 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.7 103.39 9.63 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 170.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 p -111.83 161.46 16.33 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 41.71 3.63 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 42.8 mm -86.34 130.49 49.4 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 147.36 94.72 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.74 2.293 . . . . 0.0 112.359 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.88 84.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 122.685 2.256 . . . . 0.0 111.307 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.6 77.92 Favored Pre-proline 0 N--CA 1.42 -1.949 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.841 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.08 168.94 6.69 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.668 2.246 . . . . 0.0 112.712 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -62.94 149.27 45.1 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.657 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.18 -16.0 41.16 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.511 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.25 -55.17 1.39 Allowed Pre-proline 0 C--O 1.247 0.969 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.264 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.71 109.34 1.42 Allowed 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 121.339 1.359 . . . . 0.0 111.283 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -93.64 115.49 27.96 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.004 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.4 mm -102.46 116.77 46.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 17.0 tt0 -90.18 117.18 28.74 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 105' ' ' THR . 39.2 t -117.85 121.16 66.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.657 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 85.6 m -110.95 123.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.664 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 29' ' ' LEU . 7.1 m-85 -105.2 108.51 20.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 38' ' ' THR . 7.9 t70 -121.19 132.06 54.61 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.414 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 62.8 mt -126.3 135.6 63.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.87 -170.58 2.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.02 -23.6 64.1 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -77.1 -29.31 54.82 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.169 0.509 . . . . 0.0 110.05 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.02 23.35 7.44 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.9 mt -83.35 117.64 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.3 tp -93.58 117.1 29.66 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -109.73 103.38 12.2 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 64.2 t -89.86 118.63 35.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.467 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 35.7 m -113.41 137.17 51.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 91' ' ' GLU . . . -126.79 121.18 31.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 19.7 m -118.81 123.68 45.35 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.497 0.498 . . . . 0.0 110.738 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.57 109.92 16.47 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -66.96 -17.28 64.84 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.918 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -75.6 -62.85 1.44 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.893 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -94.26 -19.47 20.68 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.55 47.96 3.59 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.821 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 107' ' ' THR . 61.3 mttp -106.78 147.24 29.91 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -149.94 131.83 15.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.338 0.589 . . . . 0.0 111.826 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -136.54 139.14 42.0 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.567 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 61.2 pttt -135.85 148.76 48.79 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 120.722 0.296 . . . . 0.0 110.815 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.4 pt -119.16 139.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -104.27 112.77 25.93 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.23 108.5 25.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.8 p -84.59 163.89 19.03 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.455 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -69.22 -40.33 78.02 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 68.41 -65.55 0.26 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 126.178 1.791 . . . . 0.0 113.194 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -174.73 -61.16 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.32 138.67 5.41 Favored Glycine 0 N--CA 1.418 -2.553 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.764 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -100.9 124.75 47.05 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt 61.71 -95.79 0.05 Allowed 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.417 1.087 . . . . 0.0 109.944 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.5 p -140.66 2.32 1.79 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.66 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.5 tttm 68.38 -51.41 0.55 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.31 1.044 . . . . 0.0 112.097 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.04 -43.09 73.44 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.125 1.37 . . . . 0.0 111.831 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.66 -32.82 73.01 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.051 0.453 . . . . 0.0 111.787 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 135' ' ' VAL . 62.3 mt -72.78 -44.23 59.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.12 -39.58 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.257 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 1.2 mmp_? -60.35 -46.35 90.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.915 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.4 ttt -55.71 -47.06 77.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.077 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 131' ' ' ILE . 69.8 t -58.45 -45.97 89.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.362 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.65 -31.8 70.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.433 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 37.1 mt-10 -64.94 -47.7 76.73 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.32 -30.63 68.49 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.231 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HA ' ' HG2' ' A' ' 142' ' ' LYS . 31.8 mt-10 -78.15 -31.55 49.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -70.62 -19.16 62.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.118 0.961 . . . . 0.0 109.291 174.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.42 27.4 8.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.33 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 139' ' ' GLU . 5.1 mmtt -48.98 -52.47 24.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.788 0.835 . . . . 0.0 112.882 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -70.54 -51.97 24.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 148' ' ' GLN 0.258 1.4 pm0 -60.28 -45.88 91.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.251 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.8 -45.62 88.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.17 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . 0.251 35.8 mt-10 -70.28 -32.53 70.37 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.735 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 143' ' ' ALA . 89.4 t -65.7 -45.77 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 14.4 mm100 -58.08 -43.88 87.28 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 110.752 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.426 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 2.6 tmt_? -61.86 -41.0 97.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.725 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 -11.48 42.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -62.4 -44.41 96.5 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.303 0.573 . . . . 0.0 110.056 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 25' ' ' VAL . 48.7 t -78.79 113.68 18.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -77.87 95.54 4.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.93 -21.0 17.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.892 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 63.61 -77.99 0.03 OUTLIER 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.085 1.354 . . . . 0.0 111.398 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -178.26 40.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.44 156.73 34.95 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.533 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -122.63 153.14 39.73 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.495 0.664 . . . . 0.0 110.622 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.25 158.25 29.88 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 168.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.4 m -135.62 130.11 33.9 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.949 -175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -161.11 173.86 14.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 63.93 79.1 0.27 Allowed 'General case' 0 C--O 1.246 0.878 0 O-C-N 124.581 1.176 . . . . 0.0 111.366 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -79.85 121.61 25.61 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.093 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.4 91.91 6.35 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.748 0.785 . . . . 0.0 110.311 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 66.3 mtt -127.26 35.21 4.59 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -52.97 125.25 16.55 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.163 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m -65.67 108.11 1.97 Allowed 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.417 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.72 89.13 3.0 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.0 m -117.87 -19.28 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.138 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.15 16.24 3.24 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -63.38 144.69 56.74 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.641 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.08 90.86 3.31 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-O 121.842 0.83 . . . . 0.0 112.237 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -121.15 25.68 6.98 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 173.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.6 8.55 11.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.12 -1.04 . . . . 0.0 112.712 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -86.07 92.16 8.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.17 116.95 5.05 Favored Glycine 0 N--CA 1.425 -2.062 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.222 -173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -93.39 81.05 4.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.8 pt -96.42 -35.96 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.378 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 18.3 m -101.17 -18.23 16.27 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.263 0.554 . . . . 0.0 110.086 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -94.39 88.27 5.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -99.04 108.05 20.61 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -84.39 113.84 21.46 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.01 0.909 . . . . 0.0 111.634 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -179.63 168.6 1.39 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 127.047 2.139 . . . . 0.0 106.32 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -68.94 -38.24 79.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 118.054 0.388 . . . . 0.0 111.795 -175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 72.31 -60.52 0.53 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.564 1.146 . . . . 0.0 112.903 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.85 132.06 64.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.0 mp -95.06 78.03 3.54 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.442 0.639 . . . . 0.0 110.286 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -165.89 158.44 14.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? 74.14 120.26 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.111 0.964 . . . . 0.0 110.967 -173.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -106.38 86.88 2.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.38 -53.61 6.74 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.036 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.62 136.14 23.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.7 mt -120.88 -58.68 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.992 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 33.2 t -84.05 99.43 10.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 120.893 0.377 . . . . 0.0 110.09 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -84.97 84.54 7.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -88.08 97.99 11.29 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -136.31 8.8 3.17 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.193 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -77.77 80.97 4.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.325 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -159.08 113.0 2.36 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 9.0 m -106.81 -56.54 2.18 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -74.78 117.95 17.2 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -134.27 -46.25 0.77 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 66.35 115.13 0.03 OUTLIER 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.411 1.484 . . . . 0.0 113.708 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -140.23 101.81 4.22 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 172.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -128.73 137.84 51.8 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -92.57 172.31 8.45 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.059 0.457 . . . . 0.0 111.969 -175.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -76.36 153.43 35.79 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.195 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -148.81 -51.59 0.16 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -60.82 -22.97 64.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.795 -174.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -62.55 -43.0 99.89 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.112 0.482 . . . . 0.0 110.077 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 212' ' ' ARG . 37.1 mmt180 -83.47 135.21 34.75 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.424 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -149.63 -67.27 0.21 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 57.68 101.13 0.02 OUTLIER 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.891 1.276 . . . . 0.0 112.754 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.43 167.22 21.63 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -100.82 -10.52 20.65 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.152 -171.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 60.26 31.13 20.36 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.551 0.741 . . . . 0.0 109.15 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.74 77.37 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 123.163 1.459 . . . . 0.0 112.794 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -92.63 118.65 68.07 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.577 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.43 151.56 33.4 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.561 2.174 . . . . 0.0 111.213 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.615 HD13 ' H ' ' A' ' 222' ' ' ILE . 0.2 OUTLIER -80.33 105.81 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.775 0.798 . . . . 0.0 110.924 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.0 pt -92.54 -2.51 10.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.356 0.598 . . . . 0.0 110.334 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 13.6 p -149.09 178.86 8.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.043 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -149.29 150.49 22.61 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.07 95.2 6.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -137.05 -81.44 0.37 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.692 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 64.0 171.88 0.18 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.906 1.283 . . . . 0.0 111.298 -174.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -132.84 -153.84 7.36 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -120.56 -27.48 5.13 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 117.093 0.446 . . . . 0.0 110.498 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 66.58 43.55 91.93 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 107.9 82.89 1.49 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 -174.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.02 -25.93 78.08 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.174 2.583 . . . . 0.0 113.181 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 142.94 94.91 0.21 Allowed Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.274 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.79 -24.89 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.319 2.013 . . . . 0.0 112.347 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.41 -177.82 17.07 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -101.39 -45.4 1.84 Allowed Glycine 0 C--O 1.246 0.904 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.101 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 73.41 149.17 0.1 Allowed 'General case' 0 C--O 1.252 1.196 0 C-N-CA 124.749 1.22 . . . . 0.0 113.72 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 112.31 -60.09 0.35 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.518 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -154.38 167.54 29.64 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.38 16.95 12.18 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 158.87 -75.77 0.2 Allowed Glycine 0 C--N 1.311 -0.824 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -80.65 116.31 3.2 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.128 1.886 . . . . 0.0 110.098 174.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.75 -41.43 90.97 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 123.118 0.567 . . . . 0.0 110.167 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.73 127.66 2.08 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -71.73 173.46 44.33 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.6 m -82.3 -24.12 34.82 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.231 0.539 . . . . 0.0 109.972 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 179.61 79.53 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.849 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 43.1 m -135.09 130.46 35.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -92.66 -146.22 18.51 Favored Glycine 0 C--O 1.248 0.986 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.37 96.04 0.4 Allowed 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.236 1.957 . . . . 0.0 109.486 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 26.5 m -88.91 73.93 8.29 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 122.584 1.183 . . . . 0.0 110.657 -174.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.88 134.64 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 CA-C-N 113.085 -1.871 . . . . 0.0 106.917 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.45 114.09 24.71 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -134.75 82.58 1.97 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 122.022 0.915 . . . . 0.0 110.728 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 13.6 p -130.67 -2.39 2.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.525 -1.216 . . . . 0.0 107.885 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 C--O 1.255 1.387 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.216 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.438 -1.031 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.43 133.2 33.77 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -84.69 100.61 11.58 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.005 0.907 . . . . 0.0 110.199 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.41 13.03 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.689 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -112.42 102.07 10.22 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.28 111.69 19.2 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.197 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.4 tp -90.43 93.32 9.26 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.8 pt? -116.49 75.86 0.99 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.279 1.038 . . . . 0.0 111.618 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.06 -57.75 2.01 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.0 mt -108.03 76.03 1.03 Allowed 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -98.07 37.9 1.38 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 112.983 -1.917 . . . . 0.0 109.955 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.59 146.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.767 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 121.59 46.86 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.455 171.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' C ' HD12 ' A' ' 15' ' ' LEU . 36.9 Cg_exo -57.58 -58.97 0.65 Allowed 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 5.8 mp -126.77 176.43 7.27 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.2 m -80.93 119.8 23.92 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -92.5 132.07 37.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.853 0.72 . . . . 0.0 109.274 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -153.72 -169.9 19.19 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.243 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.46 HD23 HG23 ' A' ' 56' ' ' ILE . 2.3 mp -131.52 163.23 28.46 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.538 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 34.5 tt0 -87.89 109.07 19.51 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 123.0 1.381 . . . . 0.0 109.802 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 11.9 p -85.74 160.21 19.58 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.494 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.54 118.49 1.79 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 125.502 1.521 . . . . 0.0 113.665 -173.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.94 4.25 39.07 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.637 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.98 39.51 27.7 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.8 t -108.44 146.77 13.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.403 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -101.87 127.81 48.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.477 0.656 . . . . 0.0 109.285 -178.178 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.7 m -123.89 116.15 22.44 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.8 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -86.55 141.35 29.11 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.754 0.659 . . . . 0.0 111.172 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.37 -39.81 6.03 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.58 112.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -79.0 154.42 29.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.342 0.591 . . . . 0.0 110.501 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -64.37 149.81 47.55 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.47 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 66.38 20.79 10.96 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 124.408 1.083 . . . . 0.0 111.881 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.6 t -90.39 126.96 36.05 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.5 119.73 7.54 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.806 0.842 . . . . 0.0 113.263 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.43 HG22 HG23 ' A' ' 38' ' ' THR . 23.7 pt -101.46 162.25 21.05 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.66 -1.154 . . . . 0.0 107.925 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 137.13 12.24 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 CA-C-N 121.341 1.515 . . . . 0.0 115.152 1.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 36' ' ' ILE . 1.1 p -107.6 154.93 20.71 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -146.83 103.74 3.66 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.97 121.32 20.31 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 m -127.95 115.97 19.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.551 0.215 . . . . 0.0 110.876 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -115.36 153.08 31.65 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.22 114.13 41.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.96 151.13 19.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.6 p -122.1 169.91 10.39 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 33.7 p -95.84 136.94 35.61 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.92 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -107.61 -1.1 21.5 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.245 0.545 . . . . 0.0 111.139 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -101.77 138.91 38.12 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.8 139.5 34.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.44 18.49 11.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.516 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 46.2 tt0 -60.22 114.79 10.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 123.045 0.538 . . . . 0.0 110.226 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.33 -5.78 10.16 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.791 2.327 . . . . 0.0 113.892 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.13 150.34 14.49 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.632 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.2 165.08 24.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.0 tp -117.92 127.82 54.21 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.46 HG23 HD23 ' A' ' 19' ' ' LEU . 3.0 mp -98.42 98.34 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.66 110.1 21.04 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.54 114.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.953 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.538 ' CE2' ' HB2' ' A' ' 20' ' ' GLU . 68.6 m-85 -107.69 156.37 19.15 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.529 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.541 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 39.8 tt0 -134.99 137.81 43.38 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.74 -107.03 1.14 Allowed Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.261 -0.971 . . . . 0.0 114.785 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' CD ' ' HZ2' ' A' ' 67' ' ' LYS . 41.8 mt-10 -79.1 158.54 27.77 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.344 1.058 . . . . 0.0 109.414 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.428 HH11 ' HA ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -122.48 -46.31 2.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.705 0.764 . . . . 0.0 112.639 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -71.97 -28.43 63.43 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.538 0.685 . . . . 0.0 110.805 -173.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.5 mmt -134.57 111.47 10.08 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.706 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.1 91.57 4.31 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.448 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 19.8 pttp -144.71 -58.54 0.36 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.403 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 5.5 m-20 -105.45 25.95 10.07 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.489 0.661 . . . . 0.0 109.518 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -74.54 160.96 30.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.377 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -93.76 129.99 39.92 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.461 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 62.2 tp -101.69 111.01 23.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.93 -51.13 7.4 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.26 159.02 32.09 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.848 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 78.5 mtm180 -138.15 136.94 37.18 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.84 144.87 30.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.49 133.58 39.32 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.563 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 5.5 tt -113.46 104.05 11.89 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 172.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -120.54 155.39 33.74 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.12 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.12 7.53 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.5 mt -79.16 132.92 61.76 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 38.0 Cg_endo -66.36 125.19 13.56 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.504 2.136 . . . . 0.0 111.249 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 32.5 Cg_exo -61.25 101.85 0.2 Allowed 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.668 2.246 . . . . 0.0 111.94 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.77 157.61 59.33 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 68.0 Cg_endo -70.76 50.73 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.762 2.975 . . . . 0.0 113.312 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' THR . 39.5 ptt180 56.42 164.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.142 2.177 . . . . 0.0 113.89 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.55 -44.2 2.21 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.346 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.6 -50.24 73.37 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 123.976 0.91 . . . . 0.0 113.171 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.75 123.24 11.38 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 121.576 1.517 . . . . 0.0 110.985 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 76.4 mt-30 -117.23 115.21 24.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.479 -175.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.33 105.58 18.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -90.62 107.78 19.38 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -107.9 124.48 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.179 0.514 . . . . 0.0 111.118 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.3 m -103.86 121.93 44.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.727 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.56 107.94 19.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.36 125.14 40.2 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.883 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.25 131.75 72.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.9 p30 -89.79 -169.76 2.57 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.376 0.422 . . . . 0.0 110.335 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.85 2.1 47.16 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.122 -0.361 . . . . 0.0 111.958 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -96.01 -13.6 23.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.56 30.18 12.4 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 67.2 mt -102.05 116.46 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.091 0.472 . . . . 0.0 109.889 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.21 111.23 22.81 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.979 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.03 114.42 27.72 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.94 126.58 58.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 122.28 31.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.82 117.83 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.6 m -113.6 117.96 33.07 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.533 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.85 107.87 11.88 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 28.2 mmmt -67.31 -20.21 65.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.613 0.765 . . . . 0.0 110.779 -177.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -69.33 -54.6 13.75 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.785 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.9 p -99.05 -15.44 19.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.058 0.456 . . . . 0.0 112.056 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 30.36 36.22 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.499 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -115.36 158.57 22.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.546 0.673 . . . . 0.0 109.504 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.64 155.88 48.66 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.563 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.1 m120 -129.35 127.61 41.42 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -119.29 145.31 46.23 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.812 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.4 tt -136.64 148.77 26.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 m -113.61 112.93 24.33 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.2 mm -107.58 94.19 2.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t -88.11 122.33 31.56 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.856 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 71.72 -85.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.098 1.359 . . . . 0.0 109.624 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.14 161.6 33.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -142.13 23.71 2.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -81.88 -26.11 50.59 Favored Glycine 0 CA--C 1.497 -1.081 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.128 -174.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 69.1 3.3 4.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.057 0.943 . . . . 0.0 113.245 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.31 147.2 26.66 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.9 p -63.26 145.58 55.23 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 123.732 0.645 . . . . 0.0 110.236 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -55.62 -36.77 67.34 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 122.811 0.444 . . . . 0.0 111.42 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 41.4 mt-10 -57.44 -40.3 78.14 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 134' ' ' MET . 8.9 mm-40 -67.07 -42.35 84.84 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 135' ' ' VAL . 61.9 mt -63.7 -41.94 94.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.47 -38.3 90.61 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.206 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 42.4 mtm105 -63.61 -42.12 98.24 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 53.4 mtt -59.86 -35.88 75.71 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.195 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 131' ' ' ILE . 58.9 t -56.77 -52.84 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -63.8 -42.17 97.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.523 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.0 mm-40 -64.76 -40.37 95.17 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.79 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.653 0.381 . . . . 0.0 111.274 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 25.4 mm-40 -77.85 -38.38 46.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.518 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -65.27 -38.76 91.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.348 0.594 . . . . 0.0 109.925 -179.434 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -111.57 28.63 8.56 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.927 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 139' ' ' GLU . 17.9 pttm -62.43 -45.25 93.96 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.47 67.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.397 0.618 . . . . 0.0 109.501 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -71.5 -54.15 11.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.184 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.1 m-20 -67.09 -55.2 15.29 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.14 -33.79 76.58 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -172.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.24 -47.82 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.184 175.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 152' ' ' VAL . 16.5 mm-40 -61.32 -41.39 96.94 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -55.29 -47.32 75.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -70.03 -9.51 55.53 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -97.9 0.59 46.85 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 148' ' ' GLN . 61.7 t -96.31 133.11 38.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 t -82.38 21.38 0.95 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.877 0.471 . . . . 0.0 112.014 -173.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.16 -21.76 59.71 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 50.06 -91.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.578 1.551 . . . . 0.0 113.177 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -155.1 67.73 0.68 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.17 140.3 41.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.168 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 76.1 mt -93.13 152.56 19.18 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 161' ' ' TYR . 10.4 tp10 -93.52 147.22 23.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.249 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.516 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 48.1 t -88.78 -26.57 21.65 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.41 ' H ' ' HG3' ' A' ' 159' ' ' GLU . 80.7 t80 69.06 112.65 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.926 1.29 . . . . 0.0 112.16 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.09 135.27 33.35 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.466 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -164.41 -57.95 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -93.18 113.48 25.71 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.819 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.9 mmm -75.47 -17.61 60.08 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.273 0.559 . . . . 0.0 110.69 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -81.06 137.73 36.0 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.1 p -73.5 158.24 35.28 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.615 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.82 116.71 4.28 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.9 t -80.67 -60.3 2.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.146 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -145.61 152.25 39.38 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.609 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.77 117.24 24.52 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -89.0 -27.38 20.92 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.047 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.09 61.26 4.6 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.986 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.48 -56.03 3.53 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -75.99 109.36 9.57 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.94 -16.79 7.73 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -60.36 -43.73 96.26 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.523 0.678 . . . . 0.0 110.209 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 55.0 mt -69.9 -30.77 45.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.91 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 65.3 m 71.1 -61.03 0.49 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.944 1.298 . . . . 0.0 111.79 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 67.36 -69.58 0.13 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.806 1.242 . . . . 0.0 110.506 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -146.15 80.81 1.58 Allowed 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -85.46 111.09 19.65 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -129.14 135.69 49.2 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 53.31 -158.12 0.16 Allowed 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.003 0.814 . . . . 0.0 109.597 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 185' ' ' LYS . 64.1 mmtt -143.8 -30.32 0.49 Allowed 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 123.448 0.699 . . . . 0.0 110.652 169.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.76 82.95 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.434 ' HB3' ' SG ' ' A' ' 190' ' ' SMC . 7.2 mp -75.34 -48.76 21.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.5 t70 62.6 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.965 -1.47 . . . . 0.0 113.236 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -114.85 105.39 12.96 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.661 0.743 . . . . 0.0 111.454 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SMC . . . . . 0.434 ' SG ' ' HB3' ' A' ' 187' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.35 -174.11 2.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.844 -172.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 192' ' ' GLU . 16.5 mp0 -52.33 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.141 1.777 . . . . 0.0 114.549 -175.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.85 141.65 39.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 171.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.5 -37.03 6.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.9 m 78.53 130.64 0.05 Allowed 'General case' 0 C--O 1.249 1.055 0 C-N-CA 125.603 1.561 . . . . 0.0 110.723 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 73.88 -55.59 0.66 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.352 1.461 . . . . 0.0 111.138 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.8 mp -71.37 -15.35 62.37 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 122.749 0.42 . . . . 0.0 110.744 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.26 -55.04 13.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.364 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 64.36 100.94 0.04 OUTLIER 'General case' 0 C--O 1.238 0.47 0 O-C-N 124.643 1.214 . . . . 0.0 108.124 -173.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -39.05 -68.89 0.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.443 1.089 . . . . 0.0 112.476 -171.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 5.8 m 57.85 34.25 24.15 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.593 1.187 . . . . 0.0 109.981 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 94.1 mt -143.15 -172.07 3.61 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -76.62 0.45 20.15 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.308 0.575 . . . . 0.0 111.328 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.33 23.05 1.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.392 0.677 . . . . 0.0 109.88 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -85.76 -170.97 3.35 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 74.71 107.06 0.07 Allowed 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 124.698 1.199 . . . . 0.0 111.205 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -75.33 124.75 27.64 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -108.09 147.14 31.63 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -70.86 115.84 10.47 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.422 0.451 . . . . 0.0 110.141 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -110.76 151.84 27.3 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -84.67 106.1 15.96 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.539 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.4 90.12 3.07 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -104.34 128.17 52.11 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.339 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -122.41 112.65 18.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.163 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp -100.07 109.35 21.66 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.912 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -101.8 139.52 37.33 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -149.73 156.04 41.18 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 122.142 0.177 . . . . 0.0 110.6 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.1 m -129.02 161.03 39.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 O-C-N 123.326 0.391 . . . . 0.0 110.734 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -123.82 100.57 37.13 Favored Pre-proline 0 C--N 1.309 -1.162 0 C-N-CA 121.386 -0.126 . . . . 0.0 111.331 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.21 125.98 14.35 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.034 1.822 . . . . 0.0 108.514 173.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 6.1 tp -111.05 114.83 48.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.502 0.668 . . . . 0.0 111.675 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 36.8 pt -101.42 140.18 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.269 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 41.9 m -143.88 105.68 4.33 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -149.94 73.12 0.29 Allowed Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 226' ' ' LEU . 1.9 pt? -117.83 -6.98 11.01 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -97.64 109.72 22.42 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.46 158.6 32.44 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.763 -1.562 . . . . 0.0 107.467 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.89 85.45 0.78 Allowed Glycine 0 C--N 1.315 -0.636 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -94.23 116.13 28.49 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 122.94 0.496 . . . . 0.0 110.159 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -119.08 154.5 16.44 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.47 114.53 1.55 Allowed Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -88.17 123.08 1.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.692 2.261 . . . . 0.0 112.156 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -129.56 111.06 1.13 Allowed Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.576 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.3 148.9 85.14 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.706 2.271 . . . . 0.0 111.428 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -75.17 -43.48 25.91 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 141.62 157.54 7.2 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -144.26 113.21 6.78 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -144.9 168.8 26.84 Favored Glycine 0 C--N 1.301 -1.371 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -157.15 108.87 2.39 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 117.353 0.577 . . . . 0.0 109.52 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -140.5 163.55 32.52 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.794 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 156.37 -161.18 30.7 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.37 143.67 97.28 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.463 2.775 . . . . 0.0 112.681 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -78.21 172.86 12.94 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.86 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -86.55 54.75 4.67 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -146.53 39.56 1.09 Allowed Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.7 m -69.05 112.28 5.57 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -91.93 -138.99 8.45 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.879 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 9.3 m 72.05 141.88 0.06 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.787 1.235 . . . . 0.0 110.458 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 113.02 -92.81 0.64 Allowed Glycine 0 C--N 1.302 -1.311 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -80.08 60.61 7.9 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.597 2.198 . . . . 0.0 110.833 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.3 t -125.5 4.88 7.6 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.138 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 38.0 pt -128.33 141.15 47.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.729 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -168.34 133.84 1.8 Allowed 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 122.978 0.511 . . . . 0.0 110.618 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.55 122.21 47.23 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 34.3 m -77.37 164.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 C--N 1.3 -1.545 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.039 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -82.79 102.09 11.35 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -110.67 160.99 16.2 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.003 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.47 120.5 45.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -83.99 119.56 25.07 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.937 0.398 . . . . 0.0 111.961 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -102.91 96.87 7.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.9 mt -68.07 130.8 44.04 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.111 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.6 tp -97.9 3.23 49.74 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.98 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 tp 71.29 -69.15 0.19 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.975 1.31 . . . . 0.0 109.727 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.66 123.44 46.37 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 36' ' ' ILE . 7.5 m-20 -86.03 75.65 9.92 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 35' ' ' THR . 27.8 m -130.72 179.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.246 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.59 130.79 54.57 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.28 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.24 -60.9 0.27 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.871 2.38 . . . . 0.0 112.359 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD2' HG23 ' A' ' 131' ' ' ILE . 3.4 mm? -119.18 174.34 6.39 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -69.51 127.43 32.97 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -95.21 140.62 29.86 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.553 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.58 -171.33 21.31 Favored Glycine 0 N--CA 1.42 -2.393 0 C-N-CA 119.552 -1.309 . . . . 0.0 113.796 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -133.71 156.9 47.11 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 35.5 tt0 -102.2 109.03 20.61 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 170.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.6 p -98.6 -63.93 1.08 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 122.39 1.091 . . . . 0.0 109.242 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.434 ' CB ' ' HG3' ' A' ' 159' ' ' GLU . . . -101.43 155.17 18.22 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.52 28.03 4.01 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.177 -1.011 . . . . 0.0 115.032 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.54 -61.01 0.18 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.99 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 155' ' ' LYS . 58.7 t -109.53 145.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 120.729 0.3 . . . . 0.0 111.099 -173.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.76 128.0 33.97 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -107.86 111.42 23.54 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.47 135.81 36.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.742 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' CE1' ' A' ' 94' ' ' PHE . 5.6 mp -109.77 -49.24 3.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.255 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.36 128.77 48.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -85.06 158.28 20.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 12.9 ptm180 -61.89 149.98 38.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.964 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 m120 68.37 11.41 8.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.111 0.964 . . . . 0.0 112.65 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.1 t -75.71 122.38 23.92 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.404 ' HA ' HG12 ' A' ' 12' ' ' VAL . 1.4 p -62.65 126.83 28.68 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.107 0.963 . . . . 0.0 112.945 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 11' ' ' ASP . 21.3 pt -87.52 152.3 51.87 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_exo -67.82 124.23 6.3 Favored 'Cis proline' 0 C--O 1.241 0.668 0 N-CA-C 115.241 1.208 . . . . 0.0 115.241 4.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -96.79 158.13 15.58 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.023 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -165.58 108.56 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 93' ' ' THR . 26.7 mm-40 -121.85 137.59 54.72 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.934 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.4 m -121.8 117.28 26.16 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.185 0.928 . . . . 0.0 109.788 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -125.48 147.87 49.07 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.8 mm -95.9 117.56 40.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.405 0.621 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.14 153.9 20.91 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.312 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 10.8 p -135.11 171.11 14.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 30.7 p -101.87 148.76 24.94 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.829 0.74 . . . . 0.0 109.85 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 37.1 m-85 -81.21 -65.33 1.03 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.16 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -75.69 144.83 41.37 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.78 145.88 44.71 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.551 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 68.62 35.46 3.14 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -73.98 118.17 67.24 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.46 -24.62 10.42 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.032 1.821 . . . . 0.0 111.951 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.01 159.02 29.26 Favored Glycine 0 N--CA 1.411 -2.976 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.92 153.21 33.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 O-C-N 123.945 0.438 . . . . 0.0 109.963 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.0 tp -106.22 115.84 30.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.11 106.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 74' ' ' ARG . 15.1 tt0 -112.47 121.43 44.82 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.0 t -90.32 135.23 26.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.574 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 90.4 m-85 -136.66 167.63 21.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.803 0.811 . . . . 0.0 111.282 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.563 ' CG ' ' HB2' ' A' ' 70' ' ' ASN . 13.4 pt-20 -136.01 151.51 49.96 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 170.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.65 136.49 3.88 Favored Glycine 0 C--N 1.277 -2.703 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' OE2' ' HD2' ' A' ' 32' ' ' ARG . 30.6 mt-10 -101.44 95.62 6.61 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 -174.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 20.7 mmt180 -146.29 170.45 16.75 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.236 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -86.44 -49.76 7.37 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.557 175.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.3 mtt -98.9 137.27 37.71 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.587 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.42 85.58 2.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.177 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -146.92 -52.17 0.21 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.472 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 7.5 m-20 -94.34 70.03 3.7 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -145.13 150.24 36.43 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.982 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.563 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 85.0 m-20 -90.68 131.57 36.29 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.08 118.41 28.78 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 mp -92.31 -56.91 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.801 0.334 . . . . 0.0 111.186 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.08 163.52 31.01 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.436 ' HB3' ' HG3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -153.2 135.39 14.88 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.9 150.12 41.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -94.97 129.98 41.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 tt -120.0 104.79 10.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 p -121.99 165.4 16.07 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.27 -0.11 14.38 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.51 125.62 88.95 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.458 0.703 . . . . 0.0 109.638 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 111' ' ' THR . 60.9 Cg_endo -70.78 168.69 22.17 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.07 2.513 . . . . 0.0 111.853 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.08 90.93 0.12 Allowed 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.546 2.164 . . . . 0.0 111.823 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.41 147.55 66.59 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.574 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.6 -171.03 0.72 Allowed 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.425 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 46' ' ' THR . 51.8 ttp180 -59.07 131.93 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.1 0.96 . . . . 0.0 111.54 -177.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 -8.5 64.89 Favored Glycine 0 C--N 1.308 -0.979 0 CA-C-N 115.833 -0.621 . . . . 0.0 114.295 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.6 t -82.88 -54.29 0.57 Allowed Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.25 107.52 2.46 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.336 1.358 . . . . 0.0 110.107 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.45 ' HB2' ' HD2' ' A' ' 109' ' ' LYS . 92.9 mt-30 -94.87 113.39 25.12 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.1 mm -98.24 115.25 37.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.04 113.46 25.72 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -116.64 123.21 71.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 42.1 m -129.45 124.58 34.41 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.3 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.402 ' CE1' HD22 ' A' ' 29' ' ' LEU . 45.9 p90 -123.6 138.23 54.59 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.927 174.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -134.31 153.2 52.01 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.499 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 64.6 mt -130.91 135.73 59.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.2 p-10 -84.81 -173.02 4.5 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.88 -13.02 60.26 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.447 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 47.6 m-80 -85.31 -29.51 24.48 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.74 28.81 2.83 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.494 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 68.9 mt -88.35 116.29 29.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 tp -95.66 120.78 36.51 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.95 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -119.99 104.2 9.95 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.12 125.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.1 m -123.45 123.44 40.65 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.61 130.62 53.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.1 m -131.58 126.8 35.71 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -83.86 116.6 22.83 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.206 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 89' ' ' GLN . 67.9 mttm -67.19 -19.33 65.55 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -74.31 -54.5 7.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.416 HG23 ' HD3' ' A' ' 81' ' ' PRO . 38.4 p -91.5 -37.01 13.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.14 14.19 36.89 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.03 136.87 35.18 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.475 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.91 137.68 45.06 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.303 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -133.09 138.75 46.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -131.4 158.34 41.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.866 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.9 141.0 44.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.1 m -128.5 113.29 15.31 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.1 mt -113.65 111.08 34.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.8 t -92.42 100.98 13.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 59.65 -164.25 0.22 Allowed 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.991 0.916 . . . . 0.0 108.719 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 t70 64.96 -160.33 0.28 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -168.59 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.17 -122.17 3.58 Favored Glycine 0 N--CA 1.415 -2.755 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -99.04 20.46 13.29 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.5 mt -124.29 141.26 52.22 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.614 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.2 p -120.55 -178.7 3.77 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.975 0.416 . . . . 0.0 111.869 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 131' ' ' ILE . 53.3 tttm -58.74 -28.7 66.11 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.867 1.267 . . . . 0.0 111.296 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.89 -40.04 95.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -68.77 -38.13 79.83 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 135' ' ' VAL . 54.1 mt -55.76 -54.11 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.726 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 45.5 mt-10 -66.38 -35.26 79.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.89 -44.13 94.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.265 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.5 mtt -72.55 -30.26 64.28 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 131' ' ' ILE . 60.0 t -62.94 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 53.7 mt-30 -55.66 -47.22 77.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.274 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.737 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.26 74.3 Favored 'General case' 0 C--O 1.196 -1.731 0 C-N-CA 122.568 0.347 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.22 -32.63 74.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.909 0.385 . . . . 0.0 111.404 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.26 -41.97 56.11 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.585 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -108.31 11.67 27.03 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.16 -43.77 64.25 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.146 0.978 . . . . 0.0 111.554 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -66.5 -43.37 85.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -177.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.7 -38.57 47.09 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.281 -0.568 . . . . 0.0 112.248 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.8 m-20 -64.3 -33.46 75.89 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.976 0.417 . . . . 0.0 109.934 174.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.68 -50.37 74.12 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 54.7 t -62.06 -46.43 96.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -55.49 -47.45 76.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.476 0.711 . . . . 0.0 111.494 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -68.15 -47.34 68.32 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.88 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -68.76 -10.73 58.3 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.2 mmt180 -72.76 -10.97 60.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.332 0.587 . . . . 0.0 110.022 172.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.15 115.77 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -55.39 -45.35 76.62 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 123.314 0.646 . . . . 0.0 112.648 -172.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.44 158.83 43.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -136.69 31.51 2.79 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.323 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -86.46 33.64 0.63 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.933 -177.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -139.56 134.14 31.77 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.29 151.71 19.27 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 121.307 0.575 . . . . 0.0 111.207 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.434 ' HG3' ' CB ' ' A' ' 22' ' ' ALA . 41.9 mt-10 -116.72 121.61 42.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 41.9 t -75.94 111.67 11.55 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.832 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -102.32 164.34 11.73 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.884 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.38 95.59 1.36 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.076 0.465 . . . . 0.0 110.704 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -83.11 158.13 22.53 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.223 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -77.09 136.99 38.67 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.239 0.542 . . . . 0.0 110.811 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 69.0 mtm -92.58 176.05 6.6 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.191 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -81.05 132.18 35.35 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.064 0.459 . . . . 0.0 112.009 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.2 m -138.53 101.35 4.33 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -164.35 105.14 0.86 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.9 t -135.67 107.51 7.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 173.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.47 -69.45 0.6 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.546 0.689 . . . . 0.0 110.064 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -165.0 132.39 3.06 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -96.45 -19.69 18.97 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -93.15 49.2 2.44 Favored Glycine 0 CA--C 1.495 -1.212 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.641 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.14 156.32 25.79 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 66.03 -172.87 0.18 Allowed 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.046 0.939 . . . . 0.0 112.689 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -154.64 172.78 33.1 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -99.92 8.24 44.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 118.092 0.946 . . . . 0.0 111.021 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.89 175.73 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.344 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 50.2 m -146.65 94.83 2.49 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -105.67 112.36 25.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.574 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -133.2 153.52 51.47 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -105.95 93.2 4.5 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.395 0.617 . . . . 0.0 110.344 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -112.34 106.51 15.06 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -134.49 163.21 30.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -79.58 128.51 33.47 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.92 74.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 122.709 1.242 . . . . 0.0 111.08 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.8 tt -150.25 77.87 1.32 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -169.5 117.4 0.61 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.518 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -93.39 -18.4 22.42 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -127.58 95.98 4.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.376 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -94.98 -50.06 5.27 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 57.0 t -121.09 128.71 76.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 36.0 pt -113.46 -9.86 12.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.113 0.482 . . . . 0.0 110.544 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.2 t -163.21 136.38 5.64 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.454 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -102.78 109.65 21.3 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.025 0.441 . . . . 0.0 109.939 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 51.8 tp -105.06 89.84 3.26 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.78 127.44 55.37 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.452 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -112.8 -29.76 7.29 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 67.1 t30 62.81 20.74 12.35 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.759 1.224 . . . . 0.0 110.572 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 10.3 p -82.8 -20.35 35.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.663 0.744 . . . . 0.0 110.529 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.691 ' H ' HD23 ' A' ' 202' ' ' LEU . 1.9 pt? -101.02 135.26 42.75 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -132.6 90.5 2.79 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.486 0.66 . . . . 0.0 110.571 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -91.46 169.38 10.82 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.672 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 211' ' ' LYS . 50.9 mtmt 71.78 93.55 0.08 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.4 1.063 . . . . 0.0 110.424 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -95.33 25.12 4.55 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.422 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 73.87 -72.85 0.11 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.706 1.603 . . . . 0.0 108.221 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -127.02 103.59 7.54 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -175.56 175.0 2.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -80.94 80.11 7.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.386 1.089 . . . . 0.0 112.211 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.444 ' HG2' ' H ' ' A' ' 205' ' ' LYS . 16.8 tppt? -134.52 96.5 3.59 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.93 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 -73.89 0.36 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -126.42 -29.67 2.93 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.886 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . 0.275 1.1 mp0 74.91 -34.05 0.26 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 215' ' ' LEU . 2.6 pt? -72.96 2.45 6.89 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.008 0.908 . . . . 0.0 109.599 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -60.15 -25.86 65.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.215 1.806 . . . . 0.0 108.552 173.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -121.36 81.94 1.86 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 172.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.0 p -83.42 -25.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.332 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.675 ' OD1' HG12 ' A' ' 222' ' ' ILE . 25.8 t-20 -143.42 129.86 10.37 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.94 -9.49 25.79 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.933 2.422 . . . . 0.0 115.938 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.675 HG12 ' OD1' ' A' ' 220' ' ' ASN . 10.8 pt -92.85 -18.43 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 118.358 -1.337 . . . . 0.0 111.101 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.09 140.88 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 120.946 0.403 . . . . 0.0 111.28 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 18.0 m -152.56 -40.5 0.1 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.362 0.601 . . . . 0.0 109.733 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.18 -41.37 2.01 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 54.98 -99.15 0.09 Allowed 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.979 1.312 . . . . 0.0 112.399 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -99.91 88.36 3.75 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -101.17 141.54 33.9 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.605 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 141.57 150.06 5.31 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.01 -17.15 41.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.364 0.602 . . . . 0.0 110.757 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 104.31 -6.77 46.48 Favored Glycine 0 C--N 1.311 -0.807 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.799 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.52 115.83 1.54 Allowed Glycine 0 C--N 1.311 -0.843 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.788 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.29 126.02 19.0 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 123.094 2.529 . . . . 0.0 111.643 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 72.31 82.52 0.29 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.183 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.16 -48.09 8.86 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.481 2.121 . . . . 0.0 111.573 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -172.79 160.88 32.04 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -116.98 90.56 0.51 Allowed Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -85.46 -14.91 44.66 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.327 0.584 . . . . 0.0 110.579 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.96 28.64 9.09 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.61 107.86 19.14 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 64.7 82.13 0.19 Allowed 'General case' 0 C--O 1.239 0.545 0 O-C-N 124.579 1.174 . . . . 0.0 112.485 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 117.46 84.5 1.03 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.158 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -84.65 -6.9 9.75 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.153 1.902 . . . . 0.0 112.291 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp 60.84 92.88 0.05 OUTLIER 'General case' 0 C--O 1.252 1.185 0 C-N-CA 124.547 1.139 . . . . 0.0 112.762 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -76.31 -58.59 3.59 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 171.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 53.92 39.38 62.41 Favored Glycine 0 CA--C 1.498 -0.977 0 CA-C-N 114.461 -0.869 . . . . 0.0 112.421 175.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 43.8 m -145.15 157.53 44.07 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 170.88 122.66 0.65 Allowed Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.047 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 40.5 m -155.39 80.01 1.04 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 54.68 -152.15 13.15 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.487 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.16 -9.99 25.22 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.891 2.394 . . . . 0.0 112.382 177.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.6 m -64.96 -58.2 6.75 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.301 0.572 . . . . 0.0 110.096 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 45.1 mm -83.3 -35.69 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.708 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.259 13.6 pt-20 47.26 76.67 0.1 Allowed 'General case' 0 C--O 1.247 0.951 0 C-N-CA 125.168 1.387 . . . . 0.0 114.612 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -129.56 17.01 5.9 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.406 1.098 . . . . 0.0 108.969 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 40.0 t -87.54 81.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.646 -175.273 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.384 0.135 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 60.49 13.76 4.36 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 59.77 85.71 0.1 Allowed 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.464 0.705 . . . . 0.0 112.077 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.82 -16.46 10.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.756 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -80.11 156.32 27.09 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.416 175.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.34 114.71 26.52 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.23 143.38 34.44 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.657 0.741 . . . . 0.0 111.776 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.3 tp -126.25 113.53 17.09 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.44 157.07 38.33 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 123.585 0.553 . . . . 0.0 111.447 -174.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp 76.76 173.62 0.22 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.146 1.378 . . . . 0.0 111.081 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.23 81.05 1.48 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.112 0.958 . . . . 0.0 110.068 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.44 178.14 3.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.126 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.97 116.67 66.89 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.71 -36.45 24.58 Favored 'Trans proline' 0 C--O 1.252 1.186 0 C-N-CA 121.733 1.622 . . . . 0.0 110.729 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 84.8 mt -108.07 174.98 5.64 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.65 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.528 ' HB2' ' HG3' ' A' ' 32' ' ' ARG . 10.0 t -103.55 -176.38 3.07 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -151.57 129.23 11.52 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 171.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.75 166.23 31.8 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.125 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.78 148.22 34.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 32.1 tt0 -86.25 112.05 21.0 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.1 p -100.49 172.36 7.17 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.86 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 124.39 20.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.977 0.417 . . . . 0.0 111.915 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.37 28.9 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.903 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.42 35.92 10.17 Favored Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.461 ' HB ' ' OG1' ' A' ' 21' ' ' THR . 27.4 t -99.17 133.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.425 ' HB2' ' OG1' ' A' ' 66' ' ' THR . 26.1 ttt -98.07 108.08 20.71 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.2 m -87.91 111.77 21.81 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.15 24.63 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.431 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.482 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.1 mp -90.7 -45.6 8.76 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.841 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.36 101.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.498 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -72.39 168.3 18.71 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.159 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.528 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 35.2 mtp-105 -61.98 150.62 37.39 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.444 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.19 17.03 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 111.604 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -73.15 129.12 37.36 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 p -68.23 114.73 6.96 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 124.272 1.029 . . . . 0.0 111.598 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 30.3 pt -94.64 164.58 19.39 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.7 Cg_exo -68.92 134.74 28.98 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.773 1.312 . . . . 0.0 113.416 -0.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.4 p -110.69 161.39 15.8 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 123.871 0.868 . . . . 0.0 110.844 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.531 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 46.7 tttp -156.96 99.42 1.82 Allowed 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -102.61 135.14 44.8 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -132.64 116.45 16.67 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.416 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 55.0 mt-30 -128.88 158.64 38.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.33 125.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 80.9 m-85 -113.36 160.44 18.37 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.331 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 11.8 p -137.97 171.76 13.94 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 122.859 0.463 . . . . 0.0 110.625 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 63.4 p -98.77 162.67 12.98 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 157' ' ' ALA . 26.9 m-85 -103.09 -5.1 23.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.194 0.521 . . . . 0.0 109.602 171.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 p -139.55 164.03 30.99 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.737 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -102.32 158.08 16.45 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.806 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 82' ' ' PRO . 44.1 m-80 71.33 14.33 6.49 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.491 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 75.4 mt-30 -63.5 129.13 93.43 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.25 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.94 -45.14 34.31 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.499 2.133 . . . . 0.0 111.445 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 78' ' ' SER . . . -166.35 153.81 23.89 Favored Glycine 0 N--CA 1.404 -3.446 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 HD11 ' A' ' 80' ' ' ILE . 19.1 m -103.97 137.77 31.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 161' ' ' TYR . 1.2 tt -101.71 109.95 21.84 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.419 ' HB ' ' CD2' ' A' ' 75' ' ' PHE . 2.3 mp -84.51 94.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . 0.251 6.6 pt20 -99.35 114.22 26.97 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.166 0.984 . . . . 0.0 111.632 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.86 126.65 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.075 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 92.4 m-85 -124.21 155.74 38.01 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 16' ' ' SER . 1.3 pp20? -127.27 165.87 18.85 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.15 124.55 3.53 Favored Glycine 0 C--N 1.263 -3.522 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 7.4 mm-40 -78.83 87.73 4.69 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.976 0.893 . . . . 0.0 109.662 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -128.04 142.11 51.32 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.791 -1.549 . . . . 0.0 107.044 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -66.9 -49.81 64.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.0 mtm -110.82 137.97 47.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.151 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 26' ' ' MET . 2.5 m -89.73 108.21 19.55 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.528 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -141.28 -53.91 0.47 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.134 0.493 . . . . 0.0 111.976 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.75 -61.57 1.35 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.6 m120 40.12 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.442 -1.708 . . . . 0.0 113.899 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -112.04 101.56 9.84 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.52 114.83 4.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.461 0.648 . . . . 0.0 110.395 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.19 -35.92 14.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.085 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.81 154.51 15.34 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.911 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -119.51 139.56 51.91 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 121.559 0.695 . . . . 0.0 109.185 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.419 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 13.8 t80 -143.48 142.09 31.03 Favored 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.41 -174.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.41 131.24 52.96 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.309 0.504 . . . . 0.0 111.249 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.3 tp -124.07 105.22 9.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.448 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 22.5 p -96.9 158.6 15.35 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.844 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.4 31.41 3.26 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.017 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 2.0 mp -77.18 116.17 55.18 Favored Pre-proline 0 C--O 1.242 0.687 0 CA-C-N 117.265 0.533 . . . . 0.0 109.894 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 25.6 Cg_exo -66.13 155.15 71.13 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 11.3 Cg_exo -74.05 82.71 1.74 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.544 2.162 . . . . 0.0 111.772 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . . . -132.6 127.63 20.62 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -37.26 -63.74 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 125.07 3.847 . . . . 0.0 115.931 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -175.4 120.26 0.19 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.62 -34.97 3.31 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.631 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.23 -56.97 6.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.863 -0.589 . . . . 0.0 111.198 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 83' ' ' ALA . 21.9 Cg_endo -64.24 104.72 0.53 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.421 1.414 . . . . 0.0 110.448 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -120.06 115.92 24.67 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.5 mm -99.51 116.3 42.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.8 tt0 -90.69 114.3 26.59 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.75 125.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 17.8 m -112.98 131.49 55.74 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.387 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CD1' HD22 ' A' ' 29' ' ' LEU . 7.7 m-85 -119.67 108.5 14.53 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.85 1.26 . . . . 0.0 109.057 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.531 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.7 p30 -123.57 136.61 54.62 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.281 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 54.7 mt -121.87 137.75 54.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.9 p-10 -100.66 -169.43 1.71 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.46 -15.34 61.81 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 43.7 m-80 -90.31 -5.38 56.33 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.983 -0.448 . . . . 0.0 110.859 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.5 25.76 49.51 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.421 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.3 mt -84.3 113.12 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.9 tp -95.87 117.0 29.75 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.095 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -107.7 121.2 44.22 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 93' ' ' THR . 69.9 t -111.61 115.66 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -117.23 127.38 54.04 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.74 118.04 30.98 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.8 m -110.48 125.8 53.68 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.705 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.61 115.63 23.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 68.0 mttm -67.51 -16.55 64.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.6 m -79.4 -50.43 10.84 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.829 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 36.2 p -83.77 -39.22 20.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.135 0.493 . . . . 0.0 111.225 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.15 12.62 48.53 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.439 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 65.4 pttt -103.05 156.43 17.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.331 . . . . 0.0 110.231 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.71 52.08 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.231 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -129.09 152.66 48.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.99 165.94 24.83 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 tt -145.65 143.49 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -122.0 113.11 19.12 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 75.3 mt -108.24 105.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.691 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.8 m -90.77 158.55 16.79 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -63.96 104.12 0.67 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.008 0.908 . . . . 0.0 110.711 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -156.6 147.04 21.46 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -104.76 88.17 2.85 Favored 'General case' 0 N--CA 1.423 -1.809 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.78 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.486 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -124.18 30.48 4.76 Favored Glycine 0 C--N 1.286 -2.246 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 170.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.486 ' HD2' ' C ' ' A' ' 124' ' ' GLY . 1.8 mpt_? -129.54 95.66 4.06 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.629 HD23 ' HG2' ' A' ' 130' ' ' GLU . 6.6 mp 67.08 -161.24 0.23 Allowed 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.08 0.862 . . . . 0.0 111.941 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 79.9 p -100.41 -72.59 0.67 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -170.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.9 -45.37 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -172.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 60.4 mm-40 -56.45 -49.2 75.27 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.136 -177.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HG2' ' A' ' 134' ' ' MET . 14.7 mp0 -57.88 -47.14 83.63 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.063 0.852 . . . . 0.0 109.76 -177.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 75.6 mt -53.15 -51.9 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.568 1.168 . . . . 0.0 110.698 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 60.6 mt-10 -74.01 -33.28 63.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.203 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 95.4 mtt180 -67.11 -35.23 79.32 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.678 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 24.3 mmt -60.14 -52.59 64.7 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.02 -52.65 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 124.027 0.83 . . . . 0.0 112.034 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 70.5 mm-40 -64.37 -45.49 87.52 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.29 -32.81 66.94 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.406 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' A' ' 142' ' ' LYS . . . -60.5 -48.43 81.81 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.466 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 21.6 mm-40 -61.89 -48.61 79.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -77.37 -24.35 50.63 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.98 13.28 7.29 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 18.5 ptpt -50.04 -43.44 51.0 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.99 78.03 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -71.21 -53.17 15.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 m-20 -64.86 -33.87 77.03 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -59.22 -51.08 71.5 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 117.651 0.205 . . . . 0.0 111.189 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.2 t -62.43 -49.34 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 O-C-N 123.635 0.584 . . . . 0.0 109.998 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -56.79 -45.64 82.03 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.833 0.708 . . . . 0.0 111.916 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 45.3 ttp180 -63.93 -32.68 74.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.163 0.585 . . . . 0.0 111.099 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -85.27 -17.27 37.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.504 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 5.2 mmp_? -80.49 -6.85 58.79 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.79 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.67 71.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.3 m 67.19 167.6 0.24 Allowed 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.497 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.13 25.85 4.9 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.78 155.41 17.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.306 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 79.0 m-20 -117.3 87.27 2.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.31 145.18 31.84 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 122.162 -0.336 . . . . 0.0 110.305 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.477 ' HG ' HG22 ' A' ' 21' ' ' THR . 0.7 OUTLIER -124.54 152.82 42.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.659 0.742 . . . . 0.0 112.206 -175.201 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -128.73 146.13 50.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 168.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.8 p -158.67 177.04 11.63 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.455 ' O ' HD12 ' A' ' 55' ' ' LEU . 62.5 t80 -108.9 106.01 15.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.954 1.302 . . . . 0.0 108.135 -177.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -103.99 143.65 32.59 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.8 t80 59.89 92.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.809 1.644 . . . . 0.0 112.859 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -78.77 129.38 34.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.4 mmt -75.81 106.12 7.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -135.02 123.11 22.78 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.437 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.6 m -156.13 101.64 2.09 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.967 0.507 . . . . 0.0 109.919 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -137.8 -164.84 1.68 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.63 121.22 25.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 O-C-N 121.88 -0.512 . . . . 0.0 110.865 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.9 103.36 16.03 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.1 t70 77.2 133.41 0.06 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.472 1.509 . . . . 0.0 112.401 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -146.59 97.76 2.97 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -104.34 89.37 0.66 Allowed Glycine 0 C--N 1.306 -1.135 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.179 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 67.5 tp -94.37 -50.77 5.08 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.184 0.516 . . . . 0.0 110.814 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -105.51 136.19 45.54 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.252 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 161.1 -39.12 0.42 Allowed Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 119.698 -1.239 . . . . 0.0 114.442 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -79.9 96.87 6.49 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -174.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.2 pt -137.5 94.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.256 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.3 t -166.62 136.63 3.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -129.88 148.81 51.79 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.08 86.75 5.5 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.394 0.616 . . . . 0.0 109.415 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.402 ' HA ' ' HE3' ' A' ' 185' ' ' LYS . 6.9 p-10 -79.6 -23.5 42.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.875 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -87.68 129.91 34.98 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.628 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? 77.42 81.95 0.08 Allowed 'General case' 0 C--N 1.316 -0.853 0 O-C-N 124.779 1.3 . . . . 0.0 113.005 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.536 ' O ' HG12 ' A' ' 186' ' ' VAL . 99.7 mttt -125.81 155.36 41.23 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 185' ' ' LYS . 0.8 OUTLIER 78.72 -14.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 127.022 2.129 . . . . 0.0 109.731 -173.329 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 185' ' ' LYS . 3.4 mm? 70.01 -82.28 0.03 OUTLIER 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.678 1.591 . . . . 0.0 114.025 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -157.06 -163.81 1.48 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -79.1 29.56 0.22 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.344 1.457 . . . . 0.0 113.386 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -123.73 140.91 52.52 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 73.15 -174.5 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.278 1.031 . . . . 0.0 111.358 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 46.0 t 65.32 -80.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 125.665 1.586 . . . . 0.0 112.471 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . 0.29 8.5 tt 42.52 92.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.852 1.661 . . . . 0.0 114.146 -175.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.8 p -77.17 134.79 38.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.944 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -139.3 120.29 14.53 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.333 0.587 . . . . 0.0 109.654 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 65.0 tp -115.99 150.69 36.8 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.36 109.91 8.23 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -102.4 91.14 4.13 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -98.46 132.87 43.56 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.8 p -90.72 125.55 35.72 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.306 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.38 117.4 26.12 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -113.41 122.58 47.77 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.836 0.351 . . . . 0.0 110.577 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -88.5 -84.89 0.2 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.776 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 206' ' ' ASP . 0.4 OUTLIER -174.59 131.9 0.35 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 -176.273 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 208' ' ' PHE . 11.3 t70 -85.5 166.23 16.48 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -95.26 88.02 5.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.961 0.886 . . . . 0.0 112.7 -174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 206' ' ' ASP . 89.1 m-85 -100.83 -22.19 14.92 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.834 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.96 -81.15 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 124.972 1.309 . . . . 0.0 111.683 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -156.37 -49.36 0.08 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -144.95 5.11 1.13 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.541 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 67.74 -56.76 0.47 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.742 1.617 . . . . 0.0 112.186 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -144.15 150.69 38.46 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -130.93 163.77 26.77 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.19 83.71 7.66 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.425 1.107 . . . . 0.0 108.107 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -90.46 -37.5 13.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.532 -175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -98.2 119.86 37.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.327 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.08 175.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.2 t30 55.79 95.32 0.05 OUTLIER Pre-proline 0 N--CA 1.486 1.364 0 C-N-CA 124.153 0.981 . . . . 0.0 112.203 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.41 108.87 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.36 2.04 . . . . 0.0 113.208 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 222' ' ' ILE . 2.9 pp -119.56 122.64 69.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 29.9 pt -132.37 169.26 22.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.234 0.54 . . . . 0.0 111.828 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.8 m -136.09 -171.57 2.91 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.17 -2.67 14.34 Favored Glycine 0 C--N 1.312 -0.801 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.789 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -144.2 116.33 8.41 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.036 0.446 . . . . 0.0 109.978 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -150.0 -68.38 0.2 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? 176.42 -48.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 120.46 -149.59 17.57 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.66 157.09 17.15 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -147.86 53.45 0.53 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -152.79 85.59 0.14 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.56 -52.3 4.85 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.695 2.263 . . . . 0.0 111.918 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -153.54 167.53 32.0 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.4 -51.19 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 122.671 2.247 . . . . 0.0 112.972 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 145.9 -165.05 28.14 Favored Glycine 0 CA--C 1.497 -1.083 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.45 26.58 73.0 Favored Glycine 0 C--N 1.318 -0.421 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.394 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -101.5 160.26 14.58 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.0 36.17 42.06 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.321 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.81 116.88 21.69 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -126.47 101.42 6.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -172.09 98.11 0.13 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.94 -24.97 28.25 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.438 2.092 . . . . 0.0 111.227 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt 67.41 87.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.158 1.383 . . . . 0.0 112.461 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -129.13 149.9 18.68 Favored Glycine 0 N--CA 1.423 -2.185 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.025 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 152.07 -35.44 0.84 Allowed Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.522 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 24.4 p -82.89 132.68 35.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.74 0.27 . . . . 0.0 111.259 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.89 175.79 51.16 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.42 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 -172.6 2.04 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -117.03 94.16 0.62 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -81.85 95.73 0.91 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.418 2.079 . . . . 0.0 111.096 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.9 p -85.43 82.13 8.44 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 121.651 0.739 . . . . 0.0 110.228 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.1 pt -80.85 158.81 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -70.58 136.36 49.17 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -175.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -108.82 91.57 3.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.81 145.24 7.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.082 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.5 177.332 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -80.03 125.54 29.91 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -162.33 120.56 2.18 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.93 84.29 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-O 122.894 1.33 . . . . 0.0 108.607 172.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.61 138.93 34.05 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.857 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . 0.285 5.7 m-20 69.89 76.08 0.21 Allowed 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 124.961 1.304 . . . . 0.0 113.479 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.5 mt -83.08 63.91 7.37 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.402 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.61 92.61 5.99 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -87.18 102.95 14.95 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.526 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.84 140.08 49.2 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.7 m-20 -84.27 67.15 9.69 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.944 0.878 . . . . 0.0 110.004 -175.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 m -134.2 179.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . . . -96.36 133.7 24.52 Favored Pre-proline 0 C--N 1.282 -2.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 36.3 Cg_endo -68.25 -38.68 11.54 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.461 2.108 . . . . 0.0 110.409 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -134.91 161.31 35.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 m -76.06 149.36 37.5 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 123.289 0.368 . . . . 0.0 110.469 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.09 142.36 44.64 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 120.993 0.425 . . . . 0.0 110.713 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -164.84 -168.76 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 C-N-CA 119.977 -1.106 . . . . 0.0 114.041 -173.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.432 HD21 HG11 ' A' ' 92' ' ' VAL . 1.7 mp -113.38 156.06 24.11 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.539 0.736 . . . . 0.0 109.118 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.95 109.35 18.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.906 0.86 . . . . 0.0 109.19 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 6.1 p -94.45 171.54 8.75 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.235 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . . . -51.51 124.77 12.83 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.779 1.232 . . . . 0.0 112.145 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.29 -2.73 57.83 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.28 39.8 25.71 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.3 t -96.5 142.03 14.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.261 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.05 107.99 20.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -107.55 111.84 24.3 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.501 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -92.27 147.57 22.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 94' ' ' PHE . 51.4 mt -115.34 -24.75 8.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.3 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 94' ' ' PHE . 3.3 mp -117.78 117.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 171.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -85.39 149.86 25.14 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 14' ' ' PRO . 10.6 ptt85 -69.83 152.53 44.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.459 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.96 -0.63 2.97 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.4 1.08 . . . . 0.0 112.147 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -89.24 122.58 32.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 2.9 p -65.18 121.16 14.12 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 123.849 0.86 . . . . 0.0 112.93 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 36.3 pt -84.94 164.94 39.72 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 47.0 Cg_exo -60.72 145.7 42.1 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 CA-C-N 120.652 1.269 . . . . 0.0 114.024 1.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 m -142.0 143.76 33.33 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 6.1 ttpm? -147.14 119.56 8.43 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.854 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 29' ' ' LEU . 30.7 mt-30 -121.8 131.81 54.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.087 0.47 . . . . 0.0 111.03 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 35.0 m -115.23 118.3 32.9 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -130.13 155.42 46.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.23 126.41 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.81 146.26 42.99 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.083 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 29.3 p -123.69 171.28 9.7 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 124.916 1.286 . . . . 0.0 107.555 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -113.07 136.85 52.25 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -98.92 -4.2 33.4 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -80.17 106.97 12.58 Favored 'General case' 0 N--CA 1.395 -3.194 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.447 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.75 133.01 44.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.373 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 64.2 29.88 13.78 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.918 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -85.23 120.31 73.24 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 88.2 Cg_endo -82.85 -0.41 10.05 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.558 2.172 . . . . 0.0 110.826 177.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.28 147.85 9.9 Favored Glycine 0 N--CA 1.408 -3.202 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.99 165.24 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 123.955 0.444 . . . . 0.0 110.503 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.9 tp -111.82 115.0 28.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.64 94.78 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -99.64 118.15 35.54 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.752 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.11 134.92 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.813 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -125.63 154.01 42.93 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -114.13 118.72 34.81 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' HA3' ' SD ' ' A' ' 134' ' ' MET . . . 154.52 175.03 25.22 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -140.89 104.26 4.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.69 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -154.74 169.45 23.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.06 -31.91 68.45 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.705 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.0 mtt -111.48 135.7 51.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.199 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.94 -13.23 59.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -64.92 -27.15 68.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -171.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -94.53 14.75 19.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.752 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.523 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 14.2 m120 -107.1 175.25 5.56 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.198 -0.314 . . . . 0.0 110.715 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.89 129.24 36.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 tp -76.27 109.17 9.74 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -82.81 -48.31 10.93 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.017 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.47 164.32 33.99 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -142.39 154.52 44.69 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 117.517 0.659 . . . . 0.0 109.84 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -155.33 158.27 38.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -106.63 147.99 28.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.789 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 tp -124.54 104.87 8.96 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.2 p -116.36 153.43 32.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.25 4.46 18.13 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 75.0 mt -79.87 130.26 67.67 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 123.664 0.786 . . . . 0.0 109.048 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -56.24 117.97 4.7 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.814 2.343 . . . . 0.0 111.403 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.98 111.84 1.85 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.778 2.318 . . . . 0.0 112.412 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.8 160.54 68.09 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.53 -23.16 37.47 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.808 2.339 . . . . 0.0 112.19 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -140.7 166.25 25.27 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.236 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.46 ' HA3' ' HB ' ' A' ' 45' ' ' THR . . . -73.86 80.54 0.81 Allowed Glycine 0 N--CA 1.432 -1.589 0 O-C-N 123.68 0.613 . . . . 0.0 114.276 -176.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.429 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 52.8 t -69.38 -45.24 27.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 32.6 Cg_exo -68.07 121.51 8.52 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.394 1.396 . . . . 0.0 110.278 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -81.98 115.61 21.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -91.76 119.51 39.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.22 104.19 16.77 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' THR . 40.6 t -110.08 117.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.619 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -103.81 116.36 32.15 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.284 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 3.0 m-85 -96.87 107.21 19.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 171.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' OD2' ' HD3' ' A' ' 39' ' ' LYS . 18.2 t70 -120.64 113.09 19.72 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 123.656 0.598 . . . . 0.0 110.566 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.76 118.4 56.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.486 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.5 p30 -85.41 -176.79 6.26 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.6 -20.29 63.17 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -80.62 -23.91 39.45 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.855 -0.528 . . . . 0.0 110.671 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.79 15.71 28.22 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.486 ' HB ' ' OD2' ' A' ' 97' ' ' ASP . 83.2 mt -80.4 119.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 114.61 27.0 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.1 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -107.51 101.44 10.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.9 t -93.72 114.27 30.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.0 m -112.1 110.73 21.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.67 117.55 34.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.3 m -119.8 128.69 53.95 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.625 0.726 . . . . 0.0 111.115 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.56 114.48 16.44 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.569 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.72 -21.4 64.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.6 p -80.19 -62.04 1.8 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.3 p -95.69 -31.36 13.27 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.389 0.614 . . . . 0.0 110.411 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.66 34.79 3.21 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.03 175.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -98.68 151.85 20.28 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 117.016 0.408 . . . . 0.0 110.889 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.95 140.59 24.6 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.845 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.82 139.74 43.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 149.2 43.76 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 tt -120.66 148.61 23.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.0 m -114.53 112.92 23.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.45 98.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.123 0.487 . . . . 0.0 110.877 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -91.73 101.78 14.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -160.13 127.65 4.57 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.55 89.4 7.7 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.463 0.649 . . . . 0.0 111.692 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm 70.64 160.71 0.22 Allowed 'General case' 0 C--O 1.25 1.115 0 C-N-CA 126.397 1.879 . . . . 0.0 111.386 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.73 -43.83 83.04 Favored Glycine 0 CA--C 1.502 -0.723 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.459 ' HA ' HD11 ' A' ' 131' ' ' ILE . 40.1 mmt180 68.33 -78.82 0.04 OUTLIER 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.474 1.11 . . . . 0.0 112.802 174.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.7 mt 57.3 -87.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.421 1.488 . . . . 0.0 113.319 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 129' ' ' GLU . 69.2 p -115.41 -12.89 11.67 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.65 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 74.01 -22.56 0.24 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.12 1.368 . . . . 0.0 110.614 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 127' ' ' SER . 32.2 tt0 -74.7 -39.71 61.77 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.089 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 134' ' ' MET . 1.4 mp0 -62.54 -38.95 91.98 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.337 175.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 125' ' ' ARG . 51.7 mt -56.87 -50.91 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.09 -45.42 87.19 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 123.575 0.75 . . . . 0.0 110.794 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -60.03 -47.73 84.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.523 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 70.3 mtm -66.55 -36.29 82.3 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 123.48 0.487 . . . . 0.0 111.573 -175.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 70.3 t -61.26 -54.71 31.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 123.621 0.576 . . . . 0.0 109.568 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.0 mt-30 -63.11 -46.77 85.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.08 -40.09 94.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -60.33 -44.5 95.44 Favored 'General case' 0 C--O 1.198 -1.616 0 O-C-N 123.05 0.219 . . . . 0.0 110.416 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 22.2 mm-40 -58.61 -39.63 80.98 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 94.5 mttt -74.21 -48.49 28.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.734 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.53 21.84 10.66 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.331 0.864 . . . . 0.0 113.331 -172.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 138' ' ' ALA . 29.2 mmtt -44.24 -58.68 2.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.06 45.57 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.716 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -58.26 -55.1 39.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.734 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -38.58 44.14 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.94 -34.16 73.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.128 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.3 -44.05 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.552 ' O ' HG23 ' A' ' 152' ' ' VAL . 67.6 mt-30 -52.75 -50.84 62.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 110.735 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -54.05 -52.66 60.18 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 124.284 0.99 . . . . 0.0 111.341 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.83 -39.15 93.53 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.922 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -63.54 -25.47 68.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 148' ' ' GLN . 22.0 t -88.79 -39.24 12.38 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.6 p -72.14 80.75 0.97 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.518 0.675 . . . . 0.0 111.494 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.42 123.51 44.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 tptm 68.34 10.43 7.85 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 124.016 0.822 . . . . 0.0 110.007 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.47 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.131 1.372 . . . . 0.0 112.66 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -114.39 134.13 55.21 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.335 -175.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 44.7 mt -93.26 152.97 18.85 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.48 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 14.2 tt0 -97.6 173.36 7.18 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.2 t -122.54 -170.37 2.07 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.597 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -68.07 87.81 0.27 Allowed 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.902 1.281 . . . . 0.0 113.076 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.75 96.57 10.49 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.878 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -90.71 -50.25 6.02 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 66.05 -72.55 0.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.573 1.549 . . . . 0.0 110.945 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 89.0 mtp 59.81 31.62 20.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.064 1.346 . . . . 0.0 113.664 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -100.26 91.18 4.62 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.2 m -73.22 -60.52 2.2 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.41 -80.13 0.02 OUTLIER 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.966 1.307 . . . . 0.0 111.969 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.264 10.2 p 41.31 77.88 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.994 1.717 . . . . 0.0 113.301 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.91 -55.39 9.82 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.616 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -110.7 146.42 36.29 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.702 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -133.48 -44.88 0.82 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.58 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -168.39 -175.06 37.69 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.165 -1.016 . . . . 0.0 111.703 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.1 mp 60.69 23.58 13.43 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.316 1.046 . . . . 0.0 111.49 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -103.76 90.06 3.52 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -174.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.78 -58.33 2.15 Favored Glycine 0 N--CA 1.465 0.571 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -65.0 142.37 58.46 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 124.277 1.031 . . . . 0.0 111.412 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.84 -59.04 3.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 15.7 m 48.0 78.58 0.08 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.703 1.201 . . . . 0.0 111.365 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -152.51 125.25 8.39 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.938 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 69.59 -81.1 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 125.519 1.527 . . . . 0.0 112.604 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 24.3 t70 62.75 107.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.172 0.989 . . . . 0.0 112.088 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -60.66 121.59 12.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.939 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -123.4 136.0 54.41 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt 65.89 175.24 0.22 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.979 1.312 . . . . 0.0 113.436 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.2 156.13 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 91.8 mt -117.66 -4.71 11.18 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.217 -173.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.47 ' HB2' ' SG ' ' A' ' 190' ' ' SMC . 6.1 p-10 -148.41 -58.43 0.23 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp 60.0 26.35 15.65 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.402 0.62 . . . . 0.0 110.215 -172.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SMC . . . . . 0.47 ' SG ' ' HB2' ' A' ' 188' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -86.89 81.31 8.18 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 69.19 153.13 0.1 Allowed 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.76 1.224 . . . . 0.0 111.343 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.29 76.76 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 123.238 1.494 . . . . 0.0 108.121 172.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 45.4 pt -74.0 139.8 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.472 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.8 m -93.17 135.19 34.6 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -80.19 118.32 21.77 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.159 -174.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.99 -163.73 0.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.766 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.3 t70 71.61 -65.61 0.34 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.298 1.839 . . . . 0.0 113.656 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -69.22 -39.04 78.82 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.898 0.38 . . . . 0.0 110.711 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -88.92 103.64 16.21 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.603 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.9 m -137.78 76.22 1.57 Allowed 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.93 129.76 40.26 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.342 -175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . 178.84 39.28 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 102.914 -2.995 . . . . 0.0 102.914 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -133.1 153.5 51.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.633 -1.622 . . . . 0.0 111.324 -166.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -167.42 175.69 7.07 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 101.441 -3.54 . . . . 0.0 101.441 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.51 96.81 1.21 Allowed 'General case' 0 C--O 1.249 1.058 0 CA-C-N 120.399 1.454 . . . . 0.0 109.835 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -165.73 107.07 0.75 Allowed 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.54 -47.6 72.35 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.792 0.33 . . . . 0.0 110.782 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -92.69 96.01 9.92 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -106.45 -55.18 2.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 168.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -98.76 69.9 1.85 Allowed 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.956 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -88.87 91.09 8.69 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -118.33 79.21 1.34 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.204 1.002 . . . . 0.0 113.082 -175.632 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.33 -73.86 0.63 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.316 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.33 80.1 3.17 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.012 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -129.27 -64.49 0.9 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -82.86 114.93 21.51 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.244 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.0 89.1 2.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -81.14 150.31 67.97 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.803 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.18 -6.39 12.05 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.203 1.935 . . . . 0.0 111.939 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 61.8 mt 71.81 -65.52 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.755 1.222 . . . . 0.0 109.782 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 83.0 mt -140.77 115.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.3 m -68.67 109.72 3.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.114 0.483 . . . . 0.0 111.309 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 100.5 -25.28 28.91 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.4 mp 62.79 -80.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.18 1.392 . . . . 0.0 113.388 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 29.4 t80 60.77 91.86 0.05 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.629 1.171 . . . . 0.0 108.542 -170.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -61.34 -34.14 74.77 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.672 -1.604 . . . . 0.0 112.909 -170.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 169.51 -168.9 41.65 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.14 -13.28 57.44 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 117.21 0.505 . . . . 0.0 110.999 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 167.89 175.55 37.75 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -136.91 64.66 0.57 Allowed Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.53 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -102.52 16.78 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.209 2.606 . . . . 0.0 111.674 176.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 238' ' ' PHE . . . -82.1 164.41 44.23 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.859 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.78 -11.35 26.27 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.329 2.686 . . . . 0.0 114.367 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -68.0 95.82 0.36 Allowed Glycine 0 C--N 1.315 -0.599 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 93.39 -40.71 2.76 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 234' ' ' GLY . 56.5 t80 -79.71 -17.22 54.1 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.635 0.731 . . . . 0.0 110.086 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -121.42 111.38 1.86 Allowed Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.41 118.19 18.03 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -118.28 105.65 11.98 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.742 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -73.22 136.33 22.31 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.12 129.33 33.77 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.973 2.449 . . . . 0.0 112.425 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -103.51 150.75 23.6 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 128.87 -159.45 22.19 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 121.15 101.97 1.79 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.7 p -82.49 -24.38 34.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.744 0.783 . . . . 0.0 109.629 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 142.12 162.99 9.45 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.248 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 46.8 m -148.33 25.48 0.99 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 253' ' ' ILE . . . -153.93 89.91 0.13 Allowed Glycine 0 N--CA 1.422 -2.237 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.085 -176.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.25 8.81 3.37 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.634 2.223 . . . . 0.0 111.059 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 1.8 p -77.97 -25.34 48.1 Favored 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 125.046 1.338 . . . . 0.0 110.463 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 250' ' ' GLY . 41.2 pt -84.06 122.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.32 0.581 . . . . 0.0 109.577 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -132.19 91.54 2.97 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.12 80.08 7.65 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.431 1.11 . . . . 0.0 108.883 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.38 93.65 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--N 1.294 -1.827 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -174.624 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.241 0.63 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -108.62 173.03 6.5 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.783 -173.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -64.84 -58.74 5.41 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.92 124.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.991 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -103.92 84.53 2.27 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 62.68 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.891 1.276 . . . . 0.0 109.885 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 mt -156.06 136.77 13.37 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 173.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.45 78.28 7.17 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.305 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.4 tp -104.6 -12.2 16.55 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 tp -160.79 178.78 9.1 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 73.17 29.5 1.71 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.121 0.968 . . . . 0.0 111.39 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 17.5 m -126.87 168.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.86 119.05 72.25 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.77 -25.96 16.45 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.245 1.963 . . . . 0.0 112.685 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.1 mp -135.18 172.19 13.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -101.75 129.8 48.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.445 HD13 HD22 ' A' ' 102' ' ' LEU . 62.2 mt -116.79 131.87 56.84 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.39 -176.57 21.94 Favored Glycine 0 N--CA 1.429 -1.816 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.64 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.89 150.53 30.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.27 108.38 17.1 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.644 HG22 HD23 ' A' ' 158' ' ' LEU . 34.6 p -107.29 -177.03 3.24 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.645 -172.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.12 119.13 5.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.88 0.872 . . . . 0.0 113.178 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.45 -8.57 22.38 Favored Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.869 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.64 57.27 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 39.4 t -110.65 149.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.1 ttt -92.72 137.81 32.04 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 122.987 0.515 . . . . 0.0 111.052 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -118.84 111.71 18.77 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.3 126.73 45.21 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.658 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -96.54 -33.79 11.69 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.29 125.57 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -120.48 146.02 46.68 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -56.07 151.48 12.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 75.07 14.37 3.13 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.14 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -103.55 133.03 49.27 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 1.6 m -68.31 144.86 54.66 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 123.814 0.846 . . . . 0.0 111.715 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.89 155.4 43.31 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_endo -62.44 152.37 65.26 Favored 'Cis proline' 0 C--N 1.356 0.964 0 CA-C-N 119.922 1.008 . . . . 0.0 113.629 -1.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -107.09 -80.45 0.56 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.014 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 43.5 tttp 65.41 99.43 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 127.424 2.29 . . . . 0.0 111.055 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -121.71 132.06 54.43 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.082 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -118.7 123.81 45.81 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.247 0.342 . . . . 0.0 110.478 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -130.61 146.23 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -93.34 133.93 32.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.92 132.4 50.88 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.8 153.09 36.25 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.7 p -81.7 135.52 35.5 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.353 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 23.1 m-85 -114.19 3.96 15.37 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 24.5 p -97.0 -179.13 4.44 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.076 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -143.18 166.36 24.91 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.263 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 60.19 19.81 9.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 48' ' ' SER . 56.0 mt-30 -101.34 113.56 65.81 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.124 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.2 Cg_endo -85.83 -2.79 8.99 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.028 2.485 . . . . 0.0 111.672 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.16 149.04 16.21 Favored Glycine 0 N--CA 1.401 -3.689 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 m -112.64 149.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.34 101.5 11.42 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 63.1 mt -90.48 117.73 34.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -129.59 119.62 23.93 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.154 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 104' ' ' VAL . 36.6 t -92.48 117.61 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.704 -178.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 59.4 m-85 -120.08 144.33 47.65 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.277 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -111.73 154.34 25.15 Favored 'General case' 0 C--O 1.272 2.244 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.219 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.08 118.34 3.5 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -78.08 95.05 4.79 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.632 0.716 . . . . 0.0 110.91 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 63' ' ' ARG . 43.3 mtp85 -136.74 157.03 47.71 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.845 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -91.04 -51.27 5.42 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.7 93.74 9.04 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.6 m -84.61 108.1 17.18 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.905 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -163.49 144.19 9.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 68.19 16.23 9.38 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.476 1.11 . . . . 0.0 111.702 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.18 173.03 10.7 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 85.0 m-20 -90.7 127.45 36.31 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.95 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.7 118.49 29.35 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.713 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.08 -53.98 3.91 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.08 156.01 26.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 10.0 ptm180 -151.19 139.14 19.97 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 123.713 0.805 . . . . 0.0 109.531 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.73 145.66 31.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.806 0.336 . . . . 0.0 111.226 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.64 110.45 22.56 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.4 tp -94.71 104.61 16.53 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 p -96.0 152.27 18.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.35 -35.27 2.09 Favored Glycine 0 CA--C 1.479 -2.188 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.1 mp -51.88 120.16 15.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 O-C-N 125.042 1.084 . . . . 0.0 110.494 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.52 146.72 10.91 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.143 1.895 . . . . 0.0 111.317 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.75 118.17 5.01 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.9 1.734 . . . . 0.0 108.246 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.7 156.75 79.74 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.757 -171.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.34 43.4 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.224 2.616 . . . . 0.0 111.823 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HG3' ' HA ' ' A' ' 47' ' ' TYR . 7.9 mpt_? 68.97 148.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.253 1.421 . . . . 0.0 113.109 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.56 -27.86 2.13 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.436 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 48.6 t -58.45 -51.99 77.87 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 7.7 Cg_exo -77.12 106.89 2.32 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 121.597 1.531 . . . . 0.0 110.446 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -101.91 103.53 14.2 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mm -91.82 120.51 41.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.519 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . 40.4 tt0 -94.87 112.31 24.04 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.16 128.23 62.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.467 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 m -122.9 120.6 33.93 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.867 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -99.57 107.79 20.03 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.48 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 1.5 p-10 -125.61 112.64 16.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.7 mt -99.9 123.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.2 p-10 -86.55 -175.35 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 123.722 0.639 . . . . 0.0 109.373 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.36 -13.12 61.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.402 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 64.3 t30 -81.54 -28.66 33.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 112.18 12.79 13.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 92.9 mt -82.13 116.1 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-O 120.996 0.427 . . . . 0.0 110.347 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.445 HD22 HD13 ' A' ' 17' ' ' LEU . 22.1 tp -88.52 108.9 19.64 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 116' ' ' LYS . 1.2 t30 -102.91 110.49 22.43 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.757 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 58' ' ' VAL . 45.4 t -88.71 114.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 116' ' ' LYS . 7.2 m -110.76 124.29 51.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.622 -175.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -132.74 119.37 20.24 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.663 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 m -120.24 127.59 52.55 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.21 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.97 111.04 21.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.082 0.553 . . . . 0.0 111.841 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 91' ' ' GLU . 96.9 mttt -69.01 -11.2 60.57 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.0 p -86.04 -47.98 9.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 118.964 -1.095 . . . . 0.0 112.908 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.0 p -96.88 -33.79 11.5 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.875 -0.515 . . . . 0.0 111.819 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.08 23.67 10.39 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.924 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.37 157.8 16.16 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 122.779 -0.248 . . . . 0.0 110.339 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.77 143.71 22.97 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.113 0.482 . . . . 0.0 111.503 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -129.45 140.69 51.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.529 ' HG2' HG23 ' A' ' 105' ' ' THR . 83.6 mttt -136.21 132.76 36.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.42 125.33 72.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.208 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 79.2 m -88.12 112.4 22.65 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.003 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 71.4 mt -101.61 94.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.338 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.5 m -74.51 158.86 33.05 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 124.782 1.233 . . . . 0.0 107.97 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -58.9 -27.63 65.43 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.069 0.461 . . . . 0.0 112.001 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.68 12.21 9.33 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -105.52 113.52 27.14 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.86 131.81 1.43 Allowed Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.834 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -103.43 19.23 20.12 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.881 0.848 . . . . 0.0 110.131 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 71.7 mt -115.19 177.76 4.54 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.1 p -112.87 -60.62 1.85 Allowed 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.102 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.8 tptm 173.41 -38.58 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.881 0.873 . . . . 0.0 108.709 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.04 -44.09 97.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.374 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -63.89 -41.11 97.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.96 -51.11 76.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.902 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.6 -27.04 64.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.078 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 21.3 ttm180 -63.79 -39.46 94.31 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -68.68 -29.94 68.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.995 0.426 . . . . 0.0 110.602 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.89 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -63.82 -36.17 83.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.741 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 7.6 mm-40 -61.07 -45.44 94.74 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.9 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.203 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.67 -37.51 76.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.942 0.401 . . . . 0.0 110.513 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.66 -42.64 67.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.634 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.537 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . 88.7 m-85 -97.84 15.65 23.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.525 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 7.0 tmtt? -48.09 -66.44 0.4 Allowed 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 124.046 0.938 . . . . 0.0 112.729 -173.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.7 87.3 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 10.0 tp10 -64.75 -54.9 24.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.2 m-20 -77.75 -28.81 50.79 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 66.5 mm-40 -61.75 -42.65 99.25 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.418 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 60.3 t -72.0 -48.52 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.822 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.5 mm-40 -54.09 -41.6 68.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -64.58 -39.86 94.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.338 0.59 . . . . 0.0 109.993 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.24 0.8 57.04 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 27.4 mmm180 -68.45 -36.42 78.98 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 172.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.407 HG12 ' HG2' ' A' ' 155' ' ' LYS . 21.6 t -93.83 83.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 m -78.25 142.51 37.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.963 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 45.72 63.37 1.83 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.376 1.47 . . . . 0.0 113.219 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 2.2 pptp? -106.22 77.25 1.21 Allowed 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 123.011 1.386 . . . . 0.0 110.213 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.09 61.94 6.78 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.296 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . . . -146.39 139.16 25.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.862 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.644 HD23 HG22 ' A' ' 21' ' ' THR . 14.0 mt -103.32 151.34 22.84 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.77 144.24 44.71 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.89 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 39.9 m -156.26 -174.64 5.03 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -162.08 156.45 22.06 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 172.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -141.53 162.88 34.41 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -79.03 102.32 8.3 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -122.41 116.6 24.27 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.651 0.739 . . . . 0.0 110.583 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 61.5 mtt -139.13 92.9 2.63 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 65.32 13.79 9.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.433 1.093 . . . . 0.0 110.228 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.5 m -74.05 -24.87 59.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.361 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -149.71 -176.97 5.62 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.9 t 66.99 89.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 124.194 0.934 . . . . 0.0 111.055 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -123.94 134.14 53.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.32 106.14 12.11 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.36 0.6 . . . . 0.0 112.334 -172.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.02 -3.36 10.14 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.434 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.41 -175.91 42.35 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 106.153 -2.779 . . . . 0.0 106.153 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 49.8 tp -79.87 115.94 19.74 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 118.688 1.244 . . . . 0.0 109.426 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 77.26 -58.91 0.48 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.562 1.545 . . . . 0.0 111.431 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 178.46 -173.25 45.67 Favored Glycine 0 CA--C 1.486 -1.761 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -83.6 83.12 8.02 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.405 0.602 . . . . 0.0 109.404 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.6 tt -161.21 102.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 122.087 0.946 . . . . 0.0 110.248 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 21.3 t -130.58 83.08 2.09 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -115.07 -13.78 11.84 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.836 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 69.15 170.67 0.3 Allowed 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.763 1.225 . . . . 0.0 111.967 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 185' ' ' LYS . 14.1 p-10 -111.27 115.92 30.14 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.429 0.633 . . . . 0.0 110.542 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -106.37 86.06 2.29 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 57.28 30.29 18.2 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.754 0.659 . . . . 0.0 109.465 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 182' ' ' ASP . 86.6 tttt -78.83 83.31 4.97 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.901 0.857 . . . . 0.0 110.855 -173.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 6.4 p -177.02 -49.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 113.034 -1.894 . . . . 0.0 107.108 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.6 pp -178.57 157.45 0.98 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.229 1.011 . . . . 0.0 110.859 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -140.35 100.1 3.81 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -121.7 149.76 42.76 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -173.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 61.08 20.57 11.03 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -84.99 69.08 10.77 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.258 1.028 . . . . 0.0 109.074 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 57.0 t -133.38 126.85 52.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 9.6 tp -83.54 84.23 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.455 1.121 . . . . 0.0 109.352 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.9 p -101.78 -78.48 0.53 Allowed 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -70.15 -32.59 70.64 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 122.745 0.418 . . . . 0.0 111.594 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 31.8 tp -92.63 145.33 24.51 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -108.39 -11.12 15.23 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.201 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 72.18 -61.64 0.49 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.657 1.583 . . . . 0.0 113.09 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -125.59 124.17 40.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.2 m -83.58 -54.69 4.76 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.909 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 95.1 mt 66.95 -175.9 0.2 Allowed 'General case' 0 C--O 1.252 1.214 0 C-N-CA 124.416 1.086 . . . . 0.0 113.087 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . 67.1 38.98 3.27 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.532 1.533 . . . . 0.0 112.409 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 205' ' ' LYS . 43.1 tt0 -74.2 98.59 3.2 Favored 'General case' 0 C--O 1.248 0.995 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.01 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.47 ' HG2' ' H ' ' A' ' 206' ' ' ASP . 36.5 ttpt 167.18 -177.23 0.02 OUTLIER 'General case' 0 C--O 1.249 1.051 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.47 ' H ' ' HG2' ' A' ' 205' ' ' LYS . 2.7 p-10 -150.43 169.34 21.7 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -139.73 39.21 2.01 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -128.46 -50.32 1.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.445 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -83.59 -38.07 22.12 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.526 -2.028 . . . . 0.0 105.526 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -78.44 99.93 6.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 168.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 211' ' ' LYS . 23.4 tptt -75.02 107.6 7.19 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.783 -171.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -126.25 -28.14 3.14 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.927 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -70.9 -20.83 62.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.269 0.557 . . . . 0.0 110.921 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -111.76 121.91 46.36 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.0 tp -88.54 119.33 28.89 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.805 -174.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.78 136.72 45.51 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -93.01 -41.4 10.01 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -168.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 18.9 m -106.62 157.16 7.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.008 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.01 145.86 98.98 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.133 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.65 97.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.694 2.262 . . . . 0.0 112.092 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 8.8 tp -114.93 -29.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.099 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 59.3 mt -84.2 133.4 29.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.5 t -84.7 84.7 7.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.25 -146.05 17.22 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.3 tt -179.8 -58.88 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -131.05 109.99 10.89 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.229 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -129.79 107.59 9.52 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.933 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -162.71 -97.21 0.12 Allowed Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.061 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -153.8 -33.89 0.11 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.07 0.462 . . . . 0.0 111.658 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 106.02 179.19 23.48 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -142.76 163.4 27.29 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.881 -1.152 . . . . 0.0 112.053 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.79 144.06 57.96 Favored 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.753 2.302 . . . . 0.0 110.5 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 140.65 -63.37 0.53 Allowed Glycine 0 C--N 1.304 -1.238 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.607 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.8 -22.36 29.27 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.906 3.071 . . . . 0.0 115.285 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -78.18 93.16 1.19 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 147.96 -6.53 1.0 Allowed Glycine 0 C--N 1.302 -1.346 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -96.26 -167.02 1.51 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.33 -81.78 1.73 Allowed Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -92.15 78.04 5.23 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 171.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -86.37 131.18 34.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.971 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 85.75 104.52 0.71 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.47 -33.95 59.57 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 123.37 2.713 . . . . 0.0 113.866 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.78 13.93 4.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.536 0.684 . . . . 0.0 109.997 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -84.44 155.76 31.29 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.1 -88.84 0.49 Allowed Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 4.8 p -96.69 96.03 8.34 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.138 0.494 . . . . 0.0 110.84 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -150.9 34.24 0.94 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 13.0 p -86.08 -22.1 27.33 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.108 0.48 . . . . 0.0 111.356 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.72 -142.89 29.45 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.731 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.14 -27.93 13.29 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.484 2.123 . . . . 0.0 112.612 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.8 m 62.03 99.36 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.215 1.006 . . . . 0.0 111.413 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 31.0 pt -78.19 0.37 2.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -72.93 99.89 2.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -86.1 -94.32 0.08 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.282 -170.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.59 -3.19 10.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.997 0.903 . . . . 0.0 109.664 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.365 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.435 -1.221 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 60.94 25.09 15.1 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -78.88 122.31 25.94 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.17 131.76 34.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.114 0.483 . . . . 0.0 110.673 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -83.97 -38.51 20.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.72 147.69 51.37 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 20.7 tp -115.96 102.24 9.48 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.563 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.3 pt? -96.44 -13.33 23.22 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -171.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.5 tp -136.33 17.26 3.17 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.762 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.402 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 97.6 mt 57.3 -164.42 0.17 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.087 -174.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.3 61.7 1.12 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.5 -177.42 2.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.621 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.01 118.87 72.45 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.05 -50.53 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.278 1.985 . . . . 0.0 111.978 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.441 HD11 HG22 ' A' ' 135' ' ' VAL . 6.3 mp -114.61 172.25 7.14 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.488 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 15.2 m -92.5 151.04 20.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.124 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.03 132.0 54.58 Favored 'General case' 0 C--O 1.261 1.669 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.923 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.11 158.1 27.57 Favored Glycine 0 N--CA 1.426 -1.982 0 O-C-N 123.91 0.756 . . . . 0.0 112.656 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.9 151.39 22.16 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -86.12 108.45 18.31 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 171.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 18.0 p -107.87 -69.61 0.84 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.286 0.565 . . . . 0.0 111.348 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.26 165.55 11.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.55 -21.05 4.3 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 116.949 1.539 . . . . 0.0 116.949 -171.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.52 33.37 2.15 Favored Glycine 0 CA--C 1.493 -1.341 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.986 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.37 121.5 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.449 0.643 . . . . 0.0 112.12 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.518 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 23.4 ttt -106.31 97.79 7.55 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.9 m -80.35 110.74 16.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.07 119.9 30.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.789 0.328 . . . . 0.0 111.047 -176.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 63.1 mt -104.93 -39.54 6.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.623 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.1 130.4 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.19 162.3 14.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 15' ' ' LEU . 63.6 mtt180 -56.69 140.11 48.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 123.714 0.634 . . . . 0.0 109.515 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 75.26 10.74 3.57 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.231 1.012 . . . . 0.0 112.786 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -81.91 114.73 20.71 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -60.38 131.75 51.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.398 1.079 . . . . 0.0 113.781 -176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 36.4 pt -95.4 160.83 29.73 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 24.7 Cg_exo -65.66 126.26 6.39 Favored 'Cis proline' 0 C--N 1.358 1.043 0 CA-C-N 120.291 1.14 . . . . 0.0 113.431 0.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.6 p -95.55 149.13 21.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.443 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 37.7 tttp -154.02 99.5 2.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' THR . 5.5 tp-100 -107.15 140.12 40.5 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 81.5 m -139.83 116.41 10.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HG3' HD22 ' A' ' 29' ' ' LEU . 86.5 mm-40 -128.61 144.17 51.1 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.22 118.83 41.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 123.669 0.606 . . . . 0.0 109.535 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.05 169.19 8.64 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.915 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 33.1 p -134.24 171.63 13.98 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.469 ' HB ' ' OG ' ' A' ' 48' ' ' SER . 27.7 p -99.86 139.62 35.25 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.484 176.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 27.6 m-85 -85.03 -11.72 54.75 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 46' ' ' THR . 29.5 p -83.75 142.27 30.82 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.905 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.0 124.01 51.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 66.32 61.43 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.693 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.517 ' H ' ' NE2' ' A' ' 51' ' ' GLN . 0.5 OUTLIER -101.3 123.11 45.87 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -85.41 -15.96 5.02 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.821 1.681 . . . . 0.0 111.132 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.59 164.64 36.92 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.43 179.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.1 tp -132.37 132.37 42.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.55 123.26 71.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 120.851 0.358 . . . . 0.0 111.52 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -114.82 129.76 56.75 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.4 123.49 64.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.58 142.97 43.2 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.248 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -111.52 121.23 44.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.57 125.33 5.6 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -172.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 3.8 mp0 -79.0 139.03 38.28 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 36.2 mmt180 -139.45 156.86 46.69 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 114.192 -1.367 . . . . 0.0 107.542 172.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.599 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -78.22 -49.87 12.96 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 92.7 mmm -105.55 122.05 45.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.13 102.08 0.1 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -174.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 56.3 pttt 179.41 -177.44 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.174 1.389 . . . . 0.0 107.549 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.98 -45.46 0.6 Allowed 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.44 1.496 . . . . 0.0 114.921 172.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.582 ' ND2' ' HG2' ' A' ' 63' ' ' ARG 0.259 85.8 m-20 -86.17 -166.19 1.47 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -88.69 112.63 23.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.994 0.902 . . . . 0.0 111.724 -167.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.7 108.24 13.1 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.204 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 95.1 mt -73.57 -55.19 6.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.96 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.89 159.07 27.99 Favored Glycine 0 N--CA 1.413 -2.887 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.966 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.29 135.22 21.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.76 168.3 24.81 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.58 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.75 144.21 25.62 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.6 tp -131.07 103.66 6.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -132.96 165.87 23.69 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 120.573 0.225 . . . . 0.0 111.04 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.07 4.95 56.47 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.78 134.39 86.02 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 37.5 Cg_exo -59.99 133.87 53.05 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.975 1.784 . . . . 0.0 109.796 177.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 22.5 Cg_exo -67.5 63.64 0.8 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.103 2.535 . . . . 0.0 111.974 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.24 153.51 39.01 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.602 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -61.36 177.9 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.459 2.773 . . . . 0.0 114.914 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.61 131.39 50.08 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.469 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 75.4 20.77 78.49 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.69 176.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.0 -49.69 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.47 116.13 4.58 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.535 1.49 . . . . 0.0 111.343 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -87.42 112.1 21.81 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.7 mm -98.82 115.94 40.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.73 112.76 24.66 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 41' ' ' THR . 96.0 t -106.07 124.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 32.5 m -124.45 128.32 48.83 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.855 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 34.7 m-85 -112.63 136.62 51.98 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 8.0 t70 -142.31 127.11 18.15 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.1 mt -124.15 126.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -89.13 -170.65 2.96 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.279 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.33 63.42 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.452 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 9.1 t30 -84.61 -29.77 25.5 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.274 0.559 . . . . 0.0 110.242 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.3 28.48 4.62 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 77.4 mt -86.89 116.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 49.0 tp -96.12 120.1 35.8 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 3.1 t-20 -105.08 105.21 15.15 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 38.8 t -92.12 120.48 41.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 174.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -126.99 122.87 35.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.69 117.17 29.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.1 m -115.75 127.73 55.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.145 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -83.04 107.38 15.59 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.23 -12.27 60.71 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 m -70.98 -54.56 10.82 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 35.7 p -86.59 -48.82 8.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.438 0.637 . . . . 0.0 111.14 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.05 5.5 28.76 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.475 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 14.2 ptmm? -92.31 152.5 19.75 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.49 162.68 38.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.337 0.589 . . . . 0.0 112.281 -174.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -129.42 128.06 42.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.09 173.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 19.6 ptpt -132.97 149.53 52.23 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.452 -178.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.4 pt -129.81 151.04 35.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.2 m -117.47 113.11 21.56 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.25 103.13 14.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -84.93 109.4 18.12 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.4 t30 79.48 119.57 0.05 Allowed 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.884 1.274 . . . . 0.0 111.413 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.87 -27.66 68.38 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.303 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -87.9 22.83 2.22 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.529 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.8 9.85 74.74 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 72' ' ' LEU . 37.6 mmt180 -128.72 147.35 50.76 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 124.69 1.196 . . . . 0.0 108.008 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 78.7 mt 53.29 -125.17 2.35 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.099 0.96 . . . . 0.0 112.431 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.0 p -150.71 158.46 44.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 63.1 tttm -66.74 -30.24 70.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.53 -45.8 92.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.448 0.699 . . . . 0.0 109.409 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 134' ' ' MET . 14.7 mm-40 -61.2 -46.49 90.24 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.694 175.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 135' ' ' VAL . 82.5 mt -60.14 -42.98 91.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 128' ' ' LYS . 67.4 mt-10 -63.25 -32.38 73.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.702 0.287 . . . . 0.0 110.923 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 44.7 mtp180 -64.03 -43.78 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.036 174.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 52.7 mtt -65.08 -35.27 80.63 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.006 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 131' ' ' ILE . 86.1 t -55.54 -52.13 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 69.8 mm-40 -65.18 -52.26 55.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.755 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.67 -51.05 71.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -67.78 -30.73 70.24 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.425 ' HA ' ' HG2' ' A' ' 142' ' ' LYS . 39.3 mt-10 -77.6 -34.96 53.32 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.548 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.96 -43.7 74.45 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.7 20.72 7.17 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.468 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 24.4 mmtt -53.3 -58.09 8.27 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -56.56 -44.81 81.33 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.443 0.464 . . . . 0.0 111.327 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.67 -48.58 71.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.794 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.43 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.2 m-20 -72.61 -36.88 68.18 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 56.4 mm-40 -60.43 -42.5 96.18 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.838 0.29 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.676 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.0 t -67.24 -49.72 69.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.409 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -63.75 -43.95 94.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.599 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 40.0 ttp180 -62.84 -48.57 78.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.419 0.628 . . . . 0.0 110.319 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 153' ' ' SER . 7.1 mm-40 -79.3 -0.28 31.75 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.476 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 21.5 mmt180 -84.23 -35.46 23.43 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 -38.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 26.3 t -66.84 103.23 1.08 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -102.79 -27.48 12.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.215 0.531 . . . . 0.0 110.961 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -161.36 154.56 21.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -74.85 86.54 2.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.384 0.611 . . . . 0.0 109.405 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.57 149.02 35.11 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.275 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 mp -109.15 149.23 29.65 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.56 156.72 19.2 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.2 p -79.42 113.74 17.8 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.241 0.544 . . . . 0.0 111.824 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -93.57 149.48 21.19 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.039 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -86.41 154.94 20.8 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -94.27 133.51 37.72 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -81.09 159.68 24.67 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.278 0.561 . . . . 0.0 110.567 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.2 ptp -133.93 176.51 8.51 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 166' ' ' LYS . 9.0 mmpt? -116.75 -179.76 3.78 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.5 m -53.65 125.2 17.42 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.46 0.475 . . . . 0.0 110.083 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.03 -5.45 59.11 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -172.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 64.6 t 76.33 110.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.072 0.949 . . . . 0.0 109.054 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -97.72 -35.64 10.5 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.337 -170.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -120.85 121.16 37.52 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -137.67 95.4 3.05 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.36 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.79 139.45 10.62 Favored Glycine 0 C--N 1.311 -0.843 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.141 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 174' ' ' LEU . 1.7 pt? -123.86 101.21 7.14 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.42 0.628 . . . . 0.0 109.315 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.2 -64.51 1.03 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.54 -174.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.53 152.57 22.11 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -96.92 79.75 2.94 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 117.921 0.861 . . . . 0.0 111.804 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.4 mp -81.37 93.69 2.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 15.9 m -118.63 -37.21 3.32 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 52.24 46.87 25.88 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.152 1.781 . . . . 0.0 111.71 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.79 80.16 8.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.782 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.412 ' OD1' ' HG3' ' A' ' 183' ' ' LYS . 4.0 p30 -76.74 -52.84 8.84 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -173.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 182' ' ' ASP . 97.2 mttt -100.96 15.38 28.82 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 121.771 -0.581 . . . . 0.0 112.345 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.637 ' HE2' ' HA ' ' A' ' 184' ' ' LYS . 8.6 mmpt? -79.52 0.45 29.68 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.411 0.624 . . . . 0.0 111.612 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -84.26 68.45 10.18 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.35 101.5 2.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -170.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.1 73.9 0.89 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.57 118.89 31.94 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt 56.98 74.94 0.39 Allowed 'General case' 0 C--O 1.245 0.86 0 O-C-N 124.427 1.08 . . . . 0.0 109.572 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -76.09 96.78 3.91 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -65.39 -66.09 0.59 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.635 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.9 p 51.91 26.76 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 125.876 1.671 . . . . 0.0 111.056 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 75.8 mt -83.64 86.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 44.8 m -142.0 91.38 2.34 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.226 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -127.73 89.47 2.95 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -158.0 89.12 0.99 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -98.62 94.18 6.52 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.817 0.818 . . . . 0.0 111.165 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -99.57 -24.61 14.69 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 171.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 65.86 -75.72 0.05 OUTLIER 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 125.863 1.665 . . . . 0.0 112.009 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 20.8 p -144.07 94.83 2.63 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 62.4 mt -126.55 85.96 2.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.495 0.664 . . . . 0.0 112.77 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -82.76 109.33 16.82 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -139.95 116.81 10.97 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.009 -171.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -117.47 96.92 5.62 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.05 -23.79 67.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.427 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.66 77.96 0.29 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.823 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -84.62 103.12 13.46 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 169.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -51.36 118.5 3.33 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 124.328 1.017 . . . . 0.0 111.929 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -94.46 104.92 16.88 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.079 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -71.6 135.6 47.03 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -156.56 132.2 9.5 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.131 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.464 ' HD3' ' H ' ' A' ' 213' ' ' LYS . 0.3 OUTLIER -116.31 113.64 23.25 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 171.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -94.38 113.4 25.28 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.14 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.28 112.85 25.47 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -83.69 -57.96 3.01 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 63.96 161.25 0.11 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.179 1.392 . . . . 0.0 112.161 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.3 m -106.45 161.86 5.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.197 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' SMC . . . . . 0.496 ' O ' ' HD3' ' A' ' 221' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -108.78 95.31 16.49 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 219' ' ' SMC . 3.3 Cg_exo -78.64 121.28 5.05 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.37 2.046 . . . . 0.0 110.933 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.6 tp -84.36 -33.32 8.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 32.2 pt 51.84 176.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 127.235 2.214 . . . . 0.0 115.441 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 13.2 t 66.78 84.82 0.15 Allowed 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.335 1.454 . . . . 0.0 111.232 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -111.06 5.52 28.84 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.023 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 226' ' ' LEU . 2.4 pt? -89.19 116.63 27.58 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -111.67 -9.1 14.16 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 70.93 -62.97 0.43 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.721 1.608 . . . . 0.0 112.87 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 112.81 164.54 16.3 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.93 155.97 23.81 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 160.35 -172.28 36.74 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -151.64 159.13 28.12 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.09 162.01 23.32 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.719 2.279 . . . . 0.0 112.436 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 235' ' ' PRO . . . -91.41 124.31 7.54 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 234' ' ' GLY . 6.2 Cg_endo -87.02 -3.68 7.99 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.528 2.152 . . . . 0.0 113.432 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 129.35 -178.01 17.63 Favored Glycine 0 C--N 1.306 -1.125 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -95.55 -146.36 20.69 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.103 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.94 -39.2 43.47 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.381 0.61 . . . . 0.0 109.736 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 110.96 109.12 3.12 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.022 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.5 93.37 9.14 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -149.43 111.54 4.63 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.806 -173.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.15 111.49 0.49 Allowed Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -50.58 138.07 40.31 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 123.492 2.795 . . . . 0.0 113.36 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -104.59 110.26 22.49 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -88.17 -25.17 32.1 Favored Glycine 0 C--N 1.307 -1.042 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 99.71 170.48 30.15 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.8 t -78.61 95.29 5.2 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.93 108.03 2.46 Favored Glycine 0 CA--C 1.498 -1.026 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 23.1 t -151.87 143.29 23.44 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -137.9 86.63 0.22 Allowed Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.14 97.97 0.52 Allowed 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 122.67 2.247 . . . . 0.0 111.848 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 5.3 m -87.31 -32.93 19.41 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 65.3 mt 68.54 99.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.505 1.122 . . . . 0.0 111.299 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -114.99 -4.33 12.56 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.087 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.02 139.92 49.78 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.88 88.06 2.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.943 0.878 . . . . 0.0 110.443 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--N 1.301 -1.504 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.206 -177.221 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt . . . . . 0 N--CA 1.431 -1.41 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -118.85 41.06 3.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 19.5 m -124.35 177.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.292 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.86 120.84 80.04 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.41 -24.38 10.72 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.219 1.946 . . . . 0.0 112.13 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.02 160.87 21.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.031 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -93.63 112.94 24.92 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -92.16 131.56 37.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.85 179.06 22.26 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.822 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.37 159.92 31.86 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -83.97 117.2 23.22 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 170.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 p -110.82 -97.8 0.41 Allowed 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.16 163.61 19.67 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.38 92.55 0.08 OUTLIER Glycine 0 CA--C 1.499 -0.962 0 O-C-N 123.76 0.662 . . . . 0.0 112.968 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' A' ' 65' ' ' MET . . . 104.69 19.17 11.39 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 124.512 0.772 . . . . 0.0 111.735 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -129.36 115.33 34.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 117.016 0.408 . . . . 0.0 110.73 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.33 115.65 27.71 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -100.27 112.64 24.98 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.34 101.67 13.91 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 5.6 mp -73.32 -49.28 28.35 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.33 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -108.42 105.28 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.02 153.54 21.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.099 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.689 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -57.05 159.33 4.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.047 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 72.56 6.12 5.38 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 124.855 1.262 . . . . 0.0 111.948 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.4 m -91.8 125.73 36.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 10.0 t -68.35 134.71 50.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.517 0.675 . . . . 0.0 112.256 -177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.43 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 33.1 pt -94.98 154.54 39.65 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.639 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.2 Cg_exo -63.26 133.73 14.9 Favored 'Cis proline' 0 N--CA 1.478 0.566 0 CA-C-N 119.873 0.991 . . . . 0.0 114.012 0.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -110.01 162.18 14.79 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.257 1.023 . . . . 0.0 109.266 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 15.4 ptpt -166.57 148.19 6.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.542 0.527 . . . . 0.0 110.807 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 29' ' ' LEU . 15.3 mm100 -147.75 118.78 7.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 125.821 1.648 . . . . 0.0 107.544 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 84.9 m -111.67 116.33 30.59 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -128.97 141.11 51.36 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.13 124.67 48.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 97.0 m-85 -111.74 160.12 17.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.75 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 21.3 p -129.89 171.96 12.19 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -113.51 138.49 50.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 119.623 1.101 . . . . 0.0 110.534 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -82.52 -39.22 22.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 p -63.88 98.17 0.19 Allowed 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.759 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.47 160.68 27.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.354 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 m120 62.82 22.42 13.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -94.46 114.11 62.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 3.3 Cg_exo -79.64 -8.04 14.71 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.82 126.75 2.43 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.45 160.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.451 HD13 ' HG2' ' A' ' 76' ' ' GLU . 53.3 tp -111.86 117.85 33.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.74 118.39 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' ' 20' ' ' GLU . 16.6 pt20 -132.85 129.85 39.0 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.331 -176.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.38 127.53 50.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -124.21 153.46 41.58 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.566 0.746 . . . . 0.0 110.107 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 37.1 mt-10 -117.09 137.12 52.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.36 -155.45 16.09 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.486 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 22.3 mt-10 -152.29 130.63 12.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.058 0.543 . . . . 0.0 110.575 174.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 27.3 mmt180 -147.67 163.91 35.17 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 170.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.54 62.85 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.644 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 58.7 mtt -109.68 135.04 51.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.102 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -65.25 98.74 0.34 Allowed 'General case' 0 N--CA 1.416 -2.126 0 O-C-N 124.076 0.86 . . . . 0.0 112.573 -175.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 19.3 pttp -176.82 169.81 2.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 66.75 11.26 8.12 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 123.621 0.768 . . . . 0.0 111.874 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 96.3 m-20 -118.63 179.96 3.98 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.416 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -90.49 151.88 21.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -118.52 121.18 39.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.7 mt -84.65 -48.13 9.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.707 0.289 . . . . 0.0 111.596 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.74 170.89 42.39 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -143.48 162.92 34.57 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -155.06 142.64 19.72 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HG2' HD13 ' A' ' 55' ' ' LEU . 43.5 mt-10 -102.68 117.87 35.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.038 0.447 . . . . 0.0 110.299 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.3 tp -92.77 112.65 24.69 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.889 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -107.95 155.36 20.4 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.32 -15.31 6.11 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.948 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.4 mp -60.5 125.41 82.17 Favored Pre-proline 0 C--O 1.247 0.939 0 C-N-CA 122.88 0.472 . . . . 0.0 110.136 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 80' ' ' ILE . 23.5 Cg_exo -65.54 126.8 16.79 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.95 1.767 . . . . 0.0 109.839 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.95 90.45 0.11 Allowed 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.594 2.196 . . . . 0.0 111.167 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.56 167.37 15.18 Favored Pre-proline 0 N--CA 1.42 -1.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.367 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.45 -179.0 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.508 2.805 . . . . 0.0 114.646 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -72.48 129.14 37.65 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.662 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 85.71 4.02 85.55 Favored Glycine 0 C--N 1.309 -0.949 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.714 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.7 t -90.55 -49.39 0.36 Allowed Pre-proline 0 CA--C 1.557 1.232 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' THR . 31.8 Cg_exo -63.31 119.93 7.19 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.328 1.352 . . . . 0.0 111.27 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.38 106.61 17.79 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.296 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.36 116.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.527 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 39.2 tt0 -90.64 117.48 29.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 41' ' ' THR . 74.1 t -110.41 113.11 43.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.4 m -99.48 111.67 23.99 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -116.67 107.86 15.2 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -174.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 39' ' ' LYS . 3.9 p30 -141.02 149.63 41.97 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.061 0.458 . . . . 0.0 111.192 -175.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.8 mt -116.62 140.17 40.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -90.63 -167.25 1.78 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -18.25 59.55 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -82.73 -29.12 30.0 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.49 0.662 . . . . 0.0 109.301 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.16 31.96 3.4 Favored Glycine 0 N--CA 1.416 -2.674 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.9 mt -99.96 121.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.283 0.563 . . . . 0.0 109.751 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 tp -89.07 121.45 31.42 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.493 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -113.41 123.08 49.23 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.02 114.29 45.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -111.49 122.73 48.6 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.297 0.373 . . . . 0.0 110.009 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.65 117.73 34.82 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -118.6 114.56 22.97 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.813 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.72 112.19 13.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.527 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 62.5 mttm -67.08 -24.57 65.97 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.669 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -65.52 -54.65 25.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -91.52 -44.61 8.98 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.53 7.08 26.5 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -85.91 137.57 32.65 Favored 'General case' 0 N--CA 1.403 -2.79 0 CA-C-O 121.061 0.457 . . . . 0.0 110.401 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.32 140.81 47.64 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.01 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -135.73 131.79 36.04 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.61 166.16 16.59 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.05 145.05 33.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.8 m -117.45 113.08 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.6 mt -126.84 119.72 53.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 O-C-N 122.324 -0.235 . . . . 0.0 110.864 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.1 t -79.51 132.55 36.35 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 C--N 1.318 -0.799 0 CA-C-O 121.161 0.505 . . . . 0.0 110.331 178.422 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 135' ' ' VAL . 60.3 mt -67.89 -41.95 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.458 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -60.14 -42.33 94.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.819 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -60.42 -43.24 96.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.7 ttm -58.62 -44.91 90.11 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.923 0.889 . . . . 0.0 110.613 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.448 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 59.4 t -63.14 -47.1 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -58.94 -43.23 91.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.73 -35.94 82.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.0 110.501 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -67.95 -30.22 69.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.511 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 7.6 mm-40 -78.79 -44.6 22.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.413 1.101 . . . . 0.0 109.082 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.63 -48.08 83.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.533 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.96 19.01 20.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.85 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 18.8 ttmm -54.32 -47.44 72.47 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.563 0.539 . . . . 0.0 112.139 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.18 70.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.168 0.509 . . . . 0.0 111.589 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.51 -46.84 68.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.447 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.86 -36.97 83.53 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.435 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 45.5 mm-40 -58.1 -50.17 74.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.677 0.217 . . . . 0.0 111.253 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.23 -47.03 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.273 0.358 . . . . 0.0 110.357 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -57.22 -46.23 83.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.73 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -66.06 -47.89 72.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.071 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -75.35 -7.78 54.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.254 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.0 mtp85 -73.99 -20.3 60.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.926 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.61 82.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.0 p -132.66 138.66 47.39 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.234 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -168.61 -54.5 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -169.37 150.1 4.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 56.6 m-80 -64.57 117.42 7.36 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.302 0.572 . . . . 0.0 110.29 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.02 161.59 38.38 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.648 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.7 mt -120.36 137.11 54.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -112.54 129.93 56.19 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 172.441 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 10' ' ' LEU 0.261 4.0 mm? . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 35' ' ' THR . 2.3 m-20 -94.52 64.42 3.06 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 m -139.52 174.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.998 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.51 120.79 72.24 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.11 -43.33 30.23 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 122.486 2.124 . . . . 0.0 113.116 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.438 ' C ' ' HB3' ' A' ' 32' ' ' ARG . 10.0 mp -123.31 174.18 7.48 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 m -88.3 127.86 35.48 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.4 130.91 37.95 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.2 -170.74 19.76 Favored Glycine 0 N--CA 1.408 -3.169 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.452 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.4 mt -129.27 162.93 26.78 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.169 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.54 144.45 28.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 HD23 ' A' ' 158' ' ' LEU . 12.9 p -126.35 -94.29 0.47 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 122.946 0.498 . . . . 0.0 111.575 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.41 106.11 14.53 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.11 -60.64 4.78 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.752 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.91 56.43 0.1 Allowed Glycine 0 C--N 1.291 -1.928 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.41 HG13 ' HG2' ' A' ' 149' ' ' ARG . 89.9 t -122.11 115.33 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -175.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.62 114.02 22.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -106.72 111.39 23.9 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.78 132.04 36.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.031 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -49.8 3.47 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.32 102.68 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 152.99 37.23 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.571 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.563 HH12 ' HA ' ' A' ' 135' ' ' VAL . 36.9 ptt180 -62.58 160.7 13.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 73.82 5.13 4.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.772 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 9.9 t -65.84 135.2 54.53 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.779 0.799 . . . . 0.0 111.548 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 pt -98.89 155.42 36.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.548 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.06 144.59 75.54 Favored 'Cis proline' 0 C--O 1.25 1.089 0 N-CA-C 115.265 1.217 . . . . 0.0 115.265 4.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 p -122.16 161.3 23.4 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.282 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 4.8 ttmp? -166.08 100.6 0.64 Allowed 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 93' ' ' THR . 54.3 mt-30 -119.0 131.09 55.98 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.102 -175.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.7 m -114.44 122.44 46.63 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.53 0.732 . . . . 0.0 110.771 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.533 ' N ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -129.46 148.7 51.4 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mm -96.23 121.7 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.206 0.527 . . . . 0.0 110.397 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 79.6 m-85 -109.26 143.66 38.43 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.625 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 16.9 p -119.78 171.17 8.59 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -113.89 141.7 47.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 29.9 m-85 -88.18 -41.09 13.22 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 p -73.87 130.43 39.89 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.557 175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -106.46 166.82 10.27 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.072 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 67.88 23.81 8.27 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.312 0.645 . . . . 0.0 112.091 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.601 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 15.0 mm-40 -81.86 132.77 53.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.07 -39.63 30.79 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.554 1.502 . . . . 0.0 110.674 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.35 166.72 33.79 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG13 HG13 ' A' ' 80' ' ' ILE . 16.1 m -106.48 135.07 46.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.09 0.471 . . . . 0.0 110.947 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.46 107.26 16.62 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.681 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -96.18 114.7 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -122.56 110.79 16.01 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.562 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.83 127.01 44.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 123.594 0.559 . . . . 0.0 111.371 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 53.0 m-85 -133.62 155.26 49.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 40.1 mt-10 -110.76 143.27 41.55 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 165.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.38 112.49 0.62 Allowed Glycine 0 C--N 1.263 -3.486 0 C-N-CA 118.285 -1.912 . . . . 0.0 111.105 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.48 86.46 5.16 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -145.18 146.02 31.58 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -66.25 -50.15 64.75 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.402 1.096 . . . . 0.0 109.846 172.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.2 mtt -112.22 130.3 55.97 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.18 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 101.79 1.03 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 123.912 0.757 . . . . 0.0 109.69 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -76.28 -52.7 9.45 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 122.01 0.91 . . . . 0.0 108.684 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -153.5 -54.0 0.11 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.36 -176.77 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.27 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 65.9 t30 -95.38 112.74 24.4 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.075 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.9 114.08 17.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.27 -34.41 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.669 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.67 176.16 39.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.23 170.4 20.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 117.032 0.416 . . . . 0.0 110.026 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -164.22 155.43 15.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -114.68 118.94 35.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.213 0.53 . . . . 0.0 110.133 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -95.49 108.03 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.3 p -97.03 150.18 21.08 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.81 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 24.01 1.78 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.812 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 50.6 mm -82.51 125.19 76.77 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.84 163.27 35.92 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.544 2.163 . . . . 0.0 112.348 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.35 40.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.217 2.611 . . . . 0.0 111.208 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 87' ' ' VAL . . . -84.74 124.91 72.37 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.75 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 16.6 Cg_exo -66.13 99.82 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.148 2.565 . . . . 0.0 115.506 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.4 mtp180 54.91 114.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.617 1.967 . . . . 0.0 115.442 167.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.98 -20.6 31.78 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.661 -0.781 . . . . 0.0 114.764 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 83' ' ' ALA . 21.7 t -73.79 -47.03 6.95 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 122.458 -0.436 . . . . 0.0 111.416 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.99 113.26 3.51 Favored 'Trans proline' 0 C--N 1.376 2.005 0 N-CA-C 108.782 -1.276 . . . . 0.0 108.782 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.288 0.0 OUTLIER -129.78 128.01 41.52 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.05 0.929 . . . . 0.0 113.049 -178.14 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 mm -107.14 126.72 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.713 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.18 107.73 19.4 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.04 120.56 60.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.322 0.582 . . . . 0.0 110.152 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 62.5 m -113.55 124.76 53.12 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.146 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -105.86 114.34 28.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -123.66 138.58 54.51 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.8 mt -125.71 141.99 43.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -104.78 -170.14 1.72 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.6 -11.81 60.55 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -84.96 -28.76 25.61 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.029 0.442 . . . . 0.0 109.825 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.44 23.34 8.03 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 86.6 mt -90.3 117.57 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-O 121.382 0.611 . . . . 0.0 109.526 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 38.6 tp -95.74 129.27 43.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.646 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 45.4 m-80 -117.62 108.68 15.74 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 47.1 t -88.84 113.79 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -111.32 114.44 27.61 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.303 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.19 123.62 47.12 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.471 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.1 m -118.5 119.92 35.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.414 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.84 104.5 6.41 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -68.31 -18.31 64.48 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.582 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -68.43 -61.96 1.6 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.855 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 p -98.98 -37.71 9.27 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 120.8 0.333 . . . . 0.0 111.346 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.24 -0.59 8.21 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.045 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.0 137.31 55.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 117.406 0.603 . . . . 0.0 112.03 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.92 136.85 32.67 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.131 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -139.96 139.52 36.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 21.4 ptmt -137.95 142.01 40.54 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.128 0.49 . . . . 0.0 110.689 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 34.4 pt -119.17 147.66 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.5 m -106.96 113.45 26.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.017 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.417 HD11 HD12 ' A' ' 117' ' ' ILE . 50.7 mt -128.83 116.4 40.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.7 m -72.54 127.32 32.19 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 168.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 N--CA 1.51 2.548 0 O-C-N 124.339 1.024 . . . . 0.0 111.217 -170.668 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.864 0.364 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 135' ' ' VAL . 48.0 mm -61.15 -45.3 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.66 -25.04 62.82 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -60.21 -45.0 94.68 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.5 mmt -59.48 -45.07 92.72 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.563 ' HA ' HH12 ' A' ' 32' ' ' ARG . 96.2 t -60.29 -57.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.085 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -70.22 -48.47 56.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -172.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.54 -38.62 91.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.02 -39.72 83.07 Favored 'General case' 0 C--O 1.19 -2.079 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.602 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -58.26 -33.31 69.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.493 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.4 -37.81 51.12 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -126.19 15.75 7.82 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -59.3 -27.31 65.74 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.48 95.52 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.772 0.796 . . . . 0.0 108.867 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 24.8 mm-40 -70.61 -44.96 66.17 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.506 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 3.0 m-20 -56.99 -45.42 83.0 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 123.545 0.528 . . . . 0.0 112.266 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 38.2 mt-10 -61.24 -39.29 89.75 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.79 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 82.9 t -63.74 -48.73 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.6 mm-40 -56.18 -46.06 79.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.519 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.436 ' HD3' ' C ' ' A' ' 149' ' ' ARG . 2.5 tmt_? -53.29 -50.83 64.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.593 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.1 pt-20 -83.18 -5.14 59.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 11.7 mmp_? -76.29 -34.54 59.07 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.88 -54.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 49.0 m -149.32 129.18 13.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.0 -38.04 9.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.01 0.434 . . . . 0.0 110.779 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HE3' ' OG1' ' A' ' 45' ' ' THR . 64.1 tttp -80.65 144.93 31.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 90.0 m-20 -76.68 99.13 4.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.319 0.581 . . . . 0.0 110.675 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -134.6 132.82 39.5 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.907 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 21' ' ' THR . 18.5 mt -101.13 114.32 28.15 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.1 119.32 37.64 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.708 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 12' ' ' VAL . 49.4 tp . . . . . 0 N--CA 1.419 -1.995 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.8 m-20 -78.76 56.99 1.98 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.538 -172.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG22 ' HG ' ' A' ' 10' ' ' LEU . 10.0 m -136.56 168.37 22.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.8 127.2 68.42 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.68 -47.34 9.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.578 2.185 . . . . 0.0 111.972 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CB ' ' HB3' ' A' ' 60' ' ' GLU . 3.9 mm? -123.19 169.83 10.86 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.151 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 19.7 m -76.79 129.47 36.32 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.1 131.55 40.97 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.84 178.13 26.6 Favored Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.865 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.7 mt -123.93 164.71 18.75 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.324 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -84.18 109.58 17.85 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 HD23 ' A' ' 158' ' ' LEU . 12.2 p -99.19 142.47 30.64 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.461 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.64 113.91 0.68 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.355 1.462 . . . . 0.0 113.049 -172.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.08 -11.46 8.2 Favored Glycine 0 N--CA 1.425 -2.06 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.384 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' A' ' 20' ' ' GLU . . . 84.49 50.33 4.29 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.64 134.75 65.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.2 ttt -94.23 101.35 13.32 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.809 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -95.42 119.23 33.56 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 143.79 26.18 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.5 mp -102.11 -44.57 5.41 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.235 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.84 129.07 76.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -85.7 167.11 15.58 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ptt85 -69.13 165.37 20.49 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.879 0.371 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 68.78 9.31 7.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.583 1.153 . . . . 0.0 112.659 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -81.61 118.74 23.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 13.2 p -62.76 126.94 29.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.9 pt -91.6 164.68 23.33 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.37 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.3 Cg_exo -68.76 122.77 5.78 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.353 1.162 . . . . 0.0 113.477 1.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -95.17 156.73 16.19 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.495 0.718 . . . . 0.0 110.106 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -160.13 104.05 1.48 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.634 HE22 ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -129.52 120.9 26.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.0 m -107.39 141.51 38.65 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.569 0.748 . . . . 0.0 110.492 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.634 ' HG3' HE22 ' A' ' 40' ' ' GLN . 88.9 mt-30 -136.62 162.01 34.31 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.703 0.401 . . . . 0.0 109.974 174.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.79 122.94 62.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -107.57 146.57 31.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.86 0.838 . . . . 0.0 111.932 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 3.3 p -114.74 173.08 6.66 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.582 -1.644 . . . . 0.0 108.749 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 p -113.31 151.13 31.55 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 112.243 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -108.0 7.38 27.83 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.725 0.774 . . . . 0.0 110.286 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -89.97 158.15 17.51 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.568 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -118.27 114.42 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 63.3 74.25 0.43 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.245 1.021 . . . . 0.0 111.081 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.45 ' CD ' ' H ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -102.73 121.13 50.59 Favored Pre-proline 0 C--N 1.292 -1.904 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.56 -178.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.18 -14.85 6.93 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.091 1.861 . . . . 0.0 110.891 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.87 150.76 20.89 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 29.0 m -118.41 158.64 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 tp -108.23 127.04 53.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.086 0.469 . . . . 0.0 111.426 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.26 105.36 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -113.02 123.51 50.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.82 119.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 123.9 0.75 . . . . 0.0 110.048 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 89.0 m-85 -122.68 156.78 33.66 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.171 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HB3' ' CB ' ' A' ' 15' ' ' LEU . 49.0 mt-10 -111.11 149.69 30.49 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.155 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -165.76 12.1 Favored Glycine 0 N--CA 1.422 -2.251 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 30.7 mt-10 -148.8 99.36 2.98 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.286 0.565 . . . . 0.0 109.88 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -130.01 153.36 48.5 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.317 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -65.98 -40.66 91.41 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.713 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 69.9 mtm -128.59 135.45 49.36 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.88 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 109.5 2.48 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 20.3 pttp -155.72 -44.99 0.08 Allowed 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.394 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.444 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 10.9 m-20 -128.67 82.74 2.1 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.464 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 19.6 m120 -145.45 170.43 16.39 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.145 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 71.0 m-20 -90.73 117.78 29.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.99 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -85.88 108.1 17.99 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.54 -42.09 23.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.459 0.647 . . . . 0.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.38 35.52 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.515 ' HD2' ' O ' ' A' ' 74' ' ' ARG . 4.4 ppt_? -146.7 147.39 30.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 122.279 0.231 . . . . 0.0 110.874 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.51 157.21 31.67 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.95 135.99 48.41 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 59.4 tp -97.12 104.5 16.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p -103.32 154.5 19.31 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.37 10.53 25.4 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.99 135.54 85.2 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.94 115.82 4.49 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.673 1.582 . . . . 0.0 110.181 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.3 102.72 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.065 2.51 . . . . 0.0 111.727 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.17 173.23 6.12 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.614 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.71 171.51 2.7 Favored 'Trans proline' 0 C--O 1.262 1.708 0 C-N-CA 122.451 2.101 . . . . 0.0 112.836 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -62.6 117.97 6.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.643 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.465 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 88.54 19.39 52.26 Favored Glycine 0 CA--C 1.494 -1.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.955 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.412 ' H ' ' HD2' ' A' ' 88' ' ' PRO . 62.7 t -91.25 -54.89 0.27 Allowed Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.398 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' A' ' 87' ' ' VAL . 18.1 Cg_endo -58.78 138.28 84.81 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 121.748 1.632 . . . . 0.0 112.044 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -102.71 96.11 6.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.642 0.734 . . . . 0.0 111.339 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.9 mm -92.48 133.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -112.63 119.14 37.11 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -120.91 127.97 76.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 95.7 m -118.71 127.41 53.53 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.66 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 29' ' ' LEU . 9.1 m-85 -105.5 113.26 26.73 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.485 ' HB3' ' HG2' ' A' ' 39' ' ' LYS . 2.6 p30 -132.92 140.97 48.12 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 60.9 mt -127.5 126.42 67.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.468 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.0 p30 -90.84 179.02 5.88 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.07 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.74 63.8 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.06 -16.7 54.51 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.03 29.18 8.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 73.1 mt -94.8 117.68 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.4 tp -94.4 115.09 27.23 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.802 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -103.56 120.75 41.5 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.629 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.94 114.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.1 m -118.01 126.96 53.31 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.81 124.59 52.15 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -126.49 120.77 30.52 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.69 99.29 5.78 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -68.98 -6.19 26.27 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -70.13 -50.23 42.63 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 p -97.82 -43.24 7.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.545 0.688 . . . . 0.0 111.242 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.18 25.66 5.49 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.82 142.15 29.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.21 149.0 48.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.143 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.407 ' OD1' ' HA ' ' A' ' 77' ' ' LEU . 10.6 m120 -144.75 135.0 24.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 125.184 1.394 . . . . 0.0 107.33 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -124.73 166.74 15.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.039 0.447 . . . . 0.0 111.214 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.0 tt -140.36 140.31 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.1 m -116.14 113.77 23.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.821 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.13 101.57 12.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.7 p -92.36 103.36 15.81 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.262 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.3 m120 . . . . . 0 N--CA 1.485 1.279 0 C-N-CA 124.511 1.124 . . . . 0.0 113.531 173.053 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.214 -0.811 0 CA-C-O 120.488 0.185 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 135' ' ' VAL . 62.8 mt -63.34 -52.4 58.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -61.82 -38.51 88.4 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.504 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -63.76 -40.66 97.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.464 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 2.1 tpt -63.1 -39.54 94.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.358 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 131' ' ' ILE . 57.4 t -55.98 -50.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 123.227 0.329 . . . . 0.0 110.221 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -58.02 -55.79 30.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.191 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.68 -43.12 99.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.83 88.9 Favored 'General case' 0 C--O 1.204 -1.308 0 O-C-N 123.41 0.444 . . . . 0.0 111.855 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -77.89 -37.64 47.62 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.817 0.341 . . . . 0.0 111.75 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -111.45 19.78 17.87 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -52.73 -56.96 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.661 1.185 . . . . 0.0 110.699 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.88 89.06 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.101 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.55 -50.9 67.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.306 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.24 -39.26 75.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.69 -33.49 75.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.781 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 70.7 t -64.58 -45.29 95.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.41 ' O ' HG23 ' A' ' 152' ' ' VAL . 78.4 mt-30 -64.25 -37.57 87.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.795 0.331 . . . . 0.0 110.643 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 52.1 ttp180 -61.62 -32.14 72.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.883 0.873 . . . . 0.0 112.01 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -89.3 -21.12 23.32 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.289 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 23.7 mmm180 -68.5 -42.85 78.02 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 148' ' ' GLN . 60.7 t -70.43 137.11 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.2 p -70.71 86.03 0.66 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.107 0.956 . . . . 0.0 111.126 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.97 166.82 10.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.532 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -170.33 164.23 8.83 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -80.29 74.91 7.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.899 0.857 . . . . 0.0 109.546 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -135.82 127.56 29.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.924 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 21' ' ' THR . 28.5 mt -97.37 152.77 18.59 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.426 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -78.02 172.37 13.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.516 ' H ' ' CD ' ' A' ' 159' ' ' GLU . 34.9 m . . . . . 0 N--CA 1.413 -2.293 0 O-C-N 121.704 -0.622 . . . . 0.0 112.25 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 tp . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 122.925 1.345 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.04 62.69 3.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.911 1.338 . . . . 0.0 110.03 177.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 35' ' ' THR . 32.4 m -144.42 -179.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.95 112.57 52.99 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.68 -13.91 10.45 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 121.586 1.524 . . . . 0.0 111.617 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 131' ' ' ILE . 89.1 mt -135.57 166.15 23.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.623 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 27.3 m -103.65 116.24 31.98 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.58 130.94 38.08 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.05 -177.62 18.18 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.072 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -124.78 166.0 17.0 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.081 0.552 . . . . 0.0 111.584 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.49 109.12 17.1 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.512 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 5.9 p -113.69 156.58 23.5 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.487 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 119.68 6.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.451 1.1 . . . . 0.0 113.286 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.72 4.44 28.15 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.286 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.59 38.31 28.47 Favored Glycine 0 CA--C 1.494 -1.247 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 152' ' ' VAL . 63.5 t -99.44 142.21 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.39 -0.905 . . . . 0.0 108.667 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.415 ' HB2' ' N ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -108.92 103.12 12.1 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.217 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -91.95 110.71 22.07 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.75 115.58 28.18 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.717 0.636 . . . . 0.0 110.551 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.493 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.5 mp -91.21 -49.3 6.45 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 16' ' ' SER . 49.5 mm -97.58 91.04 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -85.76 148.43 25.85 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.874 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -57.38 150.56 18.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 76.64 11.39 2.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.044 1.738 . . . . 0.0 112.408 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 m -94.31 113.4 25.29 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 12' ' ' VAL . 3.4 m -65.36 143.34 57.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.6 pt -96.15 162.29 24.29 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 23.7 Cg_exo -68.64 132.21 19.95 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.958 1.021 . . . . 0.0 113.614 -0.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.76 154.89 18.25 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.903 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 95' ' ' ASP . 50.9 tptt -149.04 101.46 3.16 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -124.03 135.92 53.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 92.1 m -135.51 138.57 43.22 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.37 145.94 50.8 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 122.905 0.482 . . . . 0.0 109.76 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.41 122.09 55.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -114.42 155.94 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.82 171.55 8.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 123.732 0.813 . . . . 0.0 108.879 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -98.9 136.07 39.42 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.098 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -99.18 -14.2 19.42 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.949 0.88 . . . . 0.0 109.021 172.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -95.63 113.65 25.32 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.769 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.26 139.99 41.38 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 62.04 55.95 2.4 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 52' ' ' PRO . 70.9 mm-40 -101.39 136.81 19.57 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 175.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.403 ' HD2' ' OE1' ' A' ' 51' ' ' GLN . 54.5 Cg_endo -72.14 -25.92 18.56 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.576 2.184 . . . . 0.0 111.794 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' A' ' 80' ' ' ILE . . . -171.88 168.0 41.06 Favored Glycine 0 N--CA 1.407 -3.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.569 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.25 138.01 44.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.1 tp -90.51 104.21 16.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.294 0.569 . . . . 0.0 109.822 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.98 117.1 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -135.43 119.37 17.41 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.744 -171.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.09 122.49 47.63 Favored 'Isoleucine or valine' 0 C--O 1.248 0.975 0 O-C-N 124.33 1.018 . . . . 0.0 110.811 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 69' ' ' ASN . 40.3 m-85 -120.7 149.55 42.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.905 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.427 ' OE2' HD13 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -119.17 157.74 27.33 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' SD ' ' A' ' 134' ' ' MET . . . 104.51 15.95 19.42 Favored Glycine 0 C--N 1.31 -0.909 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 167.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.595 ' OE1' ' HG3' ' A' ' 67' ' ' LYS . 47.4 mm-40 -144.14 179.52 7.16 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 118.309 1.055 . . . . 0.0 112.116 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -120.03 -72.11 0.7 Allowed 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.269 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -91.97 -50.69 5.57 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.5 mtt -127.93 145.33 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.415 ' N ' ' HB2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -72.26 107.35 4.84 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.672 -174.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.595 ' HG3' ' OE1' ' A' ' 62' ' ' GLU . 10.7 pttp -137.48 -76.45 0.4 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 123.339 0.655 . . . . 0.0 111.587 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.78 75.08 4.94 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 122.77 1.271 . . . . 0.0 110.343 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.515 HD21 ' HB2' ' A' ' 62' ' ' GLU . 22.1 m120 -122.87 152.37 40.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.713 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -111.38 140.15 46.2 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.739 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.1 tp -83.17 119.89 25.1 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.4 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.9 mt -97.2 -65.82 0.94 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.744 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.45 21.61 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.264 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 -153.3 157.49 40.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -161.8 147.72 13.62 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.625 0.578 . . . . 0.0 109.492 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -94.5 113.88 25.79 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -88.78 103.39 15.93 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 p -119.0 166.37 12.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.91 18.32 12.64 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.449 HD13 ' HA2' ' A' ' 53' ' ' GLY . 1.8 mp -77.95 130.05 74.09 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.65 154.17 74.1 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 122.483 2.122 . . . . 0.0 111.895 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.24 92.05 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.18 1.92 . . . . 0.0 110.739 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.14 155.98 80.77 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.184 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.99 176.95 8.44 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.31 2.007 . . . . 0.0 113.356 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 58.0 mtt85 -45.91 131.43 9.57 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.574 1.55 . . . . 0.0 113.124 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.43 -20.25 35.35 Favored Glycine 0 C--N 1.311 -0.807 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.427 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 54.9 t -74.73 -53.99 3.01 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 117.671 0.735 . . . . 0.0 112.805 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 5.5 Cg_exo -76.79 104.36 1.9 Allowed 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.346 1.364 . . . . 0.0 111.025 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -97.2 131.17 44.2 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.346 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.21 119.21 59.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.82 110.4 22.98 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.35 123.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.594 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.2 m -114.26 127.8 56.05 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.493 ' CD1' HD22 ' A' ' 29' ' ' LEU . 9.9 m-85 -111.3 121.01 44.13 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.621 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 1.7 p30 -138.07 137.7 38.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.942 0.401 . . . . 0.0 111.269 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 33.9 mt -121.78 123.84 70.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -88.48 -170.93 3.14 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 123.415 0.447 . . . . 0.0 111.545 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.8 -16.19 63.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.113 0.565 . . . . 0.0 112.346 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -83.18 -23.63 32.8 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.05 21.8 17.11 Favored Glycine 0 N--CA 1.419 -2.485 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 91.8 mt -90.01 117.61 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.428 0.632 . . . . 0.0 109.87 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 96' ' ' ILE . 16.7 tp -96.47 122.37 39.3 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.092 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -117.29 120.39 38.06 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.205 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.6 t -99.32 113.14 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.7 m -115.13 126.32 54.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.66 123.71 50.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 m -109.81 128.66 55.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.774 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 5.6 t0 -85.41 107.21 17.28 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 124.939 1.296 . . . . 0.0 107.647 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -67.5 -18.25 64.98 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.0 m -86.11 -36.66 19.46 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.926 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -110.87 -29.14 8.07 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.55 19.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.151 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 108' ' ' ASP . 9.9 ptpp? -92.4 161.9 14.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.97 137.59 16.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.682 0.277 . . . . 0.0 111.065 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -129.99 142.06 50.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 60.7 pttt -129.34 155.5 45.53 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.146 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.1 pt -121.11 157.58 24.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 m -129.85 113.63 14.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.445 0.641 . . . . 0.0 111.551 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.8 mt -115.39 142.66 27.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 m -117.74 166.5 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 40.9 p30 . . . . . 0 N--CA 1.477 0.91 0 CA-C-N 118.343 0.52 . . . . 0.0 111.383 177.65 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 120.99 0.424 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.547 ' HA ' HD21 ' A' ' 15' ' ' LEU . 59.2 mt -60.98 -50.23 81.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.933 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.62 -26.68 60.9 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.774 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 136' ' ' GLN . 17.3 mmm180 -62.97 -36.84 84.84 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 173.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.419 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 15.6 ttt -59.24 -50.59 73.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 47.8 t -52.23 -53.8 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 124.084 0.865 . . . . 0.0 110.344 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.55 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.5 mt-30 -56.08 -46.84 78.88 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 124.095 0.872 . . . . 0.0 112.004 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.17 -39.49 60.26 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.755 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.03 67.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 9.1 pt-20 -75.16 -41.96 57.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.1 0.476 . . . . 0.0 110.896 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 98.1 mttt -57.62 -48.55 79.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.066 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.08 21.47 6.76 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.333 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 39.3 ttmt -58.7 -44.04 90.19 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.59 0.756 . . . . 0.0 112.021 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.32 -49.43 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -63.62 -46.36 86.07 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 m-20 -66.19 -27.97 68.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.969 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 5.4 tp10 -64.47 -39.73 94.36 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.3 t -70.94 -48.23 57.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.911 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 27.7 mt-30 -57.0 -38.3 72.88 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 123.549 0.74 . . . . 0.0 112.921 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -71.43 -31.92 67.77 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.008 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.45 -8.21 56.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.164 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 23.5 mmt85 -82.14 0.84 39.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.64 0.733 . . . . 0.0 109.505 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 25' ' ' VAL . 33.4 t -114.36 113.87 45.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -78.56 153.54 31.13 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.63 67.96 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.278 1.037 . . . . 0.0 112.848 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.5 33.49 0.51 Allowed 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -59.83 157.21 12.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.736 -170.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.56 154.55 46.55 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.833 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 52.2 mt -91.73 142.88 27.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -82.97 118.52 23.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 118.106 -1.438 . . . . 0.0 107.456 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.412 -2.351 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.293 -174.027 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.4 mt . . . . . 0 CA--C 1.507 -0.677 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 75.55 16.06 2.62 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 124.91 1.284 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.76 174.94 12.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.799 0.809 . . . . 0.0 112.302 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.28 114.74 64.8 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.794 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.78 -41.72 13.64 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.393 2.062 . . . . 0.0 111.862 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -117.02 144.64 44.36 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.967 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 m -67.09 137.46 56.39 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.994 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -106.5 131.96 53.07 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.502 0.502 . . . . 0.0 109.651 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -162.67 -158.1 9.45 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.437 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.19 165.88 24.07 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.432 0.693 . . . . 0.0 109.341 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -89.12 120.45 30.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.6 p -92.22 -105.44 0.11 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' A' ' 159' ' ' GLU . . . -112.42 146.85 37.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.134 -0.354 . . . . 0.0 110.322 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -57.78 4.99 Favored Glycine 0 C--N 1.317 -0.515 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.369 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.42 41.44 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.95 141.56 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.511 ' HB2' HG23 ' A' ' 66' ' ' THR . 1.1 tmt? -86.1 134.32 33.83 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.032 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -126.46 132.27 51.49 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -102.04 142.69 32.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.155 0.503 . . . . 0.0 111.657 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 6.4 mp -99.96 -49.12 4.43 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -101.27 112.39 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -85.64 158.72 20.01 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.459 HH22 ' HG3' ' A' ' 142' ' ' LYS . 15.4 ptt-85 -58.23 151.91 18.31 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.848 0.859 . . . . 0.0 110.654 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.7 m120 76.23 11.01 2.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.567 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -87.73 124.07 33.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.147 0.498 . . . . 0.0 110.155 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -68.87 137.33 53.79 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.407 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.68 159.73 28.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.4 140.82 50.49 Favored 'Cis proline' 0 CA--C 1.501 -1.147 0 CA-C-N 120.348 1.16 . . . . 0.0 112.516 -1.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -98.54 -77.98 0.5 Allowed 'General case' 0 N--CA 1.406 -2.668 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.734 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 88.8 tttt 66.81 100.7 0.05 OUTLIER 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.491 1.117 . . . . 0.0 111.022 -171.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -128.06 130.82 48.85 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -113.01 129.04 56.64 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 123.511 0.507 . . . . 0.0 110.191 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 29' ' ' LEU . 74.4 mt-30 -133.41 141.03 47.67 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 74.8 mt -104.19 120.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.176 0.513 . . . . 0.0 109.972 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -107.33 136.3 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -111.46 162.46 15.06 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.1 p -90.25 135.81 33.44 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.589 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 31.0 m-85 -114.92 -6.36 12.58 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.529 173.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -98.34 119.96 37.92 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.08 163.23 26.83 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.018 0.199 . . . . 0.0 110.996 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.19 23.99 14.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.142 0.977 . . . . 0.0 113.199 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -85.35 120.53 73.33 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.67 -16.08 14.98 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.59 2.193 . . . . 0.0 113.767 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.87 159.05 29.41 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.266 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.69 171.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 tt -129.08 118.6 22.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 111.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -126.53 118.12 24.25 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.12 132.73 30.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.775 -172.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 79.7 m-85 -134.01 152.94 52.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.737 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -112.9 151.73 30.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.587 0.554 . . . . 0.0 110.341 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.02 152.3 26.71 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.107 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -115.44 121.42 42.7 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.38 0.609 . . . . 0.0 109.795 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -140.29 162.72 34.61 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -66.65 -37.46 84.85 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 123.865 0.728 . . . . 0.0 111.098 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.77 139.93 46.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.749 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.511 HG23 ' HB2' ' A' ' 26' ' ' MET . 0.2 OUTLIER -70.57 113.95 8.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.266 -175.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.452 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -171.69 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.985 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.83 -14.55 54.13 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.963 0.887 . . . . 0.0 109.17 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.499 ' OD1' ' HA ' ' A' ' 66' ' ' THR . 8.7 m120 -66.96 152.73 45.2 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.311 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 78.4 m-20 -89.06 121.4 31.36 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.73 115.66 21.07 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.04 -36.67 12.01 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.062 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.29 171.97 39.06 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.214 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -149.03 159.29 44.35 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.427 0.291 . . . . 0.0 111.356 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.07 154.52 25.8 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 172.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.89 133.4 53.2 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 6.1 tt -108.25 104.44 13.84 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.6 p -104.53 159.44 15.74 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.112 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.11 -14.41 5.15 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.5 -0.857 . . . . 0.0 110.971 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.19 119.23 50.75 Favored Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 123.258 0.623 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.99 166.59 11.23 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.595 2.197 . . . . 0.0 110.939 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.09 97.46 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.933 1.755 . . . . 0.0 110.378 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.72 151.41 78.05 Favored Pre-proline 0 N--CA 1.426 -1.659 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.9 133.52 40.2 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.067 2.511 . . . . 0.0 111.466 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -60.98 119.65 8.7 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.397 0.618 . . . . 0.0 111.639 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.22 -27.11 6.2 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.406 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 87.6 t -72.93 -48.82 7.89 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.336 -0.432 . . . . 0.0 111.082 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 21.9 Cg_exo -70.08 106.67 1.76 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.182 1.255 . . . . 0.0 109.301 172.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 74.3 mt-30 -113.83 115.33 27.58 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.419 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.21 111.42 25.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -90.1 104.32 16.9 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -104.75 127.11 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.084 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.7 m -122.26 123.01 40.45 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.875 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 5.1 m-85 -99.45 112.35 24.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.728 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -112.95 143.28 44.51 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 11.9 mt -130.99 127.54 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -98.58 -171.68 2.17 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.86 -23.92 64.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.06 -29.82 49.41 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.07 26.2 6.13 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.7 mt -84.59 119.61 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 65.0 tp -96.06 107.84 20.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -103.52 125.83 50.31 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.7 t -111.29 113.02 43.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.8 m -106.24 116.52 32.08 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.63 117.23 33.39 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.7 m -113.45 122.1 46.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 110.65 16.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 54.2 mtpt -67.41 -18.55 65.15 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.541 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.9 p -80.26 -56.75 3.99 Favored 'General case' 0 C--O 1.25 1.102 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.359 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.6 p -76.58 -32.06 57.9 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.168 0.508 . . . . 0.0 110.361 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.93 -8.65 54.4 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.8 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -94.49 160.41 14.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.546 0.673 . . . . 0.0 111.435 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.1 148.43 51.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.283 0.563 . . . . 0.0 111.719 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.509 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.4 m120 -130.86 132.25 45.06 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 157.97 45.56 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.382 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 tt -127.78 146.51 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.2 m -125.18 112.31 16.3 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.235 0.541 . . . . 0.0 109.693 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.59 93.84 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -82.23 107.46 14.93 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--N 1.3 -1.559 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.666 -174.312 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 134' ' ' MET . 7.7 tp10 . . . . . 0 N--CA 1.444 -0.751 0 CA-C-O 120.984 0.421 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 135' ' ' VAL . 66.0 mt -65.2 -50.58 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.662 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.7 pt-20 -63.91 -32.48 74.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 130' ' ' GLU . 53.9 mtm-85 -60.51 -46.83 88.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 23.9 mmt -60.88 -42.8 98.64 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.657 0.598 . . . . 0.0 109.772 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 131' ' ' ILE . 88.2 t -59.61 -51.77 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.042 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 24.1 mt-30 -56.53 -47.55 79.16 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 122.937 0.495 . . . . 0.0 111.434 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.22 -41.27 97.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.95 75.45 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.5 -47.09 18.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.302 0.572 . . . . 0.0 112.505 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.99 -22.82 55.44 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.328 0.585 . . . . 0.0 111.579 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -120.57 26.46 9.13 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.841 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.459 ' HG3' HH22 ' A' ' 32' ' ' ARG . 40.8 tttm -56.31 -42.13 77.1 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.109 0.964 . . . . 0.0 111.241 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.63 -52.84 18.61 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.923 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.39 -39.55 58.95 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.605 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -71.06 -49.83 40.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.412 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 37.9 mt-10 -66.26 -35.36 80.21 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.656 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 38.9 t -62.73 -50.05 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.392 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.18 -37.94 89.21 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.9 0.381 . . . . 0.0 111.726 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 58.9 ttt180 -58.11 -52.19 66.58 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.828 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 41.8 mm-40 -72.56 -19.88 61.42 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.826 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 18.4 mmm180 -70.24 -29.45 66.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.178 0.513 . . . . 0.0 109.949 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.91 -59.24 2.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.2 m -89.31 61.46 5.7 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.844 0.83 . . . . 0.0 111.113 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.94 -32.59 30.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.076 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.83 131.31 54.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -73.08 103.34 3.81 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.226 0.536 . . . . 0.0 111.432 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.549 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.41 160.27 41.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.37 140.89 51.88 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 22' ' ' ALA . 45.9 mm-40 -97.7 134.07 41.37 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.483 0.658 . . . . 0.0 111.596 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.412 -2.339 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.441 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 12' ' ' VAL . 5.1 tt . . . . . 0 N--CA 1.427 -1.619 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' THR . 3.5 m-20 -75.97 55.35 0.9 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.478 HG13 HD22 ' A' ' 10' ' ' LEU . 30.9 m -136.66 170.6 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.85 129.71 45.45 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.04 -31.56 6.05 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.069 1.846 . . . . 0.0 112.305 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.4 mp -126.65 157.55 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.436 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 20.0 m -86.34 138.16 32.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.07 131.21 48.66 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -157.03 -171.46 23.12 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.357 -176.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 92' ' ' VAL . 84.4 mt -126.36 169.88 12.49 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.09 0.556 . . . . 0.0 110.076 -176.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.38 108.44 19.96 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.441 HG22 HD23 ' A' ' 158' ' ' LEU . 6.1 p -92.52 166.37 12.56 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.36 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.68 114.05 0.97 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.411 1.084 . . . . 0.0 112.388 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.94 -2.08 21.21 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.189 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.12 72.28 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.23 145.69 7.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.438 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -92.64 117.37 29.9 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.9 m -115.05 112.19 22.24 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -93.12 135.08 34.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.199 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.3 mp -94.13 -41.0 9.74 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -109.96 113.21 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -90.34 166.64 13.19 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.822 0.82 . . . . 0.0 112.724 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -61.16 141.01 57.78 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.36 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 77.86 2.03 2.89 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.716 1.207 . . . . 0.0 111.873 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -83.47 130.58 35.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 5.5 p -65.47 130.37 43.06 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 39.5 pt -106.78 148.59 37.17 Favored Pre-proline 0 N--CA 1.435 -1.212 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 52.6 Cg_exo -61.87 132.61 10.61 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.03 1.046 . . . . 0.0 113.639 1.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 m -110.17 143.16 40.69 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.237 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -128.67 108.71 10.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -128.06 141.91 51.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -139.9 135.42 32.84 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -141.61 144.96 34.47 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 91' ' ' GLU . 42.3 mm -92.29 114.82 29.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.43 147.38 25.32 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.811 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 8.9 p -136.6 170.16 16.52 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.882 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -103.7 137.84 41.17 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.817 0.281 . . . . 0.0 110.686 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 43.8 m-85 -112.93 4.54 16.87 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -84.64 175.34 9.29 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.798 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.88 117.49 31.22 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.296 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 37.17 81.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' A' ' 159' ' ' GLU . 25.5 mt-30 -101.41 139.11 20.15 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.852 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -85.61 0.02 8.64 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.245 1.963 . . . . 0.0 111.964 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.6 176.12 44.23 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.01 152.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.8 tp -101.11 120.39 40.14 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.48 105.45 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -119.22 118.51 31.49 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 t -95.45 134.6 32.31 Favored 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.706 0.629 . . . . 0.0 111.495 -172.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.48 151.48 50.91 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.302 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -116.13 141.08 48.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.91 -117.84 1.83 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 9.4 mt-10 177.26 -99.94 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 126.115 1.766 . . . . 0.0 111.525 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.526 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 20.8 mmm180 55.4 -178.12 0.04 OUTLIER 'General case' 0 C--O 1.244 0.795 0 O-C-N 123.681 0.613 . . . . 0.0 110.524 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -91.28 -49.67 6.23 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.691 0.757 . . . . 0.0 110.663 175.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.2 mtp -97.65 126.15 42.8 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.53 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.328 0.4 OUTLIER -80.33 86.19 5.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.671 1.7 . . . . 0.0 111.418 178.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -152.42 -45.83 0.1 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.775 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.35 7.26 1.39 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.209 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' ND2' ' HG3' ' A' ' 26' ' ' MET . 89.3 m-20 -109.67 163.74 13.19 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.633 0.373 . . . . 0.0 111.493 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -91.01 136.19 33.24 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 tt -96.78 122.91 40.25 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.64 -45.18 9.53 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.279 0.362 . . . . 0.0 111.494 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.63 175.83 47.17 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.19 156.74 42.61 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.52 139.27 20.77 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -97.4 120.27 37.46 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.64 104.55 14.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 p -110.91 173.87 6.13 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.05 21.76 44.62 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 52.8 mt -90.17 135.26 30.11 Favored Pre-proline 0 N--CA 1.426 -1.673 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.65 117.02 3.9 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.563 2.175 . . . . 0.0 112.479 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.44 91.28 0.97 Allowed 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.191 1.927 . . . . 0.0 109.942 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.55 168.68 13.71 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.304 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.05 100.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.289 2.659 . . . . 0.0 113.237 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 60.85 -160.99 0.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.698 1.199 . . . . 0.0 111.349 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.7 63.33 1.18 Allowed Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 76.5 t -66.4 -48.39 56.66 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 167.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.601 ' HA ' ' OG ' ' A' ' 110' ' ' SER . 15.7 Cg_endo -59.05 129.9 33.99 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.058 1.839 . . . . 0.0 111.347 168.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.67 110.67 22.58 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.04 114.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 43' ' ' ILE . 35.1 tt0 -90.75 114.33 26.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.434 HG11 HD11 ' A' ' 19' ' ' LEU . 62.1 t -109.32 122.6 64.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.805 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.1 m -109.53 129.63 55.56 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.874 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.447 ' CD1' HD22 ' A' ' 29' ' ' LEU . 5.3 m-85 -109.9 107.74 17.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 17.7 t70 -120.06 113.12 20.01 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.826 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 44.3 mt -111.74 136.07 49.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.0 OUTLIER -100.99 -168.42 1.56 Allowed 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.32 -8.18 55.95 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.424 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -96.04 -29.82 13.91 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.96 23.85 5.41 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 46.5 mm -81.87 115.44 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.455 HD13 HG13 ' A' ' 96' ' ' ILE . 31.5 tp -105.49 113.64 27.33 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.744 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -96.6 102.69 14.52 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.5 t -89.22 113.49 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 20.7 m -119.0 118.81 32.5 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.82 118.91 36.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.6 m -119.6 118.81 31.99 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.665 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 110.5 12.07 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -66.43 -20.33 66.03 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.055 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 88' ' ' PRO . 1.5 m -70.44 -53.34 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.176 0.512 . . . . 0.0 110.823 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.3 p -95.14 -29.46 14.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.096 0.474 . . . . 0.0 112.087 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.97 19.44 24.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.864 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.39 131.36 36.21 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 121.084 0.469 . . . . 0.0 111.894 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.54 134.13 53.08 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.815 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -128.78 128.57 44.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 65.5 pttt -129.15 154.09 47.07 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.854 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 HD11 ' A' ' 119' ' ' ILE . 25.0 pt -126.93 140.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 171.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 m -103.95 112.53 25.54 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.41 HD11 HD12 ' A' ' 117' ' ' ILE . 46.2 mm -111.63 103.49 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.818 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 t -78.29 102.38 7.63 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.1 t30 . . . . . 0 N--CA 1.433 -1.304 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.881 -171.454 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 CA--C 1.516 -0.355 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 135' ' ' VAL . 81.9 mt -58.92 -53.88 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.138 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.6 -33.0 73.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -65.01 -41.54 95.24 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.566 173.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.2 ttt -68.8 -37.06 79.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.378 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 131' ' ' ILE . 81.1 t -60.89 -46.11 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -63.2 -32.33 73.7 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.763 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 22.4 mm-40 -59.23 -52.98 63.33 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.13 -29.53 69.86 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.409 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.77 -48.53 14.68 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.392 0.615 . . . . 0.0 112.439 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -71.24 -36.5 71.81 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.061 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -101.12 10.4 40.96 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 74.9 tttt -47.67 -54.48 11.91 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.974 0.91 . . . . 0.0 112.309 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.35 72.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.48 0.657 . . . . 0.0 111.413 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -72.81 -49.82 28.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.679 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -67.08 -39.41 86.8 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.499 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 48.6 mt-10 -60.37 -45.56 93.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.31 -32.92 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-O 121.405 0.621 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -74.69 -52.99 10.13 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.89 -0.507 . . . . 0.0 111.199 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 63' ' ' ARG . 55.2 ttp180 -69.82 -52.53 24.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.14 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -170.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 151' ' ' ARG . 22.6 mmt180 -91.29 -1.36 57.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.373 0.606 . . . . 0.0 110.762 176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.408 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 57.4 t -116.1 -58.3 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 t -90.94 87.39 6.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 122.659 1.219 . . . . 0.0 111.501 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.53 18.62 9.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 171.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 152' ' ' VAL . 49.9 pttt -137.64 137.77 38.79 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.217 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -94.65 97.27 9.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -143.08 127.81 18.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.441 HD23 HG22 ' A' ' 21' ' ' THR . 13.2 mt -118.72 146.75 44.5 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.4 ' HA ' HE22 ' A' ' 51' ' ' GLN 0.273 1.5 pp20? -132.47 173.77 10.95 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.313 -0.998 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.933 -171.806 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.2 tp . . . . . 0 N--CA 1.457 -0.089 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -75.52 53.55 0.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 35' ' ' THR . 24.7 m -138.22 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.48 112.51 53.34 Favored Pre-proline 0 C--N 1.281 -2.404 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.71 -32.59 18.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 121.861 1.707 . . . . 0.0 110.067 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.79 174.95 5.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.928 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 11.8 m -119.63 136.28 54.45 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.2 131.78 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.723 0.639 . . . . 0.0 109.384 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.19 178.13 32.86 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.4 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.2 mp -112.39 156.73 22.02 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.401 0.68 . . . . 0.0 109.233 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -90.9 109.37 20.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -93.66 173.73 7.54 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.727 -0.608 . . . . 0.0 111.383 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 118.61 5.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.959 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.76 6.79 32.4 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.87 39.49 64.77 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -99.14 131.08 47.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.84 118.12 29.19 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -114.07 111.38 21.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.7 122.53 38.56 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.962 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.412 HD12 ' CD2' ' A' ' 94' ' ' PHE . 48.1 mt -87.19 -37.61 17.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.413 0.625 . . . . 0.0 109.548 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 94' ' ' PHE . 3.4 mp -115.75 102.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.54 161.32 15.53 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.785 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -54.14 134.05 44.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 80.71 11.87 0.91 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.315 1.846 . . . . 0.0 113.552 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -86.22 132.97 33.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.43 ' HA ' HG12 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -62.51 140.54 58.62 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.495 1.118 . . . . 0.0 111.519 -176.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.454 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 35.3 pt -113.87 146.29 35.27 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.787 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 15.0 Cg_endo -65.31 141.63 49.68 Favored 'Cis proline' 0 CA--C 1.509 -0.731 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.055 -3.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -92.51 -70.76 0.68 Allowed 'General case' 0 N--CA 1.399 -3.008 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.464 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 1.1 tmtp? 67.12 101.0 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 124.996 1.318 . . . . 0.0 109.737 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -131.95 140.74 49.1 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 86.9 m -139.58 134.26 31.9 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -130.08 157.52 42.17 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.972 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.2 mm -89.88 114.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.34 148.08 24.03 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 19.6 p -122.8 171.49 9.15 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.857 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 24.4 p -109.08 136.93 47.79 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -90.96 -29.64 17.31 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -89.34 93.09 9.41 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.951 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 85' ' ' ARG . 6.2 p-10 -75.19 161.11 29.65 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.082 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 70.17 6.55 5.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.392 0.677 . . . . 0.0 112.705 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.3 131.43 50.6 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.0 Cg_endo -81.85 8.13 4.64 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.396 2.064 . . . . 0.0 112.322 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.41 175.03 44.32 Favored Glycine 0 N--CA 1.425 -2.035 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.6 171.59 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 123.323 0.649 . . . . 0.0 110.061 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.2 tp -111.16 128.16 55.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.782 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.83 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.5 mt-30 -123.84 127.33 47.89 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.56 114.24 37.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 124.446 1.092 . . . . 0.0 110.325 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -109.52 149.67 29.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.717 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 16' ' ' SER . 45.1 tt0 -111.39 121.44 45.23 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.74 -171.48 22.66 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.449 ' HG3' ' CB ' ' A' ' 16' ' ' SER . 13.3 mt-10 -139.17 17.7 2.61 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -64.59 131.81 48.06 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.992 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -52.63 -50.43 63.16 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.929 2.092 . . . . 0.0 113.931 -168.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtt -95.99 128.78 43.19 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.34 86.06 0.28 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -168.04 168.04 12.17 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 76.64 -46.42 0.52 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.608 1.163 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -55.6 147.97 16.96 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.349 1.06 . . . . 0.0 108.629 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 60' ' ' GLU . 2.9 p-10 -90.03 139.09 30.95 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.282 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.08 132.71 35.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.827 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.8 mt -105.1 -41.3 5.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 0.0 111.365 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.34 39.69 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.132 -1.033 . . . . 0.0 111.427 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -150.13 166.0 31.13 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -170.14 144.43 2.63 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 124.595 1.184 . . . . 0.0 108.414 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -93.88 146.83 23.62 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -118.52 105.08 11.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -94.47 169.74 9.98 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.89 -25.96 6.01 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 62.4 mt -54.14 119.91 22.31 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.109 0.963 . . . . 0.0 111.446 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 93.2 Cg_endo -80.32 151.27 20.25 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.678 2.252 . . . . 0.0 112.861 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 13.4 Cg_exo -70.97 87.71 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.791 2.327 . . . . 0.0 110.821 175.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.91 166.16 30.42 Favored Pre-proline 0 C--N 1.29 -2.005 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -49.32 141.3 24.81 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.992 2.461 . . . . 0.0 111.409 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 46' ' ' THR . 35.1 ptt180 -64.57 126.15 26.96 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 -175.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.06 -25.96 13.21 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 70.1 t -66.08 -50.44 51.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.654 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 21.3 Cg_exo -68.86 121.23 8.1 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.137 1.224 . . . . 0.0 110.327 174.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -107.08 124.7 50.05 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mm -108.51 109.24 27.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.409 ' CB ' ' HD3' ' A' ' 109' ' ' LYS . 43.9 tt0 -94.85 109.17 21.19 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 41' ' ' THR . 33.9 t -111.23 126.16 68.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.731 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 87.5 m -106.29 125.38 50.92 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.413 ' HB3' ' CD1' ' A' ' 30' ' ' ILE . 5.2 m-85 -111.08 107.91 17.44 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 39' ' ' LYS . 22.6 t70 -126.15 124.49 40.62 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.34 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' PRO . 13.6 mt -106.75 125.57 62.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.5 -179.04 6.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.574 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.91 66.44 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.627 0.771 . . . . 0.0 112.777 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -77.06 -24.39 51.96 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.5 31.08 8.1 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.7 mt -97.17 128.27 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.44 111.7 21.41 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -100.64 114.54 28.32 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.43 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.52 ' HB ' HG22 ' A' ' 117' ' ' ILE . 74.9 t -110.48 125.23 67.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 m -122.71 119.6 31.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.58 117.57 33.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.7 m -112.74 120.59 42.02 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.22 106.87 13.53 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.409 ' HD3' ' CB ' ' A' ' 91' ' ' GLU . 30.3 mmmt -67.43 -19.87 65.43 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.732 -176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.96 -61.35 1.98 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 43.0 p -80.1 -32.69 39.1 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.665 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.68 12.31 44.41 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.703 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.461 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 20.7 pttp -111.2 161.42 16.0 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.485 -0.421 . . . . 0.0 110.603 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.27 148.89 40.56 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -128.68 146.7 50.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.414 ' HD2' ' C ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -131.45 164.29 26.06 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.19 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.52 HG22 ' HB ' ' A' ' 104' ' ' VAL . 14.7 tt -136.51 144.39 32.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 m -125.59 113.6 17.62 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.23 103.92 16.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.029 0.442 . . . . 0.0 110.727 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.8 m -75.25 151.7 38.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 122.808 1.289 . . . . 0.0 110.933 176.855 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.7 mt -67.11 -41.0 86.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.622 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.84 -27.58 65.96 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.49 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -63.13 -40.62 98.12 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 mmt -63.38 -38.46 91.24 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.128 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.58 -47.88 89.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.049 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.84 -47.01 85.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.699 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.99 -32.9 74.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.682 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.42 -32.45 74.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 60.5 mm-40 -78.67 -36.66 43.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 110.793 174.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -69.0 -45.98 69.18 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.095 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.55 20.8 15.39 Favored 'General case' 0 C--O 1.198 -1.635 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 71.6 tttt -49.72 -60.14 3.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.083 1.353 . . . . 0.0 113.008 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.98 -32.74 73.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.887 0.375 . . . . 0.0 110.62 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -61.82 -53.41 56.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.048 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 10.6 m-20 -67.62 -37.45 82.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -59.52 -37.78 79.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.537 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 96.9 t -72.73 -47.08 51.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.554 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.83 -39.67 74.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -67.37 -32.71 73.82 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.99 -10.0 46.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.9 mmt180 -64.33 -36.1 83.01 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 120.835 0.35 . . . . 0.0 111.094 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.94 102.13 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.0 m -76.93 108.24 9.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.86 41.82 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-O 121.979 0.895 . . . . 0.0 112.561 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -82.17 148.13 28.64 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.64 94.76 0.45 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.182 0.515 . . . . 0.0 110.229 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -142.07 147.91 37.57 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.673 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.58 151.38 26.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -83.65 167.0 17.66 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.464 177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.425 -1.718 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -171.226 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 CA--C 1.493 -1.222 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.4 m-20 -126.46 28.6 5.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.795 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 34' ' ' SER . 20.0 m -135.09 136.51 51.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.003 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -64.86 116.13 26.82 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 12.1 Cg_exo -70.71 -36.06 8.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 111.718 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.97 167.43 11.14 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 p -97.56 150.14 21.45 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.393 1.077 . . . . 0.0 110.496 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.456 HD13 HD22 ' A' ' 102' ' ' LEU . 60.2 mt -127.17 132.67 50.45 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.363 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.64 178.05 28.32 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.88 167.55 11.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.047 0.451 . . . . 0.0 111.021 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.466 ' HG2' ' NE2' ' A' ' 57' ' ' GLN . 5.7 tp10 -84.58 109.0 17.63 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.635 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 HD23 ' A' ' 158' ' ' LEU . 16.8 p -100.82 162.58 12.81 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.509 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 155' ' ' LYS . . . -49.8 117.29 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 113.586 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.35 39.05 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.4 23.67 53.39 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.2 142.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 127.23 38.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.6 m -128.29 115.24 18.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.05 147.11 23.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.457 ' HG ' ' HG3' ' A' ' 42' ' ' GLN . 10.4 mp -116.51 -50.4 2.63 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.954 176.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 116.66 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.96 156.91 19.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.321 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.17 160.34 29.81 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.466 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 m120 70.39 16.65 7.1 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.726 1.21 . . . . 0.0 110.427 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 34.2 p -89.44 136.82 32.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.561 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 14.2 p -73.1 114.9 11.79 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 121.597 0.713 . . . . 0.0 111.184 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.463 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 22.2 pt -95.75 158.09 34.91 Favored Pre-proline 0 C--N 1.287 -2.115 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.794 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.8 Cg_exo -61.42 132.94 10.5 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 N-CA-C 114.848 1.057 . . . . 0.0 114.848 1.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -104.05 166.98 10.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.502 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.515 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 50.1 tttp -173.86 107.1 0.13 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.57 144.01 50.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -112.38 133.04 54.69 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.776 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.457 ' HG3' ' HG ' ' A' ' 29' ' ' LEU . 15.5 mm100 -128.59 134.78 48.69 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.64 129.72 49.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.501 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 96.7 m-85 -121.96 167.88 12.56 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 17.0 p -135.21 170.79 15.38 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.437 0.16 . . . . 0.0 111.32 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -83.32 176.11 9.37 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.508 ' CE2' ' HB2' ' A' ' 22' ' ' ALA . 1.5 m-85 -81.97 -46.78 13.54 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.0 p -143.79 -171.77 3.6 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.659 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.62 162.27 18.9 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.904 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 82' ' ' PRO . 32.9 m-20 71.28 5.73 5.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.73 112.5 52.29 Favored Pre-proline 0 N--CA 1.402 -2.842 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -100.08 -9.58 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.259 1.973 . . . . 0.0 115.094 -173.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . -148.84 135.13 5.29 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.44 161.15 17.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.45 ' HG ' ' HG3' ' A' ' 57' ' ' GLN . 53.9 tp -111.48 108.5 18.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.196 0.522 . . . . 0.0 109.881 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 mm -83.09 99.86 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.466 ' NE2' ' HG2' ' A' ' 20' ' ' GLU . 43.6 mt-30 -109.06 119.02 38.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 104' ' ' VAL . 45.0 t -99.27 124.49 52.59 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 O-C-N 123.655 0.597 . . . . 0.0 110.154 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 80.1 m-85 -122.13 146.84 46.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.389 0.614 . . . . 0.0 111.559 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' A' ' 72' ' ' LEU . 39.8 tt0 -111.52 120.11 41.03 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.342 177.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.55 -166.83 24.42 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -153.16 134.46 14.22 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.633 0.773 . . . . 0.0 110.118 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 65' ' ' MET . 40.1 mtp180 -158.13 -176.36 5.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.094 1.358 . . . . 0.0 108.715 171.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.16 73.98 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 122.398 1.094 . . . . 0.0 108.802 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 65.7 mtt -105.0 162.42 13.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.513 -1.676 . . . . 0.0 107.619 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.25 16.06 2.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.646 0.736 . . . . 0.0 109.679 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -85.95 154.77 21.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.557 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 81.58 -32.53 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.581 1.552 . . . . 0.0 110.967 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.614 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 12.7 m120 -64.0 168.01 5.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 35.0 t30 -90.11 117.67 29.07 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.403 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.38 122.05 27.49 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 60' ' ' GLU . 3.5 mp -95.47 -49.85 5.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.36 0.6 . . . . 0.0 109.414 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.29 162.46 34.84 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -152.91 158.05 41.55 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -159.58 163.12 35.33 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.97 143.0 33.78 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.849 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.433 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 2.1 tt -108.49 104.11 13.38 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 103.375 -2.824 . . . . 0.0 103.375 171.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.4 p -120.45 107.95 13.51 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.295 0.569 . . . . 0.0 110.622 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.97 19.25 0.02 OUTLIER Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.352 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.79 127.47 83.96 Favored Pre-proline 0 C--O 1.249 1.072 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.91 153.98 71.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.883 2.389 . . . . 0.0 111.736 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 31.3 Cg_endo -65.96 89.56 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.34 2.027 . . . . 0.0 112.284 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.33 144.65 53.3 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.8 148.78 81.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.731 2.287 . . . . 0.0 111.119 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.35 132.28 50.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.243 0.544 . . . . 0.0 111.254 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.68 -34.15 4.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.57 -56.16 1.48 Allowed Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 93.81 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.147 1.231 . . . . 0.0 110.526 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -96.46 124.7 40.54 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.503 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mm -99.72 117.48 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -90.64 106.54 18.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -102.32 115.39 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 m -109.03 126.09 52.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.536 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.411 ' CD2' HD22 ' A' ' 29' ' ' LEU . 2.9 m-85 -115.45 121.23 42.1 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.604 0.762 . . . . 0.0 109.726 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.515 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.1 p30 -140.03 137.08 34.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 71.4 mt -112.3 135.04 52.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.8 p-10 -91.19 -168.52 2.08 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -24.39 64.26 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.407 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 6.0 t30 -81.54 -29.81 33.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.135 0.493 . . . . 0.0 109.902 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.01 24.53 5.44 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 84.6 mt -88.95 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 17' ' ' LEU . 49.4 tp -94.42 118.38 31.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.663 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -103.35 115.92 31.45 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 121.415 0.626 . . . . 0.0 110.476 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 58' ' ' VAL . 96.7 t -100.38 114.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.961 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.2 m -122.94 120.59 33.87 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.19 117.51 33.42 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.9 m -116.53 124.18 49.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.363 0.414 . . . . 0.0 112.019 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.75 114.26 12.98 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 123.607 0.763 . . . . 0.0 111.076 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 109' ' ' LYS . 33.6 mmtp -67.76 -12.22 60.1 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -79.34 -62.66 1.62 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.966 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -94.68 -30.31 14.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.152 0.501 . . . . 0.0 112.303 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.98 4.97 41.61 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.274 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.85 132.02 47.66 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 121.144 0.497 . . . . 0.0 111.073 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.67 43.89 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.102 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -129.51 128.19 42.31 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 165.83 15.15 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.506 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.63 138.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.8 m -100.57 113.68 26.7 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -115.57 96.93 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 26.8 m -66.51 125.41 25.63 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 170.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.632 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.11 -41.49 89.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.815 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.33 -37.67 87.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -63.86 -45.76 88.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.614 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 40.2 ttp -54.77 -48.69 72.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.466 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.422 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 78.7 t -61.81 -40.71 87.93 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.842 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -61.94 -38.39 88.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 36.6 mt-10 -72.55 -34.42 67.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.576 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.57 -43.27 94.44 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.976 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 12.1 mm-40 -59.98 -38.04 81.42 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.952 0.882 . . . . 0.0 110.479 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 87.4 tttt -61.73 -28.56 69.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.839 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -126.91 23.49 6.6 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.342 -0.224 . . . . 0.0 111.153 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.75 -29.48 69.99 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -66.3 -40.13 89.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -70.61 -50.09 40.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 0.5 OUTLIER -59.21 -43.49 92.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.077 178.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 149' ' ' ARG 0.296 22.2 mt-10 -68.73 -32.52 72.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 118.436 -1.306 . . . . 0.0 113.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 76.6 t -61.8 -40.95 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.246 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 79.5 mt-30 -57.17 -46.21 82.98 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 8.6 ptm180 -71.49 -35.36 70.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 146' ' ' GLU . 43.2 mt-10 -72.9 -21.71 60.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.497 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 22.2 mmt180 -64.82 -28.56 69.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.312 0.577 . . . . 0.0 109.672 173.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.41 -35.58 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 51.6 m 71.04 85.4 0.13 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.906 1.282 . . . . 0.0 112.775 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 43.93 80.37 0.04 OUTLIER 'General case' 0 C--O 1.244 0.811 0 C-N-CA 125.562 1.545 . . . . 0.0 114.269 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 17.4 tppt? -81.28 110.74 17.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 4.3 t30 -111.09 33.0 4.88 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.829 1.3 . . . . 0.0 109.629 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -121.67 142.16 50.43 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 21' ' ' THR . 27.6 mt -92.5 150.0 21.03 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.311 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.43 143.79 40.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.777 0.799 . . . . 0.0 111.718 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.845 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--O 1.242 0.677 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.45 67.68 8.59 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.547 1.165 . . . . 0.0 109.883 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 28.0 m -121.24 -177.17 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-N 113.822 -1.536 . . . . 0.0 107.682 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 110.2 42.94 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.55 -27.77 45.78 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.006 1.804 . . . . 0.0 111.702 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.474 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . 99.7 mt -130.93 156.13 45.6 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.791 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 m -77.35 141.51 39.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 123.665 0.603 . . . . 0.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.7 130.96 45.2 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -157.17 -176.53 29.34 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 119.092 -1.528 . . . . 0.0 114.304 -175.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 89.0 mt -118.42 150.81 38.93 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 123.933 0.893 . . . . 0.0 109.572 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 34.8 tt0 -89.56 109.82 20.73 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.421 HG22 ' HG ' ' A' ' 158' ' ' LEU . 16.0 p -89.69 172.62 8.8 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.694 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.22 110.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.177 0.513 . . . . 0.0 111.57 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -9.16 8.42 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.96 19.41 51.16 Favored Glycine 0 CA--C 1.494 -1.23 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.88 135.64 24.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 62' ' ' GLU . 23.9 ttt -89.54 112.2 23.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.253 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 m -110.26 110.93 21.93 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -97.9 135.44 39.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.101 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -90.94 -49.44 6.43 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -96.85 114.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -80.78 141.5 34.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -58.78 154.09 15.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.673 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 80.25 3.59 1.89 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.749 1.619 . . . . 0.0 111.45 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 t -91.34 136.97 32.73 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 1.5 m -73.03 143.88 47.36 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 123.718 0.807 . . . . 0.0 111.504 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.422 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 42.4 pt -99.51 154.11 37.44 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 42.2 Cg_exo -62.09 144.61 46.07 Favored 'Cis proline' 0 C--O 1.247 0.974 0 CA-C-N 120.2 1.107 . . . . 0.0 113.258 0.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.3 m -129.44 145.53 51.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 55.0 tttp -142.33 112.75 7.18 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 29.8 tp60 -128.56 125.58 38.56 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 m -109.11 134.79 51.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -140.56 156.35 46.33 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.2 mm -101.87 128.65 54.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -117.72 166.16 12.76 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.786 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 2.9 p -148.27 170.81 17.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 122.709 0.404 . . . . 0.0 111.591 -172.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.411 ' HB ' ' OG ' ' A' ' 48' ' ' SER . 41.3 p -103.79 166.04 10.67 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.417 ' C ' ' HB3' ' A' ' 85' ' ' ARG . 93.8 m-85 -95.75 -14.97 22.91 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 165.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.411 ' OG ' ' HB ' ' A' ' 46' ' ' THR . 27.3 p -97.0 178.54 5.24 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.309 -170.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -136.06 134.49 38.49 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 126.471 1.909 . . . . 0.0 106.379 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.412 HD21 ' HB3' ' A' ' 82' ' ' PRO . 33.5 m-80 70.14 6.28 5.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 41.6 tt0 -53.52 129.2 53.1 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 123.665 0.786 . . . . 0.0 112.887 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.28 79.3 3.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.231 1.954 . . . . 0.0 112.749 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.667 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . 96.63 131.59 6.94 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.966 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -105.95 130.14 57.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HG ' ' HG3' ' A' ' 57' ' ' GLN . 55.0 tp -83.56 112.37 19.94 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.726 -176.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 45.5 mm -98.82 105.38 17.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.605 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 48.6 mt-30 -104.44 117.55 34.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -96.67 121.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 O-C-N 124.313 1.008 . . . . 0.0 110.551 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 83.4 m-85 -125.48 156.6 38.69 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.634 0.374 . . . . 0.0 110.571 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 70' ' ' ASN . 8.7 pt-20 -122.57 130.77 53.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 15' ' ' LEU . . . 144.09 -155.8 26.41 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.512 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 13.8 mt-10 -161.86 134.05 5.72 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.703 1.601 . . . . 0.0 111.487 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -158.91 170.0 23.07 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 126.554 1.942 . . . . 0.0 106.099 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.81 -47.69 29.32 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.8 mtm -116.98 123.45 46.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.0 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.43 108.71 0.85 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 125.531 1.532 . . . . 0.0 111.037 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -166.81 -36.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.337 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.53 3.89 54.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.745 0.784 . . . . 0.0 109.315 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.489 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 16.6 m120 -100.5 169.51 9.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.726 -173.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.484 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 47.7 t30 -99.4 123.68 43.88 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.442 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.0 tp -83.99 123.22 29.76 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.191 0.596 . . . . 0.0 110.224 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -95.35 -22.55 17.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.97 175.7 33.28 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.987 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 8.5 ptp180 -153.04 151.42 30.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -155.88 157.87 37.08 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -112.03 133.86 53.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.502 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.667 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 54.8 tp -87.1 106.61 17.98 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 172.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 p -67.26 125.42 26.02 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' H ' ' N ' ' A' ' 53' ' ' GLY . . . 46.19 96.73 0.01 OUTLIER Glycine 0 C--N 1.344 0.974 0 C-N-CA 125.72 1.629 . . . . 0.0 116.866 173.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.437 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -79.63 155.27 76.07 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 28.5 Cg_endo -59.97 161.95 17.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.921 2.414 . . . . 0.0 113.436 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HB3' HD21 ' A' ' 50' ' ' ASN . 21.9 Cg_endo -67.25 73.19 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.834 2.356 . . . . 0.0 112.19 175.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.43 142.1 42.86 Favored Pre-proline 0 N--CA 1.417 -2.115 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.87 167.07 28.26 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.39 2.06 . . . . 0.0 112.627 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HB3' ' C ' ' A' ' 47' ' ' TYR . 10.6 ptt180 -47.24 124.38 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.196 0.998 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.16 -29.07 9.56 Favored Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.032 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.03 -52.28 1.22 Allowed Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.993 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.22 94.78 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 CA-C-N 120.683 1.28 . . . . 0.0 110.411 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.11 113.2 17.04 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.285 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.8 mm -92.84 108.06 19.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.425 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 37.2 tt0 -90.49 106.49 18.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' THR . 47.2 t -104.81 131.98 52.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.0 m -130.64 127.45 38.96 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.267 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 4.5 m-85 -103.46 113.02 26.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.4 p30 -125.25 125.08 43.01 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.846 175.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 12.1 mt -107.83 145.35 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.25 -160.64 0.82 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.66 51.11 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.43 -29.02 52.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.918 0.39 . . . . 0.0 111.989 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.35 29.22 4.04 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 75.3 mt -87.6 116.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.9 tp -98.88 118.88 36.64 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.288 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -107.6 104.56 14.13 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.274 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 58.0 t -93.45 114.1 29.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.4 m -113.33 124.24 52.01 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.144 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.88 117.81 34.42 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 26.7 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.072 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.18 100.88 10.1 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 53.3 mtpt -67.65 -13.48 62.13 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.4 m -82.56 -47.34 12.24 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.165 0.507 . . . . 0.0 110.537 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -101.38 -27.06 13.36 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.48 45.09 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.264 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 147.82 27.23 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.73 146.24 34.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.46 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.53 131.11 48.25 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 12.3 ptmm? -122.98 135.31 54.43 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.446 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.8 pt -106.94 137.8 35.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.406 HG22 HG23 ' A' ' 120' ' ' THR . 84.9 m -108.53 112.08 24.27 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.055 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.13 97.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.406 HG23 HG22 ' A' ' 118' ' ' THR . 15.7 p -92.59 101.26 13.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.27 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 N--CA 1.478 0.932 0 O-C-N 124.381 1.051 . . . . 0.0 112.717 177.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 135' ' ' VAL . 78.1 mt -64.63 -52.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.774 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -64.0 -30.45 71.52 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.795 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 44.1 mtp85 -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.588 174.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 20.8 ptt? -70.73 -21.3 62.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.611 -0.836 . . . . 0.0 113.018 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 131' ' ' ILE . 93.5 t -63.3 -50.01 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.63 -34.94 77.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.792 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 40.7 mm-40 -62.95 -47.02 85.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.45 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.29 -29.91 70.72 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 142' ' ' LYS . 30.6 mm-40 -75.47 -45.91 35.63 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -72.59 -46.61 53.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.022 0.439 . . . . 0.0 111.077 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.65 22.84 7.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 60.0 mttp -42.84 -59.19 2.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.663 0.602 . . . . 0.0 110.524 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.33 -37.51 67.53 Favored 'General case' 0 C--O 1.231 0.086 0 O-C-N 124.312 1.007 . . . . 0.0 112.733 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.94 -53.23 11.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.778 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 13.2 m-20 -70.07 -31.6 69.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 12.4 pt-20 -67.49 -42.9 82.16 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.42 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 79.5 t -67.7 -42.38 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -61.62 -45.48 93.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 5.1 ptp180 -65.65 -32.13 73.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.817 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -78.95 -24.32 43.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 22.4 mmm180 -61.84 -40.58 95.79 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.218 176.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.63 146.07 7.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m -57.11 140.54 49.05 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.24 103.91 7.44 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -86.44 134.75 33.67 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.036 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.04 22.02 13.29 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 166.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.603 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -120.3 140.17 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.706 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 21' ' ' THR . 1.6 mp -117.53 149.97 39.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.93 163.4 12.98 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.407 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 16.0 m . . . . . 0 C--N 1.282 -2.349 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.2 tp . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 59.2 68.75 0.78 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.477 1.132 . . . . 0.0 110.032 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 35' ' ' THR . 34.1 m -137.55 -178.55 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.371 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.9 123.27 82.33 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.426 ' C ' HD12 ' A' ' 15' ' ' LEU . 19.5 Cg_endo -60.51 -51.48 5.12 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.3 2.0 . . . . 0.0 110.907 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.546 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 7.3 mp -128.1 167.37 16.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.626 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 18.5 m -72.5 142.45 48.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 O-C-N 123.614 0.571 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -114.0 132.12 56.1 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.782 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 28' ' ' ALA . . . -147.79 -177.42 22.18 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.044 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.496 HD11 HG11 ' A' ' 92' ' ' VAL . 83.6 mt -122.83 167.94 12.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.896 0.379 . . . . 0.0 111.63 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.21 109.34 17.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.391 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 p -109.47 158.34 18.07 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.437 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.11 115.93 1.36 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.903 1.281 . . . . 0.0 113.252 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.21 10.74 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.821 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.37 44.17 5.36 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.34 137.17 55.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 33.1 ttp -96.71 112.05 23.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -94.42 112.3 24.07 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . . . -90.28 133.67 34.8 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.666 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.629 ' HG ' ' OE1' ' A' ' 42' ' ' GLN . 5.9 mp -100.93 -39.67 7.64 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.69 129.85 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -101.31 162.6 12.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.42 ' HD3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -70.91 142.2 51.14 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.824 178.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' OD1' ' HD3' ' A' ' 32' ' ' ARG . 16.9 m120 80.64 -6.09 1.69 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.24 1.416 . . . . 0.0 113.252 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.7 m -65.19 115.29 5.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 12' ' ' VAL . 2.7 m -71.03 129.9 40.18 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.193 -172.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.425 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 28.4 pt -92.97 155.76 41.08 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.029 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.1 Cg_exo -63.48 141.83 42.86 Favored 'Cis proline' 0 N--CA 1.487 1.098 0 C-N-CA 124.604 -0.998 . . . . 0.0 114.24 0.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.6 p -120.89 152.84 37.97 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.762 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 47.6 tttp -153.41 99.81 2.38 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -108.42 135.31 49.93 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -124.02 127.97 48.67 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.629 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 44.8 mt-30 -132.11 150.28 52.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.91 129.42 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.533 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 89.1 m-85 -117.42 155.14 30.15 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 22.9 p -127.37 170.73 12.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 41.5 p -100.51 139.86 35.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 31.3 m-85 -117.76 5.13 12.25 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -120.74 127.16 51.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.412 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 84' ' ' PRO . 46.0 t0 -82.05 169.95 16.11 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.34 14.66 9.21 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.822 1.249 . . . . 0.0 113.232 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -90.25 114.62 61.64 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -89.8 -1.82 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.146 1.897 . . . . 0.0 111.839 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.91 145.01 8.89 Favored Glycine 0 N--CA 1.413 -2.874 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.39 147.32 13.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 117.049 0.425 . . . . 0.0 109.93 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.08 118.15 35.19 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.067 0.46 . . . . 0.0 110.705 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.72 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 90.7 mt-30 -102.2 130.01 48.74 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 t -99.48 129.0 50.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 123.714 0.634 . . . . 0.0 109.354 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.78 156.55 44.79 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.166 0.508 . . . . 0.0 111.524 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.546 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 35.8 tt0 -118.63 136.77 53.71 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.471 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.04 116.55 3.91 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.626 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 40.4 mt-10 -79.47 107.18 12.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -133.57 144.53 49.38 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.9 76.0 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 124.131 0.894 . . . . 0.0 111.552 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.8 mtt -94.76 111.49 23.26 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.271 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.411 ' HA ' ' OD1' ' A' ' 69' ' ' ASN . 1.9 m -74.71 109.83 8.51 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.066 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -175.25 -41.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.566 1.147 . . . . 0.0 109.016 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -109.21 75.44 0.95 Allowed 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 66' ' ' THR . 9.2 m120 -147.92 164.33 34.07 Favored 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 73.2 m-20 -90.61 129.3 36.75 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.0 tp -83.34 125.09 31.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.05 0.452 . . . . 0.0 111.221 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' A' ' 119' ' ' ILE . 7.4 mp -101.99 -9.38 20.69 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.52 178.33 15.37 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.882 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.507 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 6.8 ppt_? -153.33 156.91 39.24 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -150.87 152.32 33.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.39 125.01 51.94 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.06 104.22 16.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 p -105.15 163.49 12.54 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.695 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.62 7.09 45.91 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.6 mm -64.56 127.46 92.38 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.59 143.49 68.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.244 1.963 . . . . 0.0 110.613 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.63 90.58 0.6 Allowed 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 121.204 1.27 . . . . 0.0 109.646 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.16 129.53 20.94 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.995 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.429 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 17.9 Cg_endo -58.73 -61.04 0.28 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 123.296 2.664 . . . . 0.0 114.643 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 46' ' ' THR . 88.1 mtt180 -139.37 136.1 34.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.01 1.25 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 117.731 1.852 . . . . 0.0 117.731 167.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.9 t -52.3 -57.53 15.02 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 6.2 Cg_exo -81.73 103.52 1.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.641 1.56 . . . . 0.0 110.821 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -95.11 117.75 30.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.25 121.56 47.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.93 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 38.4 tt0 -91.35 115.79 28.32 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 19' ' ' LEU . 84.7 t -110.49 124.81 67.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 m -121.67 128.85 52.31 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.222 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -110.57 109.55 19.9 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.559 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.1 p30 -126.57 128.25 46.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.26 0.552 . . . . 0.0 112.12 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 45.9 mt -123.62 133.92 67.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.0 p-10 -88.72 -172.07 3.57 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.11 -5.95 55.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.41 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -87.07 -29.88 21.56 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.46 26.7 4.73 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 72.9 mt -89.07 108.0 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.408 HD23 HD12 ' A' ' 119' ' ' ILE . 32.7 tp -94.63 128.76 41.5 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.388 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER -119.74 108.02 13.91 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 174.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 61.2 t -95.59 113.81 30.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.9 m -112.86 122.03 46.43 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.1 m -122.64 122.22 38.29 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 120.842 0.353 . . . . 0.0 111.429 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -82.52 108.16 15.71 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.063 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.8 -6.88 23.48 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -79.84 -61.97 1.83 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.1 p -82.61 -30.22 29.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.68 13.1 56.01 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.982 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -91.11 144.0 26.1 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 117.626 0.713 . . . . 0.0 109.684 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -123.8 141.71 51.78 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -129.52 134.08 47.58 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 17.5 ptpt -124.25 166.55 15.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.47 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.431 HG22 ' HB ' ' A' ' 104' ' ' VAL . 15.0 tt -131.2 145.53 35.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.8 m -113.51 116.21 29.21 Favored 'General case' 0 C--N 1.276 -2.603 0 O-C-N 124.397 1.061 . . . . 0.0 110.124 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 72' ' ' LEU . 75.5 mt -120.6 125.24 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.0 m -119.92 140.7 50.48 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 124.401 1.08 . . . . 0.0 111.429 174.51 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.09 -44.42 78.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.664 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.01 -39.32 81.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.541 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -60.41 -43.01 97.15 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.594 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 tpp -58.92 -39.3 81.15 Favored 'General case' 0 C--O 1.212 -0.915 0 O-C-N 123.742 0.652 . . . . 0.0 109.828 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.77 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.084 0.468 . . . . 0.0 109.98 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -61.05 -47.67 85.32 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.708 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.46 -32.55 73.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.513 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -68.17 -55.53 12.03 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 122.158 -0.339 . . . . 0.0 110.609 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.55 -48.54 77.03 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.74 -17.81 65.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -118.3 16.18 13.95 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.554 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -55.1 -43.26 73.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.43 80.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 110.757 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.79 -44.95 65.58 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.045 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -61.32 -42.24 98.33 Favored 'General case' 0 CA--C 1.498 -1.026 0 O-C-N 123.403 0.439 . . . . 0.0 111.537 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 41.3 mt-10 -57.39 -45.51 84.44 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.982 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.65 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 46.0 t -68.76 -42.49 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.398 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -55.88 -48.8 74.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -63.91 -36.93 85.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.0 pt-20 -79.06 -15.51 58.1 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.539 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.65 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 91.6 mtt-85 -71.77 -38.76 70.29 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.9 -57.53 4.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.938 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.45 ' OG ' ' HG2' ' A' ' 155' ' ' LYS . 31.3 t -158.27 -80.78 0.06 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.501 -174.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 65.39 19.21 11.57 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 124.952 1.301 . . . . 0.0 111.771 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HG2' ' OG ' ' A' ' 153' ' ' SER . 17.0 ptpt -82.18 144.86 30.42 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 10.4 t30 -84.12 69.34 10.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.283 1.039 . . . . 0.0 111.455 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.774 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.3 151.63 35.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -115.06 175.04 5.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.42 -1.941 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.359 -176.188 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 122.726 1.251 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 36' ' ' ILE . 1.3 m-20 -85.47 74.78 10.28 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.354 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -115.84 175.86 2.62 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.907 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.895 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.08 129.45 67.18 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.45 -23.95 2.61 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 122.131 1.887 . . . . 0.0 112.372 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.43 172.4 10.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 m -94.98 129.25 42.12 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.82 131.7 43.3 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.58 -164.52 14.96 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.332 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.0 mt -131.07 161.85 31.14 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.81 120.81 32.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 117.821 -1.551 . . . . 0.0 109.223 171.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 23.6 p -97.94 -176.33 3.41 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.809 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . . . -57.71 128.83 39.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.068 0.461 . . . . 0.0 111.922 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.25 59.96 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.43 53.73 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.255 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -92.91 140.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 113.09 25.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.0 m -109.39 110.97 22.27 Favored 'General case' 0 C--N 1.279 -2.468 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.624 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.29 136.26 33.16 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.201 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.7 mp -99.45 -49.98 4.25 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.81 103.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -80.71 162.8 23.97 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.499 ' HD3' ' OE2' ' A' ' 139' ' ' GLU . 9.7 ptm180 -64.43 159.36 21.55 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.316 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m120 77.34 4.8 3.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.499 1.12 . . . . 0.0 112.243 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 m -83.32 115.75 22.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.38 132.84 45.42 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.113 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 11' ' ' ASP . 26.5 pt -91.38 161.39 34.77 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.494 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.9 Cg_exo -69.01 147.39 82.98 Favored 'Cis proline' 0 C--O 1.245 0.858 0 CA-C-N 119.834 0.976 . . . . 0.0 113.731 1.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 11.8 p -118.19 136.42 53.65 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.043 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -135.02 101.02 4.74 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 93' ' ' THR . 62.1 tt0 -121.92 131.81 54.22 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -128.67 125.1 37.35 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -135.48 152.3 51.21 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.18 122.47 50.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.088 0.47 . . . . 0.0 110.331 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.5 162.14 14.4 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.848 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 6.1 p -137.76 170.22 16.44 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.041 0.536 . . . . 0.0 109.66 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -95.93 137.01 35.6 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.303 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -108.63 32.11 5.11 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 167.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.0 p -132.19 159.43 39.01 Favored 'General case' 0 N--CA 1.391 -3.405 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.974 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -136.61 162.17 33.88 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.88 22.08 10.25 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.101 0.876 . . . . 0.0 110.934 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.521 HE22 ' HA ' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -80.48 125.71 80.26 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.959 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.16 -18.51 27.04 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 121.706 1.604 . . . . 0.0 109.657 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 78' ' ' SER . . . -178.31 175.01 47.2 Favored Glycine 0 N--CA 1.406 -3.365 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.75 129.85 55.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.119 0.485 . . . . 0.0 110.139 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.6 tp -87.17 100.29 12.56 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.595 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mm -84.15 96.98 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -109.3 110.3 21.43 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.1 t -92.98 135.97 26.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.79 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -133.77 163.24 29.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.42 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.85 165.45 25.59 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.46 -103.78 0.9 Allowed Glycine 0 C--N 1.287 -2.146 0 C-N-CA 119.025 -1.56 . . . . 0.0 114.235 170.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.652 ' OE2' ' HG3' ' A' ' 67' ' ' LYS . 39.9 mt-10 -78.46 172.16 14.04 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.594 0.358 . . . . 0.0 110.939 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -112.59 -27.47 8.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.383 -0.372 . . . . 0.0 112.001 -171.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -90.42 -52.43 4.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -172.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.1 mtm -142.1 149.64 40.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -173.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.28 82.55 2.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 O-C-N 124.082 0.863 . . . . 0.0 109.851 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.652 ' HG3' ' OE2' ' A' ' 62' ' ' GLU . 8.3 ptmm? -118.84 -76.53 0.57 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.99 12.4 30.57 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.597 0.713 . . . . 0.0 111.208 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.88 142.22 57.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.694 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -96.09 141.96 28.85 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.566 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.5 tp -76.99 123.37 26.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.458 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.6 mt -89.24 -40.16 13.03 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.521 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 171.27 36.74 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -140.2 135.05 32.0 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -143.22 135.01 26.66 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.76 118.97 37.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.953 0.406 . . . . 0.0 111.421 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.0 tp -90.73 104.29 16.89 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.415 ' HA ' ' HA3' ' A' ' 53' ' ' GLY . 15.9 p -113.55 165.95 12.0 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -168.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 4.33 39.8 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.16 113.15 46.4 Favored Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.37 138.33 50.38 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.475 2.117 . . . . 0.0 112.141 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.521 ' HA ' HE22 ' A' ' 51' ' ' GLN . 92.2 Cg_exo -47.42 125.88 11.29 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.344 3.362 . . . . 0.0 113.159 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.39 152.85 80.79 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.84 39.64 0.29 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 124.055 3.17 . . . . 0.0 115.07 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 68.34 143.57 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.665 1.586 . . . . 0.0 112.429 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.94 75.88 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.53 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.458 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.8 t -107.13 -55.11 0.07 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.924 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 15.5 Cg_exo -70.38 130.51 18.7 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 121.307 1.338 . . . . 0.0 110.71 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -110.86 123.07 49.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -110.03 125.2 67.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.6 tt0 -90.77 111.59 23.02 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -108.27 129.87 61.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 30.5 m -123.46 118.58 27.74 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.455 ' CD2' HD22 ' A' ' 29' ' ' LEU . 10.5 m-85 -100.54 116.37 32.3 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 173.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 38' ' ' THR . 12.2 t70 -128.91 116.36 19.28 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.764 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 52.5 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.4 p-10 -87.57 -172.6 3.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -13.96 61.24 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.408 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 4.6 t30 -84.79 -31.46 23.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 117.6 14.11 7.03 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.481 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 80.7 mt -80.54 119.95 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.8 tp -98.44 118.03 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.411 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.46 HD21 ' HD3' ' A' ' 116' ' ' LYS . 16.0 t-20 -112.91 111.24 21.85 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -101.82 116.64 45.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.7 m -111.67 134.34 53.31 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.46 124.12 42.17 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 m -124.22 118.42 26.8 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.521 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.5 123.34 29.63 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.728 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.486 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 75.0 mmtt -68.01 -28.82 67.75 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.875 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 m -68.68 -61.91 1.61 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.142 0.496 . . . . 0.0 110.865 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.5 p -84.01 -39.88 19.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.36 0.6 . . . . 0.0 110.799 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.25 39.29 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.16 149.04 43.27 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.496 0.665 . . . . 0.0 112.761 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.22 134.72 42.35 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.349 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 146.22 47.18 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 103' ' ' ASN . 17.7 ptpt -142.11 162.3 35.82 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.034 0.445 . . . . 0.0 111.731 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 tt -129.44 145.76 35.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.3 m -122.8 117.25 25.23 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.029 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.25 118.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 p -92.26 172.73 8.22 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.854 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 134' ' ' MET . 1.2 mp0 . . . . . 0 C--O 1.223 -0.332 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.1 mt -61.22 -50.84 78.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.783 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.2 pt-20 -72.75 -26.0 61.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -61.88 -44.05 97.59 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 95.0 mmm -60.76 -37.39 81.67 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.103 0.478 . . . . 0.0 109.764 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 88.1 t -58.2 -54.68 29.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.029 176.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 87.4 mt-30 -59.29 -53.78 54.31 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.914 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.78 -53.58 55.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.928 -176.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.61 67.77 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.499 ' OE2' ' HD3' ' A' ' 32' ' ' ARG . 26.1 mm-40 -74.27 -32.93 63.12 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.052 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -71.21 -34.29 70.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.08 11.44 23.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.888 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -53.66 -48.62 69.26 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 118.142 0.428 . . . . 0.0 111.522 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.95 74.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.813 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -74.2 -44.7 52.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 0.6 OUTLIER -60.81 -49.39 77.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 177.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.67 -32.53 74.04 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.383 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.91 -48.41 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.575 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -55.93 -41.89 75.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.87 0.468 . . . . 0.0 111.066 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.5 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 57.0 ttp180 -61.4 -51.69 67.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.486 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.462 ' HG3' ' HE ' ' A' ' 149' ' ' ARG . 47.6 mt-10 -78.36 -1.37 33.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.9 -14.0 46.16 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 29.9 t -112.18 157.77 12.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -80.56 93.09 6.02 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.323 0.583 . . . . 0.0 110.583 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -90.66 93.11 9.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.533 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -112.71 158.63 19.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.12 68.51 9.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.234 1.016 . . . . 0.0 110.761 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.74 136.18 25.38 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.693 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.93 152.38 25.02 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.903 0.382 . . . . 0.0 110.423 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 0.4 OUTLIER -97.24 119.59 36.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.419 -1.979 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.489 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.429 -1.522 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 36' ' ' ILE . 9.4 m-20 -96.23 25.91 4.61 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -126.88 170.64 16.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-O 121.211 0.529 . . . . 0.0 110.906 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.46 120.87 80.61 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.04 -21.63 23.84 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.094 1.862 . . . . 0.0 111.743 -177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.8 mt -134.49 174.45 10.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 23.5 m -101.57 123.01 44.89 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.09 0.244 . . . . 0.0 110.609 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 2.4 mm? -92.28 131.63 37.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.1 -168.41 21.11 Favored Glycine 0 N--CA 1.425 -2.052 0 C-N-CA 119.375 -1.393 . . . . 0.0 114.63 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.437 HD11 HG11 ' A' ' 92' ' ' VAL . 83.6 mt -133.63 162.79 30.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.735 -176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -94.81 109.51 21.47 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.9 p -84.16 175.37 9.52 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.083 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.96 116.51 4.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.62 -12.23 11.04 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 51.66 4.53 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.25 127.16 73.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.0 tpt -73.82 102.5 4.06 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -107.78 112.13 24.64 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.29 127.48 38.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.418 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.0 mp -95.57 -50.35 5.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.454 HG21 HD12 ' A' ' 96' ' ' ILE . 34.1 mm -94.18 92.31 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.2 154.92 30.67 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -53.81 140.28 30.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.23 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 79.84 1.7 2.12 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.585 1.554 . . . . 0.0 113.283 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.13 128.15 33.36 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -70.5 134.79 48.05 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.617 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 11' ' ' ASP . 27.6 pt -104.09 161.42 22.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.1 Cg_endo -64.44 140.88 42.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 CA-C-N 120.914 1.362 . . . . 0.0 114.115 0.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.3 p -109.59 164.12 12.82 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -159.08 101.64 1.6 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -132.46 128.05 36.61 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.4 m -119.85 124.01 45.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -124.22 146.07 48.95 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 46.0 mm -97.78 115.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -107.72 133.55 51.97 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 p -107.57 170.25 8.09 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.445 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -96.65 136.96 36.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.742 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -98.06 10.88 39.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.684 1.231 . . . . 0.0 108.623 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.3 p -116.13 145.32 43.15 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.236 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.55 159.62 21.02 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.386 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 6.6 m-20 57.82 27.49 14.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.329 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -77.27 130.16 75.67 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.523 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.34 -15.04 14.4 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.234 1.956 . . . . 0.0 111.784 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 164.19 37.75 Favored Glycine 0 N--CA 1.422 -2.278 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.8 158.51 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 123.006 0.523 . . . . 0.0 109.781 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 75' ' ' PHE . 42.7 tp -117.6 107.88 14.79 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 75' ' ' PHE . 3.8 mp -89.1 105.49 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -92.85 119.69 32.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.25 121.6 54.73 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-O 121.225 0.536 . . . . 0.0 111.035 -173.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.04 164.29 21.86 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.615 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 38.6 tt0 -134.89 132.71 38.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.383 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.03 172.23 13.44 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 27.8 mt-10 -135.12 120.87 19.55 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.074 0.937 . . . . 0.0 113.088 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 2.6 mmp_? -154.14 166.51 32.87 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.55 54.87 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.151 0.976 . . . . 0.0 110.042 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.9 mtt -133.52 121.19 21.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.35 96.62 3.43 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.373 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -168.25 -45.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.087 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 17.7 m-20 -95.7 71.3 3.05 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -145.29 160.43 41.52 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 113.186 -1.824 . . . . 0.0 107.768 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 28.0 t30 -89.87 131.08 35.98 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.33 107.84 19.47 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.25 0.547 . . . . 0.0 109.684 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.25 -23.99 27.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.311 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.11 -162.63 28.81 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.412 ' HG3' ' OE2' ' A' ' 76' ' ' GLU . 23.3 ptt180 -145.87 162.83 36.84 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.671 ' HB3' ' HB ' ' A' ' 56' ' ' ILE . 7.6 t80 -128.92 130.49 46.84 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.412 ' OE2' ' HG3' ' A' ' 74' ' ' ARG . 1.7 mp0 -104.0 104.66 14.65 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -112.14 110.19 20.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 p -130.16 166.75 19.6 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.65 19.05 16.62 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.75 129.63 61.36 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 48.4 Cg_endo -71.67 137.71 30.62 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.237 1.958 . . . . 0.0 110.97 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' ASN . 50.5 Cg_exo -56.89 107.24 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 122.59 2.193 . . . . 0.0 112.275 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.01 158.12 76.65 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.8 161.36 18.57 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.02 2.48 . . . . 0.0 112.151 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -65.62 142.27 58.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.04 -7.91 79.87 Favored Glycine 0 C--N 1.308 -1.004 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.945 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.39 -54.07 0.29 Allowed Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.8 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.59 112.62 1.83 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 121.41 1.407 . . . . 0.0 111.225 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -99.93 113.46 26.03 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.257 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -100.41 120.7 50.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 40.1 tt0 -90.6 108.98 20.15 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 19' ' ' LEU . 46.2 t -109.05 117.33 54.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.208 0.528 . . . . 0.0 109.696 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 84.8 m -108.59 125.43 51.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.562 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.418 ' CD1' HD22 ' A' ' 29' ' ' LEU . 8.8 m-85 -98.91 112.3 24.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.95 112.56 14.2 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.576 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 26.1 mt -119.12 119.79 61.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 2.5 p30 -84.11 176.75 8.59 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.781 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.12 -17.25 51.79 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.565 ' HB3' HG12 ' A' ' 101' ' ' ILE . 66.2 t30 -82.46 -15.23 53.3 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.517 0.675 . . . . 0.0 109.573 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.57 7.13 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 43.1 mm -97.28 114.21 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.92 118.49 36.45 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 25.9 m-80 -106.47 108.02 19.33 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.625 173.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.2 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.2 m -107.86 117.54 34.4 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.99 123.62 50.15 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -125.94 121.01 31.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.761 0.315 . . . . 0.0 111.634 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.57 106.98 8.54 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.907 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.9 -19.18 64.98 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -63.06 -49.83 72.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.853 0.359 . . . . 0.0 110.771 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.8 p -109.62 -23.13 11.62 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.77 53.62 2.06 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.2 126.27 50.24 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.965 0.412 . . . . 0.0 111.559 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.31 54.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.462 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -135.88 149.9 49.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 146.77 44.34 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 117.742 0.246 . . . . 0.0 111.273 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 23.0 pt -115.49 128.07 72.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 45.5 m -98.04 113.51 25.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.594 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 64.6 mt -121.84 110.47 27.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.603 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.405 ' HA ' HD13 ' A' ' 101' ' ' ILE . 11.1 m -77.87 114.74 17.03 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 168.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.313 61.6 t30 . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 117.759 -1.577 . . . . 0.0 113.942 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 CA--C 1.515 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 135' ' ' VAL . 2.0 mp -72.45 -53.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.209 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 136' ' ' GLN 0.267 0.0 OUTLIER -66.35 -30.45 70.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.446 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -67.09 -42.44 84.63 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -73.03 -26.38 61.29 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.829 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 131' ' ' ILE . 97.7 t -67.11 -39.18 82.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.582 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 27.9 mm-40 -60.41 -47.05 87.78 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.686 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -66.38 -36.45 82.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.796 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.88 73.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.453 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -79.68 -49.2 12.46 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -73.38 -42.48 62.11 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.85 31.55 5.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.36 -55.66 23.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.553 1.541 . . . . 0.0 110.799 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -67.25 -51.81 48.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.691 -175.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -55.04 -51.83 65.08 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.711 0.804 . . . . 0.0 111.05 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.88 -35.52 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -66.02 -37.23 85.38 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.515 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 64.1 t -70.18 -48.1 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.644 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -56.81 -40.2 75.54 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -56.77 -43.9 81.29 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.936 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.22 -6.68 57.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.626 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 36.3 mmt180 -76.48 -33.09 58.69 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 30.9 t -81.73 -31.22 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 172.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t 77.92 139.92 0.07 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.493 1.517 . . . . 0.0 110.479 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 -43.24 10.9 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.015 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 61.28 -164.47 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.186 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 15.1 m120 -122.93 58.88 1.08 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.605 0.716 . . . . 0.0 109.238 174.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.73 149.18 33.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.92 151.88 37.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.14 131.1 42.94 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.834 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 C--N 1.302 -1.479 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.586 -178.945 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.44 -0.963 0 CA-C-O 121.053 0.454 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 36' ' ' ILE . 33.7 m-20 -108.45 78.34 1.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 35' ' ' THR . 29.2 m -127.38 176.56 7.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.069 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.66 121.28 84.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.04 -46.35 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.42 2.08 . . . . 0.0 111.633 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.424 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 89.0 mt -128.86 173.97 9.9 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.5 m -82.84 128.56 34.53 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.46 131.85 37.27 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.65 -177.63 25.6 Favored Glycine 0 N--CA 1.413 -2.851 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.673 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 96.9 mt -126.85 150.96 48.96 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.78 109.01 17.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 25.6 p -93.13 -88.89 0.21 Allowed 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.001 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.37 172.04 12.9 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.23 88.36 0.01 OUTLIER Glycine 0 N--CA 1.469 0.882 0 O-C-N 124.71 1.256 . . . . 0.0 115.906 -173.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.66 29.55 71.23 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.773 -0.714 . . . . 0.0 114.211 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.95 136.04 52.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ttt -100.12 130.04 46.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.0 110.847 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.8 m -114.88 115.02 26.27 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.7 126.44 35.32 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.4 mp -95.58 -50.13 5.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -110.71 107.53 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -74.61 149.52 40.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.869 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.8 ptt85 -52.7 147.24 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.291 1.037 . . . . 0.0 112.322 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 76.88 2.9 3.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.255 1.422 . . . . 0.0 113.593 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -77.88 131.84 37.69 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.439 ' HA ' HG12 ' A' ' 12' ' ' VAL . 2.5 m -72.96 140.17 47.23 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 123.162 0.585 . . . . 0.0 111.506 -174.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 11' ' ' ASP . 18.7 pt -109.63 161.15 25.21 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 42.6 Cg_exo -62.19 136.84 20.84 Favored 'Cis proline' 0 C--O 1.241 0.672 0 CA-C-N 120.462 1.201 . . . . 0.0 114.57 0.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -107.44 166.21 10.82 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -167.09 102.11 0.54 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -130.31 130.37 44.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 79.5 m -115.49 126.55 54.44 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.119 0.262 . . . . 0.0 110.534 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -127.64 140.32 52.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -104.34 114.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 87.0 m-85 -106.05 138.78 41.63 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.426 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 4.8 p -106.22 170.81 7.7 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -106.54 146.12 31.02 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.792 -1.192 . . . . 0.0 110.916 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.436 ' HA ' ' HG2' ' A' ' 85' ' ' ARG . 28.0 m-85 -87.86 -28.55 21.52 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -71.76 139.0 48.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.26 172.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -104.35 154.88 19.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.797 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 61.27 25.43 15.41 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 47.9 mt-30 -65.12 133.96 95.8 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 51' ' ' GLN . 2.7 Cg_exo -80.37 -19.82 8.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.332 2.021 . . . . 0.0 110.394 171.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.9 153.05 23.47 Favored Glycine 0 N--CA 1.419 -2.435 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.926 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.06 160.42 15.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 tp -118.4 114.53 23.04 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.2 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.05 110.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 36.5 mt-30 -108.46 113.69 26.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.671 -175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 104' ' ' VAL . 34.8 t -95.19 120.9 45.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.258 0 O-C-N 123.363 0.414 . . . . 0.0 110.602 -177.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.4 146.71 52.01 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.424 ' OE2' ' HB2' ' A' ' 15' ' ' LEU . 15.4 pt-20 -120.48 150.61 40.55 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.853 0.835 . . . . 0.0 110.771 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.34 -174.01 19.8 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.86 95.52 3.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 118.192 0.996 . . . . 0.0 108.712 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -142.93 153.64 43.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.931 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -81.43 -49.55 10.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.144 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mmm -98.89 105.44 17.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.404 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 95.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.981 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -151.59 -44.51 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.54 11.14 36.2 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.615 0.721 . . . . 0.0 109.654 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.55 161.95 25.67 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.913 -173.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -90.78 115.13 27.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -82.05 113.73 20.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.98 -33.02 19.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.91 162.7 22.66 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -153.67 138.7 17.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -137.75 151.39 48.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.036 0.446 . . . . 0.0 111.46 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.55 133.16 38.47 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.292 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' CD1' HD22 ' A' ' 115' ' ' ASN . 57.5 tp -111.04 105.13 13.78 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -96.71 151.29 19.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.402 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.7 -0.62 13.77 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 121.117 -0.564 . . . . 0.0 111.835 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.08 133.96 92.82 Favored Pre-proline 0 C--O 1.254 1.319 0 C-N-CA 122.847 0.459 . . . . 0.0 110.675 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 111' ' ' THR . 19.2 Cg_endo -58.33 134.88 64.37 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.179 2.586 . . . . 0.0 112.476 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -71.44 67.66 2.79 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.596 2.197 . . . . 0.0 110.593 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.52 158.52 75.4 Favored Pre-proline 0 N--CA 1.417 -2.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.086 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.79 178.68 7.3 Favored 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.192 1.928 . . . . 0.0 114.462 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 47' ' ' TYR . 19.3 mtm180 -30.18 115.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.795 2.438 . . . . 0.0 115.138 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.82 -29.75 8.67 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.666 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.58 -51.01 4.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.41 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.92 124.38 14.38 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.447 1.432 . . . . 0.0 109.421 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -134.93 95.61 3.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.221 1.01 . . . . 0.0 110.388 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.7 mm -93.42 112.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.773 -173.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -90.16 111.9 23.21 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 105' ' ' THR . 62.0 t -111.56 125.68 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -177.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.6 m -112.78 124.27 52.21 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.446 ' CD1' HD22 ' A' ' 29' ' ' LEU . 14.5 m-85 -97.7 109.32 22.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.18 114.22 16.04 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 59.4 mt -116.44 140.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' HD12 ' A' ' 36' ' ' ILE . 1.3 p-10 -93.45 -176.5 4.13 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.35 -15.14 62.83 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -82.21 -28.76 31.77 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.63 20.15 7.47 Favored Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 78.6 mt -83.8 113.93 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 tp -95.28 118.8 32.68 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 24.0 t-20 -110.39 113.32 25.88 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 174.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 58' ' ' VAL . 59.7 t -97.4 113.78 32.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 21.1 m -103.64 126.76 50.98 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.75 126.04 49.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 113' ' ' LYS . 19.8 m -131.84 118.32 19.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.51 107.62 11.3 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -67.56 -20.53 65.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.555 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.6 t -69.44 -52.53 25.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.044 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.411 HG23 ' HD3' ' A' ' 81' ' ' PRO . 38.0 p -90.06 -32.2 16.82 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.47 43.98 3.56 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 107' ' ' THR . 54.4 mttm -116.59 133.37 56.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.2 136.64 41.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.403 HD22 ' CD1' ' A' ' 77' ' ' LEU . 28.2 m-80 -138.77 145.96 40.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.267 175.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -143.26 151.0 40.06 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 123.042 0.214 . . . . 0.0 111.288 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 32.0 pt -121.9 141.21 43.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.962 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.1 m -111.14 113.21 25.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.99 103.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.056 0.455 . . . . 0.0 109.977 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -93.75 127.41 39.46 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 124.453 1.101 . . . . 0.0 111.701 -179.689 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 134' ' ' MET . 46.8 mt-10 . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.4 mt -60.7 -52.02 66.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.793 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 9.5 pt-20 -70.42 -25.1 63.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.509 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 92.2 mmm -59.47 -43.19 93.31 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.3 t -63.24 -47.5 91.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.156 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 15.8 mm-40 -57.34 -46.95 82.78 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.82 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.79 -35.61 75.01 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.206 0.316 . . . . 0.0 111.541 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.39 77.97 Favored 'General case' 0 C--O 1.19 -2.064 0 O-C-N 123.472 0.483 . . . . 0.0 110.322 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.08 -48.2 16.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.473 0.654 . . . . 0.0 111.025 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.92 -40.48 96.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.394 -173.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.71 18.11 19.27 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.81 0.338 . . . . 0.0 110.195 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -49.03 -58.93 4.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.458 1.503 . . . . 0.0 112.451 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -71.55 -34.14 69.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 33.8 mm-40 -64.38 -53.42 48.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.044 -176.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 1.4 m-20 -63.6 -36.44 83.81 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.059 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.528 ' OE1' ' HD3' ' A' ' 149' ' ' ARG . 6.9 mm-40 -57.85 -46.43 84.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.021 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 60.2 t -63.32 -40.88 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 32.2 mm-40 -58.78 -54.08 51.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.628 0.771 . . . . 0.0 111.698 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 2.6 ptm180 -68.78 -32.82 72.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.22 -9.91 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.916 0.388 . . . . 0.0 111.752 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 92.2 mtt180 -68.8 -27.67 66.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.24 125.69 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -81.53 75.85 8.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 0.0 111.383 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -101.87 120.47 40.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.577 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -94.67 -163.12 1.01 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 18.1 m120 -76.28 80.16 3.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.847 0.832 . . . . 0.0 109.042 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.631 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.58 153.13 41.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.344 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.2 mt -125.82 136.01 52.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.09 120.2 40.91 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.278 -2.501 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.598 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp . . . . . 0 C--O 1.242 0.707 0 CA-C-O 122.252 1.025 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 36' ' ' ILE . 17.2 t70 -123.13 17.59 9.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 123.083 1.42 . . . . 0.0 108.941 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 m -136.37 171.07 17.44 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.136 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.73 118.66 72.61 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.08 -31.98 13.96 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.983 1.788 . . . . 0.0 112.335 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.04 168.83 17.78 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.428 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 24.1 m -92.67 132.44 36.9 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.08 132.03 50.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.92 179.37 28.55 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.352 -176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.47 HD11 HG11 ' A' ' 92' ' ' VAL . 97.1 mt -118.75 155.47 31.06 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.809 -0.695 . . . . 0.0 109.867 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' HB3' HE21 ' A' ' 57' ' ' GLN . 38.6 tt0 -88.59 109.35 20.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 171.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.444 HG22 ' HG ' ' A' ' 158' ' ' LEU . 17.2 p -105.3 -166.06 1.18 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.489 -174.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.33 134.69 18.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.615 0.766 . . . . 0.0 112.174 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.81 56.07 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.142 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.51 25.14 31.33 Favored Glycine 0 C--O 1.246 0.898 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 152' ' ' VAL . 64.0 t -104.52 146.54 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.507 -1.346 . . . . 0.0 109.208 -175.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.4 ttt -87.89 136.43 32.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.213 0.53 . . . . 0.0 111.983 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.6 m -123.74 112.19 17.04 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.85 116.59 29.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.782 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.515 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.4 mp -79.41 -47.22 16.1 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.04 112.95 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.19 142.46 28.33 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 32' ' ' ARG . 16.8 ptt180 -56.76 155.74 7.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 77.98 1.29 2.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.528 1.531 . . . . 0.0 111.813 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -86.12 128.99 34.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -60.05 144.91 48.33 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.408 1.083 . . . . 0.0 112.109 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.611 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 28.4 pt -106.16 169.75 6.57 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.611 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 14.7 Cg_exo -69.08 124.77 7.55 Favored 'Cis proline' 0 C--O 1.244 0.817 0 CA-C-N 121.153 1.447 . . . . 0.0 112.257 0.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -87.96 141.7 28.38 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.405 -178.194 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -148.68 100.02 3.06 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 93' ' ' THR . 14.8 mm100 -107.01 117.66 34.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 88.3 m -117.31 116.05 26.47 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.457 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 87.5 mt-30 -120.95 151.39 39.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.77 113.22 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -101.59 165.87 11.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.964 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -145.14 170.89 15.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 p -101.36 139.03 37.59 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.706 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -85.76 -18.8 31.98 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 165.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 p -71.8 110.01 6.05 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.031 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.74 126.65 32.62 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m120 62.05 68.49 0.68 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.426 0.632 . . . . 0.0 111.149 -172.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.5 tp-100 -101.56 117.27 62.23 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.72 -31.75 20.1 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.003 1.802 . . . . 0.0 113.349 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.34 140.09 6.74 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.592 -0.814 . . . . 0.0 111.114 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.85 147.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.135 0.493 . . . . 0.0 110.123 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.517 HD21 ' NH1' ' A' ' 74' ' ' ARG . 42.0 tp -114.7 111.56 21.49 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.141 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.73 105.23 16.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.498 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 14.1 mt-30 -103.91 115.11 29.85 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.238 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.02 124.04 55.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 O-C-N 123.643 0.59 . . . . 0.0 110.755 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -129.49 154.4 47.04 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.466 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 34.4 tt0 -122.27 147.74 45.85 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.97 125.73 5.66 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 16' ' ' SER . 37.5 mt-10 -79.51 126.36 30.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -152.84 168.41 25.84 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.482 0.713 . . . . 0.0 110.652 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -84.06 -51.1 7.37 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.52 0.676 . . . . 0.0 109.341 174.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.6 mtt -98.63 128.14 44.81 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.989 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -90.0 117.83 29.09 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.877 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -177.59 -52.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.528 1.131 . . . . 0.0 110.058 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.01 79.95 1.81 Allowed 'General case' 0 CA--C 1.464 -2.349 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.93 177.96 7.45 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 112.802 -1.999 . . . . 0.0 106.012 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 30.3 t30 -90.12 109.07 20.15 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.8 107.42 9.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.977 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.18 -41.79 14.38 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.533 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.37 171.52 38.71 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.068 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.517 ' NH1' HD21 ' A' ' 55' ' ' LEU . 7.2 ptp180 -152.58 140.77 20.41 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -147.15 149.02 32.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -97.21 140.14 32.13 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.7 103.39 9.63 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 170.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 p -111.83 161.46 16.33 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 41.71 3.63 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 42.8 mm -86.34 130.49 49.4 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 147.36 94.72 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.74 2.293 . . . . 0.0 112.359 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.88 84.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 122.685 2.256 . . . . 0.0 111.307 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.6 77.92 Favored Pre-proline 0 N--CA 1.42 -1.949 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.841 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.08 168.94 6.69 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.668 2.246 . . . . 0.0 112.712 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -62.94 149.27 45.1 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.657 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.18 -16.0 41.16 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.511 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.25 -55.17 1.39 Allowed Pre-proline 0 C--O 1.247 0.969 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.264 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.71 109.34 1.42 Allowed 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 121.339 1.359 . . . . 0.0 111.283 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -93.64 115.49 27.96 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.004 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.4 mm -102.46 116.77 46.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 17.0 tt0 -90.18 117.18 28.74 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 105' ' ' THR . 39.2 t -117.85 121.16 66.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.657 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 85.6 m -110.95 123.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.664 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 29' ' ' LEU . 7.1 m-85 -105.2 108.51 20.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 38' ' ' THR . 7.9 t70 -121.19 132.06 54.61 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.414 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 62.8 mt -126.3 135.6 63.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.87 -170.58 2.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.02 -23.6 64.1 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -77.1 -29.31 54.82 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.169 0.509 . . . . 0.0 110.05 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.02 23.35 7.44 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.9 mt -83.35 117.64 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.3 tp -93.58 117.1 29.66 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -109.73 103.38 12.2 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 64.2 t -89.86 118.63 35.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.467 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 35.7 m -113.41 137.17 51.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 91' ' ' GLU . . . -126.79 121.18 31.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 19.7 m -118.81 123.68 45.35 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.497 0.498 . . . . 0.0 110.738 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.57 109.92 16.47 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -66.96 -17.28 64.84 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.918 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -75.6 -62.85 1.44 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.893 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -94.26 -19.47 20.68 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.55 47.96 3.59 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.821 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 107' ' ' THR . 61.3 mttp -106.78 147.24 29.91 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -149.94 131.83 15.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.338 0.589 . . . . 0.0 111.826 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -136.54 139.14 42.0 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.567 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 61.2 pttt -135.85 148.76 48.79 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 120.722 0.296 . . . . 0.0 110.815 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.4 pt -119.16 139.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -104.27 112.77 25.93 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.23 108.5 25.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.8 p -84.59 163.89 19.03 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.455 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 C--O 1.245 0.861 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 174.85 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.051 0.453 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 135' ' ' VAL . 62.3 mt -72.78 -44.23 59.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.12 -39.58 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.257 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 1.2 mmp_? -60.35 -46.35 90.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.915 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.4 ttt -55.71 -47.06 77.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.077 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 131' ' ' ILE . 69.8 t -58.45 -45.97 89.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.362 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.65 -31.8 70.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.433 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 37.1 mt-10 -64.94 -47.7 76.73 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.32 -30.63 68.49 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.231 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HA ' ' HG2' ' A' ' 142' ' ' LYS . 31.8 mt-10 -78.15 -31.55 49.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -70.62 -19.16 62.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.118 0.961 . . . . 0.0 109.291 174.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.42 27.4 8.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.33 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 139' ' ' GLU . 5.1 mmtt -48.98 -52.47 24.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.788 0.835 . . . . 0.0 112.882 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -70.54 -51.97 24.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 148' ' ' GLN 0.258 1.4 pm0 -60.28 -45.88 91.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.8 -45.62 88.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.17 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . 0.251 35.8 mt-10 -70.28 -32.53 70.37 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.735 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 143' ' ' ALA . 89.4 t -65.7 -45.77 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 14.4 mm100 -58.08 -43.88 87.28 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 110.752 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.426 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 2.6 tmt_? -61.86 -41.0 97.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.725 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 -11.48 42.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -62.4 -44.41 96.5 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.303 0.573 . . . . 0.0 110.056 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 25' ' ' VAL . 48.7 t -78.79 113.68 18.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -77.87 95.54 4.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.93 -21.0 17.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.892 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 63.61 -77.99 0.03 OUTLIER 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.085 1.354 . . . . 0.0 111.398 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -178.26 40.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.44 156.73 34.95 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.533 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -122.63 153.14 39.73 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.495 0.664 . . . . 0.0 110.622 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.25 158.25 29.88 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 168.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 C--N 1.29 -1.995 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.949 -175.016 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.422 -1.837 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -98.07 37.9 1.38 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 112.983 -1.917 . . . . 0.0 109.955 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.59 146.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.767 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 121.59 46.86 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.455 171.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' C ' HD12 ' A' ' 15' ' ' LEU . 36.9 Cg_exo -57.58 -58.97 0.65 Allowed 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 5.8 mp -126.77 176.43 7.27 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.2 m -80.93 119.8 23.92 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -92.5 132.07 37.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.853 0.72 . . . . 0.0 109.274 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -153.72 -169.9 19.19 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.243 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.46 HD23 HG23 ' A' ' 56' ' ' ILE . 2.3 mp -131.52 163.23 28.46 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.538 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 34.5 tt0 -87.89 109.07 19.51 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 123.0 1.381 . . . . 0.0 109.802 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 11.9 p -85.74 160.21 19.58 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.494 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.54 118.49 1.79 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 125.502 1.521 . . . . 0.0 113.665 -173.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.94 4.25 39.07 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.637 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.98 39.51 27.7 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.8 t -108.44 146.77 13.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.403 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -101.87 127.81 48.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.477 0.656 . . . . 0.0 109.285 -178.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.7 m -123.89 116.15 22.44 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.8 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -86.55 141.35 29.11 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.754 0.659 . . . . 0.0 111.172 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.37 -39.81 6.03 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.58 112.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -79.0 154.42 29.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.342 0.591 . . . . 0.0 110.501 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -64.37 149.81 47.55 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.47 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 66.38 20.79 10.96 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 124.408 1.083 . . . . 0.0 111.881 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.6 t -90.39 126.96 36.05 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.5 119.73 7.54 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.806 0.842 . . . . 0.0 113.263 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.43 HG22 HG23 ' A' ' 38' ' ' THR . 23.7 pt -101.46 162.25 21.05 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.66 -1.154 . . . . 0.0 107.925 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 137.13 12.24 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 CA-C-N 121.341 1.515 . . . . 0.0 115.152 1.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 36' ' ' ILE . 1.1 p -107.6 154.93 20.71 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -146.83 103.74 3.66 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.97 121.32 20.31 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 m -127.95 115.97 19.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.551 0.215 . . . . 0.0 110.876 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -115.36 153.08 31.65 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.22 114.13 41.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.96 151.13 19.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.6 p -122.1 169.91 10.39 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 33.7 p -95.84 136.94 35.61 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.92 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -107.61 -1.1 21.5 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.245 0.545 . . . . 0.0 111.139 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -101.77 138.91 38.12 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.8 139.5 34.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.44 18.49 11.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.516 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 46.2 tt0 -60.22 114.79 10.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 123.045 0.538 . . . . 0.0 110.226 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.33 -5.78 10.16 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.791 2.327 . . . . 0.0 113.892 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.13 150.34 14.49 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.632 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.2 165.08 24.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.0 tp -117.92 127.82 54.21 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.46 HG23 HD23 ' A' ' 19' ' ' LEU . 3.0 mp -98.42 98.34 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.66 110.1 21.04 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.54 114.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.953 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.538 ' CE2' ' HB2' ' A' ' 20' ' ' GLU . 68.6 m-85 -107.69 156.37 19.15 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.529 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.541 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 39.8 tt0 -134.99 137.81 43.38 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.74 -107.03 1.14 Allowed Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.261 -0.971 . . . . 0.0 114.785 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' CD ' ' HZ2' ' A' ' 67' ' ' LYS . 41.8 mt-10 -79.1 158.54 27.77 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.344 1.058 . . . . 0.0 109.414 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.428 HH11 ' HA ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -122.48 -46.31 2.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.705 0.764 . . . . 0.0 112.639 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -71.97 -28.43 63.43 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.538 0.685 . . . . 0.0 110.805 -173.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.5 mmt -134.57 111.47 10.08 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.706 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.1 91.57 4.31 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.448 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 19.8 pttp -144.71 -58.54 0.36 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.403 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 5.5 m-20 -105.45 25.95 10.07 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.489 0.661 . . . . 0.0 109.518 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -74.54 160.96 30.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.377 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -93.76 129.99 39.92 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.2 tp -101.69 111.01 23.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.93 -51.13 7.4 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.26 159.02 32.09 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.848 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 78.5 mtm180 -138.15 136.94 37.18 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.84 144.87 30.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.49 133.58 39.32 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.563 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 5.5 tt -113.46 104.05 11.89 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 172.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -120.54 155.39 33.74 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.12 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.12 7.53 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.5 mt -79.16 132.92 61.76 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 38.0 Cg_endo -66.36 125.19 13.56 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.504 2.136 . . . . 0.0 111.249 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 32.5 Cg_exo -61.25 101.85 0.2 Allowed 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.668 2.246 . . . . 0.0 111.94 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.77 157.61 59.33 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 68.0 Cg_endo -70.76 50.73 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.762 2.975 . . . . 0.0 113.312 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' THR . 39.5 ptt180 56.42 164.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.142 2.177 . . . . 0.0 113.89 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.55 -44.2 2.21 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.346 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.6 -50.24 73.37 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 123.976 0.91 . . . . 0.0 113.171 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.75 123.24 11.38 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 121.576 1.517 . . . . 0.0 110.985 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 76.4 mt-30 -117.23 115.21 24.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.479 -175.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.33 105.58 18.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -90.62 107.78 19.38 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -107.9 124.48 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.179 0.514 . . . . 0.0 111.118 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.3 m -103.86 121.93 44.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.727 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.56 107.94 19.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.36 125.14 40.2 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.883 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.25 131.75 72.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.9 p30 -89.79 -169.76 2.57 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.376 0.422 . . . . 0.0 110.335 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.85 2.1 47.16 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.122 -0.361 . . . . 0.0 111.958 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -96.01 -13.6 23.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.56 30.18 12.4 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 67.2 mt -102.05 116.46 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.091 0.472 . . . . 0.0 109.889 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.21 111.23 22.81 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.979 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.03 114.42 27.72 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.94 126.58 58.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 122.28 31.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.82 117.83 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.6 m -113.6 117.96 33.07 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.533 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.85 107.87 11.88 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 28.2 mmmt -67.31 -20.21 65.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.613 0.765 . . . . 0.0 110.779 -177.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -69.33 -54.6 13.75 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.785 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.9 p -99.05 -15.44 19.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.058 0.456 . . . . 0.0 112.056 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 30.36 36.22 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.499 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -115.36 158.57 22.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.546 0.673 . . . . 0.0 109.504 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.64 155.88 48.66 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.563 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.1 m120 -129.35 127.61 41.42 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -119.29 145.31 46.23 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.812 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.4 tt -136.64 148.77 26.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 m -113.61 112.93 24.33 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.2 mm -107.58 94.19 2.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t -88.11 122.33 31.56 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.856 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 125.098 1.359 . . . . 0.0 109.624 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 134' ' ' MET . 8.9 mm-40 . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 135' ' ' VAL . 61.9 mt -63.7 -41.94 94.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.47 -38.3 90.61 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.206 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 42.4 mtm105 -63.61 -42.12 98.24 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 53.4 mtt -59.86 -35.88 75.71 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.195 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 131' ' ' ILE . 58.9 t -56.77 -52.84 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -63.8 -42.17 97.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.523 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.0 mm-40 -64.76 -40.37 95.17 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.79 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.653 0.381 . . . . 0.0 111.274 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 25.4 mm-40 -77.85 -38.38 46.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -65.27 -38.76 91.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.348 0.594 . . . . 0.0 109.925 -179.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -111.57 28.63 8.56 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.927 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 139' ' ' GLU . 17.9 pttm -62.43 -45.25 93.96 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.47 67.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.397 0.618 . . . . 0.0 109.501 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -71.5 -54.15 11.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.184 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.1 m-20 -67.09 -55.2 15.29 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.14 -33.79 76.58 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -172.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.24 -47.82 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.184 175.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 152' ' ' VAL . 16.5 mm-40 -61.32 -41.39 96.94 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -55.29 -47.32 75.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -70.03 -9.51 55.53 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -97.9 0.59 46.85 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 148' ' ' GLN . 61.7 t -96.31 133.11 38.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 t -82.38 21.38 0.95 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.877 0.471 . . . . 0.0 112.014 -173.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.16 -21.76 59.71 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 50.06 -91.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.578 1.551 . . . . 0.0 113.177 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -155.1 67.73 0.68 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.17 140.3 41.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.168 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 76.1 mt -93.13 152.56 19.18 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -93.52 147.22 23.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.249 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.516 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 48.1 t . . . . . 0 C--N 1.311 -1.069 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.423 -1.793 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 36' ' ' ILE . 7.5 m-20 -86.03 75.65 9.92 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 35' ' ' THR . 27.8 m -130.72 179.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.246 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.59 130.79 54.57 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.28 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.24 -60.9 0.27 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.871 2.38 . . . . 0.0 112.359 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD2' HG23 ' A' ' 131' ' ' ILE . 3.4 mm? -119.18 174.34 6.39 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -69.51 127.43 32.97 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -95.21 140.62 29.86 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.553 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.58 -171.33 21.31 Favored Glycine 0 N--CA 1.42 -2.393 0 C-N-CA 119.552 -1.309 . . . . 0.0 113.796 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -133.71 156.9 47.11 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 35.5 tt0 -102.2 109.03 20.61 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 170.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.6 p -98.6 -63.93 1.08 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 122.39 1.091 . . . . 0.0 109.242 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.434 ' CB ' ' HG3' ' A' ' 159' ' ' GLU . . . -101.43 155.17 18.22 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.52 28.03 4.01 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.177 -1.011 . . . . 0.0 115.032 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.54 -61.01 0.18 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.99 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 155' ' ' LYS . 58.7 t -109.53 145.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 120.729 0.3 . . . . 0.0 111.099 -173.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.76 128.0 33.97 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -107.86 111.42 23.54 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.47 135.81 36.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.742 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' CE1' ' A' ' 94' ' ' PHE . 5.6 mp -109.77 -49.24 3.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.255 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.36 128.77 48.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -85.06 158.28 20.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 12.9 ptm180 -61.89 149.98 38.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.964 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 m120 68.37 11.41 8.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.111 0.964 . . . . 0.0 112.65 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.1 t -75.71 122.38 23.92 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.404 ' HA ' HG12 ' A' ' 12' ' ' VAL . 1.4 p -62.65 126.83 28.68 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.107 0.963 . . . . 0.0 112.945 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 11' ' ' ASP . 21.3 pt -87.52 152.3 51.87 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_exo -67.82 124.23 6.3 Favored 'Cis proline' 0 C--O 1.241 0.668 0 N-CA-C 115.241 1.208 . . . . 0.0 115.241 4.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -96.79 158.13 15.58 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.023 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -165.58 108.56 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 93' ' ' THR . 26.7 mm-40 -121.85 137.59 54.72 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.934 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.4 m -121.8 117.28 26.16 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.185 0.928 . . . . 0.0 109.788 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -125.48 147.87 49.07 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.8 mm -95.9 117.56 40.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.405 0.621 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.14 153.9 20.91 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.312 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 10.8 p -135.11 171.11 14.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 30.7 p -101.87 148.76 24.94 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.829 0.74 . . . . 0.0 109.85 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 37.1 m-85 -81.21 -65.33 1.03 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.16 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -75.69 144.83 41.37 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.78 145.88 44.71 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.551 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 68.62 35.46 3.14 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -73.98 118.17 67.24 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.46 -24.62 10.42 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.032 1.821 . . . . 0.0 111.951 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.01 159.02 29.26 Favored Glycine 0 N--CA 1.411 -2.976 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.92 153.21 33.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 O-C-N 123.945 0.438 . . . . 0.0 109.963 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.0 tp -106.22 115.84 30.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.11 106.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 74' ' ' ARG . 15.1 tt0 -112.47 121.43 44.82 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.0 t -90.32 135.23 26.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.574 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 90.4 m-85 -136.66 167.63 21.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.803 0.811 . . . . 0.0 111.282 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.563 ' CG ' ' HB2' ' A' ' 70' ' ' ASN . 13.4 pt-20 -136.01 151.51 49.96 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 170.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.65 136.49 3.88 Favored Glycine 0 C--N 1.277 -2.703 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' OE2' ' HD2' ' A' ' 32' ' ' ARG . 30.6 mt-10 -101.44 95.62 6.61 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 -174.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 20.7 mmt180 -146.29 170.45 16.75 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.236 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -86.44 -49.76 7.37 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.557 175.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.3 mtt -98.9 137.27 37.71 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.587 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.42 85.58 2.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.177 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -146.92 -52.17 0.21 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.472 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 7.5 m-20 -94.34 70.03 3.7 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -145.13 150.24 36.43 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.982 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.563 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 85.0 m-20 -90.68 131.57 36.29 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.08 118.41 28.78 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 mp -92.31 -56.91 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.801 0.334 . . . . 0.0 111.186 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.08 163.52 31.01 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.436 ' HB3' ' HG3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -153.2 135.39 14.88 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.9 150.12 41.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -94.97 129.98 41.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 tt -120.0 104.79 10.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 p -121.99 165.4 16.07 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.27 -0.11 14.38 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.51 125.62 88.95 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.458 0.703 . . . . 0.0 109.638 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 111' ' ' THR . 60.9 Cg_endo -70.78 168.69 22.17 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.07 2.513 . . . . 0.0 111.853 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.08 90.93 0.12 Allowed 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.546 2.164 . . . . 0.0 111.823 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.41 147.55 66.59 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.574 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.6 -171.03 0.72 Allowed 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.425 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 46' ' ' THR . 51.8 ttp180 -59.07 131.93 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.1 0.96 . . . . 0.0 111.54 -177.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 -8.5 64.89 Favored Glycine 0 C--N 1.308 -0.979 0 CA-C-N 115.833 -0.621 . . . . 0.0 114.295 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.6 t -82.88 -54.29 0.57 Allowed Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.25 107.52 2.46 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.336 1.358 . . . . 0.0 110.107 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.45 ' HB2' ' HD2' ' A' ' 109' ' ' LYS . 92.9 mt-30 -94.87 113.39 25.12 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.1 mm -98.24 115.25 37.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.04 113.46 25.72 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -116.64 123.21 71.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 42.1 m -129.45 124.58 34.41 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.3 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.402 ' CE1' HD22 ' A' ' 29' ' ' LEU . 45.9 p90 -123.6 138.23 54.59 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.927 174.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -134.31 153.2 52.01 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.499 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 64.6 mt -130.91 135.73 59.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.2 p-10 -84.81 -173.02 4.5 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.88 -13.02 60.26 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.447 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 47.6 m-80 -85.31 -29.51 24.48 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.74 28.81 2.83 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.494 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 68.9 mt -88.35 116.29 29.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 tp -95.66 120.78 36.51 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.95 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -119.99 104.2 9.95 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.12 125.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.1 m -123.45 123.44 40.65 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.61 130.62 53.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.1 m -131.58 126.8 35.71 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -83.86 116.6 22.83 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.206 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 89' ' ' GLN . 67.9 mttm -67.19 -19.33 65.55 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -74.31 -54.5 7.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.416 HG23 ' HD3' ' A' ' 81' ' ' PRO . 38.4 p -91.5 -37.01 13.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.14 14.19 36.89 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.03 136.87 35.18 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.475 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.91 137.68 45.06 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.303 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -133.09 138.75 46.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -131.4 158.34 41.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.866 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.9 141.0 44.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.1 m -128.5 113.29 15.31 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.1 mt -113.65 111.08 34.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.8 t -92.42 100.98 13.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 . . . . . 0 CA--C 1.562 1.417 0 C-N-CA 123.991 0.916 . . . . 0.0 108.719 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 135' ' ' VAL . 54.1 mt -55.76 -54.11 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.726 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 45.5 mt-10 -66.38 -35.26 79.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.89 -44.13 94.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.265 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.5 mtt -72.55 -30.26 64.28 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 131' ' ' ILE . 60.0 t -62.94 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 53.7 mt-30 -55.66 -47.22 77.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.274 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.737 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.26 74.3 Favored 'General case' 0 C--O 1.196 -1.731 0 C-N-CA 122.568 0.347 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.22 -32.63 74.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.909 0.385 . . . . 0.0 111.404 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.26 -41.97 56.11 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.585 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -108.31 11.67 27.03 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.16 -43.77 64.25 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.146 0.978 . . . . 0.0 111.554 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -66.5 -43.37 85.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -177.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.7 -38.57 47.09 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.281 -0.568 . . . . 0.0 112.248 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.8 m-20 -64.3 -33.46 75.89 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.976 0.417 . . . . 0.0 109.934 174.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.68 -50.37 74.12 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 54.7 t -62.06 -46.43 96.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -55.49 -47.45 76.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.476 0.711 . . . . 0.0 111.494 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -68.15 -47.34 68.32 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.88 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -68.76 -10.73 58.3 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.2 mmt180 -72.76 -10.97 60.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.332 0.587 . . . . 0.0 110.022 172.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.15 115.77 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -55.39 -45.35 76.62 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 123.314 0.646 . . . . 0.0 112.648 -172.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.44 158.83 43.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -136.69 31.51 2.79 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -86.46 33.64 0.63 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.933 -177.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -139.56 134.14 31.77 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.29 151.71 19.27 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 121.307 0.575 . . . . 0.0 111.207 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.434 ' HG3' ' CB ' ' A' ' 22' ' ' ALA . 41.9 mt-10 -116.72 121.61 42.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.294 -1.842 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.832 -177.284 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--O 1.242 0.659 0 CA-C-O 121.368 0.604 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.23 81.05 1.48 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.112 0.958 . . . . 0.0 110.068 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.44 178.14 3.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.126 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.97 116.67 66.89 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.71 -36.45 24.58 Favored 'Trans proline' 0 C--O 1.252 1.186 0 C-N-CA 121.733 1.622 . . . . 0.0 110.729 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 84.8 mt -108.07 174.98 5.64 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.65 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.528 ' HB2' ' HG3' ' A' ' 32' ' ' ARG . 10.0 t -103.55 -176.38 3.07 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -151.57 129.23 11.52 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 171.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.75 166.23 31.8 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.125 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.78 148.22 34.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 32.1 tt0 -86.25 112.05 21.0 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.1 p -100.49 172.36 7.17 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.86 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 124.39 20.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.977 0.417 . . . . 0.0 111.915 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.37 28.9 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.903 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.42 35.92 10.17 Favored Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.461 ' HB ' ' OG1' ' A' ' 21' ' ' THR . 27.4 t -99.17 133.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.425 ' HB2' ' OG1' ' A' ' 66' ' ' THR . 26.1 ttt -98.07 108.08 20.71 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.2 m -87.91 111.77 21.81 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.15 24.63 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.431 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.482 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.1 mp -90.7 -45.6 8.76 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.841 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.36 101.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.498 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -72.39 168.3 18.71 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.159 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.528 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 35.2 mtp-105 -61.98 150.62 37.39 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.444 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.19 17.03 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 111.604 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -73.15 129.12 37.36 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 p -68.23 114.73 6.96 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 124.272 1.029 . . . . 0.0 111.598 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 30.3 pt -94.64 164.58 19.39 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.7 Cg_exo -68.92 134.74 28.98 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.773 1.312 . . . . 0.0 113.416 -0.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.4 p -110.69 161.39 15.8 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 123.871 0.868 . . . . 0.0 110.844 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.531 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 46.7 tttp -156.96 99.42 1.82 Allowed 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -102.61 135.14 44.8 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -132.64 116.45 16.67 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.416 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 55.0 mt-30 -128.88 158.64 38.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.33 125.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 80.9 m-85 -113.36 160.44 18.37 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.331 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 11.8 p -137.97 171.76 13.94 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 122.859 0.463 . . . . 0.0 110.625 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 63.4 p -98.77 162.67 12.98 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 157' ' ' ALA . 26.9 m-85 -103.09 -5.1 23.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.194 0.521 . . . . 0.0 109.602 171.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 p -139.55 164.03 30.99 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.737 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -102.32 158.08 16.45 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.806 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 82' ' ' PRO . 44.1 m-80 71.33 14.33 6.49 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.491 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 75.4 mt-30 -63.5 129.13 93.43 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.25 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.94 -45.14 34.31 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.499 2.133 . . . . 0.0 111.445 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 78' ' ' SER . . . -166.35 153.81 23.89 Favored Glycine 0 N--CA 1.404 -3.446 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 HD11 ' A' ' 80' ' ' ILE . 19.1 m -103.97 137.77 31.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.71 109.95 21.84 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.419 ' HB ' ' CD2' ' A' ' 75' ' ' PHE . 2.3 mp -84.51 94.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . 0.251 6.6 pt20 -99.35 114.22 26.97 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.166 0.984 . . . . 0.0 111.632 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.86 126.65 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.075 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 92.4 m-85 -124.21 155.74 38.01 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 16' ' ' SER . 1.3 pp20? -127.27 165.87 18.85 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.15 124.55 3.53 Favored Glycine 0 C--N 1.263 -3.522 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 7.4 mm-40 -78.83 87.73 4.69 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.976 0.893 . . . . 0.0 109.662 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -128.04 142.11 51.32 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.791 -1.549 . . . . 0.0 107.044 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -66.9 -49.81 64.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.0 mtm -110.82 137.97 47.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.151 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 26' ' ' MET . 2.5 m -89.73 108.21 19.55 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.528 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -141.28 -53.91 0.47 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.134 0.493 . . . . 0.0 111.976 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.75 -61.57 1.35 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.6 m120 40.12 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.442 -1.708 . . . . 0.0 113.899 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -112.04 101.56 9.84 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.52 114.83 4.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.461 0.648 . . . . 0.0 110.395 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.19 -35.92 14.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.085 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.81 154.51 15.34 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.911 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -119.51 139.56 51.91 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 121.559 0.695 . . . . 0.0 109.185 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.419 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 13.8 t80 -143.48 142.09 31.03 Favored 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.41 -174.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.41 131.24 52.96 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.309 0.504 . . . . 0.0 111.249 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.3 tp -124.07 105.22 9.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.448 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 22.5 p -96.9 158.6 15.35 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.844 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.4 31.41 3.26 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.017 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 2.0 mp -77.18 116.17 55.18 Favored Pre-proline 0 C--O 1.242 0.687 0 CA-C-N 117.265 0.533 . . . . 0.0 109.894 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 25.6 Cg_exo -66.13 155.15 71.13 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 11.3 Cg_exo -74.05 82.71 1.74 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.544 2.162 . . . . 0.0 111.772 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . . . -132.6 127.63 20.62 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -37.26 -63.74 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 125.07 3.847 . . . . 0.0 115.931 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -175.4 120.26 0.19 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.62 -34.97 3.31 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.631 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.23 -56.97 6.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.863 -0.589 . . . . 0.0 111.198 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 83' ' ' ALA . 21.9 Cg_endo -64.24 104.72 0.53 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.421 1.414 . . . . 0.0 110.448 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -120.06 115.92 24.67 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.5 mm -99.51 116.3 42.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.8 tt0 -90.69 114.3 26.59 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.75 125.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 17.8 m -112.98 131.49 55.74 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.387 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CD1' HD22 ' A' ' 29' ' ' LEU . 7.7 m-85 -119.67 108.5 14.53 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.85 1.26 . . . . 0.0 109.057 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.531 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.7 p30 -123.57 136.61 54.62 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.281 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 54.7 mt -121.87 137.75 54.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.9 p-10 -100.66 -169.43 1.71 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.46 -15.34 61.81 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 43.7 m-80 -90.31 -5.38 56.33 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.983 -0.448 . . . . 0.0 110.859 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.5 25.76 49.51 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.421 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.3 mt -84.3 113.12 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.9 tp -95.87 117.0 29.75 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.095 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -107.7 121.2 44.22 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 93' ' ' THR . 69.9 t -111.61 115.66 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -117.23 127.38 54.04 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.74 118.04 30.98 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.8 m -110.48 125.8 53.68 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.705 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.61 115.63 23.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 68.0 mttm -67.51 -16.55 64.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.6 m -79.4 -50.43 10.84 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.829 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 36.2 p -83.77 -39.22 20.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.135 0.493 . . . . 0.0 111.225 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.15 12.62 48.53 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.439 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 65.4 pttt -103.05 156.43 17.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.331 . . . . 0.0 110.231 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.71 52.08 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.231 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -129.09 152.66 48.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.99 165.94 24.83 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 tt -145.65 143.49 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -122.0 113.11 19.12 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 75.3 mt -108.24 105.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.691 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.8 m -90.77 158.55 16.79 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 122.008 0.908 . . . . 0.0 110.711 -179.459 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HG2' ' A' ' 134' ' ' MET . 14.7 mp0 . . . . . 0 C--O 1.217 -0.641 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 75.6 mt -53.15 -51.9 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.568 1.168 . . . . 0.0 110.698 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 60.6 mt-10 -74.01 -33.28 63.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.203 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -67.11 -35.23 79.32 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.678 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 24.3 mmt -60.14 -52.59 64.7 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.02 -52.65 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 124.027 0.83 . . . . 0.0 112.034 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 70.5 mm-40 -64.37 -45.49 87.52 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.29 -32.81 66.94 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.406 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' A' ' 142' ' ' LYS . . . -60.5 -48.43 81.81 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.466 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 21.6 mm-40 -61.89 -48.61 79.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -77.37 -24.35 50.63 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.98 13.28 7.29 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 18.5 ptpt -50.04 -43.44 51.0 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.99 78.03 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -71.21 -53.17 15.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 m-20 -64.86 -33.87 77.03 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -59.22 -51.08 71.5 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 117.651 0.205 . . . . 0.0 111.189 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.2 t -62.43 -49.34 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 O-C-N 123.635 0.584 . . . . 0.0 109.998 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -56.79 -45.64 82.03 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.833 0.708 . . . . 0.0 111.916 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 45.3 ttp180 -63.93 -32.68 74.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.163 0.585 . . . . 0.0 111.099 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -85.27 -17.27 37.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.504 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 5.2 mmp_? -80.49 -6.85 58.79 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.79 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.67 71.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.3 m 67.19 167.6 0.24 Allowed 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.497 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.13 25.85 4.9 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.78 155.41 17.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.306 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 79.0 m-20 -117.3 87.27 2.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.31 145.18 31.84 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 122.162 -0.336 . . . . 0.0 110.305 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.477 ' HG ' HG22 ' A' ' 21' ' ' THR . 0.7 OUTLIER -124.54 152.82 42.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.659 0.742 . . . . 0.0 112.206 -175.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -128.73 146.13 50.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 168.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.312 -1.055 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.938 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.425 -1.703 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.7 m-20 -84.27 67.15 9.69 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.944 0.878 . . . . 0.0 110.004 -175.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 m -134.2 179.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . . . -96.36 133.7 24.52 Favored Pre-proline 0 C--N 1.282 -2.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 36.3 Cg_endo -68.25 -38.68 11.54 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.461 2.108 . . . . 0.0 110.409 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -134.91 161.31 35.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 m -76.06 149.36 37.5 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 123.289 0.368 . . . . 0.0 110.469 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.09 142.36 44.64 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 120.993 0.425 . . . . 0.0 110.713 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -164.84 -168.76 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 C-N-CA 119.977 -1.106 . . . . 0.0 114.041 -173.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.432 HD21 HG11 ' A' ' 92' ' ' VAL . 1.7 mp -113.38 156.06 24.11 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.539 0.736 . . . . 0.0 109.118 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.95 109.35 18.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.906 0.86 . . . . 0.0 109.19 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 6.1 p -94.45 171.54 8.75 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.235 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . . . -51.51 124.77 12.83 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.779 1.232 . . . . 0.0 112.145 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.29 -2.73 57.83 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.28 39.8 25.71 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.3 t -96.5 142.03 14.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.261 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.05 107.99 20.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -107.55 111.84 24.3 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.501 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -92.27 147.57 22.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 94' ' ' PHE . 51.4 mt -115.34 -24.75 8.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.3 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 94' ' ' PHE . 3.3 mp -117.78 117.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 171.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -85.39 149.86 25.14 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 14' ' ' PRO . 10.6 ptt85 -69.83 152.53 44.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.459 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.96 -0.63 2.97 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.4 1.08 . . . . 0.0 112.147 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -89.24 122.58 32.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 2.9 p -65.18 121.16 14.12 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 123.849 0.86 . . . . 0.0 112.93 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 36.3 pt -84.94 164.94 39.72 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 47.0 Cg_exo -60.72 145.7 42.1 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 CA-C-N 120.652 1.269 . . . . 0.0 114.024 1.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 m -142.0 143.76 33.33 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 6.1 ttpm? -147.14 119.56 8.43 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.854 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 29' ' ' LEU . 30.7 mt-30 -121.8 131.81 54.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.087 0.47 . . . . 0.0 111.03 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 35.0 m -115.23 118.3 32.9 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -130.13 155.42 46.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.23 126.41 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.81 146.26 42.99 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.083 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 29.3 p -123.69 171.28 9.7 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 124.916 1.286 . . . . 0.0 107.555 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -113.07 136.85 52.25 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -98.92 -4.2 33.4 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -80.17 106.97 12.58 Favored 'General case' 0 N--CA 1.395 -3.194 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.447 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.75 133.01 44.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.373 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 64.2 29.88 13.78 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.918 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -85.23 120.31 73.24 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 88.2 Cg_endo -82.85 -0.41 10.05 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.558 2.172 . . . . 0.0 110.826 177.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.28 147.85 9.9 Favored Glycine 0 N--CA 1.408 -3.202 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.99 165.24 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 123.955 0.444 . . . . 0.0 110.503 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.9 tp -111.82 115.0 28.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.64 94.78 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -99.64 118.15 35.54 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.752 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.11 134.92 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.813 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -125.63 154.01 42.93 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -114.13 118.72 34.81 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' HA3' ' SD ' ' A' ' 134' ' ' MET . . . 154.52 175.03 25.22 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -140.89 104.26 4.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.69 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -154.74 169.45 23.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.06 -31.91 68.45 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.705 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.0 mtt -111.48 135.7 51.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.199 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.94 -13.23 59.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -64.92 -27.15 68.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -171.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -94.53 14.75 19.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.752 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.523 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 14.2 m120 -107.1 175.25 5.56 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.198 -0.314 . . . . 0.0 110.715 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.89 129.24 36.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 tp -76.27 109.17 9.74 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -82.81 -48.31 10.93 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.017 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.47 164.32 33.99 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -142.39 154.52 44.69 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 117.517 0.659 . . . . 0.0 109.84 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -155.33 158.27 38.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -106.63 147.99 28.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.789 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 tp -124.54 104.87 8.96 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.2 p -116.36 153.43 32.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.25 4.46 18.13 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 75.0 mt -79.87 130.26 67.67 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 123.664 0.786 . . . . 0.0 109.048 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -56.24 117.97 4.7 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.814 2.343 . . . . 0.0 111.403 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.98 111.84 1.85 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.778 2.318 . . . . 0.0 112.412 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.8 160.54 68.09 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.53 -23.16 37.47 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.808 2.339 . . . . 0.0 112.19 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -140.7 166.25 25.27 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.236 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.46 ' HA3' ' HB ' ' A' ' 45' ' ' THR . . . -73.86 80.54 0.81 Allowed Glycine 0 N--CA 1.432 -1.589 0 O-C-N 123.68 0.613 . . . . 0.0 114.276 -176.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.429 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 52.8 t -69.38 -45.24 27.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 32.6 Cg_exo -68.07 121.51 8.52 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.394 1.396 . . . . 0.0 110.278 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -81.98 115.61 21.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -91.76 119.51 39.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.22 104.19 16.77 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' THR . 40.6 t -110.08 117.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.619 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -103.81 116.36 32.15 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.284 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 3.0 m-85 -96.87 107.21 19.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 171.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' OD2' ' HD3' ' A' ' 39' ' ' LYS . 18.2 t70 -120.64 113.09 19.72 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 123.656 0.598 . . . . 0.0 110.566 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.76 118.4 56.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.486 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.5 p30 -85.41 -176.79 6.26 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.6 -20.29 63.17 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -80.62 -23.91 39.45 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.855 -0.528 . . . . 0.0 110.671 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.79 15.71 28.22 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.486 ' HB ' ' OD2' ' A' ' 97' ' ' ASP . 83.2 mt -80.4 119.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 114.61 27.0 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.1 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -107.51 101.44 10.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.9 t -93.72 114.27 30.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.0 m -112.1 110.73 21.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.67 117.55 34.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.3 m -119.8 128.69 53.95 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.625 0.726 . . . . 0.0 111.115 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.56 114.48 16.44 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.569 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.72 -21.4 64.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.6 p -80.19 -62.04 1.8 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.3 p -95.69 -31.36 13.27 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.389 0.614 . . . . 0.0 110.411 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.66 34.79 3.21 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.03 175.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -98.68 151.85 20.28 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 117.016 0.408 . . . . 0.0 110.889 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.95 140.59 24.6 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.845 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.82 139.74 43.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 149.2 43.76 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 tt -120.66 148.61 23.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.0 m -114.53 112.92 23.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.45 98.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.123 0.487 . . . . 0.0 110.877 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -91.73 101.78 14.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.5 t30 . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -176.376 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 134' ' ' MET . 1.4 mp0 . . . . . 0 C--O 1.216 -0.678 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 135' ' ' VAL . 51.7 mt -56.87 -50.91 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.09 -45.42 87.19 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 123.575 0.75 . . . . 0.0 110.794 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -60.03 -47.73 84.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.523 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 70.3 mtm -66.55 -36.29 82.3 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 123.48 0.487 . . . . 0.0 111.573 -175.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 70.3 t -61.26 -54.71 31.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 123.621 0.576 . . . . 0.0 109.568 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.0 mt-30 -63.11 -46.77 85.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.08 -40.09 94.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -60.33 -44.5 95.44 Favored 'General case' 0 C--O 1.198 -1.616 0 O-C-N 123.05 0.219 . . . . 0.0 110.416 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 22.2 mm-40 -58.61 -39.63 80.98 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 94.5 mttt -74.21 -48.49 28.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.734 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.53 21.84 10.66 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.331 0.864 . . . . 0.0 113.331 -172.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 138' ' ' ALA . 29.2 mmtt -44.24 -58.68 2.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.06 45.57 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.716 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -58.26 -55.1 39.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.734 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -38.58 44.14 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.94 -34.16 73.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.128 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.3 -44.05 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.552 ' O ' HG23 ' A' ' 152' ' ' VAL . 67.6 mt-30 -52.75 -50.84 62.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 110.735 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -54.05 -52.66 60.18 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 124.284 0.99 . . . . 0.0 111.341 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.83 -39.15 93.53 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.922 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -63.54 -25.47 68.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 148' ' ' GLN . 22.0 t -88.79 -39.24 12.38 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.6 p -72.14 80.75 0.97 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.518 0.675 . . . . 0.0 111.494 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.42 123.51 44.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 tptm 68.34 10.43 7.85 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 124.016 0.822 . . . . 0.0 110.007 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.47 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.131 1.372 . . . . 0.0 112.66 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -114.39 134.13 55.21 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.335 -175.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 44.7 mt -93.26 152.97 18.85 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.48 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 14.2 tt0 -97.6 173.36 7.18 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 C--N 1.292 -1.895 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.597 -176.038 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 tp . . . . . 0 N--CA 1.435 -1.221 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 73.17 29.5 1.71 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.121 0.968 . . . . 0.0 111.39 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 17.5 m -126.87 168.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.86 119.05 72.25 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.77 -25.96 16.45 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.245 1.963 . . . . 0.0 112.685 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.1 mp -135.18 172.19 13.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -101.75 129.8 48.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.445 HD13 HD22 ' A' ' 102' ' ' LEU . 62.2 mt -116.79 131.87 56.84 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.39 -176.57 21.94 Favored Glycine 0 N--CA 1.429 -1.816 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.64 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.89 150.53 30.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.27 108.38 17.1 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.644 HG22 HD23 ' A' ' 158' ' ' LEU . 34.6 p -107.29 -177.03 3.24 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.645 -172.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.12 119.13 5.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.88 0.872 . . . . 0.0 113.178 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.45 -8.57 22.38 Favored Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.869 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.64 57.27 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 39.4 t -110.65 149.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.1 ttt -92.72 137.81 32.04 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 122.987 0.515 . . . . 0.0 111.052 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -118.84 111.71 18.77 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.3 126.73 45.21 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.658 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -96.54 -33.79 11.69 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.29 125.57 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -120.48 146.02 46.68 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -56.07 151.48 12.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 75.07 14.37 3.13 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.14 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -103.55 133.03 49.27 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 1.6 m -68.31 144.86 54.66 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 123.814 0.846 . . . . 0.0 111.715 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.89 155.4 43.31 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_endo -62.44 152.37 65.26 Favored 'Cis proline' 0 C--N 1.356 0.964 0 CA-C-N 119.922 1.008 . . . . 0.0 113.629 -1.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -107.09 -80.45 0.56 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.014 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 43.5 tttp 65.41 99.43 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 127.424 2.29 . . . . 0.0 111.055 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -121.71 132.06 54.43 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.082 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -118.7 123.81 45.81 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.247 0.342 . . . . 0.0 110.478 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -130.61 146.23 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -93.34 133.93 32.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.92 132.4 50.88 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.8 153.09 36.25 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.7 p -81.7 135.52 35.5 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.353 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 23.1 m-85 -114.19 3.96 15.37 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 24.5 p -97.0 -179.13 4.44 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.076 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -143.18 166.36 24.91 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.263 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 60.19 19.81 9.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 48' ' ' SER . 56.0 mt-30 -101.34 113.56 65.81 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.124 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.2 Cg_endo -85.83 -2.79 8.99 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.028 2.485 . . . . 0.0 111.672 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.16 149.04 16.21 Favored Glycine 0 N--CA 1.401 -3.689 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 m -112.64 149.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.34 101.5 11.42 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 63.1 mt -90.48 117.73 34.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -129.59 119.62 23.93 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.154 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 104' ' ' VAL . 36.6 t -92.48 117.61 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.704 -178.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 59.4 m-85 -120.08 144.33 47.65 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.277 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -111.73 154.34 25.15 Favored 'General case' 0 C--O 1.272 2.244 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.219 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.08 118.34 3.5 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -78.08 95.05 4.79 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.632 0.716 . . . . 0.0 110.91 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.474 ' HG2' HH11 ' A' ' 63' ' ' ARG . 43.3 mtp85 -136.74 157.03 47.71 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.845 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -91.04 -51.27 5.42 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.7 93.74 9.04 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.6 m -84.61 108.1 17.18 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.905 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -163.49 144.19 9.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 68.19 16.23 9.38 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.476 1.11 . . . . 0.0 111.702 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.18 173.03 10.7 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 85.0 m-20 -90.7 127.45 36.31 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.95 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.7 118.49 29.35 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.713 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.08 -53.98 3.91 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.08 156.01 26.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 10.0 ptm180 -151.19 139.14 19.97 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 123.713 0.805 . . . . 0.0 109.531 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.73 145.66 31.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.806 0.336 . . . . 0.0 111.226 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.64 110.45 22.56 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.4 tp -94.71 104.61 16.53 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 p -96.0 152.27 18.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.35 -35.27 2.09 Favored Glycine 0 CA--C 1.479 -2.188 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.1 mp -51.88 120.16 15.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 O-C-N 125.042 1.084 . . . . 0.0 110.494 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.52 146.72 10.91 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.143 1.895 . . . . 0.0 111.317 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.75 118.17 5.01 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.9 1.734 . . . . 0.0 108.246 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.7 156.75 79.74 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.757 -171.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.34 43.4 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.224 2.616 . . . . 0.0 111.823 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HG3' ' HA ' ' A' ' 47' ' ' TYR . 7.9 mpt_? 68.97 148.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.253 1.421 . . . . 0.0 113.109 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.56 -27.86 2.13 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.436 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 48.6 t -58.45 -51.99 77.87 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 7.7 Cg_exo -77.12 106.89 2.32 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 121.597 1.531 . . . . 0.0 110.446 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -101.91 103.53 14.2 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mm -91.82 120.51 41.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.519 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . 40.4 tt0 -94.87 112.31 24.04 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.16 128.23 62.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.467 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 m -122.9 120.6 33.93 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.867 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -99.57 107.79 20.03 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.48 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 1.5 p-10 -125.61 112.64 16.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.7 mt -99.9 123.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.2 p-10 -86.55 -175.35 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 123.722 0.639 . . . . 0.0 109.373 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.36 -13.12 61.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.402 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 64.3 t30 -81.54 -28.66 33.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 112.18 12.79 13.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 92.9 mt -82.13 116.1 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-O 120.996 0.427 . . . . 0.0 110.347 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.445 HD22 HD13 ' A' ' 17' ' ' LEU . 22.1 tp -88.52 108.9 19.64 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 116' ' ' LYS . 1.2 t30 -102.91 110.49 22.43 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.757 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 58' ' ' VAL . 45.4 t -88.71 114.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 116' ' ' LYS . 7.2 m -110.76 124.29 51.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.622 -175.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -132.74 119.37 20.24 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.663 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 m -120.24 127.59 52.55 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.21 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.97 111.04 21.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.082 0.553 . . . . 0.0 111.841 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 91' ' ' GLU . 96.9 mttt -69.01 -11.2 60.57 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.0 p -86.04 -47.98 9.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 118.964 -1.095 . . . . 0.0 112.908 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.0 p -96.88 -33.79 11.5 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.875 -0.515 . . . . 0.0 111.819 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.08 23.67 10.39 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.924 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.37 157.8 16.16 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 122.779 -0.248 . . . . 0.0 110.339 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.77 143.71 22.97 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.113 0.482 . . . . 0.0 111.503 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -129.45 140.69 51.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.529 ' HG2' HG23 ' A' ' 105' ' ' THR . 83.6 mttt -136.21 132.76 36.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.42 125.33 72.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.208 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 79.2 m -88.12 112.4 22.65 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.003 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 71.4 mt -101.61 94.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.338 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.5 m -74.51 158.86 33.05 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 124.782 1.233 . . . . 0.0 107.97 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.069 0.461 . . . . 0.0 112.001 -179.242 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.96 -51.11 76.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.902 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.6 -27.04 64.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.078 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 21.3 ttm180 -63.79 -39.46 94.31 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -68.68 -29.94 68.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.995 0.426 . . . . 0.0 110.602 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.89 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -63.82 -36.17 83.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.741 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 7.6 mm-40 -61.07 -45.44 94.74 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.9 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.203 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.67 -37.51 76.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.942 0.401 . . . . 0.0 110.513 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.66 -42.64 67.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.634 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.537 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . 88.7 m-85 -97.84 15.65 23.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.525 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 7.0 tmtt? -48.09 -66.44 0.4 Allowed 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 124.046 0.938 . . . . 0.0 112.729 -173.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.7 87.3 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 10.0 tp10 -64.75 -54.9 24.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.2 m-20 -77.75 -28.81 50.79 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 66.5 mm-40 -61.75 -42.65 99.25 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.418 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 60.3 t -72.0 -48.52 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.822 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.5 mm-40 -54.09 -41.6 68.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -64.58 -39.86 94.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.338 0.59 . . . . 0.0 109.993 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.24 0.8 57.04 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 27.4 mmm180 -68.45 -36.42 78.98 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 172.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.407 HG12 ' HG2' ' A' ' 155' ' ' LYS . 21.6 t -93.83 83.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 m -78.25 142.51 37.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.963 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 45.72 63.37 1.83 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.376 1.47 . . . . 0.0 113.219 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 2.2 pptp? -106.22 77.25 1.21 Allowed 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 123.011 1.386 . . . . 0.0 110.213 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.09 61.94 6.78 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.296 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . . . -146.39 139.16 25.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.862 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.644 HD23 HG22 ' A' ' 21' ' ' THR . 14.0 mt -103.32 151.34 22.84 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.77 144.24 44.71 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.89 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.291 -1.975 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.419 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.246 0.899 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.3 61.7 1.12 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.5 -177.42 2.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.621 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.01 118.87 72.45 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.05 -50.53 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.278 1.985 . . . . 0.0 111.978 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.441 HD11 HG22 ' A' ' 135' ' ' VAL . 6.3 mp -114.61 172.25 7.14 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.488 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 15.2 m -92.5 151.04 20.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.124 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.03 132.0 54.58 Favored 'General case' 0 C--O 1.261 1.669 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.923 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.11 158.1 27.57 Favored Glycine 0 N--CA 1.426 -1.982 0 O-C-N 123.91 0.756 . . . . 0.0 112.656 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.9 151.39 22.16 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -86.12 108.45 18.31 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 171.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 18.0 p -107.87 -69.61 0.84 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.286 0.565 . . . . 0.0 111.348 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.26 165.55 11.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.55 -21.05 4.3 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 116.949 1.539 . . . . 0.0 116.949 -171.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.52 33.37 2.15 Favored Glycine 0 CA--C 1.493 -1.341 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.986 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.37 121.5 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.449 0.643 . . . . 0.0 112.12 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.518 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 23.4 ttt -106.31 97.79 7.55 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.9 m -80.35 110.74 16.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.07 119.9 30.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.789 0.328 . . . . 0.0 111.047 -176.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 63.1 mt -104.93 -39.54 6.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.623 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.1 130.4 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.19 162.3 14.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 15' ' ' LEU . 63.6 mtt180 -56.69 140.11 48.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 123.714 0.634 . . . . 0.0 109.515 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 75.26 10.74 3.57 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.231 1.012 . . . . 0.0 112.786 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -81.91 114.73 20.71 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -60.38 131.75 51.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.398 1.079 . . . . 0.0 113.781 -176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 36.4 pt -95.4 160.83 29.73 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 24.7 Cg_exo -65.66 126.26 6.39 Favored 'Cis proline' 0 C--N 1.358 1.043 0 CA-C-N 120.291 1.14 . . . . 0.0 113.431 0.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.6 p -95.55 149.13 21.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.443 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 37.7 tttp -154.02 99.5 2.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' THR . 5.5 tp-100 -107.15 140.12 40.5 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 81.5 m -139.83 116.41 10.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HG3' HD22 ' A' ' 29' ' ' LEU . 86.5 mm-40 -128.61 144.17 51.1 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.22 118.83 41.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 123.669 0.606 . . . . 0.0 109.535 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.05 169.19 8.64 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.915 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 33.1 p -134.24 171.63 13.98 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.469 ' HB ' ' OG ' ' A' ' 48' ' ' SER . 27.7 p -99.86 139.62 35.25 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.484 176.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 27.6 m-85 -85.03 -11.72 54.75 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 46' ' ' THR . 29.5 p -83.75 142.27 30.82 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.905 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.0 124.01 51.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 66.32 61.43 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.693 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.517 ' H ' ' NE2' ' A' ' 51' ' ' GLN . 0.5 OUTLIER -101.3 123.11 45.87 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -85.41 -15.96 5.02 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.821 1.681 . . . . 0.0 111.132 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.59 164.64 36.92 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.43 179.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.1 tp -132.37 132.37 42.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.55 123.26 71.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 120.851 0.358 . . . . 0.0 111.52 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -114.82 129.76 56.75 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.4 123.49 64.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.58 142.97 43.2 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.248 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -111.52 121.23 44.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.57 125.33 5.6 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -172.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 3.8 mp0 -79.0 139.03 38.28 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 36.2 mmt180 -139.45 156.86 46.69 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 114.192 -1.367 . . . . 0.0 107.542 172.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.599 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -78.22 -49.87 12.96 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 92.7 mmm -105.55 122.05 45.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.13 102.08 0.1 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -174.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 56.3 pttt 179.41 -177.44 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.174 1.389 . . . . 0.0 107.549 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.98 -45.46 0.6 Allowed 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.44 1.496 . . . . 0.0 114.921 172.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.582 ' ND2' ' HG2' ' A' ' 63' ' ' ARG 0.259 85.8 m-20 -86.17 -166.19 1.47 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -88.69 112.63 23.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.994 0.902 . . . . 0.0 111.724 -167.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.7 108.24 13.1 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.204 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.57 -55.19 6.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.96 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.89 159.07 27.99 Favored Glycine 0 N--CA 1.413 -2.887 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.966 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.29 135.22 21.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.76 168.3 24.81 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.58 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.75 144.21 25.62 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.6 tp -131.07 103.66 6.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -132.96 165.87 23.69 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 120.573 0.225 . . . . 0.0 111.04 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.07 4.95 56.47 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.78 134.39 86.02 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 37.5 Cg_exo -59.99 133.87 53.05 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.975 1.784 . . . . 0.0 109.796 177.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 22.5 Cg_exo -67.5 63.64 0.8 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.103 2.535 . . . . 0.0 111.974 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.24 153.51 39.01 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.602 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -61.36 177.9 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.459 2.773 . . . . 0.0 114.914 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.61 131.39 50.08 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.469 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 75.4 20.77 78.49 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.69 176.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.0 -49.69 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.47 116.13 4.58 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.535 1.49 . . . . 0.0 111.343 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -87.42 112.1 21.81 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.7 mm -98.82 115.94 40.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.73 112.76 24.66 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 41' ' ' THR . 96.0 t -106.07 124.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 32.5 m -124.45 128.32 48.83 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.855 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 34.7 m-85 -112.63 136.62 51.98 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 8.0 t70 -142.31 127.11 18.15 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.1 mt -124.15 126.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -89.13 -170.65 2.96 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.33 63.42 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.452 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 9.1 t30 -84.61 -29.77 25.5 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.274 0.559 . . . . 0.0 110.242 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.3 28.48 4.62 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 77.4 mt -86.89 116.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 49.0 tp -96.12 120.1 35.8 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 3.1 t-20 -105.08 105.21 15.15 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 38.8 t -92.12 120.48 41.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 174.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -126.99 122.87 35.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.69 117.17 29.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.1 m -115.75 127.73 55.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.145 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -83.04 107.38 15.59 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.23 -12.27 60.71 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 m -70.98 -54.56 10.82 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 35.7 p -86.59 -48.82 8.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.438 0.637 . . . . 0.0 111.14 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.05 5.5 28.76 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.475 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 14.2 ptmm? -92.31 152.5 19.75 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.49 162.68 38.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.337 0.589 . . . . 0.0 112.281 -174.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -129.42 128.06 42.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.09 173.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 19.6 ptpt -132.97 149.53 52.23 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.452 -178.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.4 pt -129.81 151.04 35.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.2 m -117.47 113.11 21.56 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.25 103.13 14.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -84.93 109.4 18.12 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.4 t30 . . . . . 0 C--O 1.246 0.919 0 C-N-CA 124.884 1.274 . . . . 0.0 111.413 -178.468 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 134' ' ' MET . 14.7 mm-40 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.498 0.19 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 135' ' ' VAL . 82.5 mt -60.14 -42.98 91.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 67.4 mt-10 -63.25 -32.38 73.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.702 0.287 . . . . 0.0 110.923 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 44.7 mtp180 -64.03 -43.78 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.036 174.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 52.7 mtt -65.08 -35.27 80.63 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.006 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 131' ' ' ILE . 86.1 t -55.54 -52.13 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 69.8 mm-40 -65.18 -52.26 55.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.755 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.67 -51.05 71.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -67.78 -30.73 70.24 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.425 ' HA ' ' HG2' ' A' ' 142' ' ' LYS . 39.3 mt-10 -77.6 -34.96 53.32 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.548 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.96 -43.7 74.45 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.7 20.72 7.17 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.468 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 24.4 mmtt -53.3 -58.09 8.27 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -56.56 -44.81 81.33 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.443 0.464 . . . . 0.0 111.327 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.67 -48.58 71.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.794 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.43 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.2 m-20 -72.61 -36.88 68.18 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 56.4 mm-40 -60.43 -42.5 96.18 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.838 0.29 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.676 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.0 t -67.24 -49.72 69.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.409 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -63.75 -43.95 94.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.599 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 40.0 ttp180 -62.84 -48.57 78.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.419 0.628 . . . . 0.0 110.319 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 153' ' ' SER . 7.1 mm-40 -79.3 -0.28 31.75 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.476 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 21.5 mmt180 -84.23 -35.46 23.43 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 -38.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 26.3 t -66.84 103.23 1.08 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -102.79 -27.48 12.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.215 0.531 . . . . 0.0 110.961 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -161.36 154.56 21.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -74.85 86.54 2.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.384 0.611 . . . . 0.0 109.405 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.57 149.02 35.11 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.275 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 mp -109.15 149.23 29.65 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.56 156.72 19.2 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 121.241 0.544 . . . . 0.0 111.824 -177.493 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.237 0.416 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -37.46 82.55 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 171.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -95.7 128.4 42.54 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.299 -1.319 . . . . 0.0 108.324 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.6 t -138.41 103.43 2.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -143.91 151.57 39.99 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 120.996 0.427 . . . . 0.0 110.336 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -152.17 -75.37 0.14 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.4 tp 179.33 160.59 0.74 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 60.53 -164.45 0.23 Allowed 'General case' 0 C--O 1.259 1.56 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.9 tp 76.16 -54.07 0.61 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.597 1.159 . . . . 0.0 110.87 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.51 67.95 10.12 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -118.85 41.06 3.12 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 19.5 m -124.35 177.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.292 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.86 120.84 80.04 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.41 -24.38 10.72 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.219 1.946 . . . . 0.0 112.13 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.02 160.87 21.95 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.031 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 p -93.63 112.94 24.92 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -92.16 131.56 37.3 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.85 179.06 22.26 Favored Glycine 0 N--CA 1.413 -2.846 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.822 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.37 159.92 31.86 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -83.97 117.2 23.22 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 170.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.8 p -110.82 -97.8 0.41 Allowed 'General case' 0 N--CA 1.405 -2.71 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.16 163.61 19.67 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.38 92.55 0.08 OUTLIER Glycine 0 CA--C 1.499 -0.962 0 O-C-N 123.76 0.662 . . . . 0.0 112.968 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' A' ' 65' ' ' MET . . . 104.69 19.17 11.39 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 124.512 0.772 . . . . 0.0 111.735 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -129.36 115.33 34.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 117.016 0.408 . . . . 0.0 110.73 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.33 115.65 27.71 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -100.27 112.64 24.98 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.34 101.67 13.91 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 5.6 mp -73.32 -49.28 28.35 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.33 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.0 mt -108.42 105.28 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.02 153.54 21.46 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.099 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.689 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -57.05 159.33 4.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.047 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 72.56 6.12 5.38 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 124.855 1.262 . . . . 0.0 111.948 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.4 m -91.8 125.73 36.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 10.0 t -68.35 134.71 50.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.517 0.675 . . . . 0.0 112.256 -177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.43 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 33.1 pt -94.98 154.54 39.65 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.639 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.2 Cg_exo -63.26 133.73 14.9 Favored 'Cis proline' 0 N--CA 1.478 0.566 0 CA-C-N 119.873 0.991 . . . . 0.0 114.012 0.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -110.01 162.18 14.79 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.257 1.023 . . . . 0.0 109.266 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 15.4 ptpt -166.57 148.19 6.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.542 0.527 . . . . 0.0 110.807 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 29' ' ' LEU . 15.3 mm100 -147.75 118.78 7.68 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 125.821 1.648 . . . . 0.0 107.544 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 84.9 m -111.67 116.33 30.59 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -128.97 141.11 51.36 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.13 124.67 48.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 97.0 m-85 -111.74 160.12 17.6 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.75 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 21.3 p -129.89 171.96 12.19 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.2 p -113.51 138.49 50.05 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 119.623 1.101 . . . . 0.0 110.534 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -82.52 -39.22 22.68 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 170.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.5 p -63.88 98.17 0.19 Allowed 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.759 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.47 160.68 27.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.354 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 m120 62.82 22.42 13.39 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -94.46 114.11 62.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 3.3 Cg_exo -79.64 -8.04 14.71 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.82 126.75 2.43 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -113.45 160.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.451 HD13 ' HG2' ' A' ' 76' ' ' GLU . 53.3 tp -111.86 117.85 33.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.307 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.74 118.39 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' ' 20' ' ' GLU . 16.6 pt20 -132.85 129.85 39.0 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.331 -176.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.38 127.53 50.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -124.21 153.46 41.58 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.566 0.746 . . . . 0.0 110.107 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 69' ' ' ASN . 37.1 mt-10 -117.09 137.12 52.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.36 -155.45 16.09 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.486 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 22.3 mt-10 -152.29 130.63 12.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.058 0.543 . . . . 0.0 110.575 174.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 27.3 mmt180 -147.67 163.91 35.17 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 170.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.54 62.85 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.644 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 58.7 mtt -109.68 135.04 51.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.102 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -65.25 98.74 0.34 Allowed 'General case' 0 N--CA 1.416 -2.126 0 O-C-N 124.076 0.86 . . . . 0.0 112.573 -175.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 19.3 pttp -176.82 169.81 2.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 66.75 11.26 8.12 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 123.621 0.768 . . . . 0.0 111.874 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 96.3 m-20 -118.63 179.96 3.98 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.416 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -90.49 151.88 21.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -118.52 121.18 39.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.7 mt -84.65 -48.13 9.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.707 0.289 . . . . 0.0 111.596 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.74 170.89 42.39 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -143.48 162.92 34.57 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -155.06 142.64 19.72 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HG2' HD13 ' A' ' 55' ' ' LEU . 43.5 mt-10 -102.68 117.87 35.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.038 0.447 . . . . 0.0 110.299 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.3 tp -92.77 112.65 24.69 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.889 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -107.95 155.36 20.4 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.32 -15.31 6.11 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.948 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.4 mp -60.5 125.41 82.17 Favored Pre-proline 0 C--O 1.247 0.939 0 C-N-CA 122.88 0.472 . . . . 0.0 110.136 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 80' ' ' ILE . 23.5 Cg_exo -65.54 126.8 16.79 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.95 1.767 . . . . 0.0 109.839 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.95 90.45 0.11 Allowed 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.594 2.196 . . . . 0.0 111.167 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.56 167.37 15.18 Favored Pre-proline 0 N--CA 1.42 -1.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.367 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.45 -179.0 0.17 Allowed 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.508 2.805 . . . . 0.0 114.646 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -72.48 129.14 37.65 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.662 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 85.71 4.02 85.55 Favored Glycine 0 C--N 1.309 -0.949 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.714 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.7 t -90.55 -49.39 0.36 Allowed Pre-proline 0 CA--C 1.557 1.232 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' THR . 31.8 Cg_exo -63.31 119.93 7.19 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 121.328 1.352 . . . . 0.0 111.27 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.38 106.61 17.79 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.296 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.36 116.84 46.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.527 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 39.2 tt0 -90.64 117.48 29.33 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 41' ' ' THR . 74.1 t -110.41 113.11 43.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 91.4 m -99.48 111.67 23.99 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -116.67 107.86 15.2 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -174.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 39' ' ' LYS . 3.9 p30 -141.02 149.63 41.97 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.061 0.458 . . . . 0.0 111.192 -175.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.8 mt -116.62 140.17 40.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -90.63 -167.25 1.78 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -18.25 59.55 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -82.73 -29.12 30.0 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.49 0.662 . . . . 0.0 109.301 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.16 31.96 3.4 Favored Glycine 0 N--CA 1.416 -2.674 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.9 mt -99.96 121.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-O 121.283 0.563 . . . . 0.0 109.751 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 tp -89.07 121.45 31.42 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.493 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -113.41 123.08 49.23 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.02 114.29 45.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -111.49 122.73 48.6 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 123.297 0.373 . . . . 0.0 110.009 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.65 117.73 34.82 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -118.6 114.56 22.97 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.813 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.72 112.19 13.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.527 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 62.5 mttm -67.08 -24.57 65.97 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.669 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -65.52 -54.65 25.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -91.52 -44.61 8.98 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.53 7.08 26.5 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -85.91 137.57 32.65 Favored 'General case' 0 N--CA 1.403 -2.79 0 CA-C-O 121.061 0.457 . . . . 0.0 110.401 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.32 140.81 47.64 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.01 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -135.73 131.79 36.04 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.61 166.16 16.59 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.05 145.05 33.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.8 m -117.45 113.08 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.6 mt -126.84 119.72 53.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 O-C-N 122.324 -0.235 . . . . 0.0 110.864 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.1 t -79.51 132.55 36.35 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.71 9.01 38.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.161 0.505 . . . . 0.0 110.331 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.41 -37.84 77.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.917 0.865 . . . . 0.0 108.875 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.77 154.6 21.82 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.63 -172.94 22.96 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 118.932 -1.604 . . . . 0.0 113.065 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -91.94 178.09 5.99 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 57.78 -160.43 0.25 Allowed 'General case' 0 C--O 1.255 1.374 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.4 p -95.03 -58.9 2.03 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.6 tttp 167.74 -36.45 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.952 1.301 . . . . 0.0 107.974 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -58.69 -38.69 78.79 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.671 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.96 -35.52 72.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.313 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 135' ' ' VAL . 60.3 mt -67.89 -41.95 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.458 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -60.14 -42.33 94.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.819 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -60.42 -43.24 96.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.7 ttm -58.62 -44.91 90.11 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.923 0.889 . . . . 0.0 110.613 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.448 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 59.4 t -63.14 -47.1 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -58.94 -43.23 91.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.73 -35.94 82.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.0 110.501 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -67.95 -30.22 69.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.511 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 7.6 mm-40 -78.79 -44.6 22.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.413 1.101 . . . . 0.0 109.082 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -60.63 -48.08 83.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.533 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.96 19.01 20.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.85 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 18.8 ttmm -54.32 -47.44 72.47 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.563 0.539 . . . . 0.0 112.139 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.18 70.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.168 0.509 . . . . 0.0 111.589 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.51 -46.84 68.55 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.447 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.86 -36.97 83.53 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.435 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 45.5 mm-40 -58.1 -50.17 74.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 117.677 0.217 . . . . 0.0 111.253 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.23 -47.03 94.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.273 0.358 . . . . 0.0 110.357 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -57.22 -46.23 83.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.73 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -66.06 -47.89 72.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.071 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -75.35 -7.78 54.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.254 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.0 mtp85 -73.99 -20.3 60.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.926 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.61 82.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.0 p -132.66 138.66 47.39 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.234 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -168.61 -54.5 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -169.37 150.1 4.19 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 56.6 m-80 -64.57 117.42 7.36 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 121.302 0.572 . . . . 0.0 110.29 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.02 161.59 38.38 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.648 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.7 mt -120.36 137.11 54.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -112.54 129.93 56.19 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m -97.68 145.47 26.29 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 62.22 34.35 16.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.417 0.687 . . . . 0.0 110.695 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.03 26.79 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.595 1.158 . . . . 0.0 113.05 -174.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -146.03 109.89 4.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -96.05 86.74 4.37 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.087 0.47 . . . . 0.0 110.499 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.1 tpt -78.77 -34.0 45.95 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.82 110.61 6.46 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.2 m -75.85 155.2 35.55 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.327 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.19 -65.14 0.76 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.3 m -131.27 140.69 47.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -162.92 40.96 0.11 Allowed 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 122.09 0.947 . . . . 0.0 109.951 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -164.36 85.52 0.44 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -120.66 7.68 10.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.37 160.45 36.07 Favored Glycine 0 C--O 1.249 1.063 0 CA-C-N 115.188 -0.915 . . . . 0.0 113.761 -176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.418 HD22 ' HB ' ' A' ' 178' ' ' ILE . 59.5 mt -81.46 116.78 21.42 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -143.37 -86.53 0.14 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -170.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -93.6 -43.34 3.96 Favored Glycine 0 CA--C 1.482 -2.015 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -77.34 111.41 12.97 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.418 ' HB ' HD22 ' A' ' 174' ' ' LEU . 47.5 mm 61.52 87.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 122.207 1.003 . . . . 0.0 108.807 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 40.3 m -84.76 0.29 51.17 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.958 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -101.57 96.18 6.95 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 122.098 0.951 . . . . 0.0 110.1 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 174' ' ' LEU . . . -112.12 -50.46 2.91 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.825 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 183' ' ' LYS . 34.7 t70 62.99 -73.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.376 1.47 . . . . 0.0 109.467 -173.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 182' ' ' ASP . 22.4 pttm -167.98 113.86 0.69 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.598 1.159 . . . . 0.0 109.097 174.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -114.94 -4.77 12.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.091 0.948 . . . . 0.0 109.388 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -120.82 118.11 29.13 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.0 p -109.49 -27.99 2.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 190' ' ' SMC . 3.1 pp -119.21 162.47 18.63 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.27 -51.15 0.22 Allowed 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 125.197 1.399 . . . . 0.0 107.624 173.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -88.61 29.07 1.04 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.489 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . 0.479 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 80.35 -50.87 0.34 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.989 1.316 . . . . 0.0 110.987 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -94.06 131.04 39.96 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 12.4 p -58.59 142.37 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 123.87 0.731 . . . . 0.0 111.823 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 45.8 mm -88.67 133.2 31.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.6 p -109.12 147.37 32.56 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -96.48 134.18 39.99 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.77 142.23 37.16 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.72 112.58 13.44 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.069 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -82.06 117.17 22.04 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.162 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -90.86 88.59 7.11 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.354 0.597 . . . . 0.0 109.65 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.9 m -88.56 87.32 7.23 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.625 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.7 mt -142.68 137.07 29.64 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -108.08 165.8 11.2 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -91.83 175.88 6.72 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.671 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -146.7 132.58 19.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.94 166.3 10.53 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -144.63 142.41 30.1 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 125.711 1.604 . . . . 0.0 108.707 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -134.23 161.6 34.49 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.26 140.76 17.83 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -160.93 97.29 1.15 Allowed 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.582 ' O ' ' HG3' ' A' ' 212' ' ' ARG . 4.5 ttmp? -149.96 98.85 2.77 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.002 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 211' ' ' LYS . 83.7 mtt180 179.65 139.71 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.707 2.003 . . . . 0.0 109.322 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -132.25 158.93 40.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 120.668 0.27 . . . . 0.0 111.011 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -117.48 -32.53 4.88 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.332 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.11 102.99 8.74 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -84.91 -41.31 16.06 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.096 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -120.91 153.2 37.53 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.39 95.36 3.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.641 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -115.25 100.92 54.22 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.96 126.66 15.58 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 122.566 2.177 . . . . 0.0 111.659 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 31.5 pt -109.85 147.5 14.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 8.4 tp -73.47 123.99 29.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.406 0.622 . . . . 0.0 110.743 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 40.5 p -141.47 91.87 2.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.618 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.35 142.06 7.3 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.03 171.52 8.9 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.31 172.5 18.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -140.43 127.75 21.2 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.03 122.98 6.63 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -96.65 148.22 23.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.656 0.265 . . . . 0.0 110.632 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -135.55 161.98 24.82 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -144.9 176.08 24.17 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -96.3 -173.16 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.963 2.442 . . . . 0.0 112.374 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 235' ' ' PRO . . . -145.44 141.38 9.77 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 176.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 234' ' ' GLY . 6.0 Cg_exo -75.14 101.54 1.48 Allowed 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.526 2.151 . . . . 0.0 112.246 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -99.92 71.66 0.48 Allowed Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.797 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -116.51 92.38 0.57 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -134.42 141.51 46.84 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -176.33 122.4 0.85 Allowed Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -98.09 113.64 25.59 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.089 0.445 . . . . 0.0 110.684 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -82.7 150.9 26.47 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.826 0.345 . . . . 0.0 110.743 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -153.9 79.22 0.19 Allowed Glycine 0 C--N 1.301 -1.371 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.17 128.76 14.22 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.924 2.416 . . . . 0.0 111.519 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -151.51 158.81 44.09 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 132.74 79.76 0.16 Allowed Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 121.94 41.25 0.49 Allowed Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.387 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 33.7 t -151.46 144.85 24.8 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 153.26 -153.91 25.16 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 20.2 m -81.19 107.89 14.37 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -119.79 96.2 0.62 Allowed Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.911 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.74 -170.27 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.606 2.204 . . . . 0.0 109.909 174.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.6 p -86.03 17.4 3.56 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 1.7 mp 74.87 -66.07 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.705 1.202 . . . . 0.0 111.323 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -94.48 134.92 36.49 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.835 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.542 ' HG2' HG23 ' A' ' 256' ' ' VAL . 42.5 tt0 -65.04 149.16 50.35 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -171.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.542 HG23 ' HG2' ' A' ' 255' ' ' GLU . 25.5 t 67.54 -83.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 126.429 1.891 . . . . 0.0 112.38 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 CA--C 1.486 -1.488 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.25 -176.599 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 70.46 -80.47 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.846 1.658 . . . . 0.0 110.235 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 46.79 28.2 0.79 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.452 1.901 . . . . 0.0 115.581 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.5 m -81.21 76.4 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.429 1.109 . . . . 0.0 111.221 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -144.23 105.51 4.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.332 -1.303 . . . . 0.0 108.111 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -129.88 120.92 25.69 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.3 mp 69.89 -165.39 0.17 Allowed 'General case' 0 C--O 1.244 0.79 0 O-C-N 124.25 0.969 . . . . 0.0 109.528 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 tt 65.08 71.31 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -175.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.476 ' HG ' ' H ' ' A' ' 11' ' ' ASP . 54.9 tp -76.33 -68.86 0.55 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.901 -176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 10' ' ' LEU 0.261 4.0 mm? 63.8 11.21 5.73 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.476 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 2.3 m-20 -94.52 64.42 3.06 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 m -139.52 174.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.998 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.51 120.79 72.24 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.11 -43.33 30.23 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 122.486 2.124 . . . . 0.0 113.116 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.438 ' C ' ' HB3' ' A' ' 32' ' ' ARG . 10.0 mp -123.31 174.18 7.48 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 m -88.3 127.86 35.48 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.4 130.91 37.95 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.2 -170.74 19.76 Favored Glycine 0 N--CA 1.408 -3.169 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.452 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.4 mt -129.27 162.93 26.78 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.169 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.54 144.45 28.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 HD23 ' A' ' 158' ' ' LEU . 12.9 p -126.35 -94.29 0.47 Allowed 'General case' 0 C--N 1.272 -2.797 0 C-N-CA 122.946 0.498 . . . . 0.0 111.575 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.41 106.11 14.53 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.11 -60.64 4.78 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.752 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.91 56.43 0.1 Allowed Glycine 0 C--N 1.291 -1.928 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG13 ' HG2' ' A' ' 149' ' ' ARG . 89.9 t -122.11 115.33 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -175.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.62 114.02 22.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -106.72 111.39 23.9 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.78 132.04 36.7 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.031 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -49.8 3.47 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.32 102.68 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 152.99 37.23 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.571 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.563 HH12 ' HA ' ' A' ' 135' ' ' VAL . 36.9 ptt180 -62.58 160.7 13.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 73.82 5.13 4.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.772 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 9.9 t -65.84 135.2 54.53 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.779 0.799 . . . . 0.0 111.548 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 pt -98.89 155.42 36.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.548 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.06 144.59 75.54 Favored 'Cis proline' 0 C--O 1.25 1.089 0 N-CA-C 115.265 1.217 . . . . 0.0 115.265 4.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 p -122.16 161.3 23.4 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.282 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 4.8 ttmp? -166.08 100.6 0.64 Allowed 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 93' ' ' THR . 54.3 mt-30 -119.0 131.09 55.98 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.102 -175.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.7 m -114.44 122.44 46.63 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.53 0.732 . . . . 0.0 110.771 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.533 ' N ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -129.46 148.7 51.4 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mm -96.23 121.7 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.206 0.527 . . . . 0.0 110.397 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 79.6 m-85 -109.26 143.66 38.43 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.625 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 16.9 p -119.78 171.17 8.59 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -113.89 141.7 47.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 29.9 m-85 -88.18 -41.09 13.22 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 p -73.87 130.43 39.89 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.557 175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -106.46 166.82 10.27 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.072 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 67.88 23.81 8.27 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.312 0.645 . . . . 0.0 112.091 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.601 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 15.0 mm-40 -81.86 132.77 53.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.07 -39.63 30.79 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 121.554 1.502 . . . . 0.0 110.674 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.35 166.72 33.79 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG13 HG13 ' A' ' 80' ' ' ILE . 16.1 m -106.48 135.07 46.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.09 0.471 . . . . 0.0 110.947 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.7 tp -84.46 107.26 16.62 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.681 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -96.18 114.7 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -122.56 110.79 16.01 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.562 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -91.83 127.01 44.38 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 O-C-N 123.594 0.559 . . . . 0.0 111.371 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 53.0 m-85 -133.62 155.26 49.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 70' ' ' ASN . 40.1 mt-10 -110.76 143.27 41.55 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 165.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.38 112.49 0.62 Allowed Glycine 0 C--N 1.263 -3.486 0 C-N-CA 118.285 -1.912 . . . . 0.0 111.105 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.48 86.46 5.16 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -145.18 146.02 31.58 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -66.25 -50.15 64.75 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.402 1.096 . . . . 0.0 109.846 172.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.2 mtt -112.22 130.3 55.97 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.18 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 101.79 1.03 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 123.912 0.757 . . . . 0.0 109.69 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -76.28 -52.7 9.45 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 122.01 0.91 . . . . 0.0 108.684 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -153.5 -54.0 0.11 Allowed 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.36 -176.77 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.27 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 65.9 t30 -95.38 112.74 24.4 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.075 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.9 114.08 17.54 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -92.27 -34.41 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.669 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.67 176.16 39.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.23 170.4 20.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 117.032 0.416 . . . . 0.0 110.026 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -164.22 155.43 15.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -114.68 118.94 35.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.213 0.53 . . . . 0.0 110.133 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -95.49 108.03 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.3 p -97.03 150.18 21.08 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.81 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.67 24.01 1.78 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.812 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 50.6 mm -82.51 125.19 76.77 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.84 163.27 35.92 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.544 2.163 . . . . 0.0 112.348 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.35 40.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.217 2.611 . . . . 0.0 111.208 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 87' ' ' VAL . . . -84.74 124.91 72.37 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.75 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 16.6 Cg_exo -66.13 99.82 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.148 2.565 . . . . 0.0 115.506 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.4 mtp180 54.91 114.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.617 1.967 . . . . 0.0 115.442 167.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.98 -20.6 31.78 Favored Glycine 0 C--N 1.313 -0.708 0 C-N-CA 120.661 -0.781 . . . . 0.0 114.764 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 83' ' ' ALA . 21.7 t -73.79 -47.03 6.95 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 122.458 -0.436 . . . . 0.0 111.416 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.99 113.26 3.51 Favored 'Trans proline' 0 C--N 1.376 2.005 0 N-CA-C 108.782 -1.276 . . . . 0.0 108.782 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.288 0.0 OUTLIER -129.78 128.01 41.52 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.05 0.929 . . . . 0.0 113.049 -178.14 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 mm -107.14 126.72 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.713 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.18 107.73 19.4 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.04 120.56 60.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.322 0.582 . . . . 0.0 110.152 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 62.5 m -113.55 124.76 53.12 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.146 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -105.86 114.34 28.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -123.66 138.58 54.51 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.8 mt -125.71 141.99 43.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -104.78 -170.14 1.72 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.6 -11.81 60.55 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -84.96 -28.76 25.61 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.029 0.442 . . . . 0.0 109.825 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.44 23.34 8.03 Favored Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 86.6 mt -90.3 117.57 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-O 121.382 0.611 . . . . 0.0 109.526 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 38.6 tp -95.74 129.27 43.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.646 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 45.4 m-80 -117.62 108.68 15.74 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 47.1 t -88.84 113.79 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -111.32 114.44 27.61 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.303 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.19 123.62 47.12 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.471 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.1 m -118.5 119.92 35.98 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.414 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.84 104.5 6.41 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -68.31 -18.31 64.48 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.582 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -68.43 -61.96 1.6 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.855 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 p -98.98 -37.71 9.27 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 120.8 0.333 . . . . 0.0 111.346 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.24 -0.59 8.21 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.045 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.0 137.31 55.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 117.406 0.603 . . . . 0.0 112.03 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.92 136.85 32.67 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.131 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -139.96 139.52 36.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 21.4 ptmt -137.95 142.01 40.54 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.128 0.49 . . . . 0.0 110.689 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 34.4 pt -119.17 147.66 22.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.5 m -106.96 113.45 26.94 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.017 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.417 HD11 HD12 ' A' ' 117' ' ' ILE . 50.7 mt -128.83 116.4 40.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.7 m -72.54 127.32 32.19 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 168.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -41.16 -53.68 3.06 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 124.339 1.024 . . . . 0.0 111.217 -170.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.9 t70 62.05 -148.98 0.38 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.635 0.774 . . . . 0.0 110.579 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -55.81 3.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.752 0.311 . . . . 0.0 111.448 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.85 -130.12 10.12 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -116.37 -165.75 1.08 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.3 mt 60.92 -171.98 0.14 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.228 1.011 . . . . 0.0 112.28 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.7 p -106.67 159.48 16.18 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -63.62 -29.81 71.0 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 122.642 0.377 . . . . 0.0 110.463 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.66 -42.71 97.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.957 175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.31 -30.18 69.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.706 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 135' ' ' VAL . 48.0 mm -61.15 -45.3 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.66 -25.04 62.82 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -60.21 -45.0 94.68 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.5 mmt -59.48 -45.07 92.72 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.563 ' HA ' HH12 ' A' ' 32' ' ' ARG . 96.2 t -60.29 -57.66 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.085 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -70.22 -48.47 56.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -172.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.54 -38.62 91.81 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.02 -39.72 83.07 Favored 'General case' 0 C--O 1.19 -2.079 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.602 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -58.26 -33.31 69.25 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.493 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.4 -37.81 51.12 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -126.19 15.75 7.82 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -59.3 -27.31 65.74 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.48 95.52 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.772 0.796 . . . . 0.0 108.867 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 24.8 mm-40 -70.61 -44.96 66.17 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.506 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 3.0 m-20 -56.99 -45.42 83.0 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 123.545 0.528 . . . . 0.0 112.266 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 38.2 mt-10 -61.24 -39.29 89.75 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.79 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 82.9 t -63.74 -48.73 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.6 mm-40 -56.18 -46.06 79.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.519 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.436 ' HD3' ' C ' ' A' ' 149' ' ' ARG . 2.5 tmt_? -53.29 -50.83 64.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.593 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.1 pt-20 -83.18 -5.14 59.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 11.7 mmp_? -76.29 -34.54 59.07 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.88 -54.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 49.0 m -149.32 129.18 13.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.0 -38.04 9.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.01 0.434 . . . . 0.0 110.779 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HE3' ' OG1' ' A' ' 45' ' ' THR . 64.1 tttp -80.65 144.93 31.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 90.0 m-20 -76.68 99.13 4.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.319 0.581 . . . . 0.0 110.675 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -134.6 132.82 39.5 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.907 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.598 HD23 HG22 ' A' ' 21' ' ' THR . 18.5 mt -101.13 114.32 28.15 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.1 119.32 37.64 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.0 m -86.04 131.06 34.35 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 79.9 t80 80.06 -52.84 0.38 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.098 1.359 . . . . 0.0 108.927 -172.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 60.23 92.96 0.04 OUTLIER 'General case' 0 C--O 1.245 0.824 0 C-N-CA 124.913 1.285 . . . . 0.0 112.629 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -90.41 97.01 10.94 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.871 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 47.5 95.22 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 171.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.7 mmt -103.18 108.94 20.33 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -138.38 161.49 36.82 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.339 0.59 . . . . 0.0 111.006 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.3 t -144.66 81.14 1.65 Allowed 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.58 167.46 9.78 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.27 -171.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -102.68 -169.25 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 170' ' ' GLU . 0.6 OUTLIER -86.73 118.25 26.01 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.204 0.526 . . . . 0.0 110.382 176.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.64 -32.3 47.26 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.518 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -80.08 153.0 29.04 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.581 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -88.58 66.66 3.15 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.96 76.84 9.33 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.334 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 47.3 tttm 164.09 -71.15 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 126.521 1.928 . . . . 0.0 107.594 172.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.22 117.02 0.32 Allowed Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.817 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.18 -33.68 38.08 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.2 tp -148.51 82.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.745 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 57.0 m -95.02 130.19 41.79 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.263 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -44.64 105.22 0.05 Allowed 'General case' 0 C--O 1.243 0.762 0 C-N-CA 125.345 1.458 . . . . 0.0 113.626 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.94 103.25 14.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.21 -38.87 92.6 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.098 -171.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -92.26 -38.72 11.92 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.663 -174.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 184' ' ' LYS . 0.1 OUTLIER 172.15 -33.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.78 0.832 . . . . 0.0 109.816 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.588 ' HG2' ' H ' ' A' ' 186' ' ' VAL . 37.3 ttmt -162.95 -172.16 2.95 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 101.013 -3.699 . . . . 0.0 101.013 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.588 ' H ' ' HG2' ' A' ' 185' ' ' LYS . 7.4 p -55.13 -43.14 68.87 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-N 119.198 0.908 . . . . 0.0 111.082 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 96.1 mt -138.66 -75.72 0.38 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.269 0.557 . . . . 0.0 111.627 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 185' ' ' LYS . 6.5 p-10 -86.45 -173.1 4.36 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.598 -174.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -127.87 -71.02 0.67 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -76.86 -33.19 57.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.701 0.762 . . . . 0.0 109.947 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.94 -9.27 14.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.464 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.79 -44.22 99.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 13.0 tt -109.52 -32.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.257 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.1 m -81.23 53.68 2.09 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -92.4 -23.84 19.07 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.0 mt -104.31 149.9 24.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 172.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.71 -30.35 11.78 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.976 -174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -125.1 -174.67 3.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.95 146.1 32.7 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 7.6 p -80.47 -58.89 2.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.085 0.945 . . . . 0.0 109.99 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 64.5 tp -130.02 -51.69 1.12 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -147.58 -53.27 0.21 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.34 -55.75 0.13 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.023 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -174.57 -64.23 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -167.3 135.16 2.48 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 173.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -112.49 126.72 55.63 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.05 0.452 . . . . 0.0 110.644 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -84.18 -33.92 24.08 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.895 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -140.05 124.28 17.8 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -117.83 -47.46 2.6 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -144.28 124.83 14.0 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 115.498 -0.774 . . . . 0.0 108.988 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.412 ' HB3' ' HG3' ' A' ' 214' ' ' GLU . 92.9 mtt180 -84.41 93.27 8.25 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.795 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 79.16 9.61 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.853 1.311 . . . . 0.0 110.127 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 212' ' ' ARG . 37.7 mt-10 -85.31 178.22 7.55 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.302 -1.772 . . . . 0.0 109.996 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.7 tp 76.81 149.97 0.11 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.845 1.258 . . . . 0.0 108.489 -172.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -64.18 133.03 52.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -66.76 95.8 0.37 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.568 0.699 . . . . 0.0 109.93 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.57 117.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.194 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 55.1 t30 175.27 135.2 0.17 Allowed Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.78 101.36 0.56 Allowed 'Trans proline' 0 C--O 1.247 0.951 0 N-CA-C 107.365 -1.821 . . . . 0.0 107.365 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 28.2 pt -54.8 -61.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.2 mm 57.87 97.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.337 0.655 . . . . 0.0 110.185 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 54.5 p -79.79 92.9 5.51 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.476 -0.765 . . . . 0.0 110.368 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -88.87 98.52 2.45 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 43.6 tp 63.9 80.36 0.23 Allowed 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.996 0.903 . . . . 0.0 109.695 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -82.81 -42.94 17.27 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.898 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -141.35 109.84 5.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.705 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -113.11 83.89 0.34 Allowed Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.85 113.42 9.86 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -154.59 48.42 0.51 Allowed Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -95.28 109.66 3.88 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -60.67 106.15 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.878 2.386 . . . . 0.0 112.609 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -136.93 101.24 0.34 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.35 -0.58 10.85 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.765 2.31 . . . . 0.0 112.584 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -72.99 151.52 45.84 Favored Glycine 0 C--O 1.248 1.028 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 104.53 92.79 2.27 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 80.0 t80 69.4 108.94 0.05 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.667 1.187 . . . . 0.0 110.559 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -115.39 -140.2 7.03 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.3 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -101.3 136.42 41.18 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.44 157.83 15.83 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 123.44 0.462 . . . . 0.0 109.825 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -97.4 126.98 9.06 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -63.91 111.16 1.47 Allowed 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.194 1.929 . . . . 0.0 109.738 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -64.1 108.87 1.65 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.116 -174.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 156.63 -98.62 0.18 Allowed Glycine 0 N--CA 1.424 -2.135 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -84.31 57.53 5.03 Favored Glycine 0 C--O 1.246 0.851 0 C-N-CA 121.725 -0.274 . . . . 0.0 113.762 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.7 p -78.2 132.61 37.66 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.79 -148.47 21.29 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 60.0 m -101.92 23.64 11.15 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.157 0.503 . . . . 0.0 110.923 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -159.5 98.65 0.17 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.558 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.8 76.08 3.44 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.807 2.338 . . . . 0.0 108.153 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 63.3 m 69.88 98.32 0.06 Allowed 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.045 -168.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 26.9 pt -54.43 159.05 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.573 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.63 90.25 2.8 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.519 0.676 . . . . 0.0 109.721 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.73 82.31 8.48 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.894 0.854 . . . . 0.0 110.579 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.78 100.35 3.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 C--N 1.281 -2.373 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.77 -174.627 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -84.14 95.24 8.56 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -87.14 99.8 12.19 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.93 154.18 19.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.072 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -64.31 132.19 49.47 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -53.76 -31.33 48.2 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.58 1.152 . . . . 0.0 113.396 -173.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.77 80.33 6.17 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.5 mp -103.54 72.94 1.16 Allowed 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.2 mt -125.35 104.84 8.68 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.144 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 12' ' ' VAL . 49.4 tp -91.65 88.64 6.8 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 174.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.8 m-20 -78.76 56.99 1.98 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.538 -172.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG22 ' HG ' ' A' ' 10' ' ' LEU . 10.0 m -136.56 168.37 22.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.8 127.2 68.42 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.68 -47.34 9.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.578 2.185 . . . . 0.0 111.972 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CB ' ' HB3' ' A' ' 60' ' ' GLU . 3.9 mm? -123.19 169.83 10.86 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.151 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 19.7 m -76.79 129.47 36.32 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.1 131.55 40.97 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.84 178.13 26.6 Favored Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.865 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.7 mt -123.93 164.71 18.75 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.324 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -84.18 109.58 17.85 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 HD23 ' A' ' 158' ' ' LEU . 12.2 p -99.19 142.47 30.64 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.461 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.64 113.91 0.68 Allowed 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.355 1.462 . . . . 0.0 113.049 -172.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.08 -11.46 8.2 Favored Glycine 0 N--CA 1.425 -2.06 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.384 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' A' ' 20' ' ' GLU . . . 84.49 50.33 4.29 Favored Glycine 0 N--CA 1.429 -1.818 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -123.64 134.75 65.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.2 ttt -94.23 101.35 13.32 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.809 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -95.42 119.23 33.56 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 143.79 26.18 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.5 mp -102.11 -44.57 5.41 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.235 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.84 129.07 76.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -85.7 167.11 15.58 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ptt85 -69.13 165.37 20.49 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.879 0.371 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 68.78 9.31 7.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.583 1.153 . . . . 0.0 112.659 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.2 m -81.61 118.74 23.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 13.2 p -62.76 126.94 29.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.9 pt -91.6 164.68 23.33 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.37 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.3 Cg_exo -68.76 122.77 5.78 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.353 1.162 . . . . 0.0 113.477 1.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -95.17 156.73 16.19 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.495 0.718 . . . . 0.0 110.106 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -160.13 104.05 1.48 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.634 HE22 ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -129.52 120.9 26.15 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -175.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.0 m -107.39 141.51 38.65 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.569 0.748 . . . . 0.0 110.492 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.634 ' HG3' HE22 ' A' ' 40' ' ' GLN . 88.9 mt-30 -136.62 162.01 34.31 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.703 0.401 . . . . 0.0 109.974 174.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.79 122.94 62.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -107.57 146.57 31.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.86 0.838 . . . . 0.0 111.932 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 3.3 p -114.74 173.08 6.66 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.582 -1.644 . . . . 0.0 108.749 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 p -113.31 151.13 31.55 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 112.243 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -108.0 7.38 27.83 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.725 0.774 . . . . 0.0 110.286 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -89.97 158.15 17.51 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.568 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -118.27 114.42 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 63.3 74.25 0.43 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.245 1.021 . . . . 0.0 111.081 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.45 ' CD ' ' H ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -102.73 121.13 50.59 Favored Pre-proline 0 C--N 1.292 -1.904 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.56 -178.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.18 -14.85 6.93 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.091 1.861 . . . . 0.0 110.891 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.87 150.76 20.89 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 160' ' ' SER . 29.0 m -118.41 158.64 19.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 tp -108.23 127.04 53.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.086 0.469 . . . . 0.0 111.426 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.26 105.36 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -113.02 123.51 50.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.82 119.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 123.9 0.75 . . . . 0.0 110.048 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 89.0 m-85 -122.68 156.78 33.66 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.171 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HB3' ' CB ' ' A' ' 15' ' ' LEU . 49.0 mt-10 -111.11 149.69 30.49 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.155 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -165.76 12.1 Favored Glycine 0 N--CA 1.422 -2.251 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 30.7 mt-10 -148.8 99.36 2.98 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.286 0.565 . . . . 0.0 109.88 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -130.01 153.36 48.5 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.317 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -65.98 -40.66 91.41 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.713 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 69.9 mtm -128.59 135.45 49.36 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.88 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 109.5 2.48 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 20.3 pttp -155.72 -44.99 0.08 Allowed 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.394 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.444 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 10.9 m-20 -128.67 82.74 2.1 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.464 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 19.6 m120 -145.45 170.43 16.39 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.145 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 71.0 m-20 -90.73 117.78 29.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.99 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.8 tp -85.88 108.1 17.99 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.54 -42.09 23.01 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.459 0.647 . . . . 0.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.38 35.52 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.515 ' HD2' ' O ' ' A' ' 74' ' ' ARG . 4.4 ppt_? -146.7 147.39 30.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 122.279 0.231 . . . . 0.0 110.874 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.51 157.21 31.67 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.95 135.99 48.41 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 59.4 tp -97.12 104.5 16.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 173.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.3 p -103.32 154.5 19.31 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.37 10.53 25.4 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.99 135.54 85.2 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.94 115.82 4.49 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.673 1.582 . . . . 0.0 110.181 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.3 102.72 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.065 2.51 . . . . 0.0 111.727 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.17 173.23 6.12 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.614 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.71 171.51 2.7 Favored 'Trans proline' 0 C--O 1.262 1.708 0 C-N-CA 122.451 2.101 . . . . 0.0 112.836 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -62.6 117.97 6.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.643 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.465 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 88.54 19.39 52.26 Favored Glycine 0 CA--C 1.494 -1.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.955 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.412 ' H ' ' HD2' ' A' ' 88' ' ' PRO . 62.7 t -91.25 -54.89 0.27 Allowed Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.398 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' A' ' 87' ' ' VAL . 18.1 Cg_endo -58.78 138.28 84.81 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 121.748 1.632 . . . . 0.0 112.044 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -102.71 96.11 6.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.642 0.734 . . . . 0.0 111.339 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.9 mm -92.48 133.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -112.63 119.14 37.11 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.2 t -120.91 127.97 76.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 95.7 m -118.71 127.41 53.53 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.66 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 29' ' ' LEU . 9.1 m-85 -105.5 113.26 26.73 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' HB3' ' HG2' ' A' ' 39' ' ' LYS . 2.6 p30 -132.92 140.97 48.12 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 60.9 mt -127.5 126.42 67.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.468 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.0 p30 -90.84 179.02 5.88 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.07 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.97 -21.74 63.8 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.06 -16.7 54.51 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.03 29.18 8.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 73.1 mt -94.8 117.68 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.4 tp -94.4 115.09 27.23 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.802 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -103.56 120.75 41.5 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.629 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.94 114.15 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.1 m -118.01 126.96 53.31 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.81 124.59 52.15 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -126.49 120.77 30.52 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.69 99.29 5.78 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -68.98 -6.19 26.27 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -70.13 -50.23 42.63 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 p -97.82 -43.24 7.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.545 0.688 . . . . 0.0 111.242 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.18 25.66 5.49 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -96.82 142.15 29.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -136.21 149.0 48.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.143 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.407 ' OD1' ' HA ' ' A' ' 77' ' ' LEU . 10.6 m120 -144.75 135.0 24.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 125.184 1.394 . . . . 0.0 107.33 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -124.73 166.74 15.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.039 0.447 . . . . 0.0 111.214 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.0 tt -140.36 140.31 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.1 m -116.14 113.77 23.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.821 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.6 mm -97.13 101.57 12.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.7 p -92.36 103.36 15.81 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.262 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.3 m120 76.81 149.25 0.1 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.511 1.124 . . . . 0.0 113.531 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -67.7 -43.53 79.86 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.109 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -82.64 -0.2 46.05 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.906 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.51 -11.79 65.79 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -123.57 -45.23 2.07 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.804 0.335 . . . . 0.0 111.458 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 70' ' ' ASN . 86.7 mt -118.0 -175.71 2.9 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.661 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 67.5 p -78.71 -75.98 0.21 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 127' ' ' SER . 5.4 tmtp? 156.7 -27.0 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 128.511 2.725 . . . . 0.0 106.557 174.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.63 -49.24 77.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.663 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.43 -33.36 74.64 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.353 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 135' ' ' VAL . 62.8 mt -63.34 -52.4 58.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -61.82 -38.51 88.4 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.504 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -63.76 -40.66 97.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.464 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 2.1 tpt -63.1 -39.54 94.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.358 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 131' ' ' ILE . 57.4 t -55.98 -50.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 123.227 0.329 . . . . 0.0 110.221 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -58.02 -55.79 30.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.191 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.68 -43.12 99.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.83 88.9 Favored 'General case' 0 C--O 1.204 -1.308 0 O-C-N 123.41 0.444 . . . . 0.0 111.855 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -77.89 -37.64 47.62 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.817 0.341 . . . . 0.0 111.75 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -111.45 19.78 17.87 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -52.73 -56.96 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.661 1.185 . . . . 0.0 110.699 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.88 89.06 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.101 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.55 -50.9 67.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.306 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.24 -39.26 75.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.69 -33.49 75.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.781 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 70.7 t -64.58 -45.29 95.94 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.41 ' O ' HG23 ' A' ' 152' ' ' VAL . 78.4 mt-30 -64.25 -37.57 87.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.795 0.331 . . . . 0.0 110.643 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 52.1 ttp180 -61.62 -32.14 72.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.883 0.873 . . . . 0.0 112.01 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -89.3 -21.12 23.32 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.289 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 23.7 mmm180 -68.5 -42.85 78.02 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 148' ' ' GLN . 60.7 t -70.43 137.11 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.2 p -70.71 86.03 0.66 Allowed 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.107 0.956 . . . . 0.0 111.126 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.97 166.82 10.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.532 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -170.33 164.23 8.83 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -80.29 74.91 7.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.899 0.857 . . . . 0.0 109.546 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -135.82 127.56 29.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.924 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 21' ' ' THR . 28.5 mt -97.37 152.77 18.59 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.426 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -78.02 172.37 13.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.516 ' H ' ' CD ' ' A' ' 159' ' ' GLU . 34.9 m -112.55 -25.66 9.05 Favored 'General case' 0 N--CA 1.413 -2.293 0 O-C-N 121.704 -0.622 . . . . 0.0 112.25 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -157.34 85.8 0.93 Allowed 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.135 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.1 93.47 2.39 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.384 0.612 . . . . 0.0 109.835 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -95.23 76.31 3.43 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.511 0.672 . . . . 0.0 110.455 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -67.83 -37.68 82.23 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.45 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 50.2 ttm -127.69 128.78 46.02 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.424 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -121.54 -63.26 1.33 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.7 m 64.92 -43.75 0.32 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.1 149.51 30.72 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 122.07 -0.394 . . . . 0.0 111.532 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.6 t -84.21 -29.27 7.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 68.46 99.58 0.06 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.447 1.499 . . . . 0.0 112.542 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -98.62 115.04 27.79 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.17 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.43 105.54 2.22 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 124.104 0.878 . . . . 0.0 110.641 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -122.79 122.82 5.15 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.1 mt -130.28 83.49 2.13 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 122.671 0.388 . . . . 0.0 110.106 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -150.71 103.67 3.12 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.552 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -130.08 107.61 0.79 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -87.56 -34.77 18.46 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.554 0.177 . . . . 0.0 111.252 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 57.6 mt 59.76 93.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.818 0 CA-C-O 122.053 0.93 . . . . 0.0 110.158 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 19.8 m -68.7 168.6 12.87 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.916 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 81.48 159.95 0.15 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.3 1.44 . . . . 0.0 111.408 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -102.83 3.05 36.25 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -173.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.88 134.75 40.21 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.87 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -160.57 25.64 0.15 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.694 -1.139 . . . . 0.0 107.997 174.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.02 -35.98 0.16 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.3 mptt 62.07 69.08 0.64 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.793 0.437 . . . . 0.0 111.138 -167.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 90.8 t 69.5 123.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.134 0.974 . . . . 0.0 112.191 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.0 mp -91.82 89.87 7.24 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.633 -0.667 . . . . 0.0 110.077 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -127.88 112.68 14.97 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.717 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.13 33.64 5.31 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -122.3 125.64 46.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -76.92 113.21 14.36 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.493 0.663 . . . . 0.0 112.185 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.69 133.28 61.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.71 -50.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.696 -174.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 19.9 m -85.27 90.9 8.02 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.811 0.815 . . . . 0.0 112.005 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -91.72 -35.21 14.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.811 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.9 tt -142.31 -73.47 0.3 Allowed 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.3 t70 170.64 -179.58 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -89.47 -30.94 17.93 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -159.22 101.95 1.58 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 13.5 t -63.64 122.37 16.19 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.994 0.902 . . . . 0.0 111.479 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 65.8 tp -143.99 78.0 1.57 Allowed 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.157 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -113.19 -16.86 12.49 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.099 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -93.84 109.34 21.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.053 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -115.76 131.56 56.9 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.31 108.27 19.53 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.185 0.516 . . . . 0.0 111.097 -174.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.62 107.18 19.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -146.97 138.04 23.95 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.37 112.16 21.83 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -132.65 8.19 4.18 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.768 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -117.8 86.28 2.49 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.473 ' HD3' ' N ' ' A' ' 213' ' ' LYS . 2.2 tmt_? -70.94 137.88 49.58 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.185 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.593 ' HE2' ' N ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -151.8 149.92 29.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.318 0.386 . . . . 0.0 109.974 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -144.53 125.59 14.52 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.0 mt -118.58 105.48 11.67 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 120.914 0.388 . . . . 0.0 111.206 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.551 ' OE2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -138.55 132.26 30.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 175.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -154.87 16.0 0.43 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.041 0.448 . . . . 0.0 110.431 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.551 HG22 ' OE2' ' A' ' 216' ' ' GLU 0.276 34.4 m -87.06 80.08 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 122.832 1.301 . . . . 0.0 112.476 -178.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -69.07 -52.61 15.62 Favored Pre-proline 0 CA--C 1.559 1.311 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.2 105.9 1.28 Allowed 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 121.436 1.424 . . . . 0.0 113.787 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.6 pp -107.04 151.88 8.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.005 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.37 127.77 68.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.229 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t -112.85 140.43 47.65 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -61.58 123.39 31.82 Favored Glycine 0 N--CA 1.444 -0.802 0 O-C-N 123.444 0.465 . . . . 0.0 112.821 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -91.61 91.73 8.16 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -104.3 -5.89 21.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.212 1.006 . . . . 0.0 108.717 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -65.6 115.89 6.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.107 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -171.85 105.63 0.22 Allowed Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -132.44 -173.01 3.05 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 174.41 -176.3 46.74 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.518 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 119.25 126.81 3.54 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.74 -30.33 41.56 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.027 1.818 . . . . 0.0 111.982 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 101.4 178.43 28.62 Favored Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.3 122.82 8.67 Favored 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 122.519 2.146 . . . . 0.0 111.606 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -135.87 8.89 4.22 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.26 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -114.31 63.05 0.31 Allowed Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.876 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -94.12 -66.86 0.89 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.7 120.55 2.56 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -124.12 157.41 34.7 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -113.08 116.36 29.76 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.16 65.79 0.18 Allowed Glycine 0 C--N 1.297 -1.593 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -87.68 148.0 7.23 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.062 1.842 . . . . 0.0 111.029 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -78.77 85.82 4.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.634 0.73 . . . . 0.0 110.116 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -133.5 42.9 1.32 Allowed Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -134.3 71.41 0.49 Allowed Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.8 t -86.61 115.6 24.18 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -90.92 178.93 42.52 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 120.804 -0.712 . . . . 0.0 114.49 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 27.2 t -157.49 175.23 14.23 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -82.94 152.19 29.65 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.634 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.24 -42.94 63.05 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.604 2.203 . . . . 0.0 109.636 172.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 91.2 m -100.07 112.33 24.62 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 170.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.6 pp -77.14 143.63 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.631 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.1 137.78 42.32 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.546 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -69.15 -42.49 75.89 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.155 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.9 m -87.17 77.14 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 122.627 1.203 . . . . 0.0 111.54 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.298 -1.655 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.688 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.444 -0.775 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -124.94 119.09 27.77 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.16 114.07 15.57 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.2 p -140.69 -53.83 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -127.53 25.74 6.04 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 8.5 p-10 -131.97 139.59 48.71 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.421 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 6' ' ' ASP . 26.6 mt -161.88 109.81 1.42 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 125.264 1.426 . . . . 0.0 108.718 175.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.8 mt 71.95 143.65 0.06 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.24 1.416 . . . . 0.0 111.663 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -102.05 81.01 2.05 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 tp -107.52 21.0 18.12 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.925 1.345 . . . . 0.0 108.79 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.04 62.69 3.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 122.911 1.338 . . . . 0.0 110.03 177.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 35' ' ' THR . 32.4 m -144.42 -179.81 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.95 112.57 52.99 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.68 -13.91 10.45 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 121.586 1.524 . . . . 0.0 111.617 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 131' ' ' ILE . 89.1 mt -135.57 166.15 23.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.623 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 27.3 m -103.65 116.24 31.98 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.58 130.94 38.08 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.05 -177.62 18.18 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.502 -0.856 . . . . 0.0 114.072 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.9 mt -124.78 166.0 17.0 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.081 0.552 . . . . 0.0 111.584 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.49 109.12 17.1 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.512 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 5.9 p -113.69 156.58 23.5 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.487 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 119.68 6.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.451 1.1 . . . . 0.0 113.286 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.72 4.44 28.15 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.286 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.59 38.31 28.47 Favored Glycine 0 CA--C 1.494 -1.247 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 152' ' ' VAL . 63.5 t -99.44 142.21 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.39 -0.905 . . . . 0.0 108.667 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.415 ' HB2' ' N ' ' A' ' 66' ' ' THR . 0.9 OUTLIER -108.92 103.12 12.1 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.217 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -91.95 110.71 22.07 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.75 115.58 28.18 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 123.717 0.636 . . . . 0.0 110.551 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.493 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.5 mp -91.21 -49.3 6.45 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 16' ' ' SER . 49.5 mm -97.58 91.04 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -85.76 148.43 25.85 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.874 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -57.38 150.56 18.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 76.64 11.39 2.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.044 1.738 . . . . 0.0 112.408 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 m -94.31 113.4 25.29 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.407 ' HA ' HG12 ' A' ' 12' ' ' VAL . 3.4 m -65.36 143.34 57.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 39.6 pt -96.15 162.29 24.29 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 23.7 Cg_exo -68.64 132.21 19.95 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.958 1.021 . . . . 0.0 113.614 -0.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.76 154.89 18.25 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.903 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 95' ' ' ASP . 50.9 tptt -149.04 101.46 3.16 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -124.03 135.92 53.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 92.1 m -135.51 138.57 43.22 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -133.37 145.94 50.8 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 122.905 0.482 . . . . 0.0 109.76 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.41 122.09 55.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -114.42 155.94 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.82 171.55 8.34 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 123.732 0.813 . . . . 0.0 108.879 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -98.9 136.07 39.42 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.098 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -99.18 -14.2 19.42 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.949 0.88 . . . . 0.0 109.021 172.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -95.63 113.65 25.32 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.769 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.26 139.99 41.38 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 62.04 55.95 2.4 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 52' ' ' PRO . 70.9 mm-40 -101.39 136.81 19.57 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 175.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.403 ' HD2' ' OE1' ' A' ' 51' ' ' GLN . 54.5 Cg_endo -72.14 -25.92 18.56 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.576 2.184 . . . . 0.0 111.794 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' A' ' 80' ' ' ILE . . . -171.88 168.0 41.06 Favored Glycine 0 N--CA 1.407 -3.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.569 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.25 138.01 44.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.1 tp -90.51 104.21 16.82 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.294 0.569 . . . . 0.0 109.822 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.98 117.1 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -135.43 119.37 17.41 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.744 -171.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.09 122.49 47.63 Favored 'Isoleucine or valine' 0 C--O 1.248 0.975 0 O-C-N 124.33 1.018 . . . . 0.0 110.811 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 69' ' ' ASN . 40.3 m-85 -120.7 149.55 42.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.905 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' OE2' HD13 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -119.17 157.74 27.33 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' SD ' ' A' ' 134' ' ' MET . . . 104.51 15.95 19.42 Favored Glycine 0 C--N 1.31 -0.909 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 167.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.595 ' OE1' ' HG3' ' A' ' 67' ' ' LYS . 47.4 mm-40 -144.14 179.52 7.16 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 118.309 1.055 . . . . 0.0 112.116 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -120.03 -72.11 0.7 Allowed 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.269 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -91.97 -50.69 5.57 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.5 mtt -127.93 145.33 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.415 ' N ' ' HB2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -72.26 107.35 4.84 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.672 -174.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.595 ' HG3' ' OE1' ' A' ' 62' ' ' GLU . 10.7 pttp -137.48 -76.45 0.4 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 123.339 0.655 . . . . 0.0 111.587 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.78 75.08 4.94 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 122.77 1.271 . . . . 0.0 110.343 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.515 HD21 ' HB2' ' A' ' 62' ' ' GLU . 22.1 m120 -122.87 152.37 40.82 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.713 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -111.38 140.15 46.2 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.739 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.1 tp -83.17 119.89 25.1 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.4 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.9 mt -97.2 -65.82 0.94 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.744 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.15 154.45 21.61 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.264 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ptt85 -153.3 157.49 40.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -161.8 147.72 13.62 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.625 0.578 . . . . 0.0 109.492 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -94.5 113.88 25.79 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -88.78 103.39 15.93 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 p -119.0 166.37 12.95 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.91 18.32 12.64 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.449 HD13 ' HA2' ' A' ' 53' ' ' GLY . 1.8 mp -77.95 130.05 74.09 Favored Pre-proline 0 C--N 1.313 -1.014 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.65 154.17 74.1 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 122.483 2.122 . . . . 0.0 111.895 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.24 92.05 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.18 1.92 . . . . 0.0 110.739 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.14 155.98 80.77 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.184 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.99 176.95 8.44 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.31 2.007 . . . . 0.0 113.356 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 58.0 mtt85 -45.91 131.43 9.57 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.574 1.55 . . . . 0.0 113.124 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.43 -20.25 35.35 Favored Glycine 0 C--N 1.311 -0.807 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.427 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 54.9 t -74.73 -53.99 3.01 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 117.671 0.735 . . . . 0.0 112.805 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 5.5 Cg_exo -76.79 104.36 1.9 Allowed 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.346 1.364 . . . . 0.0 111.025 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -97.2 131.17 44.2 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.346 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.21 119.21 59.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -97.82 110.4 22.98 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.35 123.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.594 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.2 m -114.26 127.8 56.05 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.654 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.493 ' CD1' HD22 ' A' ' 29' ' ' LEU . 9.9 m-85 -111.3 121.01 44.13 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.621 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 1.7 p30 -138.07 137.7 38.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.942 0.401 . . . . 0.0 111.269 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 33.9 mt -121.78 123.84 70.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -88.48 -170.93 3.14 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 123.415 0.447 . . . . 0.0 111.545 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.8 -16.19 63.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.113 0.565 . . . . 0.0 112.346 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -83.18 -23.63 32.8 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.05 21.8 17.11 Favored Glycine 0 N--CA 1.419 -2.485 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 91.8 mt -90.01 117.61 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.428 0.632 . . . . 0.0 109.87 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 96' ' ' ILE . 16.7 tp -96.47 122.37 39.3 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.092 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -117.29 120.39 38.06 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.205 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.6 t -99.32 113.14 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.7 m -115.13 126.32 54.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.66 123.71 50.56 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 m -109.81 128.66 55.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.774 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 113' ' ' LYS . 5.6 t0 -85.41 107.21 17.28 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 124.939 1.296 . . . . 0.0 107.647 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -67.5 -18.25 64.98 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.0 m -86.11 -36.66 19.46 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.926 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -110.87 -29.14 8.07 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.3 22.55 19.21 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.151 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 108' ' ' ASP . 9.9 ptpp? -92.4 161.9 14.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.97 137.59 16.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.682 0.277 . . . . 0.0 111.065 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -129.99 142.06 50.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 60.7 pttt -129.34 155.5 45.53 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.146 177.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.1 pt -121.11 157.58 24.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 m -129.85 113.63 14.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.445 0.641 . . . . 0.0 111.551 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.8 mt -115.39 142.66 27.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 m -117.74 166.5 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -80.75 15.06 1.87 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.343 0.52 . . . . 0.0 111.383 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.38 -22.96 66.85 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 123.825 0.85 . . . . 0.0 109.889 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp 67.39 88.7 0.11 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.472 1.109 . . . . 0.0 110.067 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.64 -10.99 61.16 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.409 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -141.91 156.4 45.5 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.413 HD22 ' HG2' ' A' ' 130' ' ' GLU . 34.8 mt 68.3 176.98 0.26 Allowed 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.617 1.167 . . . . 0.0 113.091 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -127.8 -175.45 3.48 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -76.77 -15.48 59.74 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.778 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.98 -43.55 98.61 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.413 ' HG2' HD22 ' A' ' 126' ' ' LEU . 3.0 mp0 -64.29 -34.87 79.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.26 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.547 ' HA ' HD21 ' A' ' 15' ' ' LEU . 59.2 mt -60.98 -50.23 81.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.933 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.62 -26.68 60.9 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.774 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 136' ' ' GLN . 17.3 mmm180 -62.97 -36.84 84.84 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 173.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.419 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 15.6 ttt -59.24 -50.59 73.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 47.8 t -52.23 -53.8 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 124.084 0.865 . . . . 0.0 110.344 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.55 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.5 mt-30 -56.08 -46.84 78.88 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 124.095 0.872 . . . . 0.0 112.004 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.17 -39.49 60.26 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.755 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.69 -28.03 67.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 9.1 pt-20 -75.16 -41.96 57.01 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.1 0.476 . . . . 0.0 110.896 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 98.1 mttt -57.62 -48.55 79.11 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.066 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.08 21.47 6.76 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.333 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 39.3 ttmt -58.7 -44.04 90.19 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.59 0.756 . . . . 0.0 112.021 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.32 -49.43 27.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -63.62 -46.36 86.07 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 m-20 -66.19 -27.97 68.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.969 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 5.4 tp10 -64.47 -39.73 94.36 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.3 t -70.94 -48.23 57.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.911 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 27.7 mt-30 -57.0 -38.3 72.88 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 123.549 0.74 . . . . 0.0 112.921 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -71.43 -31.92 67.77 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.719 -0.793 . . . . 0.0 112.008 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.45 -8.21 56.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.164 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 23.5 mmt85 -82.14 0.84 39.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.64 0.733 . . . . 0.0 109.505 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 25' ' ' VAL . 33.4 t -114.36 113.87 45.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -78.56 153.54 31.13 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.63 67.96 2.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.278 1.037 . . . . 0.0 112.848 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.5 33.49 0.51 Allowed 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -59.83 157.21 12.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.736 -170.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.56 154.55 46.55 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.833 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 52.2 mt -91.73 142.88 27.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -82.97 118.52 23.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 118.106 -1.438 . . . . 0.0 107.456 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.2 m -103.68 86.66 2.66 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.293 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -103.59 95.91 6.37 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.045 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.86 140.02 42.0 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.02 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -84.98 -36.72 21.15 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.218 0.532 . . . . 0.0 110.083 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -133.48 112.25 11.38 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.696 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 60.5 mtm 66.21 -177.41 0.19 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.382 1.073 . . . . 0.0 112.776 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -125.15 89.81 3.12 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 168.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.9 m -72.38 62.01 0.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.716 0.77 . . . . 0.0 113.012 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -136.32 85.45 2.15 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.074 -0.967 . . . . 0.0 108.638 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.39 7.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 122.067 0.937 . . . . 0.0 108.618 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -77.34 90.13 3.77 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.168 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.9 t70 58.23 86.38 0.08 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.986 1.315 . . . . 0.0 111.769 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.64 177.53 5.89 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.027 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -82.08 69.49 3.31 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.576 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.13 -20.9 47.43 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.709 0.404 . . . . 0.0 110.311 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -60.93 -42.82 98.89 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.158 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.43 159.21 31.26 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.001 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 177' ' ' LYS . 6.6 tmtm? -101.7 -16.12 16.78 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 78.2 mt 84.17 -37.75 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.296 1.438 . . . . 0.0 112.67 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.497 ' O ' ' HD2' ' A' ' 177' ' ' LYS . 32.2 t -148.63 -171.18 3.8 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 59.03 49.44 9.48 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.263 1.025 . . . . 0.0 110.921 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 61.81 78.57 0.28 Allowed 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.469 1.108 . . . . 0.0 110.112 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.432 ' CG ' ' H ' ' A' ' 177' ' ' LYS . 45.6 t0 -95.36 153.83 17.49 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.967 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 183' ' ' LYS . 10.2 mptt -111.17 168.32 9.6 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.725 -172.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 71.34 13.23 6.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.596 1.159 . . . . 0.0 113.418 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.24 -49.77 6.78 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.0 m -115.44 158.72 15.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.609 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.3 tp -99.75 118.29 35.92 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -80.61 103.67 10.62 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.566 0.698 . . . . 0.0 110.44 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -95.44 -7.26 38.78 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -77.06 78.39 3.59 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 120.479 1.49 . . . . 0.0 111.358 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 194' ' ' ILE . 40.9 tt0 -165.98 140.8 4.64 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.014 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.78 -32.35 57.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.491 ' H ' ' HG2' ' A' ' 192' ' ' GLU 0.297 9.8 tp 54.03 -56.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 C-N-CA 127.21 2.204 . . . . 0.0 114.115 -175.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.1 m -92.65 81.56 4.77 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -77.71 -7.85 57.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.054 0.93 . . . . 0.0 111.18 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.2 147.52 35.02 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -105.06 -67.2 0.92 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 69.01 151.87 0.09 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.044 1.338 . . . . 0.0 112.354 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -155.37 109.0 2.82 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.409 ' H ' ' CD ' ' A' ' 207' ' ' GLU . 39.6 p -104.8 12.05 33.12 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.74 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 89.3 mt 76.47 93.05 0.07 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 125.658 1.583 . . . . 0.0 111.756 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.15 142.26 20.34 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -83.39 -32.14 26.32 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.763 0.792 . . . . 0.0 109.149 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -91.48 177.38 6.24 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.836 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.8 103.7 1.5 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.741 0.305 . . . . 0.0 111.19 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 201' ' ' THR . 8.9 pt-20 -85.82 -29.84 23.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.958 0.885 . . . . 0.0 109.297 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -113.14 136.87 52.24 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.324 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.75 179.76 8.97 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 166.52 69.41 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 126.805 2.042 . . . . 0.0 109.344 169.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -72.43 -42.91 64.52 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -176.73 90.13 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.177 169.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -116.87 105.97 12.94 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.428 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.78 75.26 1.51 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.9 tp -128.44 -26.24 2.81 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.352 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.46 73.23 6.13 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -84.69 51.3 2.1 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.815 0.817 . . . . 0.0 110.878 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 23.3 m -82.05 86.47 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 CA-C-O 122.651 1.215 . . . . 0.0 111.051 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -104.43 157.21 34.58 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.445 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.03 50.59 0.63 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 123.345 2.696 . . . . 0.0 112.714 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.1 tt -75.46 -30.93 22.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 123.391 0.676 . . . . 0.0 109.35 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.8 pt -88.58 157.23 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 21.3 t -148.7 -41.91 0.15 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 92.88 -121.92 6.72 Favored Glycine 0 N--CA 1.423 -2.187 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 97.1 mt 67.32 102.95 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.107 0.963 . . . . 0.0 112.448 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -83.15 153.76 24.64 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.811 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -87.06 -38.32 16.63 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.108 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 166.96 -127.62 1.61 Allowed Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -114.85 101.13 8.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -76.8 -42.42 20.87 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.483 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 115.25 177.12 18.69 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -87.92 17.01 1.78 Allowed 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.761 2.308 . . . . 0.0 112.59 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 79.31 -120.58 5.3 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.23 105.46 1.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.97 1.78 . . . . 0.0 109.373 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.27 178.23 22.59 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.108 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -117.96 -65.17 0.32 Allowed Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.241 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -114.93 113.75 24.56 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.104 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -108.6 -53.55 0.63 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -148.16 -52.3 0.18 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 61.37 91.02 0.06 Allowed 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.114 1.365 . . . . 0.0 112.154 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -124.07 -87.44 0.77 Allowed Glycine 0 C--N 1.299 -1.499 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.46 147.2 46.05 Favored 'Trans proline' 0 C--O 1.254 1.284 0 C-N-CA 122.247 1.964 . . . . 0.0 111.386 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -129.12 128.18 42.95 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -77.83 81.93 1.24 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 83.34 -128.31 8.47 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 32.7 t -142.19 101.38 3.9 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.52 73.13 2.72 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 17.1 m -69.62 128.55 36.88 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -155.49 178.35 32.16 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.2 -35.84 13.47 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.71 2.273 . . . . 0.0 112.154 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 21.2 m 65.97 76.67 0.31 Allowed 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.171 0.988 . . . . 0.0 109.342 -175.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 27.4 pt -74.73 118.39 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.928 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.55 -43.18 14.75 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.366 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.6 122.84 31.09 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 7.3 p 179.22 -39.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 N--CA 1.433 -1.309 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.93 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.442 -0.86 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -98.63 116.39 30.75 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -84.68 74.5 10.43 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.401 1.096 . . . . 0.0 109.63 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.24 18.03 3.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.471 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -80.44 78.2 7.16 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.556 -0.858 . . . . 0.0 112.276 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -76.5 -39.83 51.96 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.39 86.78 3.05 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.541 174.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tt -85.64 -51.92 6.15 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.3 tp 51.87 77.28 0.15 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.445 1.498 . . . . 0.0 113.802 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.4 mt -153.8 158.46 40.92 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.746 0.818 . . . . 0.0 109.569 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 75.55 16.06 2.62 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 124.91 1.284 . . . . 0.0 112.263 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.76 174.94 12.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.799 0.809 . . . . 0.0 112.302 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.28 114.74 64.8 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.794 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.78 -41.72 13.64 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.393 2.062 . . . . 0.0 111.862 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -117.02 144.64 44.36 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.967 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 m -67.09 137.46 56.39 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.994 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -106.5 131.96 53.07 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.502 0.502 . . . . 0.0 109.651 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -162.67 -158.1 9.45 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.437 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.19 165.88 24.07 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.432 0.693 . . . . 0.0 109.341 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -89.12 120.45 30.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.6 p -92.22 -105.44 0.11 Allowed 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' A' ' 159' ' ' GLU . . . -112.42 146.85 37.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.134 -0.354 . . . . 0.0 110.322 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -57.78 4.99 Favored Glycine 0 C--N 1.317 -0.515 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.369 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.42 41.44 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.95 141.56 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.511 ' HB2' HG23 ' A' ' 66' ' ' THR . 1.1 tmt? -86.1 134.32 33.83 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.032 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -126.46 132.27 51.49 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -102.04 142.69 32.92 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.155 0.503 . . . . 0.0 111.657 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 6.4 mp -99.96 -49.12 4.43 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -101.27 112.39 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -85.64 158.72 20.01 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.459 HH22 ' HG3' ' A' ' 142' ' ' LYS . 15.4 ptt-85 -58.23 151.91 18.31 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.848 0.859 . . . . 0.0 110.654 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.7 m120 76.23 11.01 2.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.263 1.025 . . . . 0.0 110.567 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -87.73 124.07 33.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.147 0.498 . . . . 0.0 110.155 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -68.87 137.33 53.79 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.407 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.4 pt -103.68 159.73 28.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.4 140.82 50.49 Favored 'Cis proline' 0 CA--C 1.501 -1.147 0 CA-C-N 120.348 1.16 . . . . 0.0 112.516 -1.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -98.54 -77.98 0.5 Allowed 'General case' 0 N--CA 1.406 -2.668 0 C-N-CA 118.948 -1.101 . . . . 0.0 113.734 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 88.8 tttt 66.81 100.7 0.05 OUTLIER 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.491 1.117 . . . . 0.0 111.022 -171.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -128.06 130.82 48.85 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 m -113.01 129.04 56.64 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 123.511 0.507 . . . . 0.0 110.191 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 29' ' ' LEU . 74.4 mt-30 -133.41 141.03 47.67 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 74.8 mt -104.19 120.03 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.176 0.513 . . . . 0.0 109.972 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -107.33 136.3 47.38 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -111.46 162.46 15.06 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.1 p -90.25 135.81 33.44 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.589 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 31.0 m-85 -114.92 -6.36 12.58 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.529 173.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -98.34 119.96 37.92 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -77.08 163.23 26.83 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.018 0.199 . . . . 0.0 110.996 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.19 23.99 14.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.142 0.977 . . . . 0.0 113.199 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -85.35 120.53 73.33 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.67 -16.08 14.98 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.59 2.193 . . . . 0.0 113.767 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.87 159.05 29.41 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.266 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.69 171.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 tt -129.08 118.6 22.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 111.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -126.53 118.12 24.25 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.12 132.73 30.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.775 -172.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 79.7 m-85 -134.01 152.94 52.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.737 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -112.9 151.73 30.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.587 0.554 . . . . 0.0 110.341 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.02 152.3 26.71 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.107 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -115.44 121.42 42.7 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.38 0.609 . . . . 0.0 109.795 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -140.29 162.72 34.61 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -66.65 -37.46 84.85 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 123.865 0.728 . . . . 0.0 111.098 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.77 139.93 46.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.749 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.511 HG23 ' HB2' ' A' ' 26' ' ' MET . 0.2 OUTLIER -70.57 113.95 8.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.266 -175.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.452 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -171.69 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.985 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.83 -14.55 54.13 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.963 0.887 . . . . 0.0 109.17 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.499 ' OD1' ' HA ' ' A' ' 66' ' ' THR . 8.7 m120 -66.96 152.73 45.2 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.311 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 78.4 m-20 -89.06 121.4 31.36 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.73 115.66 21.07 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.04 -36.67 12.01 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.062 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.29 171.97 39.06 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.214 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -149.03 159.29 44.35 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.427 0.291 . . . . 0.0 111.356 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.07 154.52 25.8 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 172.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.89 133.4 53.2 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 6.1 tt -108.25 104.44 13.84 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.6 p -104.53 159.44 15.74 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.112 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.11 -14.41 5.15 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.5 -0.857 . . . . 0.0 110.971 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.19 119.23 50.75 Favored Pre-proline 0 C--O 1.243 0.744 0 C-N-CA 123.258 0.623 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.99 166.59 11.23 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.595 2.197 . . . . 0.0 110.939 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.09 97.46 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.933 1.755 . . . . 0.0 110.378 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.72 151.41 78.05 Favored Pre-proline 0 N--CA 1.426 -1.659 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.9 133.52 40.2 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.067 2.511 . . . . 0.0 111.466 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -60.98 119.65 8.7 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.397 0.618 . . . . 0.0 111.639 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.22 -27.11 6.2 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.406 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 87.6 t -72.93 -48.82 7.89 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.336 -0.432 . . . . 0.0 111.082 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 21.9 Cg_exo -70.08 106.67 1.76 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.182 1.255 . . . . 0.0 109.301 172.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 74.3 mt-30 -113.83 115.33 27.58 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.419 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.21 111.42 25.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -90.1 104.32 16.9 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -104.75 127.11 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.084 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.7 m -122.26 123.01 40.45 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.875 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 5.1 m-85 -99.45 112.35 24.56 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.728 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -112.95 143.28 44.51 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 11.9 mt -130.99 127.54 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -98.58 -171.68 2.17 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.86 -23.92 64.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.06 -29.82 49.41 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.07 26.2 6.13 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.7 mt -84.59 119.61 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 65.0 tp -96.06 107.84 20.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -103.52 125.83 50.31 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.7 t -111.29 113.02 43.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.8 m -106.24 116.52 32.08 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.63 117.23 33.39 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.7 m -113.45 122.1 46.29 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 110.65 16.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 54.2 mtpt -67.41 -18.55 65.15 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.541 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.9 p -80.26 -56.75 3.99 Favored 'General case' 0 C--O 1.25 1.102 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.359 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.6 p -76.58 -32.06 57.9 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.168 0.508 . . . . 0.0 110.361 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.93 -8.65 54.4 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.8 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -94.49 160.41 14.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.546 0.673 . . . . 0.0 111.435 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.1 148.43 51.05 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.283 0.563 . . . . 0.0 111.719 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.509 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.4 m120 -130.86 132.25 45.06 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 157.97 45.56 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.382 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 tt -127.78 146.51 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.2 m -125.18 112.31 16.3 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.235 0.541 . . . . 0.0 109.693 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.59 93.84 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -82.23 107.46 14.93 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.463 ' OD1' ' HD3' ' A' ' 125' ' ' ARG . 4.2 t-20 -102.94 116.28 32.24 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.666 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -127.51 91.11 3.24 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.2 mttp 65.6 -175.02 0.18 Allowed 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.023 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.51 73.34 0.58 Allowed Glycine 0 N--CA 1.469 0.846 0 N-CA-C 112.144 -0.382 . . . . 0.0 112.144 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.463 ' HD3' ' OD1' ' A' ' 121' ' ' ASN . 10.9 mmm180 -113.98 -81.24 0.6 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.533 0.682 . . . . 0.0 110.561 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -136.77 -165.54 1.75 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.1 p -70.92 -75.38 0.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.692 0.758 . . . . 0.0 109.394 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.4 tttp 176.27 -51.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 126.691 1.996 . . . . 0.0 105.741 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 132' ' ' GLU . 8.2 pt-20 -60.79 -32.46 71.8 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 113.831 -1.532 . . . . 0.0 111.802 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 134' ' ' MET . 7.7 tp10 -63.7 -40.52 96.98 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.984 0.421 . . . . 0.0 110.202 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 135' ' ' VAL . 66.0 mt -65.2 -50.58 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.662 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.7 pt-20 -63.91 -32.48 74.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 130' ' ' GLU . 53.9 mtm-85 -60.51 -46.83 88.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.085 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 23.9 mmt -60.88 -42.8 98.64 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.657 0.598 . . . . 0.0 109.772 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 131' ' ' ILE . 88.2 t -59.61 -51.77 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.042 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 24.1 mt-30 -56.53 -47.55 79.16 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 122.937 0.495 . . . . 0.0 111.434 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.22 -41.27 97.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.95 75.45 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.5 -47.09 18.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.302 0.572 . . . . 0.0 112.505 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.99 -22.82 55.44 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.328 0.585 . . . . 0.0 111.579 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -120.57 26.46 9.13 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.841 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.459 ' HG3' HH22 ' A' ' 32' ' ' ARG . 40.8 tttm -56.31 -42.13 77.1 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.109 0.964 . . . . 0.0 111.241 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.63 -52.84 18.61 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.923 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.39 -39.55 58.95 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -174.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.605 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -71.06 -49.83 40.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.412 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 37.9 mt-10 -66.26 -35.36 80.21 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.656 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 38.9 t -62.73 -50.05 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.392 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -63.18 -37.94 89.21 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.9 0.381 . . . . 0.0 111.726 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 58.9 ttt180 -58.11 -52.19 66.58 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.828 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 41.8 mm-40 -72.56 -19.88 61.42 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.826 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 18.4 mmm180 -70.24 -29.45 66.27 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.178 0.513 . . . . 0.0 109.949 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.91 -59.24 2.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 41.2 m -89.31 61.46 5.7 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.844 0.83 . . . . 0.0 111.113 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.94 -32.59 30.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.076 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.83 131.31 54.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -73.08 103.34 3.81 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.226 0.536 . . . . 0.0 111.432 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.549 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.41 160.27 41.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.37 140.89 51.88 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 22' ' ' ALA . 45.9 mm-40 -97.7 134.07 41.37 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.483 0.658 . . . . 0.0 111.596 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.7 p -87.42 124.59 33.58 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -94.17 10.46 33.79 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.789 0.805 . . . . 0.0 111.062 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -140.08 132.56 28.59 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -127.64 -51.02 1.37 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 72.57 -63.63 0.42 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.277 1.431 . . . . 0.0 111.662 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.08 158.01 0.56 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.51 98.23 0.35 Allowed 'General case' 0 C--O 1.244 0.813 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 171.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.4 m -74.07 139.25 44.52 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.469 -1.241 . . . . 0.0 114.101 -166.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 69.47 118.85 0.03 OUTLIER 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.924 1.69 . . . . 0.0 113.941 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.5 14.5 5.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.913 0.863 . . . . 0.0 108.943 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.6 172.36 8.74 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.631 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -148.6 176.35 10.41 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.44 56.81 0.93 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -120.64 17.29 9.51 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.698 HD23 ' H ' ' A' ' 174' ' ' LEU . 1.8 pt? -78.33 37.54 0.27 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.51 153.21 24.42 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 162.43 -171.18 38.23 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 55.5 tptt 68.19 111.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.557 1.143 . . . . 0.0 112.802 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.0 tp -60.84 128.55 22.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.535 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 18.2 m -84.36 112.32 20.22 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.538 ' HG2' ' HE2' ' A' ' 183' ' ' LYS . 8.2 tp10 -102.84 147.7 26.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -121.41 -45.06 2.34 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -143.13 145.57 32.96 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.648 -173.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.538 ' HE2' ' HG2' ' A' ' 180' ' ' GLU . 70.8 mmtt -134.02 11.19 3.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 176.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? 58.28 84.09 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.948 0.899 . . . . 0.0 111.84 -170.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -77.65 -24.68 49.38 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.36 139.36 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.03 135.33 18.07 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 121.373 -0.131 . . . . 0.0 110.702 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 42.5 t0 65.47 177.34 0.2 Allowed 'General case' 0 CA--C 1.553 1.06 0 O-C-N 124.771 1.294 . . . . 0.0 111.209 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -142.15 -177.59 5.31 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -73.94 -24.97 59.72 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.41 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.38 95.46 0.45 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.18 -16.9 8.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 15.6 tt -161.34 141.93 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.808 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.5 t 71.47 179.67 0.24 Allowed 'General case' 0 C--O 1.246 0.881 0 C-N-CA 125.444 1.498 . . . . 0.0 112.157 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 54.5 m95 66.99 80.62 0.21 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.701 1.6 . . . . 0.0 110.448 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -135.5 137.6 42.27 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.291 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.9 t70 74.29 115.02 0.06 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.675 1.59 . . . . 0.0 111.366 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -103.53 -36.17 8.05 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -152.57 127.61 9.71 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.955 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.9 m -82.07 121.12 26.16 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.408 HD11 ' OE2' ' A' ' 204' ' ' GLU . 3.4 tm? -95.83 130.72 42.68 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.27 -175.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -107.24 -70.55 0.79 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.195 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.408 ' OE2' HD11 ' A' ' 202' ' ' LEU . 43.2 mt-10 61.55 97.31 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.934 0.894 . . . . 0.0 112.96 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.629 ' HD3' ' N ' ' A' ' 206' ' ' ASP . 8.4 tmtt? -123.77 133.68 53.79 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.629 ' N ' ' HD3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -74.14 170.19 16.01 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.791 0.805 . . . . 0.0 112.62 -175.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -151.88 33.97 0.54 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 169.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -134.18 -11.14 2.55 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.045 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -84.2 60.37 5.89 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.524 0.678 . . . . 0.0 110.163 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -88.43 -40.7 13.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.209 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 66.74 168.63 0.23 Allowed 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.959 1.304 . . . . 0.0 112.147 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . 0.292 3.6 ppt_? -88.5 76.22 8.25 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.88 0.848 . . . . 0.0 111.844 176.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 213' ' ' LYS . 0.2 OUTLIER -57.38 -58.76 6.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.197 -178.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -168.02 138.99 2.79 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.55 -67.71 0.87 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -97.43 160.81 14.1 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.089 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -154.4 -62.04 0.13 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.806 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 15.6 m -97.71 100.09 10.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.995 0.903 . . . . 0.0 112.785 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -111.51 98.51 40.8 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.56 117.87 0.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.846 2.364 . . . . 0.0 112.744 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 36.9 pt -138.11 142.7 34.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.618 0.247 . . . . 0.0 110.414 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 14.7 tt -110.17 125.54 67.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.2 p -101.13 128.36 47.25 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.993 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -87.79 119.19 5.23 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.71 79.67 3.36 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.436 0.636 . . . . 0.0 110.395 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -85.84 121.73 28.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.703 HE21 ' HA ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -116.66 158.73 23.29 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.997 0.427 . . . . 0.0 111.057 -173.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 147.84 -174.85 27.44 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.67 18.0 18.67 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.225 0.536 . . . . 0.0 109.991 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -85.73 -4.77 84.87 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.919 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.87 89.16 0.45 Allowed Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -68.29 -40.26 8.7 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 122.165 1.91 . . . . 0.0 112.307 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 95.99 128.48 5.67 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.64 119.39 5.7 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.124 1.883 . . . . 0.0 111.355 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -156.3 -174.62 26.31 Favored Glycine 0 N--CA 1.428 -1.839 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 162.56 -127.68 1.74 Allowed Glycine 0 N--CA 1.425 -2.039 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -146.31 131.21 18.12 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -139.6 52.1 0.72 Allowed Glycine 0 CA--C 1.497 -1.073 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.823 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -138.37 127.32 23.94 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -96.19 170.35 9.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -109.99 99.38 1.19 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.39 179.05 6.89 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.673 2.249 . . . . 0.0 112.497 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 74.47 -53.36 0.68 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.045 1.738 . . . . 0.0 112.445 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -87.39 113.3 3.95 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 88.66 -68.28 2.88 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 14.6 m -78.5 103.33 8.38 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 110.48 24.28 5.68 Favored Glycine 0 C--N 1.307 -1.08 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.724 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.1 p -80.84 -11.75 59.54 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.494 0.664 . . . . 0.0 111.436 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -153.94 -133.67 1.85 Allowed Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -84.88 80.35 2.18 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 121.577 1.518 . . . . 0.0 110.093 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 43.8 m -90.47 84.14 5.95 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 122.81 1.291 . . . . 0.0 110.257 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 22.4 pt -116.23 165.36 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 113.152 -1.84 . . . . 0.0 107.67 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -116.49 99.27 7.05 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.523 0.678 . . . . 0.0 109.477 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -72.29 152.49 42.11 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.461 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.46 95.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--N 1.296 -1.721 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.91 -32.49 65.35 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.163 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -79.22 130.83 35.87 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.89 96.16 2.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -98.67 72.56 2.0 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -114.29 -59.56 2.0 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.518 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.07 74.35 1.56 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.457 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -130.09 101.93 6.03 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.08 72.3 5.61 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.301 1.048 . . . . 0.0 111.621 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 12' ' ' VAL . 5.1 tt -88.74 149.75 23.3 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' THR . 3.5 m-20 -75.97 55.35 0.9 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.478 HG13 HD22 ' A' ' 10' ' ' LEU . 30.9 m -136.66 170.6 18.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.467 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.85 129.71 45.45 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.04 -31.56 6.05 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.069 1.846 . . . . 0.0 112.305 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.4 mp -126.65 157.55 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.436 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 20.0 m -86.34 138.16 32.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.07 131.21 48.66 Favored 'General case' 0 C--O 1.263 1.803 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -157.03 -171.46 23.12 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.357 -176.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 92' ' ' VAL . 84.4 mt -126.36 169.88 12.49 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.09 0.556 . . . . 0.0 110.076 -176.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.38 108.44 19.96 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.441 HG22 HD23 ' A' ' 158' ' ' LEU . 6.1 p -92.52 166.37 12.56 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.541 -1.208 . . . . 0.0 110.36 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.68 114.05 0.97 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.411 1.084 . . . . 0.0 112.388 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.94 -2.08 21.21 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.189 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.12 72.28 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.23 145.69 7.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.438 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -92.64 117.37 29.9 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.9 m -115.05 112.19 22.24 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -93.12 135.08 34.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.199 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.3 mp -94.13 -41.0 9.74 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -109.96 113.21 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -90.34 166.64 13.19 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.822 0.82 . . . . 0.0 112.724 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -61.16 141.01 57.78 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.36 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 77.86 2.03 2.89 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.716 1.207 . . . . 0.0 111.873 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -83.47 130.58 35.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 5.5 p -65.47 130.37 43.06 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 39.5 pt -106.78 148.59 37.17 Favored Pre-proline 0 N--CA 1.435 -1.212 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 52.6 Cg_exo -61.87 132.61 10.61 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.03 1.046 . . . . 0.0 113.639 1.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 m -110.17 143.16 40.69 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.237 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -128.67 108.71 10.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -128.06 141.91 51.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -139.9 135.42 32.84 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -141.61 144.96 34.47 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 91' ' ' GLU . 42.3 mm -92.29 114.82 29.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.43 147.38 25.32 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.811 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 8.9 p -136.6 170.16 16.52 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.882 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -103.7 137.84 41.17 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 117.817 0.281 . . . . 0.0 110.686 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 157' ' ' ALA . 43.8 m-85 -112.93 4.54 16.87 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -84.64 175.34 9.29 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.798 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.88 117.49 31.22 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.296 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 37.17 81.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' A' ' 159' ' ' GLU . 25.5 mt-30 -101.41 139.11 20.15 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.852 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -85.61 0.02 8.64 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 122.245 1.963 . . . . 0.0 111.964 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.6 176.12 44.23 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.01 152.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.8 tp -101.11 120.39 40.14 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.48 105.45 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -119.22 118.51 31.49 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 t -95.45 134.6 32.31 Favored 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.706 0.629 . . . . 0.0 111.495 -172.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -130.48 151.48 50.91 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.302 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -116.13 141.08 48.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.91 -117.84 1.83 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 9.4 mt-10 177.26 -99.94 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 126.115 1.766 . . . . 0.0 111.525 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.526 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 20.8 mmm180 55.4 -178.12 0.04 OUTLIER 'General case' 0 C--O 1.244 0.795 0 O-C-N 123.681 0.613 . . . . 0.0 110.524 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -91.28 -49.67 6.23 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.691 0.757 . . . . 0.0 110.663 175.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.2 mtp -97.65 126.15 42.8 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.53 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.328 0.4 OUTLIER -80.33 86.19 5.73 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.671 1.7 . . . . 0.0 111.418 178.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -152.42 -45.83 0.1 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.775 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.35 7.26 1.39 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 113.462 -1.699 . . . . 0.0 111.209 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' ND2' ' HG3' ' A' ' 26' ' ' MET . 89.3 m-20 -109.67 163.74 13.19 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.633 0.373 . . . . 0.0 111.493 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -91.01 136.19 33.24 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 tt -96.78 122.91 40.25 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.64 -45.18 9.53 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.279 0.362 . . . . 0.0 111.494 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.63 175.83 47.17 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -149.19 156.74 42.61 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.52 139.27 20.77 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 171.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -97.4 120.27 37.46 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.64 104.55 14.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 p -110.91 173.87 6.13 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.05 21.76 44.62 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 52.8 mt -90.17 135.26 30.11 Favored Pre-proline 0 N--CA 1.426 -1.673 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.65 117.02 3.9 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.563 2.175 . . . . 0.0 112.479 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.44 91.28 0.97 Allowed 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.191 1.927 . . . . 0.0 109.942 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.55 168.68 13.71 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.304 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.05 100.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.289 2.659 . . . . 0.0 113.237 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 60.85 -160.99 0.29 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.698 1.199 . . . . 0.0 111.349 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.7 63.33 1.18 Allowed Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 76.5 t -66.4 -48.39 56.66 Favored Pre-proline 0 C--N 1.307 -1.268 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 167.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.601 ' HA ' ' OG ' ' A' ' 110' ' ' SER . 15.7 Cg_endo -59.05 129.9 33.99 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.058 1.839 . . . . 0.0 111.347 168.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.67 110.67 22.58 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.04 114.24 32.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 43' ' ' ILE . 35.1 tt0 -90.75 114.33 26.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.434 HG11 HD11 ' A' ' 19' ' ' LEU . 62.1 t -109.32 122.6 64.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.805 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.1 m -109.53 129.63 55.56 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.874 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.447 ' CD1' HD22 ' A' ' 29' ' ' LEU . 5.3 m-85 -109.9 107.74 17.78 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 17.7 t70 -120.06 113.12 20.01 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.826 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 44.3 mt -111.74 136.07 49.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.0 OUTLIER -100.99 -168.42 1.56 Allowed 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.32 -8.18 55.95 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.424 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -96.04 -29.82 13.91 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.96 23.85 5.41 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 46.5 mm -81.87 115.44 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.455 HD13 HG13 ' A' ' 96' ' ' ILE . 31.5 tp -105.49 113.64 27.33 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.744 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -96.6 102.69 14.52 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 57.5 t -89.22 113.49 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 20.7 m -119.0 118.81 32.5 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.82 118.91 36.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.6 m -119.6 118.81 31.99 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.665 -176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 110.5 12.07 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 172.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -66.43 -20.33 66.03 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.055 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 88' ' ' PRO . 1.5 m -70.44 -53.34 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.176 0.512 . . . . 0.0 110.823 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.3 p -95.14 -29.46 14.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.096 0.474 . . . . 0.0 112.087 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.97 19.44 24.13 Favored Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.864 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.39 131.36 36.21 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 121.084 0.469 . . . . 0.0 111.894 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.54 134.13 53.08 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.815 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -128.78 128.57 44.23 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 65.5 pttt -129.15 154.09 47.07 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.854 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 HD11 ' A' ' 119' ' ' ILE . 25.0 pt -126.93 140.73 48.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 171.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 m -103.95 112.53 25.54 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.41 HD11 HD12 ' A' ' 117' ' ' ILE . 46.2 mm -111.63 103.49 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.818 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 t -78.29 102.38 7.63 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 168.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -75.52 153.54 37.41 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.881 -171.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . 0.255 27.7 t0 65.14 81.26 0.21 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 125.29 1.436 . . . . 0.0 112.947 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -120.42 27.58 8.5 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.018 -1.901 . . . . 0.0 106.409 172.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.23 35.34 6.69 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -173.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.92 -56.77 12.81 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.68 140.19 40.64 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 p -84.52 169.68 14.22 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -42.98 -56.92 3.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.687 1.195 . . . . 0.0 113.037 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.447 ' HA ' ' HG2' ' A' ' 132' ' ' GLU . 29.8 mt-10 -67.75 -37.15 81.75 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.719 -175.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -63.96 -42.89 97.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 135' ' ' VAL . 81.9 mt -58.92 -53.88 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.138 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 129' ' ' GLU . 8.4 pt-20 -68.6 -33.0 73.28 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -65.01 -41.54 95.24 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.566 173.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.2 ttt -68.8 -37.06 79.01 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.378 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 131' ' ' ILE . 81.1 t -60.89 -46.11 96.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -63.2 -32.33 73.7 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.763 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 22.4 mm-40 -59.23 -52.98 63.33 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.13 -29.53 69.86 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.409 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.77 -48.53 14.68 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.392 0.615 . . . . 0.0 112.439 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -71.24 -36.5 71.81 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.061 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -101.12 10.4 40.96 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 74.9 tttt -47.67 -54.48 11.91 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.974 0.91 . . . . 0.0 112.309 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.35 72.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.48 0.657 . . . . 0.0 111.413 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -72.81 -49.82 28.09 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.679 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -67.08 -39.41 86.8 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.499 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 48.6 mt-10 -60.37 -45.56 93.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.31 -32.92 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-O 121.405 0.621 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -74.69 -52.99 10.13 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.89 -0.507 . . . . 0.0 111.199 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 63' ' ' ARG . 55.2 ttp180 -69.82 -52.53 24.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.14 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -170.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 151' ' ' ARG . 22.6 mmt180 -91.29 -1.36 57.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.373 0.606 . . . . 0.0 110.762 176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.408 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 57.4 t -116.1 -58.3 3.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 t -90.94 87.39 6.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 122.659 1.219 . . . . 0.0 111.501 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.53 18.62 9.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 171.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 152' ' ' VAL . 49.9 pttt -137.64 137.77 38.79 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.217 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -94.65 97.27 9.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -143.08 127.81 18.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.441 HD23 HG22 ' A' ' 21' ' ' THR . 13.2 mt -118.72 146.75 44.5 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.4 ' HA ' HE22 ' A' ' 51' ' ' GLN 0.273 1.5 pp20? -132.47 173.77 10.95 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 7.2 t -110.16 14.97 22.7 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.933 -171.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -104.31 -51.64 3.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 65.46 -57.43 0.31 Allowed 'General case' 0 C--O 1.25 1.12 0 C-N-CA 126.104 1.761 . . . . 0.0 114.368 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -168.55 -47.05 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -173.97 93.06 0.09 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.89 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 27.5 ttt -95.87 -42.7 8.18 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -131.5 121.89 25.24 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.4 m -82.1 -26.22 33.8 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.724 0.773 . . . . 0.0 109.026 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -131.82 140.56 49.19 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.96 133.98 42.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.017 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -51.87 120.79 5.68 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 113.024 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -78.42 116.46 18.84 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.984 174.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.19 150.3 43.53 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 82.18 5.42 89.67 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.2 96.51 10.06 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt 70.56 -33.62 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.389 1.476 . . . . 0.0 113.074 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 177' ' ' LYS . . . -72.61 104.73 1.58 Allowed Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 170.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 176' ' ' GLY . 77.5 tttt 86.63 72.62 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.758 1.623 . . . . 0.0 109.199 -170.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.689 ' H ' HD13 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -78.78 -38.36 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.435 175.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 46.1 m -161.3 -71.09 0.06 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -142.58 -173.46 3.87 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -83.4 99.36 10.01 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.3 t70 64.9 -156.44 0.29 Allowed 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.148 0.905 . . . . 0.0 108.659 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -145.33 120.91 10.42 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 118.816 0.735 . . . . 0.0 109.757 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -120.32 -68.1 0.93 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.384 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.61 119.99 31.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.877 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 32.5 t -133.39 82.13 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 57.96 66.94 1.02 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.044 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -102.53 -6.7 22.57 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.79 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 192' ' ' GLU . 65.0 tttp 67.92 102.98 0.05 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.262 1.025 . . . . 0.0 111.87 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 69.84 -66.7 0.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.886 1.675 . . . . 0.0 110.957 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.463 ' HB2' ' HE3' ' A' ' 189' ' ' LYS . 46.6 mt-10 -93.49 84.33 4.68 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.69 128.39 42.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.62 73.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 122.249 1.024 . . . . 0.0 108.827 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.0 m -157.96 110.32 2.35 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.501 -1.681 . . . . 0.0 106.504 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 44.9 t-105 -89.04 -44.01 10.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.978 -0.101 . . . . 0.0 111.109 -174.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.89 31.05 19.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.112 0.965 . . . . 0.0 112.577 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 71.2 -46.81 0.65 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 124.575 1.15 . . . . 0.0 113.669 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 69.92 -77.51 0.05 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.51 1.524 . . . . 0.0 110.143 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.37 140.83 35.61 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 202' ' ' LEU . 27.6 m -83.03 72.83 10.08 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.119 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 201' ' ' THR . 1.4 tm? 160.03 85.68 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -130.35 139.03 50.7 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.552 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -88.07 155.96 19.53 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -86.42 90.95 8.37 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . 0.274 5.1 p-10 -158.18 -100.94 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.529 174.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 66.92 -71.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.475 1.11 . . . . 0.0 108.954 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -151.09 115.35 5.07 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 172.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -41.17 114.99 0.55 Allowed 'General case' 0 C--O 1.247 0.924 0 O-C-N 124.804 1.315 . . . . 0.0 111.956 -173.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -130.11 87.2 2.49 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.69 113.83 24.67 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 168.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -67.83 110.59 3.89 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.588 0.708 . . . . 0.0 110.463 -174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -79.07 117.27 19.97 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.766 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -111.49 -178.99 3.59 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.743 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.7 mt -106.76 104.07 13.67 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.139 -175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.17 108.96 18.57 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -89.92 126.5 35.75 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.65 -3.66 9.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.684 0.754 . . . . 0.0 110.811 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -109.35 109.11 60.35 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.64 137.33 24.85 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.589 2.193 . . . . 0.0 113.192 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 12.8 tt -156.89 126.23 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.875 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.547 HG12 ' H ' ' A' ' 225' ' ' GLY . 15.7 tt -172.87 134.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 19.7 m -75.47 -24.88 57.01 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.045 0.45 . . . . 0.0 110.17 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.547 ' H ' HG12 ' A' ' 223' ' ' ILE . . . 96.93 -45.01 1.85 Allowed Glycine 0 CA--C 1.499 -0.933 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 53.2 tp -170.46 165.0 8.65 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -93.15 17.89 10.28 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.143 0.973 . . . . 0.0 111.037 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -144.26 165.5 27.71 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -70.22 108.82 2.61 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.78 -30.82 32.14 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.431 0.634 . . . . 0.0 109.533 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 105.12 -174.09 21.13 Favored Glycine 0 N--CA 1.422 -2.236 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.262 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 111.14 -96.88 0.92 Allowed Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.56 103.5 0.39 Allowed 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.625 2.217 . . . . 0.0 111.397 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -113.51 -83.42 1.21 Allowed Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.58 -27.37 61.4 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.484 2.123 . . . . 0.0 110.976 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -126.65 96.21 0.46 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -70.06 -42.62 67.43 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -134.45 -42.51 0.78 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 126.12 169.54 12.83 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.733 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -90.92 152.4 20.74 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -83.32 -21.44 33.2 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.82 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 178.25 94.37 0.09 OUTLIER Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -61.08 103.9 0.26 Allowed 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.834 2.356 . . . . 0.0 111.346 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.42 -12.03 41.42 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.79 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.92 -171.99 19.5 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.201 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -138.37 -158.67 7.83 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m 64.09 -65.23 0.13 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.703 1.601 . . . . 0.0 112.282 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.18 52.33 0.76 Allowed Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 16.0 m -82.55 -40.5 20.86 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -130.47 80.22 0.35 Allowed Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.7 149.7 43.73 Favored 'Trans proline' 0 C--O 1.245 0.873 0 C-N-CA 122.904 2.402 . . . . 0.0 112.531 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 90.6 m 69.09 94.98 0.07 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.228 0.955 . . . . 0.0 111.856 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 253' ' ' ILE . 0.2 OUTLIER -119.92 174.74 4.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.358 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 254' ' ' GLU . 1.4 mp0 -66.48 131.31 45.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.983 0.802 . . . . 0.0 110.083 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -93.55 134.68 35.58 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.821 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 41.5 t -84.57 91.88 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--N 1.291 -1.964 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.893 -171.777 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -93.82 -61.71 1.49 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.308 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -85.9 103.96 15.11 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.7 p -134.67 96.81 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.104 0.954 . . . . 0.0 108.904 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -83.26 -29.28 28.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.097 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -122.06 130.75 53.54 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.282 0.563 . . . . 0.0 112.083 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.9 mt -119.38 33.29 5.7 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.5 mt 77.12 88.92 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.765 1.626 . . . . 0.0 112.925 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 tt -94.8 111.61 23.38 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.1 134.13 54.32 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.198 0.311 . . . . 0.0 110.225 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -75.52 53.55 0.7 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 35' ' ' THR . 24.7 m -138.22 175.12 9.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.48 112.51 53.34 Favored Pre-proline 0 C--N 1.281 -2.404 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.71 -32.59 18.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 121.861 1.707 . . . . 0.0 110.067 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.79 174.95 5.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.928 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 11.8 m -119.63 136.28 54.45 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.2 131.78 56.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.723 0.639 . . . . 0.0 109.384 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.19 178.13 32.86 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.4 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 2.2 mp -112.39 156.73 22.02 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.401 0.68 . . . . 0.0 109.233 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -90.9 109.37 20.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -93.66 173.73 7.54 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.727 -0.608 . . . . 0.0 111.383 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 118.61 5.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.959 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.76 6.79 32.4 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.87 39.49 64.77 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -99.14 131.08 47.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.84 118.12 29.19 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -114.07 111.38 21.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.7 122.53 38.56 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.962 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.412 HD12 ' CD2' ' A' ' 94' ' ' PHE . 48.1 mt -87.19 -37.61 17.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.413 0.625 . . . . 0.0 109.548 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 94' ' ' PHE . 3.4 mp -115.75 102.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 173.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -90.54 161.32 15.53 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.785 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 ptt-85 -54.14 134.05 44.19 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 80.71 11.87 0.91 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.315 1.846 . . . . 0.0 113.552 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 m -86.22 132.97 33.88 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.43 ' HA ' HG12 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -62.51 140.54 58.62 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.495 1.118 . . . . 0.0 111.519 -176.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.454 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 35.3 pt -113.87 146.29 35.27 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.787 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 15.0 Cg_endo -65.31 141.63 49.68 Favored 'Cis proline' 0 CA--C 1.509 -0.731 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.055 -3.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.5 m -92.51 -70.76 0.68 Allowed 'General case' 0 N--CA 1.399 -3.008 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.464 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 1.1 tmtp? 67.12 101.0 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 124.996 1.318 . . . . 0.0 109.737 -174.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -131.95 140.74 49.1 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 86.9 m -139.58 134.26 31.9 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -130.08 157.52 42.17 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.972 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.2 mm -89.88 114.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -98.34 148.08 24.03 Favored 'General case' 0 C--N 1.272 -2.762 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 19.6 p -122.8 171.49 9.15 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.857 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 24.4 p -109.08 136.93 47.79 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -90.96 -29.64 17.31 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -89.34 93.09 9.41 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.951 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 85' ' ' ARG . 6.2 p-10 -75.19 161.11 29.65 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.082 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 70.17 6.55 5.82 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.392 0.677 . . . . 0.0 112.705 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.3 131.43 50.6 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.0 Cg_endo -81.85 8.13 4.64 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.396 2.064 . . . . 0.0 112.322 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.41 175.03 44.32 Favored Glycine 0 N--CA 1.425 -2.035 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.0 m -132.6 171.59 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 123.323 0.649 . . . . 0.0 110.061 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.444 HD22 ' O ' ' A' ' 161' ' ' TYR . 44.2 tp -111.16 128.16 55.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.782 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.83 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.5 mt-30 -123.84 127.33 47.89 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.56 114.24 37.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 124.446 1.092 . . . . 0.0 110.325 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -109.52 149.67 29.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.717 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 16' ' ' SER . 45.1 tt0 -111.39 121.44 45.23 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.74 -171.48 22.66 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.449 ' HG3' ' CB ' ' A' ' 16' ' ' SER . 13.3 mt-10 -139.17 17.7 2.61 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -64.59 131.81 48.06 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 118.836 -1.145 . . . . 0.0 110.992 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -52.63 -50.43 63.16 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.929 2.092 . . . . 0.0 113.931 -168.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtt -95.99 128.78 43.19 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.34 86.06 0.28 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -168.04 168.04 12.17 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 76.64 -46.42 0.52 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.608 1.163 . . . . 0.0 110.06 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -55.6 147.97 16.96 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.349 1.06 . . . . 0.0 108.629 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 60' ' ' GLU . 2.9 p-10 -90.03 139.09 30.95 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.282 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.08 132.71 35.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.827 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.8 mt -105.1 -41.3 5.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 0.0 111.365 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.34 39.69 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.132 -1.033 . . . . 0.0 111.427 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -150.13 166.0 31.13 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -170.14 144.43 2.63 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 124.595 1.184 . . . . 0.0 108.414 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -93.88 146.83 23.62 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -118.52 105.08 11.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -94.47 169.74 9.98 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.583 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.89 -25.96 6.01 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 62.4 mt -54.14 119.91 22.31 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.109 0.963 . . . . 0.0 111.446 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 93.2 Cg_endo -80.32 151.27 20.25 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.678 2.252 . . . . 0.0 112.861 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 13.4 Cg_exo -70.97 87.71 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.791 2.327 . . . . 0.0 110.821 175.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.91 166.16 30.42 Favored Pre-proline 0 C--N 1.29 -2.005 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -49.32 141.3 24.81 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.992 2.461 . . . . 0.0 111.409 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 46' ' ' THR . 35.1 ptt180 -64.57 126.15 26.96 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 -175.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.06 -25.96 13.21 Favored Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 70.1 t -66.08 -50.44 51.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.654 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 21.3 Cg_exo -68.86 121.23 8.1 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.137 1.224 . . . . 0.0 110.327 174.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -107.08 124.7 50.05 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.0 mm -108.51 109.24 27.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.409 ' CB ' ' HD3' ' A' ' 109' ' ' LYS . 43.9 tt0 -94.85 109.17 21.19 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 41' ' ' THR . 33.9 t -111.23 126.16 68.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.731 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 87.5 m -106.29 125.38 50.92 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.413 ' HB3' ' CD1' ' A' ' 30' ' ' ILE . 5.2 m-85 -111.08 107.91 17.44 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 39' ' ' LYS . 22.6 t70 -126.15 124.49 40.62 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.34 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' PRO . 13.6 mt -106.75 125.57 62.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.5 -179.04 6.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.574 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.91 66.44 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.627 0.771 . . . . 0.0 112.777 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -77.06 -24.39 51.96 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.5 31.08 8.1 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 73.7 mt -97.17 128.27 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.44 111.7 21.41 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -100.64 114.54 28.32 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.43 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.52 ' HB ' HG22 ' A' ' 117' ' ' ILE . 74.9 t -110.48 125.23 67.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 m -122.71 119.6 31.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.58 117.57 33.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.7 m -112.74 120.59 42.02 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.098 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.22 106.87 13.53 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.409 ' HD3' ' CB ' ' A' ' 91' ' ' GLU . 30.3 mmmt -67.43 -19.87 65.43 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.732 -176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -66.96 -61.35 1.98 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 43.0 p -80.1 -32.69 39.1 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.665 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.68 12.31 44.41 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.703 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.461 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 20.7 pttp -111.2 161.42 16.0 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.485 -0.421 . . . . 0.0 110.603 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.27 148.89 40.56 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -128.68 146.7 50.8 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.414 ' HD2' ' C ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -131.45 164.29 26.06 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.19 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.52 HG22 ' HB ' ' A' ' 104' ' ' VAL . 14.7 tt -136.51 144.39 32.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.8 m -125.59 113.6 17.62 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.23 103.92 16.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.029 0.442 . . . . 0.0 110.727 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.8 m -75.25 151.7 38.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -72.21 78.5 0.97 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.808 1.289 . . . . 0.0 110.933 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -119.53 131.67 55.6 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.141 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -86.15 84.04 7.59 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.38 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.09 -66.69 1.3 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.383 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -107.0 -5.51 18.08 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.04 0.448 . . . . 0.0 111.649 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.7 mt -123.66 151.7 42.79 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.2 p -96.59 -77.21 0.49 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.928 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.8 tptt 178.15 -32.45 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.459 ' HA ' ' HG2' ' A' ' 132' ' ' GLU . 11.3 pt-20 -65.26 -32.58 74.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.59 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -71.8 -40.34 69.24 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.7 mt -67.11 -41.0 86.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.622 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 129' ' ' GLU . 13.1 pt-20 -68.84 -27.58 65.96 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.49 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 78.7 mtp180 -63.13 -40.62 98.12 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 mmt -63.38 -38.46 91.24 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.128 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.58 -47.88 89.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.049 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.84 -47.01 85.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.699 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.99 -32.9 74.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.682 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.42 -32.45 74.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.31 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 60.5 mm-40 -78.67 -36.66 43.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 110.793 174.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -69.0 -45.98 69.18 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.095 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.55 20.8 15.39 Favored 'General case' 0 C--O 1.198 -1.635 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.463 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 71.6 tttt -49.72 -60.14 3.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.083 1.353 . . . . 0.0 113.008 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.98 -32.74 73.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.887 0.375 . . . . 0.0 110.62 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -61.82 -53.41 56.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.048 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 10.6 m-20 -67.62 -37.45 82.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -59.52 -37.78 79.24 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.537 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 96.9 t -72.73 -47.08 51.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.554 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -56.83 -39.67 74.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -67.37 -32.71 73.82 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.99 -10.0 46.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.9 mmt180 -64.33 -36.1 83.01 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 120.835 0.35 . . . . 0.0 111.094 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.94 102.13 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.0 m -76.93 108.24 9.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.86 41.82 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-O 121.979 0.895 . . . . 0.0 112.561 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -82.17 148.13 28.64 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.64 94.76 0.45 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.182 0.515 . . . . 0.0 110.229 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -142.07 147.91 37.57 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.673 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.58 151.38 26.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -83.65 167.0 17.66 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.464 177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.2 t -132.14 109.95 10.33 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -171.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.445 ' HB3' ' CE2' ' A' ' 163' ' ' PHE . 43.0 m-85 -151.79 108.55 3.5 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 125.108 1.363 . . . . 0.0 108.655 172.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.74 115.56 25.27 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 161' ' ' TYR . 76.1 m-85 -129.92 160.81 32.45 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -110.77 136.13 50.29 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.671 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.6 mmt -125.82 137.01 53.75 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -92.69 68.5 4.68 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.535 0.683 . . . . 0.0 110.169 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 p -85.52 96.52 9.65 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.404 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.52 163.17 12.97 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.8 m -112.71 -55.47 4.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 69.21 170.3 0.3 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.661 1.184 . . . . 0.0 112.326 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -159.17 166.69 30.91 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.26 -35.21 66.18 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 78.85 -63.69 3.76 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.4 mt -75.63 -68.94 0.52 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? 70.79 -70.69 0.15 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.78 1.632 . . . . 0.0 110.885 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 66.94 -106.83 1.77 Allowed Glycine 0 C--N 1.332 0.343 0 CA-C-N 116.553 -0.294 . . . . 0.0 113.012 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 74.61 138.31 0.06 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.733 1.613 . . . . 0.0 112.465 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -156.68 136.13 3.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 20.8 t -113.3 -60.73 1.84 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.309 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 68.82 155.75 0.13 Allowed 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.842 1.257 . . . . 0.0 110.284 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.02 149.97 29.95 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.586 -0.696 . . . . 0.0 109.96 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -144.5 -153.4 0.47 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 73.76 11.2 4.64 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.257 1.423 . . . . 0.0 111.174 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -168.01 152.43 6.39 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -96.31 -29.23 14.1 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.418 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 59.0 t 73.3 -66.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.546 1.138 . . . . 0.0 110.933 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.9 tp -154.22 135.86 14.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.13 144.56 31.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -108.61 15.68 23.55 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.434 ' HA ' ' OE1' ' A' ' 191' ' ' GLN . 11.3 mm-40 -86.87 117.3 25.51 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.111 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.74 -48.06 70.32 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 124.065 0.853 . . . . 0.0 109.95 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 39.5 t 57.53 88.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.438 0 O-C-N 124.569 1.168 . . . . 0.0 110.491 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.552 ' H ' HD13 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -115.33 133.1 62.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.14 -177.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.8 m -83.47 88.22 7.0 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 105.79 -1.929 . . . . 0.0 105.79 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -113.25 99.07 7.53 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.961 -172.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.34 86.52 2.4 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -73.89 -35.22 64.67 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.749 0.785 . . . . 0.0 108.913 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -123.61 96.3 4.91 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.29 -1.323 . . . . 0.0 107.694 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -75.3 111.48 10.61 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 29.9 p -73.42 98.75 2.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.022 0.439 . . . . 0.0 110.415 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 42.3 tp -163.13 15.64 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.958 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -119.8 17.32 12.68 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.49 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -68.61 116.16 8.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.433 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -125.7 165.14 19.15 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.853 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -75.26 158.72 32.46 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.472 ' OE2' ' HG3' ' A' ' 211' ' ' LYS . 37.3 tt0 -88.89 74.31 8.24 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.459 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 56.59 28.53 14.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.398 -1.728 . . . . 0.0 115.101 171.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 62.32 -40.77 0.16 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -70.32 -19.09 63.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -172.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.472 ' HG3' ' OE2' ' A' ' 207' ' ' GLU . 27.8 mmtp -69.19 153.45 43.67 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.891 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.501 ' HG2' ' H ' ' A' ' 213' ' ' LYS . 10.0 ttm180 68.35 -168.55 0.19 Allowed 'General case' 0 C--O 1.247 0.927 0 O-C-N 124.657 1.223 . . . . 0.0 108.907 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.501 ' H ' ' HG2' ' A' ' 212' ' ' ARG . 99.2 mttt 72.26 -178.16 0.2 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.759 0.824 . . . . 0.0 111.546 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 68.43 117.54 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.647 1.579 . . . . 0.0 114.307 174.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.06 28.57 3.11 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.687 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -103.11 -171.86 2.02 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.82 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -81.51 75.96 8.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.099 0.952 . . . . 0.0 111.852 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.8 111.3 28.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -76.87 120.76 83.04 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -68.94 96.87 0.54 Allowed 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.853 1.702 . . . . 0.0 111.849 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 57.2 mt -82.28 79.32 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 11.6 tt -159.29 117.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.585 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.8 t -148.65 131.99 16.56 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -88.83 62.59 3.64 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.73 115.29 25.07 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -121.78 104.88 9.89 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -92.02 124.07 35.84 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.194 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -174.01 167.04 39.39 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.63 144.87 32.01 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -128.51 -59.69 0.11 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.425 ' HA2' ' HD3' ' A' ' 233' ' ' PRO . . . 98.46 141.16 11.94 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.425 ' HD3' ' HA2' ' A' ' 232' ' ' GLY . 3.5 Cg_exo -78.44 0.73 9.67 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.389 2.06 . . . . 0.0 111.867 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.42 -158.92 28.04 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.21 119.21 6.23 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.54 2.16 . . . . 0.0 110.763 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -80.89 75.27 2.29 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 128.73 176.95 14.64 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -144.6 137.17 26.53 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -107.4 -147.65 13.83 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.342 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . 68.43 112.15 0.04 OUTLIER 'General case' 0 C--O 1.247 0.963 0 C-N-CA 125.154 1.382 . . . . 0.0 113.147 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 75.74 99.7 0.07 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.636 1.574 . . . . 0.0 112.281 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -131.05 158.5 22.7 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.39 -26.09 14.72 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.136 1.891 . . . . 0.0 111.386 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -157.06 131.12 8.34 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -97.9 -160.21 30.66 Favored Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.944 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 179.17 -170.55 42.28 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.3 m -90.88 144.85 25.26 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 120.967 0.413 . . . . 0.0 110.027 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 130.95 78.36 0.18 Allowed Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.123 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 16.6 t -90.61 -178.8 5.39 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -136.08 73.13 0.45 Allowed Glycine 0 C--N 1.306 -1.114 0 C-N-CA 119.526 -1.321 . . . . 0.0 113.224 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.46 102.96 0.63 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.759 2.306 . . . . 0.0 110.252 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 53.6 m -159.81 133.95 7.46 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 37.2 pt -85.86 148.79 4.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -109.42 104.03 13.05 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.402 0.62 . . . . 0.0 112.254 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.28 139.47 33.2 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.81 18.79 5.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 123.209 1.481 . . . . 0.0 107.52 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--N 1.306 -1.304 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.807 -178.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' A' ' 6' ' ' ASP . 48.8 m . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -99.32 3.2 45.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.154 0.502 . . . . 0.0 110.128 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -96.13 150.25 20.72 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.76 -30.01 40.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 O-C-N 123.017 0.198 . . . . 0.0 111.014 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.462 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 12.5 mm-40 -135.04 101.74 4.98 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 1' ' ' SER . 5.1 p-10 -160.28 -173.89 4.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 tt -85.18 106.94 16.99 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.171 -1.011 . . . . 0.0 108.539 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.415 HD13 ' HB2' ' A' ' 1' ' ' SER . 66.2 tp -85.51 112.26 20.75 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.051 -175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt 62.17 83.94 0.15 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.859 1.264 . . . . 0.0 114.402 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt 176.14 85.45 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 174.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.4 m-20 -126.46 28.6 5.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.795 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 34' ' ' SER . 20.0 m -135.09 136.51 51.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.003 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -64.86 116.13 26.82 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 12.1 Cg_exo -70.71 -36.06 8.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 111.718 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.97 167.43 11.14 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 p -97.56 150.14 21.45 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 124.393 1.077 . . . . 0.0 110.496 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.456 HD13 HD22 ' A' ' 102' ' ' LEU . 60.2 mt -127.17 132.67 50.45 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.363 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.64 178.05 28.32 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.88 167.55 11.02 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.047 0.451 . . . . 0.0 111.021 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.466 ' HG2' ' NE2' ' A' ' 57' ' ' GLN . 5.7 tp10 -84.58 109.0 17.63 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.635 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 HD23 ' A' ' 158' ' ' LEU . 16.8 p -100.82 162.58 12.81 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.509 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 155' ' ' LYS . . . -49.8 117.29 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 113.586 -173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.35 39.05 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.4 23.67 53.39 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.2 142.67 13.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 127.23 38.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.6 m -128.29 115.24 18.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.05 147.11 23.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.457 ' HG ' ' HG3' ' A' ' 42' ' ' GLN . 10.4 mp -116.51 -50.4 2.63 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.954 176.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 116.66 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -86.96 156.91 19.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.321 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.17 160.34 29.81 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.466 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 m120 70.39 16.65 7.1 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.726 1.21 . . . . 0.0 110.427 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 34.2 p -89.44 136.82 32.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.561 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 14.2 p -73.1 114.9 11.79 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 121.597 0.713 . . . . 0.0 111.184 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.463 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 22.2 pt -95.75 158.09 34.91 Favored Pre-proline 0 C--N 1.287 -2.115 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.794 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 36' ' ' ILE . 31.8 Cg_exo -61.42 132.94 10.5 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 N-CA-C 114.848 1.057 . . . . 0.0 114.848 1.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 p -104.05 166.98 10.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.502 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.515 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 50.1 tttp -173.86 107.1 0.13 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.57 144.01 50.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -112.38 133.04 54.69 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.776 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.457 ' HG3' ' HG ' ' A' ' 29' ' ' LEU . 15.5 mm100 -128.59 134.78 48.69 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.64 129.72 49.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.501 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 96.7 m-85 -121.96 167.88 12.56 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 17.0 p -135.21 170.79 15.38 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.437 0.16 . . . . 0.0 111.32 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -83.32 176.11 9.37 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.508 ' CE2' ' HB2' ' A' ' 22' ' ' ALA . 1.5 m-85 -81.97 -46.78 13.54 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.0 p -143.79 -171.77 3.6 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.659 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.62 162.27 18.9 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.904 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 82' ' ' PRO . 32.9 m-20 71.28 5.73 5.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.73 112.5 52.29 Favored Pre-proline 0 N--CA 1.402 -2.842 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -100.08 -9.58 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.259 1.973 . . . . 0.0 115.094 -173.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . -148.84 135.13 5.29 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.7 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.44 161.15 17.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.45 ' HG ' ' HG3' ' A' ' 57' ' ' GLN . 53.9 tp -111.48 108.5 18.06 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.196 0.522 . . . . 0.0 109.881 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 mm -83.09 99.86 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.466 ' NE2' ' HG2' ' A' ' 20' ' ' GLU . 43.6 mt-30 -109.06 119.02 38.29 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 104' ' ' VAL . 45.0 t -99.27 124.49 52.59 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 O-C-N 123.655 0.597 . . . . 0.0 110.154 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 80.1 m-85 -122.13 146.84 46.84 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.389 0.614 . . . . 0.0 111.559 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' A' ' 72' ' ' LEU . 39.8 tt0 -111.52 120.11 41.03 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.342 177.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.55 -166.83 24.42 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -153.16 134.46 14.22 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.633 0.773 . . . . 0.0 110.118 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 65' ' ' MET . 40.1 mtp180 -158.13 -176.36 5.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.094 1.358 . . . . 0.0 108.715 171.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.16 73.98 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 122.398 1.094 . . . . 0.0 108.802 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 65.7 mtt -105.0 162.42 13.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.513 -1.676 . . . . 0.0 107.619 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.25 16.06 2.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.646 0.736 . . . . 0.0 109.679 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -85.95 154.77 21.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.557 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 81.58 -32.53 0.1 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.581 1.552 . . . . 0.0 110.967 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.614 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 12.7 m120 -64.0 168.01 5.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.468 ' HA ' HD13 ' A' ' 126' ' ' LEU . 35.0 t30 -90.11 117.67 29.07 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.403 -174.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.38 122.05 27.49 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 60' ' ' GLU . 3.5 mp -95.47 -49.85 5.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.36 0.6 . . . . 0.0 109.414 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.29 162.46 34.84 Favored Glycine 0 N--CA 1.417 -2.607 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -152.91 158.05 41.55 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -159.58 163.12 35.33 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.97 143.0 33.78 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.849 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.433 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 2.1 tt -108.49 104.11 13.38 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 103.375 -2.824 . . . . 0.0 103.375 171.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.4 p -120.45 107.95 13.51 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.295 0.569 . . . . 0.0 110.622 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.97 19.25 0.02 OUTLIER Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.352 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.79 127.47 83.96 Favored Pre-proline 0 C--O 1.249 1.072 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.91 153.98 71.73 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.883 2.389 . . . . 0.0 111.736 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 31.3 Cg_endo -65.96 89.56 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.34 2.027 . . . . 0.0 112.284 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.33 144.65 53.3 Favored Pre-proline 0 C--N 1.295 -1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.8 148.78 81.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.731 2.287 . . . . 0.0 111.119 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.35 132.28 50.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.243 0.544 . . . . 0.0 111.254 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.68 -34.15 4.77 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.57 -56.16 1.48 Allowed Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 93.81 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.147 1.231 . . . . 0.0 110.526 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -96.46 124.7 40.54 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.503 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mm -99.72 117.48 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -90.64 106.54 18.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -102.32 115.39 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 m -109.03 126.09 52.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.536 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.411 ' CD2' HD22 ' A' ' 29' ' ' LEU . 2.9 m-85 -115.45 121.23 42.1 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.604 0.762 . . . . 0.0 109.726 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.515 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.1 p30 -140.03 137.08 34.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 71.4 mt -112.3 135.04 52.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.8 p-10 -91.19 -168.52 2.08 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -24.39 64.26 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.407 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 6.0 t30 -81.54 -29.81 33.37 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.135 0.493 . . . . 0.0 109.902 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.01 24.53 5.44 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 84.6 mt -88.95 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 17' ' ' LEU . 49.4 tp -94.42 118.38 31.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.663 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -103.35 115.92 31.45 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 121.415 0.626 . . . . 0.0 110.476 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 58' ' ' VAL . 96.7 t -100.38 114.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.961 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.2 m -122.94 120.59 33.87 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.19 117.51 33.42 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.9 m -116.53 124.18 49.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.363 0.414 . . . . 0.0 112.019 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.75 114.26 12.98 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 123.607 0.763 . . . . 0.0 111.076 173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 109' ' ' LYS . 33.6 mmtp -67.76 -12.22 60.1 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -79.34 -62.66 1.62 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.966 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -94.68 -30.31 14.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.152 0.501 . . . . 0.0 112.303 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.98 4.97 41.61 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.274 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.85 132.02 47.66 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-O 121.144 0.497 . . . . 0.0 111.073 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.67 43.89 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.102 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -129.51 128.19 42.31 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 165.83 15.15 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.506 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.63 138.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.8 m -100.57 113.68 26.7 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -115.57 96.93 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.99 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ILE . 26.8 m -66.51 125.41 25.63 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 170.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -60.66 96.97 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.9 t70 177.5 -33.91 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -68.87 137.65 54.06 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.021 170.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 160.96 164.99 16.84 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -113.3 9.89 18.36 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.255 0.55 . . . . 0.0 111.069 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 70' ' ' ASN . 7.5 mp -129.1 155.39 45.53 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.789 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.469 ' O ' HG13 ' A' ' 131' ' ' ILE . 37.4 p -84.27 147.69 27.1 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.646 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HA ' ' HE3' ' A' ' 128' ' ' LYS . 1.8 tpmt? -53.94 -46.98 71.71 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.147 0.579 . . . . 0.0 111.906 -174.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -59.19 -42.16 90.23 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.548 1.139 . . . . 0.0 109.907 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 127' ' ' SER . 51.9 tt0 -66.95 -41.51 86.82 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.546 1.138 . . . . 0.0 109.347 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 127' ' ' SER . 96.1 mt -61.11 -41.49 89.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.815 176.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -65.33 -37.67 87.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -63.86 -45.76 88.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.614 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 40.2 ttp -54.77 -48.69 72.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.466 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.422 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 78.7 t -61.81 -40.71 87.93 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.842 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -61.94 -38.39 88.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 36.6 mt-10 -72.55 -34.42 67.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.576 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.57 -43.27 94.44 Favored 'General case' 0 C--O 1.201 -1.483 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.976 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 12.1 mm-40 -59.98 -38.04 81.42 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.952 0.882 . . . . 0.0 110.479 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 87.4 tttt -61.73 -28.56 69.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.839 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -126.91 23.49 6.6 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.342 -0.224 . . . . 0.0 111.153 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.75 -29.48 69.99 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -66.3 -40.13 89.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -70.61 -50.09 40.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 0.5 OUTLIER -59.21 -43.49 92.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.077 178.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 149' ' ' ARG 0.296 22.2 mt-10 -68.73 -32.52 72.35 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 118.436 -1.306 . . . . 0.0 113.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 76.6 t -61.8 -40.95 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.246 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 79.5 mt-30 -57.17 -46.21 82.98 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 111.694 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 8.6 ptm180 -71.49 -35.36 70.77 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 146' ' ' GLU . 43.2 mt-10 -72.9 -21.71 60.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.497 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 22.2 mmt180 -64.82 -28.56 69.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.312 0.577 . . . . 0.0 109.672 173.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.41 -35.58 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 51.6 m 71.04 85.4 0.13 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.906 1.282 . . . . 0.0 112.775 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 43.93 80.37 0.04 OUTLIER 'General case' 0 C--O 1.244 0.811 0 C-N-CA 125.562 1.545 . . . . 0.0 114.269 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 17.4 tppt? -81.28 110.74 17.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 4.3 t30 -111.09 33.0 4.88 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.829 1.3 . . . . 0.0 109.629 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -121.67 142.16 50.43 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 21' ' ' THR . 27.6 mt -92.5 150.0 21.03 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.311 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.43 143.79 40.36 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.777 0.799 . . . . 0.0 111.718 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.5 m -123.31 92.45 3.7 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -79.35 143.93 34.66 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.502 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.05 82.88 5.18 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.845 0.355 . . . . 0.0 111.909 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 53.73 89.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.41 1.484 . . . . 0.0 113.958 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -74.02 -21.99 59.76 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 84.1 mtp -61.33 -23.27 65.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.132 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -117.22 89.11 3.04 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.1 t -121.45 129.77 53.17 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.21 -177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.6 89.76 1.2 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.21 79.34 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.868 0.842 . . . . 0.0 110.911 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 171' ' ' ASP . 6.6 pt-20 -123.88 -100.41 0.41 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.51 172.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.465 ' H ' ' HG3' ' A' ' 170' ' ' GLU . 24.7 t70 62.69 157.26 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 167.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 73.6 -54.14 0.69 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.72 1.608 . . . . 0.0 113.001 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -71.83 100.7 0.94 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -131.58 100.82 5.26 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -128.05 173.38 10.11 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.698 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -137.0 101.48 0.35 Allowed Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 65.3 178.34 0.2 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.258 1.423 . . . . 0.0 111.476 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.0 147.07 12.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.745 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 17.8 t -79.07 86.85 4.87 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.09 0.471 . . . . 0.0 109.968 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 69.56 -63.21 0.39 Allowed 'General case' 0 C--O 1.246 0.887 0 C-N-CA 125.711 1.604 . . . . 0.0 113.185 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -130.52 144.69 51.57 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 120.99 0.424 . . . . 0.0 110.876 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.44 171.2 9.2 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.462 ' NZ ' ' HA ' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -119.59 18.84 12.71 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 123.111 0.565 . . . . 0.0 110.136 -177.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.94 12.08 14.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -172.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -63.09 139.22 58.75 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.012 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.27 165.6 2.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.683 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.1 mt -82.7 130.31 35.1 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -100.64 -51.56 3.56 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 123.525 0.516 . . . . 0.0 111.897 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -141.07 110.71 6.43 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.182 -169.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -102.65 14.35 32.17 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -82.58 85.27 7.01 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.54 -35.39 50.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.205 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 29.7 pt -55.89 96.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.268 1.033 . . . . 0.0 113.17 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.4 m -102.42 -26.59 13.21 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.409 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -81.4 80.37 7.81 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 122.166 0.984 . . . . 0.0 112.583 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.3 mp -122.21 -46.0 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.297 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -72.3 141.16 48.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.725 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -136.31 12.77 3.28 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -87.01 -22.21 25.65 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.641 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 17.3 m -73.31 79.08 1.34 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.628 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 59.3 tp -173.09 101.63 0.13 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.287 1.035 . . . . 0.0 108.61 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -79.96 -63.16 1.48 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -153.82 141.59 20.04 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -93.0 113.95 26.37 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 119.251 -0.979 . . . . 0.0 112.362 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -92.18 80.91 5.02 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.36 -58.1 1.0 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.256 -1.338 . . . . 0.0 107.447 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 54.99 77.38 0.21 Allowed 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.695 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -94.24 132.22 39.03 Favored 'General case' 0 N--CA 1.416 -2.134 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.071 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -61.08 -54.16 48.09 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 123.51 0.506 . . . . 0.0 109.946 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -149.07 69.53 1.07 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . 0.265 75.3 ttt180 42.6 -104.53 0.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 112.307 -2.224 . . . . 0.0 112.552 -170.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -157.06 22.46 0.31 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -150.37 160.13 43.96 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -175.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 51.6 tp -149.53 152.76 36.09 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 67.29 84.66 0.15 Allowed 'General case' 0 C--N 1.344 0.353 0 O-C-N 124.429 1.08 . . . . 0.0 110.404 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.35 105.28 17.37 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.372 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.1 m -142.05 98.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.536 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -147.08 119.58 4.81 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -48.01 -43.23 30.79 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.296 2.664 . . . . 0.0 112.769 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 50.3 mm -101.59 94.46 3.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.717 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.0 mm -81.55 -34.37 13.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 22.8 t -169.22 169.87 8.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 178.54 -153.22 12.36 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 94.2 mt 62.26 35.35 15.38 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.621 0.768 . . . . 0.0 110.595 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -89.63 141.65 28.4 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.344 0.592 . . . . 0.0 111.406 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -121.92 94.21 4.24 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 85.28 -73.5 2.6 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -128.67 -68.04 0.77 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.12 44.32 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.595 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -166.53 177.0 41.58 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.72 145.45 98.13 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.019 2.479 . . . . 0.0 111.587 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -92.62 116.32 5.07 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-O 119.626 -0.541 . . . . 0.0 113.061 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.51 145.78 78.31 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 123.702 2.935 . . . . 0.0 113.231 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -149.54 -100.13 0.21 Allowed Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 89.05 21.32 42.61 Favored Glycine 0 C--N 1.312 -0.793 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -103.21 142.85 33.45 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.264 1.026 . . . . 0.0 108.668 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -125.77 -153.35 8.41 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -77.09 108.93 10.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -94.76 -26.86 16.08 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 102.23 96.52 2.32 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.83 115.65 2.7 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.08 2.52 . . . . 0.0 112.822 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -113.92 -6.85 13.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.224 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -105.71 -1.65 39.95 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -145.54 156.12 26.81 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 49.7 m -86.84 138.35 31.65 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 117.158 0.479 . . . . 0.0 111.262 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.588 ' HA2' ' O ' ' A' ' 252' ' ' THR . . . -81.42 -155.5 13.86 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.156 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 77.7 p 63.81 -35.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.999 1.719 . . . . 0.0 114.666 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -144.07 -67.99 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.115 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.964 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.81 -62.16 0.25 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.06 2.507 . . . . 0.0 114.747 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.588 ' O ' ' HA2' ' A' ' 248' ' ' GLY . 14.0 m -120.59 114.6 21.97 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.421 ' H ' HD13 ' A' ' 253' ' ' ILE . 0.2 OUTLIER -127.25 -61.56 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.8 -178.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -147.85 -60.78 0.26 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -147.37 123.07 10.54 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.027 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.577 HG23 ' H ' ' A' ' 257' ' ' ASP . 3.3 m -115.39 -81.1 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.577 ' H ' HG23 ' A' ' 256' ' ' VAL . 38.2 t70 . . . . . 0 CA--C 1.488 -1.429 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -90.94 8.0 37.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.976 0.417 . . . . 0.0 111.928 -175.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -83.42 5.3 24.15 Favored 'General case' 0 CA--C 1.505 -0.783 0 O-C-N 121.897 -0.502 . . . . 0.0 111.345 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.88 -34.84 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.405 ' HA ' HD23 ' A' ' 8' ' ' LEU . 46.3 mt-30 -99.44 78.71 2.21 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -91.47 -64.37 1.13 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.668 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.1 tp -147.48 85.29 1.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.324 0.583 . . . . 0.0 110.399 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 5' ' ' GLN . 3.3 mm? -110.82 -24.23 10.56 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.699 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.0 85.04 7.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.726 0.775 . . . . 0.0 110.022 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.85 -179.9 4.31 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.106 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -82.45 67.68 8.59 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.547 1.165 . . . . 0.0 109.883 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 28.0 m -121.24 -177.17 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-N 113.822 -1.536 . . . . 0.0 107.682 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.26 110.2 42.94 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.55 -27.77 45.78 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.006 1.804 . . . . 0.0 111.702 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.474 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . 99.7 mt -130.93 156.13 45.6 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.791 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 m -77.35 141.51 39.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 123.665 0.603 . . . . 0.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -98.7 130.96 45.2 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -157.17 -176.53 29.34 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 119.092 -1.528 . . . . 0.0 114.304 -175.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 89.0 mt -118.42 150.81 38.93 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 123.933 0.893 . . . . 0.0 109.572 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 34.8 tt0 -89.56 109.82 20.73 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.421 HG22 ' HG ' ' A' ' 158' ' ' LEU . 16.0 p -89.69 172.62 8.8 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.694 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.22 110.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.177 0.513 . . . . 0.0 111.57 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -9.16 8.42 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.96 19.41 51.16 Favored Glycine 0 CA--C 1.494 -1.23 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.88 135.64 24.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 62' ' ' GLU . 23.9 ttt -89.54 112.2 23.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.253 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.5 m -110.26 110.93 21.93 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -97.9 135.44 39.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.101 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 mp -90.94 -49.44 6.43 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -96.85 114.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -80.78 141.5 34.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -58.78 154.09 15.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.673 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 80.25 3.59 1.89 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.749 1.619 . . . . 0.0 111.45 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 t -91.34 136.97 32.73 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 1.5 m -73.03 143.88 47.36 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 123.718 0.807 . . . . 0.0 111.504 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.422 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 42.4 pt -99.51 154.11 37.44 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 42.2 Cg_exo -62.09 144.61 46.07 Favored 'Cis proline' 0 C--O 1.247 0.974 0 CA-C-N 120.2 1.107 . . . . 0.0 113.258 0.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.3 m -129.44 145.53 51.41 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 55.0 tttp -142.33 112.75 7.18 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 29.8 tp60 -128.56 125.58 38.56 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.5 m -109.11 134.79 51.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -140.56 156.35 46.33 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.2 mm -101.87 128.65 54.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.174 0.511 . . . . 0.0 110.087 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -117.72 166.16 12.76 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.786 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 2.9 p -148.27 170.81 17.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 122.709 0.404 . . . . 0.0 111.591 -172.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.411 ' HB ' ' OG ' ' A' ' 48' ' ' SER . 41.3 p -103.79 166.04 10.67 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.417 ' C ' ' HB3' ' A' ' 85' ' ' ARG . 93.8 m-85 -95.75 -14.97 22.91 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 165.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.411 ' OG ' ' HB ' ' A' ' 46' ' ' THR . 27.3 p -97.0 178.54 5.24 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.309 -170.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -136.06 134.49 38.49 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 126.471 1.909 . . . . 0.0 106.379 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.412 HD21 ' HB3' ' A' ' 82' ' ' PRO . 33.5 m-80 70.14 6.28 5.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 41.6 tt0 -53.52 129.2 53.1 Favored Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 123.665 0.786 . . . . 0.0 112.887 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.28 79.3 3.37 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.231 1.954 . . . . 0.0 112.749 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.667 ' HA2' ' O ' ' A' ' 77' ' ' LEU . . . 96.63 131.59 6.94 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.966 176.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -105.95 130.14 57.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HG ' ' HG3' ' A' ' 57' ' ' GLN . 55.0 tp -83.56 112.37 19.94 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.726 -176.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 45.5 mm -98.82 105.38 17.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.605 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 48.6 mt-30 -104.44 117.55 34.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -96.67 121.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 O-C-N 124.313 1.008 . . . . 0.0 110.551 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 83.4 m-85 -125.48 156.6 38.69 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.634 0.374 . . . . 0.0 110.571 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 70' ' ' ASN . 8.7 pt-20 -122.57 130.77 53.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 15' ' ' LEU . . . 144.09 -155.8 26.41 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.512 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 13.8 mt-10 -161.86 134.05 5.72 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 125.703 1.601 . . . . 0.0 111.487 168.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -158.91 170.0 23.07 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 126.554 1.942 . . . . 0.0 106.099 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.81 -47.69 29.32 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.8 mtm -116.98 123.45 46.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.0 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.43 108.71 0.85 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 125.531 1.532 . . . . 0.0 111.037 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -166.81 -36.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.337 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -93.53 3.89 54.82 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.745 0.784 . . . . 0.0 109.315 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.489 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 16.6 m120 -100.5 169.51 9.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.726 -173.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.484 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 47.7 t30 -99.4 123.68 43.88 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.442 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.0 tp -83.99 123.22 29.76 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.191 0.596 . . . . 0.0 110.224 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -95.35 -22.55 17.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.97 175.7 33.28 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.987 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 8.5 ptp180 -153.04 151.42 30.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -155.88 157.87 37.08 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -112.03 133.86 53.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.502 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.667 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 54.8 tp -87.1 106.61 17.98 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 172.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 p -67.26 125.42 26.02 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' H ' ' N ' ' A' ' 53' ' ' GLY . . . 46.19 96.73 0.01 OUTLIER Glycine 0 C--N 1.344 0.974 0 C-N-CA 125.72 1.629 . . . . 0.0 116.866 173.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.437 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -79.63 155.27 76.07 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 174.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 28.5 Cg_endo -59.97 161.95 17.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.921 2.414 . . . . 0.0 113.436 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HB3' HD21 ' A' ' 50' ' ' ASN . 21.9 Cg_endo -67.25 73.19 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.834 2.356 . . . . 0.0 112.19 175.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.43 142.1 42.86 Favored Pre-proline 0 N--CA 1.417 -2.115 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.87 167.07 28.26 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.39 2.06 . . . . 0.0 112.627 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HB3' ' C ' ' A' ' 47' ' ' TYR . 10.6 ptt180 -47.24 124.38 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.196 0.998 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.16 -29.07 9.56 Favored Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.032 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.03 -52.28 1.22 Allowed Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.993 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.22 94.78 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 CA-C-N 120.683 1.28 . . . . 0.0 110.411 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.11 113.2 17.04 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.285 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.8 mm -92.84 108.06 19.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.425 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 37.2 tt0 -90.49 106.49 18.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' THR . 47.2 t -104.81 131.98 52.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.0 m -130.64 127.45 38.96 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.267 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 4.5 m-85 -103.46 113.02 26.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.4 p30 -125.25 125.08 43.01 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.846 175.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 12.1 mt -107.83 145.35 15.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.25 -160.64 0.82 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.66 51.11 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.43 -29.02 52.72 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.918 0.39 . . . . 0.0 111.989 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.35 29.22 4.04 Favored Glycine 0 C--N 1.298 -1.574 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 75.3 mt -87.6 116.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.9 tp -98.88 118.88 36.64 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.288 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -107.6 104.56 14.13 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.274 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 58.0 t -93.45 114.1 29.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.4 m -113.33 124.24 52.01 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.144 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.88 117.81 34.42 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 26.7 m -112.17 127.76 56.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.072 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.18 100.88 10.1 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 53.3 mtpt -67.65 -13.48 62.13 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.4 m -82.56 -47.34 12.24 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.165 0.507 . . . . 0.0 110.537 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -101.38 -27.06 13.36 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.48 45.09 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 120.256 -0.973 . . . . 0.0 115.264 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 147.82 27.23 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.73 146.24 34.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.46 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.53 131.11 48.25 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 12.3 ptmm? -122.98 135.31 54.43 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.446 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.8 pt -106.94 137.8 35.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.406 HG22 HG23 ' A' ' 120' ' ' THR . 84.9 m -108.53 112.08 24.27 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.055 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.13 97.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.406 HG23 HG22 ' A' ' 118' ' ' THR . 15.7 p -92.59 101.26 13.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.27 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 43.97 72.94 0.16 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.381 1.051 . . . . 0.0 112.717 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -128.06 137.44 52.16 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -101.85 14.35 32.2 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.988 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.36 -125.04 6.94 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.549 173.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -117.08 -29.36 5.97 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.629 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . 88.5 mt -97.61 142.89 28.86 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.86 0.362 . . . . 0.0 111.179 -177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.0 p -82.17 170.94 14.87 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.104 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 9.8 ptpp? -56.01 -33.24 64.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' HG2' ' A' ' 132' ' ' GLU . 45.2 tt0 -68.94 -41.11 78.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 110.857 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 126' ' ' LEU . 66.4 mm-40 -68.66 -34.72 76.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 135' ' ' VAL . 78.1 mt -64.63 -52.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.774 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 129' ' ' GLU . 9.5 pt-20 -64.0 -30.45 71.52 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.795 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 44.1 mtp85 -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.588 174.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 20.8 ptt? -70.73 -21.3 62.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.611 -0.836 . . . . 0.0 113.018 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 131' ' ' ILE . 93.5 t -63.3 -50.01 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.63 -34.94 77.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.792 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 40.7 mm-40 -62.95 -47.02 85.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.45 175.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.29 -29.91 70.72 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 142' ' ' LYS . 30.6 mm-40 -75.47 -45.91 35.63 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -72.59 -46.61 53.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.022 0.439 . . . . 0.0 111.077 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.65 22.84 7.58 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 60.0 mttp -42.84 -59.19 2.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 123.663 0.602 . . . . 0.0 110.524 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.33 -37.51 67.53 Favored 'General case' 0 C--O 1.231 0.086 0 O-C-N 124.312 1.007 . . . . 0.0 112.733 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.94 -53.23 11.83 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.778 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 13.2 m-20 -70.07 -31.6 69.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 12.4 pt-20 -67.49 -42.9 82.16 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.42 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 79.5 t -67.7 -42.38 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -61.62 -45.48 93.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 5.1 ptp180 -65.65 -32.13 73.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.817 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -78.95 -24.32 43.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 22.4 mmm180 -61.84 -40.58 95.79 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.218 176.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.63 146.07 7.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m -57.11 140.54 49.05 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.24 103.91 7.44 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -86.44 134.75 33.67 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.036 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.04 22.02 13.29 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 166.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.603 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -120.3 140.17 51.65 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.706 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 21' ' ' THR . 1.6 mp -117.53 149.97 39.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.93 163.4 12.98 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.407 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 16.0 m -153.06 90.19 1.43 Allowed 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 71.9 t80 76.5 89.08 0.08 Allowed 'General case' 0 C--O 1.242 0.69 0 O-C-N 124.836 1.335 . . . . 0.0 109.839 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 85.89 138.73 0.05 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.145 1.778 . . . . 0.0 112.627 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -90.42 83.09 5.87 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.275 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.3 t30 71.89 153.3 0.13 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.49 1.116 . . . . 0.0 111.597 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.0 mmt -119.4 11.5 12.2 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.731 -0.606 . . . . 0.0 110.88 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -122.05 177.89 5.13 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.0 t -92.55 102.64 15.08 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.1 88.11 3.0 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.342 0.591 . . . . 0.0 110.528 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.79 160.04 3.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.016 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -130.97 91.29 3.02 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.913 0.863 . . . . 0.0 111.336 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -80.56 -40.16 26.38 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.918 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 64.19 -81.57 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.831 1.252 . . . . 0.0 111.708 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 66.17 -136.45 34.94 Favored Glycine 0 N--CA 1.436 -1.341 0 O-C-N 123.489 0.493 . . . . 0.0 113.012 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.4 mt 71.83 4.83 5.17 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.449 1.5 . . . . 0.0 111.903 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -126.28 161.63 27.32 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.63 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 91.16 47.47 3.57 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.56 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -158.75 172.09 18.88 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.1 pp -138.5 -174.44 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 123.109 0.564 . . . . 0.0 111.333 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 29.9 m 85.24 7.63 0.42 Allowed 'General case' 0 C--O 1.248 1.008 0 C-N-CA 125.891 1.677 . . . . 0.0 113.04 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -82.44 -60.11 2.31 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -126.23 99.48 5.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -104.56 161.8 13.8 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -69.22 -50.14 50.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.224 0.535 . . . . 0.0 110.689 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -142.69 97.9 3.19 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -130.1 89.7 2.84 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.68 0.752 . . . . 0.0 109.105 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.95 3.3 7.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.926 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.5 tp -117.46 150.63 38.6 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.91 76.36 3.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.742 1.258 . . . . 0.0 111.676 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -94.06 85.09 4.61 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 69.63 176.46 0.28 Allowed 'General case' 0 C--O 1.245 0.833 0 O-C-N 124.197 0.936 . . . . 0.0 110.887 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 67.73 17.42 9.8 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 122.126 0.965 . . . . 0.0 109.422 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 52.9 t -104.57 113.33 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 16.4 tt -102.04 85.5 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.535 1.159 . . . . 0.0 111.081 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.2 m -86.98 118.49 26.39 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.0 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 25.1 m-90 -84.84 87.3 7.32 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.643 HD23 ' H ' ' A' ' 197' ' ' LEU . 2.2 pt? -83.23 -19.7 35.94 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -81.82 98.98 8.75 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -90.58 161.9 15.24 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -74.44 131.75 41.33 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 17.6 m -53.02 116.92 2.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 124.523 1.139 . . . . 0.0 110.867 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 49.1 tp -87.22 81.69 7.88 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 122.05 0.929 . . . . 0.0 109.843 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.24 97.01 2.25 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.541 ' HG3' ' HG3' ' A' ' 205' ' ' LYS . 12.5 tp10 -79.53 -70.49 0.51 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.304 -172.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.541 ' HG3' ' HG3' ' A' ' 204' ' ' GLU . 49.1 mttm -139.99 116.76 10.91 Favored 'General case' 0 CA--C 1.498 -1.028 0 O-C-N 121.791 -0.568 . . . . 0.0 110.914 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -108.14 94.13 4.9 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.85 171.82 11.91 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.848 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -149.36 111.99 4.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -53.58 132.96 41.27 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.322 0.649 . . . . 0.0 112.447 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -113.06 85.52 2.19 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.067 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.36 89.57 3.14 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -176.29 102.85 0.06 Allowed 'General case' 0 C--O 1.248 0.984 0 O-C-N 123.895 0.747 . . . . 0.0 110.67 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt 171.57 83.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.374 1.469 . . . . 0.0 107.806 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.58 144.67 27.63 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.06 153.64 30.04 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -108.99 165.25 11.73 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -152.98 96.75 2.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.365 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.97 96.21 4.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -121.63 120.37 28.77 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.16 121.74 9.9 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.168 1.912 . . . . 0.0 111.607 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 63.4 mt -85.07 91.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.47 2.34 6.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.662 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 30.8 t -117.41 121.4 40.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.329 0.585 . . . . 0.0 110.31 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -147.71 112.6 0.6 Allowed Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.7 tt -94.51 96.23 9.34 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.382 0.61 . . . . 0.0 109.786 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -148.69 114.48 5.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -133.7 -52.16 0.86 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.725 -172.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 143.44 113.06 0.89 Allowed Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.638 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -125.78 154.67 42.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -151.24 -157.33 7.81 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.535 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -161.97 87.76 0.11 Allowed Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.973 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.79 128.0 20.99 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.586 2.191 . . . . 0.0 110.531 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -135.18 101.82 0.41 Allowed Glycine 0 N--CA 1.427 -1.9 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.0 154.38 57.83 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 122.079 1.853 . . . . 0.0 110.836 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.96 34.25 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.053 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.35 75.54 2.31 Favored Glycine 0 C--N 1.299 -1.519 0 C-N-CA 121.244 -0.503 . . . . 0.0 111.869 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -76.74 143.25 40.07 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 112.58 81.1 1.07 Allowed Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -175.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.1 85.31 6.93 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.218 0.532 . . . . 0.0 110.815 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -150.0 115.6 5.54 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -105.2 -159.45 23.27 Favored Glycine 0 C--N 1.292 -1.915 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.75 104.45 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.646 2.231 . . . . 0.0 111.097 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -78.2 109.96 12.76 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 162.11 -157.1 28.88 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -171.47 -51.18 0.04 OUTLIER Glycine 0 C--N 1.301 -1.404 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.697 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 23.3 t 64.12 86.48 0.12 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 124.886 1.274 . . . . 0.0 110.13 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -142.14 47.56 0.82 Allowed Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.625 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 16.0 m -88.7 154.95 19.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -75.55 162.74 53.4 Favored Glycine 0 C--O 1.246 0.903 0 CA-C-O 119.846 -0.419 . . . . 0.0 112.665 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.91 127.47 18.65 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 123.131 2.554 . . . . 0.0 111.83 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 15.7 m -81.2 84.83 6.47 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.458 0.647 . . . . 0.0 110.996 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 253' ' ' ILE . 2.3 pp -95.35 123.7 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.024 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.19 -31.27 34.05 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -170.46 147.79 3.03 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 173.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.26 74.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-O 121.934 0.873 . . . . 0.0 110.602 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.282 178.062 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.241 0.642 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 72.8 -43.66 0.57 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.3 m120 70.55 78.96 0.18 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.509 1.123 . . . . 0.0 109.884 -176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.17 -11.93 11.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.075 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -106.82 9.18 31.04 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.775 0.798 . . . . 0.0 109.677 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.55 157.49 18.6 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.695 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.5 mt -131.46 121.54 24.71 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.773 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp 70.11 141.28 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.864 1.352 . . . . 0.0 112.013 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 tp -97.79 98.5 9.89 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.2 tp -102.74 164.3 11.72 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.388 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 59.2 68.75 0.78 Allowed 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.477 1.132 . . . . 0.0 110.032 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 35' ' ' THR . 34.1 m -137.55 -178.55 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.371 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.9 123.27 82.33 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.426 ' C ' HD12 ' A' ' 15' ' ' LEU . 19.5 Cg_endo -60.51 -51.48 5.12 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.3 2.0 . . . . 0.0 110.907 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.546 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 7.3 mp -128.1 167.37 16.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 174.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.626 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 18.5 m -72.5 142.45 48.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 O-C-N 123.614 0.571 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -114.0 132.12 56.1 Favored 'General case' 0 C--O 1.257 1.497 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.782 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 28' ' ' ALA . . . -147.79 -177.42 22.18 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.044 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.496 HD11 HG11 ' A' ' 92' ' ' VAL . 83.6 mt -122.83 167.94 12.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.896 0.379 . . . . 0.0 111.63 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.21 109.34 17.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.391 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 p -109.47 158.34 18.07 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.437 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.11 115.93 1.36 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.903 1.281 . . . . 0.0 113.252 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.21 10.74 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.821 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.37 44.17 5.36 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.34 137.17 55.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 33.1 ttp -96.71 112.05 23.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -94.42 112.3 24.07 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' ' CA ' ' A' ' 18' ' ' GLY . . . -90.28 133.67 34.8 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.666 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.629 ' HG ' ' OE1' ' A' ' 42' ' ' GLN . 5.9 mp -100.93 -39.67 7.64 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.69 129.85 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -101.31 162.6 12.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.42 ' HD3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -70.91 142.2 51.14 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.824 178.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' OD1' ' HD3' ' A' ' 32' ' ' ARG . 16.9 m120 80.64 -6.09 1.69 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.24 1.416 . . . . 0.0 113.252 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.7 m -65.19 115.29 5.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 12' ' ' VAL . 2.7 m -71.03 129.9 40.18 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.193 -172.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.425 ' HA ' ' C ' ' A' ' 37' ' ' PRO . 28.4 pt -92.97 155.76 41.08 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.029 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 34.1 Cg_exo -63.48 141.83 42.86 Favored 'Cis proline' 0 N--CA 1.487 1.098 0 C-N-CA 124.604 -0.998 . . . . 0.0 114.24 0.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.6 p -120.89 152.84 37.97 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.762 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.559 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 47.6 tttp -153.41 99.81 2.38 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -108.42 135.31 49.93 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.5 m -124.02 127.97 48.67 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 44.8 mt-30 -132.11 150.28 52.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.91 129.42 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.533 ' HA ' ' ND2' ' A' ' 156' ' ' ASN . 89.1 m-85 -117.42 155.14 30.15 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 22.9 p -127.37 170.73 12.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 41.5 p -100.51 139.86 35.6 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 31.3 m-85 -117.76 5.13 12.25 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -120.74 127.16 51.74 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.412 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 84' ' ' PRO . 46.0 t0 -82.05 169.95 16.11 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 68.34 14.66 9.21 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.822 1.249 . . . . 0.0 113.232 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -90.25 114.62 61.64 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -89.8 -1.82 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.146 1.897 . . . . 0.0 111.839 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.91 145.01 8.89 Favored Glycine 0 N--CA 1.413 -2.874 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.39 147.32 13.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 117.049 0.425 . . . . 0.0 109.93 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.08 118.15 35.19 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.067 0.46 . . . . 0.0 110.705 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.72 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 74' ' ' ARG . 90.7 mt-30 -102.2 130.01 48.74 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 t -99.48 129.0 50.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 123.714 0.634 . . . . 0.0 109.354 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.78 156.55 44.79 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.166 0.508 . . . . 0.0 111.524 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.546 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 35.8 tt0 -118.63 136.77 53.71 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.471 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.04 116.55 3.91 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.626 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 40.4 mt-10 -79.47 107.18 12.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -133.57 144.53 49.38 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.9 76.0 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 124.131 0.894 . . . . 0.0 111.552 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.8 mtt -94.76 111.49 23.26 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.271 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.411 ' HA ' ' OD1' ' A' ' 69' ' ' ASN . 1.9 m -74.71 109.83 8.51 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.066 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -175.25 -41.46 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.566 1.147 . . . . 0.0 109.016 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -109.21 75.44 0.95 Allowed 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 66' ' ' THR . 9.2 m120 -147.92 164.33 34.07 Favored 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 73.2 m-20 -90.61 129.3 36.75 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.0 tp -83.34 125.09 31.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.05 0.452 . . . . 0.0 111.221 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' A' ' 119' ' ' ILE . 7.4 mp -101.99 -9.38 20.69 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.52 178.33 15.37 Favored Glycine 0 C--N 1.298 -1.571 0 C-N-CA 120.238 -0.982 . . . . 0.0 110.882 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.507 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 6.8 ppt_? -153.33 156.91 39.24 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -150.87 152.32 33.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -109.39 125.01 51.94 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -93.06 104.22 16.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 p -105.15 163.49 12.54 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.695 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.62 7.09 45.91 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.6 mm -64.56 127.46 92.38 Favored Pre-proline 0 C--O 1.248 1.016 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.59 143.49 68.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.244 1.963 . . . . 0.0 110.613 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.63 90.58 0.6 Allowed 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 121.204 1.27 . . . . 0.0 109.646 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.16 129.53 20.94 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.995 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.429 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 17.9 Cg_endo -58.73 -61.04 0.28 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 0 C-N-CA 123.296 2.664 . . . . 0.0 114.643 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 46' ' ' THR . 88.1 mtt180 -139.37 136.1 34.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -173.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.01 1.25 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 117.731 1.852 . . . . 0.0 117.731 167.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.9 t -52.3 -57.53 15.02 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 6.2 Cg_exo -81.73 103.52 1.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.641 1.56 . . . . 0.0 110.821 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -95.11 117.75 30.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.25 121.56 47.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.93 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 38.4 tt0 -91.35 115.79 28.32 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 19' ' ' LEU . 84.7 t -110.49 124.81 67.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 m -121.67 128.85 52.31 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.222 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -110.57 109.55 19.9 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.559 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 3.1 p30 -126.57 128.25 46.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.26 0.552 . . . . 0.0 112.12 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 45.9 mt -123.62 133.92 67.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.0 p-10 -88.72 -172.07 3.57 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.11 -5.95 55.33 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.41 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -87.07 -29.88 21.56 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.46 26.7 4.73 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 72.9 mt -89.07 108.0 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.408 HD23 HD12 ' A' ' 119' ' ' ILE . 32.7 tp -94.63 128.76 41.5 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.388 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER -119.74 108.02 13.91 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 174.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 61.2 t -95.59 113.81 30.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.9 m -112.86 122.03 46.43 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.91 122.95 48.54 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.1 m -122.64 122.22 38.29 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 120.842 0.353 . . . . 0.0 111.429 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -82.52 108.16 15.71 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.063 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.8 -6.88 23.48 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -79.84 -61.97 1.83 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 38.1 p -82.61 -30.22 29.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.68 13.1 56.01 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.982 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -91.11 144.0 26.1 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 117.626 0.713 . . . . 0.0 109.684 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -123.8 141.71 51.78 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -129.52 134.08 47.58 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 17.5 ptpt -124.25 166.55 15.69 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.47 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.431 HG22 ' HB ' ' A' ' 104' ' ' VAL . 15.0 tt -131.2 145.53 35.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.8 m -113.51 116.21 29.21 Favored 'General case' 0 C--N 1.276 -2.603 0 O-C-N 124.397 1.061 . . . . 0.0 110.124 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 72' ' ' LEU . 75.5 mt -120.6 125.24 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.0 m -119.92 140.7 50.48 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 79.48 -82.94 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.401 1.08 . . . . 0.0 111.429 174.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -156.48 173.11 17.39 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -155.88 164.39 38.57 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.01 -76.42 0.52 Allowed Glycine 0 C--O 1.24 0.521 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.448 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.346 3.2 mpt_? 75.93 89.82 0.08 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -129.96 -170.77 2.37 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.5 p -89.48 158.28 17.76 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.128 -1.429 . . . . 0.0 108.01 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -55.78 -41.24 73.77 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -173.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 129' ' ' GLU 0.281 0.8 OUTLIER -73.95 -23.4 59.5 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.755 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.01 -34.52 71.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.09 -44.42 78.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.664 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.01 -39.32 81.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.541 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -60.41 -43.01 97.15 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.594 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.5 tpp -58.92 -39.3 81.15 Favored 'General case' 0 C--O 1.212 -0.915 0 O-C-N 123.742 0.652 . . . . 0.0 109.828 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.77 -57.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.084 0.468 . . . . 0.0 109.98 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -61.05 -47.67 85.32 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.708 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.46 -32.55 73.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.513 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -68.17 -55.53 12.03 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 122.158 -0.339 . . . . 0.0 110.609 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.55 -48.54 77.03 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -66.74 -17.81 65.05 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -118.3 16.18 13.95 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.554 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -55.1 -43.26 73.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -37.43 80.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.158 0.504 . . . . 0.0 110.757 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.79 -44.95 65.58 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.045 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -61.32 -42.24 98.33 Favored 'General case' 0 CA--C 1.498 -1.026 0 O-C-N 123.403 0.439 . . . . 0.0 111.537 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 41.3 mt-10 -57.39 -45.51 84.44 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.982 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.65 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 46.0 t -68.76 -42.49 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.398 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -55.88 -48.8 74.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -63.91 -36.93 85.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 146' ' ' GLU . 10.0 pt-20 -79.06 -15.51 58.1 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.539 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.65 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 91.6 mtt-85 -71.77 -38.76 70.29 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.9 -57.53 4.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.938 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.45 ' OG ' ' HG2' ' A' ' 155' ' ' LYS . 31.3 t -158.27 -80.78 0.06 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.501 -174.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 65.39 19.21 11.57 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 124.952 1.301 . . . . 0.0 111.771 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HG2' ' OG ' ' A' ' 153' ' ' SER . 17.0 ptpt -82.18 144.86 30.42 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 44' ' ' PHE . 10.4 t30 -84.12 69.34 10.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.283 1.039 . . . . 0.0 111.455 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.94 159.43 42.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.774 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.3 151.63 35.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -115.06 175.04 5.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t -145.84 -175.79 4.88 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.359 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . 0.34 41.7 m-85 69.5 81.34 0.17 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -127.14 11.57 7.03 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.238 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -99.64 90.72 4.58 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.488 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.418 ' OD1' ' HG3' ' A' ' 165' ' ' MET . 52.0 t-20 -142.79 114.25 7.92 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 176.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.418 ' HG3' ' OD1' ' A' ' 164' ' ' ASN . 90.5 mtp 72.07 22.36 3.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.766 0.827 . . . . 0.0 112.247 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -97.27 81.25 2.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.1 p -152.47 -54.97 0.13 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.266 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.63 28.04 2.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.24 0.543 . . . . 0.0 110.365 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.99 144.45 25.34 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -90.58 76.83 6.5 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -99.02 117.83 34.41 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.523 -175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 173.44 -63.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 126.155 1.782 . . . . 0.0 106.216 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -163.07 154.14 24.96 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.1 mp -119.4 3.31 11.29 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 117.03 0.415 . . . . 0.0 110.628 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt 72.11 140.02 0.05 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.739 1.216 . . . . 0.0 112.306 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -145.06 64.2 0.46 Allowed Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.072 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -80.18 83.25 6.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.28 -43.51 84.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 19.1 m -157.03 141.67 16.77 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.2 -37.55 45.34 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 48.22 37.86 9.05 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.643 1.177 . . . . 0.0 113.002 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.81 -68.73 0.49 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.875 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt 61.73 -84.58 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.317 1.047 . . . . 0.0 112.806 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -131.83 172.43 12.32 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -107.37 136.15 47.66 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.9 m -86.57 96.5 5.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.999 0.904 . . . . 0.0 108.571 172.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.6 tp -69.03 -31.05 69.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.676 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -99.55 69.95 1.66 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 122.315 1.055 . . . . 0.0 108.473 171.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -62.91 130.91 46.85 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.818 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -121.08 108.16 13.49 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.87 128.64 49.77 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 32.9 m -81.13 -16.57 12.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.394 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . 0.307 8.5 tp 52.0 -70.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 126.963 2.105 . . . . 0.0 114.109 -177.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.3 m -145.61 136.1 24.14 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -95.96 108.61 21.01 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 120.284 -0.567 . . . . 0.0 109.507 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.7 mp -95.44 90.35 5.75 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.94 136.13 52.07 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.828 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -98.25 36.69 1.55 Allowed 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.666 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -61.26 -45.9 92.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.157 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 60.2 m -152.24 110.95 3.79 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.909 0.385 . . . . 0.0 110.6 176.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 203' ' ' ALA . 3.8 pp -114.86 -38.55 3.9 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.508 ' N ' HD12 ' A' ' 202' ' ' LEU . . . -168.01 89.69 0.28 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.229 0.538 . . . . 0.0 111.161 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -100.9 -6.91 24.0 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.549 0.69 . . . . 0.0 109.429 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.609 ' HD3' ' H ' ' A' ' 206' ' ' ASP . 4.9 tmtt? -103.08 149.53 24.5 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.609 ' H ' ' HD3' ' A' ' 205' ' ' LYS . 3.2 m-20 -56.36 152.93 10.47 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.665 1.186 . . . . 0.0 109.438 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.79 69.14 0.75 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.878 0.847 . . . . 0.0 112.864 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -106.76 -53.92 2.55 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -91.48 -25.78 19.12 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.735 0.779 . . . . 0.0 109.081 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -96.01 147.18 23.97 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -144.91 153.14 41.24 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -62.31 129.13 39.34 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 213' ' ' LYS . 34.2 mmtp -116.84 87.63 2.73 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.013 0.911 . . . . 0.0 110.265 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -92.58 106.42 18.41 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 113.689 -1.596 . . . . 0.0 107.645 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.74 -0.78 5.42 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.225 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -98.58 123.2 42.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.172 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 71.55 35.21 1.51 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.471 1.109 . . . . 0.0 111.5 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.03 -10.5 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.814 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 12.4 t30 50.15 80.89 0.28 Allowed Pre-proline 0 N--CA 1.468 0.457 0 C-N-CA 124.978 1.311 . . . . 0.0 111.726 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -84.11 104.61 1.06 Allowed 'Trans proline' 0 N--CA 1.433 -2.081 0 C-N-CA 122.369 2.046 . . . . 0.0 112.025 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.52 HD13 ' H ' ' A' ' 222' ' ' ILE . 0.2 OUTLIER -74.33 151.9 7.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.155 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.65 120.08 34.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.356 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.9 m -65.96 139.72 58.26 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.352 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -157.56 123.99 1.35 Allowed Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 118.544 -1.789 . . . . 0.0 113.612 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 70.8 mt -85.22 99.8 11.35 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -91.87 131.05 37.49 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.287 0.565 . . . . 0.0 111.626 -172.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -123.26 137.88 54.76 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -82.6 116.0 4.13 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.36 115.9 5.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.933 0.396 . . . . 0.0 110.91 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 159.02 -155.85 26.92 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 164.29 100.56 0.15 Allowed Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -83.79 107.05 1.31 Allowed 'Trans proline' 0 N--CA 1.44 -1.63 0 C-N-CA 122.008 1.806 . . . . 0.0 112.253 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -161.61 86.36 0.11 Allowed Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.36 108.29 0.68 Allowed 'Trans proline' 0 C--O 1.249 1.055 0 C-N-CA 122.739 2.293 . . . . 0.0 111.948 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -100.61 2.46 55.93 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.762 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -87.05 -174.51 49.03 Favored Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.287 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 64.16 74.72 0.4 Allowed 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.484 1.114 . . . . 0.0 111.091 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -170.08 -38.21 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.186 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -102.93 85.01 2.45 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.212 0.53 . . . . 0.0 110.03 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -136.94 96.88 3.39 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 243' ' ' PRO . . . -91.67 118.93 5.59 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.809 -175.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 242' ' ' GLY . 16.8 Cg_exo -69.28 165.93 28.75 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 122.852 2.368 . . . . 0.0 111.412 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -99.94 107.47 19.46 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.509 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -141.41 162.33 26.9 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -114.85 97.05 0.8 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.2 m -94.47 27.05 3.12 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.084 0.469 . . . . 0.0 111.377 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.85 31.66 5.08 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 18.7 m -94.43 123.68 37.99 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -72.89 156.65 51.92 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.11 -2.59 12.5 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 122.505 2.137 . . . . 0.0 111.955 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.1 t -169.31 153.36 5.29 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 20.1 pt -139.66 178.54 3.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.0 -176.29 3.51 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -79.19 99.1 6.86 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.859 0.837 . . . . 0.0 110.858 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.12 19.46 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 CA--C 1.497 -1.093 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.363 -177.852 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 66.65 68.9 0.42 Allowed 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.837 1.255 . . . . 0.0 114.384 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -132.33 157.36 44.66 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 171.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.2 t 65.89 80.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -170.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -63.88 152.98 38.24 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.816 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -60.84 102.15 0.18 Allowed 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 123.654 0.596 . . . . 0.0 110.83 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.82 121.26 44.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.403 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.4 tp -89.33 -43.51 10.88 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.154 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.4 mt -111.05 123.28 49.89 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.378 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.2 mt -102.15 17.36 23.51 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.726 1.251 . . . . 0.0 108.775 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 36' ' ' ILE . 1.3 m-20 -85.47 74.78 10.28 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.354 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -115.84 175.86 2.62 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.907 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.895 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.08 129.45 67.18 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.45 -23.95 2.61 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 122.131 1.887 . . . . 0.0 112.372 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.43 172.4 10.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.6 m -94.98 129.25 42.12 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.82 131.7 43.3 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.58 -164.52 14.96 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.332 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.0 mt -131.07 161.85 31.14 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.81 120.81 32.86 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 117.821 -1.551 . . . . 0.0 109.223 171.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 23.6 p -97.94 -176.33 3.41 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.809 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . . . -57.71 128.83 39.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.068 0.461 . . . . 0.0 111.922 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.25 59.96 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.803 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.8 32.43 53.73 Favored Glycine 0 C--O 1.244 0.78 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.255 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -92.91 140.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 113.09 25.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.0 m -109.39 110.97 22.27 Favored 'General case' 0 C--N 1.279 -2.468 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.624 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.29 136.26 33.16 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.201 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.7 mp -99.45 -49.98 4.25 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.81 103.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -80.71 162.8 23.97 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.499 ' HD3' ' OE2' ' A' ' 139' ' ' GLU . 9.7 ptm180 -64.43 159.36 21.55 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.316 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m120 77.34 4.8 3.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.499 1.12 . . . . 0.0 112.243 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 m -83.32 115.75 22.13 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.38 132.84 45.42 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.113 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 11' ' ' ASP . 26.5 pt -91.38 161.39 34.77 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.494 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 16.9 Cg_exo -69.01 147.39 82.98 Favored 'Cis proline' 0 C--O 1.245 0.858 0 CA-C-N 119.834 0.976 . . . . 0.0 113.731 1.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 11.8 p -118.19 136.42 53.65 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.043 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -135.02 101.02 4.74 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 93' ' ' THR . 62.1 tt0 -121.92 131.81 54.22 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 m -128.67 125.1 37.35 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -135.48 152.3 51.21 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.0 mm -99.18 122.47 50.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.088 0.47 . . . . 0.0 110.331 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.5 162.14 14.4 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.848 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 6.1 p -137.76 170.22 16.44 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.041 0.536 . . . . 0.0 109.66 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -95.93 137.01 35.6 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.303 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -108.63 32.11 5.11 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 167.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 162' ' ' ALA . 33.0 p -132.19 159.43 39.01 Favored 'General case' 0 N--CA 1.391 -3.405 0 CA-C-N 112.726 -2.034 . . . . 0.0 108.974 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -136.61 162.17 33.88 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m120 66.88 22.08 10.25 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.101 0.876 . . . . 0.0 110.934 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.521 HE22 ' HA ' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -80.48 125.71 80.26 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.959 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.16 -18.51 27.04 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 121.706 1.604 . . . . 0.0 109.657 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 78' ' ' SER . . . -178.31 175.01 47.2 Favored Glycine 0 N--CA 1.406 -3.365 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.75 129.85 55.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.119 0.485 . . . . 0.0 110.139 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.6 tp -87.17 100.29 12.56 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.595 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mm -84.15 96.98 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -109.3 110.3 21.43 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.1 t -92.98 135.97 26.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.79 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -133.77 163.24 29.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.42 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.85 165.45 25.59 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.46 -103.78 0.9 Allowed Glycine 0 C--N 1.287 -2.146 0 C-N-CA 119.025 -1.56 . . . . 0.0 114.235 170.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.652 ' OE2' ' HG3' ' A' ' 67' ' ' LYS . 39.9 mt-10 -78.46 172.16 14.04 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.594 0.358 . . . . 0.0 110.939 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -112.59 -27.47 8.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.383 -0.372 . . . . 0.0 112.001 -171.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -90.42 -52.43 4.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -172.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.1 mtm -142.1 149.64 40.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -173.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.28 82.55 2.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 O-C-N 124.082 0.863 . . . . 0.0 109.851 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.652 ' HG3' ' OE2' ' A' ' 62' ' ' GLU . 8.3 ptmm? -118.84 -76.53 0.57 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.99 12.4 30.57 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.597 0.713 . . . . 0.0 111.208 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -61.88 142.22 57.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.694 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -96.09 141.96 28.85 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.566 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.5 tp -76.99 123.37 26.24 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.458 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 73.6 mt -89.24 -40.16 13.03 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.521 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 171.27 36.74 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -140.2 135.05 32.0 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -143.22 135.01 26.66 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.76 118.97 37.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.953 0.406 . . . . 0.0 111.421 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.0 tp -90.73 104.29 16.89 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.415 ' HA ' ' HA3' ' A' ' 53' ' ' GLY . 15.9 p -113.55 165.95 12.0 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -168.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 4.33 39.8 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.16 113.15 46.4 Favored Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.37 138.33 50.38 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.475 2.117 . . . . 0.0 112.141 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.521 ' HA ' HE22 ' A' ' 51' ' ' GLN . 92.2 Cg_exo -47.42 125.88 11.29 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.344 3.362 . . . . 0.0 113.159 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.39 152.85 80.79 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.84 39.64 0.29 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 124.055 3.17 . . . . 0.0 115.07 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 68.34 143.57 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.665 1.586 . . . . 0.0 112.429 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.94 75.88 Favored Glycine 0 C--N 1.319 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.53 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.458 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 58.8 t -107.13 -55.11 0.07 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.924 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 15.5 Cg_exo -70.38 130.51 18.7 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 121.307 1.338 . . . . 0.0 110.71 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -110.86 123.07 49.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -110.03 125.2 67.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.6 tt0 -90.77 111.59 23.02 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -108.27 129.87 61.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 30.5 m -123.46 118.58 27.74 Favored 'General case' 0 N--CA 1.42 -1.956 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.455 ' CD2' HD22 ' A' ' 29' ' ' LEU . 10.5 m-85 -100.54 116.37 32.3 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 173.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 38' ' ' THR . 12.2 t70 -128.91 116.36 19.28 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.764 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 52.5 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.4 p-10 -87.57 -172.6 3.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -13.96 61.24 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.408 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 4.6 t30 -84.79 -31.46 23.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 117.6 14.11 7.03 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.481 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 80.7 mt -80.54 119.95 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.8 tp -98.44 118.03 34.19 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.411 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.46 HD21 ' HD3' ' A' ' 116' ' ' LYS . 16.0 t-20 -112.91 111.24 21.85 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -101.82 116.64 45.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.7 m -111.67 134.34 53.31 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.46 124.12 42.17 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 m -124.22 118.42 26.8 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.521 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.5 123.34 29.63 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.728 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.486 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 75.0 mmtt -68.01 -28.82 67.75 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.875 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 m -68.68 -61.91 1.61 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.142 0.496 . . . . 0.0 110.865 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.5 p -84.01 -39.88 19.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.36 0.6 . . . . 0.0 110.799 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.25 39.29 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.16 149.04 43.27 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.496 0.665 . . . . 0.0 112.761 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.22 134.72 42.35 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.349 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 146.22 47.18 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 103' ' ' ASN . 17.7 ptpt -142.11 162.3 35.82 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.034 0.445 . . . . 0.0 111.731 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 tt -129.44 145.76 35.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.3 m -122.8 117.25 25.23 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.029 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.25 118.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.8 p -92.26 172.73 8.22 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.67 -24.01 59.92 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -58.65 -50.26 74.5 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.022 -177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -128.38 91.87 3.33 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.91 -116.8 3.41 Favored Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -144.83 143.12 30.46 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.2 mp 66.61 -171.25 0.19 Allowed 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.018 0.824 . . . . 0.0 111.19 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.1 p -96.03 -77.65 0.48 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 56.3 tttp -166.49 -45.1 0.02 OUTLIER 'General case' 0 CA--C 1.484 -1.559 0 CA-C-O 120.638 0.256 . . . . 0.0 110.374 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.36 -49.02 77.21 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.987 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 134' ' ' MET . 1.2 mp0 -57.59 -42.6 83.52 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.103 0.961 . . . . 0.0 109.359 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.1 mt -61.22 -50.84 78.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.783 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 9.2 pt-20 -72.75 -26.0 61.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -61.88 -44.05 97.59 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 95.0 mmm -60.76 -37.39 81.67 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.103 0.478 . . . . 0.0 109.764 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 88.1 t -58.2 -54.68 29.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.029 176.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 87.4 mt-30 -59.29 -53.78 54.31 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.914 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.78 -53.58 55.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.928 -176.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.61 67.77 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.499 ' OE2' ' HD3' ' A' ' 32' ' ' ARG . 26.1 mm-40 -74.27 -32.93 63.12 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.052 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -71.21 -34.29 70.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.08 11.44 23.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.888 176.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -53.66 -48.62 69.26 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 118.142 0.428 . . . . 0.0 111.522 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.95 74.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.813 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -74.2 -44.7 52.27 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 0.6 OUTLIER -60.81 -49.39 77.68 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 177.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.67 -32.53 74.04 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.383 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 82.0 t -71.91 -48.41 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.575 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -55.93 -41.89 75.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.87 0.468 . . . . 0.0 111.066 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.5 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 57.0 ttp180 -61.4 -51.69 67.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.486 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.462 ' HG3' ' HE ' ' A' ' 149' ' ' ARG . 47.6 mt-10 -78.36 -1.37 33.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.9 -14.0 46.16 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 172.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 29.9 t -112.18 157.77 12.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -80.56 93.09 6.02 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.323 0.583 . . . . 0.0 110.583 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -90.66 93.11 9.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.533 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -112.71 158.63 19.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.12 68.51 9.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.234 1.016 . . . . 0.0 110.761 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.74 136.18 25.38 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.693 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.93 152.38 25.02 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.903 0.382 . . . . 0.0 110.423 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 0.4 OUTLIER -97.24 119.59 36.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 174.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.1 t -134.4 100.63 4.72 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 66.5 25.94 10.05 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.441 1.096 . . . . 0.0 112.054 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 48' ' ' SER . . . -69.69 -11.92 61.22 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -73.46 -16.45 61.3 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.893 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 57.74 85.95 0.08 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.07 0.948 . . . . 0.0 112.012 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -165.46 117.01 1.11 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.69 130.82 48.14 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.018 -176.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.9 m -109.22 122.96 48.45 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -166.28 172.57 10.96 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.04 97.99 5.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -115.25 129.2 56.56 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.387 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -136.37 -18.24 1.5 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.204 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -75.27 -44.12 47.61 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.789 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 90.72 -156.52 24.71 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 55.4 tp -87.78 -25.84 23.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.393 0.616 . . . . 0.0 110.859 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -151.83 138.76 19.01 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.651 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -86.33 -22.26 48.6 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.307 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 177' ' ' LYS . 3.4 mptp? -76.5 100.97 5.44 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.678 0.391 . . . . 0.0 110.124 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.4 pt -108.21 3.0 9.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.6 0.714 . . . . 0.0 110.037 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 12.8 p -90.83 158.82 16.6 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.182 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -69.56 113.82 7.2 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.568 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.46 107.07 7.34 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.37 103.71 11.31 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.62 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 134.15 38.12 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -114.19 172.01 7.27 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.761 -171.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.43 ' HA ' ' OD1' ' A' ' 188' ' ' ASP . 13.2 mptt -74.95 97.65 3.41 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.623 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.78 -62.0 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.938 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 30.3 tp -139.83 24.44 2.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.13 0.966 . . . . 0.0 110.335 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 185' ' ' LYS . 5.8 p-10 -92.77 13.14 21.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 174.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -93.9 118.46 31.5 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -137.06 135.21 37.32 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 174.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -88.86 84.82 6.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 55.2 t -72.16 -36.05 55.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.851 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 59.0 mt -104.68 105.05 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.6 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.5 m -93.56 104.6 16.71 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -103.26 -30.81 10.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.485 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 tp -146.61 31.98 0.97 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.33 -35.29 79.9 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.827 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -140.3 -15.18 0.98 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.0 t30 71.94 -71.77 0.13 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.327 1.051 . . . . 0.0 111.466 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 18.5 m 63.71 -76.68 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.907 1.283 . . . . 0.0 112.128 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 71.0 mt 59.05 -81.59 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.022 1.729 . . . . 0.0 112.29 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.86 138.05 16.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -127.06 -54.71 1.38 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.423 0.63 . . . . 0.0 110.782 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -97.1 146.71 24.77 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.521 ' HB2' ' HB3' ' A' ' 209' ' ' GLU . 4.1 m-20 -73.55 141.92 46.67 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -60.28 -30.98 69.82 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -114.89 -19.79 10.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.803 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.531 ' OE2' ' HG2' ' A' ' 212' ' ' ARG . 3.6 tp10 -92.15 6.13 47.74 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 122.067 -0.396 . . . . 0.0 110.91 -172.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -86.14 -8.66 57.69 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.249 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -132.31 86.92 2.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.614 0.721 . . . . 0.0 109.794 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.531 ' HG2' ' OE2' ' A' ' 209' ' ' GLU . 4.1 ppt_? -162.73 150.41 13.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.417 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm 59.06 -172.83 0.1 Allowed 'General case' 0 C--O 1.241 0.648 0 O-C-N 124.309 1.006 . . . . 0.0 111.735 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.29 85.42 2.8 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 102.332 -3.21 . . . . 0.0 102.332 169.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 34.2 tp -70.43 141.23 52.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.661 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -61.39 -46.79 88.69 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.358 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -79.25 91.94 5.06 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.55 100.28 4.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.117 0.96 . . . . 0.0 112.561 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -74.48 148.75 85.98 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.244 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.99 104.46 0.71 Allowed 'Trans proline' 0 C--O 1.242 0.687 0 C-N-CA 122.68 2.254 . . . . 0.0 113.962 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.4 HG22 HG13 ' A' ' 223' ' ' ILE . 1.8 mp -114.07 133.91 58.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 171.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.4 HG13 HG22 ' A' ' 222' ' ' ILE . 80.9 mt 76.06 101.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.931 0 O-C-N 124.17 0.919 . . . . 0.0 108.612 -172.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 50.1 m -147.59 162.43 39.13 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 158.91 -121.7 1.07 Allowed Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.926 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.22 174.0 14.24 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.8 t80 68.02 74.79 0.29 Allowed 'General case' 0 C--O 1.244 0.806 0 C-N-CA 124.326 1.05 . . . . 0.0 109.044 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -151.79 -57.57 0.15 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.526 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.5 -151.34 5.85 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.548 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -122.62 149.0 44.58 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 172.01 106.57 0.19 Allowed Glycine 0 C--N 1.299 -1.476 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.477 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 176.97 75.33 0.05 OUTLIER Glycine 0 C--N 1.295 -1.718 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.78 167.8 11.19 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.692 2.262 . . . . 0.0 111.256 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -143.06 121.87 1.8 Allowed Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.5 115.95 4.53 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.118 1.878 . . . . 0.0 111.946 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 88.06 -157.74 28.54 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.31 -97.71 0.24 Allowed Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -134.63 116.94 15.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -73.77 97.82 0.92 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.357 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -138.22 127.66 24.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.71 -33.69 8.85 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 78.64 120.89 0.27 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.698 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.75 129.09 33.14 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.647 2.231 . . . . 0.0 111.915 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -65.75 -47.99 73.38 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.447 0.641 . . . . 0.0 110.236 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.04 -137.86 6.93 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 157.2 53.2 0.01 OUTLIER Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.7 t -66.46 -49.48 66.53 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 78.09 13.92 82.83 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.474 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 38.4 m -137.42 129.06 28.53 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -153.11 144.2 11.12 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.54 104.75 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.236 2.624 . . . . 0.0 112.389 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.2 m -126.9 45.37 2.71 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 26.9 pt -132.49 143.5 39.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.029 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -127.45 112.3 14.81 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.719 0.771 . . . . 0.0 111.577 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.87 100.42 8.84 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 35.2 m -87.87 176.57 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.134 -175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--N 1.313 -1.011 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.0 -178.883 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 C--O 1.246 0.916 0 CA-C-O 121.495 0.664 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -92.08 134.44 34.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.546 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -87.02 -33.94 19.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.336 0.589 . . . . 0.0 110.109 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.5 t 70.32 -84.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 124.8 1.24 . . . . 0.0 108.812 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 61.7 -76.72 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.698 1.199 . . . . 0.0 112.666 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -132.93 11.71 4.3 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt 70.63 85.03 0.14 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.287 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mp 69.46 87.71 0.12 Allowed 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.296 -1.32 . . . . 0.0 111.913 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 tp -64.19 -43.8 93.97 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -114.49 123.9 50.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.296 176.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 36' ' ' ILE . 9.4 m-20 -96.23 25.91 4.61 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 m -126.88 170.64 16.52 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-O 121.211 0.529 . . . . 0.0 110.906 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.46 120.87 80.61 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.04 -21.63 23.84 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.094 1.862 . . . . 0.0 111.743 -177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.8 mt -134.49 174.45 10.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 23.5 m -101.57 123.01 44.89 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.09 0.244 . . . . 0.0 110.609 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 2.4 mm? -92.28 131.63 37.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.1 -168.41 21.11 Favored Glycine 0 N--CA 1.425 -2.052 0 C-N-CA 119.375 -1.393 . . . . 0.0 114.63 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.437 HD11 HG11 ' A' ' 92' ' ' VAL . 83.6 mt -133.63 162.79 30.96 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.735 -176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -94.81 109.51 21.47 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.9 p -84.16 175.37 9.52 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.083 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.96 116.51 4.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.62 -12.23 11.04 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 51.66 4.53 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.25 127.16 73.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.0 tpt -73.82 102.5 4.06 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -107.78 112.13 24.64 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.29 127.48 38.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.418 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.0 mp -95.57 -50.35 5.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.454 HG21 HD12 ' A' ' 96' ' ' ILE . 34.1 mm -94.18 92.31 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.2 154.92 30.67 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -53.81 140.28 30.6 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.23 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 79.84 1.7 2.12 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.585 1.554 . . . . 0.0 113.283 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.13 128.15 33.36 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -70.5 134.79 48.05 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.617 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 11' ' ' ASP . 27.6 pt -104.09 161.42 22.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.1 Cg_endo -64.44 140.88 42.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 CA-C-N 120.914 1.362 . . . . 0.0 114.115 0.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.3 p -109.59 164.12 12.82 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.007 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -159.08 101.64 1.6 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -132.46 128.05 36.61 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.4 m -119.85 124.01 45.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -124.22 146.07 48.95 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 156' ' ' ASN . 46.0 mm -97.78 115.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -107.72 133.55 51.97 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.2 p -107.57 170.25 8.09 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.445 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -96.65 136.96 36.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.742 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -98.06 10.88 39.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.684 1.231 . . . . 0.0 108.623 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.3 p -116.13 145.32 43.15 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.236 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.55 159.62 21.02 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.386 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 6.6 m-20 57.82 27.49 14.6 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.329 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -77.27 130.16 75.67 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.523 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.34 -15.04 14.4 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 122.234 1.956 . . . . 0.0 111.784 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 164.19 37.75 Favored Glycine 0 N--CA 1.422 -2.278 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.8 158.51 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 123.006 0.523 . . . . 0.0 109.781 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 75' ' ' PHE . 42.7 tp -117.6 107.88 14.79 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 75' ' ' PHE . 3.8 mp -89.1 105.49 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -92.85 119.69 32.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -103.25 121.6 54.73 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 CA-C-O 121.225 0.536 . . . . 0.0 111.035 -173.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.04 164.29 21.86 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.615 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 38.6 tt0 -134.89 132.71 38.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.383 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.03 172.23 13.44 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 27.8 mt-10 -135.12 120.87 19.55 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 118.074 0.937 . . . . 0.0 113.088 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 2.6 mmp_? -154.14 166.51 32.87 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 175.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.55 54.87 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.151 0.976 . . . . 0.0 110.042 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.9 mtt -133.52 121.19 21.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.35 96.62 3.43 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.373 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -168.25 -45.53 0.02 OUTLIER 'General case' 0 C--O 1.243 0.734 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.087 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 17.7 m-20 -95.7 71.3 3.05 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -145.29 160.43 41.52 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 113.186 -1.824 . . . . 0.0 107.768 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 28.0 t30 -89.87 131.08 35.98 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.33 107.84 19.47 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.25 0.547 . . . . 0.0 109.684 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.25 -23.99 27.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.311 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.11 -162.63 28.81 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.412 ' HG3' ' OE2' ' A' ' 76' ' ' GLU . 23.3 ptt180 -145.87 162.83 36.84 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.671 ' HB3' ' HB ' ' A' ' 56' ' ' ILE . 7.6 t80 -128.92 130.49 46.84 Favored 'General case' 0 C--N 1.273 -2.72 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.412 ' OE2' ' HG3' ' A' ' 74' ' ' ARG . 1.7 mp0 -104.0 104.66 14.65 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.4 tp -112.14 110.19 20.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 p -130.16 166.75 19.6 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -174.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.65 19.05 16.62 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.2 mt -82.75 129.63 61.36 Favored Pre-proline 0 N--CA 1.438 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 48.4 Cg_endo -71.67 137.71 30.62 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.237 1.958 . . . . 0.0 110.97 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' ASN . 50.5 Cg_exo -56.89 107.24 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 122.59 2.193 . . . . 0.0 112.275 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.01 158.12 76.65 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.8 161.36 18.57 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.02 2.48 . . . . 0.0 112.151 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -65.62 142.27 58.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.04 -7.91 79.87 Favored Glycine 0 C--N 1.308 -1.004 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.945 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.39 -54.07 0.29 Allowed Pre-proline 0 C--N 1.316 -0.857 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.8 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.59 112.62 1.83 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 121.41 1.407 . . . . 0.0 111.225 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -99.93 113.46 26.03 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.257 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -100.41 120.7 50.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 40.1 tt0 -90.6 108.98 20.15 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 19' ' ' LEU . 46.2 t -109.05 117.33 54.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.208 0.528 . . . . 0.0 109.696 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 84.8 m -108.59 125.43 51.84 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.562 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' CD1' HD22 ' A' ' 29' ' ' LEU . 8.8 m-85 -98.91 112.3 24.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.95 112.56 14.2 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.576 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 26.1 mt -119.12 119.79 61.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 2.5 p30 -84.11 176.75 8.59 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.781 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.12 -17.25 51.79 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.565 ' HB3' HG12 ' A' ' 101' ' ' ILE . 66.2 t30 -82.46 -15.23 53.3 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.517 0.675 . . . . 0.0 109.573 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.35 33.57 7.13 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 43.1 mm -97.28 114.21 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.92 118.49 36.45 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 25.9 m-80 -106.47 108.02 19.33 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.625 173.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.2 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.2 m -107.86 117.54 34.4 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.99 123.62 50.15 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -125.94 121.01 31.89 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.761 0.315 . . . . 0.0 111.634 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.57 106.98 8.54 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.907 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 65.3 mttm -67.9 -19.18 64.98 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 m -63.06 -49.83 72.99 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.853 0.359 . . . . 0.0 110.771 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.8 p -109.62 -23.13 11.62 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.77 53.62 2.06 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -120.2 126.27 50.24 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.965 0.412 . . . . 0.0 111.559 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.31 54.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.462 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -135.88 149.9 49.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 146.77 44.34 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 117.742 0.246 . . . . 0.0 111.273 177.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 23.0 pt -115.49 128.07 72.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 45.5 m -98.04 113.51 25.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.594 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 64.6 mt -121.84 110.47 27.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.603 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.405 ' HA ' HD13 ' A' ' 101' ' ' ILE . 11.1 m -77.87 114.74 17.03 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 168.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.313 61.6 t30 -77.6 81.87 4.04 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 117.759 -1.577 . . . . 0.0 113.942 -174.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -176.21 73.58 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 101.951 -3.351 . . . . 0.0 101.951 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -87.71 -13.93 41.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.877 -1.51 . . . . 0.0 112.313 -171.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.31 32.45 31.34 Favored Glycine 0 C--N 1.31 -0.877 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -118.75 140.87 49.25 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp 66.47 176.22 0.23 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.263 0.977 . . . . 0.0 110.437 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.7 p -104.82 -92.34 0.37 Allowed 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.005 0.431 . . . . 0.0 110.026 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -161.54 -32.4 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.491 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 36.2 mt-10 -60.81 -33.08 72.47 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 121.03 0.443 . . . . 0.0 111.414 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -67.99 -31.06 70.5 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.124 0.488 . . . . 0.0 109.908 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 135' ' ' VAL . 2.0 mp -72.45 -53.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.209 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 136' ' ' GLN 0.267 0.0 OUTLIER -66.35 -30.45 70.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.446 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -67.09 -42.44 84.63 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -73.03 -26.38 61.29 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.829 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 131' ' ' ILE . 97.7 t -67.11 -39.18 82.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.582 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 27.9 mm-40 -60.41 -47.05 87.78 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.686 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -66.38 -36.45 82.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.796 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.88 73.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.453 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -79.68 -49.2 12.46 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -73.38 -42.48 62.11 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.85 31.55 5.58 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.36 -55.66 23.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.553 1.541 . . . . 0.0 110.799 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -67.25 -51.81 48.56 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.691 -175.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -55.04 -51.83 65.08 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.711 0.804 . . . . 0.0 111.05 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.88 -35.52 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -66.02 -37.23 85.38 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.515 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 64.1 t -70.18 -48.1 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.644 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -56.81 -40.2 75.54 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -56.77 -43.9 81.29 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.936 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.22 -6.68 57.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.626 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 36.3 mmt180 -76.48 -33.09 58.69 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 30.9 t -81.73 -31.22 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 172.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t 77.92 139.92 0.07 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.493 1.517 . . . . 0.0 110.479 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.61 -43.24 10.9 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.015 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 61.28 -164.47 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.186 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 15.1 m120 -122.93 58.88 1.08 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.605 0.716 . . . . 0.0 109.238 174.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.73 149.18 33.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.92 151.88 37.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.14 131.1 42.94 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.834 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.9 p -97.52 25.53 5.65 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.586 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -99.4 99.21 10.1 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.473 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -97.38 -18.98 18.78 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 66.2 t80 71.68 -72.29 0.12 Allowed 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 125.526 1.531 . . . . 0.0 110.19 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -90.72 102.92 15.68 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 122.043 0.925 . . . . 0.0 110.469 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 24.2 ptm -139.12 16.03 2.62 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.771 -1.559 . . . . 0.0 107.21 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.92 -34.05 11.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.101 -173.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.0 m -80.01 85.66 5.58 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -99.85 83.76 2.79 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.92 134.09 29.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.602 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -106.81 137.68 44.39 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -176.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.52 -23.5 34.56 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 78.21 140.47 0.07 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.609 1.564 . . . . 0.0 111.758 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -112.99 64.24 0.28 Allowed Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.777 -173.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.24 -63.83 1.38 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.45 -67.07 0.12 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.056 1.343 . . . . 0.0 112.594 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 169.13 57.3 0.03 OUTLIER Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 106.432 -2.667 . . . . 0.0 106.432 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -83.09 -35.43 25.66 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.108 -1.046 . . . . 0.0 109.856 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.3 mp -83.0 91.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 35.2 p -102.17 -25.24 13.78 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.409 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -110.02 97.04 6.63 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -101.67 -62.75 1.22 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.141 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -154.46 155.4 34.84 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -161.8 39.11 0.13 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.053 0.93 . . . . 0.0 108.733 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.437 ' C ' ' HD3' ' A' ' 185' ' ' LYS . 33.7 mmtp -85.57 47.66 1.47 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.869 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.437 ' HD3' ' C ' ' A' ' 184' ' ' LYS 0.303 0.0 OUTLIER 42.57 67.02 0.66 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.769 1.228 . . . . 0.0 112.725 -177.238 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.8 m -103.22 152.97 5.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.917 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.76 149.71 50.13 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.654 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -153.38 167.66 28.68 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -88.01 -26.5 22.57 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -77.31 86.0 3.73 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -77.96 -13.14 59.98 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.326 1.06 . . . . 0.0 109.664 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 14.8 m -106.78 96.29 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.239 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -73.9 135.3 27.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 74.7 m -153.58 154.94 35.21 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.662 0.744 . . . . 0.0 112.206 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -136.58 150.04 48.38 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.7 tt -139.43 96.58 3.12 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -130.0 -154.44 0.63 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -61.75 137.39 58.24 Favored 'General case' 0 C--O 1.249 1.076 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -80.2 89.77 5.47 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.024 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 9.0 t -174.92 142.15 0.64 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.7 pp -97.88 138.92 34.51 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -88.61 82.11 6.95 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.153 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -127.82 89.32 2.92 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.046 0.927 . . . . 0.0 110.59 174.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -135.97 87.12 2.28 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.43 -36.9 64.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -87.22 -4.29 59.09 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.861 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -148.62 78.58 1.42 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.535 0.683 . . . . 0.0 110.198 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 210' ' ' HIS 0.339 0.0 OUTLIER -128.68 -94.77 0.42 Allowed 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.277 174.931 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.582 ' H ' ' CD ' ' A' ' 209' ' ' GLU . 41.5 m80 56.82 20.88 5.53 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.471 1.108 . . . . 0.0 111.189 -176.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -88.09 147.61 24.86 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.18 107.79 2.46 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -114.26 99.04 7.3 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.314 1.054 . . . . 0.0 113.646 -172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.83 15.74 18.57 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.81 102.09 13.96 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.767 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.27 117.27 12.58 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -85.07 29.69 0.63 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.446 0.698 . . . . 0.0 112.03 -171.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.5 p -84.96 -2.38 7.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.788 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -121.4 91.08 48.16 Favored Pre-proline 0 C--N 1.308 -1.209 0 O-C-N 121.959 -0.463 . . . . 0.0 110.563 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.21 83.55 1.68 Allowed 'Trans proline' 0 N--CA 1.431 -2.191 0 C-N-CA 121.882 1.721 . . . . 0.0 109.233 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.3 tp -82.59 70.57 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-O 123.246 1.498 . . . . 0.0 111.727 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mt -92.09 76.02 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 27.4 p -81.96 114.2 20.39 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.228 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.71 -59.89 2.28 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.498 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 65.29 179.55 0.19 Allowed 'General case' 0 C--O 1.253 1.252 0 C-N-CA 124.058 0.943 . . . . 0.0 111.696 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -131.47 168.35 17.79 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -87.91 100.03 12.58 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.833 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -77.9 121.65 5.81 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -134.23 129.76 36.18 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -103.04 -146.94 18.04 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 233' ' ' PRO . . . -79.58 117.39 4.5 Favored Glycine 0 C--N 1.308 -1.008 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 232' ' ' GLY . 2.8 Cg_exo -74.66 111.84 3.41 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.34 2.026 . . . . 0.0 111.575 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 154.69 171.18 21.24 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.07 -31.23 24.05 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.759 2.306 . . . . 0.0 111.872 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 107.99 -65.4 0.25 Allowed Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 106.25 126.08 5.59 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -110.81 -18.43 13.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 72.07 -88.71 0.48 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.653 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . 64.95 79.02 0.26 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.763 1.225 . . . . 0.0 112.051 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . 0.482 HE21 ' HA ' ' A' ' 241' ' ' GLN . 0.1 OUTLIER -164.48 124.32 1.98 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -139.55 84.98 0.22 Allowed Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.067 -1.063 . . . . 0.0 112.261 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -63.59 129.79 26.14 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.382 2.055 . . . . 0.0 111.052 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -95.95 -7.93 35.22 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.661 0.743 . . . . 0.0 109.8 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.07 -128.04 8.3 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -141.41 161.96 26.91 Favored Glycine 0 N--CA 1.421 -2.321 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.0 m -79.21 -28.63 42.56 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 154.62 -104.35 0.25 Allowed Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.096 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 31.8 p -169.34 140.7 2.36 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -127.08 -156.31 9.12 Favored Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.628 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -85.99 106.58 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 122.831 2.354 . . . . 0.0 110.926 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 30.0 m -70.21 113.78 7.72 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.2 pt -75.35 94.04 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -171.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -85.41 95.5 9.27 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 172.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -162.05 176.54 10.62 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.973 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 65.8 t 68.1 -79.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 124.525 1.13 . . . . 0.0 109.43 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.26 1.651 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -178.753 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -99.63 128.48 45.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -81.37 76.28 8.31 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.441 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.11 52.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 123.862 1.791 . . . . 0.0 107.446 174.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -143.84 -47.3 0.28 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -96.37 -160.52 0.8 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.0 tp 71.49 128.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.114 0.966 . . . . 0.0 111.983 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.9 tp -74.99 108.84 7.99 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.04 98.36 2.52 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.05 139.47 52.65 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.549 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 36' ' ' ILE . 33.7 m-20 -108.45 78.34 1.16 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 35' ' ' THR . 29.2 m -127.38 176.56 7.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.069 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.66 121.28 84.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.04 -46.35 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.42 2.08 . . . . 0.0 111.633 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.424 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 89.0 mt -128.86 173.97 9.9 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.5 m -82.84 128.56 34.53 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -92.46 131.85 37.27 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.65 -177.63 25.6 Favored Glycine 0 N--CA 1.413 -2.851 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.673 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 96.9 mt -126.85 150.96 48.96 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.78 109.01 17.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 25.6 p -93.13 -88.89 0.21 Allowed 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.001 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.37 172.04 12.9 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.23 88.36 0.01 OUTLIER Glycine 0 N--CA 1.469 0.882 0 O-C-N 124.71 1.256 . . . . 0.0 115.906 -173.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.66 29.55 71.23 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.773 -0.714 . . . . 0.0 114.211 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.95 136.04 52.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ttt -100.12 130.04 46.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.0 110.847 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.8 m -114.88 115.02 26.27 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.7 126.44 35.32 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.4 mp -95.58 -50.13 5.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 110.4 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -110.71 107.53 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -74.61 149.52 40.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.869 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.8 ptt85 -52.7 147.24 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.291 1.037 . . . . 0.0 112.322 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 76.88 2.9 3.36 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.255 1.422 . . . . 0.0 113.593 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -77.88 131.84 37.69 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.439 ' HA ' HG12 ' A' ' 12' ' ' VAL . 2.5 m -72.96 140.17 47.23 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 123.162 0.585 . . . . 0.0 111.506 -174.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 11' ' ' ASP . 18.7 pt -109.63 161.15 25.21 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 42.6 Cg_exo -62.19 136.84 20.84 Favored 'Cis proline' 0 C--O 1.241 0.672 0 CA-C-N 120.462 1.201 . . . . 0.0 114.57 0.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -107.44 166.21 10.82 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -167.09 102.11 0.54 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -130.31 130.37 44.41 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 79.5 m -115.49 126.55 54.44 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.119 0.262 . . . . 0.0 110.534 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -127.64 140.32 52.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -104.34 114.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 156' ' ' ASN . 87.0 m-85 -106.05 138.78 41.63 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.426 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 4.8 p -106.22 170.81 7.7 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -106.54 146.12 31.02 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.792 -1.192 . . . . 0.0 110.916 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.436 ' HA ' ' HG2' ' A' ' 85' ' ' ARG . 28.0 m-85 -87.86 -28.55 21.52 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -71.76 139.0 48.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.26 172.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -104.35 154.88 19.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.797 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 61.27 25.43 15.41 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 47.9 mt-30 -65.12 133.96 95.8 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 51' ' ' GLN . 2.7 Cg_exo -80.37 -19.82 8.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.332 2.021 . . . . 0.0 110.394 171.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.9 153.05 23.47 Favored Glycine 0 N--CA 1.419 -2.435 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.926 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.06 160.42 15.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 tp -118.4 114.53 23.04 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.2 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.05 110.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 36.5 mt-30 -108.46 113.69 26.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.671 -175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 104' ' ' VAL . 34.8 t -95.19 120.9 45.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.258 0 O-C-N 123.363 0.414 . . . . 0.0 110.602 -177.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.4 146.71 52.01 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' OE2' ' HB2' ' A' ' 15' ' ' LEU . 15.4 pt-20 -120.48 150.61 40.55 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.853 0.835 . . . . 0.0 110.771 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.34 -174.01 19.8 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -132.86 95.52 3.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 118.192 0.996 . . . . 0.0 108.712 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -142.93 153.64 43.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.931 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -81.43 -49.55 10.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.144 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mmm -98.89 105.44 17.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.404 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.92 95.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.981 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -151.59 -44.51 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -96.54 11.14 36.2 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.615 0.721 . . . . 0.0 109.654 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.55 161.95 25.67 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.913 -173.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -90.78 115.13 27.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -82.05 113.73 20.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.98 -33.02 19.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.91 162.7 22.66 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -153.67 138.7 17.28 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -137.75 151.39 48.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.036 0.446 . . . . 0.0 111.46 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.55 133.16 38.47 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.292 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' CD1' HD22 ' A' ' 115' ' ' ASN . 57.5 tp -111.04 105.13 13.78 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -96.71 151.29 19.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.402 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.7 -0.62 13.77 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 121.117 -0.564 . . . . 0.0 111.835 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.08 133.96 92.82 Favored Pre-proline 0 C--O 1.254 1.319 0 C-N-CA 122.847 0.459 . . . . 0.0 110.675 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 111' ' ' THR . 19.2 Cg_endo -58.33 134.88 64.37 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.179 2.586 . . . . 0.0 112.476 -177.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -71.44 67.66 2.79 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.596 2.197 . . . . 0.0 110.593 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.52 158.52 75.4 Favored Pre-proline 0 N--CA 1.417 -2.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.086 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.79 178.68 7.3 Favored 'Trans proline' 0 CA--C 1.552 1.396 0 C-N-CA 122.192 1.928 . . . . 0.0 114.462 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 47' ' ' TYR . 19.3 mtm180 -30.18 115.67 0.12 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.795 2.438 . . . . 0.0 115.138 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.82 -29.75 8.67 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.666 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.58 -51.01 4.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.41 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.92 124.38 14.38 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.447 1.432 . . . . 0.0 109.421 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -134.93 95.61 3.36 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.221 1.01 . . . . 0.0 110.388 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.7 mm -93.42 112.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.773 -173.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -90.16 111.9 23.21 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 105' ' ' THR . 62.0 t -111.56 125.68 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -177.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.6 m -112.78 124.27 52.21 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.555 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.446 ' CD1' HD22 ' A' ' 29' ' ' LEU . 14.5 m-85 -97.7 109.32 22.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.18 114.22 16.04 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 59.4 mt -116.44 140.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' HD12 ' A' ' 36' ' ' ILE . 1.3 p-10 -93.45 -176.5 4.13 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.35 -15.14 62.83 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -82.21 -28.76 31.77 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.63 20.15 7.47 Favored Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 78.6 mt -83.8 113.93 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 tp -95.28 118.8 32.68 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 24.0 t-20 -110.39 113.32 25.88 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 174.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 58' ' ' VAL . 59.7 t -97.4 113.78 32.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 21.1 m -103.64 126.76 50.98 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.75 126.04 49.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 113' ' ' LYS . 19.8 m -131.84 118.32 19.71 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.153 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.51 107.62 11.3 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -67.56 -20.53 65.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.555 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.6 t -69.44 -52.53 25.9 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.044 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.411 HG23 ' HD3' ' A' ' 81' ' ' PRO . 38.0 p -90.06 -32.2 16.82 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.47 43.98 3.56 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 107' ' ' THR . 54.4 mttm -116.59 133.37 56.1 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.2 136.64 41.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.403 HD22 ' CD1' ' A' ' 77' ' ' LEU . 28.2 m-80 -138.77 145.96 40.82 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.267 175.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -143.26 151.0 40.06 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 123.042 0.214 . . . . 0.0 111.288 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 32.0 pt -121.9 141.21 43.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.962 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.1 m -111.14 113.21 25.56 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -105.99 103.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.056 0.455 . . . . 0.0 109.977 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -93.75 127.41 39.46 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 72.05 114.65 0.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.453 1.101 . . . . 0.0 111.701 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.76 147.2 23.27 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.737 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.9 mttp 67.56 81.54 0.19 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.763 1.225 . . . . 0.0 113.717 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -111.45 -21.49 6.5 Favored Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -84.23 -15.73 45.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.507 0.67 . . . . 0.0 110.361 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.33 152.68 36.34 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.148 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.528 ' O ' HG13 ' A' ' 131' ' ' ILE . 45.8 p -106.61 174.01 6.07 Favored 'General case' 0 C--N 1.28 -2.426 0 O-C-N 124.245 0.966 . . . . 0.0 108.988 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -44.56 -53.28 7.24 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.647 1.179 . . . . 0.0 114.087 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.12 -33.93 75.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.807 0.337 . . . . 0.0 111.391 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 134' ' ' MET . 46.8 mt-10 -70.81 -36.11 72.81 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 127' ' ' SER . 84.4 mt -60.7 -52.02 66.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.793 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 9.5 pt-20 -70.42 -25.1 63.06 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.509 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -60.28 -42.98 96.59 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 92.2 mmm -59.47 -43.19 93.31 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.3 t -63.24 -47.5 91.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.156 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 15.8 mm-40 -57.34 -46.95 82.78 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.82 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.79 -35.61 75.01 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.206 0.316 . . . . 0.0 111.541 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.39 77.97 Favored 'General case' 0 C--O 1.19 -2.064 0 O-C-N 123.472 0.483 . . . . 0.0 110.322 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.08 -48.2 16.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.473 0.654 . . . . 0.0 111.025 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.92 -40.48 96.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.394 -173.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.71 18.11 19.27 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.81 0.338 . . . . 0.0 110.195 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -49.03 -58.93 4.1 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.458 1.503 . . . . 0.0 112.451 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -71.55 -34.14 69.74 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 33.8 mm-40 -64.38 -53.42 48.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.044 -176.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 1.4 m-20 -63.6 -36.44 83.81 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.059 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.528 ' OE1' ' HD3' ' A' ' 149' ' ' ARG . 6.9 mm-40 -57.85 -46.43 84.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.021 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 151' ' ' ARG . 60.2 t -63.32 -40.88 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 32.2 mm-40 -58.78 -54.08 51.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.628 0.771 . . . . 0.0 111.698 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 145' ' ' ASP . 2.6 ptm180 -68.78 -32.82 72.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -77.22 -9.91 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.916 0.388 . . . . 0.0 111.752 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 148' ' ' GLN . 92.2 mtt180 -68.8 -27.67 66.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 173.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.24 125.69 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -81.53 75.85 8.47 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.969 0.89 . . . . 0.0 111.383 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -101.87 120.47 40.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.577 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -94.67 -163.12 1.01 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 18.1 m120 -76.28 80.16 3.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.847 0.832 . . . . 0.0 109.042 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.631 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.58 153.13 41.48 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.344 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.2 mt -125.82 136.01 52.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.09 120.2 40.91 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.8 p -155.73 164.79 38.12 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -140.59 143.25 35.16 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.1 89.6 4.83 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 73.44 121.27 0.04 OUTLIER 'General case' 0 C--O 1.245 0.843 0 C-N-CA 125.323 1.449 . . . . 0.0 111.436 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.39 170.67 12.72 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.673 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 68.4 mtm 62.54 74.51 0.43 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.25 1.02 . . . . 0.0 112.157 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -142.57 126.61 17.35 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 47.2 m -145.83 79.05 1.55 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.406 0.622 . . . . 0.0 110.34 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -126.54 112.48 15.59 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.4 m -82.67 123.09 38.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.361 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.03 102.51 11.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -117.21 128.86 55.51 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -172.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 63.14 89.75 0.08 Allowed 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.552 1.541 . . . . 0.0 112.315 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.42 104.07 1.46 Allowed Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.708 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 52.7 tp -81.62 142.23 32.96 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -129.0 169.76 14.29 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 93.08 16.12 48.89 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -131.99 100.62 5.12 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 123.388 0.675 . . . . 0.0 109.577 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.7 mm -76.97 126.63 37.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 8.5 m -51.0 122.14 7.08 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.854 0.862 . . . . 0.0 111.246 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -87.43 57.03 4.21 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.971 0.891 . . . . 0.0 110.983 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -98.95 87.26 3.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -89.69 150.59 22.27 Favored 'General case' 0 CA--C 1.479 -1.779 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.945 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -83.01 96.95 8.5 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.414 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -76.69 113.29 14.18 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.42 ' HD2' ' HB2' ' A' ' 188' ' ' ASP . 74.5 mttt -102.58 174.51 5.86 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.19 -53.78 7.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.58 102.88 13.67 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.908 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 185' ' ' LYS . 15.9 t70 -150.0 131.88 15.14 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -81.97 83.64 7.19 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.183 -176.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.407 ' C ' ' H ' ' A' ' 193' ' ' VAL . 7.5 pt20 -128.45 14.15 6.57 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.254 1.026 . . . . 0.0 109.094 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -82.0 30.97 0.38 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.043 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 191' ' ' GLN . 33.5 m -81.9 -10.95 12.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 124.014 0.926 . . . . 0.0 110.823 -176.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 14.6 tt -109.47 0.77 9.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 122.263 1.03 . . . . 0.0 108.344 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.0 m -121.82 154.46 36.99 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.419 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 25.7 m-90 -105.33 132.26 51.75 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -80.87 -5.9 57.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.232 1.015 . . . . 0.0 109.012 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -107.69 109.43 21.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.51 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -149.99 -41.03 0.14 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -84.87 3.67 36.88 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 122.201 1.0 . . . . 0.0 109.69 -176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.2 p -83.29 -19.62 35.94 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.194 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.53 136.57 32.97 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -75.49 85.28 2.58 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.054 0.93 . . . . 0.0 110.481 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -102.34 95.2 6.13 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -114.47 -52.69 2.7 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.387 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 63.51 73.28 0.45 Allowed 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.895 1.278 . . . . 0.0 113.537 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -99.3 141.13 32.47 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.771 174.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -120.01 126.68 51.43 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -118.38 106.94 13.25 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.088 0.47 . . . . 0.0 111.557 -173.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -144.84 -34.32 0.36 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.518 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -158.15 138.05 12.24 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.183 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -135.45 10.36 3.46 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.62 111.32 12.59 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.12 164.86 19.98 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.676 -174.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.1 pp -126.07 142.98 51.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 171.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -112.92 146.77 38.38 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.401 -174.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.34 -15.23 58.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . 0.305 13.1 p 52.66 107.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.527 1.531 . . . . 0.0 114.207 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 222' ' ' ILE . 47.9 t-20 -73.52 123.63 89.61 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.52 87.65 1.52 Allowed 'Trans proline' 0 N--CA 1.44 -1.625 0 C-N-CA 122.185 1.923 . . . . 0.0 111.784 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.4 HG23 ' OD1' ' A' ' 220' ' ' ASN . 25.1 pt -123.04 141.0 45.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.003 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 35.2 pt -127.69 153.54 37.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 26.9 m -143.58 156.58 44.63 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -176.48 -163.54 29.05 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.08 108.29 3.51 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -93.59 -52.54 4.43 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.447 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -97.1 112.92 24.48 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.0 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -127.01 75.36 0.41 Allowed Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.07 153.13 27.52 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.818 0.342 . . . . 0.0 111.118 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -129.41 -175.99 14.26 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.81 86.0 0.38 Allowed Glycine 0 C--N 1.302 -1.353 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.14 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -85.18 92.55 0.69 Allowed 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 122.347 2.031 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -141.82 111.67 0.71 Allowed Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.31 145.17 88.75 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.989 2.459 . . . . 0.0 111.568 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -136.03 -166.49 10.96 Favored Glycine 0 C--N 1.307 -1.049 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.04 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 107.41 59.16 0.57 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -105.14 130.0 53.42 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -154.4 174.22 32.81 Favored Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -135.13 -65.18 0.63 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 117.067 0.433 . . . . 0.0 109.844 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 70.12 164.37 0.26 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.705 1.202 . . . . 0.0 112.091 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 106.28 -154.95 16.79 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 121.156 -0.545 . . . . 0.0 111.763 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.63 139.63 44.94 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 123.151 2.568 . . . . 0.0 112.456 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -112.46 107.61 16.45 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.97 -51.16 4.53 Favored Glycine 0 C--N 1.316 -0.562 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -172.8 -146.3 5.36 Favored Glycine 0 N--CA 1.415 -2.703 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.7 m -102.93 119.34 38.66 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.81 66.58 2.76 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 35.8 t -143.86 95.74 2.78 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -125.53 96.44 0.49 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.58 -73.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.062 2.508 . . . . 0.0 112.878 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 17.2 m -132.41 97.26 4.05 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.533 ' H ' HD13 ' A' ' 253' ' ' ILE . 0.2 OUTLIER -116.75 166.59 10.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 73.51 78.52 0.13 Allowed 'General case' 0 C--O 1.243 0.749 0 O-C-N 124.621 1.201 . . . . 0.0 111.22 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -163.7 145.54 9.35 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.638 1.175 . . . . 0.0 107.953 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.71 116.48 34.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.526 0.679 . . . . 0.0 111.771 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--N 1.307 -1.276 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.981 -179.867 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -110.12 105.22 14.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.6 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -85.46 88.85 7.56 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.6 m -80.68 127.53 39.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.369 -175.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 62.07 94.46 0.04 OUTLIER 'General case' 0 C--O 1.238 0.487 0 O-C-N 124.412 1.07 . . . . 0.0 112.508 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -84.73 149.89 25.47 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.819 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.5 tp -93.91 44.41 1.12 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.477 0.656 . . . . 0.0 110.514 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.2 tp -81.58 -62.58 1.6 Allowed 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.04 -0.412 . . . . 0.0 111.155 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.62 -57.49 2.65 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.13 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.1 tp 62.5 73.92 0.45 Allowed 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.57 1.148 . . . . 0.0 109.862 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 36' ' ' ILE . 17.2 t70 -123.13 17.59 9.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 123.083 1.42 . . . . 0.0 108.941 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 m -136.37 171.07 17.44 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.136 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.73 118.66 72.61 Favored Pre-proline 0 C--N 1.294 -1.82 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.08 -31.98 13.96 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.983 1.788 . . . . 0.0 112.335 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.04 168.83 17.78 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.428 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 24.1 m -92.67 132.44 36.9 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -104.08 132.03 50.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.92 179.37 28.55 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.352 -176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.47 HD11 HG11 ' A' ' 92' ' ' VAL . 97.1 mt -118.75 155.47 31.06 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.809 -0.695 . . . . 0.0 109.867 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' HB3' HE21 ' A' ' 57' ' ' GLN . 38.6 tt0 -88.59 109.35 20.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 171.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.444 HG22 ' HG ' ' A' ' 158' ' ' LEU . 17.2 p -105.3 -166.06 1.18 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.489 -174.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.33 134.69 18.29 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.615 0.766 . . . . 0.0 112.174 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.97 -16.81 56.07 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.142 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.51 25.14 31.33 Favored Glycine 0 C--O 1.246 0.898 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 152' ' ' VAL . 64.0 t -104.52 146.54 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.507 -1.346 . . . . 0.0 109.208 -175.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.4 ttt -87.89 136.43 32.96 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.213 0.53 . . . . 0.0 111.983 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.6 m -123.74 112.19 17.04 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.85 116.59 29.18 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.782 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.515 HD22 ' CD2' ' A' ' 94' ' ' PHE . 5.4 mp -79.41 -47.22 16.1 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.04 112.95 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.19 142.46 28.33 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 32' ' ' ARG . 16.8 ptt180 -56.76 155.74 7.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 m120 77.98 1.29 2.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.528 1.531 . . . . 0.0 111.813 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -86.12 128.99 34.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -60.05 144.91 48.33 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.408 1.083 . . . . 0.0 112.109 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.611 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 28.4 pt -106.16 169.75 6.57 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.611 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 14.7 Cg_exo -69.08 124.77 7.55 Favored 'Cis proline' 0 C--O 1.244 0.817 0 CA-C-N 121.153 1.447 . . . . 0.0 112.257 0.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -87.96 141.7 28.38 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.405 -178.194 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -148.68 100.02 3.06 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 93' ' ' THR . 14.8 mm100 -107.01 117.66 34.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 88.3 m -117.31 116.05 26.47 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.457 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 87.5 mt-30 -120.95 151.39 39.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.77 113.22 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -101.59 165.87 11.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.964 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.2 p -145.14 170.89 15.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.6 p -101.36 139.03 37.59 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.706 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -85.76 -18.8 31.98 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 165.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 p -71.8 110.01 6.05 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.031 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.74 126.65 32.62 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m120 62.05 68.49 0.68 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.426 0.632 . . . . 0.0 111.149 -172.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.5 tp-100 -101.56 117.27 62.23 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.72 -31.75 20.1 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.003 1.802 . . . . 0.0 113.349 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.34 140.09 6.74 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 120.592 -0.814 . . . . 0.0 111.114 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.85 147.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.135 0.493 . . . . 0.0 110.123 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.517 HD21 ' NH1' ' A' ' 74' ' ' ARG . 42.0 tp -114.7 111.56 21.49 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.141 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.73 105.23 16.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.498 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 14.1 mt-30 -103.91 115.11 29.85 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.238 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.02 124.04 55.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 O-C-N 123.643 0.59 . . . . 0.0 110.755 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -129.49 154.4 47.04 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.466 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 70' ' ' ASN . 34.4 tt0 -122.27 147.74 45.85 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.97 125.73 5.66 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 16' ' ' SER . 37.5 mt-10 -79.51 126.36 30.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -152.84 168.41 25.84 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.482 0.713 . . . . 0.0 110.652 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -84.06 -51.1 7.37 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.52 0.676 . . . . 0.0 109.341 174.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.6 mtt -98.63 128.14 44.81 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.989 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -90.0 117.83 29.09 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.877 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -177.59 -52.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.528 1.131 . . . . 0.0 110.058 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.01 79.95 1.81 Allowed 'General case' 0 CA--C 1.464 -2.349 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -136.93 177.96 7.45 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 112.802 -1.999 . . . . 0.0 106.012 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 30.3 t30 -90.12 109.07 20.15 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.8 107.42 9.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.977 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.18 -41.79 14.38 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.533 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.37 171.52 38.71 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.068 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.517 ' NH1' HD21 ' A' ' 55' ' ' LEU . 7.2 ptp180 -152.58 140.77 20.41 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -147.15 149.02 32.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -97.21 140.14 32.13 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 tp -118.7 103.39 9.63 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 170.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 p -111.83 161.46 16.33 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 -173.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 41.71 3.63 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 42.8 mm -86.34 130.49 49.4 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 147.36 94.72 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.74 2.293 . . . . 0.0 112.359 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.88 84.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 122.685 2.256 . . . . 0.0 111.307 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.82 157.6 77.92 Favored Pre-proline 0 N--CA 1.42 -1.949 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.841 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.08 168.94 6.69 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.668 2.246 . . . . 0.0 112.712 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -62.94 149.27 45.1 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.657 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.18 -16.0 41.16 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.511 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.25 -55.17 1.39 Allowed Pre-proline 0 C--O 1.247 0.969 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.264 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.71 109.34 1.42 Allowed 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 121.339 1.359 . . . . 0.0 111.283 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -93.64 115.49 27.96 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.004 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.4 mm -102.46 116.77 46.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 17.0 tt0 -90.18 117.18 28.74 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 105' ' ' THR . 39.2 t -117.85 121.16 66.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.657 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 85.6 m -110.95 123.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.664 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 29' ' ' LEU . 7.1 m-85 -105.2 108.51 20.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 38' ' ' THR . 7.9 t70 -121.19 132.06 54.61 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.414 -176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 62.8 mt -126.3 135.6 63.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.87 -170.58 2.16 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.02 -23.6 64.1 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -77.1 -29.31 54.82 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.169 0.509 . . . . 0.0 110.05 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.02 23.35 7.44 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 81.9 mt -83.35 117.64 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.3 tp -93.58 117.1 29.66 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -109.73 103.38 12.2 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 64.2 t -89.86 118.63 35.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.467 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 35.7 m -113.41 137.17 51.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 91' ' ' GLU . . . -126.79 121.18 31.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 91' ' ' GLU . 19.7 m -118.81 123.68 45.35 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 123.497 0.498 . . . . 0.0 110.738 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.57 109.92 16.47 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -66.96 -17.28 64.84 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.918 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.4 m -75.6 -62.85 1.44 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.893 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -94.26 -19.47 20.68 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.55 47.96 3.59 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.821 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 107' ' ' THR . 61.3 mttp -106.78 147.24 29.91 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -149.94 131.83 15.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.338 0.589 . . . . 0.0 111.826 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -136.54 139.14 42.0 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.567 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 61.2 pttt -135.85 148.76 48.79 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 120.722 0.296 . . . . 0.0 110.815 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.4 pt -119.16 139.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -104.27 112.77 25.93 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.23 108.5 25.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.8 p -84.59 163.89 19.03 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.728 -0.214 . . . . 0.0 110.455 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -69.22 -40.33 78.02 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 68.41 -65.55 0.26 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 126.178 1.791 . . . . 0.0 113.194 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -174.73 -61.16 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.32 138.67 5.41 Favored Glycine 0 N--CA 1.418 -2.553 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.764 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -100.9 124.75 47.05 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt 61.71 -95.79 0.05 Allowed 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 124.417 1.087 . . . . 0.0 109.944 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.5 p -140.66 2.32 1.79 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.66 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.5 tttm 68.38 -51.41 0.55 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.31 1.044 . . . . 0.0 112.097 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.04 -43.09 73.44 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.125 1.37 . . . . 0.0 111.831 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -61.66 -32.82 73.01 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.051 0.453 . . . . 0.0 111.787 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 135' ' ' VAL . 62.3 mt -72.78 -44.23 59.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.12 -39.58 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.257 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 137' ' ' GLU . 1.2 mmp_? -60.35 -46.35 90.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.915 175.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 21.4 ttt -55.71 -47.06 77.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.077 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 131' ' ' ILE . 69.8 t -58.45 -45.97 89.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.362 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -69.65 -31.8 70.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.433 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 37.1 mt-10 -64.94 -47.7 76.73 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.32 -30.63 68.49 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.231 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HA ' ' HG2' ' A' ' 142' ' ' LYS . 31.8 mt-10 -78.15 -31.55 49.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -70.62 -19.16 62.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.118 0.961 . . . . 0.0 109.291 174.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -118.42 27.4 8.97 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.33 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 139' ' ' GLU . 5.1 mmtt -48.98 -52.47 24.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.788 0.835 . . . . 0.0 112.882 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -70.54 -51.97 24.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.981 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 148' ' ' GLN 0.258 1.4 pm0 -60.28 -45.88 91.79 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.8 -45.62 88.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.17 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . 0.251 35.8 mt-10 -70.28 -32.53 70.37 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.735 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 143' ' ' ALA . 89.4 t -65.7 -45.77 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 14.4 mm100 -58.08 -43.88 87.28 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 110.752 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.426 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 2.6 tmt_? -61.86 -41.0 97.3 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.725 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -89.52 -11.48 42.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -62.4 -44.41 96.5 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.303 0.573 . . . . 0.0 110.056 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 25' ' ' VAL . 48.7 t -78.79 113.68 18.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -77.87 95.54 4.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.93 -21.0 17.1 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.892 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 63.61 -77.99 0.03 OUTLIER 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.085 1.354 . . . . 0.0 111.398 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -178.26 40.81 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.44 156.73 34.95 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.533 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -122.63 153.14 39.73 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.495 0.664 . . . . 0.0 110.622 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -122.25 158.25 29.88 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 168.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.4 m -135.62 130.11 33.9 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.949 -175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -161.11 173.86 14.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 63.93 79.1 0.27 Allowed 'General case' 0 C--O 1.246 0.878 0 O-C-N 124.581 1.176 . . . . 0.0 111.366 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -79.85 121.61 25.61 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.093 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.4 91.91 6.35 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.748 0.785 . . . . 0.0 110.311 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 66.3 mtt -127.26 35.21 4.59 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -52.97 125.25 16.55 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.163 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m -65.67 108.11 1.97 Allowed 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.417 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.72 89.13 3.0 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.0 m -117.87 -19.28 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.138 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.15 16.24 3.24 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -63.38 144.69 56.74 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.641 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.08 90.86 3.31 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-O 121.842 0.83 . . . . 0.0 112.237 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -121.15 25.68 6.98 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 173.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.6 8.55 11.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.12 -1.04 . . . . 0.0 112.712 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -86.07 92.16 8.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.17 116.95 5.05 Favored Glycine 0 N--CA 1.425 -2.062 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.222 -173.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -93.39 81.05 4.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.8 pt -96.42 -35.96 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.378 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 18.3 m -101.17 -18.23 16.27 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.263 0.554 . . . . 0.0 110.086 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -94.39 88.27 5.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -99.04 108.05 20.61 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -84.39 113.84 21.46 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.01 0.909 . . . . 0.0 111.634 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -179.63 168.6 1.39 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 127.047 2.139 . . . . 0.0 106.32 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -68.94 -38.24 79.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 118.054 0.388 . . . . 0.0 111.795 -175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 72.31 -60.52 0.53 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.564 1.146 . . . . 0.0 112.903 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.85 132.06 64.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.0 mp -95.06 78.03 3.54 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.442 0.639 . . . . 0.0 110.286 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -165.89 158.44 14.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? 74.14 120.26 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.111 0.964 . . . . 0.0 110.967 -173.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -106.38 86.88 2.42 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.38 -53.61 6.74 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.036 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.62 136.14 23.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 38.7 mt -120.88 -58.68 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.992 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 33.2 t -84.05 99.43 10.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 120.893 0.377 . . . . 0.0 110.09 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -84.97 84.54 7.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -88.08 97.99 11.29 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -136.31 8.8 3.17 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.193 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -77.77 80.97 4.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.325 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -159.08 113.0 2.36 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 9.0 m -106.81 -56.54 2.18 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -74.78 117.95 17.2 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -134.27 -46.25 0.77 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 66.35 115.13 0.03 OUTLIER 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.411 1.484 . . . . 0.0 113.708 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -140.23 101.81 4.22 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 172.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -128.73 137.84 51.8 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -92.57 172.31 8.45 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.059 0.457 . . . . 0.0 111.969 -175.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -76.36 153.43 35.79 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.195 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -148.81 -51.59 0.16 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -60.82 -22.97 64.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.795 -174.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -62.55 -43.0 99.89 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.112 0.482 . . . . 0.0 110.077 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 212' ' ' ARG . 37.1 mmt180 -83.47 135.21 34.75 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.424 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -149.63 -67.27 0.21 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 57.68 101.13 0.02 OUTLIER 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.891 1.276 . . . . 0.0 112.754 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.43 167.22 21.63 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -100.82 -10.52 20.65 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.152 -171.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 60.26 31.13 20.36 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.551 0.741 . . . . 0.0 109.15 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.74 77.37 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 123.163 1.459 . . . . 0.0 112.794 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -92.63 118.65 68.07 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.577 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.43 151.56 33.4 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.561 2.174 . . . . 0.0 111.213 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.615 HD13 ' H ' ' A' ' 222' ' ' ILE . 0.2 OUTLIER -80.33 105.81 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.775 0.798 . . . . 0.0 110.924 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.0 pt -92.54 -2.51 10.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.356 0.598 . . . . 0.0 110.334 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 13.6 p -149.09 178.86 8.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.043 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -149.29 150.49 22.61 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.07 95.2 6.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -137.05 -81.44 0.37 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.692 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 64.0 171.88 0.18 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.906 1.283 . . . . 0.0 111.298 -174.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -132.84 -153.84 7.36 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 177.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -120.56 -27.48 5.13 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 117.093 0.446 . . . . 0.0 110.498 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 66.58 43.55 91.93 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 107.9 82.89 1.49 Allowed Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 -174.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.02 -25.93 78.08 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.174 2.583 . . . . 0.0 113.181 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 142.94 94.91 0.21 Allowed Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.274 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.79 -24.89 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.319 2.013 . . . . 0.0 112.347 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.41 -177.82 17.07 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -101.39 -45.4 1.84 Allowed Glycine 0 C--O 1.246 0.904 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.101 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 73.41 149.17 0.1 Allowed 'General case' 0 C--O 1.252 1.196 0 C-N-CA 124.749 1.22 . . . . 0.0 113.72 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 112.31 -60.09 0.35 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.518 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -154.38 167.54 29.64 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.38 16.95 12.18 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 158.87 -75.77 0.2 Allowed Glycine 0 C--N 1.311 -0.824 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -80.65 116.31 3.2 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.128 1.886 . . . . 0.0 110.098 174.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.75 -41.43 90.97 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 123.118 0.567 . . . . 0.0 110.167 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.73 127.66 2.08 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -71.73 173.46 44.33 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.6 m -82.3 -24.12 34.82 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.231 0.539 . . . . 0.0 109.972 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 179.61 79.53 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.849 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 43.1 m -135.09 130.46 35.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -92.66 -146.22 18.51 Favored Glycine 0 C--O 1.248 0.986 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.37 96.04 0.4 Allowed 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.236 1.957 . . . . 0.0 109.486 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 26.5 m -88.91 73.93 8.29 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 122.584 1.183 . . . . 0.0 110.657 -174.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.88 134.64 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 CA-C-N 113.085 -1.871 . . . . 0.0 106.917 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.45 114.09 24.71 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -134.75 82.58 1.97 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 122.022 0.915 . . . . 0.0 110.728 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 13.6 p -130.67 -2.39 2.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.525 -1.216 . . . . 0.0 107.885 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 C--O 1.255 1.387 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.216 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.438 -1.031 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.43 133.2 33.77 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -84.69 100.61 11.58 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.005 0.907 . . . . 0.0 110.199 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.41 13.03 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.689 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -112.42 102.07 10.22 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.28 111.69 19.2 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.197 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.4 tp -90.43 93.32 9.26 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.8 pt? -116.49 75.86 0.99 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.279 1.038 . . . . 0.0 111.618 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.06 -57.75 2.01 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.0 mt -108.03 76.03 1.03 Allowed 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -98.07 37.9 1.38 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 112.983 -1.917 . . . . 0.0 109.955 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.59 146.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.767 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 121.59 46.86 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.455 171.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' C ' HD12 ' A' ' 15' ' ' LEU . 36.9 Cg_exo -57.58 -58.97 0.65 Allowed 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 5.8 mp -126.77 176.43 7.27 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.2 m -80.93 119.8 23.92 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -92.5 132.07 37.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 123.853 0.72 . . . . 0.0 109.274 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -153.72 -169.9 19.19 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.243 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.46 HD23 HG23 ' A' ' 56' ' ' ILE . 2.3 mp -131.52 163.23 28.46 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.538 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 34.5 tt0 -87.89 109.07 19.51 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 123.0 1.381 . . . . 0.0 109.802 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 11.9 p -85.74 160.21 19.58 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.494 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.54 118.49 1.79 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 125.502 1.521 . . . . 0.0 113.665 -173.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.94 4.25 39.07 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.637 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.98 39.51 27.7 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.8 t -108.44 146.77 13.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.403 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -101.87 127.81 48.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.477 0.656 . . . . 0.0 109.285 -178.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.7 m -123.89 116.15 22.44 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.8 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -86.55 141.35 29.11 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 123.754 0.659 . . . . 0.0 111.172 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.37 -39.81 6.03 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.58 112.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -79.0 154.42 29.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.342 0.591 . . . . 0.0 110.501 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -64.37 149.81 47.55 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.47 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 66.38 20.79 10.96 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 124.408 1.083 . . . . 0.0 111.881 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.6 t -90.39 126.96 36.05 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.5 119.73 7.54 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.806 0.842 . . . . 0.0 113.263 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.43 HG22 HG23 ' A' ' 38' ' ' THR . 23.7 pt -101.46 162.25 21.05 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.66 -1.154 . . . . 0.0 107.925 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 137.13 12.24 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 CA-C-N 121.341 1.515 . . . . 0.0 115.152 1.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.43 HG23 HG22 ' A' ' 36' ' ' ILE . 1.1 p -107.6 154.93 20.71 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -146.83 103.74 3.66 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.97 121.32 20.31 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.2 m -127.95 115.97 19.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.551 0.215 . . . . 0.0 110.876 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -115.36 153.08 31.65 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.22 114.13 41.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.96 151.13 19.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.6 p -122.1 169.91 10.39 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 85' ' ' ARG . 33.7 p -95.84 136.94 35.61 Favored 'General case' 0 N--CA 1.422 -1.865 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.92 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -107.61 -1.1 21.5 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.245 0.545 . . . . 0.0 111.139 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -101.77 138.91 38.12 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.8 139.5 34.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.814 0.34 . . . . 0.0 111.076 -173.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.44 18.49 11.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.516 ' NE2' ' HB2' ' A' ' 160' ' ' SER . 46.2 tt0 -60.22 114.79 10.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 123.045 0.538 . . . . 0.0 110.226 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.33 -5.78 10.16 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.791 2.327 . . . . 0.0 113.892 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.13 150.34 14.49 Favored Glycine 0 N--CA 1.424 -2.139 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.632 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.2 165.08 24.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.0 tp -117.92 127.82 54.21 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.46 HG23 HD23 ' A' ' 19' ' ' LEU . 3.0 mp -98.42 98.34 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.66 110.1 21.04 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.54 114.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.953 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.538 ' CE2' ' HB2' ' A' ' 20' ' ' GLU . 68.6 m-85 -107.69 156.37 19.15 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.529 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.541 ' CG ' ' HB2' ' A' ' 15' ' ' LEU . 39.8 tt0 -134.99 137.81 43.38 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.74 -107.03 1.14 Allowed Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.261 -0.971 . . . . 0.0 114.785 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' CD ' ' HZ2' ' A' ' 67' ' ' LYS . 41.8 mt-10 -79.1 158.54 27.77 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.344 1.058 . . . . 0.0 109.414 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.428 HH11 ' HA ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -122.48 -46.31 2.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.705 0.764 . . . . 0.0 112.639 -175.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . . . -71.97 -28.43 63.43 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.538 0.685 . . . . 0.0 110.805 -173.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.5 mmt -134.57 111.47 10.08 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.706 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.1 91.57 4.31 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.448 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 19.8 pttp -144.71 -58.54 0.36 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.403 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 5.5 m-20 -105.45 25.95 10.07 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-O 121.489 0.661 . . . . 0.0 109.518 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -74.54 160.96 30.22 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.377 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -93.76 129.99 39.92 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.461 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 62.2 tp -101.69 111.01 23.12 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.93 -51.13 7.4 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.26 159.02 32.09 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.848 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 78.5 mtm180 -138.15 136.94 37.18 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -145.84 144.87 30.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.49 133.58 39.32 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.324 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.563 ' HG ' ' OD1' ' A' ' 115' ' ' ASN . 5.5 tt -113.46 104.05 11.89 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 172.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -120.54 155.39 33.74 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.12 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.12 7.53 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.5 mt -79.16 132.92 61.76 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 38.0 Cg_endo -66.36 125.19 13.56 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.504 2.136 . . . . 0.0 111.249 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 32.5 Cg_exo -61.25 101.85 0.2 Allowed 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.668 2.246 . . . . 0.0 111.94 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.77 157.61 59.33 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 68.0 Cg_endo -70.76 50.73 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.762 2.975 . . . . 0.0 113.312 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' THR . 39.5 ptt180 56.42 164.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.142 2.177 . . . . 0.0 113.89 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.55 -44.2 2.21 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.346 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.6 -50.24 73.37 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 123.976 0.91 . . . . 0.0 113.171 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.75 123.24 11.38 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 121.576 1.517 . . . . 0.0 110.985 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 109' ' ' LYS . 76.4 mt-30 -117.23 115.21 24.86 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.479 -175.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.33 105.58 18.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -90.62 107.78 19.38 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -107.9 124.48 64.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.179 0.514 . . . . 0.0 111.118 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.3 m -103.86 121.93 44.09 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.727 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.56 107.94 19.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.36 125.14 40.2 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.883 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.25 131.75 72.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.9 p30 -89.79 -169.76 2.57 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.376 0.422 . . . . 0.0 110.335 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.85 2.1 47.16 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.122 -0.361 . . . . 0.0 111.958 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -96.01 -13.6 23.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.56 30.18 12.4 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 67.2 mt -102.05 116.46 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 CA-C-O 121.091 0.472 . . . . 0.0 109.889 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.21 111.23 22.81 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.979 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.03 114.42 27.72 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.94 126.58 58.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 122.28 31.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.82 117.83 35.22 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.6 m -113.6 117.96 33.07 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.533 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.85 107.87 11.88 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 28.2 mmmt -67.31 -20.21 65.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.613 0.765 . . . . 0.0 110.779 -177.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -69.33 -54.6 13.75 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.785 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.9 p -99.05 -15.44 19.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.058 0.456 . . . . 0.0 112.056 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 30.36 36.22 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.499 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -115.36 158.57 22.24 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.546 0.673 . . . . 0.0 109.504 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.64 155.88 48.66 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.563 ' OD1' ' HG ' ' A' ' 77' ' ' LEU . 17.1 m120 -129.35 127.61 41.42 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -119.29 145.31 46.23 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.812 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.4 tt -136.64 148.77 26.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 m -113.61 112.93 24.33 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.2 mm -107.58 94.19 2.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t -88.11 122.33 31.56 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.856 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 71.72 -85.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.098 1.359 . . . . 0.0 109.624 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.14 161.6 33.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -142.13 23.71 2.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 71' ' ' LEU . . . -81.88 -26.11 50.59 Favored Glycine 0 CA--C 1.497 -1.081 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.128 -174.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 69.1 3.3 4.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.057 0.943 . . . . 0.0 113.245 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.31 147.2 26.66 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.9 p -63.26 145.58 55.23 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 123.732 0.645 . . . . 0.0 110.236 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -55.62 -36.77 67.34 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 122.811 0.444 . . . . 0.0 111.42 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 41.4 mt-10 -57.44 -40.3 78.14 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HG3' ' A' ' 134' ' ' MET . 8.9 mm-40 -67.07 -42.35 84.84 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 135' ' ' VAL . 61.9 mt -63.7 -41.94 94.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -63.47 -38.3 90.61 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.206 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 42.4 mtm105 -63.61 -42.12 98.24 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 53.4 mtt -59.86 -35.88 75.71 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.195 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 131' ' ' ILE . 58.9 t -56.77 -52.84 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -63.8 -42.17 97.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.523 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 12.0 mm-40 -64.76 -40.37 95.17 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.79 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.653 0.381 . . . . 0.0 111.274 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 25.4 mm-40 -77.85 -38.38 46.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -65.27 -38.76 91.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.348 0.594 . . . . 0.0 109.925 -179.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -111.57 28.63 8.56 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.927 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 139' ' ' GLU . 17.9 pttm -62.43 -45.25 93.96 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.47 67.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.397 0.618 . . . . 0.0 109.501 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -71.5 -54.15 11.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.184 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.1 m-20 -67.09 -55.2 15.29 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -66.14 -33.79 76.58 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -172.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.24 -47.82 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.184 175.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 152' ' ' VAL . 16.5 mm-40 -61.32 -41.39 96.94 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -55.29 -47.32 75.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -70.03 -9.51 55.53 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -97.9 0.59 46.85 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 148' ' ' GLN . 61.7 t -96.31 133.11 38.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 t -82.38 21.38 0.95 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.877 0.471 . . . . 0.0 112.014 -173.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.16 -21.76 59.71 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 50.06 -91.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.578 1.551 . . . . 0.0 113.177 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -155.1 67.73 0.68 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.17 140.3 41.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.168 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 76.1 mt -93.13 152.56 19.18 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 161' ' ' TYR . 10.4 tp10 -93.52 147.22 23.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.249 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.516 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 48.1 t -88.78 -26.57 21.65 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.41 ' H ' ' HG3' ' A' ' 159' ' ' GLU . 80.7 t80 69.06 112.65 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.926 1.29 . . . . 0.0 112.16 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.09 135.27 33.35 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.466 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -164.41 -57.95 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -93.18 113.48 25.71 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.819 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.9 mmm -75.47 -17.61 60.08 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.273 0.559 . . . . 0.0 110.69 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -81.06 137.73 36.0 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.1 p -73.5 158.24 35.28 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.615 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.82 116.71 4.28 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.9 t -80.67 -60.3 2.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.146 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -145.61 152.25 39.38 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.609 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.77 117.24 24.52 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -89.0 -27.38 20.92 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.047 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -81.09 61.26 4.6 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.986 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.48 -56.03 3.53 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -75.99 109.36 9.57 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.94 -16.79 7.73 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -60.36 -43.73 96.26 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.523 0.678 . . . . 0.0 110.209 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 55.0 mt -69.9 -30.77 45.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.91 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 65.3 m 71.1 -61.03 0.49 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.944 1.298 . . . . 0.0 111.79 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 67.36 -69.58 0.13 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.806 1.242 . . . . 0.0 110.506 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -146.15 80.81 1.58 Allowed 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -85.46 111.09 19.65 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -129.14 135.69 49.2 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 53.31 -158.12 0.16 Allowed 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.003 0.814 . . . . 0.0 109.597 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 64.1 mmtt -143.8 -30.32 0.49 Allowed 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 123.448 0.699 . . . . 0.0 110.652 169.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.76 82.95 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.434 ' HB3' ' SG ' ' A' ' 190' ' ' SMC . 7.2 mp -75.34 -48.76 21.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.5 t70 62.6 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.965 -1.47 . . . . 0.0 113.236 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -114.85 105.39 12.96 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.661 0.743 . . . . 0.0 111.454 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . 0.434 ' SG ' ' HB3' ' A' ' 187' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.35 -174.11 2.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.844 -172.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 192' ' ' GLU . 16.5 mp0 -52.33 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.141 1.777 . . . . 0.0 114.549 -175.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.85 141.65 39.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 171.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.5 -37.03 6.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.9 m 78.53 130.64 0.05 Allowed 'General case' 0 C--O 1.249 1.055 0 C-N-CA 125.603 1.561 . . . . 0.0 110.723 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 73.88 -55.59 0.66 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.352 1.461 . . . . 0.0 111.138 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 6.8 mp -71.37 -15.35 62.37 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 122.749 0.42 . . . . 0.0 110.744 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.26 -55.04 13.6 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.364 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 64.36 100.94 0.04 OUTLIER 'General case' 0 C--O 1.238 0.47 0 O-C-N 124.643 1.214 . . . . 0.0 108.124 -173.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -39.05 -68.89 0.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.443 1.089 . . . . 0.0 112.476 -171.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 5.8 m 57.85 34.25 24.15 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.593 1.187 . . . . 0.0 109.981 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 94.1 mt -143.15 -172.07 3.61 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -76.62 0.45 20.15 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.308 0.575 . . . . 0.0 111.328 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.33 23.05 1.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.392 0.677 . . . . 0.0 109.88 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -85.76 -170.97 3.35 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 74.71 107.06 0.07 Allowed 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 124.698 1.199 . . . . 0.0 111.205 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -75.33 124.75 27.64 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -108.09 147.14 31.63 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -70.86 115.84 10.47 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.422 0.451 . . . . 0.0 110.141 -177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -110.76 151.84 27.3 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -84.67 106.1 15.96 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.539 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.4 90.12 3.07 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -104.34 128.17 52.11 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.339 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -122.41 112.65 18.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.163 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp -100.07 109.35 21.66 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.912 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -101.8 139.52 37.33 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -149.73 156.04 41.18 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 122.142 0.177 . . . . 0.0 110.6 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.1 m -129.02 161.03 39.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 O-C-N 123.326 0.391 . . . . 0.0 110.734 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -123.82 100.57 37.13 Favored Pre-proline 0 C--N 1.309 -1.162 0 C-N-CA 121.386 -0.126 . . . . 0.0 111.331 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.21 125.98 14.35 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.034 1.822 . . . . 0.0 108.514 173.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 6.1 tp -111.05 114.83 48.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.502 0.668 . . . . 0.0 111.675 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 36.8 pt -101.42 140.18 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.269 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 41.9 m -143.88 105.68 4.33 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -149.94 73.12 0.29 Allowed Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 226' ' ' LEU . 1.9 pt? -117.83 -6.98 11.01 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -97.64 109.72 22.42 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.46 158.6 32.44 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.763 -1.562 . . . . 0.0 107.467 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -74.89 85.45 0.78 Allowed Glycine 0 C--N 1.315 -0.636 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -94.23 116.13 28.49 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 122.94 0.496 . . . . 0.0 110.159 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -119.08 154.5 16.44 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.47 114.53 1.55 Allowed Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -88.17 123.08 1.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.692 2.261 . . . . 0.0 112.156 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -129.56 111.06 1.13 Allowed Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.576 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.3 148.9 85.14 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.706 2.271 . . . . 0.0 111.428 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -75.17 -43.48 25.91 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 141.62 157.54 7.2 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -144.26 113.21 6.78 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -144.9 168.8 26.84 Favored Glycine 0 C--N 1.301 -1.371 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -157.15 108.87 2.39 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 117.353 0.577 . . . . 0.0 109.52 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -140.5 163.55 32.52 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.794 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 156.37 -161.18 30.7 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.37 143.67 97.28 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.463 2.775 . . . . 0.0 112.681 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -78.21 172.86 12.94 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.86 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -86.55 54.75 4.67 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -146.53 39.56 1.09 Allowed Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 19.7 m -69.05 112.28 5.57 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -91.93 -138.99 8.45 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.879 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 9.3 m 72.05 141.88 0.06 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.787 1.235 . . . . 0.0 110.458 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 113.02 -92.81 0.64 Allowed Glycine 0 C--N 1.302 -1.311 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -80.08 60.61 7.9 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.597 2.198 . . . . 0.0 110.833 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.3 t -125.5 4.88 7.6 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.138 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 38.0 pt -128.33 141.15 47.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.729 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -168.34 133.84 1.8 Allowed 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 122.978 0.511 . . . . 0.0 110.618 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.55 122.21 47.23 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 34.3 m -77.37 164.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 C--N 1.3 -1.545 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.039 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -82.79 102.09 11.35 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -110.67 160.99 16.2 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.003 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.47 120.5 45.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -83.99 119.56 25.07 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.937 0.398 . . . . 0.0 111.961 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -102.91 96.87 7.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.9 mt -68.07 130.8 44.04 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.111 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.6 tp -97.9 3.23 49.74 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.98 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 tp 71.29 -69.15 0.19 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.975 1.31 . . . . 0.0 109.727 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.66 123.44 46.37 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 36' ' ' ILE . 7.5 m-20 -86.03 75.65 9.92 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 35' ' ' THR . 27.8 m -130.72 179.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.246 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.59 130.79 54.57 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.28 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.24 -60.9 0.27 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.871 2.38 . . . . 0.0 112.359 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD2' HG23 ' A' ' 131' ' ' ILE . 3.4 mm? -119.18 174.34 6.39 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -69.51 127.43 32.97 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -95.21 140.62 29.86 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.553 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.58 -171.33 21.31 Favored Glycine 0 N--CA 1.42 -2.393 0 C-N-CA 119.552 -1.309 . . . . 0.0 113.796 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -133.71 156.9 47.11 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 35.5 tt0 -102.2 109.03 20.61 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 170.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.6 p -98.6 -63.93 1.08 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 122.39 1.091 . . . . 0.0 109.242 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.434 ' CB ' ' HG3' ' A' ' 159' ' ' GLU . . . -101.43 155.17 18.22 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.52 28.03 4.01 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.177 -1.011 . . . . 0.0 115.032 -169.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.54 -61.01 0.18 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 119.831 -1.176 . . . . 0.0 113.99 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 155' ' ' LYS . 58.7 t -109.53 145.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 120.729 0.3 . . . . 0.0 111.099 -173.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.76 128.0 33.97 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -107.86 111.42 23.54 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.47 135.81 36.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.742 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' CE1' ' A' ' 94' ' ' PHE . 5.6 mp -109.77 -49.24 3.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.255 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.36 128.77 48.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -85.06 158.28 20.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HD2' ' OE2' ' A' ' 62' ' ' GLU . 12.9 ptm180 -61.89 149.98 38.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.964 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 m120 68.37 11.41 8.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.111 0.964 . . . . 0.0 112.65 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.1 t -75.71 122.38 23.92 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.404 ' HA ' HG12 ' A' ' 12' ' ' VAL . 1.4 p -62.65 126.83 28.68 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.107 0.963 . . . . 0.0 112.945 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 11' ' ' ASP . 21.3 pt -87.52 152.3 51.87 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_exo -67.82 124.23 6.3 Favored 'Cis proline' 0 C--O 1.241 0.668 0 N-CA-C 115.241 1.208 . . . . 0.0 115.241 4.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -96.79 158.13 15.58 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.023 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -165.58 108.56 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 93' ' ' THR . 26.7 mm-40 -121.85 137.59 54.72 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.934 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.4 m -121.8 117.28 26.16 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.185 0.928 . . . . 0.0 109.788 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -125.48 147.87 49.07 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.8 mm -95.9 117.56 40.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.405 0.621 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -105.14 153.9 20.91 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.312 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 10.8 p -135.11 171.11 14.9 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 30.7 p -101.87 148.76 24.94 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 118.829 0.74 . . . . 0.0 109.85 175.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 37.1 m-85 -81.21 -65.33 1.03 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.16 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -75.69 144.83 41.37 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.78 145.88 44.71 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.551 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 68.62 35.46 3.14 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -73.98 118.17 67.24 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.46 -24.62 10.42 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.032 1.821 . . . . 0.0 111.951 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.01 159.02 29.26 Favored Glycine 0 N--CA 1.411 -2.976 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.92 153.21 33.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 O-C-N 123.945 0.438 . . . . 0.0 109.963 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.0 tp -106.22 115.84 30.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.11 106.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 74' ' ' ARG . 15.1 tt0 -112.47 121.43 44.82 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.0 t -90.32 135.23 26.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.574 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 90.4 m-85 -136.66 167.63 21.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.803 0.811 . . . . 0.0 111.282 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.563 ' CG ' ' HB2' ' A' ' 70' ' ' ASN . 13.4 pt-20 -136.01 151.51 49.96 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 170.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.65 136.49 3.88 Favored Glycine 0 C--N 1.277 -2.703 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' OE2' ' HD2' ' A' ' 32' ' ' ARG . 30.6 mt-10 -101.44 95.62 6.61 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 -174.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 68' ' ' ASP . 20.7 mmt180 -146.29 170.45 16.75 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.236 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -86.44 -49.76 7.37 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.557 175.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.3 mtt -98.9 137.27 37.71 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.587 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.42 85.58 2.0 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.177 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -146.92 -52.17 0.21 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.472 ' HB2' ' HG3' ' A' ' 63' ' ' ARG . 7.5 m-20 -94.34 70.03 3.7 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -145.13 150.24 36.43 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.982 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.563 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 85.0 m-20 -90.68 131.57 36.29 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.08 118.41 28.78 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 mp -92.31 -56.91 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.801 0.334 . . . . 0.0 111.186 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -154.08 163.52 31.01 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.436 ' HB3' ' HG3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -153.2 135.39 14.88 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.9 150.12 41.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -94.97 129.98 41.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 tt -120.0 104.79 10.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 p -121.99 165.4 16.07 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.27 -0.11 14.38 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -64.51 125.62 88.95 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.458 0.703 . . . . 0.0 109.638 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 111' ' ' THR . 60.9 Cg_endo -70.78 168.69 22.17 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.07 2.513 . . . . 0.0 111.853 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.08 90.93 0.12 Allowed 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.546 2.164 . . . . 0.0 111.823 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.41 147.55 66.59 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.574 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.6 -171.03 0.72 Allowed 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.359 2.706 . . . . 0.0 113.425 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 46' ' ' THR . 51.8 ttp180 -59.07 131.93 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.1 0.96 . . . . 0.0 111.54 -177.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 -8.5 64.89 Favored Glycine 0 C--N 1.308 -0.979 0 CA-C-N 115.833 -0.621 . . . . 0.0 114.295 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.6 t -82.88 -54.29 0.57 Allowed Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.25 107.52 2.46 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.336 1.358 . . . . 0.0 110.107 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.45 ' HB2' ' HD2' ' A' ' 109' ' ' LYS . 92.9 mt-30 -94.87 113.39 25.12 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.1 mm -98.24 115.25 37.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.04 113.46 25.72 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -116.64 123.21 71.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 42.1 m -129.45 124.58 34.41 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.3 177.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.402 ' CE1' HD22 ' A' ' 29' ' ' LEU . 45.9 p90 -123.6 138.23 54.59 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.927 174.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -134.31 153.2 52.01 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.499 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 64.6 mt -130.91 135.73 59.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.2 p-10 -84.81 -173.02 4.5 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.88 -13.02 60.26 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.447 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 47.6 m-80 -85.31 -29.51 24.48 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.74 28.81 2.83 Favored Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.494 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 68.9 mt -88.35 116.29 29.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 tp -95.66 120.78 36.51 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.95 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -119.99 104.2 9.95 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.12 125.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.1 m -123.45 123.44 40.65 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.61 130.62 53.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.1 m -131.58 126.8 35.71 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -83.86 116.6 22.83 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.206 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 89' ' ' GLN . 67.9 mttm -67.19 -19.33 65.55 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -74.31 -54.5 7.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.833 0.349 . . . . 0.0 110.938 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.416 HG23 ' HD3' ' A' ' 81' ' ' PRO . 38.4 p -91.5 -37.01 13.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.14 14.19 36.89 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.03 136.87 35.18 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.475 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.91 137.68 45.06 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.303 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -133.09 138.75 46.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -131.4 158.34 41.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.866 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.9 141.0 44.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.1 m -128.5 113.29 15.31 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 65.1 mt -113.65 111.08 34.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.8 t -92.42 100.98 13.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 59.65 -164.25 0.22 Allowed 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.991 0.916 . . . . 0.0 108.719 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 t70 64.96 -160.33 0.28 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -168.59 -27.19 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.17 -122.17 3.58 Favored Glycine 0 N--CA 1.415 -2.755 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -99.04 20.46 13.29 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.5 mt -124.29 141.26 52.22 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.614 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.2 p -120.55 -178.7 3.77 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.975 0.416 . . . . 0.0 111.869 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 131' ' ' ILE . 53.3 tttm -58.74 -28.7 66.11 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.867 1.267 . . . . 0.0 111.296 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.89 -40.04 95.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -68.77 -38.13 79.83 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 135' ' ' VAL . 54.1 mt -55.76 -54.11 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.726 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 136' ' ' GLN . 45.5 mt-10 -66.38 -35.26 79.88 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -59.89 -44.13 94.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.265 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.5 mtt -72.55 -30.26 64.28 Favored 'General case' 0 C--O 1.202 -1.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 131' ' ' ILE . 60.0 t -62.94 -50.16 80.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 53.7 mt-30 -55.66 -47.22 77.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.274 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.737 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.26 74.3 Favored 'General case' 0 C--O 1.196 -1.731 0 C-N-CA 122.568 0.347 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.22 -32.63 74.4 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.909 0.385 . . . . 0.0 111.404 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -75.26 -41.97 56.11 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.585 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -108.31 11.67 27.03 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.16 -43.77 64.25 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.146 0.978 . . . . 0.0 111.554 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -66.5 -43.37 85.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -177.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.7 -38.57 47.09 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.281 -0.568 . . . . 0.0 112.248 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.8 m-20 -64.3 -33.46 75.89 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.976 0.417 . . . . 0.0 109.934 174.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.68 -50.37 74.12 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 54.7 t -62.06 -46.43 96.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -55.49 -47.45 76.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.476 0.711 . . . . 0.0 111.494 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -68.15 -47.34 68.32 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.88 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -68.76 -10.73 58.3 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 31.2 mmt180 -72.76 -10.97 60.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.332 0.587 . . . . 0.0 110.022 172.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.15 115.77 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -55.39 -45.35 76.62 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 123.314 0.646 . . . . 0.0 112.648 -172.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.44 158.83 43.18 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -136.69 31.51 2.79 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -86.46 33.64 0.63 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.933 -177.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -139.56 134.14 31.77 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.29 151.71 19.27 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 121.307 0.575 . . . . 0.0 111.207 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.434 ' HG3' ' CB ' ' A' ' 22' ' ' ALA . 41.9 mt-10 -116.72 121.61 42.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 41.9 t -75.94 111.67 11.55 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.832 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -102.32 164.34 11.73 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.884 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.38 95.59 1.36 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.076 0.465 . . . . 0.0 110.704 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -83.11 158.13 22.53 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.223 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -77.09 136.99 38.67 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.239 0.542 . . . . 0.0 110.811 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 69.0 mtm -92.58 176.05 6.6 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.191 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -81.05 132.18 35.35 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.064 0.459 . . . . 0.0 112.009 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.2 m -138.53 101.35 4.33 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -164.35 105.14 0.86 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.9 t -135.67 107.51 7.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 173.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.47 -69.45 0.6 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.546 0.689 . . . . 0.0 110.064 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -165.0 132.39 3.06 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -96.45 -19.69 18.97 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -93.15 49.2 2.44 Favored Glycine 0 CA--C 1.495 -1.212 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.641 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.14 156.32 25.79 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 66.03 -172.87 0.18 Allowed 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.046 0.939 . . . . 0.0 112.689 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -154.64 172.78 33.1 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -99.92 8.24 44.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 118.092 0.946 . . . . 0.0 111.021 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.89 175.73 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.344 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 50.2 m -146.65 94.83 2.49 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -105.67 112.36 25.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.574 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -133.2 153.52 51.47 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -105.95 93.2 4.5 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.395 0.617 . . . . 0.0 110.344 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -112.34 106.51 15.06 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -134.49 163.21 30.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -79.58 128.51 33.47 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.92 74.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 122.709 1.242 . . . . 0.0 111.08 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.8 tt -150.25 77.87 1.32 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -169.5 117.4 0.61 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.518 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -93.39 -18.4 22.42 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -127.58 95.98 4.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.376 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -94.98 -50.06 5.27 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 57.0 t -121.09 128.71 76.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 36.0 pt -113.46 -9.86 12.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 121.113 0.482 . . . . 0.0 110.544 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 25.2 t -163.21 136.38 5.64 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.454 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -102.78 109.65 21.3 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.025 0.441 . . . . 0.0 109.939 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 51.8 tp -105.06 89.84 3.26 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.78 127.44 55.37 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.452 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -112.8 -29.76 7.29 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.81 20.74 12.35 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 124.759 1.224 . . . . 0.0 110.572 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 10.3 p -82.8 -20.35 35.93 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.663 0.744 . . . . 0.0 110.529 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.691 ' H ' HD23 ' A' ' 202' ' ' LEU . 1.9 pt? -101.02 135.26 42.75 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -132.6 90.5 2.79 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.486 0.66 . . . . 0.0 110.571 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -91.46 169.38 10.82 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.672 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 211' ' ' LYS . 50.9 mtmt 71.78 93.55 0.08 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.4 1.063 . . . . 0.0 110.424 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -95.33 25.12 4.55 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.422 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 73.87 -72.85 0.11 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.706 1.603 . . . . 0.0 108.221 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -127.02 103.59 7.54 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -175.56 175.0 2.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -80.94 80.11 7.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.386 1.089 . . . . 0.0 112.211 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.444 ' HG2' ' H ' ' A' ' 205' ' ' LYS . 16.8 tppt? -134.52 96.5 3.59 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.93 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.84 -73.89 0.36 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -126.42 -29.67 2.93 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.886 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . 0.275 1.1 mp0 74.91 -34.05 0.26 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 215' ' ' LEU . 2.6 pt? -72.96 2.45 6.89 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.008 0.908 . . . . 0.0 109.599 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -60.15 -25.86 65.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.215 1.806 . . . . 0.0 108.552 173.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -121.36 81.94 1.86 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 172.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.0 p -83.42 -25.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.332 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.675 ' OD1' HG12 ' A' ' 222' ' ' ILE . 25.8 t-20 -143.42 129.86 10.37 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.94 -9.49 25.79 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.933 2.422 . . . . 0.0 115.938 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.675 HG12 ' OD1' ' A' ' 220' ' ' ASN . 10.8 pt -92.85 -18.43 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 118.358 -1.337 . . . . 0.0 111.101 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.09 140.88 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 120.946 0.403 . . . . 0.0 111.28 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 18.0 m -152.56 -40.5 0.1 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.362 0.601 . . . . 0.0 109.733 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.18 -41.37 2.01 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 54.98 -99.15 0.09 Allowed 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.979 1.312 . . . . 0.0 112.399 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -99.91 88.36 3.75 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -101.17 141.54 33.9 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.605 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 141.57 150.06 5.31 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.01 -17.15 41.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.364 0.602 . . . . 0.0 110.757 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 104.31 -6.77 46.48 Favored Glycine 0 C--N 1.311 -0.807 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.799 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.52 115.83 1.54 Allowed Glycine 0 C--N 1.311 -0.843 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.788 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.29 126.02 19.0 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 123.094 2.529 . . . . 0.0 111.643 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 72.31 82.52 0.29 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.183 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.16 -48.09 8.86 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.481 2.121 . . . . 0.0 111.573 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -172.79 160.88 32.04 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -116.98 90.56 0.51 Allowed Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -85.46 -14.91 44.66 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.327 0.584 . . . . 0.0 110.579 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.96 28.64 9.09 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -88.61 107.86 19.14 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 64.7 82.13 0.19 Allowed 'General case' 0 C--O 1.239 0.545 0 O-C-N 124.579 1.174 . . . . 0.0 112.485 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 117.46 84.5 1.03 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.158 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -84.65 -6.9 9.75 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.153 1.902 . . . . 0.0 112.291 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp 60.84 92.88 0.05 OUTLIER 'General case' 0 C--O 1.252 1.185 0 C-N-CA 124.547 1.139 . . . . 0.0 112.762 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -76.31 -58.59 3.59 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 107.557 -2.217 . . . . 0.0 107.557 171.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 53.92 39.38 62.41 Favored Glycine 0 CA--C 1.498 -0.977 0 CA-C-N 114.461 -0.869 . . . . 0.0 112.421 175.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 43.8 m -145.15 157.53 44.07 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 170.88 122.66 0.65 Allowed Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.047 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 40.5 m -155.39 80.01 1.04 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 54.68 -152.15 13.15 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.487 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.16 -9.99 25.22 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.891 2.394 . . . . 0.0 112.382 177.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 23.6 m -64.96 -58.2 6.75 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.301 0.572 . . . . 0.0 110.096 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 45.1 mm -83.3 -35.69 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.708 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . 0.259 13.6 pt-20 47.26 76.67 0.1 Allowed 'General case' 0 C--O 1.247 0.951 0 C-N-CA 125.168 1.387 . . . . 0.0 114.612 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -129.56 17.01 5.9 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.406 1.098 . . . . 0.0 108.969 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 40.0 t -87.54 81.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.646 -175.273 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.384 0.135 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 60.49 13.76 4.36 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 59.77 85.71 0.1 Allowed 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.464 0.705 . . . . 0.0 112.077 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.82 -16.46 10.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.756 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -80.11 156.32 27.09 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.416 175.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.34 114.71 26.52 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.23 143.38 34.44 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.657 0.741 . . . . 0.0 111.776 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.3 tp -126.25 113.53 17.09 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.44 157.07 38.33 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 123.585 0.553 . . . . 0.0 111.447 -174.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp 76.76 173.62 0.22 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.146 1.378 . . . . 0.0 111.081 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.23 81.05 1.48 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.112 0.958 . . . . 0.0 110.068 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.44 178.14 3.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.126 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.97 116.67 66.89 Favored Pre-proline 0 C--N 1.289 -2.044 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.71 -36.45 24.58 Favored 'Trans proline' 0 C--O 1.252 1.186 0 C-N-CA 121.733 1.622 . . . . 0.0 110.729 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 84.8 mt -108.07 174.98 5.64 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.65 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.528 ' HB2' ' HG3' ' A' ' 32' ' ' ARG . 10.0 t -103.55 -176.38 3.07 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -151.57 129.23 11.52 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 171.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.75 166.23 31.8 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.125 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.9 mt -111.78 148.22 34.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 32.1 tt0 -86.25 112.05 21.0 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 32.1 p -100.49 172.36 7.17 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.86 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 124.39 20.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.977 0.417 . . . . 0.0 111.915 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.25 -9.37 28.9 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.903 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.42 35.92 10.17 Favored Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.461 ' HB ' ' OG1' ' A' ' 21' ' ' THR . 27.4 t -99.17 133.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.425 ' HB2' ' OG1' ' A' ' 66' ' ' THR . 26.1 ttt -98.07 108.08 20.71 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.2 m -87.91 111.77 21.81 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.15 24.63 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.844 0.354 . . . . 0.0 110.431 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.482 HD22 ' CD1' ' A' ' 94' ' ' PHE . 6.1 mp -90.7 -45.6 8.76 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.841 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.36 101.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.498 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -72.39 168.3 18.71 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.159 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.528 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 35.2 mtp-105 -61.98 150.62 37.39 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.444 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.19 17.03 10.3 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.91 1.284 . . . . 0.0 111.604 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -73.15 129.12 37.36 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 p -68.23 114.73 6.96 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 124.272 1.029 . . . . 0.0 111.598 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 30.3 pt -94.64 164.58 19.39 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 22.7 Cg_exo -68.92 134.74 28.98 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.773 1.312 . . . . 0.0 113.416 -0.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.4 p -110.69 161.39 15.8 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 123.871 0.868 . . . . 0.0 110.844 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.531 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 46.7 tttp -156.96 99.42 1.82 Allowed 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -102.61 135.14 44.8 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -132.64 116.45 16.67 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.416 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 55.0 mt-30 -128.88 158.64 38.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.33 125.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 156' ' ' ASN . 80.9 m-85 -113.36 160.44 18.37 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.331 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 11.8 p -137.97 171.76 13.94 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 122.859 0.463 . . . . 0.0 110.625 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 63.4 p -98.77 162.67 12.98 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 157' ' ' ALA . 26.9 m-85 -103.09 -5.1 23.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.194 0.521 . . . . 0.0 109.602 171.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 p -139.55 164.03 30.99 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.737 -174.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -102.32 158.08 16.45 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.806 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 82' ' ' PRO . 44.1 m-80 71.33 14.33 6.49 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.491 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 75.4 mt-30 -63.5 129.13 93.43 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.25 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.94 -45.14 34.31 Favored 'Trans proline' 0 C--O 1.243 0.765 0 C-N-CA 122.499 2.133 . . . . 0.0 111.445 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 78' ' ' SER . . . -166.35 153.81 23.89 Favored Glycine 0 N--CA 1.404 -3.446 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 HD11 ' A' ' 80' ' ' ILE . 19.1 m -103.97 137.77 31.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 161' ' ' TYR . 1.2 tt -101.71 109.95 21.84 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.419 ' HB ' ' CD2' ' A' ' 75' ' ' PHE . 2.3 mp -84.51 94.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . 0.251 6.6 pt20 -99.35 114.22 26.97 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.166 0.984 . . . . 0.0 111.632 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.86 126.65 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.075 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 20' ' ' GLU . 92.4 m-85 -124.21 155.74 38.01 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 16' ' ' SER . 1.3 pp20? -127.27 165.87 18.85 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.15 124.55 3.53 Favored Glycine 0 C--N 1.263 -3.522 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 7.4 mm-40 -78.83 87.73 4.69 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.976 0.893 . . . . 0.0 109.662 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -128.04 142.11 51.32 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.791 -1.549 . . . . 0.0 107.044 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -66.9 -49.81 64.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.0 mtm -110.82 137.97 47.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.151 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 26' ' ' MET . 2.5 m -89.73 108.21 19.55 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.528 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -141.28 -53.91 0.47 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.134 0.493 . . . . 0.0 111.976 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.75 -61.57 1.35 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.6 m120 40.12 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 113.442 -1.708 . . . . 0.0 113.899 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -112.04 101.56 9.84 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.52 114.83 4.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.461 0.648 . . . . 0.0 110.395 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -91.19 -35.92 14.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.085 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.81 154.51 15.34 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.911 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -119.51 139.56 51.91 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 121.559 0.695 . . . . 0.0 109.185 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.419 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 13.8 t80 -143.48 142.09 31.03 Favored 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.41 -174.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.41 131.24 52.96 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.309 0.504 . . . . 0.0 111.249 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.3 tp -124.07 105.22 9.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.448 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 22.5 p -96.9 158.6 15.35 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.844 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.4 31.41 3.26 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.017 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 51' ' ' GLN . 2.0 mp -77.18 116.17 55.18 Favored Pre-proline 0 C--O 1.242 0.687 0 CA-C-N 117.265 0.533 . . . . 0.0 109.894 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 25.6 Cg_exo -66.13 155.15 71.13 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 11.3 Cg_exo -74.05 82.71 1.74 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.544 2.162 . . . . 0.0 111.772 177.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . . . -132.6 127.63 20.62 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -37.26 -63.74 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 125.07 3.847 . . . . 0.0 115.931 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -175.4 120.26 0.19 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.62 -34.97 3.31 Favored Glycine 0 CA--C 1.494 -1.251 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.631 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.23 -56.97 6.37 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.863 -0.589 . . . . 0.0 111.198 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 83' ' ' ALA . 21.9 Cg_endo -64.24 104.72 0.53 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.421 1.414 . . . . 0.0 110.448 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -120.06 115.92 24.67 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.5 mm -99.51 116.3 42.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 34.8 tt0 -90.69 114.3 26.59 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.75 125.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 17.8 m -112.98 131.49 55.74 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.387 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CD1' HD22 ' A' ' 29' ' ' LEU . 7.7 m-85 -119.67 108.5 14.53 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.85 1.26 . . . . 0.0 109.057 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.531 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 2.7 p30 -123.57 136.61 54.62 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.281 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 54.7 mt -121.87 137.75 54.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 2.9 p-10 -100.66 -169.43 1.71 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.46 -15.34 61.81 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 43.7 m-80 -90.31 -5.38 56.33 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.983 -0.448 . . . . 0.0 110.859 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.5 25.76 49.51 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.421 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 69.3 mt -84.3 113.12 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.9 tp -95.87 117.0 29.75 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.095 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -107.7 121.2 44.22 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 93' ' ' THR . 69.9 t -111.61 115.66 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.5 m -117.23 127.38 54.04 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.74 118.04 30.98 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.8 m -110.48 125.8 53.68 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.705 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.61 115.63 23.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 91' ' ' GLU . 68.0 mttm -67.51 -16.55 64.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.6 m -79.4 -50.43 10.84 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.829 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 36.2 p -83.77 -39.22 20.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.135 0.493 . . . . 0.0 111.225 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.15 12.62 48.53 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.439 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 65.4 pttt -103.05 156.43 17.69 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.331 . . . . 0.0 110.231 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.71 52.08 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.231 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -129.09 152.66 48.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.99 165.94 24.83 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.5 tt -145.65 143.49 21.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -122.0 113.11 19.12 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 75.3 mt -108.24 105.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.691 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.8 m -90.77 158.55 16.79 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -63.96 104.12 0.67 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.008 0.908 . . . . 0.0 110.711 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -156.6 147.04 21.46 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -104.76 88.17 2.85 Favored 'General case' 0 N--CA 1.423 -1.809 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.78 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.486 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -124.18 30.48 4.76 Favored Glycine 0 C--N 1.286 -2.246 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 170.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.486 ' HD2' ' C ' ' A' ' 124' ' ' GLY . 1.8 mpt_? -129.54 95.66 4.06 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.629 HD23 ' HG2' ' A' ' 130' ' ' GLU . 6.6 mp 67.08 -161.24 0.23 Allowed 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.08 0.862 . . . . 0.0 111.941 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 79.9 p -100.41 -72.59 0.67 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -170.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.9 -45.37 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -172.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 60.4 mm-40 -56.45 -49.2 75.27 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 114.319 -1.31 . . . . 0.0 111.136 -177.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HG2' ' A' ' 134' ' ' MET . 14.7 mp0 -57.88 -47.14 83.63 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.063 0.852 . . . . 0.0 109.76 -177.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 75.6 mt -53.15 -51.9 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.568 1.168 . . . . 0.0 110.698 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 60.6 mt-10 -74.01 -33.28 63.73 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.203 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 95.4 mtt180 -67.11 -35.23 79.32 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.678 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 24.3 mmt -60.14 -52.59 64.7 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.1 t -56.02 -52.65 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 124.027 0.83 . . . . 0.0 112.034 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 70.5 mm-40 -64.37 -45.49 87.52 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.29 -32.81 66.94 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.406 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' A' ' 142' ' ' LYS . . . -60.5 -48.43 81.81 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.466 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 21.6 mm-40 -61.89 -48.61 79.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -77.37 -24.35 50.63 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -174.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.98 13.28 7.29 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 18.5 ptpt -50.04 -43.44 51.0 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.19 -42.99 78.03 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -71.21 -53.17 15.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 m-20 -64.86 -33.87 77.03 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -59.22 -51.08 71.5 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 117.651 0.205 . . . . 0.0 111.189 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.2 t -62.43 -49.34 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 O-C-N 123.635 0.584 . . . . 0.0 109.998 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -56.79 -45.64 82.03 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.833 0.708 . . . . 0.0 111.916 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.57 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 45.3 ttp180 -63.93 -32.68 74.29 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.163 0.585 . . . . 0.0 111.099 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -85.27 -17.27 37.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.504 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 5.2 mmp_? -80.49 -6.85 58.79 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.79 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.67 71.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.3 m 67.19 167.6 0.24 Allowed 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.497 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.13 25.85 4.9 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.78 155.41 17.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.306 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 44' ' ' PHE . 79.0 m-20 -117.3 87.27 2.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -144.31 145.18 31.84 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 122.162 -0.336 . . . . 0.0 110.305 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.477 ' HG ' HG22 ' A' ' 21' ' ' THR . 0.7 OUTLIER -124.54 152.82 42.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.659 0.742 . . . . 0.0 112.206 -175.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -128.73 146.13 50.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 168.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.8 p -158.67 177.04 11.63 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.455 ' O ' HD12 ' A' ' 55' ' ' LEU . 62.5 t80 -108.9 106.01 15.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.954 1.302 . . . . 0.0 108.135 -177.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -103.99 143.65 32.59 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.8 t80 59.89 92.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.809 1.644 . . . . 0.0 112.859 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -78.77 129.38 34.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.4 mmt -75.81 106.12 7.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -135.02 123.11 22.78 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.437 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.6 m -156.13 101.64 2.09 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.967 0.507 . . . . 0.0 109.919 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -137.8 -164.84 1.68 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.63 121.22 25.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 O-C-N 121.88 -0.512 . . . . 0.0 110.865 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.9 103.36 16.03 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.1 t70 77.2 133.41 0.06 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.472 1.509 . . . . 0.0 112.401 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -146.59 97.76 2.97 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -104.34 89.37 0.66 Allowed Glycine 0 C--N 1.306 -1.135 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.179 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 67.5 tp -94.37 -50.77 5.08 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.184 0.516 . . . . 0.0 110.814 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -105.51 136.19 45.54 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.252 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 161.1 -39.12 0.42 Allowed Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 119.698 -1.239 . . . . 0.0 114.442 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -79.9 96.87 6.49 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -174.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.2 pt -137.5 94.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.256 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.3 t -166.62 136.63 3.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -129.88 148.81 51.79 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.08 86.75 5.5 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.394 0.616 . . . . 0.0 109.415 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.402 ' HA ' ' HE3' ' A' ' 185' ' ' LYS . 6.9 p-10 -79.6 -23.5 42.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.875 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -87.68 129.91 34.98 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.628 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? 77.42 81.95 0.08 Allowed 'General case' 0 C--N 1.316 -0.853 0 O-C-N 124.779 1.3 . . . . 0.0 113.005 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.536 ' O ' HG12 ' A' ' 186' ' ' VAL . 99.7 mttt -125.81 155.36 41.23 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 172.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 185' ' ' LYS . 0.8 OUTLIER 78.72 -14.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 127.022 2.129 . . . . 0.0 109.731 -173.329 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 185' ' ' LYS . 3.4 mm? 70.01 -82.28 0.03 OUTLIER 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.678 1.591 . . . . 0.0 114.025 176.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -157.06 -163.81 1.48 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -79.1 29.56 0.22 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.344 1.457 . . . . 0.0 113.386 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -123.73 140.91 52.52 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 73.15 -174.5 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.278 1.031 . . . . 0.0 111.358 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 46.0 t 65.32 -80.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 125.665 1.586 . . . . 0.0 112.471 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . 0.29 8.5 tt 42.52 92.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.852 1.661 . . . . 0.0 114.146 -175.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.8 p -77.17 134.79 38.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.944 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -139.3 120.29 14.53 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.333 0.587 . . . . 0.0 109.654 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 65.0 tp -115.99 150.69 36.8 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.36 109.91 8.23 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -102.4 91.14 4.13 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -98.46 132.87 43.56 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.8 p -90.72 125.55 35.72 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.306 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.38 117.4 26.12 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -113.41 122.58 47.77 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.836 0.351 . . . . 0.0 110.577 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -88.5 -84.89 0.2 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.776 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 206' ' ' ASP . 0.4 OUTLIER -174.59 131.9 0.35 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 -176.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 208' ' ' PHE . 11.3 t70 -85.5 166.23 16.48 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -174.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -95.26 88.02 5.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.961 0.886 . . . . 0.0 112.7 -174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 206' ' ' ASP . 89.1 m-85 -100.83 -22.19 14.92 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.834 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.96 -81.15 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 124.972 1.309 . . . . 0.0 111.683 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -156.37 -49.36 0.08 Allowed 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -144.95 5.11 1.13 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.541 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 67.74 -56.76 0.47 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.742 1.617 . . . . 0.0 112.186 -172.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -144.15 150.69 38.46 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -130.93 163.77 26.77 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.19 83.71 7.66 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 122.425 1.107 . . . . 0.0 108.107 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -90.46 -37.5 13.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.532 -175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -98.2 119.86 37.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.327 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.08 175.72 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.2 t30 55.79 95.32 0.05 OUTLIER Pre-proline 0 N--CA 1.486 1.364 0 C-N-CA 124.153 0.981 . . . . 0.0 112.203 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.41 108.87 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.36 2.04 . . . . 0.0 113.208 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 222' ' ' ILE . 2.9 pp -119.56 122.64 69.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 29.9 pt -132.37 169.26 22.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.234 0.54 . . . . 0.0 111.828 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.8 m -136.09 -171.57 2.91 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.17 -2.67 14.34 Favored Glycine 0 C--N 1.312 -0.801 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.789 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -144.2 116.33 8.41 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.036 0.446 . . . . 0.0 109.978 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -150.0 -68.38 0.2 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.42 -48.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 120.46 -149.59 17.57 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.66 157.09 17.15 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -147.86 53.45 0.53 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -152.79 85.59 0.14 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.56 -52.3 4.85 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.695 2.263 . . . . 0.0 111.918 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -153.54 167.53 32.0 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.4 -51.19 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 122.671 2.247 . . . . 0.0 112.972 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 145.9 -165.05 28.14 Favored Glycine 0 CA--C 1.497 -1.083 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.45 26.58 73.0 Favored Glycine 0 C--N 1.318 -0.421 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.394 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -101.5 160.26 14.58 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.0 36.17 42.06 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.321 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.81 116.88 21.69 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -126.47 101.42 6.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -172.09 98.11 0.13 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.94 -24.97 28.25 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.438 2.092 . . . . 0.0 111.227 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt 67.41 87.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.158 1.383 . . . . 0.0 112.461 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -129.13 149.9 18.68 Favored Glycine 0 N--CA 1.423 -2.185 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.025 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 152.07 -35.44 0.84 Allowed Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.522 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 24.4 p -82.89 132.68 35.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.74 0.27 . . . . 0.0 111.259 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.89 175.79 51.16 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.42 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 -172.6 2.04 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -117.03 94.16 0.62 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -81.85 95.73 0.91 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.418 2.079 . . . . 0.0 111.096 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.9 p -85.43 82.13 8.44 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 121.651 0.739 . . . . 0.0 110.228 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.1 pt -80.85 158.81 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -70.58 136.36 49.17 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -175.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -108.82 91.57 3.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.81 145.24 7.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.082 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.5 177.332 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -80.03 125.54 29.91 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -162.33 120.56 2.18 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.93 84.29 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-O 122.894 1.33 . . . . 0.0 108.607 172.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.61 138.93 34.05 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.857 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . 0.285 5.7 m-20 69.89 76.08 0.21 Allowed 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 124.961 1.304 . . . . 0.0 113.479 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.5 mt -83.08 63.91 7.37 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.402 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.61 92.61 5.99 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -87.18 102.95 14.95 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.526 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.84 140.08 49.2 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' THR . 22.7 m-20 -84.27 67.15 9.69 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.944 0.878 . . . . 0.0 110.004 -175.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 m -134.2 179.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . . . -96.36 133.7 24.52 Favored Pre-proline 0 C--N 1.282 -2.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 36.3 Cg_endo -68.25 -38.68 11.54 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.461 2.108 . . . . 0.0 110.409 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -134.91 161.31 35.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 m -76.06 149.36 37.5 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 123.289 0.368 . . . . 0.0 110.469 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.09 142.36 44.64 Favored 'General case' 0 CA--C 1.48 -1.716 0 CA-C-O 120.993 0.425 . . . . 0.0 110.713 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 28' ' ' ALA . . . -164.84 -168.76 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 C-N-CA 119.977 -1.106 . . . . 0.0 114.041 -173.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.432 HD21 HG11 ' A' ' 92' ' ' VAL . 1.7 mp -113.38 156.06 24.11 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.539 0.736 . . . . 0.0 109.118 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.95 109.35 18.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.906 0.86 . . . . 0.0 109.19 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 6.1 p -94.45 171.54 8.75 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.235 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . . . -51.51 124.77 12.83 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.779 1.232 . . . . 0.0 112.145 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.29 -2.73 57.83 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.28 39.8 25.71 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.3 t -96.5 142.03 14.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.517 -0.842 . . . . 0.0 109.261 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.05 107.99 20.35 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.3 m -107.55 111.84 24.3 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.501 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . . . -92.27 147.57 22.82 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 94' ' ' PHE . 51.4 mt -115.34 -24.75 8.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.3 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 94' ' ' PHE . 3.3 mp -117.78 117.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 171.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -85.39 149.86 25.14 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 14' ' ' PRO . 10.6 ptt85 -69.83 152.53 44.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.459 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.3 m120 70.96 -0.63 2.97 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.4 1.08 . . . . 0.0 112.147 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -89.24 122.58 32.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 2.9 p -65.18 121.16 14.12 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 123.849 0.86 . . . . 0.0 112.93 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 36.3 pt -84.94 164.94 39.72 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 47.0 Cg_exo -60.72 145.7 42.1 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 CA-C-N 120.652 1.269 . . . . 0.0 114.024 1.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 m -142.0 143.76 33.33 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 6.1 ttpm? -147.14 119.56 8.43 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.854 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 29' ' ' LEU . 30.7 mt-30 -121.8 131.81 54.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.087 0.47 . . . . 0.0 111.03 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 35.0 m -115.23 118.3 32.9 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -130.13 155.42 46.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.23 126.41 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.81 146.26 42.99 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.083 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 29.3 p -123.69 171.28 9.7 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 124.916 1.286 . . . . 0.0 107.555 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -113.07 136.85 52.25 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -98.92 -4.2 33.4 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 167.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -80.17 106.97 12.58 Favored 'General case' 0 N--CA 1.395 -3.194 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.447 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.75 133.01 44.35 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.373 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 64.2 29.88 13.78 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.918 172.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -85.23 120.31 73.24 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 88.2 Cg_endo -82.85 -0.41 10.05 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.558 2.172 . . . . 0.0 110.826 177.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.28 147.85 9.9 Favored Glycine 0 N--CA 1.408 -3.202 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.99 165.24 22.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 123.955 0.444 . . . . 0.0 110.503 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.9 tp -111.82 115.0 28.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -88.64 94.78 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -99.64 118.15 35.54 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.752 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.11 134.92 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.813 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -125.63 154.01 42.93 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -114.13 118.72 34.81 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' HA3' ' SD ' ' A' ' 134' ' ' MET . . . 154.52 175.03 25.22 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -140.89 104.26 4.65 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.69 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -154.74 169.45 23.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.06 -31.91 68.45 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.694 0.759 . . . . 0.0 109.705 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.0 mtt -111.48 135.7 51.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.199 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.94 -13.23 59.95 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -64.92 -27.15 68.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -171.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -94.53 14.75 19.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.752 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.523 ' HA ' ' SD ' ' A' ' 134' ' ' MET . 14.2 m120 -107.1 175.25 5.56 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.198 -0.314 . . . . 0.0 110.715 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.89 129.24 36.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 tp -76.27 109.17 9.74 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -82.81 -48.31 10.93 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.017 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.47 164.32 33.99 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -142.39 154.52 44.69 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 117.517 0.659 . . . . 0.0 109.84 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -155.33 158.27 38.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -106.63 147.99 28.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.789 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 tp -124.54 104.87 8.96 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.2 p -116.36 153.43 32.02 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.6 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.25 4.46 18.13 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 75.0 mt -79.87 130.26 67.67 Favored Pre-proline 0 C--N 1.318 -0.776 0 C-N-CA 123.664 0.786 . . . . 0.0 109.048 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -56.24 117.97 4.7 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.814 2.343 . . . . 0.0 111.403 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.98 111.84 1.85 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.778 2.318 . . . . 0.0 112.412 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.8 160.54 68.09 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.53 -23.16 37.47 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.808 2.339 . . . . 0.0 112.19 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -140.7 166.25 25.27 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.236 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.46 ' HA3' ' HB ' ' A' ' 45' ' ' THR . . . -73.86 80.54 0.81 Allowed Glycine 0 N--CA 1.432 -1.589 0 O-C-N 123.68 0.613 . . . . 0.0 114.276 -176.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.429 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 52.8 t -69.38 -45.24 27.39 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 32.6 Cg_exo -68.07 121.51 8.52 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.394 1.396 . . . . 0.0 110.278 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -81.98 115.61 21.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -91.76 119.51 39.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.22 104.19 16.77 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' THR . 40.6 t -110.08 117.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.619 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -103.81 116.36 32.15 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.284 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 3.0 m-85 -96.87 107.21 19.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 171.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' OD2' ' HD3' ' A' ' 39' ' ' LYS . 18.2 t70 -120.64 113.09 19.72 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 123.656 0.598 . . . . 0.0 110.566 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.76 118.4 56.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.486 ' OD2' ' HB ' ' A' ' 101' ' ' ILE . 2.5 p30 -85.41 -176.79 6.26 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.6 -20.29 63.17 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -80.62 -23.91 39.45 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 121.855 -0.528 . . . . 0.0 110.671 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.79 15.71 28.22 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.486 ' HB ' ' OD2' ' A' ' 97' ' ' ASP . 83.2 mt -80.4 119.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 114.61 27.0 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.1 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -107.51 101.44 10.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.9 t -93.72 114.27 30.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.0 m -112.1 110.73 21.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.67 117.55 34.4 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.3 m -119.8 128.69 53.95 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.625 0.726 . . . . 0.0 111.115 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.56 114.48 16.44 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.569 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -68.72 -21.4 64.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.6 p -80.19 -62.04 1.8 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.3 p -95.69 -31.36 13.27 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.389 0.614 . . . . 0.0 110.411 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.66 34.79 3.21 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.03 175.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -98.68 151.85 20.28 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 117.016 0.408 . . . . 0.0 110.889 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.95 140.59 24.6 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.845 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.82 139.74 43.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 149.2 43.76 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 tt -120.66 148.61 23.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.0 m -114.53 112.92 23.71 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.45 98.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.123 0.487 . . . . 0.0 110.877 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -91.73 101.78 14.39 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -160.13 127.65 4.57 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.55 89.4 7.7 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.463 0.649 . . . . 0.0 111.692 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm 70.64 160.71 0.22 Allowed 'General case' 0 C--O 1.25 1.115 0 C-N-CA 126.397 1.879 . . . . 0.0 111.386 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.73 -43.83 83.04 Favored Glycine 0 CA--C 1.502 -0.723 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.459 ' HA ' HD11 ' A' ' 131' ' ' ILE . 40.1 mmt180 68.33 -78.82 0.04 OUTLIER 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.474 1.11 . . . . 0.0 112.802 174.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.7 mt 57.3 -87.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.421 1.488 . . . . 0.0 113.319 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 129' ' ' GLU . 69.2 p -115.41 -12.89 11.67 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.65 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 74.01 -22.56 0.24 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.12 1.368 . . . . 0.0 110.614 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 127' ' ' SER . 32.2 tt0 -74.7 -39.71 61.77 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.089 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 134' ' ' MET . 1.4 mp0 -62.54 -38.95 91.98 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.337 175.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 125' ' ' ARG . 51.7 mt -56.87 -50.91 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.09 -45.42 87.19 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 123.575 0.75 . . . . 0.0 110.794 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -60.03 -47.73 84.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.523 ' SD ' ' HA ' ' A' ' 69' ' ' ASN . 70.3 mtm -66.55 -36.29 82.3 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 123.48 0.487 . . . . 0.0 111.573 -175.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 70.3 t -61.26 -54.71 31.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 123.621 0.576 . . . . 0.0 109.568 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 97.0 mt-30 -63.11 -46.77 85.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.589 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.08 -40.09 94.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.212 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -60.33 -44.5 95.44 Favored 'General case' 0 C--O 1.198 -1.616 0 O-C-N 123.05 0.219 . . . . 0.0 110.416 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 135' ' ' VAL . 22.2 mm-40 -58.61 -39.63 80.98 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 136' ' ' GLN . 94.5 mttt -74.21 -48.49 28.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.734 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -98.53 21.84 10.66 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 113.331 0.864 . . . . 0.0 113.331 -172.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 138' ' ' ALA . 29.2 mmtt -44.24 -58.68 2.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.06 45.57 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.716 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -58.26 -55.1 39.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.734 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.05 -38.58 44.14 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.94 -34.16 73.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.128 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.3 -44.05 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.552 ' O ' HG23 ' A' ' 152' ' ' VAL . 67.6 mt-30 -52.75 -50.84 62.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 110.735 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -54.05 -52.66 60.18 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 124.284 0.99 . . . . 0.0 111.341 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.83 -39.15 93.53 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.922 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -63.54 -25.47 68.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 148' ' ' GLN . 22.0 t -88.79 -39.24 12.38 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.6 p -72.14 80.75 0.97 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.518 0.675 . . . . 0.0 111.494 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.42 123.51 44.74 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 tptm 68.34 10.43 7.85 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 124.016 0.822 . . . . 0.0 110.007 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.47 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.131 1.372 . . . . 0.0 112.66 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -114.39 134.13 55.21 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.335 -175.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 44.7 mt -93.26 152.97 18.85 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.48 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 14.2 tt0 -97.6 173.36 7.18 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.2 t -122.54 -170.37 2.07 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.597 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -68.07 87.81 0.27 Allowed 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.902 1.281 . . . . 0.0 113.076 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.75 96.57 10.49 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.878 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -90.71 -50.25 6.02 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 66.05 -72.55 0.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.573 1.549 . . . . 0.0 110.945 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 89.0 mtp 59.81 31.62 20.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.064 1.346 . . . . 0.0 113.664 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -100.26 91.18 4.62 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.2 m -73.22 -60.52 2.2 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.41 -80.13 0.02 OUTLIER 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.966 1.307 . . . . 0.0 111.969 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . 0.264 10.2 p 41.31 77.88 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.994 1.717 . . . . 0.0 113.301 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.91 -55.39 9.82 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.616 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -110.7 146.42 36.29 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.702 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -133.48 -44.88 0.82 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.58 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -168.39 -175.06 37.69 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.165 -1.016 . . . . 0.0 111.703 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.1 mp 60.69 23.58 13.43 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.316 1.046 . . . . 0.0 111.49 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -103.76 90.06 3.52 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -174.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.78 -58.33 2.15 Favored Glycine 0 N--CA 1.465 0.571 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -65.0 142.37 58.46 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 124.277 1.031 . . . . 0.0 111.412 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.84 -59.04 3.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 15.7 m 48.0 78.58 0.08 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.703 1.201 . . . . 0.0 111.365 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -152.51 125.25 8.39 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.938 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 69.59 -81.1 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 125.519 1.527 . . . . 0.0 112.604 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 24.3 t70 62.75 107.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.172 0.989 . . . . 0.0 112.088 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -60.66 121.59 12.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.939 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -123.4 136.0 54.41 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt 65.89 175.24 0.22 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.979 1.312 . . . . 0.0 113.436 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.2 156.13 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 91.8 mt -117.66 -4.71 11.18 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.217 -173.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.47 ' HB2' ' SG ' ' A' ' 190' ' ' SMC . 6.1 p-10 -148.41 -58.43 0.23 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp 60.0 26.35 15.65 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.402 0.62 . . . . 0.0 110.215 -172.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . 0.47 ' SG ' ' HB2' ' A' ' 188' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.668 HE21 ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -86.89 81.31 8.18 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 69.19 153.13 0.1 Allowed 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.76 1.224 . . . . 0.0 111.343 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.29 76.76 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 123.238 1.494 . . . . 0.0 108.121 172.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 45.4 pt -74.0 139.8 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.472 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.8 m -93.17 135.19 34.6 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -80.19 118.32 21.77 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.159 -174.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.99 -163.73 0.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.766 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.3 t70 71.61 -65.61 0.34 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.298 1.839 . . . . 0.0 113.656 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -69.22 -39.04 78.82 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.898 0.38 . . . . 0.0 110.711 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -88.92 103.64 16.21 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.603 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.9 m -137.78 76.22 1.57 Allowed 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.93 129.76 40.26 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.342 -175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . 178.84 39.28 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 102.914 -2.995 . . . . 0.0 102.914 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -133.1 153.5 51.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.633 -1.622 . . . . 0.0 111.324 -166.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -167.42 175.69 7.07 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 101.441 -3.54 . . . . 0.0 101.441 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.51 96.81 1.21 Allowed 'General case' 0 C--O 1.249 1.058 0 CA-C-N 120.399 1.454 . . . . 0.0 109.835 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 8.3 tp10 -165.73 107.07 0.75 Allowed 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 103.75 -2.685 . . . . 0.0 103.75 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.54 -47.6 72.35 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.792 0.33 . . . . 0.0 110.782 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -92.69 96.01 9.92 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' A' ' 207' ' ' GLU . 26.6 m80 -106.45 -55.18 2.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 168.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -98.76 69.9 1.85 Allowed 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.956 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -88.87 91.09 8.69 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -118.33 79.21 1.34 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.204 1.002 . . . . 0.0 113.082 -175.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.33 -73.86 0.63 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.316 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.33 80.1 3.17 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.012 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -129.27 -64.49 0.9 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -82.86 114.93 21.51 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.244 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.0 89.1 2.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -81.14 150.31 67.97 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.803 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.18 -6.39 12.05 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.203 1.935 . . . . 0.0 111.939 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 61.8 mt 71.81 -65.52 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.755 1.222 . . . . 0.0 109.782 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 83.0 mt -140.77 115.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.3 m -68.67 109.72 3.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.114 0.483 . . . . 0.0 111.309 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 100.5 -25.28 28.91 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.4 mp 62.79 -80.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.18 1.392 . . . . 0.0 113.388 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 29.4 t80 60.77 91.86 0.05 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.629 1.171 . . . . 0.0 108.542 -170.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -61.34 -34.14 74.77 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.672 -1.604 . . . . 0.0 112.909 -170.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 169.51 -168.9 41.65 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.14 -13.28 57.44 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 117.21 0.505 . . . . 0.0 110.999 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 167.89 175.55 37.75 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -136.91 64.66 0.57 Allowed Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.53 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -102.52 16.78 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.209 2.606 . . . . 0.0 111.674 176.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 238' ' ' PHE . . . -82.1 164.41 44.23 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 121.188 -0.53 . . . . 0.0 111.859 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.78 -11.35 26.27 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.329 2.686 . . . . 0.0 114.367 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -68.0 95.82 0.36 Allowed Glycine 0 C--N 1.315 -0.599 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 93.39 -40.71 2.76 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 234' ' ' GLY . 56.5 t80 -79.71 -17.22 54.1 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.635 0.731 . . . . 0.0 110.086 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -121.42 111.38 1.86 Allowed Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.41 118.19 18.03 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -118.28 105.65 11.98 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.742 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -73.22 136.33 22.31 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.12 129.33 33.77 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.973 2.449 . . . . 0.0 112.425 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -103.51 150.75 23.6 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 128.87 -159.45 22.19 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 121.15 101.97 1.79 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.7 p -82.49 -24.38 34.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.744 0.783 . . . . 0.0 109.629 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 142.12 162.99 9.45 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.248 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 46.8 m -148.33 25.48 0.99 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 253' ' ' ILE . . . -153.93 89.91 0.13 Allowed Glycine 0 N--CA 1.422 -2.237 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.085 -176.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.25 8.81 3.37 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.634 2.223 . . . . 0.0 111.059 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 1.8 p -77.97 -25.34 48.1 Favored 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 125.046 1.338 . . . . 0.0 110.463 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 250' ' ' GLY . 41.2 pt -84.06 122.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.32 0.581 . . . . 0.0 109.577 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -132.19 91.54 2.97 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.12 80.08 7.65 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.431 1.11 . . . . 0.0 108.883 -176.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.38 93.65 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--N 1.294 -1.827 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -174.624 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.241 0.63 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -108.62 173.03 6.5 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.783 -173.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -64.84 -58.74 5.41 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.92 124.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.991 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -103.92 84.53 2.27 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 62.68 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.891 1.276 . . . . 0.0 109.885 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 mt -156.06 136.77 13.37 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 173.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.45 78.28 7.17 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.305 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.4 tp -104.6 -12.2 16.55 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 tp -160.79 178.78 9.1 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 73.17 29.5 1.71 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.121 0.968 . . . . 0.0 111.39 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 17.5 m -126.87 168.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.86 119.05 72.25 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.77 -25.96 16.45 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.245 1.963 . . . . 0.0 112.685 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.1 mp -135.18 172.19 13.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -101.75 129.8 48.01 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.445 HD13 HD22 ' A' ' 102' ' ' LEU . 62.2 mt -116.79 131.87 56.84 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.39 -176.57 21.94 Favored Glycine 0 N--CA 1.429 -1.816 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.64 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.89 150.53 30.32 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.27 108.38 17.1 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.644 HG22 HD23 ' A' ' 158' ' ' LEU . 34.6 p -107.29 -177.03 3.24 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.645 -172.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.12 119.13 5.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.88 0.872 . . . . 0.0 113.178 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.45 -8.57 22.38 Favored Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.869 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.64 57.27 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 39.4 t -110.65 149.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 23.1 ttt -92.72 137.81 32.04 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 122.987 0.515 . . . . 0.0 111.052 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -118.84 111.71 18.77 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.3 126.73 45.21 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.658 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -96.54 -33.79 11.69 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.29 125.57 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -120.48 146.02 46.68 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -56.07 151.48 12.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 m120 75.07 14.37 3.13 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.14 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -103.55 133.03 49.27 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 1.6 m -68.31 144.86 54.66 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 123.814 0.846 . . . . 0.0 111.715 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.89 155.4 43.31 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 18.5 Cg_endo -62.44 152.37 65.26 Favored 'Cis proline' 0 C--N 1.356 0.964 0 CA-C-N 119.922 1.008 . . . . 0.0 113.629 -1.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -107.09 -80.45 0.56 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.014 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 95' ' ' ASP . 43.5 tttp 65.41 99.43 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 127.424 2.29 . . . . 0.0 111.055 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -121.71 132.06 54.43 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.082 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 m -118.7 123.81 45.81 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 123.247 0.342 . . . . 0.0 110.478 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -130.61 146.23 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -93.34 133.93 32.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.92 132.4 50.88 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -119.8 153.09 36.25 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.7 p -81.7 135.52 35.5 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.353 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 23.1 m-85 -114.19 3.96 15.37 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . 24.5 p -97.0 -179.13 4.44 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 113.028 -1.896 . . . . 0.0 109.076 178.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -143.18 166.36 24.91 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.263 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 60.19 19.81 9.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 48' ' ' SER . 56.0 mt-30 -101.34 113.56 65.81 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.124 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 89.2 Cg_endo -85.83 -2.79 8.99 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.028 2.485 . . . . 0.0 111.672 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.16 149.04 16.21 Favored Glycine 0 N--CA 1.401 -3.689 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 m -112.64 149.56 15.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.34 101.5 11.42 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 63.1 mt -90.48 117.73 34.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -129.59 119.62 23.93 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.154 -168.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 104' ' ' VAL . 36.6 t -92.48 117.61 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.704 -178.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 70' ' ' ASN . 59.4 m-85 -120.08 144.33 47.65 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.277 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -111.73 154.34 25.15 Favored 'General case' 0 C--O 1.272 2.244 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.219 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.08 118.34 3.5 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -78.08 95.05 4.79 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.632 0.716 . . . . 0.0 110.91 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.474 ' HG2' HH11 ' A' ' 63' ' ' ARG . 43.3 mtp85 -136.74 157.03 47.71 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.845 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 145' ' ' ASP . . . -91.04 -51.27 5.42 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.7 93.74 9.04 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.6 m -84.61 108.1 17.18 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.905 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -163.49 144.19 9.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 68.19 16.23 9.38 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.476 1.11 . . . . 0.0 111.702 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.18 173.03 10.7 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 85.0 m-20 -90.7 127.45 36.31 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.95 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.7 118.49 29.35 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.713 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.6 mt -93.08 -53.98 3.91 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.08 156.01 26.71 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 10.0 ptm180 -151.19 139.14 19.97 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 123.713 0.805 . . . . 0.0 109.531 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.73 145.66 31.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.806 0.336 . . . . 0.0 111.226 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.64 110.45 22.56 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.4 tp -94.71 104.61 16.53 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.0 p -96.0 152.27 18.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.35 -35.27 2.09 Favored Glycine 0 CA--C 1.479 -2.188 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' PRO . 2.1 mp -51.88 120.16 15.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 O-C-N 125.042 1.084 . . . . 0.0 110.494 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.52 146.72 10.91 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.143 1.895 . . . . 0.0 111.317 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.75 118.17 5.01 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.9 1.734 . . . . 0.0 108.246 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.7 156.75 79.74 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.757 -171.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.34 43.4 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.224 2.616 . . . . 0.0 111.823 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HG3' ' HA ' ' A' ' 47' ' ' TYR . 7.9 mpt_? 68.97 148.45 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.253 1.421 . . . . 0.0 113.109 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.56 -27.86 2.13 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.436 ' HB ' ' HD3' ' A' ' 88' ' ' PRO . 48.6 t -58.45 -51.99 77.87 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' A' ' 87' ' ' VAL . 7.7 Cg_exo -77.12 106.89 2.32 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 121.597 1.531 . . . . 0.0 110.446 176.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -101.91 103.53 14.2 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mm -91.82 120.51 41.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.519 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . 40.4 tt0 -94.87 112.31 24.04 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.16 128.23 62.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.467 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 m -122.9 120.6 33.93 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.867 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -99.57 107.79 20.03 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.48 ' HB3' ' HG3' ' A' ' 39' ' ' LYS . 1.5 p-10 -125.61 112.64 16.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 47.7 mt -99.9 123.34 52.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 1.2 p-10 -86.55 -175.35 5.41 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 123.722 0.639 . . . . 0.0 109.373 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.36 -13.12 61.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.402 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 64.3 t30 -81.54 -28.66 33.82 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 112.18 12.79 13.08 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 92.9 mt -82.13 116.1 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-O 120.996 0.427 . . . . 0.0 110.347 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.445 HD22 HD13 ' A' ' 17' ' ' LEU . 22.1 tp -88.52 108.9 19.64 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 116' ' ' LYS . 1.2 t30 -102.91 110.49 22.43 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.757 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 58' ' ' VAL . 45.4 t -88.71 114.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 116' ' ' LYS . 7.2 m -110.76 124.29 51.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.622 -175.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -132.74 119.37 20.24 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.663 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 m -120.24 127.59 52.55 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.21 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.97 111.04 21.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.082 0.553 . . . . 0.0 111.841 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 91' ' ' GLU . 96.9 mttt -69.01 -11.2 60.57 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.0 p -86.04 -47.98 9.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 118.964 -1.095 . . . . 0.0 112.908 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.0 p -96.88 -33.79 11.5 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.875 -0.515 . . . . 0.0 111.819 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.08 23.67 10.39 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.924 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.37 157.8 16.16 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 122.779 -0.248 . . . . 0.0 110.339 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.77 143.71 22.97 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.113 0.482 . . . . 0.0 111.503 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -129.45 140.69 51.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.529 ' HG2' HG23 ' A' ' 105' ' ' THR . 83.6 mttt -136.21 132.76 36.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.42 125.33 72.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.208 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 79.2 m -88.12 112.4 22.65 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.003 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 71.4 mt -101.61 94.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.338 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.5 m -74.51 158.86 33.05 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 124.782 1.233 . . . . 0.0 107.97 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -58.9 -27.63 65.43 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.069 0.461 . . . . 0.0 112.001 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.68 12.21 9.33 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -105.52 113.52 27.14 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.86 131.81 1.43 Allowed Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.834 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -103.43 19.23 20.12 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.881 0.848 . . . . 0.0 110.131 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 71.7 mt -115.19 177.76 4.54 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.1 p -112.87 -60.62 1.85 Allowed 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.102 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.8 tptm 173.41 -38.58 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 123.881 0.873 . . . . 0.0 108.709 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.04 -44.09 97.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.374 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -63.89 -41.11 97.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.96 -51.11 76.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.132 -1.395 . . . . 0.0 109.902 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.6 -27.04 64.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.078 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 137' ' ' GLU . 21.3 ttm180 -63.79 -39.46 94.31 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 92.9 mmm -68.68 -29.94 68.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.995 0.426 . . . . 0.0 110.602 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.89 -46.14 97.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -63.82 -36.17 83.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.741 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 7.6 mm-40 -61.07 -45.44 94.74 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.9 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.203 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -69.67 -37.51 76.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.942 0.401 . . . . 0.0 110.513 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.66 -42.64 67.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.634 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.537 ' HB3' ' OD1' ' A' ' 145' ' ' ASP . 88.7 m-85 -97.84 15.65 23.16 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.525 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 7.0 tmtt? -48.09 -66.44 0.4 Allowed 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 124.046 0.938 . . . . 0.0 112.729 -173.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.7 87.3 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 10.0 tp10 -64.75 -54.9 24.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.2 m-20 -77.75 -28.81 50.79 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -173.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 66.5 mm-40 -61.75 -42.65 99.25 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.418 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 60.3 t -72.0 -48.52 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.822 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 79.5 mm-40 -54.09 -41.6 68.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -64.58 -39.86 94.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.338 0.59 . . . . 0.0 109.993 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.24 0.8 57.04 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.607 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 27.4 mmm180 -68.45 -36.42 78.98 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 172.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.407 HG12 ' HG2' ' A' ' 155' ' ' LYS . 21.6 t -93.83 83.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.2 m -78.25 142.51 37.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.963 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 45.72 63.37 1.83 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.376 1.47 . . . . 0.0 113.219 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 2.2 pptp? -106.22 77.25 1.21 Allowed 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 123.011 1.386 . . . . 0.0 110.213 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.09 61.94 6.78 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.296 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . . . -146.39 139.16 25.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.862 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.644 HD23 HG22 ' A' ' 21' ' ' THR . 14.0 mt -103.32 151.34 22.84 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.77 144.24 44.71 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.89 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 39.9 m -156.26 -174.64 5.03 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -162.08 156.45 22.06 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 172.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -141.53 162.88 34.41 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -79.03 102.32 8.3 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -122.41 116.6 24.27 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.651 0.739 . . . . 0.0 110.583 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 61.5 mtt -139.13 92.9 2.63 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 65.32 13.79 9.02 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.433 1.093 . . . . 0.0 110.228 -176.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.5 m -74.05 -24.87 59.59 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.361 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -149.71 -176.97 5.62 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.9 t 66.99 89.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 124.194 0.934 . . . . 0.0 111.055 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -123.94 134.14 53.57 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.32 106.14 12.11 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.36 0.6 . . . . 0.0 112.334 -172.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -120.02 -3.36 10.14 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.434 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.41 -175.91 42.35 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 106.153 -2.779 . . . . 0.0 106.153 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 49.8 tp -79.87 115.94 19.74 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 118.688 1.244 . . . . 0.0 109.426 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 77.26 -58.91 0.48 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.562 1.545 . . . . 0.0 111.431 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 178.46 -173.25 45.67 Favored Glycine 0 CA--C 1.486 -1.761 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -83.6 83.12 8.02 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.405 0.602 . . . . 0.0 109.404 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.6 tt -161.21 102.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 122.087 0.946 . . . . 0.0 110.248 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 21.3 t -130.58 83.08 2.09 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -115.07 -13.78 11.84 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.836 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 69.15 170.67 0.3 Allowed 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.763 1.225 . . . . 0.0 111.967 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 185' ' ' LYS . 14.1 p-10 -111.27 115.92 30.14 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.429 0.633 . . . . 0.0 110.542 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -106.37 86.06 2.29 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 57.28 30.29 18.2 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.754 0.659 . . . . 0.0 109.465 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 182' ' ' ASP . 86.6 tttt -78.83 83.31 4.97 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.901 0.857 . . . . 0.0 110.855 -173.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 6.4 p -177.02 -49.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 113.034 -1.894 . . . . 0.0 107.108 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.6 pp -178.57 157.45 0.98 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.229 1.011 . . . . 0.0 110.859 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -140.35 100.1 3.81 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -121.7 149.76 42.76 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -173.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 61.08 20.57 11.03 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -84.99 69.08 10.77 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.258 1.028 . . . . 0.0 109.074 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 57.0 t -133.38 126.85 52.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 9.6 tp -83.54 84.23 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.455 1.121 . . . . 0.0 109.352 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.9 p -101.78 -78.48 0.53 Allowed 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -70.15 -32.59 70.64 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 122.745 0.418 . . . . 0.0 111.594 -174.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 31.8 tp -92.63 145.33 24.51 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -108.39 -11.12 15.23 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.201 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . 72.18 -61.64 0.49 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.657 1.583 . . . . 0.0 113.09 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -125.59 124.17 40.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.2 m -83.58 -54.69 4.76 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.909 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 95.1 mt 66.95 -175.9 0.2 Allowed 'General case' 0 C--O 1.252 1.214 0 C-N-CA 124.416 1.086 . . . . 0.0 113.087 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . 67.1 38.98 3.27 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.532 1.533 . . . . 0.0 112.409 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 205' ' ' LYS . 43.1 tt0 -74.2 98.59 3.2 Favored 'General case' 0 C--O 1.248 0.995 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.01 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.47 ' HG2' ' H ' ' A' ' 206' ' ' ASP . 36.5 ttpt 167.18 -177.23 0.02 OUTLIER 'General case' 0 C--O 1.249 1.051 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.47 ' H ' ' HG2' ' A' ' 205' ' ' LYS . 2.7 p-10 -150.43 169.34 21.7 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -139.73 39.21 2.01 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -128.46 -50.32 1.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.445 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -83.59 -38.07 22.12 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 105.526 -2.028 . . . . 0.0 105.526 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -78.44 99.93 6.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 168.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 211' ' ' LYS . 23.4 tptt -75.02 107.6 7.19 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.783 -171.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -126.25 -28.14 3.14 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.927 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -70.9 -20.83 62.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.269 0.557 . . . . 0.0 110.921 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -111.76 121.91 46.36 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.0 tp -88.54 119.33 28.89 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.805 -174.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.78 136.72 45.51 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -93.01 -41.4 10.01 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -168.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 18.9 m -106.62 157.16 7.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.709 -0.797 . . . . 0.0 112.008 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.01 145.86 98.98 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.133 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.65 97.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.694 2.262 . . . . 0.0 112.092 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 8.8 tp -114.93 -29.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.099 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 59.3 mt -84.2 133.4 29.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.5 t -84.7 84.7 7.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.25 -146.05 17.22 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.3 tt -179.8 -58.88 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -131.05 109.99 10.89 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.229 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -129.79 107.59 9.52 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.933 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -162.71 -97.21 0.12 Allowed Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.061 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -153.8 -33.89 0.11 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.07 0.462 . . . . 0.0 111.658 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 106.02 179.19 23.48 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -142.76 163.4 27.29 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.881 -1.152 . . . . 0.0 112.053 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.79 144.06 57.96 Favored 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.753 2.302 . . . . 0.0 110.5 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 140.65 -63.37 0.53 Allowed Glycine 0 C--N 1.304 -1.238 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.607 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.8 -22.36 29.27 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.906 3.071 . . . . 0.0 115.285 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -78.18 93.16 1.19 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 147.96 -6.53 1.0 Allowed Glycine 0 C--N 1.302 -1.346 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -96.26 -167.02 1.51 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.33 -81.78 1.73 Allowed Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -92.15 78.04 5.23 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 171.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -86.37 131.18 34.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.971 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 85.75 104.52 0.71 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.47 -33.95 59.57 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 123.37 2.713 . . . . 0.0 113.866 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.78 13.93 4.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.536 0.684 . . . . 0.0 109.997 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -84.44 155.76 31.29 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.1 -88.84 0.49 Allowed Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 4.8 p -96.69 96.03 8.34 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.138 0.494 . . . . 0.0 110.84 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -150.9 34.24 0.94 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 13.0 p -86.08 -22.1 27.33 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.108 0.48 . . . . 0.0 111.356 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.72 -142.89 29.45 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.731 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.14 -27.93 13.29 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.484 2.123 . . . . 0.0 112.612 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.8 m 62.03 99.36 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.215 1.006 . . . . 0.0 111.413 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 31.0 pt -78.19 0.37 2.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -72.93 99.89 2.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -86.1 -94.32 0.08 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.282 -170.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.59 -3.19 10.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.997 0.903 . . . . 0.0 109.664 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.365 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.435 -1.221 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 60.94 25.09 15.1 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -78.88 122.31 25.94 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.17 131.76 34.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.114 0.483 . . . . 0.0 110.673 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -83.97 -38.51 20.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.72 147.69 51.37 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 20.7 tp -115.96 102.24 9.48 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.3 pt? -96.44 -13.33 23.22 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -171.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.5 tp -136.33 17.26 3.17 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.762 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.402 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 97.6 mt 57.3 -164.42 0.17 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.087 -174.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.3 61.7 1.12 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.5 -177.42 2.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.879 -1.509 . . . . 0.0 108.621 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.01 118.87 72.45 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.05 -50.53 2.07 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.278 1.985 . . . . 0.0 111.978 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.441 HD11 HG22 ' A' ' 135' ' ' VAL . 6.3 mp -114.61 172.25 7.14 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.488 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 15.2 m -92.5 151.04 20.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.124 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.03 132.0 54.58 Favored 'General case' 0 C--O 1.261 1.669 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.923 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.11 158.1 27.57 Favored Glycine 0 N--CA 1.426 -1.982 0 O-C-N 123.91 0.756 . . . . 0.0 112.656 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.9 151.39 22.16 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -86.12 108.45 18.31 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 171.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 157' ' ' ALA . 18.0 p -107.87 -69.61 0.84 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.286 0.565 . . . . 0.0 111.348 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.26 165.55 11.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.55 -21.05 4.3 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 116.949 1.539 . . . . 0.0 116.949 -171.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.52 33.37 2.15 Favored Glycine 0 CA--C 1.493 -1.341 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.986 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.37 121.5 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.449 0.643 . . . . 0.0 112.12 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.518 ' O ' ' HD2' ' A' ' 149' ' ' ARG . 23.4 ttt -106.31 97.79 7.55 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.9 m -80.35 110.74 16.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.07 119.9 30.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.789 0.328 . . . . 0.0 111.047 -176.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 63.1 mt -104.93 -39.54 6.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.623 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.1 130.4 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -107.19 162.3 14.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 15' ' ' LEU . 63.6 mtt180 -56.69 140.11 48.28 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 123.714 0.634 . . . . 0.0 109.515 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 75.26 10.74 3.57 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.231 1.012 . . . . 0.0 112.786 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -81.91 114.73 20.71 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -60.38 131.75 51.75 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.398 1.079 . . . . 0.0 113.781 -176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 37' ' ' PRO . 36.4 pt -95.4 160.83 29.73 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 24.7 Cg_exo -65.66 126.26 6.39 Favored 'Cis proline' 0 C--N 1.358 1.043 0 CA-C-N 120.291 1.14 . . . . 0.0 113.431 0.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 1.6 p -95.55 149.13 21.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.443 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' PHE . 37.7 tttp -154.02 99.5 2.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' THR . 5.5 tp-100 -107.15 140.12 40.5 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 81.5 m -139.83 116.41 10.75 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HG3' HD22 ' A' ' 29' ' ' LEU . 86.5 mm-40 -128.61 144.17 51.1 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.22 118.83 41.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 123.669 0.606 . . . . 0.0 109.535 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.05 169.19 8.64 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.915 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 157' ' ' ALA . 33.1 p -134.24 171.63 13.98 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.469 ' HB ' ' OG ' ' A' ' 48' ' ' SER . 27.7 p -99.86 139.62 35.25 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.484 176.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 27.6 m-85 -85.03 -11.72 54.75 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 46' ' ' THR . 29.5 p -83.75 142.27 30.82 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.905 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.0 124.01 51.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 66.32 61.43 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.693 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.517 ' H ' ' NE2' ' A' ' 51' ' ' GLN . 0.5 OUTLIER -101.3 123.11 45.87 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -85.41 -15.96 5.02 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.821 1.681 . . . . 0.0 111.132 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.59 164.64 36.92 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.5 m -143.43 179.41 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.1 tp -132.37 132.37 42.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.55 123.26 71.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 120.851 0.358 . . . . 0.0 111.52 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -114.82 129.76 56.75 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.4 123.49 64.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.58 142.97 43.2 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.248 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -111.52 121.23 44.61 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.57 125.33 5.6 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -172.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HG3' ' HB2' ' A' ' 16' ' ' SER . 3.8 mp0 -79.0 139.03 38.28 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 36.2 mmt180 -139.45 156.86 46.69 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 114.192 -1.367 . . . . 0.0 107.542 172.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.599 ' HA ' ' HB2' ' A' ' 149' ' ' ARG . . . -78.22 -49.87 12.96 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 92.7 mmm -105.55 122.05 45.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.13 102.08 0.1 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -174.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 56.3 pttt 179.41 -177.44 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.174 1.389 . . . . 0.0 107.549 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.98 -45.46 0.6 Allowed 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.44 1.496 . . . . 0.0 114.921 172.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.582 ' ND2' ' HG2' ' A' ' 63' ' ' ARG 0.259 85.8 m-20 -86.17 -166.19 1.47 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -88.69 112.63 23.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.994 0.902 . . . . 0.0 111.724 -167.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.7 108.24 13.1 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.204 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 95.1 mt -73.57 -55.19 6.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.193 0.521 . . . . 0.0 109.96 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.89 159.07 27.99 Favored Glycine 0 N--CA 1.413 -2.887 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.966 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.29 135.22 21.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.76 168.3 24.81 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.58 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.75 144.21 25.62 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.6 tp -131.07 103.66 6.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -132.96 165.87 23.69 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 120.573 0.225 . . . . 0.0 111.04 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.07 4.95 56.47 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.78 134.39 86.02 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 37.5 Cg_exo -59.99 133.87 53.05 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.975 1.784 . . . . 0.0 109.796 177.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 22.5 Cg_exo -67.5 63.64 0.8 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 123.103 2.535 . . . . 0.0 111.974 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.24 153.51 39.01 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.602 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -61.36 177.9 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.459 2.773 . . . . 0.0 114.914 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -57.61 131.39 50.08 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.469 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 75.4 20.77 78.49 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.69 176.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.0 -49.69 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.47 116.13 4.58 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.535 1.49 . . . . 0.0 111.343 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -87.42 112.1 21.81 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.7 mm -98.82 115.94 40.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.73 112.76 24.66 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 41' ' ' THR . 96.0 t -106.07 124.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 32.5 m -124.45 128.32 48.83 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.855 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 39' ' ' LYS . 34.7 m-85 -112.63 136.62 51.98 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 8.0 t70 -142.31 127.11 18.15 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 63.1 mt -124.15 126.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -89.13 -170.65 2.96 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.33 63.42 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.452 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 9.1 t30 -84.61 -29.77 25.5 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.274 0.559 . . . . 0.0 110.242 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.3 28.48 4.62 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 96' ' ' ILE . 77.4 mt -86.89 116.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 49.0 tp -96.12 120.1 35.8 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 3.1 t-20 -105.08 105.21 15.15 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 38.8 t -92.12 120.48 41.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 174.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.5 m -126.99 122.87 35.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.69 117.17 29.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.1 m -115.75 127.73 55.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.145 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -83.04 107.38 15.59 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -68.23 -12.27 60.71 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 m -70.98 -54.56 10.82 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 113' ' ' LYS . 35.7 p -86.59 -48.82 8.0 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.438 0.637 . . . . 0.0 111.14 177.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 110.05 5.5 28.76 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.475 ' HG2' ' OG1' ' A' ' 111' ' ' THR . 14.2 ptmm? -92.31 152.5 19.75 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.49 162.68 38.57 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.337 0.589 . . . . 0.0 112.281 -174.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -129.42 128.06 42.2 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.09 173.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 19.6 ptpt -132.97 149.53 52.23 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.452 -178.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.4 pt -129.81 151.04 35.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.2 m -117.47 113.11 21.56 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.25 103.13 14.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.0 t -84.93 109.4 18.12 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.4 t30 79.48 119.57 0.05 Allowed 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.884 1.274 . . . . 0.0 111.413 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.87 -27.66 68.38 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.303 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -87.9 22.83 2.22 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.529 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.8 9.85 74.74 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 72' ' ' LEU . 37.6 mmt180 -128.72 147.35 50.76 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 124.69 1.196 . . . . 0.0 108.008 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 78.7 mt 53.29 -125.17 2.35 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.099 0.96 . . . . 0.0 112.431 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.0 p -150.71 158.46 44.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 63.1 tttm -66.74 -30.24 70.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.53 -45.8 92.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.448 0.699 . . . . 0.0 109.409 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 134' ' ' MET . 14.7 mm-40 -61.2 -46.49 90.24 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.694 175.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 135' ' ' VAL . 82.5 mt -60.14 -42.98 91.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 128' ' ' LYS . 67.4 mt-10 -63.25 -32.38 73.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.702 0.287 . . . . 0.0 110.923 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 44.7 mtp180 -64.03 -43.78 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.036 174.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 52.7 mtt -65.08 -35.27 80.63 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.006 -178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 131' ' ' ILE . 86.1 t -55.54 -52.13 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 132' ' ' GLU . 69.8 mm-40 -65.18 -52.26 55.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.755 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.67 -51.05 71.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 142' ' ' LYS . . . -67.78 -30.73 70.24 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.425 ' HA ' ' HG2' ' A' ' 142' ' ' LYS . 39.3 mt-10 -77.6 -34.96 53.32 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.548 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.96 -43.7 74.45 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.7 20.72 7.17 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.468 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 146' ' ' GLU . 24.4 mmtt -53.3 -58.09 8.27 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -56.56 -44.81 81.33 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.443 0.464 . . . . 0.0 111.327 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.67 -48.58 71.59 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.794 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.43 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 1.2 m-20 -72.61 -36.88 68.18 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 56.4 mm-40 -60.43 -42.5 96.18 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.838 0.29 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.676 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 88.0 t -67.24 -49.72 69.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.409 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -63.75 -43.95 94.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.599 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 40.0 ttp180 -62.84 -48.57 78.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.419 0.628 . . . . 0.0 110.319 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 153' ' ' SER . 7.1 mm-40 -79.3 -0.28 31.75 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.476 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 21.5 mmt180 -84.23 -35.46 23.43 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.96 -38.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 26.3 t -66.84 103.23 1.08 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -102.79 -27.48 12.66 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.215 0.531 . . . . 0.0 110.961 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -161.36 154.56 21.23 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -74.85 86.54 2.24 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.384 0.611 . . . . 0.0 109.405 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 45' ' ' THR . . . -144.57 149.02 35.11 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.275 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 mp -109.15 149.23 29.65 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.56 156.72 19.2 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.2 p -79.42 113.74 17.8 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.241 0.544 . . . . 0.0 111.824 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -93.57 149.48 21.19 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.039 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -86.41 154.94 20.8 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -94.27 133.51 37.72 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -81.09 159.68 24.67 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.278 0.561 . . . . 0.0 110.567 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.2 ptp -133.93 176.51 8.51 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 166' ' ' LYS . 9.0 mmpt? -116.75 -179.76 3.78 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.5 m -53.65 125.2 17.42 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 123.46 0.475 . . . . 0.0 110.083 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.03 -5.45 59.11 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -172.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 64.6 t 76.33 110.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.072 0.949 . . . . 0.0 109.054 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -97.72 -35.64 10.5 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.337 -170.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -120.85 121.16 37.52 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -137.67 95.4 3.05 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.36 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.79 139.45 10.62 Favored Glycine 0 C--N 1.311 -0.843 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.141 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 174' ' ' LEU . 1.7 pt? -123.86 101.21 7.14 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.42 0.628 . . . . 0.0 109.315 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.2 -64.51 1.03 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.54 -174.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.53 152.57 22.11 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -96.92 79.75 2.94 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 117.921 0.861 . . . . 0.0 111.804 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.4 mp -81.37 93.69 2.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 15.9 m -118.63 -37.21 3.32 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 52.24 46.87 25.88 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.152 1.781 . . . . 0.0 111.71 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.79 80.16 8.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.782 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.412 ' OD1' ' HG3' ' A' ' 183' ' ' LYS . 4.0 p30 -76.74 -52.84 8.84 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -173.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 182' ' ' ASP . 97.2 mttt -100.96 15.38 28.82 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 121.771 -0.581 . . . . 0.0 112.345 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.637 ' HE2' ' HA ' ' A' ' 184' ' ' LYS . 8.6 mmpt? -79.52 0.45 29.68 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.411 0.624 . . . . 0.0 111.612 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -84.26 68.45 10.18 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 171.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.35 101.5 2.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -170.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.1 73.9 0.89 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.57 118.89 31.94 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt 56.98 74.94 0.39 Allowed 'General case' 0 C--O 1.245 0.86 0 O-C-N 124.427 1.08 . . . . 0.0 109.572 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SMC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -76.09 96.78 3.91 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -65.39 -66.09 0.59 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.635 -177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.9 p 51.91 26.76 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 125.876 1.671 . . . . 0.0 111.056 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 75.8 mt -83.64 86.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 44.8 m -142.0 91.38 2.34 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.226 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -127.73 89.47 2.95 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -158.0 89.12 0.99 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -98.62 94.18 6.52 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.817 0.818 . . . . 0.0 111.165 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -99.57 -24.61 14.69 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 171.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 65.86 -75.72 0.05 OUTLIER 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 125.863 1.665 . . . . 0.0 112.009 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 20.8 p -144.07 94.83 2.63 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 62.4 mt -126.55 85.96 2.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.495 0.664 . . . . 0.0 112.77 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -82.76 109.33 16.82 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -139.95 116.81 10.97 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.009 -171.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -117.47 96.92 5.62 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.05 -23.79 67.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.427 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.66 77.96 0.29 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.823 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -84.62 103.12 13.46 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 169.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -51.36 118.5 3.33 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 124.328 1.017 . . . . 0.0 111.929 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -94.46 104.92 16.88 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.079 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -71.6 135.6 47.03 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -156.56 132.2 9.5 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.131 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.464 ' HD3' ' H ' ' A' ' 213' ' ' LYS . 0.3 OUTLIER -116.31 113.64 23.25 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 171.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -94.38 113.4 25.28 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.14 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.28 112.85 25.47 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -83.69 -57.96 3.01 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 63.96 161.25 0.11 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.179 1.392 . . . . 0.0 112.161 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.3 m -106.45 161.86 5.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.197 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' SMC . . . . . 0.496 ' O ' ' HD3' ' A' ' 221' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -108.78 95.31 16.49 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 219' ' ' SMC . 3.3 Cg_exo -78.64 121.28 5.05 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.37 2.046 . . . . 0.0 110.933 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.6 tp -84.36 -33.32 8.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 32.2 pt 51.84 176.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 127.235 2.214 . . . . 0.0 115.441 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 13.2 t 66.78 84.82 0.15 Allowed 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.335 1.454 . . . . 0.0 111.232 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -111.06 5.52 28.84 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.023 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 226' ' ' LEU . 2.4 pt? -89.19 116.63 27.58 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -111.67 -9.1 14.16 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 70.93 -62.97 0.43 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.721 1.608 . . . . 0.0 112.87 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 112.81 164.54 16.3 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.93 155.97 23.81 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 160.35 -172.28 36.74 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -151.64 159.13 28.12 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.09 162.01 23.32 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.719 2.279 . . . . 0.0 112.436 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 235' ' ' PRO . . . -91.41 124.31 7.54 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 234' ' ' GLY . 6.2 Cg_endo -87.02 -3.68 7.99 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.528 2.152 . . . . 0.0 113.432 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 129.35 -178.01 17.63 Favored Glycine 0 C--N 1.306 -1.125 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -95.55 -146.36 20.69 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.103 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.94 -39.2 43.47 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.381 0.61 . . . . 0.0 109.736 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 110.96 109.12 3.12 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.022 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -86.5 93.37 9.14 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -149.43 111.54 4.63 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.806 -173.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.15 111.49 0.49 Allowed Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -50.58 138.07 40.31 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 123.492 2.795 . . . . 0.0 113.36 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -104.59 110.26 22.49 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -88.17 -25.17 32.1 Favored Glycine 0 C--N 1.307 -1.042 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 99.71 170.48 30.15 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.8 t -78.61 95.29 5.2 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -75.93 108.03 2.46 Favored Glycine 0 CA--C 1.498 -1.026 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 23.1 t -151.87 143.29 23.44 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -137.9 86.63 0.22 Allowed Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.14 97.97 0.52 Allowed 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 122.67 2.247 . . . . 0.0 111.848 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 5.3 m -87.31 -32.93 19.41 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 65.3 mt 68.54 99.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.505 1.122 . . . . 0.0 111.299 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -114.99 -4.33 12.56 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.087 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.02 139.92 49.78 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 16.0 m -82.88 88.06 2.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.943 0.878 . . . . 0.0 110.443 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--N 1.301 -1.504 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.206 -177.221 . . . . . . . . 0 0 . 1 stop_ save_